data_1vve_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1vve _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 022 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.306 0.574 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.59 173.45 11.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.489 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.525 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -127.0 108.61 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 0.0 110.458 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.533 ' NE2' ' CE1' ' A' ' 20' ' ' PHE . 9.2 mm100 -87.68 174.81 8.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.2 p -43.01 139.97 2.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.891 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.596 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 46.6 Cg_endo -69.59 161.04 47.46 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.083 1.57 . . . . 0.0 111.031 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.86 171.95 16.84 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.089 1.573 . . . . 0.0 109.938 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -73.01 176.47 5.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.051 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.555 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -169.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.175 0.988 . . . . 0.0 111.369 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -52.56 96.41 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.74 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 10' ' ' SER . 8.4 m120 40.63 61.78 1.55 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.453 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.5 161.99 32.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.6 mtt85 -105.88 -176.82 3.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -1.148 . . . . 0.0 109.808 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.62 -176.28 5.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.933 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 1.3 t30 66.52 136.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.065 -1.022 . . . . 0.0 109.905 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.86 -60.43 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 4.0 t80 -151.46 35.85 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -1.089 . . . . 0.0 110.116 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -145.09 -162.74 1.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 1.3 p30 -147.57 -38.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 109.879 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.609 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 3.2 m-85 -93.62 -162.05 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.609 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER 171.89 -16.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.531 -0.73 . . . . 0.0 110.996 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.525 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 7.0 p 47.73 -95.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 112.311 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -152.16 161.75 42.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.788 -1.195 . . . . 0.0 110.428 -178.46 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.85 19.9 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 6.6 m -105.14 178.04 4.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.54 -0.976 . . . . 0.0 110.566 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.497 HG11 ' N ' ' A' ' 27' ' ' VAL . 24.7 t -151.8 156.35 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.103 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' CD1' ' A' ' 29' ' ' TYR . 15.0 t -135.09 117.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.572 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.95 103.28 5.1 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.341 -1.343 . . . . 0.0 107.928 178.113 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.619 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.24 128.09 35.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 110.05 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -82.96 157.81 22.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.577 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 35.5 m -123.28 155.17 37.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -47.94 160.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 33' ' ' SER . 12.3 p -59.98 105.16 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.475 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.53 -3.24 29.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -94.32 131.49 39.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -1.193 . . . . 0.0 110.422 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.592 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -81.39 140.14 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -90.38 99.71 12.68 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.51 HG21 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.5 162.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.185 -0.947 . . . . 0.0 109.078 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.99 171.85 47.9 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -45.96 129.04 9.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -1.159 . . . . 0.0 109.997 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 28' ' ' THR . 0.0 OUTLIER -74.01 53.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.476 -179.666 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 162.23 119.51 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.8 t -60.24 -175.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.022 -1.281 . . . . 0.0 108.051 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.2 tp -146.48 97.49 2.93 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.4 OUTLIER -84.9 108.79 17.72 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.217 178.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.8 m -126.84 82.02 2.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.554 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.82 43.57 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.408 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 64.51 11.07 46.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -132.14 120.94 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -1.203 . . . . 0.0 110.28 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.6 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 80.8 m95 -76.36 138.75 40.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 0.0 109.742 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -141.41 158.06 44.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.992 . . . . 0.0 111.129 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 62.62 65.28 1.5 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 111.381 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.8 Cg_endo -91.2 133.61 1.59 Allowed 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 124.275 1.671 . . . . 0.0 110.215 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 51.3 Cg_endo -82.55 177.2 7.17 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.929 1.489 . . . . 0.0 110.34 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 17.8 p -112.04 162.17 15.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 111.528 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 m -129.21 77.1 1.77 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 177.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.55 -170.24 1.69 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.366 0.603 . . . . 0.0 110.32 -178.26 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.03 146.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.677 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 16.4 m -134.23 41.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.916 -1.115 . . . . 0.0 110.999 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 8.2 mtpt -81.02 98.82 8.13 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.931 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 37.4 m -70.22 165.94 38.91 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.589 -0.695 . . . . 0.0 111.387 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 50.6 Cg_endo -75.43 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.315 1.692 . . . . 0.0 110.659 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.482 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -153.78 131.67 6.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.89 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.602 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 54.3 Cg_endo -76.12 66.22 6.98 Favored 'Trans proline' 0 C--N 1.295 -2.254 0 O-C-N 123.595 1.313 . . . . 0.0 109.476 -179.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -87.97 175.46 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.531 -0.731 . . . . 0.0 110.686 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -178.26 161.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.0 t -72.11 111.67 7.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.0 110.864 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 61.5 m-20 36.53 49.14 0.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.641 -0.662 . . . . 0.0 111.325 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' A' ' 66' ' ' ILE . . . -159.42 23.76 0.3 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.518 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.8 p90 -36.41 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.953 1.359 . . . . 0.0 112.718 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -49.14 -70.59 0.08 Allowed 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.835 178.038 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER 79.96 10.05 1.34 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.41 -0.806 . . . . 0.0 109.891 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 t -114.34 -44.75 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.541 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -178.67 100.2 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.61 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -109.03 172.41 6.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -1.07 . . . . 0.0 109.742 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -158.89 161.08 36.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.543 -179.741 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -54.06 -37.47 64.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.772 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 m -144.02 163.31 33.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.538 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.9 m-85 -135.68 -179.2 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 17.3 p -163.06 111.9 1.3 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.042 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.644 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 18.2 t80 30.97 38.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.515 -0.741 . . . . 0.0 111.592 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 103' ' ' CYS . 30.6 t30 -176.48 -140.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.444 -1.41 . . . . 0.0 110.995 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 74.3 m-20 55.26 66.53 1.2 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.917 -1.115 . . . . 0.0 108.987 -178.323 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.54 ' N ' HG21 ' A' ' 102' ' ' THR . 25.0 t30 -70.65 97.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 34.9 m -86.15 131.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.172 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -88.56 131.04 35.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.867 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 20.4 m-85 -88.66 125.45 34.84 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.53 1.157 . . . . 0.0 112.758 -177.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -104.97 108.63 20.24 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.116 -179.473 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.456 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -60.68 133.99 56.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.766 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -44.61 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 110.241 -179.544 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.594 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.0 p90 -148.93 149.31 31.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 111.007 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 42.9 36.9 2.71 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 17.3 m-85 -139.38 149.43 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -1.087 . . . . 0.0 110.213 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.501 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.44 139.93 46.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.209 179.9 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 23.5 mt -75.6 102.97 5.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.495 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -80.15 95.32 6.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.324 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.24 -85.93 0.16 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.553 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -157.12 125.5 5.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -1.152 . . . . 0.0 110.554 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.3 p -86.19 25.08 1.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.83 . . . . 0.0 110.882 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.4 p -169.89 106.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.494 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 1.7 m -127.48 164.84 21.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.046 0.927 . . . . 0.0 110.924 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.541 ' CG2' ' C ' ' A' ' 82' ' ' ASN . 26.8 m -139.79 139.4 36.41 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.962 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.558 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 11.8 t -49.52 94.4 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.671 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -66.62 174.12 2.02 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.934 -1.104 . . . . 0.0 112.366 -178.095 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.677 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 49.6 Cg_endo -79.44 14.33 1.83 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.635 1.86 . . . . 0.0 111.809 -178.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -116.31 18.72 13.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 106' ' ' GLY . 10.2 t-20 67.32 54.5 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.591 -0.947 . . . . 0.0 110.263 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.472 ' HA ' ' CD ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -167.19 -176.88 3.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 110.741 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.602 ' NE1' ' N ' ' A' ' 64' ' ' PRO . 46.6 m95 -105.97 98.84 8.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.415 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -105.73 141.99 23.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.214 -179.575 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.553 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.2 Cg_endo -71.78 174.8 45.13 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.888 -0.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.5 mm-40 -38.38 142.34 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 111.14 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.538 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -60.75 141.21 92.82 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.975 179.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 42.9 Cg_endo -73.13 155.59 52.07 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 124.302 1.685 . . . . 0.0 111.226 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.6 ttpt -120.17 101.91 8.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.371 -0.83 . . . . 0.0 110.09 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -54.66 103.19 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.094 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -112.71 178.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.633 0.73 . . . . 0.0 110.823 -179.145 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.508 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 6.4 ptt85 . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.443 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -130.09 178.23 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 110.059 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.582 ' SG ' ' CZ2' ' A' ' 50' ' ' TRP . 2.8 t -160.08 97.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.527 -0.733 . . . . 0.0 110.259 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 pm0 -80.26 -175.26 4.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.1 p -45.26 142.57 2.98 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.473 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.607 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 45.8 Cg_endo -69.76 157.57 59.93 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.992 1.522 . . . . 0.0 111.261 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.27 173.25 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.971 1.511 . . . . 0.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.68 177.95 4.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.293 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.545 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.85 -170.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.24 1.019 . . . . 0.0 111.722 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 9' ' ' ILE . 25.4 m -38.32 92.48 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.004 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.8 m-20 40.28 34.82 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.338 -0.851 . . . . 0.0 110.78 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.91 12.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -139.7 179.01 6.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.379 -1.071 . . . . 0.0 109.957 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.607 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -137.78 114.23 10.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 110.338 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.72 122.81 21.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.42 -111.41 2.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -157.09 29.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 110.113 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 1.6 pm0 -162.99 173.62 13.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -102.26 -51.08 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.936 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -100.41 139.66 35.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.967 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.564 ' CE1' ' HG3' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -120.01 -11.96 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.641 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 21.1 p 51.14 -99.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.556 -0.715 . . . . 0.0 111.694 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -147.95 163.34 37.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.053 -1.029 . . . . 0.0 110.575 -178.579 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.47 25.31 68.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.561 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -107.04 -179.62 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.819 . . . . 0.0 110.201 -179.281 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 24.3 t -155.04 155.48 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.589 HG13 ' CD1' ' A' ' 29' ' ' TYR . 17.2 t -140.51 116.21 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.655 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.444 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -70.49 103.84 2.59 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.374 -1.33 . . . . 0.0 107.851 178.064 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.657 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.8 m-30 -68.28 135.01 51.26 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.327 -178.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.524 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 4.4 t -90.25 -172.36 3.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.385 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.446 ' N ' ' OG ' ' A' ' 30' ' ' SER . 85.9 m -149.33 159.9 43.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.077 -1.014 . . . . 0.0 110.226 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.541 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 76.0 m-20 -46.04 139.51 4.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.937 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.51 109.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.16 17.62 10.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.541 ' CD2' ' HB2' ' A' ' 32' ' ' ASN . 3.2 m-85 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.017 -1.284 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.56 ' CB ' HG23 ' A' ' 59' ' ' VAL . 66.3 m -92.17 133.16 36.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 111.027 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 5.3 tp -88.17 116.17 26.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.37 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -109.26 157.62 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.086 -1.009 . . . . 0.0 109.815 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.52 -169.37 18.27 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -58.61 119.24 6.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.045 -1.268 . . . . 0.0 109.51 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.1 p -68.45 58.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.588 179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 40' ' ' ASN . . . 155.96 115.22 0.5 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.657 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.9 t -61.52 -175.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.214 . . . . 0.0 108.212 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.7 tp -144.06 101.38 3.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.189 -0.944 . . . . 0.0 110.115 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.584 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 1.1 t -85.22 108.42 17.73 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.72 179.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -129.31 103.68 7.07 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.211 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 79.43 52.79 4.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.83 50.12 8.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.56 73.42 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -1.051 . . . . 0.0 110.446 -179.854 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.584 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 68.8 m95 -46.21 131.72 10.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.562 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 5.9 m -142.65 168.98 18.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 111.099 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 11.7 m-20 59.95 66.34 2.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.687 -0.633 . . . . 0.0 111.111 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -90.8 130.22 1.47 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 124.366 1.719 . . . . 0.0 110.335 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.557 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 55.6 Cg_endo -79.34 -176.24 3.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.838 1.441 . . . . 0.0 110.534 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 11.0 p -112.1 -169.42 1.47 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.997 0.903 . . . . 0.0 111.634 -178.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 36' ' ' SER . 67.9 m -152.03 86.72 1.31 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.542 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -117.8 -143.39 0.37 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.778 -177.845 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.549 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -134.43 100.5 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.686 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 30.8 m -101.19 70.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 112.587 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 27.9 mtpt -65.52 -170.86 0.07 Allowed 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 117.239 -1.785 . . . . 0.0 107.989 178.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 m -143.9 159.8 52.12 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.292 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 46.0 Cg_endo -85.31 -79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 124.783 1.938 . . . . 0.0 110.558 179.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 171.63 128.6 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.691 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 53.2 Cg_endo -80.27 66.36 8.82 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.8 1.421 . . . . 0.0 109.783 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.518 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 1.2 p -84.25 -171.49 3.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.349 -0.844 . . . . 0.0 109.698 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.543 ' CG1' ' N ' ' A' ' 67' ' ' SER . 0.2 OUTLIER 172.44 170.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.298 179.035 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.543 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 69.5 m -77.0 107.4 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.155 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 5.7 m-80 38.56 65.92 0.57 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.496 ' C ' ' CD1' ' A' ' 70' ' ' TYR . . . -155.53 -37.98 0.02 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 43.5 p90 35.14 -155.78 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.591 1.186 . . . . 0.0 112.265 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.59 HD22 ' CE2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -155.13 126.89 7.49 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.696 -175.486 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.6 t -100.53 15.92 26.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 86' ' ' ASP . 2.8 m -80.66 -92.3 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 111.258 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.16 88.19 0.18 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -95.76 165.87 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.612 -179.336 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.577 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 5.4 tttt -164.25 156.12 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.459 -0.775 . . . . 0.0 109.756 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -30.47 59.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 0.0 110.45 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.9 p -143.95 138.24 28.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.607 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 25.0 m-85 -114.51 -140.77 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.509 ' C ' HG22 ' A' ' 59' ' ' VAL . 82.7 p -162.7 -123.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.878 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -105.27 27.3 8.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.841 -1.162 . . . . 0.0 111.089 -178.276 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 103' ' ' CYS . 45.8 t-20 -164.98 -110.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.942 -1.099 . . . . 0.0 110.285 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 0.2 OUTLIER 48.86 71.82 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.661 -1.274 . . . . 0.0 109.101 -179.252 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.3 t-20 -68.86 109.44 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.574 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 27.7 m -99.36 120.63 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 0.0 111.242 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 23.7 t70 -78.88 135.42 37.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.182 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.59 ' CE2' HD22 ' A' ' 71' ' ' LEU . 13.1 m-85 -90.85 133.29 35.34 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.651 -1.281 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.36 81.94 2.12 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.777 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -40.48 126.74 2.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.55 -0.719 . . . . 0.0 110.745 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 17.2 mtpt -66.56 143.12 57.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 109.506 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.49 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.29 53.47 1.86 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CE2' ' HD2' ' A' ' 118' ' ' ARG . 3.2 m-85 -102.29 155.4 18.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -1.035 . . . . 0.0 109.251 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -101.24 146.82 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.637 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.525 HD23 ' CG ' ' A' ' 114' ' ' PRO . 1.4 mt -87.64 90.84 8.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.87 -1.144 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 t -72.48 98.83 2.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.312 -0.868 . . . . 0.0 109.846 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 139.74 -41.38 1.32 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.608 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 98.2 p -178.41 -166.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.166 -1.196 . . . . 0.0 111.386 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.23 -39.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.577 0.703 . . . . 0.0 109.174 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 37.2 p -123.9 91.96 3.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' HG21 ' A' ' 85' ' ' VAL . 24.2 m -103.25 146.3 28.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 111.226 -178.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -117.78 136.86 53.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.688 0.756 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.561 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -65.73 92.06 0.14 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 110.375 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.476 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -64.82 173.59 1.6 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.484 -0.76 . . . . 0.0 111.012 -179.664 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.686 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.3 Cg_endo -76.22 125.06 8.26 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.381 1.727 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.71 -3.91 8.06 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 9.3 m-80 80.75 94.01 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.881 -0.776 . . . . 0.0 110.428 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.419 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.6 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.801 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.592 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 26.1 m95 -153.99 90.21 1.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.435 -0.791 . . . . 0.0 110.403 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.8 mtpp -96.15 141.62 23.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 110.284 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.47 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.6 Cg_endo -72.48 170.38 68.29 Favored 'Cis proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.915 -2.119 . . . . 0.0 110.559 -0.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' LEU . 11.9 pt-20 -40.58 131.43 2.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.387 -0.821 . . . . 0.0 110.427 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -41.27 142.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 0.0 110.03 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.525 ' CG ' HD23 ' A' ' 95' ' ' LEU . 46.4 Cg_endo -77.45 170.26 19.67 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.447 1.761 . . . . 0.0 111.616 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -126.37 113.2 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.603 -0.685 . . . . 0.0 110.157 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.552 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.7 t -67.72 108.57 2.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.96 . . . . 0.0 109.051 179.353 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -117.41 -179.61 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.622 0.725 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.585 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.952 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.245 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' ' 2' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.122 0.486 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.414 ' N ' HG21 ' A' ' 1' ' ' VAL . 18.0 ptmt -146.12 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.659 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 3.9 t -147.9 105.26 3.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.757 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -88.95 -179.11 5.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.342 -179.908 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -44.58 140.14 3.28 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.378 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.599 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 55.3 Cg_endo -71.31 168.2 24.1 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.031 1.543 . . . . 0.0 110.781 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.43 -178.46 2.61 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.81 1.426 . . . . 0.0 108.457 178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -82.32 45.32 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.843 -1.161 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.665 HG13 ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER 39.08 -170.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 122.204 1.002 . . . . 0.0 110.618 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.665 ' N ' HG13 ' A' ' 9' ' ' ILE . 47.4 m -102.11 112.06 24.58 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.75 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 74.64 38.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.612 -0.68 . . . . 0.0 110.393 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' HA3' HD12 ' A' ' 9' ' ' ILE . . . -179.03 -155.5 14.95 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -137.36 -171.61 3.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -1.208 . . . . 0.0 110.987 -179.621 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 9.6 p80 -145.0 153.91 41.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.164 0.506 . . . . 0.0 110.097 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -152.68 -87.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.22 -109.07 3.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -178.18 48.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -1.16 . . . . 0.0 110.327 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 176.25 -165.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.463 179.909 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.02 -48.29 1.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.845 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -92.07 139.11 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.643 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.6 OUTLIER -130.63 -13.87 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 111.262 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.563 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 17.4 p 44.51 -98.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 111.435 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -147.4 158.29 43.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.072 . . . . 0.0 110.154 -178.764 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.27 21.34 79.35 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.643 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 8.1 m -106.75 176.91 5.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.643 -0.916 . . . . 0.0 110.329 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.556 HG11 ' N ' ' A' ' 27' ' ' VAL . 42.8 t -151.25 152.24 11.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.486 -0.759 . . . . 0.0 109.864 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.591 HG13 ' CD1' ' A' ' 29' ' ' TYR . 12.7 t -130.82 121.95 51.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.997 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.31 102.33 5.04 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.848 177.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.4 m-30 -68.49 151.73 46.38 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 110.665 -178.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.412 ' C ' ' SG ' ' A' ' 31' ' ' CYS . 1.2 p -114.53 175.72 5.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.43 -0.794 . . . . 0.0 109.526 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 11.2 m -142.91 154.11 43.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 22.2 m-80 -43.59 157.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.16 115.65 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.266 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.68 10.48 35.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-85 -106.65 138.94 41.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -1.183 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.575 ' CB ' HG23 ' A' ' 59' ' ' VAL . 70.6 m -89.16 117.52 28.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 110.695 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.471 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 3.2 tp -79.6 119.37 22.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -0.956 . . . . 0.0 109.613 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.568 HG21 ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -111.88 170.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.145 179.522 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.61 44.08 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 9.7 p30 -57.81 142.22 46.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.092 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 28' ' ' THR . 25.6 p -85.6 56.95 4.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 159.23 106.57 0.22 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.639 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.7 t -53.8 -175.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.011 -1.287 . . . . 0.0 108.547 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.4 tp -144.92 99.17 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 110.197 178.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -83.11 118.6 23.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -0.984 . . . . 0.0 109.744 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.463 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -123.87 69.94 1.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 110.481 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' HB2' ' A' ' 23' ' ' ASP . . . 101.23 50.47 1.23 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 19.64 57.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.86 71.19 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.146 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 83.5 m95 -46.18 133.85 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.136 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 p -143.96 160.99 39.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.532 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 61.44 65.17 1.9 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 111.192 179.516 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.37 134.86 1.37 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.361 1.716 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.9 Cg_endo -76.55 -176.17 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.821 1.432 . . . . 0.0 109.929 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.514 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.8 p -115.83 -178.12 3.32 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.276 1.036 . . . . 0.0 112.094 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.497 ' SG ' ' CD1' ' A' ' 9' ' ' ILE . 55.5 m -148.07 74.76 1.31 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.99 -167.13 1.15 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.485 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.19 105.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -0.852 . . . . 0.0 109.379 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.575 HG23 ' CB ' ' A' ' 36' ' ' SER . 32.8 m -95.78 67.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 111.674 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mptp? -68.87 174.86 4.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.354 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.76 161.86 60.93 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 118.43 -1.308 . . . . 0.0 113.565 -177.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.2 Cg_endo -81.26 -82.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.832 1.964 . . . . 0.0 110.054 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.58 131.93 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.0 110.295 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.619 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.0 Cg_endo -86.79 88.09 0.71 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.739 1.389 . . . . 0.0 108.615 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.575 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.3 p -108.77 -42.0 4.62 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.364 1.078 . . . . 0.0 110.554 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.652 HG23 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 49.91 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.6 -178.867 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.499 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -70.45 108.4 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.617 -0.677 . . . . 0.0 111.696 -178.481 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.473 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 4.4 m-80 39.05 38.13 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.641 -0.662 . . . . 0.0 111.381 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -118.43 -40.81 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.236 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.592 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 1.0 OUTLIER 40.57 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.942 1.353 . . . . 0.0 112.259 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -138.5 159.15 42.79 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.246 -179.002 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 t -134.65 29.09 3.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.301 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.491 ' HB2' ' CB ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -108.14 -72.32 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 0.0 110.805 -179.53 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -143.47 85.69 0.19 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -112.38 167.67 10.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.405 -1.056 . . . . 0.0 110.232 -179.631 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 tttm -165.79 164.46 18.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -62.57 -22.39 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.25 152.38 37.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 110.588 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.599 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 17.0 m-85 -133.23 -146.32 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.301 -0.874 . . . . 0.0 110.069 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.499 ' C ' HG22 ' A' ' 59' ' ' VAL . 90.5 p -165.32 -120.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -105.11 36.86 2.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.016 -178.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 103' ' ' CYS . 10.0 p30 -176.2 -114.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.907 -1.121 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 43.95 79.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.816 -1.178 . . . . 0.0 109.567 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 20.7 p30 -69.2 137.8 53.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 0.0 110.706 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.48 HG12 ' CH2' ' A' ' 109' ' ' TRP . 29.8 m -119.97 118.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.34 -0.85 . . . . 0.0 110.56 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.4 t0 -83.33 123.49 29.69 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.652 ' CD1' HG23 ' A' ' 66' ' ' ILE . 56.9 m-85 -82.27 139.52 34.15 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.278 1.037 . . . . 0.0 113.048 -177.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -116.19 86.12 2.43 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.248 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -38.64 126.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 -179.203 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 1.4 mmtt -38.55 -92.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.552 -0.717 . . . . 0.0 111.038 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -146.92 150.31 34.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.004 -1.06 . . . . 0.0 111.034 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 40.94 33.65 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 19.6 m-85 -134.92 148.25 50.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -1.026 . . . . 0.0 109.975 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 3.7 tttt -108.23 151.29 26.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 109.987 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 10.4 mt -89.22 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -76.49 103.64 6.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 179.914 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.35 -90.01 0.19 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.7 m -153.61 121.85 6.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -1.164 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 87' ' ' PHE . 2.7 p -75.5 -6.05 48.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -138.15 120.52 15.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.033 -1.042 . . . . 0.0 109.961 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.466 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 20.3 m -136.84 166.37 23.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.52 153.35 51.71 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.842 . . . . 0.0 110.427 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.594 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -82.81 75.01 9.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.52 -179.519 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.431 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -56.01 174.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 111.072 -179.79 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.568 ' CG ' HG21 ' A' ' 38' ' ' ILE . 42.5 Cg_endo -74.84 123.46 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.427 1.751 . . . . 0.0 110.153 -179.417 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.72 -14.73 4.96 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.0 OUTLIER 85.06 94.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.646 0.736 . . . . 0.0 111.104 179.43 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.441 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.92 -160.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.689 0.756 . . . . 0.0 110.882 179.281 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.619 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 19.9 m95 -148.11 77.97 1.42 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.806 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -88.39 151.73 48.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 110.435 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.65 177.88 31.88 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.908 -0.163 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.58 114.59 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.341 0.591 . . . . 0.0 110.988 -179.229 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 4.3 tp -40.58 142.67 0.75 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.529 -0.732 . . . . 0.0 110.191 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.555 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 41.3 Cg_endo -70.61 165.32 32.32 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.005 1.529 . . . . 0.0 110.219 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 117' ' ' VAL . 62.3 tttt -128.58 103.28 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.902 179.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -58.2 87.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.052 -1.03 . . . . 0.0 109.06 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -95.42 179.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.837 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.575 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 3.1 ptp85 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.271 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.278 0.561 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.94 174.34 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.548 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -130.45 79.46 1.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 7.9 mp0 -47.49 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 1.3 p -55.04 146.06 40.95 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.058 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 46.5 Cg_endo -69.24 155.08 68.7 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.804 1.423 . . . . 0.0 111.11 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.04 174.64 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.105 1.582 . . . . 0.0 110.305 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.17 179.53 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.64 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.539 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -147.78 -169.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 122.208 1.004 . . . . 0.0 111.377 -179.888 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 15.1 m -53.5 97.96 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.543 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' SER . 35.2 m-80 41.0 61.69 1.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -168.61 151.19 17.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.3 mtm180 -104.09 -169.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -1.157 . . . . 0.0 110.675 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.6 p80 -147.75 -153.38 0.49 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.384 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 18' ' ' GLU . 16.2 t-20 58.28 149.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -39.3 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 10.5 t80 -160.64 40.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -1.217 . . . . 0.0 110.581 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -165.03 -166.82 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 5' ' ' SER . 1.6 m-20 -140.24 -41.29 0.42 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 110.657 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.59 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 33.2 p90 -131.04 105.9 8.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.941 -1.1 . . . . 0.0 110.845 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 12.7 m-85 -72.84 -163.51 0.13 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.612 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.548 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -149.8 -64.83 0.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 111.015 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 5.4 t0 -165.23 146.38 7.41 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 66.27 15.13 62.88 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 1.5 m -97.21 164.3 12.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 109.962 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 27' ' ' VAL . 43.4 t -138.68 154.35 26.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 110.54 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.603 HG13 ' CD1' ' A' ' 29' ' ' TYR . 11.2 t -131.62 122.3 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.509 -179.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.95 103.08 8.66 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.371 -1.332 . . . . 0.0 107.71 177.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.635 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.3 m-30 -67.66 107.08 2.41 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.421 -178.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -69.21 158.01 35.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 110.312 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 18.8 m -123.44 146.32 48.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 4.1 m120 -43.87 138.56 2.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 109.951 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' ASN . 5.3 t -44.39 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 126.75 -1.22 7.39 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.576 ' CE2' HG13 ' A' ' 58' ' ' ILE . 14.3 m-85 -106.39 143.26 34.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -1.183 . . . . 0.0 110.391 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.531 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -92.24 139.86 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 110.84 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.553 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 3.0 tp -91.34 99.12 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.309 179.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.601 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.7 OUTLIER -87.98 147.14 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.619 -179.76 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.97 -176.96 27.47 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.7 134.36 51.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -1.15 . . . . 0.0 109.777 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.65 53.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.5 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 159.33 116.46 0.45 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.635 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.5 t -58.44 -178.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.001 -1.294 . . . . 0.0 107.866 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.2 tp -146.14 94.82 2.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.305 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 0.0 109.078 178.79 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.8 p -132.45 111.31 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.411 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 18.31 39.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.3 31.31 47.17 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -151.95 100.56 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -1.175 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.585 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 81.3 m95 -54.03 136.99 40.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 7.4 m -146.09 155.64 42.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.05 -1.031 . . . . 0.0 111.061 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.543 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.6 t0 68.95 64.86 0.54 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.625 -0.672 . . . . 0.0 111.199 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.2 Cg_endo -92.29 132.71 1.17 Allowed 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.971 1.781 . . . . 0.0 110.597 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 54.3 Cg_endo -82.84 173.89 9.93 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.862 1.454 . . . . 0.0 109.481 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 74.2 p -114.22 134.77 54.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.869 -1.144 . . . . 0.0 111.366 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.2 m -98.09 75.58 2.33 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.8 171.37 7.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.365 0.602 . . . . 0.0 110.533 -178.376 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.576 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -87.94 124.74 41.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.011 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.591 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 33.9 m -110.38 53.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 111.269 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -78.74 107.68 11.62 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.578 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 71.0 m -74.46 162.86 71.91 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.244 -0.91 . . . . 0.0 111.665 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.8 Cg_endo -71.39 -78.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.622 1.854 . . . . 0.0 110.66 179.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.523 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER 178.41 131.02 0.22 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 54.2 Cg_endo -76.68 65.17 7.53 Favored 'Trans proline' 0 C--N 1.295 -2.275 0 O-C-N 123.714 1.376 . . . . 0.0 110.254 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.532 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -95.93 141.34 29.47 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.036 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.585 ' CD1' HD22 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -135.8 154.79 34.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.092 -178.908 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.88 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.77 -179.701 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.7 OUTLIER 68.0 -55.51 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 67' ' ' SER . . . -52.71 -169.3 0.02 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 12.6 p90 175.12 -165.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.598 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -125.14 153.73 42.56 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.233 178.237 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t -139.01 24.83 2.54 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -106.71 -73.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.33 81.1 0.29 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.6 t80 -101.01 164.16 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 109.775 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.625 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -160.5 167.98 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.543 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -71.78 -29.37 64.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.255 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 p -139.12 135.19 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 38.8 m-85 -117.13 -170.28 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.809 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.54 ' C ' ' CG2' ' A' ' 59' ' ' VAL . 89.1 p -145.77 -99.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.0 111.201 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -120.95 22.01 11.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.494 -1.379 . . . . 0.0 110.357 -178.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' CYS . 16.4 p30 -159.39 -116.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 110.606 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.431 ' C ' HG21 ' A' ' 102' ' ' THR . 1.1 t70 52.09 73.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.799 -1.188 . . . . 0.0 109.367 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 31.4 t30 -69.46 105.02 2.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.799 . . . . 0.0 110.906 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 34.6 m -91.54 118.42 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.028 -1.045 . . . . 0.0 110.757 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.85 137.76 38.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.429 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.598 ' CE1' HD11 ' A' ' 71' ' ' LEU . 38.3 m-85 -97.44 155.61 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.943 -178.255 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' TYR . 1.4 mmtt -136.33 123.1 21.18 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.582 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.464 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -68.56 132.04 46.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 110.376 -179.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -38.62 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.512 -0.742 . . . . 0.0 110.527 179.894 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -172.96 120.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.148 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.565 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 78.59 50.2 6.21 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 77.4 m-85 -158.83 167.64 28.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.473 -1.016 . . . . 0.0 110.396 -178.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.541 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 21.1 tttm -121.39 124.87 45.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 0.0 109.607 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.585 HD22 ' CD1' ' A' ' 66' ' ' ILE . 2.3 mt -66.69 92.84 0.23 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.913 -1.117 . . . . 0.0 110.076 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -76.57 112.41 13.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.91 -79.31 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -169.37 122.47 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -1.053 . . . . 0.0 110.135 -179.635 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -83.86 17.3 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.734 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 85.7 p -157.15 105.86 2.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.974 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.503 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 m -123.64 175.63 6.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.199 -0.938 . . . . 0.0 110.943 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.08 132.63 19.79 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.603 0.716 . . . . 0.0 110.176 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.559 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -61.79 89.23 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.507 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.459 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -75.21 178.58 1.74 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 111.186 -179.046 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.591 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 44.0 Cg_endo -76.83 130.5 11.51 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.394 1.734 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.83 -10.3 7.52 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 9.3 m-80 81.42 76.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 122.102 -0.646 . . . . 0.0 110.738 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -171.16 -169.28 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 0.0 111.361 179.746 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.603 ' CZ2' ' HD3' ' A' ' 64' ' ' PRO . 32.0 m95 -133.09 95.72 3.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.626 -0.671 . . . . 0.0 110.104 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.9 mmtt -101.61 146.63 32.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.518 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.32 178.62 33.06 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.782 -2.174 . . . . 0.0 110.528 -0.291 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -37.56 124.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 110.908 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.552 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 1.5 tp -46.48 143.54 3.88 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 110.226 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 40.1 Cg_endo -70.67 168.09 23.75 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.056 1.556 . . . . 0.0 110.636 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.3 tttt -132.76 109.42 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -62.8 89.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.13 -0.981 . . . . 0.0 108.85 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.4 m -104.9 -173.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.925 0.869 . . . . 0.0 111.215 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtt-85 . . . . . 0 C--N 1.294 -1.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.479 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 13.3 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.363 0.602 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.38 162.71 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.099 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.523 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -130.54 91.71 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.286 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 2.2 mp0 -64.03 164.98 9.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 109.885 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.74 141.52 1.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.799 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.609 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 49.1 Cg_endo -69.27 162.57 41.29 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.954 1.502 . . . . 0.0 110.874 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.32 170.22 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.036 1.546 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -89.36 104.32 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -51.13 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.103 0.954 . . . . 0.0 111.251 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.64 141.0 30.95 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.085 -179.337 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.4 m120 50.57 19.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -160.68 168.47 36.13 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.054 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' N ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -132.34 -177.62 4.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -1.106 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.609 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.3 p80 -126.67 143.85 51.1 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.563 -0.71 . . . . 0.0 110.553 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.28 -166.98 1.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.127 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.67 -91.28 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -170.64 28.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -1.16 . . . . 0.0 110.211 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -165.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.427 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -164.98 25.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -150.68 49.22 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 110.822 -179.753 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.3 m-85 -50.15 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.522 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p -141.0 -54.53 0.48 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.089 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 6.6 t70 -172.63 148.18 1.9 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.858 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.28 14.72 54.92 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.181 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.596 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.98 174.53 7.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -1.006 . . . . 0.0 109.641 179.854 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 49.6 t -148.99 154.71 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.15 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.588 HG13 ' CD1' ' A' ' 29' ' ' TYR . 8.7 t -131.85 119.1 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.631 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.92 103.66 5.22 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.141 178.177 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.632 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.33 175.7 3.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.763 -178.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -131.55 161.84 31.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.571 179.576 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.51 ' SG ' ' CD1' ' A' ' 37' ' ' LEU . 55.9 m -140.1 130.94 25.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 110.431 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -44.4 136.74 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.4 p -46.09 111.75 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.93 -9.06 7.59 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -114.6 115.38 27.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -1.166 . . . . 0.0 110.258 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.613 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -63.94 127.91 33.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.602 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD1' ' SG ' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -82.83 99.91 10.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.142 178.983 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.569 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.6 OUTLIER -86.16 145.38 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 109.196 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.91 -143.98 15.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.53 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.6 m120 -126.41 51.24 1.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.201 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 40' ' ' ASN . 10.8 m 22.79 66.38 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.655 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 152.85 108.63 0.37 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.632 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.7 t -65.27 -177.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.994 -1.298 . . . . 0.0 108.329 178.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 25' ' ' SER . 7.6 tp -145.96 97.35 2.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.544 178.606 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.25 115.02 20.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 178.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.471 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 83.6 p -127.27 109.24 11.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.613 -0.679 . . . . 0.0 110.471 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.42 41.57 13.18 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 63.41 33.27 86.78 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.64 107.1 4.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -1.182 . . . . 0.0 110.613 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.2 m95 -66.74 138.85 57.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.636 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -149.26 169.75 20.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 111.405 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 49.72 64.85 7.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.784 -0.572 . . . . 0.0 111.421 179.679 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.5 Cg_endo -92.78 147.6 2.64 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 121.919 1.746 . . . . 0.0 110.296 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.587 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -81.52 173.89 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.895 1.471 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.569 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.6 p -125.3 141.13 52.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.01 . . . . 0.0 111.231 -179.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.455 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 75.7 m -100.66 73.91 1.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.7 OUTLIER -118.76 175.84 5.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.043 -179.086 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.5 149.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.258 -0.902 . . . . 0.0 108.767 179.057 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.613 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 33.1 m -124.21 47.46 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 111.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -76.07 155.71 34.56 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.255 178.131 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -120.44 172.24 4.89 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.847 -1.158 . . . . 0.0 111.476 -178.808 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.0 Cg_endo -78.08 -63.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.649 1.868 . . . . 0.0 110.744 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.581 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 163.07 128.56 0.01 OUTLIER Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.203 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.7 Cg_endo -76.54 69.52 6.65 Favored 'Trans proline' 0 C--N 1.294 -2.302 0 O-C-N 123.696 1.366 . . . . 0.0 110.377 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.536 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -94.22 -173.78 3.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.757 . . . . 0.0 109.403 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 178.5 169.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 110.272 179.455 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.528 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.32 103.89 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.875 -179.536 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 59.9 m-80 44.68 51.12 8.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.47 ' HA3' HD12 ' A' ' 66' ' ' ILE . . . -164.64 26.54 0.19 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.556 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -39.27 162.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 123.012 1.386 . . . . 0.0 113.166 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -45.83 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.603 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER 80.59 25.87 0.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.284 0.564 . . . . 0.0 110.094 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.73 -73.67 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 110.467 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -108.1 -98.31 2.55 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 6.8 t80 57.05 164.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.408 -1.054 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.647 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -170.16 167.44 8.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.438 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -52.83 -26.8 15.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.507 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.486 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 8.0 t -149.69 146.92 27.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -142.53 175.69 9.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 81' ' ' TYR . 1.8 p -170.65 136.61 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.004 -1.06 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.636 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 54.6 t80 31.44 104.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.708 -0.62 . . . . 0.0 111.872 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 38.2 t30 90.19 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 122.005 -0.434 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 80' ' ' SER . 4.5 m-20 55.3 76.64 0.25 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.765 -1.209 . . . . 0.0 108.817 -178.314 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 t-20 -71.29 146.25 49.03 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.63 0.729 . . . . 0.0 111.599 -178.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.583 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 2.3 m -127.53 123.57 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.014 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.04 132.36 34.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.906 -1.121 . . . . 0.0 108.69 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 38.1 m-85 -94.55 136.6 34.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.291 1.043 . . . . 0.0 112.674 -177.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.447 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 2.4 tttp -111.89 102.41 10.66 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.474 -179.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.444 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -51.68 131.08 29.74 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 109.705 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.18 -79.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.958 -179.746 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.7 m-85 -165.66 141.31 5.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 0.0 110.298 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.56 61.46 6.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -162.71 175.19 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.45 -1.029 . . . . 0.0 110.208 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' VAL . 1.3 tttt -132.14 116.0 16.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.865 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 5.6 mt -55.3 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.475 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -71.95 99.21 2.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.206 -0.934 . . . . 0.0 109.561 179.341 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.75 -86.24 0.18 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.588 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -162.77 122.07 2.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 110.434 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.9 p -73.52 1.34 10.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.878 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 p -147.55 113.69 5.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 15.2 m -121.3 -173.39 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.518 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 16.1 m -155.83 139.1 15.67 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.942 -178.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.637 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.6 t -69.03 84.03 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 109.371 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -73.82 177.73 1.94 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.555 ' CG ' HG21 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -77.37 130.25 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.569 1.826 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.34 -6.77 12.78 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.595 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.9 OUTLIER 83.15 85.32 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.991 -0.711 . . . . 0.0 111.435 179.364 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.576 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.65 171.83 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.64 0.733 . . . . 0.0 111.14 178.703 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.647 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 51.6 m95 -119.21 93.72 4.18 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.713 -0.617 . . . . 0.0 110.29 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.0 mmtm -98.94 146.05 31.0 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.708 . . . . 0.0 110.566 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.588 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -70.55 169.5 66.38 Favored 'Cis proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.94 -2.108 . . . . 0.0 110.871 -0.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 52.2 tt0 -36.03 126.16 0.74 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.568 0.699 . . . . 0.0 111.707 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -42.77 143.51 1.18 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.541 -0.725 . . . . 0.0 109.977 179.105 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 39.2 Cg_endo -71.43 164.11 36.83 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 124.158 1.609 . . . . 0.0 111.242 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.475 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -130.57 108.12 9.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 110.411 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.5 t -65.05 93.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 179.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.2 m -112.35 179.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.708 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.591 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.566 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.233 0.54 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 169.96 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.544 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -135.32 95.73 3.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.467 ' HG3' ' CE2' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -71.88 175.73 5.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.483 179.437 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -50.41 138.79 20.87 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.816 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.641 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 47.8 Cg_endo -68.91 156.26 65.96 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.913 1.481 . . . . 0.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.67 167.69 25.88 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.906 1.477 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' ILE . 84.8 p -81.19 99.67 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.606 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -50.97 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.389 1.09 . . . . 0.0 111.877 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -61.06 116.65 4.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.159 -179.168 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 m120 42.94 43.62 3.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.331 -0.855 . . . . 0.0 111.115 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -158.92 139.06 6.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -95.9 -168.83 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.893 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.641 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 14.9 p80 -148.79 120.74 8.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.801 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -71.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.027 . . . . 0.0 110.745 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.58 -97.58 1.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER 179.82 30.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -1.179 . . . . 0.0 110.576 -179.944 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 178.59 -171.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 110.585 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -105.5 -50.53 3.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.018 179.757 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.8 m-85 -88.7 -170.52 2.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 1.7 m-85 -169.52 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.33 -0.856 . . . . 0.0 111.96 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.544 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p 48.72 -97.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.0 -1.062 . . . . 0.0 112.167 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.7 OUTLIER -145.36 157.91 43.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.215 . . . . 0.0 110.342 -178.293 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.4 65.1 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.49 ' CB ' ' HB3' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -92.03 160.78 15.07 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.588 -0.948 . . . . 0.0 110.105 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 53.8 t -140.78 152.76 20.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.771 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.645 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 25.2 t -138.02 116.71 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.123 -1.031 . . . . 0.0 111.391 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.66 103.61 2.59 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.519 178.098 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.657 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.84 125.95 27.89 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 110.218 -178.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -82.05 153.5 26.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.251 -0.906 . . . . 0.0 109.93 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 1.6 t -121.55 138.2 54.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.79 158.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.041 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -62.91 131.51 48.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.33 -33.33 6.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -89.59 136.54 32.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -1.122 . . . . 0.0 109.973 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.544 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.92 144.8 25.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.786 -179.635 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.6 tp -96.39 100.91 12.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.432 -0.792 . . . . 0.0 109.331 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.586 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.1 148.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.06 -168.61 12.64 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.565 -1.303 . . . . 0.0 109.878 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.32 134.16 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 28' ' ' THR . 89.2 p -74.41 56.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.699 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.86 114.02 0.3 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.657 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.0 t -64.91 -178.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.2 tp -145.82 99.11 3.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.04 -1.037 . . . . 0.0 110.465 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -86.35 110.11 19.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.356 178.902 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.55 100.37 6.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.381 -0.824 . . . . 0.0 110.629 -179.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 84.75 45.14 6.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.481 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 62.33 33.6 86.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.34 95.71 2.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -1.156 . . . . 0.0 110.665 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 72.9 m95 -60.07 137.32 58.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.163 -0.961 . . . . 0.0 109.309 179.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 t -139.58 179.2 6.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 0.0 111.397 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.53 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.3 m-20 38.57 64.75 3.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.78 -0.575 . . . . 0.0 111.535 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.9 Cg_endo -91.97 138.69 2.0 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 121.95 1.767 . . . . 0.0 109.558 178.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.441 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 52.3 Cg_endo -78.93 -178.99 5.06 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.734 1.386 . . . . 0.0 110.495 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.492 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 9.0 p -115.06 172.83 6.82 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.801 0.81 . . . . 0.0 111.194 -179.039 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -137.64 77.44 1.63 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.83 -164.26 0.9 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.412 -178.676 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.32 131.24 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.642 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 11.4 m -125.42 47.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 111.493 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 14.3 mttp -74.08 166.25 23.73 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.846 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.13 171.0 8.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.554 -1.341 . . . . 0.0 112.684 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.57 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 51.9 Cg_endo -86.12 -57.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.81 1.953 . . . . 0.0 109.71 178.841 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 161.76 122.72 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.377 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.63 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 55.8 Cg_endo -76.1 66.41 6.94 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 O-C-N 123.645 1.34 . . . . 0.0 109.893 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.547 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.4 p -85.34 -173.25 4.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.275 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.539 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 176.52 170.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.34 179.159 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.538 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 1.1 p -79.79 111.16 15.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 111.434 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.497 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 10.3 m-20 36.83 63.0 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -154.48 -44.54 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 33.7 p90 39.99 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.256 1.027 . . . . 0.0 111.302 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -135.58 154.46 51.34 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.984 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.77 -17.43 13.94 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.895 -1.128 . . . . 0.0 110.2 -178.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.9 t -49.63 -95.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.462 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.06 88.87 0.11 Allowed Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.049 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -78.55 100.34 6.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -1.074 . . . . 0.0 109.479 179.457 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.588 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 1.8 ttmt -88.65 133.72 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.913 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.6 ttt180 -40.27 -32.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.406 -0.809 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -128.23 134.11 48.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.447 -0.783 . . . . 0.0 110.08 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.596 ' OH ' ' CD1' ' A' ' 75' ' ' PHE . 1.2 m-85 -117.81 -159.75 0.76 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.544 ' CA ' HG21 ' A' ' 59' ' ' VAL . 90.5 p -157.84 -111.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.845 -1.159 . . . . 0.0 111.672 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -115.24 11.74 16.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.328 -1.482 . . . . 0.0 110.8 -178.396 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -159.03 -3.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.749 -1.219 . . . . 0.0 112.896 -179.243 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -55.04 86.39 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.848 -1.158 . . . . 0.0 108.706 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASN . 48.8 t30 -72.74 129.45 38.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 111.796 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 2.8 m -116.79 117.14 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -82.99 120.83 26.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 108.955 179.639 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.565 ' CD2' ' HG3' ' A' ' 114' ' ' PRO . 57.3 m-85 -82.25 138.76 34.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 112.451 -177.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -113.26 84.24 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.067 -179.641 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -38.28 128.95 1.36 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.704 . . . . 0.0 110.712 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.497 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.48 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.592 -0.692 . . . . 0.0 110.452 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.1 t80 -166.13 143.3 5.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 0.0 109.889 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.23 46.5 85.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.604 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 17.9 m-85 -151.57 157.28 42.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -1.033 . . . . 0.0 109.973 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.472 ' O ' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.36 112.12 19.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.09 179.884 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.545 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 18.6 mt -48.18 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.491 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -74.93 94.06 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.212 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.05 -89.6 0.14 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.564 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -154.5 118.17 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -1.172 . . . . 0.0 110.618 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.2 p -72.82 -7.27 49.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -141.69 101.72 4.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 0.0 109.857 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.488 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 10.9 m -111.15 162.49 14.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 110.923 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 82' ' ' ASN . 3.5 m -138.68 134.25 33.37 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.17 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 49.3 t -61.93 95.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.134 -1.027 . . . . 0.0 108.806 179.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.4 175.97 0.45 Allowed Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.508 -0.745 . . . . 0.0 111.259 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.8 Cg_endo -81.24 19.55 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.523 1.802 . . . . 0.0 111.205 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -113.5 8.19 24.35 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 76.27 61.15 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.785 -0.833 . . . . 0.0 110.508 179.708 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -176.83 173.38 1.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.073 -1.017 . . . . 0.0 111.854 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.63 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 27.8 m95 -95.69 92.26 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.575 0.703 . . . . 0.0 110.692 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 10.5 mmtm -109.61 135.35 20.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.577 -0.702 . . . . 0.0 109.628 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.2 Cg_endo -69.81 166.41 74.25 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.179 -2.009 . . . . 0.0 111.285 -0.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -43.67 139.87 2.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -47.99 146.62 4.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.254 179.441 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.565 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 42.9 Cg_endo -72.57 160.41 46.65 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 124.363 1.717 . . . . 0.0 110.713 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.3 ttmt -122.48 106.9 11.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.967 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.108 -0.995 . . . . 0.0 109.18 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.1 m -113.41 178.59 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.608 0.718 . . . . 0.0 110.812 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.581 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.796 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.269 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 18.9 mttt -159.89 174.23 14.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -122.7 91.58 3.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' SER . 36.8 mt-30 -71.53 175.55 5.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.706 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -41.79 138.04 1.82 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.874 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.599 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 47.9 Cg_endo -69.08 158.44 57.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.97 1.51 . . . . 0.0 111.091 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.68 169.01 23.34 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.886 1.466 . . . . 0.0 110.264 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.6 p -73.32 176.24 6.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.564 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.86 -170.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.166 0.984 . . . . 0.0 111.462 179.726 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 16.7 m -40.08 91.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -178.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.0 m120 43.09 40.11 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 110.433 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -132.22 176.48 19.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 3.3 mtp180 -123.29 -174.93 3.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.386 -1.067 . . . . 0.0 109.759 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.25 122.99 6.81 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.1 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 14' ' ' HIS . 72.1 m-80 -156.61 122.12 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -118.69 31.16 5.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 2.1 t80 66.53 25.38 10.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.106 . . . . 0.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.497 ' CD ' ' CZ ' ' A' ' 21' ' ' TYR . 9.9 pt-20 -159.34 -174.3 4.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' SER . 12.0 m-20 -123.41 -28.6 3.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 0.0 110.14 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -105.36 -170.81 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.808 -179.465 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 1.4 m-85 -174.3 -31.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.699 -0.626 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.564 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 17.2 m 67.28 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 112.509 178.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.11 155.05 40.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.733 -1.229 . . . . 0.0 109.963 -178.424 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.54 56.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.66 162.58 18.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.615 -0.932 . . . . 0.0 110.239 -179.897 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 78.3 t -139.21 152.29 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.592 HG22 ' CH2' ' A' ' 50' ' ' TRP . 24.4 t -135.06 124.52 42.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.696 -179.068 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.26 101.31 4.63 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.073 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.64 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.2 m-30 -68.48 153.24 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.017 -178.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.485 ' HB2' ' HG3' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -115.1 160.89 19.11 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.597 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 17.6 m -128.44 149.46 50.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.04 -1.038 . . . . 0.0 110.534 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -56.25 148.92 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 179.825 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 p -49.8 115.48 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.13 31.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 2.0 m-85 -118.1 131.54 56.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -1.203 . . . . 0.0 110.348 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.606 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 8.2 m -82.83 138.31 34.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 110.821 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.47 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 6.2 tp -94.59 101.23 13.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -96.17 159.9 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 89.35 34.77 8.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 6.2 m120 66.18 176.27 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -1.144 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.7 OUTLIER -116.8 70.71 0.78 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.721 179.632 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 169.93 109.69 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -69.81 -174.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -1.204 . . . . 0.0 108.445 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.6 tp -144.55 102.19 3.78 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.061 178.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -88.52 108.76 19.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 179.083 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -125.84 107.81 10.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.49 41.58 6.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.465 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 58.95 30.06 65.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -145.96 105.86 4.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -1.22 . . . . 0.0 110.608 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CH2' HG22 ' A' ' 27' ' ' VAL . 85.8 m95 -62.07 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.795 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.6 169.72 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.009 . . . . 0.0 111.075 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 47.45 65.22 7.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.821 -0.55 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.5 Cg_endo -90.81 135.03 1.91 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.381 1.727 . . . . 0.0 109.506 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -74.29 161.36 40.61 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.71 1.374 . . . . 0.0 110.072 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 38' ' ' ILE . 18.0 p -104.0 143.83 32.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 111.849 -178.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 63.5 m -109.76 74.86 0.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.94 173.81 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.519 0.676 . . . . 0.0 110.755 -178.169 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.34 145.37 7.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.629 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 16.1 m -126.29 48.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.756 -178.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 7.0 mtpt -86.05 160.95 19.16 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 118.842 -1.143 . . . . 0.0 107.961 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.497 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 16.0 m -122.73 167.86 13.34 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.516 -1.365 . . . . 0.0 112.154 -178.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 42.6 Cg_endo -75.42 -59.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.632 1.859 . . . . 0.0 110.47 179.489 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.22 124.0 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.184 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.61 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 53.4 Cg_endo -75.87 71.96 5.35 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 O-C-N 123.715 1.377 . . . . 0.0 109.707 -179.009 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.445 ' C ' HG23 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -94.78 177.48 5.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.735 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -171.47 167.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.427 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.48 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.4 OUTLIER -73.39 106.69 5.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.499 -0.751 . . . . 0.0 110.677 -179.498 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.7 m120 40.7 36.63 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 110.502 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -145.0 31.13 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -44.89 -175.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.577 1.179 . . . . 0.0 112.186 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -110.45 160.95 16.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.772 179.091 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.6 t -149.6 24.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.739 -1.226 . . . . 0.0 109.951 -179.343 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.52 ' HB3' ' CB ' ' A' ' 86' ' ' ASP . 24.0 t -112.39 -37.26 5.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.734 -179.405 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.05 95.62 0.12 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.584 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -125.98 150.24 48.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -1.068 . . . . 0.0 109.734 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 12.7 ttmm -154.15 140.53 18.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.179 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 76' ' ' LYS . 3.3 mtt180 -41.57 -51.88 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.1 m -94.99 168.26 10.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.808 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.595 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 48.8 m-85 -149.16 179.97 7.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.2 m -159.58 -160.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.597 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.71 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 1.8 t80 -73.91 54.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.648 -1.282 . . . . 0.0 109.866 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 81' ' ' TYR . 8.4 p-10 173.51 -125.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.91 -1.118 . . . . 0.0 109.939 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.475 ' C ' HG21 ' A' ' 102' ' ' THR . 0.3 OUTLIER 49.87 67.83 0.84 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.878 -1.139 . . . . 0.0 109.62 -179.42 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.544 ' N ' HG21 ' A' ' 102' ' ' THR . 7.7 p-10 -69.81 104.05 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.541 -179.045 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.598 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 17.3 m -83.97 123.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.141 . . . . 0.0 110.546 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.3 t70 -81.11 124.88 29.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.926 -1.109 . . . . 0.0 109.001 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CE1' HD11 ' A' ' 71' ' ' LEU . 26.5 m-85 -88.41 123.46 32.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.997 -1.064 . . . . 0.0 111.851 -178.581 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.5 tttm -102.31 109.28 20.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.659 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -58.79 130.51 47.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.071 -1.018 . . . . 0.0 110.192 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 21.7 mmtt -39.41 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 33.9 p90 -144.82 149.62 35.74 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.083 -1.011 . . . . 0.0 110.724 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 39.76 37.3 0.89 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 17.5 m-85 -137.64 146.56 44.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -1.082 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -106.66 162.76 13.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 108.956 179.097 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -96.31 106.29 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.742 -1.224 . . . . 0.0 110.618 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 117' ' ' VAL . 1.5 t -86.83 102.06 13.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.505 -0.747 . . . . 0.0 109.578 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.471 ' O ' ' OG ' ' A' ' 98' ' ' SER . . . 137.47 -43.59 1.2 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.532 ' OG ' ' CG ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER 175.49 -166.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 111.238 -179.595 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -67.85 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.707 -0.621 . . . . 0.0 109.999 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 56.2 p -92.09 84.01 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.805 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 85' ' ' VAL . 1.4 m -86.29 166.52 15.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.314 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.544 HG21 ' N ' ' A' ' 84' ' ' ASN . 3.9 m -146.13 139.46 25.98 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.57 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 51.8 t -61.76 104.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -74.12 176.59 2.72 Favored Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 111.319 -178.495 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.629 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 52.4 Cg_endo -80.28 10.03 3.39 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.722 1.906 . . . . 0.0 110.974 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -104.99 7.37 44.44 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 76.13 61.16 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.708 -0.878 . . . . 0.0 109.953 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -176.97 175.5 1.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.771 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.7 m95 -98.41 95.36 7.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.573 0.701 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.4 mmmt -107.59 136.36 19.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.532 ' CG ' ' OG ' ' A' ' 98' ' ' SER . 44.2 Cg_endo -70.4 166.02 76.88 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.25 -1.979 . . . . 0.0 111.29 0.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 14.9 tt0 -42.3 134.93 2.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.51 -0.744 . . . . 0.0 109.88 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -42.18 139.56 1.76 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.95 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 40.1 Cg_endo -71.22 169.54 20.43 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.233 1.649 . . . . 0.0 111.535 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.509 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.5 tttt -125.04 108.34 11.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.773 . . . . 0.0 110.901 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -61.04 97.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 108.875 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -103.36 -179.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.828 0.823 . . . . 0.0 111.183 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.35 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.471 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 3.9 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.258 0.552 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.431 ' N ' HG21 ' A' ' 1' ' ' VAL . 9.9 pttp -160.9 166.37 28.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.555 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -126.61 72.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 110.12 -179.892 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.28 179.6 0.1 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.302 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.4 p -43.17 142.8 1.48 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.037 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.496 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 47.6 Cg_endo -72.49 164.15 36.46 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.057 1.556 . . . . 0.0 110.569 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.48 169.51 21.58 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.98 1.516 . . . . 0.0 110.286 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.243 -0.91 . . . . 0.0 109.804 179.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.13 -170.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.329 1.061 . . . . 0.0 111.886 179.91 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.1 t -59.85 83.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.285 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.1 m120 54.68 59.28 4.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -159.25 147.24 14.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' SER . 10.2 mtt180 -93.96 -170.43 2.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -1.141 . . . . 0.0 110.919 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.525 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 11.8 m170 -85.39 -139.23 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.461 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 52.8 t30 -87.37 -54.99 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.217 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.09 -37.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 11.8 t80 -174.42 79.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.5 mp0 -108.41 177.41 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 4.9 t0 178.04 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.973 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -141.91 88.89 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.055 -1.028 . . . . 0.0 109.493 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.643 ' CD2' ' CB ' ' A' ' 25' ' ' SER . 2.9 m-85 -98.49 -9.53 24.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.78 . . . . 0.0 111.116 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.555 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.2 p 43.22 -92.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.548 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 21' ' ' TYR . 3.7 t0 -153.57 131.91 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.985 -1.072 . . . . 0.0 110.475 -178.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.46 47.75 2.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.643 ' CB ' ' CD2' ' A' ' 21' ' ' TYR . 42.2 m -148.41 154.34 39.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -1.171 . . . . 0.0 110.376 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 26.7 t -129.31 152.61 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 111.567 -178.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.577 HG22 ' CH2' ' A' ' 50' ' ' TRP . 33.4 t -122.27 114.39 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.628 -0.67 . . . . 0.0 111.484 -179.568 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -71.99 103.63 3.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.404 -1.318 . . . . 0.0 107.623 177.771 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.667 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.2 m-30 -67.75 118.56 11.16 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 110.138 -178.198 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.532 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.53 154.66 38.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 179.539 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 36.1 m -128.54 153.46 47.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.63 166.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.844 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.61 98.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 110.399 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 11.08 8.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.0 m-30 -105.76 119.2 38.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.173 . . . . 0.0 110.184 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.542 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 19.8 t -68.32 141.87 55.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.581 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 1.4 tp -95.89 108.58 20.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -103.22 140.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.346 -0.846 . . . . 0.0 109.313 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 134.82 -142.03 13.42 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -110.55 52.57 0.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -1.191 . . . . 0.0 110.335 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 40' ' ' ASN . 20.2 p 26.3 59.14 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.881 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 133.57 122.24 2.28 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.412 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.667 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.7 t -61.53 176.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.14 -1.212 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.451 HD11 ' CG2' ' A' ' 26' ' ' VAL . 2.7 tp -142.39 93.97 2.6 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.639 -1.225 . . . . 0.0 110.686 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.92 109.8 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.371 178.213 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 t -131.04 98.26 4.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.549 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.45 9.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 84.24 10.25 80.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.95 116.6 15.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.072 -1.252 . . . . 0.0 110.765 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -68.48 140.32 55.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.89 150.61 34.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.062 -1.024 . . . . 0.0 111.188 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.519 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 64.35 65.71 1.07 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.685 -0.635 . . . . 0.0 111.637 179.21 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.0 Cg_endo -91.71 136.37 1.78 Allowed 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.369 1.721 . . . . 0.0 109.559 178.588 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.532 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.7 Cg_endo -80.57 179.1 6.35 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.71 1.374 . . . . 0.0 110.745 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' ILE . 5.2 p -123.91 148.9 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.8 . . . . 0.0 111.371 -178.68 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.2 m -110.51 78.59 1.13 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.31 -159.39 0.68 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.415 0.626 . . . . 0.0 110.368 -178.923 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.15 125.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.936 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 22.5 m -118.9 52.99 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.13 -0.981 . . . . 0.0 111.597 -179.102 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 13.2 mtpt -60.82 -179.86 0.14 Allowed 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 117.811 -1.556 . . . . 0.0 107.964 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 80' ' ' SER . 93.4 m -136.71 160.51 66.18 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.762 -178.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.5 Cg_endo -85.2 -72.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.736 1.913 . . . . 0.0 109.95 178.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.58 124.9 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.743 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.606 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.5 Cg_endo -77.44 65.61 8.0 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.867 1.456 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -81.86 161.23 23.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.293 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.585 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -157.11 166.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 0.0 110.743 -179.664 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.47 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.39 108.11 10.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.691 -179.385 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.497 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 0.9 OUTLIER 39.93 41.19 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.483 -0.761 . . . . 0.0 110.615 179.573 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -151.5 33.11 0.92 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.585 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.3 p90 -44.84 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 112.469 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.609 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -112.0 161.67 16.2 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.938 179.353 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.83 30.19 1.48 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.829 -1.169 . . . . 0.0 110.382 -179.131 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -110.81 -86.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.47 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.24 71.8 0.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.1 t80 -99.51 166.25 11.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -1.065 . . . . 0.0 110.018 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.639 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -171.05 161.2 6.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 109.79 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -51.14 -32.57 23.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.098 . . . . 0.0 109.451 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.467 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.2 m -144.82 170.76 15.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.67 -0.644 . . . . 0.0 109.798 179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 3.8 m-85 -143.72 -134.68 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 0.0 109.938 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.514 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 60.4 p -167.34 -133.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.839 -1.163 . . . . 0.0 111.133 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -87.22 14.88 6.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.771 -1.206 . . . . 0.0 110.873 -178.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.504 ' HA ' HG21 ' A' ' 102' ' ' THR . 59.9 t30 -160.53 -116.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.711 -1.243 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 5.8 m-20 54.51 76.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.81 -1.181 . . . . 0.0 108.888 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.554 ' N ' HG22 ' A' ' 102' ' ' THR . 22.4 t-20 -71.43 109.83 5.65 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 110.535 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.583 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 14.8 m -87.38 119.44 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.4 t0 -80.6 129.52 34.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 108.798 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CE1' HD11 ' A' ' 71' ' ' LEU . 35.0 m-85 -89.04 142.22 27.82 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.038 -1.039 . . . . 0.0 112.19 -178.237 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -121.26 92.06 3.67 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.51 -179.607 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -42.41 130.74 3.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.425 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.497 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 5.5 mmtt -42.55 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -153.21 154.58 34.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.421 -179.977 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 43.55 31.53 1.7 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.7 m-85 -143.35 144.88 32.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 110.316 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 117' ' ' VAL . 16.4 pttp -113.59 139.43 49.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.875 . . . . 0.0 109.577 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.515 ' CD2' ' HG2' ' A' ' 114' ' ' PRO . 1.2 mt -66.9 114.15 5.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.099 -1.001 . . . . 0.0 111.118 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.517 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -92.16 98.02 11.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.613 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 140.14 -45.82 0.97 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.228 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.526 ' CB ' ' CG ' ' A' ' 111' ' ' PRO . 10.7 t -177.3 -172.99 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.249 . . . . 0.0 111.69 -179.458 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 p -144.76 -27.32 0.49 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -132.48 97.01 3.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.865 -1.147 . . . . 0.0 109.694 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 85' ' ' VAL . 24.8 m -103.3 162.66 12.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 84' ' ' ASN . 1.1 m -136.56 137.02 39.78 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.784 -0.572 . . . . 0.0 110.148 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.606 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 45.5 t -77.28 96.85 4.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.354 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -66.38 -176.3 0.23 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.602 -0.686 . . . . 0.0 110.741 179.936 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.598 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.7 Cg_endo -77.81 124.37 6.81 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.978 1.515 . . . . 0.0 110.55 -179.53 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.48 -7.28 6.25 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.8 m-20 79.35 95.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.898 -0.766 . . . . 0.0 110.976 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.44 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.0 -160.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -0.767 . . . . 0.0 111.088 179.453 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.606 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 26.9 m95 -149.73 111.43 4.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.588 -0.695 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.7 mttt -112.11 127.1 27.32 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 110.157 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.526 ' CG ' ' CB ' ' A' ' 98' ' ' SER . 41.5 Cg_endo -68.14 174.08 35.93 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.064 -2.057 . . . . 0.0 110.549 0.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 113' ' ' LEU . 3.7 mt-10 -63.96 59.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.602 -0.686 . . . . 0.0 111.27 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.536 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER 55.94 143.95 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 121.442 0.639 . . . . 0.0 111.383 178.951 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.566 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 43.0 Cg_endo -84.08 166.87 12.71 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.271 1.669 . . . . 0.0 111.09 -179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' O ' HG21 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -122.0 109.28 14.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.234 -0.916 . . . . 0.0 110.748 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.1 t -65.28 104.68 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.02 . . . . 0.0 109.258 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -119.18 -176.02 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.667 0.746 . . . . 0.0 111.023 -179.103 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 . . . . . 0 C--N 1.294 -1.833 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.367 -179.84 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.414 HG13 ' HA3' ' A' ' 48' ' ' GLY . 96.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.271 0.558 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.77 174.59 8.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.264 -0.897 . . . . 0.0 110.574 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 52.9 t -130.0 158.58 39.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -133.68 178.06 7.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.415 -0.803 . . . . 0.0 109.978 179.884 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.5 136.88 7.21 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.476 -0.765 . . . . 0.0 110.254 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.609 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.0 Cg_endo -70.24 155.67 63.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.157 1.609 . . . . 0.0 110.998 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.68 174.39 12.74 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.841 1.443 . . . . 0.0 109.785 178.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -69.89 177.15 3.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.099 -1.001 . . . . 0.0 110.2 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.39 -170.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.261 1.029 . . . . 0.0 111.54 179.872 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -47.06 101.32 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.744 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 10' ' ' SER . 24.8 m-20 40.29 47.3 2.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.29 161.81 30.66 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' SER . 5.1 mpt_? -112.01 -169.89 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.489 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.609 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.1 p80 -144.67 119.38 9.82 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.73 81.3 1.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 110.451 -179.538 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -91.28 28.44 8.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 32.9 p90 37.05 50.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.98 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 14.5 mm-40 -140.11 -169.48 2.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -147.55 -36.91 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 9.0 p90 -142.2 79.09 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.346 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 34.0 m-85 -55.43 -166.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.516 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -152.4 -67.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.91 -1.119 . . . . 0.0 110.743 -179.736 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.96 136.79 9.22 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.546 -0.721 . . . . 0.0 109.357 -179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 73.07 7.9 72.45 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.606 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.8 m -73.54 156.37 38.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -1.031 . . . . 0.0 109.809 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 54.1 t -138.66 153.39 25.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' A' ' 43' ' ' VAL . 41.4 t -138.67 118.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.37 -179.543 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.16 106.31 3.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.407 -1.317 . . . . 0.0 107.591 178.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.634 ' CE1' HG22 ' A' ' 43' ' ' VAL . 3.3 m-30 -68.02 139.01 56.3 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 110.356 -178.053 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -93.98 159.07 15.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.0 m -123.23 149.68 44.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -45.54 138.0 4.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -44.42 106.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 179.993 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.52 15.47 6.95 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.04 137.22 50.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -1.123 . . . . 0.0 110.393 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.562 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -85.78 147.01 26.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 110.929 -179.531 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.6 tp -95.9 100.63 12.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -96.27 173.81 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 108.953 179.55 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 80.62 175.91 49.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.929 179.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -42.51 111.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -1.067 . . . . 0.0 110.021 179.822 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.2 p -70.51 55.18 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 110.102 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 155.37 95.48 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.634 HG22 ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -45.91 175.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.357 -1.084 . . . . 0.0 108.768 179.5 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -141.12 101.0 3.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.405 -0.809 . . . . 0.0 109.923 178.707 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 6.2 t -78.09 109.38 12.12 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -117.64 128.94 55.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.439 -0.788 . . . . 0.0 109.838 179.787 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.59 30.93 57.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' A' ' 1' ' ' VAL . . . 73.38 45.56 29.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -151.56 97.78 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.132 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 97.9 m95 -64.33 125.59 25.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.25 171.34 14.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.639 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.539 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 52.59 64.53 7.23 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.721 . . . . 0.0 110.635 -179.833 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.9 130.08 1.43 Allowed 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 121.913 1.742 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.8 Cg_endo -74.27 176.12 10.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.822 1.433 . . . . 0.0 110.536 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.502 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.4 p -105.62 173.67 6.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.842 0.83 . . . . 0.0 111.266 -179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.6 m -139.75 75.43 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.6 mm-40 -114.21 -152.13 0.5 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.735 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.67 138.42 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.5 m -128.25 41.2 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.01 -1.056 . . . . 0.0 110.966 -179.115 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 16.6 mttt -53.93 178.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.358 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.16 162.33 40.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.578 -179.021 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.0 Cg_endo -83.8 -68.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.829 1.963 . . . . 0.0 110.306 179.08 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.31 128.73 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.382 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.64 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 49.4 Cg_endo -78.01 60.34 7.29 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 O-C-N 123.571 1.301 . . . . 0.0 109.841 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 2.3 p -74.76 -177.3 3.18 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.565 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -176.26 167.77 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.967 179.463 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 6.8 m -70.1 89.76 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.589 -0.694 . . . . 0.0 110.688 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.3 m120 50.23 49.62 20.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.87 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -162.66 40.62 0.36 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.577 ' O ' ' O ' ' A' ' 69' ' ' GLY . 50.2 p90 -48.25 -151.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.968 1.366 . . . . 0.0 113.076 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.591 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.46 122.82 13.94 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.619 -176.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 t -100.4 14.96 29.37 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.52 -0.737 . . . . 0.0 109.968 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.7 t -76.11 -91.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.969 -179.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.43 81.25 0.3 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.591 ' CE1' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -100.04 125.37 46.1 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.358 -1.083 . . . . 0.0 109.713 179.494 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 77' ' ' ARG . 10.0 ttmm -111.05 149.76 30.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 0.0 109.931 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -41.47 -41.46 2.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.863 . . . . 0.0 110.015 -179.988 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m -137.55 152.94 49.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.439 -0.788 . . . . 0.0 109.981 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -125.62 -162.52 1.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.575 ' CA ' HG21 ' A' ' 59' ' ' VAL . 2.3 m -153.94 -102.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.314 -0.866 . . . . 0.0 109.583 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.8 137.96 49.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.732 -1.23 . . . . 0.0 108.198 179.234 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 103' ' ' CYS . 37.4 t-20 71.49 -104.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.739 -0.6 . . . . 0.0 110.594 -178.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' C ' HG21 ' A' ' 102' ' ' THR . 39.5 m-20 44.96 74.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.606 -1.309 . . . . 0.0 109.355 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.512 ' N ' HG21 ' A' ' 102' ' ' THR . 1.1 t-20 -69.82 140.3 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 111.056 -178.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 3.7 m -129.73 126.33 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.0 110.114 179.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.83 132.99 33.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.031 . . . . 0.0 109.32 179.399 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.591 ' CZ ' HD21 ' A' ' 71' ' ' LEU . 44.4 m-85 -89.31 149.11 23.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.145 -0.972 . . . . 0.0 111.935 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.65 90.2 3.27 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.162 0.506 . . . . 0.0 110.037 -179.514 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.432 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -43.14 124.5 3.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.9 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 110.801 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -97.2 -161.05 0.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 110.372 -179.73 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.75 58.36 0.14 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 118' ' ' ARG . 3.0 m-30 -112.15 160.79 17.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.721 -0.87 . . . . 0.0 109.404 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 10.6 tttt -101.05 136.43 40.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.991 -1.068 . . . . 0.0 110.52 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.6 mt -79.56 90.65 5.12 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.534 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.8 101.94 1.82 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.829 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.58 -78.02 0.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.133 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.563 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -171.48 117.22 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -1.12 . . . . 0.0 110.635 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 -1.51 13.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -0.92 . . . . 0.0 110.966 -179.696 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 p -144.61 112.39 6.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.808 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.3 m -118.44 177.19 4.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 111.041 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -146.95 128.68 15.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.969 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.59 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 5.4 t -68.91 88.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.705 . . . . 0.0 109.51 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -69.16 -178.41 0.45 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.793 . . . . 0.0 111.193 -179.248 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.3 Cg_endo -80.7 124.96 5.33 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.564 1.823 . . . . 0.0 110.6 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 128.37 -8.12 6.64 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 7.2 m-20 83.48 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.5 0.667 . . . . 0.0 111.31 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.486 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -170.96 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.723 0.773 . . . . 0.0 111.21 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.64 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 32.1 m95 -137.73 92.37 2.67 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.451 0.643 . . . . 0.0 110.22 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 28.4 mttt -103.56 142.96 25.67 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.8 Cg_endo -70.58 167.57 73.0 Favored 'Cis proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.072 -2.054 . . . . 0.0 111.035 -0.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 113' ' ' LEU . 42.5 mt-10 -38.91 129.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.56 -0.712 . . . . 0.0 111.293 -179.239 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -40.06 147.25 0.36 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 110.594 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.565 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 39.7 Cg_endo -74.04 167.47 27.13 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.441 1.758 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 0.7 OUTLIER -130.43 105.08 7.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.919 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -61.57 101.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.837 . . . . 0.0 109.213 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -115.28 -175.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.698 0.761 . . . . 0.0 110.588 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.0 mtm180 . . . . . 0 C--N 1.295 -1.791 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.32 0.581 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 138.75 44.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.0 110.257 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -108.01 99.21 8.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.847 . . . . 0.0 110.117 -179.921 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 9.9 mt-30 -88.38 177.19 6.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -39.09 136.89 0.97 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.544 -0.723 . . . . 0.0 110.586 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 53.2 Cg_endo -71.27 158.31 54.91 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.058 1.557 . . . . 0.0 110.855 -179.453 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.25 170.94 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.754 1.397 . . . . 0.0 109.865 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.59 175.31 4.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.666 179.695 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -138.37 -170.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.138 0.97 . . . . 0.0 111.463 179.861 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -46.19 90.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER 48.11 48.62 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.786 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -147.65 164.75 28.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.493 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -110.13 -169.95 1.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -1.076 . . . . 0.0 110.524 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -158.89 121.3 3.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.258 0.552 . . . . 0.0 109.981 -179.675 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.79 79.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.137 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.18 -98.0 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 t80 -150.76 34.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.222 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.549 ' CD ' ' CE1' ' A' ' 21' ' ' TYR . 2.5 pt-20 -177.81 -159.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.043 -1.035 . . . . 0.0 110.527 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -162.03 24.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.089 -179.962 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 22' ' ' THR . 0.3 OUTLIER -140.54 29.69 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 36.7 m-85 -37.05 142.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 23' ' ' ASP . 27.8 p -133.8 89.56 2.6 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.228 1.013 . . . . 0.0 110.488 179.248 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER 55.27 152.24 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.83 179.127 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 19.77 8.88 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 6.4 m -87.41 177.88 6.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -1.063 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.4 t -158.41 156.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.05 179.495 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.602 ' CG2' ' CH2' ' A' ' 50' ' ' TRP . 30.3 t -144.99 124.05 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.77 -179.439 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.82 101.34 5.07 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.398 -1.321 . . . . 0.0 107.725 177.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.63 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.8 m-30 -67.99 128.12 35.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 110.423 -178.21 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.493 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.6 t -77.89 -173.7 3.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.196 -0.94 . . . . 0.0 108.883 178.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.463 ' N ' ' OG ' ' A' ' 30' ' ' SER . 89.1 m -147.36 168.25 22.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.104 -0.998 . . . . 0.0 110.239 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.93 148.52 39.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.897 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.5 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.974 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.19 0.29 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -110.88 140.85 45.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -1.138 . . . . 0.0 110.276 -179.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -87.68 145.72 26.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.905 . . . . 0.0 110.623 -179.937 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.05 103.16 15.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.323 -0.86 . . . . 0.0 109.937 179.557 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.552 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -97.18 171.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 108.826 179.124 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 87.0 -168.59 39.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.95 117.82 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -1.125 . . . . 0.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.423 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.69 56.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -0.987 . . . . 0.0 109.644 179.53 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 160.27 94.19 0.1 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.63 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -48.33 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.341 -1.093 . . . . 0.0 108.85 179.849 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 25' ' ' SER . 10.8 tp -142.64 102.04 3.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.985 178.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -73.63 118.32 16.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.912 179.612 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -133.92 126.83 31.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.164 -0.96 . . . . 0.0 110.177 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.01 19.46 77.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.457 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 83.64 25.67 45.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.4 133.9 26.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.292 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CH2' ' CG2' ' A' ' 27' ' ' VAL . 88.6 m95 -80.07 132.72 36.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.976 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.426 ' O ' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -136.18 162.16 33.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 110.935 -179.604 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 60.57 66.22 1.9 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.509 -0.745 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.6 Cg_endo -90.75 127.2 1.26 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 121.91 1.74 . . . . 0.0 110.069 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 45.8 Cg_endo -71.15 176.89 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.668 1.352 . . . . 0.0 110.111 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.55 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.7 p -113.39 151.45 31.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -0.936 . . . . 0.0 111.916 -178.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.489 ' N ' ' OE1' ' A' ' 57' ' ' GLN . 69.4 m -116.04 80.74 1.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.878 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -116.8 -162.45 0.85 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 110.425 -178.031 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.4 137.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 26.0 m -118.77 43.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 111.037 -179.266 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -83.38 98.79 9.67 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.709 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.551 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 56.4 m -68.68 164.31 46.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.803 . . . . 0.0 111.804 -177.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -66.61 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.514 1.797 . . . . 0.0 110.303 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -165.27 133.94 2.6 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.595 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 51.6 Cg_endo -76.5 69.37 6.68 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 O-C-N 123.703 1.37 . . . . 0.0 110.018 -178.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.465 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 1.2 p -92.2 -176.85 4.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 109.07 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -174.64 162.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.592 179.494 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 67' ' ' SER . 3.7 p -69.38 101.31 1.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.547 -0.721 . . . . 0.0 110.395 -179.612 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.509 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 21.6 m-20 41.51 57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.177 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -170.14 37.31 0.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.762 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.569 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.4 p90 -44.06 -170.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 123.419 1.58 . . . . 0.0 112.907 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 1.7 pp -107.46 116.16 31.45 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.55 179.498 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -82.28 1.38 37.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.42 -0.8 . . . . 0.0 109.602 -179.725 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.0 t -74.72 -86.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.76 . . . . 0.0 110.711 -179.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.14 94.5 0.12 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.163 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -81.28 104.3 11.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -1.07 . . . . 0.0 109.296 179.303 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.9 tptt -76.75 145.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.304 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -48.37 70.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.042 179.761 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 27.4 p -117.4 135.29 53.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 95.2 m-85 -113.81 -179.61 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.781 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' ASN . 2.9 m -170.54 108.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.976 -1.077 . . . . 0.0 111.308 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 11.5 t80 34.92 24.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.356 -0.84 . . . . 0.0 113.106 178.771 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.559 ' HA ' HG23 ' A' ' 102' ' ' THR . 37.3 t-20 -176.51 -125.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.067 -1.646 . . . . 0.0 111.472 178.388 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 49.29 75.42 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.633 -1.292 . . . . 0.0 108.828 -178.359 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 22.4 p-10 -69.57 139.9 53.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.476 -0.765 . . . . 0.0 110.512 -179.054 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.596 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -126.43 120.83 57.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.702 179.07 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 10.7 t0 -75.38 136.02 40.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 108.847 179.368 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CD2' ' CD ' ' A' ' 114' ' ' PRO . 16.5 m-85 -99.36 135.15 41.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.952 -1.092 . . . . 0.0 111.895 -178.564 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' TYR . 3.0 ttpt -109.53 154.91 22.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -100.28 128.18 46.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.92 -1.113 . . . . 0.0 110.098 179.891 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -44.68 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.701 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 93' ' ' TYR . 1.2 m-85 -95.71 -163.81 1.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 110.576 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.37 59.45 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.601 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-85 -109.38 168.94 9.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.788 -0.831 . . . . 0.0 110.009 -179.317 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 22.0 mttt -117.3 110.71 18.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.54 HD22 ' CD1' ' A' ' 66' ' ' ILE . 1.5 mt -49.14 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -74.43 95.74 2.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 110.044 179.817 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.34 -68.78 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.333 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.559 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -175.95 119.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -1.156 . . . . 0.0 111.03 -179.148 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.12 24.13 0.44 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.99 -1.069 . . . . 0.0 111.339 179.676 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 p -167.22 129.17 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.951 -1.093 . . . . 0.0 109.273 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 66.4 m -143.58 160.66 40.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 111.189 -179.145 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.559 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.38 137.83 50.07 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.575 0.703 . . . . 0.0 109.931 179.301 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.571 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 1.8 t -56.25 92.75 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.718 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 1.1 p -71.3 179.29 0.97 Allowed Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 110.118 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.0 Cg_endo -78.51 170.75 17.88 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 O-C-N 124.018 1.536 . . . . 0.0 111.448 -179.026 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 86.13 -57.24 4.79 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -178.906 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.6 OUTLIER 141.66 68.76 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.365 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.26 165.65 24.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.652 -1.28 . . . . 0.0 112.032 -179.473 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.596 ' CZ3' HG21 ' A' ' 85' ' ' VAL . 35.7 m95 -105.99 97.79 7.56 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.307 0.575 . . . . 0.0 109.849 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 5.1 mmmt -99.37 138.85 20.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.56 -179.338 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.559 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.7 Cg_endo -72.06 167.84 75.67 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.793 -0.48 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.4 tt0 -41.4 134.06 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.576 HD11 ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -42.27 152.07 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.385 -0.822 . . . . 0.0 110.706 -179.736 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.592 ' CD ' ' CD2' ' A' ' 87' ' ' PHE . 38.0 Cg_endo -79.42 159.3 25.85 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.554 1.818 . . . . 0.0 111.487 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.506 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.1 tptt -119.03 106.57 12.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.512 -0.742 . . . . 0.0 110.713 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.4 t -62.43 97.86 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 108.774 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 1.3 m -112.02 178.28 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.55 0.691 . . . . 0.0 110.592 -179.396 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.491 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.662 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.435 HG23 ' HA3' ' A' ' 48' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.327 0.584 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -120.11 174.4 6.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -140.11 85.08 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.696 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 25.3 mt-30 -60.47 171.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 p -47.77 149.39 2.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.614 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 51.4 Cg_endo -72.31 155.76 55.58 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.95 1.5 . . . . 0.0 110.946 -179.159 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.44 169.08 23.33 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.599 1.315 . . . . 0.0 109.686 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.27 177.22 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.993 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.492 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -170.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.197 0.998 . . . . 0.0 111.475 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -45.62 94.0 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 -179.396 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.0 m120 41.76 53.08 4.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.287 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.85 152.65 24.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 30' ' ' SER . 9.9 mtt180 -94.99 -169.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -1.146 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.2 p80 -160.4 132.72 6.23 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 -179.631 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER 173.77 104.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.056 . . . . 0.0 110.7 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 17' ' ' TYR . . . -81.51 -69.11 1.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.555 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 33.0 p90 178.61 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.334 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.51 -139.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.823 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -149.9 -36.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 110.992 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 14.8 p90 -143.98 90.46 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.859 -1.151 . . . . 0.0 111.227 -179.403 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 44.8 m-85 -57.8 171.2 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.532 178.88 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.465 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -125.96 -49.07 1.6 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.832 -1.168 . . . . 0.0 111.192 -179.359 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -175.44 142.58 0.59 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.304 -0.872 . . . . 0.0 109.565 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.33 69.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -178.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.601 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.9 m -87.8 178.38 6.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.615 -0.932 . . . . 0.0 110.15 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 31.5 t -154.46 154.04 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG22 ' CH2' ' A' ' 50' ' ' TRP . 39.6 t -135.8 118.69 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.39 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -71.0 103.32 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.707 177.915 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.652 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.14 134.46 50.57 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 13' ' ' ARG . 1.1 m -93.15 159.3 15.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.612 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 34.2 m -126.08 154.01 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -44.39 158.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.011 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 t -62.08 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 110.356 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.31 22.36 3.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-30 -113.36 146.18 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -1.216 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.62 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -88.01 134.38 33.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.676 -0.64 . . . . 0.0 110.816 -179.43 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 55' ' ' THR . 1.2 tp -96.24 102.37 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 178.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -94.48 143.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.233 -0.917 . . . . 0.0 109.08 179.632 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 -175.86 21.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.242 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 5.0 p30 -65.65 142.86 57.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.041 -1.27 . . . . 0.0 109.83 179.763 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.76 51.24 1.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 110.445 -179.713 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 166.29 102.25 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.394 179.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.652 HG22 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -49.0 178.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.165 -1.197 . . . . 0.0 108.5 179.157 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' HA ' HG21 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -140.05 98.21 3.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 110.081 178.548 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.6 t -79.77 118.58 21.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.433 178.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -131.02 114.8 15.64 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.411 ' HA2' HG12 ' A' ' 1' ' ' VAL . . . 70.44 29.02 70.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 76.41 48.29 9.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.616 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -159.06 87.62 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 179.823 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.6 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 88.0 m95 -58.42 123.94 17.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.105 -0.997 . . . . 0.0 109.314 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -133.02 165.14 25.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 111.445 -179.22 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 1.6 m-20 58.28 65.57 3.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.86 -0.525 . . . . 0.0 111.242 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.7 Cg_endo -92.87 132.23 0.96 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 121.972 1.782 . . . . 0.0 109.985 178.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -75.23 177.32 8.78 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.579 1.305 . . . . 0.0 109.879 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.499 ' OG1' HG12 ' A' ' 38' ' ' ILE . 8.4 p -118.84 141.48 48.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 111.721 -178.667 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' SER . 89.4 m -106.76 79.87 1.39 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.23 -151.72 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.808 -0.558 . . . . 0.0 109.928 -178.692 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.52 122.73 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 108.766 179.177 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.651 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 19.7 m -116.33 52.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 111.653 -178.311 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mtpt -65.2 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.801 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -129.8 151.26 77.86 Favored Pre-proline 0 C--N 1.295 -1.763 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.871 -178.368 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.534 ' HG3' ' HA ' ' A' ' 108' ' ' THR . 47.0 Cg_endo -84.51 9.4 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.649 1.868 . . . . 0.0 109.356 177.439 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.535 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 69.0 120.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.484 -0.76 . . . . 0.0 110.039 -179.172 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.565 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 56.2 Cg_endo -83.64 96.87 0.77 Allowed 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 123.957 1.504 . . . . 0.0 109.784 179.773 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.552 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 2.9 p -110.01 -42.28 4.25 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.191 0.996 . . . . 0.0 110.208 -179.18 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.605 HG23 ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 48.01 166.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.717 -178.406 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -69.48 104.47 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 111.14 -178.576 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 1.2 m120 40.51 41.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.826 . . . . 0.0 111.252 178.936 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -121.5 -39.14 0.59 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.043 -1.551 . . . . 0.0 109.807 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.5 p90 39.01 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.761 1.267 . . . . 0.0 112.196 -178.862 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -134.86 155.99 49.71 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.44 -178.916 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -105.79 -10.24 16.82 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 110.442 -178.891 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -53.74 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.79 79.74 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -69.19 163.41 24.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -1.075 . . . . 0.0 109.362 179.708 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.2 ttpt -154.56 160.38 41.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 -179.702 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -44.9 -52.35 8.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.202 179.895 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.508 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 74.3 m -131.65 164.67 25.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.1 m-85 -134.22 -140.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.514 ' CA ' HG21 ' A' ' 59' ' ' VAL . 59.9 p -170.08 -126.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.915 -1.116 . . . . 0.0 111.155 179.781 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -96.09 21.35 8.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.023 -1.048 . . . . 0.0 110.636 -178.663 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 103' ' ' CYS . 40.4 t-20 -164.15 -112.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.814 -1.178 . . . . 0.0 110.741 179.212 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 5.6 m-20 46.38 76.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.62 -1.3 . . . . 0.0 108.964 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.2 p-10 -69.23 145.92 52.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.819 . . . . 0.0 110.992 -178.855 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 2.1 m -131.08 118.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.22 178.947 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 11.4 t0 -83.04 119.53 24.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.877 . . . . 0.0 108.956 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.605 ' CD1' HG23 ' A' ' 66' ' ' ILE . 47.6 m-85 -78.7 135.56 37.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.136 0.97 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 5.9 tttt -117.1 88.2 2.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 -179.413 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.482 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -36.72 127.69 0.85 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.843 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -36.9 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.744 179.891 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.5 t80 -157.3 142.66 17.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.38 43.2 90.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 18.5 m-85 -147.8 159.06 44.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.528 -0.983 . . . . 0.0 110.182 -179.68 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 16.8 tttp -122.45 112.24 17.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' A' ' 66' ' ' ILE . 6.1 mt -48.76 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.37 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -81.33 96.38 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.693 179.615 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.27 -115.72 0.9 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 30.0 m -123.35 127.22 48.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -1.144 . . . . 0.0 110.224 -179.877 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -42.87 56.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.7 p -101.54 137.34 40.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 109.862 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 50.5 m -147.64 153.42 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.587 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -129.22 145.25 51.37 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.284 179.588 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 82' ' ' ASN . 3.4 t -67.08 78.09 0.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.65 -0.656 . . . . 0.0 110.45 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.88 172.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 111.064 -179.613 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.651 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 49.2 Cg_endo -81.82 36.27 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.444 1.76 . . . . 0.0 112.003 -178.309 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -128.07 8.48 6.74 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 178.396 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.2 t30 75.7 59.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.797 -0.825 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -170.25 178.85 3.66 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.445 -179.721 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.597 ' CZ3' HG21 ' A' ' 85' ' ' VAL . 19.9 m95 -108.55 87.93 2.61 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.234 0.54 . . . . 0.0 110.168 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.2 mmtt -99.43 147.45 33.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.0 Cg_endo -71.13 175.71 39.71 Favored 'Cis proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.998 -2.084 . . . . 0.0 110.883 0.404 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 tt0 -37.15 134.48 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.461 0.648 . . . . 0.0 110.97 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.586 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 1.6 tp -59.33 148.26 73.34 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.529 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 44.7 Cg_endo -75.45 165.74 30.05 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.049 1.552 . . . . 0.0 110.446 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.539 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -127.05 103.61 7.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -0.967 . . . . 0.0 110.215 179.668 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -55.65 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 109.483 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.6 m -108.26 -173.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.856 0.836 . . . . 0.0 111.04 -179.491 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.25 179.542 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -126.39 145.8 50.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.059 179.969 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' TYR . 1.7 m -69.25 156.96 37.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.497 -0.752 . . . . 0.0 110.976 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 11.3 mt-30 -127.8 167.86 15.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.98 179.299 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' GLN . 5.1 p -45.81 137.44 5.88 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.888 -1.133 . . . . 0.0 109.402 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.601 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 50.3 Cg_endo -69.84 160.79 48.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.071 1.564 . . . . 0.0 111.79 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.7 176.94 9.34 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.152 1.606 . . . . 0.0 110.012 178.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.09 177.28 7.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.538 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.06 -170.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 179.917 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -43.78 92.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.801 -179.344 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.6 m-80 40.27 52.07 2.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.535 179.701 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -148.97 170.52 29.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 30' ' ' SER . 1.6 mtt180 -115.63 -168.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -1.197 . . . . 0.0 110.783 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 19.3 p80 -156.49 127.08 6.69 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.338 0.59 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -124.11 -41.96 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.53 -102.13 0.78 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -172.69 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.112 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.489 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 11.0 pt-20 -178.29 -146.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.788 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.22 -43.11 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 28.9 p90 -128.51 118.26 22.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.709 179.335 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 15.9 m-85 -82.68 -175.05 5.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.516 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.89 -54.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.717 -1.239 . . . . 0.0 111.073 -178.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.04 137.28 0.07 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 109.295 -179.423 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.93 16.86 80.29 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -179.254 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -99.63 177.13 5.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -1.029 . . . . 0.0 110.153 -179.923 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 7.9 t -147.18 162.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.593 HG13 ' CE1' ' A' ' 29' ' ' TYR . 14.5 t -137.5 113.94 11.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.414 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -71.94 105.41 3.84 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.78 178.055 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.599 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.9 m-30 -68.09 170.63 8.11 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.86 -178.387 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -123.26 147.68 46.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.764 179.578 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.8 m -124.36 144.46 50.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.148 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.71 149.55 3.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -53.17 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.345 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.17 -2.77 4.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 7.8 m-85 -120.6 126.19 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.175 -1.191 . . . . 0.0 110.219 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.5 OUTLIER -76.15 149.5 37.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.554 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.4 OUTLIER -92.49 96.15 10.05 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.884 178.836 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.571 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.5 OUTLIER -86.56 148.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 -179.841 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 129.64 -160.86 22.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.852 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.475 ' O ' ' C ' ' A' ' 41' ' ' SER . 17.1 m-20 -92.17 54.06 2.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -1.203 . . . . 0.0 109.894 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 40' ' ' ASN . 75.5 p 31.1 48.78 0.08 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.41 179.581 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 143.81 134.98 2.91 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.599 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.8 t -67.1 178.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.254 -1.145 . . . . 0.0 108.34 178.685 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 26' ' ' VAL . 5.7 tp -139.65 99.08 3.62 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.202 177.996 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -83.36 114.62 21.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.393 178.756 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 p -132.65 81.43 1.95 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.13 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' GLY . . . 110.61 60.55 0.49 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.817 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.22 29.67 1.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.863 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -147.35 134.37 20.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -1.131 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.624 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.8 m95 -93.43 139.8 30.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.909 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -139.61 159.81 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.33 70.58 2.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.958 -0.464 . . . . 0.0 111.576 179.405 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -89.99 135.9 2.41 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.182 1.622 . . . . 0.0 109.077 178.612 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.559 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.4 Cg_endo -72.2 146.86 46.84 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 123.691 1.364 . . . . 0.0 110.746 -179.483 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.571 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 55.9 p -90.85 171.96 8.95 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.948 0.88 . . . . 0.0 111.689 -179.047 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 10' ' ' SER . 56.6 m -129.7 77.24 1.78 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.653 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.544 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -116.53 -157.29 0.65 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.54 -177.866 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 139.64 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.501 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.643 HG22 ' CB ' ' A' ' 81' ' ' TYR . 34.3 m -129.65 43.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.986 . . . . 0.0 111.086 -178.441 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -69.61 98.31 1.15 Allowed 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 56.4 m -69.33 163.52 57.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 110.79 -179.2 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.4 Cg_endo -70.62 -90.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.325 1.698 . . . . 0.0 110.569 -179.877 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.405 ' HB3' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -163.74 131.78 2.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.626 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -77.35 67.83 7.63 Favored 'Trans proline' 0 C--N 1.298 -2.125 0 O-C-N 123.565 1.298 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.54 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -89.21 -178.28 5.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 179.996 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.55 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -176.41 163.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.564 179.398 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.504 ' N ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -70.19 96.24 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.437 -179.737 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 22.1 m120 47.76 44.19 17.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -150.14 32.41 1.05 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.802 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 88' ' ' LYS . 10.5 p90 -45.76 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.523 1.154 . . . . 0.0 112.46 -179.121 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.571 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -115.0 164.01 14.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.244 -179.571 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.34 -7.78 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 -179.765 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 t -59.59 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.77 93.82 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -89.2 177.79 6.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -1.157 . . . . 0.0 109.601 179.527 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -167.33 153.39 7.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 110.189 -179.461 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.1 mtm-85 -46.48 -36.66 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -146.24 154.54 41.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.633 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.593 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 45.3 m-85 -123.63 -167.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.0 109.688 179.653 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 5.8 p -170.08 91.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.643 ' CB ' HG22 ' A' ' 59' ' ' VAL . 8.5 t80 56.18 135.38 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.605 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.562 ' HA ' HG23 ' A' ' 102' ' ' THR . 63.1 t30 65.09 -127.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.882 -1.137 . . . . 0.0 110.114 -179.258 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 1.7 m-20 52.98 70.75 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.684 -1.26 . . . . 0.0 109.009 -178.556 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 22.2 p-10 -72.91 140.04 47.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.487 -0.758 . . . . 0.0 111.259 -178.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.561 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 4.1 m -128.29 118.63 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.026 178.623 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.6 t70 -78.35 127.71 32.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.737 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE1' HD11 ' A' ' 71' ' ' LEU . 37.4 m-85 -89.07 122.79 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.249 1.023 . . . . 0.0 112.213 -178.289 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -97.63 94.53 7.03 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.791 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -44.24 129.03 6.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.061 -1.024 . . . . 0.0 110.001 -179.836 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.2 mmtt -40.35 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.53 -179.571 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -158.82 139.58 12.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 0.0 110.25 179.963 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.61 49.48 46.32 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 14.4 m-85 -155.22 147.42 23.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -1.071 . . . . 0.0 109.553 -179.614 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 117' ' ' VAL . 2.3 ttmt -105.06 148.6 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.961 -1.087 . . . . 0.0 110.26 -179.871 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 87' ' ' PHE . 1.2 mt -85.34 87.18 7.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 110.664 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -70.41 106.2 3.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 109.257 179.101 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.68 -86.56 0.21 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.562 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -162.91 115.76 1.6 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.164 -1.198 . . . . 0.0 110.676 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' PHE . 19.4 m -64.12 -40.32 95.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.27 -0.894 . . . . 0.0 110.793 179.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -107.85 117.61 34.58 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.958 -1.089 . . . . 0.0 110.793 -179.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.5 m -119.47 -170.89 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.562 HG23 ' HA ' ' A' ' 82' ' ' ASN . 9.3 m -163.08 134.32 4.88 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.408 -178.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -62.7 90.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.037 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.503 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 1.3 m -64.63 170.47 3.84 Favored Pre-proline 0 C--N 1.297 -1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 112.057 -178.669 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.618 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 49.8 Cg_endo -80.32 30.55 0.5 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.811 1.953 . . . . 0.0 111.886 -178.584 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -130.49 12.34 5.72 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 178.661 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.502 ' O ' ' CG2' ' A' ' 108' ' ' THR . 6.1 m-80 71.75 69.19 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.734 -0.863 . . . . 0.0 110.242 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -175.19 -163.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 111.206 -179.943 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.626 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 39.2 m95 -133.13 91.77 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.497 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -104.25 144.92 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 110.16 -179.705 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.2 Cg_endo -71.18 168.74 71.56 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.943 -2.107 . . . . 0.0 111.23 -0.478 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.46 127.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.472 0.653 . . . . 0.0 111.846 -178.994 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.55 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -42.18 142.99 1.1 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.714 . . . . 0.0 109.72 178.976 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.3 Cg_endo -71.44 169.91 19.73 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.214 1.639 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 117' ' ' VAL . 7.8 tttp -130.61 106.97 8.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.125 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.533 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.0 t -65.4 74.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 109.086 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.6 m -82.55 -175.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.057 0.932 . . . . 0.0 111.467 -179.154 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.705 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.633 179.883 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -138.06 177.33 7.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.854 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -138.92 93.14 2.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.974 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 1.1 mp0 -72.76 -175.89 1.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.21 139.44 45.79 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.024 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.606 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.2 Cg_endo -72.81 153.21 53.36 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.982 1.517 . . . . 0.0 110.275 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.58 169.57 22.01 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.908 1.478 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.7 p -70.86 176.19 4.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -142.91 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.175 0.988 . . . . 0.0 111.364 179.778 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -40.96 95.84 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.855 -179.215 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 9' ' ' ILE . 15.7 m-80 40.69 38.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.189 -0.944 . . . . 0.0 110.721 179.62 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -141.96 149.21 20.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.499 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 1.5 ptt180 -102.84 -173.19 2.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -1.149 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.606 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 14.6 p80 -136.64 133.54 36.35 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.259 0.552 . . . . 0.0 110.423 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -56.48 120.39 7.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.268 -179.853 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.09 71.62 0.32 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -88.43 -13.08 41.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -1.1 . . . . 0.0 110.172 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.614 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -120.02 -142.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.97 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -153.03 -39.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.606 179.765 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 5.1 p90 -128.93 79.56 1.92 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.194 -0.941 . . . . 0.0 109.935 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.627 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.6 m-85 -52.03 -29.77 22.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 110.779 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 69.66 -77.08 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.352 -0.843 . . . . 0.0 112.22 178.803 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 1.9 t70 -165.06 160.24 18.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.789 -1.195 . . . . 0.0 110.282 -179.083 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 63.18 16.67 58.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.627 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 33.0 m -95.69 173.9 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -1.009 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 40.5 t -154.22 153.84 7.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.706 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 29' ' ' TYR . 17.0 t -139.06 111.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.348 -179.437 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -67.3 105.29 1.72 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.295 -1.362 . . . . 0.0 107.783 178.248 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.619 ' CE1' HG23 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.19 109.0 3.36 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.442 -0.786 . . . . 0.0 110.147 -178.195 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.499 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -69.24 152.94 44.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.074 -1.016 . . . . 0.0 109.448 179.519 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.6 m -121.01 160.42 23.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.697 -179.37 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -44.69 164.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.366 -0.834 . . . . 0.0 109.972 179.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -67.39 86.59 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.59 1.9 5.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 2.6 m-30 -94.04 128.82 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -1.201 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.602 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -76.86 134.49 39.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 110.518 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -89.73 106.16 18.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.428 179.214 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.57 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.83 146.41 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.376 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 107.75 -172.47 17.46 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.72 -179.855 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.49 142.81 47.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 109.888 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.5 p -77.92 52.25 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.514 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 149.14 115.29 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' CE1' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -48.78 173.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.56 -1.256 . . . . 0.0 107.732 179.181 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.01 94.94 2.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.777 178.846 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.3 OUTLIER -80.32 105.75 11.82 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.998 178.847 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.2 95.87 3.63 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.271 -179.371 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.96 19.96 5.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' HG3' ' A' ' 49' ' ' GLU . . . 83.35 13.02 77.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG3' ' C ' ' A' ' 48' ' ' GLY . 47.2 mt-10 -145.96 138.61 25.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.161 . . . . 0.0 110.262 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 94.8 m95 -80.79 143.3 32.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -142.62 160.2 40.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -0.984 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.513 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.5 t0 58.3 65.44 3.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 111.448 179.465 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -91.16 134.19 1.67 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.385 1.729 . . . . 0.0 109.754 178.877 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -81.29 174.05 11.06 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.72 1.379 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.1 p -115.28 140.9 48.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 111.506 -178.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 10' ' ' SER . 62.9 m -105.46 76.77 1.23 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.08 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.15 177.65 4.64 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.457 0.646 . . . . 0.0 110.614 -178.292 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -92.0 148.68 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.589 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.659 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 13.0 m -129.15 47.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.821 -178.118 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 4.9 mmtt -85.43 160.83 19.64 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.032 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 108' ' ' THR . 65.4 m -135.6 166.3 29.6 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.216 -1.553 . . . . 0.0 113.019 -178.268 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 39.0 Cg_endo -66.94 -87.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.828 1.962 . . . . 0.0 110.386 179.158 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 132.42 1.79 Allowed Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.602 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.7 Cg_endo -75.84 65.06 6.81 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 123.825 1.434 . . . . 0.0 108.995 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.406 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -83.42 164.32 20.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.664 -0.648 . . . . 0.0 110.877 -179.058 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.574 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -164.17 164.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 179.725 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.444 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 32.8 t -73.88 106.17 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.514 -0.741 . . . . 0.0 110.848 -179.563 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 19.0 m-20 42.37 27.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.918 179.315 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -134.71 33.05 2.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.534 ' O ' ' O ' ' A' ' 69' ' ' GLY . 7.9 p90 -45.05 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.65 1.214 . . . . 0.0 112.275 -179.439 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.588 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.02 160.53 16.75 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.667 179.766 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 3.0 t -134.43 30.89 3.49 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.942 . . . . 0.0 109.823 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.5 t -103.66 -81.39 0.51 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -179.556 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.8 85.9 0.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.602 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.65 166.02 12.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -1.06 . . . . 0.0 109.684 179.705 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 4.0 tttt -162.41 158.51 24.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 -179.753 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -50.92 -33.41 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 0.0 109.888 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 6.6 p -136.57 173.33 11.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 0.0 109.927 179.682 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.602 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 52.8 m-85 -144.13 -171.69 3.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 1.2 p -146.2 -157.7 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.248 -0.907 . . . . 0.0 110.624 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.629 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -83.99 61.22 6.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.534 -1.354 . . . . 0.0 110.352 -179.759 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER 162.17 -16.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.986 -1.071 . . . . 0.0 111.518 179.516 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 38.9 m-20 -58.2 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.962 -1.086 . . . . 0.0 108.613 179.232 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p30 -76.78 145.19 38.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.552 -0.717 . . . . 0.0 111.294 -178.134 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.512 HG12 ' CH2' ' A' ' 109' ' ' TRP . 11.9 m -133.78 116.41 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 178.665 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -80.06 135.37 36.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 49.5 m-85 -92.93 138.72 31.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.893 -1.129 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 0.2 OUTLIER -113.79 92.97 4.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.89 -179.657 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.94 132.42 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 110.233 -179.731 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.45 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.805 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.7 t80 -157.96 128.89 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 62.24 57.15 18.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 35.6 m-85 -162.12 147.9 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.996 . . . . 0.0 109.982 -179.384 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 117' ' ' VAL . 10.8 mttm -101.85 152.62 20.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.816 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -94.05 87.5 5.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.554 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 11.2 t -71.68 107.72 4.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.057 -1.027 . . . . 0.0 109.609 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.44 -78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.558 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -172.46 116.21 0.33 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.344 -1.092 . . . . 0.0 110.62 -179.693 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.5 p -68.6 -11.91 60.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.5 p -134.3 140.59 46.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.873 -1.142 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.0 m -154.77 162.9 40.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 -179.459 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.537 ' CG2' ' C ' ' A' ' 82' ' ' ASN . 5.2 m -136.42 138.31 41.39 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.3 0.572 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 80' ' ' SER . 1.9 t -43.58 -28.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.421 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER 64.2 165.99 0.11 Allowed Pre-proline 0 C--N 1.293 -1.88 0 CA-C-O 121.391 0.615 . . . . 0.0 112.031 178.321 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.659 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 50.6 Cg_endo -81.96 4.4 7.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.636 1.861 . . . . 0.0 111.1 -179.026 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -103.51 2.64 46.17 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.594 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 17.0 m-80 73.68 48.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.885 -0.774 . . . . 0.0 110.743 179.825 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.553 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -166.44 150.71 7.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 110.864 178.805 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.602 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 58.2 m95 -71.79 88.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.709 0.766 . . . . 0.0 110.959 -179.336 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.4 mmtp -104.02 132.51 20.94 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.729 -0.607 . . . . 0.0 109.559 179.633 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.558 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.2 Cg_endo -72.55 167.78 76.8 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.859 -2.142 . . . . 0.0 110.52 0.377 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.6 mp0 -43.1 149.83 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.214 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -55.13 151.57 17.0 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.264 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 38.4 Cg_endo -73.57 169.47 22.25 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 O-C-N 124.299 1.684 . . . . 0.0 110.868 -179.868 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -126.77 110.14 12.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.24 -0.912 . . . . 0.0 110.475 -179.779 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -66.3 73.81 0.08 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.817 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 94' ' ' LYS . 1.2 m -84.09 -175.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.845 0.831 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.579 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 8.2 ptt85 . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.4 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.324 0.583 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -133.17 174.58 10.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 179.685 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -142.3 85.71 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.936 -179.952 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.497 ' HG2' ' CE1' ' A' ' 20' ' ' PHE . 30.0 mt-30 -63.05 177.74 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.903 -1.123 . . . . 0.0 109.71 179.803 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 4' ' ' GLN . 3.6 p -43.28 145.87 0.95 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 0.0 109.74 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.595 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 49.2 Cg_endo -69.84 170.88 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.713 -179.541 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.84 171.75 13.97 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.011 1.532 . . . . 0.0 109.523 178.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.02 97.69 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.246 -179.937 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.57 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.31 -175.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 0.0 110.918 -179.779 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -101.85 140.26 36.38 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.546 179.909 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t-20 71.39 8.76 6.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.708 179.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.13 -179.46 34.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -132.68 -166.85 1.81 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.364 -1.08 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 17.0 p80 -155.59 -163.38 1.5 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.768 179.968 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 4.6 t-20 65.33 -141.17 0.21 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.02 -67.09 0.41 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -120.09 -4.67 10.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 109.572 179.536 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 26.9 mt-10 -106.68 -174.86 2.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.791 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 169.06 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.07 -1.019 . . . . 0.0 111.153 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -139.04 67.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 111.396 -179.055 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.623 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 3.1 m-85 -75.26 174.58 9.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 108.999 178.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.54 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 36.4 p -137.87 -57.34 0.67 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.756 -1.215 . . . . 0.0 111.356 -178.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.04 130.15 0.77 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.185 -0.947 . . . . 0.0 110.083 -179.169 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.77 22.39 61.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.471 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.619 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 28.0 m -111.33 168.87 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -1.026 . . . . 0.0 110.049 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.581 ' CG1' ' HA3' ' A' ' 42' ' ' GLY . 21.8 t -140.77 148.22 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 112.205 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 29' ' ' TYR . 28.8 t -116.3 122.84 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.561 -0.712 . . . . 0.0 111.662 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.83 102.66 7.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.478 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.656 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.6 m-30 -68.11 149.87 49.08 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.256 -178.098 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -95.47 152.75 18.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 179.427 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.452 ' SG ' HD13 ' A' ' 37' ' ' LEU . 86.0 m -125.63 146.6 49.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 0.0 110.393 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.2 145.66 25.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.231 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.7 p -56.05 110.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.33 -4.62 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.552 ' CE1' HG12 ' A' ' 58' ' ' ILE . 8.9 m-85 -124.42 155.88 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.268 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.564 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -101.29 149.9 23.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.242 179.659 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 55' ' ' THR . 1.0 OUTLIER -88.25 108.59 19.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.451 -0.78 . . . . 0.0 109.511 179.242 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -100.55 143.97 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.175 -179.856 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.68 -156.26 22.37 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 m-20 -93.26 55.49 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.325 . . . . 0.0 109.774 179.497 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 40' ' ' ASN . 53.1 p 30.07 47.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.484 179.636 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.581 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 143.7 136.34 3.1 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.551 179.671 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.656 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.8 t -65.36 179.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.206 -1.173 . . . . 0.0 108.067 178.706 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 1.6 tp -143.25 95.19 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.669 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -80.57 113.23 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 109.048 178.774 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.11 112.26 18.01 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.265 -179.553 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.23 58.79 8.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 49.54 53.96 18.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.38 95.23 1.01 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -1.112 . . . . 0.0 110.59 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 74.3 m95 -65.88 133.52 51.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 52' ' ' ASP . 15.9 m -142.7 177.25 8.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.698 -179.37 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 3.2 p30 36.15 71.25 0.93 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.969 -0.457 . . . . 0.0 111.874 179.651 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.23 138.13 3.25 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.05 1.552 . . . . 0.0 109.515 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.52 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 46.4 Cg_endo -73.36 176.95 8.53 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.79 1.416 . . . . 0.0 110.644 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 8.8 p -121.86 157.53 30.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 111.54 -178.679 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.1 m -116.68 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.823 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -118.03 -156.96 0.66 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.204 -178.454 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.552 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -108.78 152.86 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.856 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.586 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 26.3 m -137.39 48.29 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 111.115 -178.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mttt -90.63 173.45 8.04 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.49 178.7 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 47.8 m -132.65 167.16 24.09 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.479 -1.388 . . . . 0.0 112.333 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.2 Cg_endo -76.19 -53.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.747 1.919 . . . . 0.0 109.909 178.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.95 125.37 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.946 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.608 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 45.6 Cg_endo -75.08 59.78 5.33 Favored 'Trans proline' 0 C--N 1.292 -2.403 0 O-C-N 123.69 1.363 . . . . 0.0 110.554 -178.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.504 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 1.2 p -78.62 -171.79 2.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.465 -0.772 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER 178.25 168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.643 179.356 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.509 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -71.79 102.84 2.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.499 -0.75 . . . . 0.0 110.83 -179.638 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.527 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 2.5 m-20 40.05 43.99 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.456 -0.778 . . . . 0.0 110.858 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.621 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -155.02 35.26 0.66 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.621 ' O ' ' O ' ' A' ' 69' ' ' GLY . 15.6 p90 -42.49 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 123.409 1.576 . . . . 0.0 114.188 -179.325 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.592 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -149.34 136.53 19.91 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -175.491 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t -121.8 27.39 8.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 109.775 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -69.83 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 111.39 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -124.03 -73.45 0.25 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.879 -178.823 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.549 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 22.8 t80 58.44 163.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -1.012 . . . . 0.0 109.973 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.571 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 8.0 tttm -178.94 140.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.455 -0.778 . . . . 0.0 110.059 179.731 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -42.74 -36.01 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 179.67 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 2.6 p -125.88 166.27 17.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.676 . . . . 0.0 109.75 179.369 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 74.0 m-85 -141.07 -168.9 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.535 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 3.9 m -155.54 -158.54 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -69.38 2.94 2.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.349 -1.47 . . . . 0.0 111.19 -179.057 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.506 ' HA ' HG23 ' A' ' 102' ' ' THR . 8.8 p30 -139.21 -111.53 0.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.781 -1.199 . . . . 0.0 110.266 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.468 ' C ' HG21 ' A' ' 102' ' ' THR . 1.5 m-20 50.88 65.69 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.849 -1.157 . . . . 0.0 109.623 -179.406 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.524 ' N ' HG21 ' A' ' 102' ' ' THR . 18.8 p-10 -69.4 110.86 4.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.606 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 26.0 m -97.26 121.85 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.862 -1.149 . . . . 0.0 111.204 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -78.05 138.79 38.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.204 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CE2' HD21 ' A' ' 71' ' ' LEU . 24.4 m-85 -98.64 145.54 26.76 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.986 -1.072 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.82 96.81 5.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.648 -0.658 . . . . 0.0 110.093 -179.708 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.501 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -46.46 134.5 9.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.527 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -41.14 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.338 -0.851 . . . . 0.0 110.241 -179.855 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -160.74 124.78 3.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 69.27 53.84 16.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.675 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 51.6 m-85 -160.68 152.21 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -1.022 . . . . 0.0 109.892 -179.249 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.476 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -107.27 136.78 46.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.012 . . . . 0.0 109.963 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.522 HD22 ' CD1' ' A' ' 66' ' ' ILE . 0.9 OUTLIER -75.65 89.82 2.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.075 -179.875 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.4 t -74.74 101.86 4.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -0.905 . . . . 0.0 110.285 -179.999 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.06 -64.79 0.44 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 177.35 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -1.105 . . . . 0.0 110.377 -179.606 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.8 p -68.94 -3.94 14.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.943 . . . . 0.0 110.743 -179.564 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 64.5 p -140.13 93.76 2.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.545 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 19.5 m -104.04 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 110.991 -179.411 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.524 HG21 ' N ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.98 137.76 23.78 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.929 -0.709 . . . . 0.0 110.455 -179.614 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.61 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 49.2 t -56.74 107.28 0.38 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -0.778 . . . . 0.0 109.461 179.642 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.5 175.1 4.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.556 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HA ' ' CB ' ' A' ' 59' ' ' VAL . 41.2 Cg_endo -77.45 167.19 24.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.857 1.451 . . . . 0.0 111.584 -179.166 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 89.93 -58.72 3.62 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 -178.545 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.621 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 147.13 71.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 122.271 0.228 . . . . 0.0 111.123 178.537 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -169.78 166.95 9.55 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.314 -1.491 . . . . 0.0 112.536 179.236 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 24.2 m95 -101.55 92.09 4.74 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 179.564 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 16.2 mttt -101.03 142.59 24.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.222 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.545 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.4 Cg_endo -71.0 168.97 70.64 Favored 'Cis proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.706 -0.849 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -39.8 129.96 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.544 -0.723 . . . . 0.0 110.847 -179.6 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -39.7 147.07 0.34 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 0.0 110.422 179.385 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 38.5 Cg_endo -70.35 166.7 27.45 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.398 1.736 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.53 ' HG2' ' CG1' ' A' ' 117' ' ' VAL . 4.7 ttpt -127.29 107.83 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.463 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.9 t -64.4 90.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.077 -1.015 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.53 ' CG1' ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -103.77 -175.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.904 0.859 . . . . 0.0 110.821 -179.414 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.928 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.448 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 2' ' ' LYS . 12.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.228 0.537 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.421 ' N ' HG21 ' A' ' 1' ' ' VAL . 0.3 OUTLIER -126.79 176.79 7.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.511 -179.743 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 4.1 t -159.37 101.25 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.217 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.6 mt-30 -87.46 -177.59 5.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -39.69 141.05 0.77 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 -179.766 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 49.9 Cg_endo -71.32 159.89 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.095 1.576 . . . . 0.0 111.228 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.6 170.91 19.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.102 1.58 . . . . 0.0 109.898 179.371 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -73.26 174.4 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.45 -170.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.219 1.009 . . . . 0.0 111.559 179.631 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -38.62 94.1 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.986 -179.138 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.2 m120 41.39 30.83 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -132.16 150.44 19.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.936 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 30' ' ' SER . 3.8 mtt180 -96.36 -170.87 2.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -1.075 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 18.9 p80 -147.16 120.09 8.74 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.228 0.537 . . . . 0.0 109.965 -179.738 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -123.46 109.53 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.748 -179.552 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' CA ' ' OH ' ' A' ' 21' ' ' TYR . . . -101.5 -5.47 51.77 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.463 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 68.44 24.2 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.279 -1.13 . . . . 0.0 110.375 179.975 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 3.8 pt-20 -160.57 -160.56 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 19' ' ' ASP . 5.7 t0 -131.83 -27.41 1.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.073 -1.017 . . . . 0.0 110.714 -179.586 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 9.9 m-85 -119.88 134.88 55.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.78 -179.63 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -124.08 -13.93 7.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.459 -0.776 . . . . 0.0 110.204 179.882 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.541 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . 47.6 p 45.95 -98.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.554 -0.716 . . . . 0.0 111.68 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -143.7 156.82 44.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 110.438 -178.443 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 70.13 16.25 72.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.086 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -94.29 174.9 6.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.624 -0.927 . . . . 0.0 110.328 -179.7 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 37.9 t -154.21 153.22 8.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.048 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.616 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 41.5 t -139.65 123.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.66 -179.433 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.56 101.9 3.71 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.247 . . . . 0.0 107.78 177.899 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.654 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.2 m-30 -68.03 134.24 50.34 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.308 -178.208 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.01 163.09 15.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.914 179.606 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 37' ' ' LEU . 70.9 m -127.36 159.25 35.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 110.175 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.92 154.85 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.894 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 100.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.74 8.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.9 m-30 -110.01 158.66 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -1.177 . . . . 0.0 110.005 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.55 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 24.3 m -103.71 130.39 51.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.389 -0.819 . . . . 0.0 110.677 -179.337 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.505 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 3.2 tp -83.0 117.71 23.0 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.237 179.132 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.571 HG22 ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -115.97 143.77 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.31 -168.02 12.8 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.561 -1.815 . . . . 0.0 108.561 -179.0 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 30.5 p-10 -66.37 130.76 44.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.968 -1.313 . . . . 0.0 109.496 179.476 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 28' ' ' THR . 30.2 p -70.01 57.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.992 . . . . 0.0 109.511 179.767 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 155.92 117.34 0.57 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.491 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.654 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -61.19 -176.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.95 -1.323 . . . . 0.0 107.848 179.248 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.9 tp -144.47 102.29 3.81 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.318 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -86.15 111.91 20.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.363 -0.835 . . . . 0.0 109.656 179.423 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 88.39 2.93 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.43 50.52 3.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 57.27 25.07 53.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' TRP . 2.3 tt0 -125.8 71.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.606 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 72.9 m95 -45.84 129.67 9.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -144.1 173.4 11.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.996 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.523 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 53.29 65.1 6.11 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 110.884 -179.949 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.6 Cg_endo -91.53 135.63 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.444 1.76 . . . . 0.0 110.096 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.91 -173.56 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.739 1.389 . . . . 0.0 110.37 179.593 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -120.13 -172.01 2.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.963 0.887 . . . . 0.0 111.564 -178.833 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 95.9 m -152.05 80.91 1.26 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.468 ' C ' HG13 ' A' ' 58' ' ' ILE . 5.2 mm100 -111.41 -139.8 0.38 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.413 0.625 . . . . 0.0 110.912 -177.747 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.468 HG13 ' C ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -137.57 106.55 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.848 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 26.8 m -105.51 64.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.153 -0.967 . . . . 0.0 112.526 -178.224 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 14.8 mttt -67.49 -175.69 0.53 Allowed 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 117.531 -1.668 . . . . 0.0 107.624 178.072 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.64 163.59 35.43 Favored Pre-proline 0 C--N 1.296 -1.741 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.597 -178.085 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -86.91 -83.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.92 2.011 . . . . 0.0 110.6 179.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.484 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 175.14 130.75 0.14 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.611 -0.681 . . . . 0.0 109.298 -179.433 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.61 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 49.8 Cg_endo -80.02 64.06 8.82 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 O-C-N 123.739 1.389 . . . . 0.0 109.896 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 p -77.05 175.65 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.813 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.594 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -172.84 168.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 118.522 -1.271 . . . . 0.0 110.7 179.307 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.491 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.69 100.32 3.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.527 -0.733 . . . . 0.0 110.691 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 35.1 m-20 42.41 48.15 4.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -160.28 37.81 0.45 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.594 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 54.3 p90 -50.2 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.952 1.358 . . . . 0.0 112.922 -179.783 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.587 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -142.84 127.03 17.52 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.736 -176.562 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -109.14 19.22 19.72 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 110.192 -179.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 31.3 t -84.17 -88.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.906 -179.47 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -101.03 -71.91 0.96 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.279 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 51.1 t80 57.04 170.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -1.07 . . . . 0.0 109.665 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.635 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 174.23 130.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 179.932 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 76' ' ' LYS . 9.4 mtt180 -40.76 -32.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.797 . . . . 0.0 110.027 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.84 126.24 20.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 11.2 m-85 -106.11 -151.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 103' ' ' CYS . 59.9 p -159.85 -126.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.944 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.597 ' N ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -102.07 33.63 3.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.987 -1.071 . . . . 0.0 110.84 -179.243 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 103' ' ' CYS . 17.9 t-20 -172.29 -112.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.093 -1.005 . . . . 0.0 110.367 179.007 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 t0 47.39 75.06 0.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.641 -1.287 . . . . 0.0 109.162 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.494 ' HB3' HG22 ' A' ' 102' ' ' THR . 12.7 p-10 -69.62 112.69 6.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.576 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 31.4 m -98.15 121.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.983 -1.073 . . . . 0.0 111.17 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -80.12 139.58 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.395 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.587 ' CZ ' HD21 ' A' ' 71' ' ' LEU . 65.3 m-85 -95.5 146.52 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.811 -1.181 . . . . 0.0 112.396 -178.205 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.73 91.55 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.367 179.695 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.46 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 135.28 3.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.928 . . . . 0.0 109.957 -179.551 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 89' ' ' CYS . 6.8 mmmt -39.63 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 110.687 -179.545 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.6 t80 -168.68 130.81 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.297 -0.877 . . . . 0.0 110.358 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.18 53.43 46.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 25.2 m-85 -158.77 150.47 20.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -1.013 . . . . 0.0 109.959 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -102.95 154.59 19.07 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.401 -0.812 . . . . 0.0 109.038 179.362 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -93.93 96.26 9.6 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 110.499 -179.447 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.454 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.13 101.82 4.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 109.646 179.526 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.53 -77.17 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.561 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -171.59 114.43 0.37 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 110.896 -179.632 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 m -71.34 -2.45 16.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.231 -0.918 . . . . 0.0 110.481 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -143.33 113.83 7.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.111 179.773 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.497 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 27.3 m -126.0 160.16 30.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.6 139.53 50.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.582 0.706 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.51 84.36 1.52 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.485 -0.76 . . . . 0.0 110.107 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.429 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -62.95 173.99 0.95 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.985 -179.55 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.8 Cg_endo -73.34 123.46 8.73 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.391 1.732 . . . . 0.0 110.104 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.58 -9.31 4.96 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -178.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.8 m120 80.71 89.35 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.909 -0.76 . . . . 0.0 110.295 179.701 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.06 -160.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.281 -0.887 . . . . 0.0 110.933 179.85 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 30.4 m95 -145.84 86.09 1.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.608 0.718 . . . . 0.0 109.712 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 21.0 mttt -99.77 139.05 20.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.705 . . . . 0.0 110.255 -179.349 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.561 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.9 Cg_endo -71.34 166.51 77.83 Favored 'Cis proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.009 -2.079 . . . . 0.0 110.781 -0.127 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.2 mp0 -40.37 137.81 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.539 -0.725 . . . . 0.0 110.644 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.57 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.7 OUTLIER -43.52 155.98 0.29 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 179.744 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.555 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 40.8 Cg_endo -80.06 169.48 17.66 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 124.397 1.735 . . . . 0.0 111.074 -179.609 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 117' ' ' VAL . 6.8 tttt -127.35 111.12 13.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.532 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -67.67 98.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.117 -0.989 . . . . 0.0 109.425 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -112.76 -176.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.736 0.779 . . . . 0.0 110.507 -179.627 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.46 ' OXT' ' HG3' ' A' ' 118' ' ' ARG . 9.0 ptt85 . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.451 179.63 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.26 0.552 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -122.19 162.6 21.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -143.33 78.38 1.6 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.22 179.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -51.91 145.44 17.15 Favored Pre-proline 0 C--N 1.3 -1.559 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.76 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.621 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.7 Cg_endo -73.99 159.86 43.99 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.896 1.472 . . . . 0.0 110.117 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.93 170.0 19.91 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.661 1.348 . . . . 0.0 109.997 179.284 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 p -88.82 105.06 17.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.983 . . . . 0.0 110.365 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.595 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -56.29 -170.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.03 0.919 . . . . 0.0 111.289 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.13 138.15 31.74 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.424 -178.846 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 56' ' ' CYS . 10.5 m120 49.05 20.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.48 -0.763 . . . . 0.0 110.931 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.2 157.66 27.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.437 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 mpt_? -118.23 -166.33 1.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -1.19 . . . . 0.0 111.059 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.621 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.5 p80 -151.22 131.55 13.69 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.614 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -155.34 -145.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 110.751 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . 129.4 4.89 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 7.7 t80 70.96 24.31 4.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.163 -1.198 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CG ' ' HE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -126.12 168.9 13.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.068 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.24 -31.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 110.515 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.25 139.06 52.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.08 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.2 m-85 -123.03 -7.08 8.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 110.985 -179.624 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.558 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.8 p 43.3 -96.61 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 111.405 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 17.4 t0 -153.52 138.49 17.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.953 -1.092 . . . . 0.0 110.363 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.49 37.4 8.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.641 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 66.4 m -135.17 161.33 35.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.261 -1.141 . . . . 0.0 109.951 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.562 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 25.3 t -134.19 147.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.0 112.28 -178.141 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.584 HG22 ' CH2' ' A' ' 50' ' ' TRP . 32.3 t -117.95 119.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.725 -0.609 . . . . 0.0 111.743 -179.523 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -73.4 102.95 3.9 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.78 -1.168 . . . . 0.0 107.897 177.641 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.636 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.12 126.72 30.41 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.419 -0.8 . . . . 0.0 109.848 -178.515 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.63 163.62 25.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.0 -1.063 . . . . 0.0 109.36 179.467 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.44 49.44 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.051 -1.03 . . . . 0.0 110.433 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.62 143.34 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -62.55 106.17 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.74 -11.51 6.28 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.489 ' CE2' HG13 ' A' ' 58' ' ' ILE . 3.9 m-85 -114.06 146.31 40.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.149 -1.206 . . . . 0.0 110.629 -179.617 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.606 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -84.17 142.27 30.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -0.911 . . . . 0.0 110.753 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.5 OUTLIER -98.61 95.01 6.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.535 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.592 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.7 OUTLIER -81.16 152.1 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.785 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 127.92 -146.54 16.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 41' ' ' SER . 36.4 m-80 -120.73 53.26 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 110.128 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 40' ' ' ASN . 71.3 p 28.03 48.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.774 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.511 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 156.94 125.49 0.87 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.673 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.636 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.0 t -71.48 179.45 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.502 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.86 92.61 2.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.648 -1.282 . . . . 0.0 111.247 179.55 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.598 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -79.47 106.97 11.88 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.407 178.125 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.483 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -135.11 103.51 5.58 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.226 -179.054 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.77 11.25 35.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.5 19.07 60.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' TRP . 9.1 mt-10 -139.16 91.4 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -1.153 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 70.7 m95 -43.3 135.88 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 p -147.64 166.29 27.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 111.048 -179.707 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 57.3 64.35 4.35 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.603 -0.686 . . . . 0.0 111.285 179.837 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.9 Cg_endo -92.72 145.65 2.55 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.992 1.795 . . . . 0.0 110.086 179.084 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 52.9 Cg_endo -84.28 176.79 6.29 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.7 1.369 . . . . 0.0 109.949 179.245 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.592 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 27.3 p -130.21 141.88 50.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 111.54 -179.53 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -100.51 88.52 3.66 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.584 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 36' ' ' SER . 51.6 mm-40 -120.36 -165.57 1.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.424 -178.314 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.489 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -115.4 104.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.04 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.606 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 13.0 m -92.97 47.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 111.801 -178.199 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -88.65 97.7 11.26 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.345 178.586 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 36.0 m -69.55 162.51 66.55 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 112.12 -178.004 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 45.4 Cg_endo -71.61 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.651 1.869 . . . . 0.0 110.762 -179.73 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.409 ' C ' ' NE1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -161.58 133.65 4.19 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.705 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 50.3 Cg_endo -78.01 65.26 8.34 Favored 'Trans proline' 0 C--N 1.293 -2.35 0 O-C-N 123.674 1.355 . . . . 0.0 109.784 -179.329 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.527 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -83.08 171.95 13.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.608 -0.682 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.54 HD12 ' HA3' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.67 166.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.522 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.45 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -75.28 109.94 9.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.534 -0.729 . . . . 0.0 111.0 -179.254 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.505 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.6 m-80 38.63 34.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.765 . . . . 0.0 110.844 179.299 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.54 ' HA3' HD12 ' A' ' 66' ' ' ILE . . . -143.68 30.36 1.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.527 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.3 p90 -45.66 -171.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.718 1.247 . . . . 0.0 112.479 -179.612 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.554 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -116.4 157.97 24.24 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.794 178.792 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.75 26.52 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.082 -179.181 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -73.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.669 -179.586 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.459 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -127.43 75.97 0.41 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.627 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.5 t80 -104.36 165.72 10.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.585 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -163.16 162.88 25.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -56.76 -35.86 69.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.92 179.936 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -139.83 167.35 22.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.988 179.698 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.555 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.0 m-85 -138.51 -173.93 3.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.735 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.8 m -169.39 106.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 111.283 -179.75 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.63 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 3.2 t80 46.31 15.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.154 -0.966 . . . . 0.0 112.686 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 103' ' ' CYS . 17.1 t-20 -175.84 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 119.926 -1.734 . . . . 0.0 111.987 178.308 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 8.3 m-20 49.63 76.87 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.671 -1.268 . . . . 0.0 108.747 -178.027 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.5 p-10 -69.2 135.42 50.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 0.0 111.109 -178.689 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.581 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 10.8 m -115.81 120.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.519 179.11 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t0 -85.15 130.71 34.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 108.651 179.436 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' HB3' ' CD2' ' A' ' 95' ' ' LEU . 67.6 m-85 -89.87 129.52 36.23 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.291 1.043 . . . . 0.0 112.567 -177.88 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -104.43 91.64 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.48 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -45.27 127.38 7.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.957 -1.09 . . . . 0.0 109.59 -179.736 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.505 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 15.8 mmtp -37.27 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.687 -0.633 . . . . 0.0 110.787 -179.097 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.586 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 17.6 t80 -158.99 136.12 9.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.544 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.67 44.68 97.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 28.3 m-85 -154.56 150.86 28.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.503 -0.998 . . . . 0.0 109.846 -179.338 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.477 ' O ' HG21 ' A' ' 117' ' ' VAL . 18.1 ptpt -116.98 126.46 52.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.674 179.529 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -56.69 112.95 1.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.758 -179.255 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -89.51 94.79 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.525 179.287 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.85 -39.17 1.42 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.4 OUTLIER 172.55 -178.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.155 -1.203 . . . . 0.0 111.037 -179.65 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 51.7 p -141.76 10.39 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 0.0 109.967 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -169.53 113.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.491 -0.755 . . . . 0.0 109.107 179.831 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 29.8 m -124.75 162.4 24.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.225 -0.922 . . . . 0.0 111.048 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.13 142.26 50.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 3.0 t -60.92 83.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.645 -0.66 . . . . 0.0 109.3 179.468 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.94 170.33 8.89 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.0 110.867 -179.245 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.0 Cg_endo -73.77 127.54 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.176 1.619 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.57 -11.43 5.75 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -179.055 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 14.0 m-20 82.0 76.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.068 -0.666 . . . . 0.0 110.39 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -169.87 -158.81 0.19 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.517 -0.739 . . . . 0.0 110.786 179.789 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.583 ' CZ2' ' HD3' ' A' ' 64' ' ' PRO . 21.0 m95 -142.26 98.96 3.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.343 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 45.8 mttt -100.73 141.9 23.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 110.155 -179.597 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.516 ' CG ' ' OG ' ' A' ' 98' ' ' SER . 49.2 Cg_endo -72.07 170.57 66.39 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.057 -2.059 . . . . 0.0 110.866 0.256 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.5 tt0 -40.28 125.8 2.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 110.114 179.853 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.561 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -41.08 141.32 1.02 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.431 -0.793 . . . . 0.0 110.032 -179.84 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.529 ' HB3' ' O ' ' A' ' 98' ' ' SER . 46.6 Cg_endo -80.26 166.87 20.1 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.467 1.772 . . . . 0.0 112.074 -178.38 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.526 ' O ' HG23 ' A' ' 117' ' ' VAL . 11.0 ttpt -125.63 106.16 9.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.669 . . . . 0.0 109.977 179.53 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -58.7 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.016 . . . . 0.0 109.297 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.0 m -110.63 -171.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.936 0.874 . . . . 0.0 111.224 -179.438 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.491 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 1' ' ' VAL . 32.9 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.216 0.532 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -115.55 161.97 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -131.43 81.93 2.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 110.57 -179.862 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.4 mt-30 -60.91 177.06 0.35 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.047 -1.033 . . . . 0.0 109.093 179.225 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.6 p -40.91 144.21 0.65 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 44.4 Cg_endo -67.9 162.42 39.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.713 1.375 . . . . 0.0 110.893 -179.097 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.77 166.5 29.78 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.06 1.558 . . . . 0.0 110.118 179.702 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.04 176.07 5.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.179 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.467 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.25 -169.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.164 0.983 . . . . 0.0 111.544 179.934 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 11' ' ' ASN . 29.7 t -63.25 114.04 3.56 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.619 -178.665 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER 37.32 41.99 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.664 -0.647 . . . . 0.0 111.266 179.127 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.41 154.86 25.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.575 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.505 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -109.56 -179.41 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -1.188 . . . . 0.0 110.777 -179.825 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.0 p80 -139.29 -154.89 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 12.5 t30 66.53 -170.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.105 -179.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.16 -4.76 18.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -32.48 2.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -1.194 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.574 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 179.16 -176.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 0.0 110.291 -179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 5' ' ' SER . 9.9 t70 -103.96 -25.07 13.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.596 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.6 m-85 -105.71 -174.81 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -178.71 -25.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.422 179.655 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 7.6 p 59.55 -94.36 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.588 -0.695 . . . . 0.0 112.661 178.839 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -148.17 159.38 44.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.646 -1.283 . . . . 0.0 110.582 -178.078 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 13.28 57.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.585 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.603 -0.94 . . . . 0.0 110.123 -179.867 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.0 t -155.69 155.75 5.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.579 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 43' ' ' VAL . 21.6 t -139.34 125.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.886 -179.487 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.76 103.9 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.601 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.09 121.31 15.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -177.937 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.505 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -75.67 153.57 37.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.998 . . . . 0.0 109.127 178.904 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.9 m -121.02 170.54 9.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.692 -179.285 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -62.94 137.26 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -46.96 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 110.324 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 123.32 17.04 3.34 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 13.6 m-85 -125.8 141.1 52.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 110.18 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.532 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -85.24 142.13 29.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.944 . . . . 0.0 110.967 -179.455 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.0 tp -89.61 98.1 11.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.424 -0.798 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.582 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.7 OUTLIER -86.47 141.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.312 -179.764 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.63 -172.48 14.63 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.654 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -64.5 145.25 56.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.07 179.863 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -76.22 53.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 152.5 115.37 0.62 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -54.73 -178.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.004 -1.292 . . . . 0.0 107.853 178.831 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.4 tp -146.19 99.32 3.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 110.217 178.681 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.79 109.18 16.71 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.644 179.103 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.88 107.98 10.07 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.82 8.48 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.895 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 60.92 38.75 95.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.859 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 25.0 mt-10 -151.04 88.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 110.798 -179.582 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 78.5 m95 -50.68 136.99 20.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.339 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.79 162.22 36.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.958 -1.089 . . . . 0.0 111.507 -179.325 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.9 t0 58.57 66.09 2.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.8 Cg_endo -90.94 126.55 1.14 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 O-C-N 124.394 1.734 . . . . 0.0 109.753 178.774 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -74.24 165.53 31.66 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.864 1.455 . . . . 0.0 110.252 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 66.1 p -105.52 150.91 24.92 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.12 -0.988 . . . . 0.0 111.215 -179.444 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 57' ' ' GLN . 77.0 m -111.72 82.18 1.57 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 3.1 mm100 -115.4 -150.7 0.47 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.713 0.768 . . . . 0.0 110.738 -177.817 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.78 125.86 71.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.691 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.612 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 31.0 m -115.68 50.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 0.0 112.08 -178.163 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 30.6 mttt -59.51 -173.31 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 117.739 -1.584 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.516 ' SG ' ' CD ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -146.0 170.12 8.48 Favored Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.948 -178.724 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.516 ' CD ' ' SG ' ' A' ' 61' ' ' CYS . 45.3 Cg_endo -92.19 -72.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.396 2.064 . . . . 0.0 109.848 179.226 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.18 125.42 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.718 -0.614 . . . . 0.0 109.674 -179.636 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.602 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.6 Cg_endo -78.36 71.07 6.95 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 123.81 1.426 . . . . 0.0 110.172 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -89.91 171.69 9.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.925 179.915 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.59 HG22 ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -170.84 155.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.057 -1.027 . . . . 0.0 110.266 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 68' ' ' ASN . 35.5 t -61.45 107.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.751 . . . . 0.0 111.014 -179.357 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 3.3 m-20 39.95 37.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 0.0 110.682 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -143.48 27.15 2.11 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.54 ' O ' ' O ' ' A' ' 69' ' ' GLY . 2.0 p90 -44.32 -174.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.737 1.256 . . . . 0.0 112.362 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.584 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -111.18 164.38 12.93 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.58 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -144.77 20.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 110.039 -179.626 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -103.02 -79.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 110.856 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.27 77.35 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -106.12 168.54 9.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.45 -1.029 . . . . 0.0 110.021 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -171.87 155.58 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 110.262 -179.851 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -52.07 -27.42 13.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.752 179.659 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.52 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 4.4 t -143.59 163.02 34.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.244 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.576 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 21.2 m-85 -137.35 -148.54 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 93.8 p -154.34 -113.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.813 -1.18 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -107.88 12.35 27.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.556 -1.34 . . . . 0.0 110.67 -178.922 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 103' ' ' CYS . 12.5 t-20 -162.25 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.808 -1.183 . . . . 0.0 110.179 179.471 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ASN . 31.8 t0 43.26 76.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.726 -1.234 . . . . 0.0 108.955 -179.48 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' N ' HG21 ' A' ' 102' ' ' THR . 6.3 p30 -68.35 126.96 31.23 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 110.664 -178.385 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 15.9 m -109.73 119.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.194 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 6.4 t0 -82.56 134.12 35.19 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.591 ' CD2' ' HG3' ' A' ' 114' ' ' PRO . 39.3 m-85 -92.5 131.8 37.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.956 -1.09 . . . . 0.0 112.252 -178.022 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.83 90.43 3.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.905 -179.944 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.26 129.46 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.65 179.984 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -38.14 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.521 -0.737 . . . . 0.0 110.637 -179.28 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -157.22 131.99 8.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.965 . . . . 0.0 110.157 179.911 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.21 56.08 27.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.635 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 24.5 m-85 -161.05 148.46 15.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.854 -179.356 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 6.5 tttm -106.25 138.9 41.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.906 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 mt -76.02 93.5 3.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.409 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -69.84 100.32 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 0.0 109.666 179.6 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.24 -97.17 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.579 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 t -148.41 114.98 5.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -1.204 . . . . 0.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 90.7 p -72.87 0.48 10.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.934 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -145.63 100.13 3.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.91 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 85' ' ' VAL . 19.7 m -115.78 167.63 10.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.623 -179.566 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -136.38 144.15 44.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.557 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 10.2 t -75.95 89.31 2.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 110.253 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' CD ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -65.74 179.89 0.41 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 111.327 -179.622 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.612 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.3 Cg_endo -75.32 125.79 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.271 1.669 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.99 -1.83 13.25 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 7.0 m-80 78.31 96.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.813 -0.816 . . . . 0.0 110.835 179.68 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -175.82 -166.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.086 179.556 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.602 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 19.5 m95 -151.64 91.24 1.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.373 0.606 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.53 ' CD ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -115.25 157.78 42.89 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.498 179.739 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.579 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 39.8 Cg_endo -70.8 171.8 56.31 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.01 -2.079 . . . . 0.0 111.85 0.379 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.2 pm0 -23.49 119.02 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.451 0.643 . . . . 0.0 112.624 -178.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 2.4 tp -45.82 137.28 5.95 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 109.014 178.585 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.591 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 42.8 Cg_endo -70.5 165.78 30.69 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 123.887 1.467 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HG2' ' CG1' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -133.56 108.65 8.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -61.1 89.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 94' ' ' LYS . 1.8 m -106.59 -167.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.839 0.828 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 7.7 mtm180 . . . . . 0 C--N 1.291 -1.969 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.293 0.568 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -93.63 174.83 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.363 -179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.54 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -136.48 92.9 2.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.873 . . . . 0.0 110.212 179.844 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -67.47 170.8 6.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.297 179.518 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.45 143.45 1.11 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.847 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 50.9 Cg_endo -70.86 152.45 63.6 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.988 1.52 . . . . 0.0 110.741 -179.207 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.38 170.27 20.61 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.747 1.393 . . . . 0.0 109.865 179.416 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.68 176.3 3.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 109.813 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.55 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.54 -169.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 122.168 0.985 . . . . 0.0 111.498 179.838 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 7.9 t -40.62 92.66 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.536 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 9' ' ' ILE . 12.1 m120 42.63 45.94 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.49 178.42 19.99 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 180.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER -126.25 -169.33 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -1.202 . . . . 0.0 110.695 -179.915 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p80 -157.9 125.36 5.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.898 -0.502 . . . . 0.0 110.512 -179.41 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.39 -33.82 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 44.4 -122.43 4.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.59 -0.79 2.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -1.16 . . . . 0.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 7.4 pt-20 -164.12 -167.35 1.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.491 -179.811 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.28 19.31 2.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.88 . . . . 0.0 110.589 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.42 45.43 2.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.007 -1.058 . . . . 0.0 110.441 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 23.2 m-85 -58.26 179.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.642 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.54 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 2.2 p -147.14 -61.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 111.045 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -163.37 137.37 5.93 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.53 15.04 80.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.552 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.73 175.3 6.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.948 . . . . 0.0 109.543 179.81 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 39.8 t -149.22 154.11 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.993 -179.756 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.592 HG22 ' CH2' ' A' ' 50' ' ' TRP . 24.3 t -134.24 122.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.252 -179.739 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -74.33 103.31 4.67 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.315 -1.354 . . . . 0.0 108.015 177.805 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.641 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.3 m-30 -68.45 176.57 2.79 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.763 -178.487 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.52 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.5 t -130.79 -177.15 4.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.839 179.616 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 91.0 m -147.72 135.38 20.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.0 109.616 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 6.5 m120 -99.52 -177.87 3.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 110.744 -179.527 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 6.0 p 44.76 56.77 4.99 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.707 0.765 . . . . 0.0 110.278 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 43.46 49.63 6.94 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 33' ' ' SER . 4.5 m-30 -102.4 131.78 48.83 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.915 -1.344 . . . . 0.0 111.164 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.603 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -74.59 138.52 43.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.742 -0.599 . . . . 0.0 110.679 -179.792 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tt -89.44 109.66 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.128 -0.983 . . . . 0.0 109.453 178.986 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.549 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.6 OUTLIER -103.02 143.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.468 -179.988 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.41 -141.1 11.41 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 41' ' ' SER . 27.6 t30 -111.42 52.39 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.239 . . . . 0.0 109.907 179.462 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.511 ' C ' ' O ' ' A' ' 40' ' ' ASN . 27.7 p 22.67 49.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.749 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 157.11 119.33 0.59 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.3 t -65.51 -179.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.254 . . . . 0.0 108.176 179.198 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.6 tp -144.88 97.74 3.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.32 179.048 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 18.4 t -79.79 126.25 30.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.225 178.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.6 p -129.68 110.18 11.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.226 -179.865 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.35 22.51 62.56 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.91 8.11 76.64 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.8 114.59 22.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -1.174 . . . . 0.0 110.538 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CH2' HG22 ' A' ' 27' ' ' VAL . 79.8 m95 -69.9 134.81 48.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.787 179.539 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.19 168.36 20.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 111.025 -179.716 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 15.6 t0 54.07 66.27 4.53 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.734 -0.604 . . . . 0.0 111.047 179.802 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -90.6 138.28 2.56 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.38 1.726 . . . . 0.0 110.154 179.349 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.2 Cg_endo -75.31 175.8 10.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.839 1.442 . . . . 0.0 110.591 179.938 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.549 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.8 p -111.23 -175.24 2.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.832 . . . . 0.0 111.359 -179.019 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 33.6 m -142.51 75.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.859 0.837 . . . . 0.0 108.803 178.839 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -108.6 -148.67 0.43 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.728 -179.146 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.461 HG23 ' HD2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -125.99 121.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.049 . . . . 0.0 108.632 179.347 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.603 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 20.4 m -114.68 49.46 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.025 -1.047 . . . . 0.0 112.324 -178.197 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -60.55 -172.24 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 C-N-CA 117.779 -1.569 . . . . 0.0 107.519 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -147.95 166.73 15.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 117.84 -1.544 . . . . 0.0 113.979 -178.296 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.0 Cg_endo -87.84 -74.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 125.02 2.063 . . . . 0.0 110.618 179.551 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 166.12 125.4 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.074 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.604 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.1 Cg_endo -75.36 65.64 6.37 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.629 1.331 . . . . 0.0 109.455 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -82.48 175.93 9.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 110.311 -179.536 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.571 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -171.99 167.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 110.404 -179.623 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 46.5 p -72.81 100.39 2.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 110.55 -179.674 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 88.5 m-20 42.85 49.09 5.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.815 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.598 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -161.86 38.52 0.39 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.598 ' O ' ' O ' ' A' ' 69' ' ' GLY . 49.4 p90 -47.0 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.101 1.429 . . . . 0.0 113.141 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -139.06 127.18 22.51 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.682 -176.948 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.6 t -103.89 16.88 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.494 -0.754 . . . . 0.0 110.087 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.65 101.37 6.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.161 -0.962 . . . . 0.0 111.538 -179.008 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 85' ' ' VAL . . . 71.84 103.42 0.06 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.563 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 7.8 t80 -156.92 154.11 29.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -1.085 . . . . 0.0 110.266 179.431 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 1.1 tttm -161.35 147.96 14.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' LYS . 29.8 mtm180 -42.47 -37.01 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.055 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -131.9 165.03 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 110.118 179.835 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 22.8 m-85 -137.04 -142.87 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 55.6 p -156.48 -117.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.951 -1.093 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.22 11.65 32.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.752 -1.218 . . . . 0.0 111.845 -178.664 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.549 ' ND2' ' CZ ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -163.64 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.642 -1.286 . . . . 0.0 110.72 178.938 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 82' ' ' ASN . 7.6 m-20 42.41 74.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.723 -1.236 . . . . 0.0 109.272 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 47.4 t30 -68.82 121.91 17.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.614 -178.664 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.609 HG12 ' CH2' ' A' ' 109' ' ' TRP . 29.0 m -106.44 123.14 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.844 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -80.24 139.34 36.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.336 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 32.0 m-85 -95.15 143.25 26.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 112.38 -177.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.37 98.18 6.6 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 -179.857 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.454 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -50.22 134.98 22.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.397 -179.639 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.39 -69.84 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.784 . . . . 0.0 110.402 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 23.5 t80 -172.19 141.71 1.3 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.304 -0.873 . . . . 0.0 110.391 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 47.71 15.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 11.1 m-85 -149.23 150.0 31.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -1.019 . . . . 0.0 109.803 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 117' ' ' VAL . 4.8 mtmt -103.3 143.37 32.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.532 HD22 ' CD1' ' A' ' 66' ' ' ILE . 0.7 OUTLIER -85.09 92.38 8.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 110.187 -179.956 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.476 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -78.96 105.02 10.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.928 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.3 -79.83 0.24 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.227 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.564 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 24.9 p -159.7 99.27 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -1.092 . . . . 0.0 110.922 -179.191 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.41 47.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.073 -1.017 . . . . 0.0 109.591 179.203 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 p -140.63 108.45 5.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.551 179.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 2.8 m -123.67 167.67 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.215 -0.928 . . . . 0.0 111.16 -179.238 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -134.48 145.19 48.58 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.782 0.801 . . . . 0.0 110.339 179.617 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -82.24 80.13 8.53 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.827 -0.546 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.513 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -58.4 -177.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 111.358 -179.212 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.9 Cg_endo -77.37 125.42 7.71 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.386 1.73 . . . . 0.0 110.211 -179.707 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.26 -8.37 7.07 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.8 m-20 79.47 94.7 0.06 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.749 -0.853 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER 178.49 -166.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.832 . . . . 0.0 111.092 179.445 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.609 ' CH2' HG12 ' A' ' 85' ' ' VAL . 38.0 m95 -144.04 87.69 1.92 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.539 0.685 . . . . 0.0 109.729 -179.845 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -100.26 140.81 21.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.658 -179.238 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.0 Cg_endo -74.83 170.93 70.31 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.555 -2.269 . . . . 0.0 110.039 -0.231 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 11.8 pt-20 -36.75 137.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.562 -0.712 . . . . 0.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.574 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -46.76 157.86 0.44 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.846 . . . . 0.0 109.799 179.511 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.4 Cg_endo -79.95 165.51 21.87 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 124.206 1.635 . . . . 0.0 111.126 -179.715 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 117' ' ' VAL . 9.0 ttmt -124.36 104.53 8.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.3 t -60.34 83.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.356 179.623 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.8 m -95.77 -175.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.87 0.843 . . . . 0.0 110.808 -179.6 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.538 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.81 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.442 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.231 0.539 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HD3' ' CE1' ' A' ' 20' ' ' PHE . 3.9 ttmt -132.88 172.13 13.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.367 -179.734 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.576 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 10.4 t -163.81 136.14 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 110.102 -179.918 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' SER . 6.5 pt20 -117.2 -176.71 3.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -40.3 142.38 0.74 Allowed Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.273 -179.999 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.6 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 55.4 Cg_endo -71.68 167.37 26.69 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 124.143 1.601 . . . . 0.0 110.647 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.03 171.86 15.01 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.797 1.419 . . . . 0.0 108.756 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -78.18 104.96 9.1 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.893 -1.13 . . . . 0.0 110.616 -179.563 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.642 ' HB ' ' CE2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -42.64 173.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.9 0.857 . . . . 0.0 110.012 -179.904 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.574 ' N ' HG13 ' A' ' 9' ' ' ILE . 34.5 m -99.86 140.92 33.38 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.604 -1.238 . . . . 0.0 109.697 178.293 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 6.8 m120 63.37 17.06 10.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.731 -179.02 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -167.05 -164.52 22.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' SER . 7.2 mtp180 -140.39 -171.81 3.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -1.135 . . . . 0.0 110.566 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 7.9 p80 -148.11 133.34 18.41 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.812 -0.555 . . . . 0.0 110.37 -179.937 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 14' ' ' HIS . 3.1 m-20 -167.01 75.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -101.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.917 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -175.84 38.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -1.15 . . . . 0.0 109.793 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.563 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -154.48 -169.38 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.332 -179.665 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 -37.97 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.54 ' CE1' ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -111.72 118.75 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.643 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -104.36 -12.78 16.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 110.429 -179.741 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.54 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 p 45.45 -96.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.921 . . . . 0.0 111.867 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -148.47 154.01 39.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 0.0 110.115 -178.588 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.2 19.64 79.69 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.232 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.643 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 7.1 m -98.34 171.1 8.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.695 -0.885 . . . . 0.0 110.212 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 38.9 t -147.87 155.29 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.176 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.585 HG22 ' CH2' ' A' ' 50' ' ' TRP . 13.1 t -134.12 111.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.639 -179.132 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 103.25 1.52 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.461 -1.296 . . . . 0.0 107.738 178.085 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.642 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 1.3 m-30 -68.02 -176.55 0.71 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.998 -178.435 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -133.99 155.3 50.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.291 179.057 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.1 m -126.41 139.72 53.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.561 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' SER . 31.9 m-20 -83.49 174.35 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.0 110.392 179.905 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.487 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 28.8 t 42.31 -165.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.137 179.211 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.84 2.66 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 33' ' ' SER . 12.0 m-85 -89.08 107.76 19.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.95 -1.324 . . . . 0.0 111.185 -179.419 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.596 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -60.39 139.68 57.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 0.0 110.357 179.281 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.5 OUTLIER -84.38 102.19 12.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.316 179.078 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.543 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.4 OUTLIER -94.3 150.95 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 108.991 179.785 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.31 -143.43 14.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.223 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 3.3 m120 -114.58 49.62 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -1.23 . . . . 0.0 109.837 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER 25.21 62.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.941 179.505 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 141.88 115.22 1.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.593 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.63 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -58.45 -178.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.522 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.3 tp -142.88 105.8 4.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.005 -1.06 . . . . 0.0 110.097 178.458 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.2 t -88.29 109.4 19.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.9 m -126.77 126.06 42.79 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.13 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.524 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 70.45 28.62 70.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.54 26.44 73.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.03 115.4 12.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 110.174 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.8 m95 -76.58 136.28 39.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.862 179.812 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.73 171.76 19.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 110.998 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 53.67 64.73 6.35 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.872 -0.518 . . . . 0.0 111.212 179.77 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -91.99 145.28 2.96 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.958 1.772 . . . . 0.0 109.841 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.4 Cg_endo -79.44 174.9 11.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.731 1.385 . . . . 0.0 110.11 179.53 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.543 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 14.4 p -114.39 -177.31 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 111.13 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 11' ' ' ASN . 84.7 m -140.57 73.42 1.42 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.019 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -116.52 177.57 4.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.736 -178.975 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.484 HG21 ' CD ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -88.94 145.15 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.1 179.719 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.596 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 29.0 m -129.93 40.96 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.371 -179.128 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.484 ' CD ' HG21 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -78.87 101.21 7.56 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.429 179.843 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 50.2 m -73.04 162.71 73.23 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.454 -0.778 . . . . 0.0 111.253 -178.913 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.3 Cg_endo -70.82 -89.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.359 1.715 . . . . 0.0 110.628 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -172.25 133.42 0.76 Allowed Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.0 Cg_endo -86.7 83.8 1.09 Allowed 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 123.69 1.363 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.577 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 4.1 p -100.7 -42.38 6.53 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.39 1.091 . . . . 0.0 110.288 -178.954 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.638 HG23 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 48.86 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.927 -179.216 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.533 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 49.6 m -69.32 107.61 3.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 111.666 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 27.6 m120 38.06 43.78 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.0 111.77 178.438 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -126.6 -44.08 0.25 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.805 -1.664 . . . . 0.0 109.903 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 23.3 p90 41.35 -174.61 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 122.639 1.209 . . . . 0.0 111.827 -179.13 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.627 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.63 153.62 50.89 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.239 -179.243 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -13.88 12.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.888 -1.133 . . . . 0.0 110.287 -178.78 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.9 t -51.41 -54.44 26.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.19 106.6 0.21 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.81 -177.34 3.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.962 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 27.5 tttm -159.68 168.75 25.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.55 -0.719 . . . . 0.0 109.89 -179.585 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -65.86 -39.25 90.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 m -139.64 126.21 20.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CD2' ' CH2' ' A' ' 109' ' ' TRP . 60.4 m-85 -95.32 -175.99 3.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 81' ' ' TYR . 29.0 t -170.47 96.87 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.301 179.941 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.571 ' CB ' HG23 ' A' ' 59' ' ' VAL . 2.2 t80 52.06 125.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.381 -0.825 . . . . 0.0 110.664 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.553 ' HA ' HG23 ' A' ' 102' ' ' THR . 13.7 t-20 73.51 -128.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.941 -1.1 . . . . 0.0 110.381 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.428 ' C ' HG21 ' A' ' 102' ' ' THR . 0.4 OUTLIER 54.29 71.08 0.54 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.701 -1.249 . . . . 0.0 109.11 -178.451 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 10.6 t30 -70.39 142.17 52.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.533 -0.73 . . . . 0.0 111.093 -178.998 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.632 ' CG2' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -129.57 120.01 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.328 -0.858 . . . . 0.0 110.072 179.002 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -84.29 124.17 30.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 178.966 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD1' HG23 ' A' ' 66' ' ' ILE . 50.2 m-85 -80.94 136.38 36.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.316 1.055 . . . . 0.0 112.527 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -114.76 86.1 2.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.439 -179.643 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.68 128.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 0.0 110.795 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 15.1 mmtt -38.95 -84.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.538 -0.726 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 19.0 t80 -160.58 149.6 16.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.12 -0.987 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.49 31.46 14.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.6 m-85 -142.65 146.12 34.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.501 -0.999 . . . . 0.0 110.234 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.73 135.07 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.885 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.584 ' CD2' ' CD1' ' A' ' 66' ' ' ILE . 5.5 mt -67.24 111.06 3.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.524 -179.702 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.429 ' HB2' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.19 106.62 18.31 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.136 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -90.38 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.589 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -149.0 120.39 7.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -1.15 . . . . 0.0 110.538 -179.474 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.5 p -80.15 4.8 16.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 0.0 110.905 -179.635 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -144.9 115.81 7.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 110.093 179.719 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 17.5 m -126.82 -175.53 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.699 -179.714 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 82' ' ' ASN . 13.9 m -157.24 134.4 10.34 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.114 -178.926 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.584 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 6.2 t -59.72 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.877 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.21 172.38 9.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.7 Cg_endo -74.85 123.74 8.19 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.334 1.702 . . . . 0.0 110.925 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.2 -7.61 5.07 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.9 m120 81.12 77.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.971 -0.723 . . . . 0.0 110.384 179.83 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -174.4 -168.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.852 . . . . 0.0 111.612 179.82 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.632 ' CZ3' ' CG2' ' A' ' 85' ' ' VAL . 22.5 m95 -134.37 100.65 4.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 -179.691 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 102' ' ' THR . 2.7 mttm -102.71 149.12 36.46 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.216 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.589 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.9 Cg_endo -75.28 -174.58 14.48 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.906 -2.123 . . . . 0.0 110.551 -0.371 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.1 tp10 -39.13 117.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.341 0.591 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.591 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 1.8 tp -43.74 141.94 2.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.825 . . . . 0.0 110.785 -179.694 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.537 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 41.7 Cg_endo -72.31 167.05 27.95 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.085 1.571 . . . . 0.0 110.502 179.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -132.33 95.33 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.923 . . . . 0.0 110.525 179.879 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.7 t -46.62 102.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.073 -1.017 . . . . 0.0 109.135 179.475 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -113.58 -178.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.729 0.775 . . . . 0.0 111.083 -179.135 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.412 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.162 0.506 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -162.58 171.5 16.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.516 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -130.55 151.96 50.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 41.6 mt-30 -134.03 174.7 10.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.072 -1.018 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.25 130.69 7.62 Favored Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.603 ' HG2' ' CG ' ' A' ' 14' ' ' HIS . 48.8 Cg_endo -70.46 158.83 54.88 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.944 1.497 . . . . 0.0 110.77 -179.752 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.05 175.14 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.014 1.534 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' ILE . 88.7 p -85.75 99.21 11.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.133 179.906 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.0 -170.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.381 1.086 . . . . 0.0 111.917 -179.664 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 9' ' ' ILE . 1.9 p -37.48 95.79 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.012 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 41.03 29.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 110.758 179.682 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -119.32 174.32 15.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.498 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 1.6 mtt85 -113.53 -168.49 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 15.3 p80 -158.94 119.45 3.22 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.321 0.581 . . . . 0.0 110.265 -179.899 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -107.11 -162.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.634 -179.621 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 18' ' ' GLU . . . 147.3 -20.67 1.54 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.986 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.12 34.78 16.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -1.132 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 38.2 mm-40 -121.43 -155.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.004 179.721 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -153.36 -39.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.617 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 7.8 p90 -143.48 80.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.707 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 25.7 m-85 -49.75 -179.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.052 -1.03 . . . . 0.0 110.112 179.938 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.516 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -142.61 -68.56 0.36 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.616 -1.303 . . . . 0.0 111.183 -179.07 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -156.86 141.42 16.76 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 109.757 -178.954 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 69.27 7.97 58.21 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.843 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.605 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 40.5 m -71.31 174.91 5.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.11 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 36.3 t -156.77 157.63 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 43' ' ' VAL . 34.0 t -144.68 121.26 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.102 -179.655 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.46 101.88 3.06 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.869 178.249 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.619 ' CE2' ' CG2' ' A' ' 9' ' ' ILE . 2.1 m-30 -67.99 154.93 40.59 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.414 -0.804 . . . . 0.0 110.136 -178.31 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.498 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.7 t -114.37 -177.14 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.021 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 57.4 m -146.9 149.89 34.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.25 149.97 5.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -54.34 107.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 179.968 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.1 10.05 9.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.948 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 4.4 m-85 -124.24 120.86 33.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.725 -179.693 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.596 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -73.05 138.2 45.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.428 179.678 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.9 tp -90.42 98.57 11.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.139 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -92.05 170.39 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.096 179.414 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 83.93 -178.82 52.14 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.684 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.19 121.66 15.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -1.141 . . . . 0.0 109.943 179.917 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.507 ' O ' ' CG2' ' A' ' 28' ' ' THR . 6.2 t -73.11 53.4 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.491 -179.755 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 174.78 88.08 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.336 179.892 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.596 HG22 ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -45.32 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.316 -1.108 . . . . 0.0 108.935 179.45 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 ' CG2' ' A' ' 26' ' ' VAL . 6.3 tp -139.69 106.18 5.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 110.151 178.809 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.61 107.54 14.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.138 -0.976 . . . . 0.0 109.771 179.595 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -129.16 121.33 27.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -7.4 80.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.6 16.37 8.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -144.69 138.17 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -1.14 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.6 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 99.8 m95 -77.92 136.39 38.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.878 179.696 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t -132.12 163.88 27.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.485 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 27.8 m-20 51.09 66.7 5.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.808 -0.558 . . . . 0.0 111.191 179.681 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -90.42 137.88 2.57 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 124.399 1.736 . . . . 0.0 109.733 179.123 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.1 Cg_endo -75.68 178.02 7.93 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.664 1.35 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.52 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.5 p -118.92 147.04 44.45 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 0.0 112.072 -178.635 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 92.4 m -110.37 76.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.317 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.04 178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.457 0.646 . . . . 0.0 110.392 -178.575 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.38 134.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.053 179.703 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.603 HG23 ' CB ' ' A' ' 81' ' ' TYR . 28.2 m -119.8 43.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -178.992 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 25.4 mttt -80.06 97.66 6.92 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 119.406 -0.917 . . . . 0.0 108.904 179.5 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 60.2 m -69.06 161.88 69.39 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -178.607 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.1 Cg_endo -72.08 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.503 1.791 . . . . 0.0 110.34 -179.638 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -157.46 131.55 4.99 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.593 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.1 Cg_endo -76.91 66.18 7.65 Favored 'Trans proline' 0 C--N 1.297 -2.132 0 O-C-N 123.725 1.382 . . . . 0.0 109.888 -178.906 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.527 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -87.87 -174.65 4.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.547 -0.72 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.562 HD11 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 178.32 166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.355 179.471 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.3 OUTLIER -69.8 96.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.746 -179.594 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.534 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.7 m-20 48.72 40.49 16.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.925 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -146.3 28.58 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.6 p90 -45.15 -175.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.641 1.21 . . . . 0.0 112.346 -179.08 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.538 ' C ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.5 162.12 15.45 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.347 179.527 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t -144.66 22.74 1.62 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.971 -1.08 . . . . 0.0 110.449 -179.094 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.9 t -100.12 -82.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.698 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.44 75.88 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.711 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -95.88 157.99 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -1.05 . . . . 0.0 109.592 179.554 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.552 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -147.6 168.41 22.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 110.667 -179.636 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -76.3 -35.55 58.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.971 179.798 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 p -124.88 131.82 53.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.716 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.583 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 89.8 m-85 -112.5 170.79 7.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.512 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 81' ' ' TYR . 92.6 p -165.39 91.2 0.51 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 179.9 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.603 ' CB ' HG23 ' A' ' 59' ' ' VAL . 6.0 t80 52.42 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.815 0.817 . . . . 0.0 110.44 -179.47 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HA ' HG23 ' A' ' 102' ' ' THR . 15.3 t-20 65.33 -127.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.487 -1.383 . . . . 0.0 110.094 -179.215 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 6.2 m-20 51.82 73.92 0.29 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.622 -1.299 . . . . 0.0 109.044 -178.54 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.0 t30 -72.28 146.42 47.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.519 -0.738 . . . . 0.0 111.351 -178.703 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.655 ' CG2' ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -132.16 124.27 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 109.553 179.021 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.8 t0 -83.82 124.23 30.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.995 -1.065 . . . . 0.0 109.48 179.643 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.599 ' CD2' ' CG ' ' A' ' 114' ' ' PRO . 8.4 m-85 -87.11 120.65 28.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.182 -0.949 . . . . 0.0 111.56 -178.651 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -95.75 94.93 7.97 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.169 179.932 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -44.37 125.36 4.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.07 -1.019 . . . . 0.0 109.488 179.78 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 4.9 mmtp -35.85 -67.33 0.16 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.672 -0.643 . . . . 0.0 111.001 -178.938 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 36.3 t80 -173.6 144.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.595 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.37 47.37 11.49 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 10.4 m-85 -149.83 153.87 37.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -1.027 . . . . 0.0 109.899 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' CG ' HG21 ' A' ' 117' ' ' VAL . 4.4 ptpt -113.99 130.11 56.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -66.66 93.21 0.24 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.603 -179.455 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 117' ' ' VAL . 2.4 t -74.61 103.85 5.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.61 179.508 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.54 -77.76 0.3 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.826 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -172.47 116.1 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.16 . . . . 0.0 110.454 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.576 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -67.78 -77.22 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.87 . . . . 0.0 110.637 -179.944 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 100' ' ' SER . 5.0 p -68.82 104.99 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.792 -179.219 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.4 m -107.41 -170.75 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.906 179.538 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 82' ' ' ASN . 7.8 m -161.49 138.12 8.39 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.289 -178.966 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.653 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.5 t -59.49 105.64 0.38 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 179.78 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.96 168.16 16.3 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.814 -179.464 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.574 ' CG ' ' CG2' ' A' ' 38' ' ' ILE . 43.1 Cg_endo -76.32 126.91 9.44 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.418 1.747 . . . . 0.0 110.632 -179.519 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 122.41 3.84 9.32 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.287 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.6 OUTLIER 77.3 83.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.756 -0.849 . . . . 0.0 110.635 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.04 -168.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 111.81 179.628 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.655 ' CZ3' ' CG2' ' A' ' 85' ' ' VAL . 33.8 m95 -134.08 95.07 3.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 110.289 -179.601 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -98.95 143.79 27.01 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.614 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.541 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.67 172.63 58.18 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.837 -2.151 . . . . 0.0 110.616 -0.634 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 39.4 tt0 -39.1 128.2 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 0.0 111.263 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.54 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.41 152.16 0.28 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 0.0 109.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CG ' ' CD2' ' A' ' 87' ' ' PHE . 39.7 Cg_endo -82.87 167.5 14.46 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 O-C-N 124.301 1.685 . . . . 0.0 111.119 -179.362 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 117' ' ' VAL . 3.0 ttpt -126.71 108.04 10.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.819 179.66 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.3 t -64.24 74.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.543 HG21 ' CG ' ' A' ' 94' ' ' LYS . 3.7 m -90.52 -175.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.771 0.796 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.578 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.6 ppt_? . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.481 179.412 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.18 178.57 3.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.871 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -135.39 127.82 30.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.985 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 35.8 mt-30 -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.154 179.254 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -43.37 142.93 1.56 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.042 -1.036 . . . . 0.0 110.461 -179.479 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.627 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.5 Cg_endo -73.5 160.23 44.79 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.191 1.627 . . . . 0.0 110.532 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.5 171.59 17.83 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.522 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.33 98.89 10.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 109.865 179.706 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.611 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -51.4 -170.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.389 1.09 . . . . 0.0 111.944 -179.17 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 5.3 p -58.49 122.79 14.21 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.68 -178.887 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . 2.0 m-20 33.6 34.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.996 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.53 162.58 26.93 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.529 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -111.8 -171.46 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -1.197 . . . . 0.0 110.934 -179.65 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.1 p80 -154.19 123.99 6.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.886 -0.509 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.9 -158.46 0.86 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.654 -179.621 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' OE2' ' A' ' 18' ' ' GLU . . . 138.35 -7.02 3.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 66.93 58.73 0.58 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -1.152 . . . . 0.0 110.186 -179.942 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -137.22 -69.42 0.46 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.28 -0.887 . . . . 0.0 109.821 -179.84 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 2.7 m-20 68.32 18.01 9.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.614 -0.679 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -170.53 50.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.049 -1.032 . . . . 0.0 110.595 179.761 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.652 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 9.7 m-85 -55.59 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.139 179.389 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 21' ' ' TYR . 1.9 p -161.95 -69.22 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.823 -1.173 . . . . 0.0 111.2 -179.959 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -164.16 138.31 5.55 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.048 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.81 12.21 83.08 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.737 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.602 ' OG ' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -86.19 169.27 13.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.975 . . . . 0.0 109.951 179.947 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 92.6 t -143.59 151.19 16.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.615 178.596 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.652 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 30.0 t -136.59 120.37 23.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.311 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.41 101.41 4.78 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.025 -1.47 . . . . 0.0 107.579 177.989 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.671 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.5 m-30 -67.55 127.28 32.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.622 -178.418 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -74.75 169.3 18.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 179.615 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -140.13 134.15 30.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' SER . 1.7 m120 -43.46 116.23 0.91 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.571 179.581 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ASN . 10.6 m -38.65 113.13 0.27 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.639 -179.443 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.34 -26.11 6.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' HG13 ' A' ' 58' ' ' ILE . 2.8 m-85 -91.8 144.86 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -1.142 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.548 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 48.2 t -81.88 119.8 24.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 111.114 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tp -79.48 106.63 11.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.071 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.561 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.3 OUTLIER -98.79 152.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.955 . . . . 0.0 109.14 -179.63 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 104.89 -177.91 23.58 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.806 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 42' ' ' GLY . 23.7 p-10 -67.98 131.73 46.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.697 179.571 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.5 p -73.17 56.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.79 179.91 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.497 ' O ' ' ND2' ' A' ' 40' ' ' ASN . . . 165.52 96.13 0.11 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.646 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.671 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -48.55 177.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.156 . . . . 0.0 108.054 179.38 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.3 tp -143.51 99.16 3.37 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.962 -1.086 . . . . 0.0 110.249 178.777 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.596 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.0 t -80.5 121.18 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.39 178.744 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.23 126.88 41.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.694 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.33 25.94 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.905 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.4 31.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.889 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -140.69 119.27 12.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -77.36 136.29 38.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.629 179.696 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -141.45 160.01 41.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 111.412 -179.33 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.7 t0 53.84 65.84 5.07 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.923 -0.486 . . . . 0.0 111.521 179.332 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.1 Cg_endo -91.26 129.95 1.31 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 124.378 1.725 . . . . 0.0 109.265 178.516 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 44.8 Cg_endo -72.16 166.02 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.574 1.302 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.561 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 24.8 p -104.33 -174.59 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.189 0.995 . . . . 0.0 111.612 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.6 t -146.16 74.6 1.38 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.532 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.22 -170.5 1.67 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.331 -178.459 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.58 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -111.5 86.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 81' ' ' TYR . 20.1 m -76.03 51.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 111.368 -179.115 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -55.22 175.78 0.06 Allowed 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 117.671 -1.612 . . . . 0.0 107.831 179.305 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.543 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 66.9 m -134.24 142.58 43.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.16 -178.305 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 41.8 Cg_endo -74.61 -83.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.491 1.785 . . . . 0.0 110.486 179.439 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.573 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER 177.58 126.19 0.19 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.539 -0.726 . . . . 0.0 109.251 -179.559 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.585 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 50.5 Cg_endo -77.13 57.54 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.788 1.415 . . . . 0.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.539 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.76 166.11 23.51 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.47 0.652 . . . . 0.0 110.593 -179.673 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.579 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -166.33 167.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.171 179.504 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 116' ' ' CYS . 1.7 t -76.34 113.13 13.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 110.78 -179.403 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.524 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 72.9 m-20 36.21 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.675 -0.641 . . . . 0.0 111.401 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -145.32 38.09 1.26 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.008 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.628 ' O ' ' O ' ' A' ' 69' ' ' GLY . 50.1 p90 -44.85 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 123.438 1.589 . . . . 0.0 113.401 -179.682 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -139.42 122.83 17.18 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.491 -176.807 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -104.48 15.71 27.58 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.466 -0.771 . . . . 0.0 110.237 -178.951 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.95 95.56 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.44 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.02 106.55 1.91 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.711 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 9.2 t80 -173.89 170.49 3.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -1.173 . . . . 0.0 110.255 179.719 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.623 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.0 tttm -179.93 142.72 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.463 -0.773 . . . . 0.0 109.727 -179.684 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 76' ' ' LYS . 12.7 mtp180 -41.42 -27.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -148.08 141.49 25.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 110.175 179.877 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -124.99 -164.75 1.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 109.607 179.762 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.7 p -170.67 107.89 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.613 ' N ' HG22 ' A' ' 59' ' ' VAL . 2.3 t80 53.24 156.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.112 -0.992 . . . . 0.0 110.672 179.167 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.591 ' HA ' HG23 ' A' ' 102' ' ' THR . 27.4 t-20 38.18 -110.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.713 -179.224 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.474 ' OD2' ' N ' ' A' ' 80' ' ' SER . 74.9 m-20 50.79 69.0 0.69 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.765 -1.21 . . . . 0.0 109.143 -179.419 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 84' ' ' ASN . 11.3 p-10 -69.43 129.98 41.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.753 -178.92 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.527 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 15.8 m -121.53 128.85 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.998 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 20.4 t0 -85.37 136.78 33.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 108.575 178.977 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CE2' HD21 ' A' ' 71' ' ' LEU . 51.2 m-85 -96.69 143.5 27.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.969 -1.082 . . . . 0.0 111.907 -178.43 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 5.7 tttm -115.38 110.03 18.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.448 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.522 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -66.55 132.79 48.99 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.835 -1.165 . . . . 0.0 109.943 -179.251 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.524 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -38.76 -91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 111.173 -179.132 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.3 t80 -148.44 138.56 22.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 0.0 110.786 -179.293 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 51.08 60.1 7.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.672 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 12.2 m-85 -162.96 136.45 5.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -1.06 . . . . 0.0 109.943 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.536 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 34.5 pttt -101.23 112.23 24.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.423 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.3 mt -45.58 125.9 6.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.554 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -102.24 103.55 14.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 0.0 109.501 179.215 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.59 -57.42 0.58 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.599 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 172.65 119.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -1.148 . . . . 0.0 111.098 -179.417 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -78.11 -3.87 44.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.201 -0.937 . . . . 0.0 110.703 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.7 p -142.09 112.46 7.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 109.806 179.86 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.3 m -121.75 -179.7 4.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.993 -179.272 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -153.29 132.34 12.58 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 103' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 82' ' ' ASN . 36.6 t -78.72 82.91 4.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 110.09 -179.868 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -55.74 -179.91 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.594 -0.691 . . . . 0.0 111.503 -179.596 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.9 Cg_endo -73.43 117.6 5.14 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.559 1.821 . . . . 0.0 110.572 -179.271 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 138.0 -10.25 3.62 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 6.2 m120 83.37 90.42 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.163 -0.61 . . . . 0.0 110.728 179.461 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -177.35 -161.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 111.527 179.635 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.585 ' NE1' ' N ' ' A' ' 64' ' ' PRO . 17.7 m95 -149.95 80.18 1.37 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.487 0.66 . . . . 0.0 109.729 -179.831 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.9 mttm -95.18 143.26 25.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.824 -179.739 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -71.04 174.27 45.66 Favored 'Cis proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 -2.0 . . . . 0.0 110.987 -0.144 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.23 128.24 5.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -39.86 144.15 0.54 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 110.272 179.323 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 38.3 Cg_endo -71.74 164.26 36.25 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 111.356 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.493 ' O ' HG21 ' A' ' 117' ' ' VAL . 9.7 tttt -132.59 119.76 20.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 67' ' ' SER . 1.3 m -62.12 113.23 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.047 -1.033 . . . . 0.0 110.194 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.554 HG23 ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -127.52 173.48 12.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.761 179.113 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.306 0.574 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.59 173.45 11.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.489 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.525 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -127.0 108.61 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 0.0 110.458 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.533 ' NE2' ' CE1' ' A' ' 20' ' ' PHE . 9.2 mm100 -87.68 174.81 8.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.2 p -43.01 139.97 2.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.891 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.596 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 46.6 Cg_endo -69.59 161.04 47.46 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.083 1.57 . . . . 0.0 111.031 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.86 171.95 16.84 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.089 1.573 . . . . 0.0 109.938 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -73.01 176.47 5.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.051 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.555 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -169.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.175 0.988 . . . . 0.0 111.369 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -52.56 96.41 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.74 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 10' ' ' SER . 8.4 m120 40.63 61.78 1.55 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.453 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.5 161.99 32.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.6 mtt85 -105.88 -176.82 3.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -1.148 . . . . 0.0 109.808 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.62 -176.28 5.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.933 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 1.3 t30 66.52 136.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.065 -1.022 . . . . 0.0 109.905 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.86 -60.43 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 4.0 t80 -151.46 35.85 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -1.089 . . . . 0.0 110.116 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -145.09 -162.74 1.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 1.3 p30 -147.57 -38.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 109.879 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.609 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 3.2 m-85 -93.62 -162.05 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.609 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.2 OUTLIER 171.89 -16.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.531 -0.73 . . . . 0.0 110.996 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.525 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 7.0 p 47.73 -95.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 112.311 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -152.16 161.75 42.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.788 -1.195 . . . . 0.0 110.428 -178.46 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.85 19.9 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 6.6 m -105.14 178.04 4.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.54 -0.976 . . . . 0.0 110.566 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.497 HG11 ' N ' ' A' ' 27' ' ' VAL . 24.7 t -151.8 156.35 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.103 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG13 ' CD1' ' A' ' 29' ' ' TYR . 15.0 t -135.09 117.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.572 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.95 103.28 5.1 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.341 -1.343 . . . . 0.0 107.928 178.113 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.619 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.24 128.09 35.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 110.05 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -82.96 157.81 22.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.577 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 35.5 m -123.28 155.17 37.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -47.94 160.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 33' ' ' SER . 12.3 p -59.98 105.16 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.475 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.53 -3.24 29.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.458 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -94.32 131.49 39.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -1.193 . . . . 0.0 110.422 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.592 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -81.39 140.14 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -90.38 99.71 12.68 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.51 HG21 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.5 162.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.185 -0.947 . . . . 0.0 109.078 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.99 171.85 47.9 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -45.96 129.04 9.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -1.159 . . . . 0.0 109.997 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 28' ' ' THR . 0.0 OUTLIER -74.01 53.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.476 -179.666 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 162.23 119.51 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.8 t -60.24 -175.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.022 -1.281 . . . . 0.0 108.051 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.2 tp -146.48 97.49 2.93 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.4 OUTLIER -84.9 108.79 17.72 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.217 178.818 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.8 m -126.84 82.02 2.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.554 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.82 43.57 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.408 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 64.51 11.07 46.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -132.14 120.94 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -1.203 . . . . 0.0 110.28 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.6 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 80.8 m95 -76.36 138.75 40.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 0.0 109.742 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -141.41 158.06 44.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.992 . . . . 0.0 111.129 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 62.62 65.28 1.5 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 111.381 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.8 Cg_endo -91.2 133.61 1.59 Allowed 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 124.275 1.671 . . . . 0.0 110.215 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 51.3 Cg_endo -82.55 177.2 7.17 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.929 1.489 . . . . 0.0 110.34 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 17.8 p -112.04 162.17 15.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 111.528 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 m -129.21 77.1 1.77 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 177.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.55 -170.24 1.69 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.366 0.603 . . . . 0.0 110.32 -178.26 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.03 146.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.032 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.677 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 16.4 m -134.23 41.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.916 -1.115 . . . . 0.0 110.999 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 8.2 mtpt -81.02 98.82 8.13 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.931 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 37.4 m -70.22 165.94 38.91 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.589 -0.695 . . . . 0.0 111.387 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 50.6 Cg_endo -75.43 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.315 1.692 . . . . 0.0 110.659 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.482 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -153.78 131.67 6.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.89 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.602 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 54.3 Cg_endo -76.12 66.22 6.98 Favored 'Trans proline' 0 C--N 1.295 -2.254 0 O-C-N 123.595 1.313 . . . . 0.0 109.476 -179.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -87.97 175.46 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.531 -0.731 . . . . 0.0 110.686 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -178.26 161.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.0 t -72.11 111.67 7.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.0 110.864 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 61.5 m-20 36.53 49.14 0.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.641 -0.662 . . . . 0.0 111.325 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.499 ' HA3' HD12 ' A' ' 66' ' ' ILE . . . -159.42 23.76 0.3 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.518 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 3.8 p90 -36.41 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.953 1.359 . . . . 0.0 112.718 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.713 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -49.14 -70.59 0.08 Allowed 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.835 178.038 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER 79.96 10.05 1.34 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.41 -0.806 . . . . 0.0 109.891 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 t -114.34 -44.75 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.541 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.406 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -178.67 100.2 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.61 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -109.03 172.41 6.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -1.07 . . . . 0.0 109.742 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -158.89 161.08 36.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.543 -179.741 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -54.06 -37.47 64.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.772 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 m -144.02 163.31 33.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.538 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.9 m-85 -135.68 -179.2 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 17.3 p -163.06 111.9 1.3 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.042 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.644 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 18.2 t80 30.97 38.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.515 -0.741 . . . . 0.0 111.592 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 103' ' ' CYS . 30.6 t30 -176.48 -140.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.444 -1.41 . . . . 0.0 110.995 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 74.3 m-20 55.26 66.53 1.2 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.917 -1.115 . . . . 0.0 108.987 -178.323 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.54 ' N ' HG21 ' A' ' 102' ' ' THR . 25.0 t30 -70.65 97.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 34.9 m -86.15 131.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.172 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' O ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -88.56 131.04 35.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.867 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 20.4 m-85 -88.66 125.45 34.84 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.53 1.157 . . . . 0.0 112.758 -177.56 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.465 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -104.97 108.63 20.24 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.116 -179.473 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.456 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -60.68 133.99 56.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.766 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -44.61 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 110.241 -179.544 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.594 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.0 p90 -148.93 149.31 31.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 111.007 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 42.9 36.9 2.71 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 17.3 m-85 -139.38 149.43 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -1.087 . . . . 0.0 110.213 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.501 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.44 139.93 46.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.209 179.9 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.546 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 23.5 mt -75.6 102.97 5.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.495 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -80.15 95.32 6.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.324 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.24 -85.93 0.16 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.553 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -157.12 125.5 5.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -1.152 . . . . 0.0 110.554 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.3 p -86.19 25.08 1.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.83 . . . . 0.0 110.882 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.4 p -169.89 106.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.494 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 1.7 m -127.48 164.84 21.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.046 0.927 . . . . 0.0 110.924 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.541 ' CG2' ' C ' ' A' ' 82' ' ' ASN . 26.8 m -139.79 139.4 36.41 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.962 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.558 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 11.8 t -49.52 94.4 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.671 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -66.62 174.12 2.02 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.934 -1.104 . . . . 0.0 112.366 -178.095 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.677 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 49.6 Cg_endo -79.44 14.33 1.83 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.635 1.86 . . . . 0.0 111.809 -178.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -116.31 18.72 13.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 106' ' ' GLY . 10.2 t-20 67.32 54.5 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.591 -0.947 . . . . 0.0 110.263 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.472 ' HA ' ' CD ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -167.19 -176.88 3.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 110.741 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.602 ' NE1' ' N ' ' A' ' 64' ' ' PRO . 46.6 m95 -105.97 98.84 8.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.415 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -105.73 141.99 23.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.214 -179.575 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.553 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.2 Cg_endo -71.78 174.8 45.13 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.888 -0.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.5 mm-40 -38.38 142.34 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 111.14 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.538 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -60.75 141.21 92.82 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.975 179.558 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 42.9 Cg_endo -73.13 155.59 52.07 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 124.302 1.685 . . . . 0.0 111.226 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 117' ' ' VAL . 2.6 ttpt -120.17 101.91 8.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.371 -0.83 . . . . 0.0 110.09 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -54.66 103.19 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.094 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -112.71 178.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.633 0.73 . . . . 0.0 110.823 -179.145 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.508 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 6.4 ptt85 . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.443 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -130.09 178.23 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 110.059 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.582 ' SG ' ' CZ2' ' A' ' 50' ' ' TRP . 2.8 t -160.08 97.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.527 -0.733 . . . . 0.0 110.259 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 pm0 -80.26 -175.26 4.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.1 p -45.26 142.57 2.98 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.473 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.607 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 45.8 Cg_endo -69.76 157.57 59.93 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.992 1.522 . . . . 0.0 111.261 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.27 173.25 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.971 1.511 . . . . 0.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.68 177.95 4.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.293 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.545 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.85 -170.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.24 1.019 . . . . 0.0 111.722 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 9' ' ' ILE . 25.4 m -38.32 92.48 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.004 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.8 m-20 40.28 34.82 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.338 -0.851 . . . . 0.0 110.78 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.91 12.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -139.7 179.01 6.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.379 -1.071 . . . . 0.0 109.957 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.607 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -137.78 114.23 10.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 110.338 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.72 122.81 21.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.42 -111.41 2.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -157.09 29.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 110.113 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 1.6 pm0 -162.99 173.62 13.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -102.26 -51.08 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.936 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -100.41 139.66 35.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.967 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.564 ' CE1' ' HG3' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -120.01 -11.96 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.641 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 21.1 p 51.14 -99.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.556 -0.715 . . . . 0.0 111.694 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -147.95 163.34 37.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.053 -1.029 . . . . 0.0 110.575 -178.579 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.47 25.31 68.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.561 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -107.04 -179.62 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.819 . . . . 0.0 110.201 -179.281 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 24.3 t -155.04 155.48 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.589 HG13 ' CD1' ' A' ' 29' ' ' TYR . 17.2 t -140.51 116.21 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.655 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.444 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -70.49 103.84 2.59 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.374 -1.33 . . . . 0.0 107.851 178.064 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.657 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.8 m-30 -68.28 135.01 51.26 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.327 -178.262 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.524 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 4.4 t -90.25 -172.36 3.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.385 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.446 ' N ' ' OG ' ' A' ' 30' ' ' SER . 85.9 m -149.33 159.9 43.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.077 -1.014 . . . . 0.0 110.226 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.541 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 76.0 m-20 -46.04 139.51 4.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.937 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.51 109.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.16 17.62 10.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.541 ' CD2' ' HB2' ' A' ' 32' ' ' ASN . 3.2 m-85 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.017 -1.284 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.56 ' CB ' HG23 ' A' ' 59' ' ' VAL . 66.3 m -92.17 133.16 36.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 111.027 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 5.3 tp -88.17 116.17 26.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.37 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.542 ' O ' ' CB ' ' A' ' 54' ' ' PRO . 0.3 OUTLIER -109.26 157.62 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.086 -1.009 . . . . 0.0 109.815 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.52 -169.37 18.27 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -58.61 119.24 6.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.045 -1.268 . . . . 0.0 109.51 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.1 p -68.45 58.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.588 179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 40' ' ' ASN . . . 155.96 115.22 0.5 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.657 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.9 t -61.52 -175.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.214 . . . . 0.0 108.212 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.7 tp -144.06 101.38 3.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.189 -0.944 . . . . 0.0 110.115 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.584 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 1.1 t -85.22 108.42 17.73 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.72 179.111 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -129.31 103.68 7.07 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.211 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 79.43 52.79 4.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.83 50.12 8.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.56 73.42 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -1.051 . . . . 0.0 110.446 -179.854 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.584 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 68.8 m95 -46.21 131.72 10.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.562 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 5.9 m -142.65 168.98 18.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 111.099 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.499 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 11.7 m-20 59.95 66.34 2.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.687 -0.633 . . . . 0.0 111.111 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.499 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -90.8 130.22 1.47 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 124.366 1.719 . . . . 0.0 110.335 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.557 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 55.6 Cg_endo -79.34 -176.24 3.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.838 1.441 . . . . 0.0 110.534 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.523 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 11.0 p -112.1 -169.42 1.47 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.997 0.903 . . . . 0.0 111.634 -178.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 36' ' ' SER . 67.9 m -152.03 86.72 1.31 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.542 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -117.8 -143.39 0.37 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.778 -177.845 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.549 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -134.43 100.5 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.686 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 30.8 m -101.19 70.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 112.587 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 27.9 mtpt -65.52 -170.86 0.07 Allowed 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 117.239 -1.785 . . . . 0.0 107.989 178.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 m -143.9 159.8 52.12 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.292 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 46.0 Cg_endo -85.31 -79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 124.783 1.938 . . . . 0.0 110.558 179.377 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 171.63 128.6 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.691 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 53.2 Cg_endo -80.27 66.36 8.82 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.8 1.421 . . . . 0.0 109.783 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.518 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 1.2 p -84.25 -171.49 3.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.349 -0.844 . . . . 0.0 109.698 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.543 ' CG1' ' N ' ' A' ' 67' ' ' SER . 0.2 OUTLIER 172.44 170.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.298 179.035 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.543 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 69.5 m -77.0 107.4 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.155 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 5.7 m-80 38.56 65.92 0.57 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.496 ' C ' ' CD1' ' A' ' 70' ' ' TYR . . . -155.53 -37.98 0.02 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 43.5 p90 35.14 -155.78 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.591 1.186 . . . . 0.0 112.265 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.59 HD22 ' CE2' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -155.13 126.89 7.49 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.696 -175.486 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.6 t -100.53 15.92 26.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 86' ' ' ASP . 2.8 m -80.66 -92.3 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 111.258 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.16 88.19 0.18 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -95.76 165.87 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.612 -179.336 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.577 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 5.4 tttt -164.25 156.12 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.459 -0.775 . . . . 0.0 109.756 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -30.47 59.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 0.0 110.45 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.9 p -143.95 138.24 28.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.607 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 25.0 m-85 -114.51 -140.77 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.509 ' C ' HG22 ' A' ' 59' ' ' VAL . 82.7 p -162.7 -123.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.878 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -105.27 27.3 8.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.841 -1.162 . . . . 0.0 111.089 -178.276 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.538 ' O ' ' N ' ' A' ' 103' ' ' CYS . 45.8 t-20 -164.98 -110.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.942 -1.099 . . . . 0.0 110.285 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 0.2 OUTLIER 48.86 71.82 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.661 -1.274 . . . . 0.0 109.101 -179.252 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.3 t-20 -68.86 109.44 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.574 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 27.7 m -99.36 120.63 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 0.0 111.242 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 23.7 t70 -78.88 135.42 37.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.182 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.59 ' CE2' HD22 ' A' ' 71' ' ' LEU . 13.1 m-85 -90.85 133.29 35.34 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.651 -1.281 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.616 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.36 81.94 2.12 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.777 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.5 OUTLIER -40.48 126.74 2.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.55 -0.719 . . . . 0.0 110.745 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 17.2 mtpt -66.56 143.12 57.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 109.506 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.49 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.29 53.47 1.86 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CE2' ' HD2' ' A' ' 118' ' ' ARG . 3.2 m-85 -102.29 155.4 18.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -1.035 . . . . 0.0 109.251 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -101.24 146.82 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.637 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.525 HD23 ' CG ' ' A' ' 114' ' ' PRO . 1.4 mt -87.64 90.84 8.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.87 -1.144 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 t -72.48 98.83 2.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.312 -0.868 . . . . 0.0 109.846 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 139.74 -41.38 1.32 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.608 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 98.2 p -178.41 -166.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.166 -1.196 . . . . 0.0 111.386 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -159.23 -39.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.577 0.703 . . . . 0.0 109.174 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 37.2 p -123.9 91.96 3.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.43 ' O ' HG21 ' A' ' 85' ' ' VAL . 24.2 m -103.25 146.3 28.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 111.226 -178.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -117.78 136.86 53.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.688 0.756 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.561 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -65.73 92.06 0.14 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 110.375 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.476 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -64.82 173.59 1.6 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.484 -0.76 . . . . 0.0 111.012 -179.664 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.686 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.3 Cg_endo -76.22 125.06 8.26 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.381 1.727 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.71 -3.91 8.06 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 9.3 m-80 80.75 94.01 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.881 -0.776 . . . . 0.0 110.428 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.419 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.6 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.801 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.592 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 26.1 m95 -153.99 90.21 1.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.435 -0.791 . . . . 0.0 110.403 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.8 mtpp -96.15 141.62 23.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 110.284 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.47 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.6 Cg_endo -72.48 170.38 68.29 Favored 'Cis proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.915 -2.119 . . . . 0.0 110.559 -0.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' LEU . 11.9 pt-20 -40.58 131.43 2.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.387 -0.821 . . . . 0.0 110.427 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -41.27 142.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 0.0 110.03 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.525 ' CG ' HD23 ' A' ' 95' ' ' LEU . 46.4 Cg_endo -77.45 170.26 19.67 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.447 1.761 . . . . 0.0 111.616 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.496 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -126.37 113.2 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.603 -0.685 . . . . 0.0 110.157 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.552 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.7 t -67.72 108.57 2.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.96 . . . . 0.0 109.051 179.353 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -117.41 -179.61 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.622 0.725 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.585 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.952 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.245 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.414 HG21 ' N ' ' A' ' 2' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.122 0.486 . . . . 0.0 110.051 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' N ' HG21 ' A' ' 1' ' ' VAL . 18.0 ptmt -146.12 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.659 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 3.9 t -147.9 105.26 3.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.757 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -88.95 -179.11 5.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.342 -179.908 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -44.58 140.14 3.28 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.378 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.599 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 55.3 Cg_endo -71.31 168.2 24.1 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.031 1.543 . . . . 0.0 110.781 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.43 -178.46 2.61 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.81 1.426 . . . . 0.0 108.457 178.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -82.32 45.32 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.843 -1.161 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.665 HG13 ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER 39.08 -170.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 122.204 1.002 . . . . 0.0 110.618 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.665 ' N ' HG13 ' A' ' 9' ' ' ILE . 47.4 m -102.11 112.06 24.58 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.75 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 74.64 38.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.612 -0.68 . . . . 0.0 110.393 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' HA3' HD12 ' A' ' 9' ' ' ILE . . . -179.03 -155.5 14.95 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.478 ' O ' HG23 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -137.36 -171.61 3.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -1.208 . . . . 0.0 110.987 -179.621 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 9.6 p80 -145.0 153.91 41.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.164 0.506 . . . . 0.0 110.097 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -152.68 -87.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.22 -109.07 3.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.455 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -178.18 48.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -1.16 . . . . 0.0 110.327 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 176.25 -165.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.463 179.909 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.02 -48.29 1.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.845 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -92.07 139.11 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.643 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.6 OUTLIER -130.63 -13.87 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 111.262 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.563 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 17.4 p 44.51 -98.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 111.435 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -147.4 158.29 43.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.072 . . . . 0.0 110.154 -178.764 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.27 21.34 79.35 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.643 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 8.1 m -106.75 176.91 5.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.643 -0.916 . . . . 0.0 110.329 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.556 HG11 ' N ' ' A' ' 27' ' ' VAL . 42.8 t -151.25 152.24 11.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.486 -0.759 . . . . 0.0 109.864 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.591 HG13 ' CD1' ' A' ' 29' ' ' TYR . 12.7 t -130.82 121.95 51.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.997 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.31 102.33 5.04 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.848 177.866 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.639 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.4 m-30 -68.49 151.73 46.38 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 110.665 -178.136 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.412 ' C ' ' SG ' ' A' ' 31' ' ' CYS . 1.2 p -114.53 175.72 5.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.43 -0.794 . . . . 0.0 109.526 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 11.2 m -142.91 154.11 43.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 22.2 m-80 -43.59 157.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.16 115.65 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.266 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.68 10.48 35.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-85 -106.65 138.94 41.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -1.183 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.575 ' CB ' HG23 ' A' ' 59' ' ' VAL . 70.6 m -89.16 117.52 28.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 110.695 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.471 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 3.2 tp -79.6 119.37 22.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -0.956 . . . . 0.0 109.613 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.568 HG21 ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -111.88 170.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.145 179.522 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.61 44.08 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.447 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 9.7 p30 -57.81 142.22 46.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.092 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 28' ' ' THR . 25.6 p -85.6 56.95 4.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 159.23 106.57 0.22 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.639 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.7 t -53.8 -175.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.011 -1.287 . . . . 0.0 108.547 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.454 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.4 tp -144.92 99.17 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 110.197 178.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -83.11 118.6 23.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -0.984 . . . . 0.0 109.744 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.463 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -123.87 69.94 1.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 110.481 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.408 ' N ' ' HB2' ' A' ' 23' ' ' ASP . . . 101.23 50.47 1.23 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 19.64 57.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.86 71.19 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.146 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.603 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 83.5 m95 -46.18 133.85 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.136 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 p -143.96 160.99 39.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.532 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 61.44 65.17 1.9 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 111.192 179.516 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.532 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.37 134.86 1.37 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.361 1.716 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.6 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.9 Cg_endo -76.55 -176.17 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.821 1.432 . . . . 0.0 109.929 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.514 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.8 p -115.83 -178.12 3.32 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.276 1.036 . . . . 0.0 112.094 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.497 ' SG ' ' CD1' ' A' ' 9' ' ' ILE . 55.5 m -148.07 74.76 1.31 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.99 -167.13 1.15 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.485 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.19 105.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -0.852 . . . . 0.0 109.379 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.575 HG23 ' CB ' ' A' ' 36' ' ' SER . 32.8 m -95.78 67.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 111.674 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.55 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mptp? -68.87 174.86 4.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.354 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.76 161.86 60.93 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 118.43 -1.308 . . . . 0.0 113.565 -177.864 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.2 Cg_endo -81.26 -82.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.832 1.964 . . . . 0.0 110.054 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.58 131.93 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.0 110.295 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.619 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.0 Cg_endo -86.79 88.09 0.71 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.739 1.389 . . . . 0.0 108.615 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.575 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 3.3 p -108.77 -42.0 4.62 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.364 1.078 . . . . 0.0 110.554 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.652 HG23 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 49.91 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.6 -178.867 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.499 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.1 OUTLIER -70.45 108.4 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.617 -0.677 . . . . 0.0 111.696 -178.481 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.473 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 4.4 m-80 39.05 38.13 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.641 -0.662 . . . . 0.0 111.381 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -118.43 -40.81 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.236 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.592 ' CD1' ' O ' ' A' ' 69' ' ' GLY . 1.0 OUTLIER 40.57 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.942 1.353 . . . . 0.0 112.259 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.58 ' N ' ' CD2' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -138.5 159.15 42.79 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.246 -179.002 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 t -134.65 29.09 3.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.301 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.491 ' HB2' ' CB ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -108.14 -72.32 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 0.0 110.805 -179.53 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.454 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -143.47 85.69 0.19 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -112.38 167.67 10.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.405 -1.056 . . . . 0.0 110.232 -179.631 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 tttm -165.79 164.46 18.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -62.57 -22.39 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.25 152.38 37.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 110.588 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 17.0 m-85 -133.23 -146.32 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.301 -0.874 . . . . 0.0 110.069 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.499 ' C ' HG22 ' A' ' 59' ' ' VAL . 90.5 p -165.32 -120.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -105.11 36.86 2.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.016 -178.912 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.535 ' N ' ' O ' ' A' ' 103' ' ' CYS . 10.0 p30 -176.2 -114.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.907 -1.121 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 43.95 79.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.816 -1.178 . . . . 0.0 109.567 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 20.7 p30 -69.2 137.8 53.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 0.0 110.706 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.48 HG12 ' CH2' ' A' ' 109' ' ' TRP . 29.8 m -119.97 118.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.34 -0.85 . . . . 0.0 110.56 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.4 t0 -83.33 123.49 29.69 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.652 ' CD1' HG23 ' A' ' 66' ' ' ILE . 56.9 m-85 -82.27 139.52 34.15 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.278 1.037 . . . . 0.0 113.048 -177.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -116.19 86.12 2.43 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.248 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -38.64 126.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 -179.203 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 1.4 mmtt -38.55 -92.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.552 -0.717 . . . . 0.0 111.038 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -146.92 150.31 34.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.004 -1.06 . . . . 0.0 111.034 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 40.94 33.65 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 19.6 m-85 -134.92 148.25 50.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -1.026 . . . . 0.0 109.975 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 3.7 tttt -108.23 151.29 26.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 109.987 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 10.4 mt -89.22 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.425 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -76.49 103.64 6.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 179.914 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.35 -90.01 0.19 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.7 m -153.61 121.85 6.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -1.164 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 87' ' ' PHE . 2.7 p -75.5 -6.05 48.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -138.15 120.52 15.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.033 -1.042 . . . . 0.0 109.961 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.466 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 20.3 m -136.84 166.37 23.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.52 153.35 51.71 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.842 . . . . 0.0 110.427 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.594 ' SG ' ' CZ2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -82.81 75.01 9.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.52 -179.519 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.431 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -56.01 174.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 111.072 -179.79 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.568 ' CG ' HG21 ' A' ' 38' ' ' ILE . 42.5 Cg_endo -74.84 123.46 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.427 1.751 . . . . 0.0 110.153 -179.417 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.72 -14.73 4.96 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.575 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.0 OUTLIER 85.06 94.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.646 0.736 . . . . 0.0 111.104 179.43 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.441 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.92 -160.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.689 0.756 . . . . 0.0 110.882 179.281 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.619 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 19.9 m95 -148.11 77.97 1.42 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.806 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -88.39 151.73 48.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 110.435 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.65 177.88 31.88 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.908 -0.163 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.58 114.59 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.341 0.591 . . . . 0.0 110.988 -179.229 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.593 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 4.3 tp -40.58 142.67 0.75 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.529 -0.732 . . . . 0.0 110.191 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.555 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 41.3 Cg_endo -70.61 165.32 32.32 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.005 1.529 . . . . 0.0 110.219 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.526 ' O ' ' N ' ' A' ' 117' ' ' VAL . 62.3 tttt -128.58 103.28 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.902 179.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.515 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -58.2 87.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.052 -1.03 . . . . 0.0 109.06 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -95.42 179.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.837 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.575 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 3.1 ptp85 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.271 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.278 0.561 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.94 174.34 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.548 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -130.45 79.46 1.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 7.9 mp0 -47.49 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 1.3 p -55.04 146.06 40.95 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.058 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 46.5 Cg_endo -69.24 155.08 68.7 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.804 1.423 . . . . 0.0 111.11 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.04 174.64 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.105 1.582 . . . . 0.0 110.305 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.17 179.53 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.64 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.539 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -147.78 -169.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 122.208 1.004 . . . . 0.0 111.377 -179.888 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 15.1 m -53.5 97.96 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.543 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' SER . 35.2 m-80 41.0 61.69 1.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -168.61 151.19 17.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.3 mtm180 -104.09 -169.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -1.157 . . . . 0.0 110.675 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.6 p80 -147.75 -153.38 0.49 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.384 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 18' ' ' GLU . 16.2 t-20 58.28 149.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -39.3 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 10.5 t80 -160.64 40.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -1.217 . . . . 0.0 110.581 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.544 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -165.03 -166.82 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 5' ' ' SER . 1.6 m-20 -140.24 -41.29 0.42 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 110.657 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.59 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 33.2 p90 -131.04 105.9 8.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.941 -1.1 . . . . 0.0 110.845 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 12.7 m-85 -72.84 -163.51 0.13 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.612 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.548 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -149.8 -64.83 0.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 111.015 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 5.4 t0 -165.23 146.38 7.41 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 66.27 15.13 62.88 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 1.5 m -97.21 164.3 12.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 109.962 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 27' ' ' VAL . 43.4 t -138.68 154.35 26.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 110.54 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.603 HG13 ' CD1' ' A' ' 29' ' ' TYR . 11.2 t -131.62 122.3 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.509 -179.08 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.95 103.08 8.66 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.371 -1.332 . . . . 0.0 107.71 177.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.635 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.3 m-30 -67.66 107.08 2.41 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.421 -178.462 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -69.21 158.01 35.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 110.312 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 18.8 m -123.44 146.32 48.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 4.1 m120 -43.87 138.56 2.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 109.951 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' ASN . 5.3 t -44.39 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 126.75 -1.22 7.39 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.576 ' CE2' HG13 ' A' ' 58' ' ' ILE . 14.3 m-85 -106.39 143.26 34.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -1.183 . . . . 0.0 110.391 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.531 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -92.24 139.86 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 110.84 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 3.0 tp -91.34 99.12 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.309 179.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.601 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.7 OUTLIER -87.98 147.14 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.619 -179.76 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.97 -176.96 27.47 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.7 134.36 51.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -1.15 . . . . 0.0 109.777 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.65 53.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.5 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 159.33 116.46 0.45 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.635 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.5 t -58.44 -178.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.001 -1.294 . . . . 0.0 107.866 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.2 tp -146.14 94.82 2.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.305 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 0.0 109.078 178.79 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.8 p -132.45 111.31 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.411 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 18.31 39.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.3 31.31 47.17 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -151.95 100.56 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -1.175 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.585 ' CD2' ' SG ' ' A' ' 45' ' ' CYS . 81.3 m95 -54.03 136.99 40.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 7.4 m -146.09 155.64 42.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.05 -1.031 . . . . 0.0 111.061 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.543 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.6 t0 68.95 64.86 0.54 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.625 -0.672 . . . . 0.0 111.199 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.2 Cg_endo -92.29 132.71 1.17 Allowed 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.971 1.781 . . . . 0.0 110.597 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.537 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 54.3 Cg_endo -82.84 173.89 9.93 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.862 1.454 . . . . 0.0 109.481 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.601 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 74.2 p -114.22 134.77 54.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.869 -1.144 . . . . 0.0 111.366 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.2 m -98.09 75.58 2.33 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.527 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.8 171.37 7.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.365 0.602 . . . . 0.0 110.533 -178.376 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.576 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -87.94 124.74 41.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.011 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.591 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 33.9 m -110.38 53.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 111.269 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -78.74 107.68 11.62 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.578 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 71.0 m -74.46 162.86 71.91 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.244 -0.91 . . . . 0.0 111.665 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.8 Cg_endo -71.39 -78.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.622 1.854 . . . . 0.0 110.66 179.319 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.523 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER 178.41 131.02 0.22 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 54.2 Cg_endo -76.68 65.17 7.53 Favored 'Trans proline' 0 C--N 1.295 -2.275 0 O-C-N 123.714 1.376 . . . . 0.0 110.254 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.532 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -95.93 141.34 29.47 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.036 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.585 ' CD1' HD22 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -135.8 154.79 34.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.092 -178.908 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.88 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.77 -179.701 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.7 OUTLIER 68.0 -55.51 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 67' ' ' SER . . . -52.71 -169.3 0.02 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.531 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 12.6 p90 175.12 -165.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.598 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -125.14 153.73 42.56 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.233 178.237 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t -139.01 24.83 2.54 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -106.71 -73.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.33 81.1 0.29 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.6 t80 -101.01 164.16 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 109.775 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.625 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -160.5 167.98 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.543 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -71.78 -29.37 64.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.255 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 p -139.12 135.19 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 38.8 m-85 -117.13 -170.28 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.809 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.54 ' C ' ' CG2' ' A' ' 59' ' ' VAL . 89.1 p -145.77 -99.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.0 111.201 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.589 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -120.95 22.01 11.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.494 -1.379 . . . . 0.0 110.357 -178.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 103' ' ' CYS . 16.4 p30 -159.39 -116.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 110.606 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.431 ' C ' HG21 ' A' ' 102' ' ' THR . 1.1 t70 52.09 73.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.799 -1.188 . . . . 0.0 109.367 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 31.4 t30 -69.46 105.02 2.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.799 . . . . 0.0 110.906 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 34.6 m -91.54 118.42 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.028 -1.045 . . . . 0.0 110.757 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.85 137.76 38.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.429 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.598 ' CE1' HD11 ' A' ' 71' ' ' LEU . 38.3 m-85 -97.44 155.61 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.943 -178.255 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 70' ' ' TYR . 1.4 mmtt -136.33 123.1 21.18 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.582 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.464 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -68.56 132.04 46.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 110.376 -179.915 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -38.62 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.512 -0.742 . . . . 0.0 110.527 179.894 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -172.96 120.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.148 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.565 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 78.59 50.2 6.21 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 77.4 m-85 -158.83 167.64 28.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.473 -1.016 . . . . 0.0 110.396 -178.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.541 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 21.1 tttm -121.39 124.87 45.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 0.0 109.607 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.585 HD22 ' CD1' ' A' ' 66' ' ' ILE . 2.3 mt -66.69 92.84 0.23 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.913 -1.117 . . . . 0.0 110.076 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.439 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -76.57 112.41 13.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.91 -79.31 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -169.37 122.47 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -1.053 . . . . 0.0 110.135 -179.635 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -83.86 17.3 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.734 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 85.7 p -157.15 105.86 2.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.974 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.503 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.1 m -123.64 175.63 6.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.199 -0.938 . . . . 0.0 110.943 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.08 132.63 19.79 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.603 0.716 . . . . 0.0 110.176 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.559 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -61.79 89.23 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.507 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.459 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -75.21 178.58 1.74 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 111.186 -179.046 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.591 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 44.0 Cg_endo -76.83 130.5 11.51 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.394 1.734 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.83 -10.3 7.52 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.574 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 9.3 m-80 81.42 76.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 122.102 -0.646 . . . . 0.0 110.738 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -171.16 -169.28 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 0.0 111.361 179.746 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.603 ' CZ2' ' HD3' ' A' ' 64' ' ' PRO . 32.0 m95 -133.09 95.72 3.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.626 -0.671 . . . . 0.0 110.104 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.9 mmtt -101.61 146.63 32.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.518 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.32 178.62 33.06 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.782 -2.174 . . . . 0.0 110.528 -0.291 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -37.56 124.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 110.908 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 1.5 tp -46.48 143.54 3.88 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 110.226 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 40.1 Cg_endo -70.67 168.09 23.75 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.056 1.556 . . . . 0.0 110.636 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.3 tttt -132.76 109.42 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.517 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -62.8 89.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.13 -0.981 . . . . 0.0 108.85 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 2.4 m -104.9 -173.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.925 0.869 . . . . 0.0 111.215 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.547 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtt-85 . . . . . 0 C--N 1.294 -1.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.479 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 13.3 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.363 0.602 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.38 162.71 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.099 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.523 ' O ' ' N ' ' A' ' 21' ' ' TYR . 1.0 OUTLIER -130.54 91.71 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.286 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 2.2 mp0 -64.03 164.98 9.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 109.885 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.74 141.52 1.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.799 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.609 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 49.1 Cg_endo -69.27 162.57 41.29 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.954 1.502 . . . . 0.0 110.874 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.32 170.22 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.036 1.546 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -89.36 104.32 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -51.13 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.103 0.954 . . . . 0.0 111.251 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.64 141.0 30.95 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.085 -179.337 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.4 m120 50.57 19.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -160.68 168.47 36.13 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.054 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' N ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -132.34 -177.62 4.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -1.106 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.609 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.3 p80 -126.67 143.85 51.1 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.563 -0.71 . . . . 0.0 110.553 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.28 -166.98 1.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.127 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.67 -91.28 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -170.64 28.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -1.16 . . . . 0.0 110.211 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -165.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.427 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -164.98 25.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -150.68 49.22 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 110.822 -179.753 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.3 m-85 -50.15 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.522 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p -141.0 -54.53 0.48 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.089 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 6.6 t70 -172.63 148.18 1.9 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.858 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.28 14.72 54.92 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.181 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.596 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.98 174.53 7.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -1.006 . . . . 0.0 109.641 179.854 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 49.6 t -148.99 154.71 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.15 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.588 HG13 ' CD1' ' A' ' 29' ' ' TYR . 8.7 t -131.85 119.1 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.631 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.92 103.66 5.22 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.141 178.177 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.632 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.33 175.7 3.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.763 -178.699 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -131.55 161.84 31.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.571 179.576 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.51 ' SG ' ' CD1' ' A' ' 37' ' ' LEU . 55.9 m -140.1 130.94 25.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 110.431 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -44.4 136.74 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.4 p -46.09 111.75 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.93 -9.06 7.59 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -114.6 115.38 27.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -1.166 . . . . 0.0 110.258 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.613 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -63.94 127.91 33.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.602 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.51 ' CD1' ' SG ' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -82.83 99.91 10.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.142 178.983 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.569 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.6 OUTLIER -86.16 145.38 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 109.196 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.91 -143.98 15.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.53 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.6 m120 -126.41 51.24 1.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.201 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 40' ' ' ASN . 10.8 m 22.79 66.38 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.655 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 152.85 108.63 0.37 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.632 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.7 t -65.27 -177.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.994 -1.298 . . . . 0.0 108.329 178.8 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 25' ' ' SER . 7.6 tp -145.96 97.35 2.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.544 178.606 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.25 115.02 20.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 178.905 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.471 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 83.6 p -127.27 109.24 11.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.613 -0.679 . . . . 0.0 110.471 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.42 41.57 13.18 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 63.41 33.27 86.78 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.64 107.1 4.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -1.182 . . . . 0.0 110.613 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.2 m95 -66.74 138.85 57.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.636 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -149.26 169.75 20.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 111.405 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 49.72 64.85 7.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.784 -0.572 . . . . 0.0 111.421 179.679 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.5 Cg_endo -92.78 147.6 2.64 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 121.919 1.746 . . . . 0.0 110.296 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.587 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -81.52 173.89 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.895 1.471 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.569 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.6 p -125.3 141.13 52.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.01 . . . . 0.0 111.231 -179.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.455 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 75.7 m -100.66 73.91 1.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.7 OUTLIER -118.76 175.84 5.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.043 -179.086 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.5 149.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.258 -0.902 . . . . 0.0 108.767 179.057 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.613 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 33.1 m -124.21 47.46 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 111.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -76.07 155.71 34.56 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.255 178.131 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.474 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -120.44 172.24 4.89 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.847 -1.158 . . . . 0.0 111.476 -178.808 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.0 Cg_endo -78.08 -63.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.649 1.868 . . . . 0.0 110.744 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.581 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 163.07 128.56 0.01 OUTLIER Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.203 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.7 Cg_endo -76.54 69.52 6.65 Favored 'Trans proline' 0 C--N 1.294 -2.302 0 O-C-N 123.696 1.366 . . . . 0.0 110.377 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.536 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -94.22 -173.78 3.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.757 . . . . 0.0 109.403 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 178.5 169.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 110.272 179.455 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.528 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.32 103.89 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.875 -179.536 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 59.9 m-80 44.68 51.12 8.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.47 ' HA3' HD12 ' A' ' 66' ' ' ILE . . . -164.64 26.54 0.19 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.556 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -39.27 162.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 123.012 1.386 . . . . 0.0 113.166 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -45.83 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.603 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER 80.59 25.87 0.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.284 0.564 . . . . 0.0 110.094 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.73 -73.67 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 110.467 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -108.1 -98.31 2.55 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.647 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 6.8 t80 57.05 164.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.408 -1.054 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.647 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -170.16 167.44 8.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.438 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -52.83 -26.8 15.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.507 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.486 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 8.0 t -149.69 146.92 27.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -142.53 175.69 9.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 81' ' ' TYR . 1.8 p -170.65 136.61 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.004 -1.06 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.636 ' O ' ' CB ' ' A' ' 82' ' ' ASN . 54.6 t80 31.44 104.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.708 -0.62 . . . . 0.0 111.872 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 38.2 t30 90.19 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 122.005 -0.434 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 80' ' ' SER . 4.5 m-20 55.3 76.64 0.25 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.765 -1.209 . . . . 0.0 108.817 -178.314 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 t-20 -71.29 146.25 49.03 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.63 0.729 . . . . 0.0 111.599 -178.527 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.583 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 2.3 m -127.53 123.57 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.014 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.04 132.36 34.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.906 -1.121 . . . . 0.0 108.69 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 38.1 m-85 -94.55 136.6 34.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.291 1.043 . . . . 0.0 112.674 -177.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.447 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 2.4 tttp -111.89 102.41 10.66 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.474 -179.109 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.444 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -51.68 131.08 29.74 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 109.705 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.18 -79.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.958 -179.746 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.7 m-85 -165.66 141.31 5.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 0.0 110.298 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.56 61.46 6.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -162.71 175.19 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.45 -1.029 . . . . 0.0 110.208 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' VAL . 1.3 tttt -132.14 116.0 16.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.865 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 5.6 mt -55.3 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.475 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -71.95 99.21 2.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.206 -0.934 . . . . 0.0 109.561 179.341 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.75 -86.24 0.18 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.588 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -162.77 122.07 2.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 110.434 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.9 p -73.52 1.34 10.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.878 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 p -147.55 113.69 5.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.526 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 15.2 m -121.3 -173.39 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.518 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 16.1 m -155.83 139.1 15.67 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.942 -178.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.637 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.6 t -69.03 84.03 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 109.371 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -73.82 177.73 1.94 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.555 ' CG ' HG21 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -77.37 130.25 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.569 1.826 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.34 -6.77 12.78 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.595 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.9 OUTLIER 83.15 85.32 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.991 -0.711 . . . . 0.0 111.435 179.364 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.576 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.65 171.83 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.64 0.733 . . . . 0.0 111.14 178.703 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.647 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 51.6 m95 -119.21 93.72 4.18 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.713 -0.617 . . . . 0.0 110.29 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.0 mmtm -98.94 146.05 31.0 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.708 . . . . 0.0 110.566 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.588 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -70.55 169.5 66.38 Favored 'Cis proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.94 -2.108 . . . . 0.0 110.871 -0.786 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 52.2 tt0 -36.03 126.16 0.74 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.568 0.699 . . . . 0.0 111.707 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -42.77 143.51 1.18 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.541 -0.725 . . . . 0.0 109.977 179.105 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 39.2 Cg_endo -71.43 164.11 36.83 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 124.158 1.609 . . . . 0.0 111.242 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.475 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -130.57 108.12 9.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 110.411 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.5 t -65.05 93.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 179.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.506 ' O ' ' N ' ' A' ' 94' ' ' LYS . 3.2 m -112.35 179.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.708 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.591 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.566 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.233 0.54 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 169.96 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.544 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -135.32 95.73 3.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.467 ' HG3' ' CE2' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -71.88 175.73 5.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.483 179.437 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -50.41 138.79 20.87 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.816 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.641 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 47.8 Cg_endo -68.91 156.26 65.96 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.913 1.481 . . . . 0.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.67 167.69 25.88 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.906 1.477 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' ILE . 84.8 p -81.19 99.67 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.606 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -50.97 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.389 1.09 . . . . 0.0 111.877 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -61.06 116.65 4.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.159 -179.168 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 m120 42.94 43.62 3.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.331 -0.855 . . . . 0.0 111.115 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -158.92 139.06 6.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -95.9 -168.83 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.893 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.641 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 14.9 p80 -148.79 120.74 8.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.801 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -71.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.027 . . . . 0.0 110.745 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.58 -97.58 1.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.453 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER 179.82 30.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -1.179 . . . . 0.0 110.576 -179.944 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 178.59 -171.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 110.585 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -105.5 -50.53 3.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.018 179.757 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.8 m-85 -88.7 -170.52 2.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 1.7 m-85 -169.52 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.33 -0.856 . . . . 0.0 111.96 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.544 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p 48.72 -97.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.0 -1.062 . . . . 0.0 112.167 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.448 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.7 OUTLIER -145.36 157.91 43.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.215 . . . . 0.0 110.342 -178.293 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.4 65.1 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.49 ' CB ' ' HB3' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -92.03 160.78 15.07 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.588 -0.948 . . . . 0.0 110.105 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 53.8 t -140.78 152.76 20.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.771 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.645 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 25.2 t -138.02 116.71 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.123 -1.031 . . . . 0.0 111.391 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.66 103.61 2.59 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.519 178.098 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.657 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.84 125.95 27.89 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 110.218 -178.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -82.05 153.5 26.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.251 -0.906 . . . . 0.0 109.93 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 1.6 t -121.55 138.2 54.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.79 158.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.041 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -62.91 131.51 48.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.33 -33.33 6.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -89.59 136.54 32.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -1.122 . . . . 0.0 109.973 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.544 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.92 144.8 25.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.786 -179.635 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.6 tp -96.39 100.91 12.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.432 -0.792 . . . . 0.0 109.331 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.586 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.1 148.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.06 -168.61 12.64 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.565 -1.303 . . . . 0.0 109.878 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.32 134.16 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 28' ' ' THR . 89.2 p -74.41 56.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.699 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 163.86 114.02 0.3 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.657 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.0 t -64.91 -178.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.2 tp -145.82 99.11 3.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.04 -1.037 . . . . 0.0 110.465 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -86.35 110.11 19.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.356 178.902 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.55 100.37 6.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.381 -0.824 . . . . 0.0 110.629 -179.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 84.75 45.14 6.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.481 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 62.33 33.6 86.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.34 95.71 2.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -1.156 . . . . 0.0 110.665 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 72.9 m95 -60.07 137.32 58.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.163 -0.961 . . . . 0.0 109.309 179.263 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 t -139.58 179.2 6.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 0.0 111.397 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.53 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.3 m-20 38.57 64.75 3.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.78 -0.575 . . . . 0.0 111.535 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.9 Cg_endo -91.97 138.69 2.0 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 121.95 1.767 . . . . 0.0 109.558 178.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.441 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 52.3 Cg_endo -78.93 -178.99 5.06 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.734 1.386 . . . . 0.0 110.495 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.492 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 9.0 p -115.06 172.83 6.82 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.801 0.81 . . . . 0.0 111.194 -179.039 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -137.64 77.44 1.63 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.83 -164.26 0.9 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.412 -178.676 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.32 131.24 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.642 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 11.4 m -125.42 47.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 111.493 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 14.3 mttp -74.08 166.25 23.73 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.846 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.13 171.0 8.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.554 -1.341 . . . . 0.0 112.684 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.57 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 51.9 Cg_endo -86.12 -57.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.81 1.953 . . . . 0.0 109.71 178.841 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 161.76 122.72 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.377 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.63 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 55.8 Cg_endo -76.1 66.41 6.94 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 O-C-N 123.645 1.34 . . . . 0.0 109.893 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.547 ' N ' HD22 ' A' ' 113' ' ' LEU . 1.4 p -85.34 -173.25 4.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.275 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.539 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 176.52 170.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.34 179.159 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.538 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 1.1 p -79.79 111.16 15.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 111.434 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.497 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 10.3 m-20 36.83 63.0 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -154.48 -44.54 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 33.7 p90 39.99 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.256 1.027 . . . . 0.0 111.302 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -135.58 154.46 51.34 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.984 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.77 -17.43 13.94 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.895 -1.128 . . . . 0.0 110.2 -178.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.9 t -49.63 -95.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.462 -179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.06 88.87 0.11 Allowed Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.049 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -78.55 100.34 6.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -1.074 . . . . 0.0 109.479 179.457 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.588 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 1.8 ttmt -88.65 133.72 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.913 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.6 ttt180 -40.27 -32.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.406 -0.809 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -128.23 134.11 48.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.447 -0.783 . . . . 0.0 110.08 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.596 ' OH ' ' CD1' ' A' ' 75' ' ' PHE . 1.2 m-85 -117.81 -159.75 0.76 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.544 ' CA ' HG21 ' A' ' 59' ' ' VAL . 90.5 p -157.84 -111.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.845 -1.159 . . . . 0.0 111.672 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -115.24 11.74 16.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.328 -1.482 . . . . 0.0 110.8 -178.396 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.579 ' O ' ' N ' ' A' ' 84' ' ' ASN . 0.7 OUTLIER -159.03 -3.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.749 -1.219 . . . . 0.0 112.896 -179.243 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -55.04 86.39 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.848 -1.158 . . . . 0.0 108.706 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASN . 48.8 t30 -72.74 129.45 38.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 111.796 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 2.8 m -116.79 117.14 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -82.99 120.83 26.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 108.955 179.639 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.565 ' CD2' ' HG3' ' A' ' 114' ' ' PRO . 57.3 m-85 -82.25 138.76 34.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 112.451 -177.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -113.26 84.24 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.067 -179.641 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.468 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -38.28 128.95 1.36 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.704 . . . . 0.0 110.712 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.497 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.48 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.592 -0.692 . . . . 0.0 110.452 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.1 t80 -166.13 143.3 5.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 0.0 109.889 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.23 46.5 85.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.604 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 17.9 m-85 -151.57 157.28 42.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -1.033 . . . . 0.0 109.973 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.472 ' O ' HG21 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.36 112.12 19.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.09 179.884 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.545 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 18.6 mt -48.18 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.491 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -74.93 94.06 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.212 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.05 -89.6 0.14 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.564 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -154.5 118.17 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -1.172 . . . . 0.0 110.618 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.2 p -72.82 -7.27 49.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -141.69 101.72 4.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 0.0 109.857 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.488 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 10.9 m -111.15 162.49 14.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 110.923 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 82' ' ' ASN . 3.5 m -138.68 134.25 33.37 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.17 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 49.3 t -61.93 95.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.134 -1.027 . . . . 0.0 108.806 179.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.4 175.97 0.45 Allowed Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.508 -0.745 . . . . 0.0 111.259 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.642 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 47.8 Cg_endo -81.24 19.55 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.523 1.802 . . . . 0.0 111.205 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -113.5 8.19 24.35 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 76.27 61.15 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.785 -0.833 . . . . 0.0 110.508 179.708 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.532 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -176.83 173.38 1.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.073 -1.017 . . . . 0.0 111.854 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.63 ' CZ2' ' HG3' ' A' ' 64' ' ' PRO . 27.8 m95 -95.69 92.26 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.575 0.703 . . . . 0.0 110.692 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.467 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 10.5 mmtm -109.61 135.35 20.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.577 -0.702 . . . . 0.0 109.628 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.2 Cg_endo -69.81 166.41 74.25 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.179 -2.009 . . . . 0.0 111.285 -0.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -43.67 139.87 2.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -47.99 146.62 4.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.254 179.441 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.565 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 42.9 Cg_endo -72.57 160.41 46.65 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 124.363 1.717 . . . . 0.0 110.713 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' O ' HG23 ' A' ' 117' ' ' VAL . 9.3 ttmt -122.48 106.9 11.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.967 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.108 -0.995 . . . . 0.0 109.18 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.1 m -113.41 178.59 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.608 0.718 . . . . 0.0 110.812 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.581 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.796 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.269 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 18.9 mttt -159.89 174.23 14.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.564 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -122.7 91.58 3.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' SER . 36.8 mt-30 -71.53 175.55 5.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.706 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -41.79 138.04 1.82 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.874 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.599 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 47.9 Cg_endo -69.08 158.44 57.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.97 1.51 . . . . 0.0 111.091 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.68 169.01 23.34 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.886 1.466 . . . . 0.0 110.264 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.6 p -73.32 176.24 6.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.564 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.86 -170.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.166 0.984 . . . . 0.0 111.462 179.726 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 16.7 m -40.08 91.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -178.997 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.0 m120 43.09 40.11 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 110.433 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -132.22 176.48 19.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.485 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 3.3 mtp180 -123.29 -174.93 3.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.386 -1.067 . . . . 0.0 109.759 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.25 122.99 6.81 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.1 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 14' ' ' HIS . 72.1 m-80 -156.61 122.12 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -118.69 31.16 5.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 2.1 t80 66.53 25.38 10.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.106 . . . . 0.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.497 ' CD ' ' CZ ' ' A' ' 21' ' ' TYR . 9.9 pt-20 -159.34 -174.3 4.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' SER . 12.0 m-20 -123.41 -28.6 3.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 0.0 110.14 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -105.36 -170.81 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.808 -179.465 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 1.4 m-85 -174.3 -31.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.699 -0.626 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.564 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 17.2 m 67.28 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 112.509 178.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.11 155.05 40.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.733 -1.229 . . . . 0.0 109.963 -178.424 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.54 56.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.536 ' CB ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.66 162.58 18.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.615 -0.932 . . . . 0.0 110.239 -179.897 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 78.3 t -139.21 152.29 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.592 HG22 ' CH2' ' A' ' 50' ' ' TRP . 24.4 t -135.06 124.52 42.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.696 -179.068 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.26 101.31 4.63 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.073 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.64 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.2 m-30 -68.48 153.24 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.017 -178.547 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.485 ' HB2' ' HG3' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -115.1 160.89 19.11 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.597 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 37' ' ' LEU . 17.6 m -128.44 149.46 50.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.04 -1.038 . . . . 0.0 110.534 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -56.25 148.92 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 179.825 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 p -49.8 115.48 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.13 31.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 2.0 m-85 -118.1 131.54 56.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -1.203 . . . . 0.0 110.348 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.606 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 8.2 m -82.83 138.31 34.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 110.821 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.47 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 6.2 tp -94.59 101.23 13.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.597 ' CG2' ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -96.17 159.9 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 89.35 34.77 8.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 6.2 m120 66.18 176.27 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -1.144 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.7 OUTLIER -116.8 70.71 0.78 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.721 179.632 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 169.93 109.69 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -69.81 -174.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -1.204 . . . . 0.0 108.445 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 25' ' ' SER . 2.6 tp -144.55 102.19 3.78 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.061 178.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -88.52 108.76 19.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 179.083 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -125.84 107.81 10.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.49 41.58 6.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.465 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 58.95 30.06 65.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -145.96 105.86 4.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -1.22 . . . . 0.0 110.608 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CH2' HG22 ' A' ' 27' ' ' VAL . 85.8 m95 -62.07 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.795 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.6 169.72 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.009 . . . . 0.0 111.075 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 47.45 65.22 7.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.821 -0.55 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.5 Cg_endo -90.81 135.03 1.91 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.381 1.727 . . . . 0.0 109.506 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -74.29 161.36 40.61 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.71 1.374 . . . . 0.0 110.072 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.534 ' N ' ' O ' ' A' ' 38' ' ' ILE . 18.0 p -104.0 143.83 32.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 111.849 -178.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 63.5 m -109.76 74.86 0.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.94 173.81 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.519 0.676 . . . . 0.0 110.755 -178.169 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.34 145.37 7.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.629 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 16.1 m -126.29 48.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.756 -178.164 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 7.0 mtpt -86.05 160.95 19.16 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 118.842 -1.143 . . . . 0.0 107.961 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.497 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 16.0 m -122.73 167.86 13.34 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.516 -1.365 . . . . 0.0 112.154 -178.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 42.6 Cg_endo -75.42 -59.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.632 1.859 . . . . 0.0 110.47 179.489 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.22 124.0 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.184 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.61 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 53.4 Cg_endo -75.87 71.96 5.35 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 O-C-N 123.715 1.377 . . . . 0.0 109.707 -179.009 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.445 ' C ' HG23 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -94.78 177.48 5.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.735 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.557 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -171.47 167.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.427 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.48 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.4 OUTLIER -73.39 106.69 5.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.499 -0.751 . . . . 0.0 110.677 -179.498 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.7 m120 40.7 36.63 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 110.502 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -145.0 31.13 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -44.89 -175.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.577 1.179 . . . . 0.0 112.186 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -110.45 160.95 16.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.772 179.091 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.6 t -149.6 24.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.739 -1.226 . . . . 0.0 109.951 -179.343 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.52 ' HB3' ' CB ' ' A' ' 86' ' ' ASP . 24.0 t -112.39 -37.26 5.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.734 -179.405 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.05 95.62 0.12 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.656 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.584 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -125.98 150.24 48.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -1.068 . . . . 0.0 109.734 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 12.7 ttmm -154.15 140.53 18.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.179 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 76' ' ' LYS . 3.3 mtt180 -41.57 -51.88 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.1 m -94.99 168.26 10.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.808 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.595 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 48.8 m-85 -149.16 179.97 7.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.2 m -159.58 -160.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.597 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.71 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 1.8 t80 -73.91 54.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.648 -1.282 . . . . 0.0 109.866 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 81' ' ' TYR . 8.4 p-10 173.51 -125.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.91 -1.118 . . . . 0.0 109.939 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.475 ' C ' HG21 ' A' ' 102' ' ' THR . 0.3 OUTLIER 49.87 67.83 0.84 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.878 -1.139 . . . . 0.0 109.62 -179.42 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.544 ' N ' HG21 ' A' ' 102' ' ' THR . 7.7 p-10 -69.81 104.05 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.541 -179.045 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.598 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 17.3 m -83.97 123.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.141 . . . . 0.0 110.546 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.537 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.3 t70 -81.11 124.88 29.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.926 -1.109 . . . . 0.0 109.001 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CE1' HD11 ' A' ' 71' ' ' LEU . 26.5 m-85 -88.41 123.46 32.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.997 -1.064 . . . . 0.0 111.851 -178.581 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.5 tttm -102.31 109.28 20.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.659 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -58.79 130.51 47.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.071 -1.018 . . . . 0.0 110.192 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 21.7 mmtt -39.41 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 33.9 p90 -144.82 149.62 35.74 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.083 -1.011 . . . . 0.0 110.724 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 39.76 37.3 0.89 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 17.5 m-85 -137.64 146.56 44.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -1.082 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -106.66 162.76 13.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 108.956 179.097 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.539 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -96.31 106.29 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.742 -1.224 . . . . 0.0 110.618 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.444 ' HB3' HG23 ' A' ' 117' ' ' VAL . 1.5 t -86.83 102.06 13.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.505 -0.747 . . . . 0.0 109.578 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.471 ' O ' ' OG ' ' A' ' 98' ' ' SER . . . 137.47 -43.59 1.2 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.532 ' OG ' ' CG ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER 175.49 -166.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 111.238 -179.595 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -67.85 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.707 -0.621 . . . . 0.0 109.999 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 56.2 p -92.09 84.01 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.805 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 85' ' ' VAL . 1.4 m -86.29 166.52 15.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.314 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.544 HG21 ' N ' ' A' ' 84' ' ' ASN . 3.9 m -146.13 139.46 25.98 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.57 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 51.8 t -61.76 104.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -74.12 176.59 2.72 Favored Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 111.319 -178.495 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.629 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 52.4 Cg_endo -80.28 10.03 3.39 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.722 1.906 . . . . 0.0 110.974 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -104.99 7.37 44.44 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 76.13 61.16 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.708 -0.878 . . . . 0.0 109.953 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -176.97 175.5 1.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.771 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.7 m95 -98.41 95.36 7.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.573 0.701 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.481 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.4 mmmt -107.59 136.36 19.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.532 ' CG ' ' OG ' ' A' ' 98' ' ' SER . 44.2 Cg_endo -70.4 166.02 76.88 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.25 -1.979 . . . . 0.0 111.29 0.693 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 14.9 tt0 -42.3 134.93 2.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.51 -0.744 . . . . 0.0 109.88 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -42.18 139.56 1.76 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.95 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.539 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 40.1 Cg_endo -71.22 169.54 20.43 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.233 1.649 . . . . 0.0 111.535 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.509 ' O ' HG23 ' A' ' 117' ' ' VAL . 8.5 tttt -125.04 108.34 11.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.773 . . . . 0.0 110.901 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -61.04 97.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 108.875 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -103.36 -179.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.828 0.823 . . . . 0.0 111.183 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.35 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.471 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 3.9 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.258 0.552 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.431 ' N ' HG21 ' A' ' 1' ' ' VAL . 9.9 pttp -160.9 166.37 28.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 179.916 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.555 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -126.61 72.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 110.12 -179.892 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.28 179.6 0.1 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.302 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.4 p -43.17 142.8 1.48 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.037 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.496 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 47.6 Cg_endo -72.49 164.15 36.46 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.057 1.556 . . . . 0.0 110.569 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.48 169.51 21.58 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.98 1.516 . . . . 0.0 110.286 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.243 -0.91 . . . . 0.0 109.804 179.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.634 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.13 -170.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.329 1.061 . . . . 0.0 111.886 179.91 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.1 t -59.85 83.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.285 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.1 m120 54.68 59.28 4.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -159.25 147.24 14.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' SER . 10.2 mtt180 -93.96 -170.43 2.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -1.141 . . . . 0.0 110.919 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.525 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 11.8 m170 -85.39 -139.23 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.461 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 52.8 t30 -87.37 -54.99 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.217 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.09 -37.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 11.8 t80 -174.42 79.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.5 mp0 -108.41 177.41 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 4.9 t0 178.04 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.973 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -141.91 88.89 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.055 -1.028 . . . . 0.0 109.493 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.643 ' CD2' ' CB ' ' A' ' 25' ' ' SER . 2.9 m-85 -98.49 -9.53 24.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.78 . . . . 0.0 111.116 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.555 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.2 p 43.22 -92.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.548 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 21' ' ' TYR . 3.7 t0 -153.57 131.91 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.985 -1.072 . . . . 0.0 110.475 -178.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.46 47.75 2.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.643 ' CB ' ' CD2' ' A' ' 21' ' ' TYR . 42.2 m -148.41 154.34 39.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -1.171 . . . . 0.0 110.376 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 26.7 t -129.31 152.61 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 111.567 -178.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.577 HG22 ' CH2' ' A' ' 50' ' ' TRP . 33.4 t -122.27 114.39 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.628 -0.67 . . . . 0.0 111.484 -179.568 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -71.99 103.63 3.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.404 -1.318 . . . . 0.0 107.623 177.771 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.667 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.2 m-30 -67.75 118.56 11.16 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 110.138 -178.198 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.532 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.53 154.66 38.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 179.539 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 36.1 m -128.54 153.46 47.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.63 166.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.844 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.61 98.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 110.399 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 11.08 8.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.0 m-30 -105.76 119.2 38.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.173 . . . . 0.0 110.184 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.542 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 19.8 t -68.32 141.87 55.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.581 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 1.4 tp -95.89 108.58 20.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.553 HG22 ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -103.22 140.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.346 -0.846 . . . . 0.0 109.313 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 134.82 -142.03 13.42 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -110.55 52.57 0.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -1.191 . . . . 0.0 110.335 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 40' ' ' ASN . 20.2 p 26.3 59.14 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.881 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 133.57 122.24 2.28 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.412 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.667 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.7 t -61.53 176.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.14 -1.212 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.451 HD11 ' CG2' ' A' ' 26' ' ' VAL . 2.7 tp -142.39 93.97 2.6 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.639 -1.225 . . . . 0.0 110.686 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.92 109.8 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.371 178.213 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 t -131.04 98.26 4.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.549 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.45 9.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 84.24 10.25 80.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.95 116.6 15.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.072 -1.252 . . . . 0.0 110.765 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -68.48 140.32 55.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.89 150.61 34.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.062 -1.024 . . . . 0.0 111.188 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.519 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 64.35 65.71 1.07 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.685 -0.635 . . . . 0.0 111.637 179.21 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.0 Cg_endo -91.71 136.37 1.78 Allowed 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.369 1.721 . . . . 0.0 109.559 178.588 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.532 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.7 Cg_endo -80.57 179.1 6.35 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.71 1.374 . . . . 0.0 110.745 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' ILE . 5.2 p -123.91 148.9 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.8 . . . . 0.0 111.371 -178.68 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.2 m -110.51 78.59 1.13 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.31 -159.39 0.68 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.415 0.626 . . . . 0.0 110.368 -178.923 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.15 125.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.936 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 22.5 m -118.9 52.99 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.13 -0.981 . . . . 0.0 111.597 -179.102 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 13.2 mtpt -60.82 -179.86 0.14 Allowed 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 117.811 -1.556 . . . . 0.0 107.964 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 80' ' ' SER . 93.4 m -136.71 160.51 66.18 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.762 -178.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.5 Cg_endo -85.2 -72.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.736 1.913 . . . . 0.0 109.95 178.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.58 124.9 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.743 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.606 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.5 Cg_endo -77.44 65.61 8.0 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.867 1.456 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -81.86 161.23 23.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.293 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.585 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -157.11 166.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 0.0 110.743 -179.664 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.47 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.39 108.11 10.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.691 -179.385 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.497 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 0.9 OUTLIER 39.93 41.19 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.483 -0.761 . . . . 0.0 110.615 179.573 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -151.5 33.11 0.92 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.585 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.3 p90 -44.84 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 112.469 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.609 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -112.0 161.67 16.2 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.938 179.353 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.83 30.19 1.48 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.829 -1.169 . . . . 0.0 110.382 -179.131 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -110.81 -86.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.47 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.24 71.8 0.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.1 t80 -99.51 166.25 11.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -1.065 . . . . 0.0 110.018 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.639 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -171.05 161.2 6.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 109.79 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -51.14 -32.57 23.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.098 . . . . 0.0 109.451 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.467 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.2 m -144.82 170.76 15.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.67 -0.644 . . . . 0.0 109.798 179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 3.8 m-85 -143.72 -134.68 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 0.0 109.938 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.514 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 60.4 p -167.34 -133.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.839 -1.163 . . . . 0.0 111.133 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -87.22 14.88 6.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.771 -1.206 . . . . 0.0 110.873 -178.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.504 ' HA ' HG21 ' A' ' 102' ' ' THR . 59.9 t30 -160.53 -116.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.711 -1.243 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 5.8 m-20 54.51 76.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.81 -1.181 . . . . 0.0 108.888 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.554 ' N ' HG22 ' A' ' 102' ' ' THR . 22.4 t-20 -71.43 109.83 5.65 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 110.535 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.583 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 14.8 m -87.38 119.44 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.4 t0 -80.6 129.52 34.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 108.798 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CE1' HD11 ' A' ' 71' ' ' LEU . 35.0 m-85 -89.04 142.22 27.82 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.038 -1.039 . . . . 0.0 112.19 -178.237 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -121.26 92.06 3.67 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.51 -179.607 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -42.41 130.74 3.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.425 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.497 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 5.5 mmtt -42.55 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -153.21 154.58 34.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.421 -179.977 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 43.55 31.53 1.7 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.7 m-85 -143.35 144.88 32.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 110.316 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 117' ' ' VAL . 16.4 pttp -113.59 139.43 49.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.875 . . . . 0.0 109.577 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.515 ' CD2' ' HG2' ' A' ' 114' ' ' PRO . 1.2 mt -66.9 114.15 5.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.099 -1.001 . . . . 0.0 111.118 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.517 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -92.16 98.02 11.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.613 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 140.14 -45.82 0.97 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.228 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.526 ' CB ' ' CG ' ' A' ' 111' ' ' PRO . 10.7 t -177.3 -172.99 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.249 . . . . 0.0 111.69 -179.458 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 p -144.76 -27.32 0.49 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -132.48 97.01 3.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.865 -1.147 . . . . 0.0 109.694 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 85' ' ' VAL . 24.8 m -103.3 162.66 12.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.554 HG22 ' N ' ' A' ' 84' ' ' ASN . 1.1 m -136.56 137.02 39.78 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.784 -0.572 . . . . 0.0 110.148 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.606 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 45.5 t -77.28 96.85 4.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.354 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -66.38 -176.3 0.23 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.602 -0.686 . . . . 0.0 110.741 179.936 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.598 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.7 Cg_endo -77.81 124.37 6.81 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.978 1.515 . . . . 0.0 110.55 -179.53 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.48 -7.28 6.25 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.8 m-20 79.35 95.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.898 -0.766 . . . . 0.0 110.976 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.44 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.0 -160.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -0.767 . . . . 0.0 111.088 179.453 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.606 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 26.9 m95 -149.73 111.43 4.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.588 -0.695 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.7 mttt -112.11 127.1 27.32 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 110.157 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.526 ' CG ' ' CB ' ' A' ' 98' ' ' SER . 41.5 Cg_endo -68.14 174.08 35.93 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.064 -2.057 . . . . 0.0 110.549 0.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 113' ' ' LEU . 3.7 mt-10 -63.96 59.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.602 -0.686 . . . . 0.0 111.27 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.536 HD13 ' CZ ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER 55.94 143.95 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 121.442 0.639 . . . . 0.0 111.383 178.951 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.566 ' HD3' ' CE2' ' A' ' 87' ' ' PHE . 43.0 Cg_endo -84.08 166.87 12.71 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.271 1.669 . . . . 0.0 111.09 -179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' O ' HG21 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -122.0 109.28 14.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.234 -0.916 . . . . 0.0 110.748 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.1 t -65.28 104.68 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.02 . . . . 0.0 109.258 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -119.18 -176.02 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.667 0.746 . . . . 0.0 111.023 -179.103 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 . . . . . 0 C--N 1.294 -1.833 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.367 -179.84 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.414 HG13 ' HA3' ' A' ' 48' ' ' GLY . 96.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.271 0.558 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.77 174.59 8.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.264 -0.897 . . . . 0.0 110.574 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 52.9 t -130.0 158.58 39.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -133.68 178.06 7.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.415 -0.803 . . . . 0.0 109.978 179.884 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.5 136.88 7.21 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.476 -0.765 . . . . 0.0 110.254 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.609 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.0 Cg_endo -70.24 155.67 63.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.157 1.609 . . . . 0.0 110.998 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.68 174.39 12.74 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.841 1.443 . . . . 0.0 109.785 178.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -69.89 177.15 3.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.099 -1.001 . . . . 0.0 110.2 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.39 -170.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.261 1.029 . . . . 0.0 111.54 179.872 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.1 OUTLIER -47.06 101.32 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.744 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 10' ' ' SER . 24.8 m-20 40.29 47.3 2.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.29 161.81 30.66 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' SER . 5.1 mpt_? -112.01 -169.89 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.489 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.609 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.1 p80 -144.67 119.38 9.82 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.73 81.3 1.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 110.451 -179.538 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -91.28 28.44 8.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 32.9 p90 37.05 50.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.98 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 14.5 mm-40 -140.11 -169.48 2.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -147.55 -36.91 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 9.0 p90 -142.2 79.09 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.346 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 34.0 m-85 -55.43 -166.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.516 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -152.4 -67.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.91 -1.119 . . . . 0.0 110.743 -179.736 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.96 136.79 9.22 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.546 -0.721 . . . . 0.0 109.357 -179.238 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 73.07 7.9 72.45 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.606 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.8 m -73.54 156.37 38.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -1.031 . . . . 0.0 109.809 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 54.1 t -138.66 153.39 25.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' A' ' 43' ' ' VAL . 41.4 t -138.67 118.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.37 -179.543 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.16 106.31 3.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.407 -1.317 . . . . 0.0 107.591 178.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.634 ' CE1' HG22 ' A' ' 43' ' ' VAL . 3.3 m-30 -68.02 139.01 56.3 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 110.356 -178.053 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -93.98 159.07 15.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.0 m -123.23 149.68 44.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -45.54 138.0 4.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -44.42 106.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 179.993 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.52 15.47 6.95 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.04 137.22 50.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -1.123 . . . . 0.0 110.393 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.562 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -85.78 147.01 26.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 110.929 -179.531 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.486 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.6 tp -95.9 100.63 12.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -96.27 173.81 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 108.953 179.55 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.474 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 80.62 175.91 49.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.929 179.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.478 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -42.51 111.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -1.067 . . . . 0.0 110.021 179.822 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 89.2 p -70.51 55.18 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 110.102 179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.522 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 155.37 95.48 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.634 HG22 ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -45.91 175.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.357 -1.084 . . . . 0.0 108.768 179.5 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -141.12 101.0 3.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.405 -0.809 . . . . 0.0 109.923 178.707 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 6.2 t -78.09 109.38 12.12 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -117.64 128.94 55.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.439 -0.788 . . . . 0.0 109.838 179.787 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.59 30.93 57.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' A' ' 1' ' ' VAL . . . 73.38 45.56 29.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -151.56 97.78 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.132 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 97.9 m95 -64.33 125.59 25.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.25 171.34 14.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.639 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.539 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 52.59 64.53 7.23 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.721 . . . . 0.0 110.635 -179.833 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.9 130.08 1.43 Allowed 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 121.913 1.742 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.8 Cg_endo -74.27 176.12 10.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.822 1.433 . . . . 0.0 110.536 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.502 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.4 p -105.62 173.67 6.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.842 0.83 . . . . 0.0 111.266 -179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.6 m -139.75 75.43 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.6 mm-40 -114.21 -152.13 0.5 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.735 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.67 138.42 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 34.5 m -128.25 41.2 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.01 -1.056 . . . . 0.0 110.966 -179.115 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 16.6 mttt -53.93 178.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.358 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.16 162.33 40.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.578 -179.021 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.0 Cg_endo -83.8 -68.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.829 1.963 . . . . 0.0 110.306 179.08 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.31 128.73 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.382 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.64 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 49.4 Cg_endo -78.01 60.34 7.29 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 O-C-N 123.571 1.301 . . . . 0.0 109.841 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 2.3 p -74.76 -177.3 3.18 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.565 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -176.26 167.77 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.967 179.463 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 6.8 m -70.1 89.76 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.589 -0.694 . . . . 0.0 110.688 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.3 m120 50.23 49.62 20.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.87 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -162.66 40.62 0.36 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.712 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.577 ' O ' ' O ' ' A' ' 69' ' ' GLY . 50.2 p90 -48.25 -151.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.968 1.366 . . . . 0.0 113.076 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.591 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.46 122.82 13.94 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.619 -176.973 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 t -100.4 14.96 29.37 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.52 -0.737 . . . . 0.0 109.968 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.7 t -76.11 -91.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.969 -179.4 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.43 81.25 0.3 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.591 ' CE1' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -100.04 125.37 46.1 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.358 -1.083 . . . . 0.0 109.713 179.494 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 77' ' ' ARG . 10.0 ttmm -111.05 149.76 30.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 0.0 109.931 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -41.47 -41.46 2.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.863 . . . . 0.0 110.015 -179.988 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m -137.55 152.94 49.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.439 -0.788 . . . . 0.0 109.981 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -125.62 -162.52 1.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.575 ' CA ' HG21 ' A' ' 59' ' ' VAL . 2.3 m -153.94 -102.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.314 -0.866 . . . . 0.0 109.583 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.571 ' N ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.8 137.96 49.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.732 -1.23 . . . . 0.0 108.198 179.234 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 103' ' ' CYS . 37.4 t-20 71.49 -104.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.739 -0.6 . . . . 0.0 110.594 -178.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' C ' HG21 ' A' ' 102' ' ' THR . 39.5 m-20 44.96 74.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.606 -1.309 . . . . 0.0 109.355 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.512 ' N ' HG21 ' A' ' 102' ' ' THR . 1.1 t-20 -69.82 140.3 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 111.056 -178.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 3.7 m -129.73 126.33 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.0 110.114 179.127 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.83 132.99 33.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.031 . . . . 0.0 109.32 179.399 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.591 ' CZ ' HD21 ' A' ' 71' ' ' LEU . 44.4 m-85 -89.31 149.11 23.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.145 -0.972 . . . . 0.0 111.935 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.65 90.2 3.27 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.162 0.506 . . . . 0.0 110.037 -179.514 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.432 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -43.14 124.5 3.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.9 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 110.801 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -97.2 -161.05 0.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 110.372 -179.73 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.75 58.36 0.14 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 118' ' ' ARG . 3.0 m-30 -112.15 160.79 17.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.721 -0.87 . . . . 0.0 109.404 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.529 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 10.6 tttt -101.05 136.43 40.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.991 -1.068 . . . . 0.0 110.52 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.6 mt -79.56 90.65 5.12 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.534 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.8 101.94 1.82 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.829 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.58 -78.02 0.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.133 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.563 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -171.48 117.22 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -1.12 . . . . 0.0 110.635 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 -1.51 13.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -0.92 . . . . 0.0 110.966 -179.696 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 p -144.61 112.39 6.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.808 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.524 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.3 m -118.44 177.19 4.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 111.041 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -146.95 128.68 15.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.969 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.59 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 5.4 t -68.91 88.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.705 . . . . 0.0 109.51 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -69.16 -178.41 0.45 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.793 . . . . 0.0 111.193 -179.248 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.3 Cg_endo -80.7 124.96 5.33 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.564 1.823 . . . . 0.0 110.6 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 128.37 -8.12 6.64 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.428 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.566 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 7.2 m-20 83.48 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.5 0.667 . . . . 0.0 111.31 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.486 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -170.96 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.723 0.773 . . . . 0.0 111.21 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.64 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 32.1 m95 -137.73 92.37 2.67 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.451 0.643 . . . . 0.0 110.22 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 28.4 mttt -103.56 142.96 25.67 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.563 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.8 Cg_endo -70.58 167.57 73.0 Favored 'Cis proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.072 -2.054 . . . . 0.0 111.035 -0.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 113' ' ' LEU . 42.5 mt-10 -38.91 129.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.56 -0.712 . . . . 0.0 111.293 -179.239 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.553 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -40.06 147.25 0.36 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 110.594 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.565 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 39.7 Cg_endo -74.04 167.47 27.13 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.441 1.758 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' HB3' ' CB ' ' A' ' 96' ' ' SER . 0.7 OUTLIER -130.43 105.08 7.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.919 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -61.57 101.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.837 . . . . 0.0 109.213 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -115.28 -175.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.698 0.761 . . . . 0.0 110.588 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.0 mtm180 . . . . . 0 C--N 1.295 -1.791 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.32 0.581 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 138.75 44.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.0 110.257 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -108.01 99.21 8.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.847 . . . . 0.0 110.117 -179.921 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 9.9 mt-30 -88.38 177.19 6.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -39.09 136.89 0.97 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.544 -0.723 . . . . 0.0 110.586 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 53.2 Cg_endo -71.27 158.31 54.91 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.058 1.557 . . . . 0.0 110.855 -179.453 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.25 170.94 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.754 1.397 . . . . 0.0 109.865 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.59 175.31 4.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.666 179.695 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 ' O ' ' N ' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -138.37 -170.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.138 0.97 . . . . 0.0 111.463 179.861 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -46.19 90.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER 48.11 48.62 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.786 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -147.65 164.75 28.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.493 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -110.13 -169.95 1.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -1.076 . . . . 0.0 110.524 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -158.89 121.3 3.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.258 0.552 . . . . 0.0 109.981 -179.675 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.79 79.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.137 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.18 -98.0 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 t80 -150.76 34.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.222 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' CD ' ' CE1' ' A' ' 21' ' ' TYR . 2.5 pt-20 -177.81 -159.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.043 -1.035 . . . . 0.0 110.527 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -162.03 24.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.089 -179.962 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 22' ' ' THR . 0.3 OUTLIER -140.54 29.69 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 36.7 m-85 -37.05 142.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.479 ' O ' ' O ' ' A' ' 23' ' ' ASP . 27.8 p -133.8 89.56 2.6 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.228 1.013 . . . . 0.0 110.488 179.248 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER 55.27 152.24 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.83 179.127 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 19.77 8.88 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.609 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 6.4 m -87.41 177.88 6.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -1.063 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 26.4 t -158.41 156.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.05 179.495 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.602 ' CG2' ' CH2' ' A' ' 50' ' ' TRP . 30.3 t -144.99 124.05 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.77 -179.439 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.82 101.34 5.07 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.398 -1.321 . . . . 0.0 107.725 177.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.63 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.8 m-30 -67.99 128.12 35.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 110.423 -178.21 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.493 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.6 t -77.89 -173.7 3.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.196 -0.94 . . . . 0.0 108.883 178.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.463 ' N ' ' OG ' ' A' ' 30' ' ' SER . 89.1 m -147.36 168.25 22.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.104 -0.998 . . . . 0.0 110.239 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.93 148.52 39.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.897 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.5 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.974 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.19 0.29 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -110.88 140.85 45.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -1.138 . . . . 0.0 110.276 -179.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -87.68 145.72 26.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.905 . . . . 0.0 110.623 -179.937 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.05 103.16 15.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.323 -0.86 . . . . 0.0 109.937 179.557 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.552 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -97.18 171.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 108.826 179.124 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 87.0 -168.59 39.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.95 117.82 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -1.125 . . . . 0.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.423 ' HA ' HD23 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.69 56.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -0.987 . . . . 0.0 109.644 179.53 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 160.27 94.19 0.1 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.63 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -48.33 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.341 -1.093 . . . . 0.0 108.85 179.849 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 25' ' ' SER . 10.8 tp -142.64 102.04 3.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.985 178.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -73.63 118.32 16.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.912 179.612 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -133.92 126.83 31.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.164 -0.96 . . . . 0.0 110.177 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.01 19.46 77.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 83.64 25.67 45.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.4 133.9 26.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.292 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CH2' ' CG2' ' A' ' 27' ' ' VAL . 88.6 m95 -80.07 132.72 36.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.976 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.426 ' O ' HG11 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -136.18 162.16 33.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 110.935 -179.604 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.508 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 60.57 66.22 1.9 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.509 -0.745 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.6 Cg_endo -90.75 127.2 1.26 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 121.91 1.74 . . . . 0.0 110.069 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 45.8 Cg_endo -71.15 176.89 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.668 1.352 . . . . 0.0 110.111 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.55 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.7 p -113.39 151.45 31.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -0.936 . . . . 0.0 111.916 -178.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.489 ' N ' ' OE1' ' A' ' 57' ' ' GLN . 69.4 m -116.04 80.74 1.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.878 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -116.8 -162.45 0.85 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 110.425 -178.031 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.4 137.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.604 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 26.0 m -118.77 43.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 111.037 -179.266 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -83.38 98.79 9.67 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.709 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.551 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 56.4 m -68.68 164.31 46.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.803 . . . . 0.0 111.804 -177.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -66.61 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.514 1.797 . . . . 0.0 110.303 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -165.27 133.94 2.6 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.595 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 51.6 Cg_endo -76.5 69.37 6.68 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 O-C-N 123.703 1.37 . . . . 0.0 110.018 -178.953 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.465 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 1.2 p -92.2 -176.85 4.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 109.07 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -174.64 162.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.592 179.494 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 67' ' ' SER . 3.7 p -69.38 101.31 1.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.547 -0.721 . . . . 0.0 110.395 -179.612 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.509 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 21.6 m-20 41.51 57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.177 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.541 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -170.14 37.31 0.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.762 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.569 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.4 p90 -44.06 -170.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 123.419 1.58 . . . . 0.0 112.907 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 1.7 pp -107.46 116.16 31.45 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.55 179.498 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.417 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -82.28 1.38 37.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.42 -0.8 . . . . 0.0 109.602 -179.725 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.0 t -74.72 -86.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.76 . . . . 0.0 110.711 -179.61 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.14 94.5 0.12 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.163 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -81.28 104.3 11.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -1.07 . . . . 0.0 109.296 179.303 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.9 tptt -76.75 145.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.304 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -48.37 70.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.042 179.761 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 27.4 p -117.4 135.29 53.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 95.2 m-85 -113.81 -179.61 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.781 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 82' ' ' ASN . 2.9 m -170.54 108.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.976 -1.077 . . . . 0.0 111.308 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.61 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 11.5 t80 34.92 24.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.356 -0.84 . . . . 0.0 113.106 178.771 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.559 ' HA ' HG23 ' A' ' 102' ' ' THR . 37.3 t-20 -176.51 -125.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.067 -1.646 . . . . 0.0 111.472 178.388 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 49.29 75.42 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.633 -1.292 . . . . 0.0 108.828 -178.359 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 22.4 p-10 -69.57 139.9 53.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.476 -0.765 . . . . 0.0 110.512 -179.054 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.596 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -126.43 120.83 57.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.702 179.07 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 10.7 t0 -75.38 136.02 40.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 108.847 179.368 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CD2' ' CD ' ' A' ' 114' ' ' PRO . 16.5 m-85 -99.36 135.15 41.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.952 -1.092 . . . . 0.0 111.895 -178.564 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' TYR . 3.0 ttpt -109.53 154.91 22.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -100.28 128.18 46.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.92 -1.113 . . . . 0.0 110.098 179.891 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -44.68 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.701 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 93' ' ' TYR . 1.2 m-85 -95.71 -163.81 1.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 110.576 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.37 59.45 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.601 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-85 -109.38 168.94 9.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.788 -0.831 . . . . 0.0 110.009 -179.317 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 22.0 mttt -117.3 110.71 18.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.54 HD22 ' CD1' ' A' ' 66' ' ' ILE . 1.5 mt -49.14 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -74.43 95.74 2.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 110.044 179.817 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.34 -68.78 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.333 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.559 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -175.95 119.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -1.156 . . . . 0.0 111.03 -179.148 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.12 24.13 0.44 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.99 -1.069 . . . . 0.0 111.339 179.676 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 p -167.22 129.17 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.951 -1.093 . . . . 0.0 109.273 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 66.4 m -143.58 160.66 40.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 111.189 -179.145 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.559 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.38 137.83 50.07 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.575 0.703 . . . . 0.0 109.931 179.301 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.571 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 1.8 t -56.25 92.75 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.718 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 1.1 p -71.3 179.29 0.97 Allowed Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 110.118 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.0 Cg_endo -78.51 170.75 17.88 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 O-C-N 124.018 1.536 . . . . 0.0 111.448 -179.026 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 86.13 -57.24 4.79 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -178.906 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.6 OUTLIER 141.66 68.76 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.365 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.26 165.65 24.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.652 -1.28 . . . . 0.0 112.032 -179.473 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.596 ' CZ3' HG21 ' A' ' 85' ' ' VAL . 35.7 m95 -105.99 97.79 7.56 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.307 0.575 . . . . 0.0 109.849 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 5.1 mmmt -99.37 138.85 20.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.56 -179.338 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.559 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.7 Cg_endo -72.06 167.84 75.67 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.793 -0.48 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.4 tt0 -41.4 134.06 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.576 HD11 ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -42.27 152.07 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.385 -0.822 . . . . 0.0 110.706 -179.736 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.592 ' CD ' ' CD2' ' A' ' 87' ' ' PHE . 38.0 Cg_endo -79.42 159.3 25.85 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.554 1.818 . . . . 0.0 111.487 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.506 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.1 tptt -119.03 106.57 12.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.512 -0.742 . . . . 0.0 110.713 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.4 t -62.43 97.86 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 108.774 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 94' ' ' LYS . 1.3 m -112.02 178.28 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.55 0.691 . . . . 0.0 110.592 -179.396 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.491 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.662 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.435 HG23 ' HA3' ' A' ' 48' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.327 0.584 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -120.11 174.4 6.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -140.11 85.08 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.696 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 25.3 mt-30 -60.47 171.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 p -47.77 149.39 2.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.614 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 51.4 Cg_endo -72.31 155.76 55.58 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.95 1.5 . . . . 0.0 110.946 -179.159 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.44 169.08 23.33 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.599 1.315 . . . . 0.0 109.686 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.27 177.22 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.993 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.492 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -170.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.197 0.998 . . . . 0.0 111.475 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -45.62 94.0 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 -179.396 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.0 m120 41.76 53.08 4.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.287 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.85 152.65 24.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 30' ' ' SER . 9.9 mtt180 -94.99 -169.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -1.146 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.2 p80 -160.4 132.72 6.23 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 -179.631 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER 173.77 104.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.056 . . . . 0.0 110.7 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 17' ' ' TYR . . . -81.51 -69.11 1.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.555 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 33.0 p90 178.61 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.334 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.51 -139.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.823 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -149.9 -36.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 110.992 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 14.8 p90 -143.98 90.46 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.859 -1.151 . . . . 0.0 111.227 -179.403 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 44.8 m-85 -57.8 171.2 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.532 178.88 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.465 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -125.96 -49.07 1.6 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.832 -1.168 . . . . 0.0 111.192 -179.359 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -175.44 142.58 0.59 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.304 -0.872 . . . . 0.0 109.565 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.33 69.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -178.741 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.601 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.9 m -87.8 178.38 6.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.615 -0.932 . . . . 0.0 110.15 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 31.5 t -154.46 154.04 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG22 ' CH2' ' A' ' 50' ' ' TRP . 39.6 t -135.8 118.69 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.39 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -71.0 103.32 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.707 177.915 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.652 ' CE1' HG22 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.14 134.46 50.57 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.406 ' O ' ' N ' ' A' ' 13' ' ' ARG . 1.1 m -93.15 159.3 15.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.612 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 34.2 m -126.08 154.01 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -44.39 158.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.011 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 t -62.08 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 110.356 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.31 22.36 3.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-30 -113.36 146.18 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -1.216 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.62 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -88.01 134.38 33.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.676 -0.64 . . . . 0.0 110.816 -179.43 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 55' ' ' THR . 1.2 tp -96.24 102.37 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 178.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -94.48 143.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.233 -0.917 . . . . 0.0 109.08 179.632 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 -175.86 21.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.242 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 5.0 p30 -65.65 142.86 57.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.041 -1.27 . . . . 0.0 109.83 179.763 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.76 51.24 1.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 110.445 -179.713 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 166.29 102.25 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.394 179.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.652 HG22 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -49.0 178.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.165 -1.197 . . . . 0.0 108.5 179.157 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' HA ' HG21 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -140.05 98.21 3.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 110.081 178.548 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.6 t -79.77 118.58 21.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.433 178.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -131.02 114.8 15.64 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.411 ' HA2' HG12 ' A' ' 1' ' ' VAL . . . 70.44 29.02 70.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.453 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 76.41 48.29 9.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.616 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -159.06 87.62 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 179.823 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.6 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 88.0 m95 -58.42 123.94 17.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.105 -0.997 . . . . 0.0 109.314 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -133.02 165.14 25.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 111.445 -179.22 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 1.6 m-20 58.28 65.57 3.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.86 -0.525 . . . . 0.0 111.242 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.7 Cg_endo -92.87 132.23 0.96 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 121.972 1.782 . . . . 0.0 109.985 178.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -75.23 177.32 8.78 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.579 1.305 . . . . 0.0 109.879 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.499 ' OG1' HG12 ' A' ' 38' ' ' ILE . 8.4 p -118.84 141.48 48.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 111.721 -178.667 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 10' ' ' SER . 89.4 m -106.76 79.87 1.39 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.099 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.23 -151.72 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.808 -0.558 . . . . 0.0 109.928 -178.692 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.52 122.73 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 108.766 179.177 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.651 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 19.7 m -116.33 52.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 111.653 -178.311 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mtpt -65.2 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.801 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -129.8 151.26 77.86 Favored Pre-proline 0 C--N 1.295 -1.763 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.871 -178.368 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.534 ' HG3' ' HA ' ' A' ' 108' ' ' THR . 47.0 Cg_endo -84.51 9.4 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.649 1.868 . . . . 0.0 109.356 177.439 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.535 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 69.0 120.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.484 -0.76 . . . . 0.0 110.039 -179.172 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.565 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 56.2 Cg_endo -83.64 96.87 0.77 Allowed 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 123.957 1.504 . . . . 0.0 109.784 179.773 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.552 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 2.9 p -110.01 -42.28 4.25 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.191 0.996 . . . . 0.0 110.208 -179.18 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.605 HG23 ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER 48.01 166.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.717 -178.406 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -69.48 104.47 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 111.14 -178.576 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 1.2 m120 40.51 41.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.826 . . . . 0.0 111.252 178.936 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -121.5 -39.14 0.59 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.043 -1.551 . . . . 0.0 109.807 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.5 p90 39.01 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.761 1.267 . . . . 0.0 112.196 -178.862 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -134.86 155.99 49.71 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.44 -178.916 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.448 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -105.79 -10.24 16.82 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 110.442 -178.891 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.8 m -53.74 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.79 79.74 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -69.19 163.41 24.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -1.075 . . . . 0.0 109.362 179.708 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.2 ttpt -154.56 160.38 41.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 -179.702 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -44.9 -52.35 8.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.202 179.895 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.508 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 74.3 m -131.65 164.67 25.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.1 m-85 -134.22 -140.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.514 ' CA ' HG21 ' A' ' 59' ' ' VAL . 59.9 p -170.08 -126.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.915 -1.116 . . . . 0.0 111.155 179.781 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -96.09 21.35 8.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.023 -1.048 . . . . 0.0 110.636 -178.663 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 103' ' ' CYS . 40.4 t-20 -164.15 -112.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.814 -1.178 . . . . 0.0 110.741 179.212 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 5.6 m-20 46.38 76.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.62 -1.3 . . . . 0.0 108.964 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.506 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.2 p-10 -69.23 145.92 52.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.819 . . . . 0.0 110.992 -178.855 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 2.1 m -131.08 118.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.22 178.947 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 11.4 t0 -83.04 119.53 24.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.877 . . . . 0.0 108.956 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.605 ' CD1' HG23 ' A' ' 66' ' ' ILE . 47.6 m-85 -78.7 135.56 37.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.136 0.97 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.611 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 5.9 tttt -117.1 88.2 2.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 -179.413 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.482 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -36.72 127.69 0.85 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.843 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -36.9 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.744 179.891 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.5 t80 -157.3 142.66 17.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.38 43.2 90.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 18.5 m-85 -147.8 159.06 44.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.528 -0.983 . . . . 0.0 110.182 -179.68 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 16.8 tttp -122.45 112.24 17.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.537 HD21 ' CD1' ' A' ' 66' ' ' ILE . 6.1 mt -48.76 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.37 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.462 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -81.33 96.38 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.693 179.615 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.27 -115.72 0.9 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 30.0 m -123.35 127.22 48.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -1.144 . . . . 0.0 110.224 -179.877 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -42.87 56.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.7 p -101.54 137.34 40.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 109.862 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 50.5 m -147.64 153.42 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.587 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -129.22 145.25 51.37 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.284 179.588 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.523 ' N ' ' O ' ' A' ' 82' ' ' ASN . 3.4 t -67.08 78.09 0.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.65 -0.656 . . . . 0.0 110.45 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.88 172.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 111.064 -179.613 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.651 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 49.2 Cg_endo -81.82 36.27 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.444 1.76 . . . . 0.0 112.003 -178.309 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -128.07 8.48 6.74 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 178.396 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.2 t30 75.7 59.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.797 -0.825 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -170.25 178.85 3.66 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.445 -179.721 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.597 ' CZ3' HG21 ' A' ' 85' ' ' VAL . 19.9 m95 -108.55 87.93 2.61 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.234 0.54 . . . . 0.0 110.168 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.2 mmtt -99.43 147.45 33.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.0 Cg_endo -71.13 175.71 39.71 Favored 'Cis proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.998 -2.084 . . . . 0.0 110.883 0.404 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 tt0 -37.15 134.48 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.461 0.648 . . . . 0.0 110.97 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.586 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 1.6 tp -59.33 148.26 73.34 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.529 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 44.7 Cg_endo -75.45 165.74 30.05 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.049 1.552 . . . . 0.0 110.446 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.539 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -127.05 103.61 7.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -0.967 . . . . 0.0 110.215 179.668 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -55.65 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 109.483 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.6 m -108.26 -173.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.856 0.836 . . . . 0.0 111.04 -179.491 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.25 179.542 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -126.39 145.8 50.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.059 179.969 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' TYR . 1.7 m -69.25 156.96 37.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.497 -0.752 . . . . 0.0 110.976 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 11.3 mt-30 -127.8 167.86 15.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.98 179.299 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' GLN . 5.1 p -45.81 137.44 5.88 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.888 -1.133 . . . . 0.0 109.402 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.601 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 50.3 Cg_endo -69.84 160.79 48.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.071 1.564 . . . . 0.0 111.79 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.7 176.94 9.34 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.152 1.606 . . . . 0.0 110.012 178.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.09 177.28 7.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.538 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.06 -170.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 179.917 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -43.78 92.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.801 -179.344 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.6 m-80 40.27 52.07 2.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.535 179.701 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -148.97 170.52 29.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 30' ' ' SER . 1.6 mtt180 -115.63 -168.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -1.197 . . . . 0.0 110.783 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 19.3 p80 -156.49 127.08 6.69 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.338 0.59 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -124.11 -41.96 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 67.53 -102.13 0.78 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -172.69 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.112 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.489 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 11.0 pt-20 -178.29 -146.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.788 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.22 -43.11 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 28.9 p90 -128.51 118.26 22.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.709 179.335 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.614 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 15.9 m-85 -82.68 -175.05 5.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.516 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.89 -54.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.717 -1.239 . . . . 0.0 111.073 -178.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.04 137.28 0.07 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 109.295 -179.423 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.93 16.86 80.29 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -179.254 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.614 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -99.63 177.13 5.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -1.029 . . . . 0.0 110.153 -179.923 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 7.9 t -147.18 162.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.593 HG13 ' CE1' ' A' ' 29' ' ' TYR . 14.5 t -137.5 113.94 11.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.414 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -71.94 105.41 3.84 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.78 178.055 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.599 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.9 m-30 -68.09 170.63 8.11 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.86 -178.387 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -123.26 147.68 46.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.764 179.578 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.8 m -124.36 144.46 50.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.148 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.71 149.55 3.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -53.17 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.345 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.17 -2.77 4.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 7.8 m-85 -120.6 126.19 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.175 -1.191 . . . . 0.0 110.219 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 57' ' ' GLN . 0.5 OUTLIER -76.15 149.5 37.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.554 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.4 OUTLIER -92.49 96.15 10.05 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.884 178.836 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.571 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.5 OUTLIER -86.56 148.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 -179.841 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 129.64 -160.86 22.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.852 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' O ' ' C ' ' A' ' 41' ' ' SER . 17.1 m-20 -92.17 54.06 2.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -1.203 . . . . 0.0 109.894 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 40' ' ' ASN . 75.5 p 31.1 48.78 0.08 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.41 179.581 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 143.81 134.98 2.91 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.599 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.8 t -67.1 178.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.254 -1.145 . . . . 0.0 108.34 178.685 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HA ' HG21 ' A' ' 26' ' ' VAL . 5.7 tp -139.65 99.08 3.62 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.202 177.996 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.624 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -83.36 114.62 21.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.393 178.756 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 p -132.65 81.43 1.95 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.13 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' GLY . . . 110.61 60.55 0.49 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.817 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.22 29.67 1.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.863 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -147.35 134.37 20.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -1.131 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.624 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.8 m95 -93.43 139.8 30.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.909 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -139.61 159.81 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.33 70.58 2.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.958 -0.464 . . . . 0.0 111.576 179.405 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -89.99 135.9 2.41 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.182 1.622 . . . . 0.0 109.077 178.612 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.559 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.4 Cg_endo -72.2 146.86 46.84 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 123.691 1.364 . . . . 0.0 110.746 -179.483 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.571 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 55.9 p -90.85 171.96 8.95 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.948 0.88 . . . . 0.0 111.689 -179.047 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 10' ' ' SER . 56.6 m -129.7 77.24 1.78 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.653 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.544 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -116.53 -157.29 0.65 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.54 -177.866 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.45 139.64 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.501 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.643 HG22 ' CB ' ' A' ' 81' ' ' TYR . 34.3 m -129.65 43.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.986 . . . . 0.0 111.086 -178.441 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.0 mttp -69.61 98.31 1.15 Allowed 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.423 179.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 56.4 m -69.33 163.52 57.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 110.79 -179.2 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.4 Cg_endo -70.62 -90.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.325 1.698 . . . . 0.0 110.569 -179.877 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.405 ' HB3' HG21 ' A' ' 65' ' ' THR . 0.0 OUTLIER -163.74 131.78 2.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.626 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -77.35 67.83 7.63 Favored 'Trans proline' 0 C--N 1.298 -2.125 0 O-C-N 123.565 1.298 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.54 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -89.21 -178.28 5.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 179.996 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.55 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -176.41 163.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.564 179.398 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.504 ' N ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -70.19 96.24 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.437 -179.737 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 22.1 m120 47.76 44.19 17.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -150.14 32.41 1.05 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.802 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 88' ' ' LYS . 10.5 p90 -45.76 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.523 1.154 . . . . 0.0 112.46 -179.121 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.571 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -115.0 164.01 14.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.244 -179.571 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.34 -7.78 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 -179.765 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 t -59.59 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.77 93.82 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.922 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -89.2 177.79 6.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -1.157 . . . . 0.0 109.601 179.527 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -167.33 153.39 7.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 110.189 -179.461 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.1 mtm-85 -46.48 -36.66 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -146.24 154.54 41.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.633 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.593 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 45.3 m-85 -123.63 -167.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.0 109.688 179.653 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 5.8 p -170.08 91.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.643 ' CB ' HG22 ' A' ' 59' ' ' VAL . 8.5 t80 56.18 135.38 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.605 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.562 ' HA ' HG23 ' A' ' 102' ' ' THR . 63.1 t30 65.09 -127.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.882 -1.137 . . . . 0.0 110.114 -179.258 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 1.7 m-20 52.98 70.75 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.684 -1.26 . . . . 0.0 109.009 -178.556 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 22.2 p-10 -72.91 140.04 47.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.487 -0.758 . . . . 0.0 111.259 -178.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.561 HG21 ' CZ3' ' A' ' 109' ' ' TRP . 4.1 m -128.29 118.63 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.026 178.623 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.6 t70 -78.35 127.71 32.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.737 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE1' HD11 ' A' ' 71' ' ' LEU . 37.4 m-85 -89.07 122.79 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.249 1.023 . . . . 0.0 112.213 -178.289 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -97.63 94.53 7.03 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.791 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -44.24 129.03 6.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.061 -1.024 . . . . 0.0 110.001 -179.836 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 2.2 mmtt -40.35 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.53 -179.571 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -158.82 139.58 12.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 0.0 110.25 179.963 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.61 49.48 46.32 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 14.4 m-85 -155.22 147.42 23.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -1.071 . . . . 0.0 109.553 -179.614 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 117' ' ' VAL . 2.3 ttmt -105.06 148.6 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.961 -1.087 . . . . 0.0 110.26 -179.871 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 87' ' ' PHE . 1.2 mt -85.34 87.18 7.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 110.664 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -70.41 106.2 3.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 109.257 179.101 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.68 -86.56 0.21 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.562 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -162.91 115.76 1.6 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.164 -1.198 . . . . 0.0 110.676 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' PHE . 19.4 m -64.12 -40.32 95.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.27 -0.894 . . . . 0.0 110.793 179.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -107.85 117.61 34.58 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.958 -1.089 . . . . 0.0 110.793 -179.591 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.52 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 13.5 m -119.47 -170.89 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.562 HG23 ' HA ' ' A' ' 82' ' ' ASN . 9.3 m -163.08 134.32 4.88 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.408 -178.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -62.7 90.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.037 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.503 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 1.3 m -64.63 170.47 3.84 Favored Pre-proline 0 C--N 1.297 -1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 112.057 -178.669 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.618 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 49.8 Cg_endo -80.32 30.55 0.5 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.811 1.953 . . . . 0.0 111.886 -178.584 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -130.49 12.34 5.72 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 178.661 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.502 ' O ' ' CG2' ' A' ' 108' ' ' THR . 6.1 m-80 71.75 69.19 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.734 -0.863 . . . . 0.0 110.242 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.502 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -175.19 -163.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 111.206 -179.943 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.626 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 39.2 m95 -133.13 91.77 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.497 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -104.25 144.92 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 110.16 -179.705 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.2 Cg_endo -71.18 168.74 71.56 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.943 -2.107 . . . . 0.0 111.23 -0.478 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.46 127.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.472 0.653 . . . . 0.0 111.846 -178.994 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.55 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -42.18 142.99 1.1 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.714 . . . . 0.0 109.72 178.976 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.3 Cg_endo -71.44 169.91 19.73 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.214 1.639 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' A' ' 117' ' ' VAL . 7.8 tttp -130.61 106.97 8.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.125 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.533 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.0 t -65.4 74.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 109.086 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.6 m -82.55 -175.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.057 0.932 . . . . 0.0 111.467 -179.154 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.473 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.705 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.633 179.883 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -138.06 177.33 7.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.854 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -138.92 93.14 2.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.974 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 1.1 mp0 -72.76 -175.89 1.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.21 139.44 45.79 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.024 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.606 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.2 Cg_endo -72.81 153.21 53.36 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.982 1.517 . . . . 0.0 110.275 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.58 169.57 22.01 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.908 1.478 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.7 p -70.86 176.19 4.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -142.91 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.175 0.988 . . . . 0.0 111.364 179.778 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -40.96 95.84 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.855 -179.215 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 9' ' ' ILE . 15.7 m-80 40.69 38.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.189 -0.944 . . . . 0.0 110.721 179.62 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -141.96 149.21 20.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.499 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 1.5 ptt180 -102.84 -173.19 2.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -1.149 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.606 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 14.6 p80 -136.64 133.54 36.35 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.259 0.552 . . . . 0.0 110.423 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -56.48 120.39 7.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.268 -179.853 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.09 71.62 0.32 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -88.43 -13.08 41.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -1.1 . . . . 0.0 110.172 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.614 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -120.02 -142.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.97 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -153.03 -39.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.606 179.765 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 5.1 p90 -128.93 79.56 1.92 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.194 -0.941 . . . . 0.0 109.935 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.627 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.6 m-85 -52.03 -29.77 22.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 110.779 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.53 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 69.66 -77.08 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.352 -0.843 . . . . 0.0 112.22 178.803 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 1.9 t70 -165.06 160.24 18.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.789 -1.195 . . . . 0.0 110.282 -179.083 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 63.18 16.67 58.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.627 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 33.0 m -95.69 173.9 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -1.009 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.544 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 40.5 t -154.22 153.84 7.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.706 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG13 ' CD1' ' A' ' 29' ' ' TYR . 17.0 t -139.06 111.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.348 -179.437 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -67.3 105.29 1.72 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.295 -1.362 . . . . 0.0 107.783 178.248 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.619 ' CE1' HG23 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.19 109.0 3.36 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.442 -0.786 . . . . 0.0 110.147 -178.195 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.499 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -69.24 152.94 44.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.074 -1.016 . . . . 0.0 109.448 179.519 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.6 m -121.01 160.42 23.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.697 -179.37 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -44.69 164.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.366 -0.834 . . . . 0.0 109.972 179.779 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -67.39 86.59 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.59 1.9 5.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 2.6 m-30 -94.04 128.82 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -1.201 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.602 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -76.86 134.49 39.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 110.518 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -89.73 106.16 18.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.428 179.214 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.57 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.83 146.41 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.376 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 107.75 -172.47 17.46 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.72 -179.855 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.49 142.81 47.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 109.888 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.5 p -77.92 52.25 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.514 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 149.14 115.29 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.619 HG23 ' CE1' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -48.78 173.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.56 -1.256 . . . . 0.0 107.732 179.181 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.01 94.94 2.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.777 178.846 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.3 OUTLIER -80.32 105.75 11.82 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.998 178.847 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.2 95.87 3.63 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.271 -179.371 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.96 19.96 5.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' HG3' ' A' ' 49' ' ' GLU . . . 83.35 13.02 77.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG3' ' C ' ' A' ' 48' ' ' GLY . 47.2 mt-10 -145.96 138.61 25.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.161 . . . . 0.0 110.262 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 94.8 m95 -80.79 143.3 32.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -142.62 160.2 40.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -0.984 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.513 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.5 t0 58.3 65.44 3.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 111.448 179.465 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -91.16 134.19 1.67 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.385 1.729 . . . . 0.0 109.754 178.877 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -81.29 174.05 11.06 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.72 1.379 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.1 p -115.28 140.9 48.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 111.506 -178.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 10' ' ' SER . 62.9 m -105.46 76.77 1.23 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.08 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.15 177.65 4.64 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.457 0.646 . . . . 0.0 110.614 -178.292 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.455 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -92.0 148.68 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.589 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.659 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 13.0 m -129.15 47.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.821 -178.118 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 4.9 mmtt -85.43 160.83 19.64 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.032 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 108' ' ' THR . 65.4 m -135.6 166.3 29.6 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.216 -1.553 . . . . 0.0 113.019 -178.268 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 39.0 Cg_endo -66.94 -87.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.828 1.962 . . . . 0.0 110.386 179.158 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 132.42 1.79 Allowed Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.602 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.7 Cg_endo -75.84 65.06 6.81 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 123.825 1.434 . . . . 0.0 108.995 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.406 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -83.42 164.32 20.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.664 -0.648 . . . . 0.0 110.877 -179.058 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.574 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -164.17 164.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 179.725 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.444 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 32.8 t -73.88 106.17 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.514 -0.741 . . . . 0.0 110.848 -179.563 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 19.0 m-20 42.37 27.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.918 179.315 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -134.71 33.05 2.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.534 ' O ' ' O ' ' A' ' 69' ' ' GLY . 7.9 p90 -45.05 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.65 1.214 . . . . 0.0 112.275 -179.439 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.588 HD11 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.02 160.53 16.75 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.667 179.766 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 3.0 t -134.43 30.89 3.49 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.942 . . . . 0.0 109.823 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.5 t -103.66 -81.39 0.51 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -179.556 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.8 85.9 0.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.602 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.65 166.02 12.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -1.06 . . . . 0.0 109.684 179.705 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 4.0 tttt -162.41 158.51 24.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 -179.753 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -50.92 -33.41 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 0.0 109.888 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 6.6 p -136.57 173.33 11.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 0.0 109.927 179.682 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.602 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 52.8 m-85 -144.13 -171.69 3.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.544 ' O ' ' HB3' ' A' ' 103' ' ' CYS . 1.2 p -146.2 -157.7 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.248 -0.907 . . . . 0.0 110.624 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.629 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -83.99 61.22 6.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.534 -1.354 . . . . 0.0 110.352 -179.759 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 0.4 OUTLIER 162.17 -16.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.986 -1.071 . . . . 0.0 111.518 179.516 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.483 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 38.9 m-20 -58.2 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.962 -1.086 . . . . 0.0 108.613 179.232 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p30 -76.78 145.19 38.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.552 -0.717 . . . . 0.0 111.294 -178.134 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.512 HG12 ' CH2' ' A' ' 109' ' ' TRP . 11.9 m -133.78 116.41 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 178.665 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -80.06 135.37 36.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.601 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 49.5 m-85 -92.93 138.72 31.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.893 -1.129 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 0.2 OUTLIER -113.79 92.97 4.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.89 -179.657 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.94 132.42 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 110.233 -179.731 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.45 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.805 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.7 t80 -157.96 128.89 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 62.24 57.15 18.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 35.6 m-85 -162.12 147.9 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.996 . . . . 0.0 109.982 -179.384 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 117' ' ' VAL . 10.8 mttm -101.85 152.62 20.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.816 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -94.05 87.5 5.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.554 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 11.2 t -71.68 107.72 4.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.057 -1.027 . . . . 0.0 109.609 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.44 -78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.558 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -172.46 116.21 0.33 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.344 -1.092 . . . . 0.0 110.62 -179.693 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.5 p -68.6 -11.91 60.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.5 p -134.3 140.59 46.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.873 -1.142 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.478 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.0 m -154.77 162.9 40.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 -179.459 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.537 ' CG2' ' C ' ' A' ' 82' ' ' ASN . 5.2 m -136.42 138.31 41.39 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.3 0.572 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 80' ' ' SER . 1.9 t -43.58 -28.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.421 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER 64.2 165.99 0.11 Allowed Pre-proline 0 C--N 1.293 -1.88 0 CA-C-O 121.391 0.615 . . . . 0.0 112.031 178.321 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.659 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 50.6 Cg_endo -81.96 4.4 7.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.636 1.861 . . . . 0.0 111.1 -179.026 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -103.51 2.64 46.17 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.594 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 106' ' ' GLY . 17.0 m-80 73.68 48.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.885 -0.774 . . . . 0.0 110.743 179.825 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.553 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 0.2 OUTLIER -166.44 150.71 7.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 110.864 178.805 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.602 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 58.2 m95 -71.79 88.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.709 0.766 . . . . 0.0 110.959 -179.336 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.432 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.4 mmtp -104.02 132.51 20.94 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.729 -0.607 . . . . 0.0 109.559 179.633 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.558 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.2 Cg_endo -72.55 167.78 76.8 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.859 -2.142 . . . . 0.0 110.52 0.377 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.6 mp0 -43.1 149.83 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.214 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.601 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 0.8 OUTLIER -55.13 151.57 17.0 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.264 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 38.4 Cg_endo -73.57 169.47 22.25 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 O-C-N 124.299 1.684 . . . . 0.0 110.868 -179.868 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -126.77 110.14 12.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.24 -0.912 . . . . 0.0 110.475 -179.779 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -66.3 73.81 0.08 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.817 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' A' ' 94' ' ' LYS . 1.2 m -84.09 -175.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.845 0.831 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.579 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 8.2 ptt85 . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.4 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.324 0.583 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -133.17 174.58 10.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 179.685 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -142.3 85.71 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.936 -179.952 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.497 ' HG2' ' CE1' ' A' ' 20' ' ' PHE . 30.0 mt-30 -63.05 177.74 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.903 -1.123 . . . . 0.0 109.71 179.803 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 4' ' ' GLN . 3.6 p -43.28 145.87 0.95 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 0.0 109.74 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.595 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 49.2 Cg_endo -69.84 170.88 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.713 -179.541 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.84 171.75 13.97 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.011 1.532 . . . . 0.0 109.523 178.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.02 97.69 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.246 -179.937 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.57 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.31 -175.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 0.0 110.918 -179.779 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -101.85 140.26 36.38 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.546 179.909 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t-20 71.39 8.76 6.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.708 179.882 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.13 -179.46 34.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.836 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -132.68 -166.85 1.81 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.364 -1.08 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 17.0 p80 -155.59 -163.38 1.5 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.768 179.968 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 4.6 t-20 65.33 -141.17 0.21 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.02 -67.09 0.41 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -120.09 -4.67 10.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 109.572 179.536 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.623 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 26.9 mt-10 -106.68 -174.86 2.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.791 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 169.06 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.07 -1.019 . . . . 0.0 111.153 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -139.04 67.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 111.396 -179.055 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.623 ' CE1' ' HB3' ' A' ' 18' ' ' GLU . 3.1 m-85 -75.26 174.58 9.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 108.999 178.56 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.54 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 36.4 p -137.87 -57.34 0.67 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.756 -1.215 . . . . 0.0 111.356 -178.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.04 130.15 0.77 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.185 -0.947 . . . . 0.0 110.083 -179.169 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.77 22.39 61.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.471 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.619 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 28.0 m -111.33 168.87 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -1.026 . . . . 0.0 110.049 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.581 ' CG1' ' HA3' ' A' ' 42' ' ' GLY . 21.8 t -140.77 148.22 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 112.205 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG13 ' CD1' ' A' ' 29' ' ' TYR . 28.8 t -116.3 122.84 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.561 -0.712 . . . . 0.0 111.662 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.83 102.66 7.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.478 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.656 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.6 m-30 -68.11 149.87 49.08 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.256 -178.098 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -95.47 152.75 18.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 179.427 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.452 ' SG ' HD13 ' A' ' 37' ' ' LEU . 86.0 m -125.63 146.6 49.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 0.0 110.393 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.2 145.66 25.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.231 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.7 p -56.05 110.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.33 -4.62 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.552 ' CE1' HG12 ' A' ' 58' ' ' ILE . 8.9 m-85 -124.42 155.88 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.268 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.564 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -101.29 149.9 23.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.242 179.659 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.505 ' HA ' ' O ' ' A' ' 55' ' ' THR . 1.0 OUTLIER -88.25 108.59 19.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.451 -0.78 . . . . 0.0 109.511 179.242 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.539 ' N ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -100.55 143.97 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.175 -179.856 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.68 -156.26 22.37 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 m-20 -93.26 55.49 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.325 . . . . 0.0 109.774 179.497 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 40' ' ' ASN . 53.1 p 30.07 47.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.484 179.636 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.581 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 143.7 136.34 3.1 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.551 179.671 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.656 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 1.8 t -65.36 179.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.206 -1.173 . . . . 0.0 108.067 178.706 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HB3' ' OD2' ' A' ' 52' ' ' ASP . 1.6 tp -143.25 95.19 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.669 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -80.57 113.23 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 109.048 178.774 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.11 112.26 18.01 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.265 -179.553 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.23 58.79 8.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 49.54 53.96 18.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.38 95.23 1.01 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -1.112 . . . . 0.0 110.59 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 74.3 m95 -65.88 133.52 51.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 52' ' ' ASP . 15.9 m -142.7 177.25 8.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.698 -179.37 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 3.2 p30 36.15 71.25 0.93 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.969 -0.457 . . . . 0.0 111.874 179.651 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.23 138.13 3.25 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.05 1.552 . . . . 0.0 109.515 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 46.4 Cg_endo -73.36 176.95 8.53 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.79 1.416 . . . . 0.0 110.644 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 8.8 p -121.86 157.53 30.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 111.54 -178.679 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 94.1 m -116.68 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.823 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -118.03 -156.96 0.66 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.204 -178.454 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.552 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -108.78 152.86 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.856 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.586 ' CB ' ' HA ' ' A' ' 105' ' ' PRO . 26.3 m -137.39 48.29 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 111.115 -178.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mttt -90.63 173.45 8.04 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.49 178.7 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.529 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 47.8 m -132.65 167.16 24.09 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.479 -1.388 . . . . 0.0 112.333 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.2 Cg_endo -76.19 -53.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.747 1.919 . . . . 0.0 109.909 178.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.95 125.37 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.946 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.608 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 45.6 Cg_endo -75.08 59.78 5.33 Favored 'Trans proline' 0 C--N 1.292 -2.403 0 O-C-N 123.69 1.363 . . . . 0.0 110.554 -178.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.504 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 1.2 p -78.62 -171.79 2.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.465 -0.772 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER 178.25 168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.643 179.356 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.509 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -71.79 102.84 2.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.499 -0.75 . . . . 0.0 110.83 -179.638 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.527 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 2.5 m-20 40.05 43.99 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.456 -0.778 . . . . 0.0 110.858 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.621 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -155.02 35.26 0.66 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.621 ' O ' ' O ' ' A' ' 69' ' ' GLY . 15.6 p90 -42.49 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 123.409 1.576 . . . . 0.0 114.188 -179.325 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.592 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -149.34 136.53 19.91 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -175.491 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t -121.8 27.39 8.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 109.775 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -69.83 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 111.39 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -124.03 -73.45 0.25 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.879 -178.823 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.549 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 22.8 t80 58.44 163.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -1.012 . . . . 0.0 109.973 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.571 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 8.0 tttm -178.94 140.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.455 -0.778 . . . . 0.0 110.059 179.731 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -42.74 -36.01 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 179.67 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 2.6 p -125.88 166.27 17.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.676 . . . . 0.0 109.75 179.369 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 74.0 m-85 -141.07 -168.9 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.535 ' O ' ' SG ' ' A' ' 103' ' ' CYS . 3.9 m -155.54 -158.54 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -69.38 2.94 2.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.349 -1.47 . . . . 0.0 111.19 -179.057 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.506 ' HA ' HG23 ' A' ' 102' ' ' THR . 8.8 p30 -139.21 -111.53 0.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.781 -1.199 . . . . 0.0 110.266 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.468 ' C ' HG21 ' A' ' 102' ' ' THR . 1.5 m-20 50.88 65.69 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.849 -1.157 . . . . 0.0 109.623 -179.406 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.524 ' N ' HG21 ' A' ' 102' ' ' THR . 18.8 p-10 -69.4 110.86 4.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.606 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 26.0 m -97.26 121.85 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.862 -1.149 . . . . 0.0 111.204 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -78.05 138.79 38.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.204 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CE2' HD21 ' A' ' 71' ' ' LEU . 24.4 m-85 -98.64 145.54 26.76 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.986 -1.072 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.82 96.81 5.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.648 -0.658 . . . . 0.0 110.093 -179.708 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.501 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -46.46 134.5 9.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.527 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -41.14 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.338 -0.851 . . . . 0.0 110.241 -179.855 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -160.74 124.78 3.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 69.27 53.84 16.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.675 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 51.6 m-85 -160.68 152.21 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -1.022 . . . . 0.0 109.892 -179.249 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.476 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -107.27 136.78 46.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.012 . . . . 0.0 109.963 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.522 HD22 ' CD1' ' A' ' 66' ' ' ILE . 0.9 OUTLIER -75.65 89.82 2.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.075 -179.875 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.4 t -74.74 101.86 4.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -0.905 . . . . 0.0 110.285 -179.999 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.06 -64.79 0.44 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 177.35 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -1.105 . . . . 0.0 110.377 -179.606 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.8 p -68.94 -3.94 14.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.943 . . . . 0.0 110.743 -179.564 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 64.5 p -140.13 93.76 2.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.545 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 19.5 m -104.04 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 110.991 -179.411 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.524 HG21 ' N ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.98 137.76 23.78 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.929 -0.709 . . . . 0.0 110.455 -179.614 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.61 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 49.2 t -56.74 107.28 0.38 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -0.778 . . . . 0.0 109.461 179.642 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.5 175.1 4.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.556 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.586 ' HA ' ' CB ' ' A' ' 59' ' ' VAL . 41.2 Cg_endo -77.45 167.19 24.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.857 1.451 . . . . 0.0 111.584 -179.166 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 89.93 -58.72 3.62 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 -178.545 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.621 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 147.13 71.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 122.271 0.228 . . . . 0.0 111.123 178.537 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -169.78 166.95 9.55 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.314 -1.491 . . . . 0.0 112.536 179.236 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 24.2 m95 -101.55 92.09 4.74 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 179.564 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.492 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 16.2 mttt -101.03 142.59 24.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.222 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.545 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.4 Cg_endo -71.0 168.97 70.64 Favored 'Cis proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.706 -0.849 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -39.8 129.96 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.544 -0.723 . . . . 0.0 110.847 -179.6 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -39.7 147.07 0.34 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 0.0 110.422 179.385 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 38.5 Cg_endo -70.35 166.7 27.45 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.398 1.736 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.53 ' HG2' ' CG1' ' A' ' 117' ' ' VAL . 4.7 ttpt -127.29 107.83 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.463 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.9 t -64.4 90.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.077 -1.015 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.53 ' CG1' ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -103.77 -175.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.904 0.859 . . . . 0.0 110.821 -179.414 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.928 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.448 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 2' ' ' LYS . 12.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.228 0.537 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.421 ' N ' HG21 ' A' ' 1' ' ' VAL . 0.3 OUTLIER -126.79 176.79 7.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.511 -179.743 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 4.1 t -159.37 101.25 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.217 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.6 mt-30 -87.46 -177.59 5.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -39.69 141.05 0.77 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 -179.766 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 49.9 Cg_endo -71.32 159.89 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.095 1.576 . . . . 0.0 111.228 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.6 170.91 19.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.102 1.58 . . . . 0.0 109.898 179.371 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -73.26 174.4 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.571 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.45 -170.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.219 1.009 . . . . 0.0 111.559 179.631 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -38.62 94.1 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.986 -179.138 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.2 m120 41.39 30.83 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -132.16 150.44 19.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.936 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 30' ' ' SER . 3.8 mtt180 -96.36 -170.87 2.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -1.075 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 18.9 p80 -147.16 120.09 8.74 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.228 0.537 . . . . 0.0 109.965 -179.738 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -123.46 109.53 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.748 -179.552 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' CA ' ' OH ' ' A' ' 21' ' ' TYR . . . -101.5 -5.47 51.77 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.463 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 68.44 24.2 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.279 -1.13 . . . . 0.0 110.375 179.975 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 3.8 pt-20 -160.57 -160.56 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 19' ' ' ASP . 5.7 t0 -131.83 -27.41 1.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.073 -1.017 . . . . 0.0 110.714 -179.586 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.424 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 9.9 m-85 -119.88 134.88 55.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.78 -179.63 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -124.08 -13.93 7.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.459 -0.776 . . . . 0.0 110.204 179.882 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.541 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . 47.6 p 45.95 -98.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.554 -0.716 . . . . 0.0 111.68 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -143.7 156.82 44.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 110.438 -178.443 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 70.13 16.25 72.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.086 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -94.29 174.9 6.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.624 -0.927 . . . . 0.0 110.328 -179.7 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 37.9 t -154.21 153.22 8.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.048 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.616 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 41.5 t -139.65 123.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.66 -179.433 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.56 101.9 3.71 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.247 . . . . 0.0 107.78 177.899 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.654 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.2 m-30 -68.03 134.24 50.34 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.308 -178.208 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.01 163.09 15.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.914 179.606 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 37' ' ' LEU . 70.9 m -127.36 159.25 35.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 110.175 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.92 154.85 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.894 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 100.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.74 8.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.9 m-30 -110.01 158.66 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -1.177 . . . . 0.0 110.005 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.55 ' OG ' ' CG2' ' A' ' 59' ' ' VAL . 24.3 m -103.71 130.39 51.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.389 -0.819 . . . . 0.0 110.677 -179.337 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.505 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 3.2 tp -83.0 117.71 23.0 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.237 179.132 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.571 HG22 ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -115.97 143.77 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.31 -168.02 12.8 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.561 -1.815 . . . . 0.0 108.561 -179.0 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 30.5 p-10 -66.37 130.76 44.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.968 -1.313 . . . . 0.0 109.496 179.476 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 28' ' ' THR . 30.2 p -70.01 57.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.992 . . . . 0.0 109.511 179.767 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 155.92 117.34 0.57 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.491 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.654 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -61.19 -176.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.95 -1.323 . . . . 0.0 107.848 179.248 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.9 tp -144.47 102.29 3.81 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.318 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -86.15 111.91 20.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.363 -0.835 . . . . 0.0 109.656 179.423 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 88.39 2.93 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.43 50.52 3.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 57.27 25.07 53.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' TRP . 2.3 tt0 -125.8 71.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.606 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 72.9 m95 -45.84 129.67 9.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -144.1 173.4 11.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.996 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.523 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 53.29 65.1 6.11 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 110.884 -179.949 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.6 Cg_endo -91.53 135.63 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.444 1.76 . . . . 0.0 110.096 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.91 -173.56 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.739 1.389 . . . . 0.0 110.37 179.593 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -120.13 -172.01 2.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.963 0.887 . . . . 0.0 111.564 -178.833 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 95.9 m -152.05 80.91 1.26 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.663 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.468 ' C ' HG13 ' A' ' 58' ' ' ILE . 5.2 mm100 -111.41 -139.8 0.38 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.413 0.625 . . . . 0.0 110.912 -177.747 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.468 HG13 ' C ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -137.57 106.55 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.848 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 26.8 m -105.51 64.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.153 -0.967 . . . . 0.0 112.526 -178.224 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 14.8 mttt -67.49 -175.69 0.53 Allowed 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 117.531 -1.668 . . . . 0.0 107.624 178.072 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.64 163.59 35.43 Favored Pre-proline 0 C--N 1.296 -1.741 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.597 -178.085 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -86.91 -83.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.92 2.011 . . . . 0.0 110.6 179.306 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.484 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 175.14 130.75 0.14 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.611 -0.681 . . . . 0.0 109.298 -179.433 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.61 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 49.8 Cg_endo -80.02 64.06 8.82 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 O-C-N 123.739 1.389 . . . . 0.0 109.896 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 p -77.05 175.65 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.813 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.594 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -172.84 168.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 118.522 -1.271 . . . . 0.0 110.7 179.307 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.491 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.69 100.32 3.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.527 -0.733 . . . . 0.0 110.691 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 35.1 m-20 42.41 48.15 4.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -160.28 37.81 0.45 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.594 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 54.3 p90 -50.2 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.952 1.358 . . . . 0.0 112.922 -179.783 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.587 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -142.84 127.03 17.52 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.736 -176.562 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -109.14 19.22 19.72 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 110.192 -179.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 31.3 t -84.17 -88.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.906 -179.47 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -101.03 -71.91 0.96 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.279 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 51.1 t80 57.04 170.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -1.07 . . . . 0.0 109.665 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.635 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 174.23 130.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 179.932 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 76' ' ' LYS . 9.4 mtt180 -40.76 -32.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.797 . . . . 0.0 110.027 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.84 126.24 20.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 11.2 m-85 -106.11 -151.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 103' ' ' CYS . 59.9 p -159.85 -126.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.944 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.597 ' N ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -102.07 33.63 3.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.987 -1.071 . . . . 0.0 110.84 -179.243 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 103' ' ' CYS . 17.9 t-20 -172.29 -112.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.093 -1.005 . . . . 0.0 110.367 179.007 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 t0 47.39 75.06 0.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.641 -1.287 . . . . 0.0 109.162 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.494 ' HB3' HG22 ' A' ' 102' ' ' THR . 12.7 p-10 -69.62 112.69 6.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.576 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 31.4 m -98.15 121.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.983 -1.073 . . . . 0.0 111.17 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -80.12 139.58 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.395 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.587 ' CZ ' HD21 ' A' ' 71' ' ' LEU . 65.3 m-85 -95.5 146.52 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.811 -1.181 . . . . 0.0 112.396 -178.205 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.73 91.55 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.367 179.695 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.46 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 135.28 3.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.928 . . . . 0.0 109.957 -179.551 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 89' ' ' CYS . 6.8 mmmt -39.63 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 110.687 -179.545 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.6 t80 -168.68 130.81 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.297 -0.877 . . . . 0.0 110.358 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.18 53.43 46.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 25.2 m-85 -158.77 150.47 20.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -1.013 . . . . 0.0 109.959 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -102.95 154.59 19.07 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.401 -0.812 . . . . 0.0 109.038 179.362 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -93.93 96.26 9.6 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 110.499 -179.447 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.454 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.13 101.82 4.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 109.646 179.526 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.53 -77.17 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.561 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -171.59 114.43 0.37 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 110.896 -179.632 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 m -71.34 -2.45 16.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.231 -0.918 . . . . 0.0 110.481 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -143.33 113.83 7.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.111 179.773 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.497 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 27.3 m -126.0 160.16 30.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.6 139.53 50.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.582 0.706 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.51 84.36 1.52 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.485 -0.76 . . . . 0.0 110.107 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.429 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -62.95 173.99 0.95 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.985 -179.55 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.605 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.8 Cg_endo -73.34 123.46 8.73 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.391 1.732 . . . . 0.0 110.104 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.58 -9.31 4.96 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -178.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 1.8 m120 80.71 89.35 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.909 -0.76 . . . . 0.0 110.295 179.701 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.06 -160.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.281 -0.887 . . . . 0.0 110.933 179.85 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 30.4 m95 -145.84 86.09 1.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.608 0.718 . . . . 0.0 109.712 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 21.0 mttt -99.77 139.05 20.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.705 . . . . 0.0 110.255 -179.349 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.561 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.9 Cg_endo -71.34 166.51 77.83 Favored 'Cis proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.009 -2.079 . . . . 0.0 110.781 -0.127 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.2 mp0 -40.37 137.81 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.539 -0.725 . . . . 0.0 110.644 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.57 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.7 OUTLIER -43.52 155.98 0.29 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 179.744 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.555 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 40.8 Cg_endo -80.06 169.48 17.66 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 124.397 1.735 . . . . 0.0 111.074 -179.609 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.465 ' O ' HG23 ' A' ' 117' ' ' VAL . 6.8 tttt -127.35 111.12 13.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.532 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -67.67 98.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.117 -0.989 . . . . 0.0 109.425 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -112.76 -176.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.736 0.779 . . . . 0.0 110.507 -179.627 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.46 ' OXT' ' HG3' ' A' ' 118' ' ' ARG . 9.0 ptt85 . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.451 179.63 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.26 0.552 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -122.19 162.6 21.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -143.33 78.38 1.6 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.22 179.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -51.91 145.44 17.15 Favored Pre-proline 0 C--N 1.3 -1.559 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.76 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.7 Cg_endo -73.99 159.86 43.99 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.896 1.472 . . . . 0.0 110.117 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.93 170.0 19.91 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.661 1.348 . . . . 0.0 109.997 179.284 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 p -88.82 105.06 17.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.983 . . . . 0.0 110.365 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.595 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -56.29 -170.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.03 0.919 . . . . 0.0 111.289 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.13 138.15 31.74 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.424 -178.846 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.494 ' HB2' ' HB3' ' A' ' 56' ' ' CYS . 10.5 m120 49.05 20.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.48 -0.763 . . . . 0.0 110.931 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.2 157.66 27.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.437 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 mpt_? -118.23 -166.33 1.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -1.19 . . . . 0.0 111.059 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.621 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.5 p80 -151.22 131.55 13.69 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.614 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -155.34 -145.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 110.751 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . 129.4 4.89 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 7.7 t80 70.96 24.31 4.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.163 -1.198 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.424 ' CG ' ' HE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -126.12 168.9 13.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.068 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.24 -31.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 110.515 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.25 139.06 52.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.08 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.2 m-85 -123.03 -7.08 8.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 110.985 -179.624 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.558 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.8 p 43.3 -96.61 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 111.405 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 17.4 t0 -153.52 138.49 17.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.953 -1.092 . . . . 0.0 110.363 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.49 37.4 8.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.641 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 66.4 m -135.17 161.33 35.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.261 -1.141 . . . . 0.0 109.951 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.562 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 25.3 t -134.19 147.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.0 112.28 -178.141 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.584 HG22 ' CH2' ' A' ' 50' ' ' TRP . 32.3 t -117.95 119.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.725 -0.609 . . . . 0.0 111.743 -179.523 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.478 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -73.4 102.95 3.9 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.78 -1.168 . . . . 0.0 107.897 177.641 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.636 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.12 126.72 30.41 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.419 -0.8 . . . . 0.0 109.848 -178.515 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.63 163.62 25.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.0 -1.063 . . . . 0.0 109.36 179.467 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.44 49.44 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.051 -1.03 . . . . 0.0 110.433 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.62 143.34 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -62.55 106.17 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.74 -11.51 6.28 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.489 ' CE2' HG13 ' A' ' 58' ' ' ILE . 3.9 m-85 -114.06 146.31 40.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.149 -1.206 . . . . 0.0 110.629 -179.617 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.606 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -84.17 142.27 30.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -0.911 . . . . 0.0 110.753 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.5 OUTLIER -98.61 95.01 6.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.535 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.592 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.7 OUTLIER -81.16 152.1 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.785 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 127.92 -146.54 16.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 41' ' ' SER . 36.4 m-80 -120.73 53.26 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 110.128 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 40' ' ' ASN . 71.3 p 28.03 48.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.774 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.511 ' HA3' ' CG1' ' A' ' 26' ' ' VAL . . . 156.94 125.49 0.87 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.673 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.636 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 2.0 t -71.48 179.45 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.502 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.86 92.61 2.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.648 -1.282 . . . . 0.0 111.247 179.55 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.598 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -79.47 106.97 11.88 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.407 178.125 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.483 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -135.11 103.51 5.58 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.226 -179.054 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.77 11.25 35.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.5 19.07 60.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' TRP . 9.1 mt-10 -139.16 91.4 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -1.153 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 70.7 m95 -43.3 135.88 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 p -147.64 166.29 27.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 111.048 -179.707 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 57.3 64.35 4.35 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.603 -0.686 . . . . 0.0 111.285 179.837 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.9 Cg_endo -92.72 145.65 2.55 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.992 1.795 . . . . 0.0 110.086 179.084 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 52.9 Cg_endo -84.28 176.79 6.29 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.7 1.369 . . . . 0.0 109.949 179.245 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.592 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 27.3 p -130.21 141.88 50.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 111.54 -179.53 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -100.51 88.52 3.66 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.584 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 36' ' ' SER . 51.6 mm-40 -120.36 -165.57 1.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.424 -178.314 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.489 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -115.4 104.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.04 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.606 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 13.0 m -92.97 47.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 111.801 -178.199 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -88.65 97.7 11.26 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.345 178.586 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 36.0 m -69.55 162.51 66.55 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 112.12 -178.004 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 45.4 Cg_endo -71.61 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.651 1.869 . . . . 0.0 110.762 -179.73 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.409 ' C ' ' NE1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -161.58 133.65 4.19 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.705 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.583 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 50.3 Cg_endo -78.01 65.26 8.34 Favored 'Trans proline' 0 C--N 1.293 -2.35 0 O-C-N 123.674 1.355 . . . . 0.0 109.784 -179.329 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.527 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -83.08 171.95 13.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.608 -0.682 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.54 HD12 ' HA3' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.67 166.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.522 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.45 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -75.28 109.94 9.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.534 -0.729 . . . . 0.0 111.0 -179.254 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.505 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.6 m-80 38.63 34.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.765 . . . . 0.0 110.844 179.299 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.54 ' HA3' HD12 ' A' ' 66' ' ' ILE . . . -143.68 30.36 1.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.527 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.3 p90 -45.66 -171.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.718 1.247 . . . . 0.0 112.479 -179.612 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.554 ' O ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -116.4 157.97 24.24 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.794 178.792 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.75 26.52 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.082 -179.181 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -73.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.669 -179.586 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.459 ' O ' HG11 ' A' ' 85' ' ' VAL . . . -127.43 75.97 0.41 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.627 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.5 t80 -104.36 165.72 10.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.585 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -163.16 162.88 25.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -56.76 -35.86 69.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.92 179.936 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -139.83 167.35 22.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.988 179.698 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.555 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.0 m-85 -138.51 -173.93 3.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.735 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.8 m -169.39 106.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 111.283 -179.75 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.63 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 3.2 t80 46.31 15.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.154 -0.966 . . . . 0.0 112.686 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.527 ' N ' ' O ' ' A' ' 103' ' ' CYS . 17.1 t-20 -175.84 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 119.926 -1.734 . . . . 0.0 111.987 178.308 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 8.3 m-20 49.63 76.87 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.671 -1.268 . . . . 0.0 108.747 -178.027 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.5 p-10 -69.2 135.42 50.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 0.0 111.109 -178.689 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.581 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 10.8 m -115.81 120.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.519 179.11 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t0 -85.15 130.71 34.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 108.651 179.436 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' HB3' ' CD2' ' A' ' 95' ' ' LEU . 67.6 m-85 -89.87 129.52 36.23 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.291 1.043 . . . . 0.0 112.567 -177.88 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -104.43 91.64 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.48 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -45.27 127.38 7.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.957 -1.09 . . . . 0.0 109.59 -179.736 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.505 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 15.8 mmtp -37.27 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.687 -0.633 . . . . 0.0 110.787 -179.097 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.586 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 17.6 t80 -158.99 136.12 9.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.544 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.67 44.68 97.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 28.3 m-85 -154.56 150.86 28.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.503 -0.998 . . . . 0.0 109.846 -179.338 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.477 ' O ' HG21 ' A' ' 117' ' ' VAL . 18.1 ptpt -116.98 126.46 52.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.674 179.529 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.54 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -56.69 112.95 1.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.758 -179.255 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.472 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -89.51 94.79 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.525 179.287 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.85 -39.17 1.42 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.4 OUTLIER 172.55 -178.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.155 -1.203 . . . . 0.0 111.037 -179.65 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 51.7 p -141.76 10.39 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 0.0 109.967 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -169.53 113.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.491 -0.755 . . . . 0.0 109.107 179.831 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 29.8 m -124.75 162.4 24.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.225 -0.922 . . . . 0.0 111.048 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.13 142.26 50.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 3.0 t -60.92 83.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.645 -0.66 . . . . 0.0 109.3 179.468 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.94 170.33 8.89 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.0 110.867 -179.245 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.573 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.0 Cg_endo -73.77 127.54 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.176 1.619 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.57 -11.43 5.75 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -179.055 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 14.0 m-20 82.0 76.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.068 -0.666 . . . . 0.0 110.39 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.457 ' O ' ' HB3' ' A' ' 61' ' ' CYS . 0.0 OUTLIER -169.87 -158.81 0.19 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.517 -0.739 . . . . 0.0 110.786 179.789 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.583 ' CZ2' ' HD3' ' A' ' 64' ' ' PRO . 21.0 m95 -142.26 98.96 3.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.343 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 45.8 mttt -100.73 141.9 23.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 110.155 -179.597 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.516 ' CG ' ' OG ' ' A' ' 98' ' ' SER . 49.2 Cg_endo -72.07 170.57 66.39 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.057 -2.059 . . . . 0.0 110.866 0.256 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.5 tt0 -40.28 125.8 2.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 110.114 179.853 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.561 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -41.08 141.32 1.02 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.431 -0.793 . . . . 0.0 110.032 -179.84 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.529 ' HB3' ' O ' ' A' ' 98' ' ' SER . 46.6 Cg_endo -80.26 166.87 20.1 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.467 1.772 . . . . 0.0 112.074 -178.38 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.526 ' O ' HG23 ' A' ' 117' ' ' VAL . 11.0 ttpt -125.63 106.16 9.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.669 . . . . 0.0 109.977 179.53 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -58.7 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.016 . . . . 0.0 109.297 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 115' ' ' LYS . 2.0 m -110.63 -171.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.936 0.874 . . . . 0.0 111.224 -179.438 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.491 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 1' ' ' VAL . 32.9 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.216 0.532 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -115.55 161.97 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -131.43 81.93 2.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 110.57 -179.862 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.4 mt-30 -60.91 177.06 0.35 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.047 -1.033 . . . . 0.0 109.093 179.225 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.6 p -40.91 144.21 0.65 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 44.4 Cg_endo -67.9 162.42 39.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.713 1.375 . . . . 0.0 110.893 -179.097 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.77 166.5 29.78 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.06 1.558 . . . . 0.0 110.118 179.702 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.04 176.07 5.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.179 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.467 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.25 -169.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.164 0.983 . . . . 0.0 111.544 179.934 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 11' ' ' ASN . 29.7 t -63.25 114.04 3.56 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.619 -178.665 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER 37.32 41.99 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.664 -0.647 . . . . 0.0 111.266 179.127 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.41 154.86 25.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.575 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.505 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -109.56 -179.41 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -1.188 . . . . 0.0 110.777 -179.825 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.0 p80 -139.29 -154.89 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 12.5 t30 66.53 -170.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.105 -179.898 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.16 -4.76 18.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -32.48 2.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -1.194 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.574 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 179.16 -176.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 0.0 110.291 -179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 5' ' ' SER . 9.9 t70 -103.96 -25.07 13.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.6 m-85 -105.71 -174.81 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.596 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 0.4 OUTLIER -178.71 -25.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.422 179.655 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 7.6 p 59.55 -94.36 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.588 -0.695 . . . . 0.0 112.661 178.839 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -148.17 159.38 44.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.646 -1.283 . . . . 0.0 110.582 -178.078 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 13.28 57.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.585 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.603 -0.94 . . . . 0.0 110.123 -179.867 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 25.0 t -155.69 155.75 5.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.579 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 43' ' ' VAL . 21.6 t -139.34 125.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.886 -179.487 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.76 103.9 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.601 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.09 121.31 15.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -177.937 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.505 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -75.67 153.57 37.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.998 . . . . 0.0 109.127 178.904 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.9 m -121.02 170.54 9.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.692 -179.285 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -62.94 137.26 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -46.96 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 110.324 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 123.32 17.04 3.34 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.428 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 13.6 m-85 -125.8 141.1 52.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 110.18 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.532 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -85.24 142.13 29.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.944 . . . . 0.0 110.967 -179.455 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.517 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 2.0 tp -89.61 98.1 11.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.424 -0.798 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.582 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.7 OUTLIER -86.47 141.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.312 -179.764 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.63 -172.48 14.63 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.654 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -64.5 145.25 56.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.07 179.863 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -76.22 53.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 152.5 115.37 0.62 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -54.73 -178.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.004 -1.292 . . . . 0.0 107.853 178.831 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.4 tp -146.19 99.32 3.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 110.217 178.681 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.79 109.18 16.71 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.644 179.103 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.88 107.98 10.07 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.82 8.48 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.895 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.47 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 60.92 38.75 95.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.859 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 25.0 mt-10 -151.04 88.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 110.798 -179.582 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 78.5 m95 -50.68 136.99 20.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.339 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.79 162.22 36.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.958 -1.089 . . . . 0.0 111.507 -179.325 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.9 t0 58.57 66.09 2.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.8 Cg_endo -90.94 126.55 1.14 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 O-C-N 124.394 1.734 . . . . 0.0 109.753 178.774 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -74.24 165.53 31.66 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.864 1.455 . . . . 0.0 110.252 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 66.1 p -105.52 150.91 24.92 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.12 -0.988 . . . . 0.0 111.215 -179.444 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 57' ' ' GLN . 77.0 m -111.72 82.18 1.57 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.77 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 3.1 mm100 -115.4 -150.7 0.47 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.713 0.768 . . . . 0.0 110.738 -177.817 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.78 125.86 71.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.691 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.612 ' HB ' ' HA ' ' A' ' 105' ' ' PRO . 31.0 m -115.68 50.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 0.0 112.08 -178.163 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 30.6 mttt -59.51 -173.31 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 117.739 -1.584 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.516 ' SG ' ' CD ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -146.0 170.12 8.48 Favored Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.948 -178.724 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.516 ' CD ' ' SG ' ' A' ' 61' ' ' CYS . 45.3 Cg_endo -92.19 -72.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.396 2.064 . . . . 0.0 109.848 179.226 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.18 125.42 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.718 -0.614 . . . . 0.0 109.674 -179.636 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.602 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.6 Cg_endo -78.36 71.07 6.95 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 123.81 1.426 . . . . 0.0 110.172 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -89.91 171.69 9.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.925 179.915 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.59 HG22 ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -170.84 155.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.057 -1.027 . . . . 0.0 110.266 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.439 ' O ' ' C ' ' A' ' 68' ' ' ASN . 35.5 t -61.45 107.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.751 . . . . 0.0 111.014 -179.357 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 3.3 m-20 39.95 37.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 0.0 110.682 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.54 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -143.48 27.15 2.11 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.54 ' O ' ' O ' ' A' ' 69' ' ' GLY . 2.0 p90 -44.32 -174.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.737 1.256 . . . . 0.0 112.362 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.584 HD22 ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -111.18 164.38 12.93 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.58 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -144.77 20.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 110.039 -179.626 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -103.02 -79.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 110.856 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.27 77.35 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -106.12 168.54 9.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.45 -1.029 . . . . 0.0 110.021 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -171.87 155.58 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 110.262 -179.851 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -52.07 -27.42 13.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.752 179.659 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.52 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 4.4 t -143.59 163.02 34.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.244 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.576 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 21.2 m-85 -137.35 -148.54 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 93.8 p -154.34 -113.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.813 -1.18 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -107.88 12.35 27.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.556 -1.34 . . . . 0.0 110.67 -178.922 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 103' ' ' CYS . 12.5 t-20 -162.25 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.808 -1.183 . . . . 0.0 110.179 179.471 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ASN . 31.8 t0 43.26 76.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.726 -1.234 . . . . 0.0 108.955 -179.48 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' N ' HG21 ' A' ' 102' ' ' THR . 6.3 p30 -68.35 126.96 31.23 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 110.664 -178.385 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 15.9 m -109.73 119.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.194 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 6.4 t0 -82.56 134.12 35.19 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.872 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.591 ' CD2' ' HG3' ' A' ' 114' ' ' PRO . 39.3 m-85 -92.5 131.8 37.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.956 -1.09 . . . . 0.0 112.252 -178.022 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.83 90.43 3.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.905 -179.944 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.26 129.46 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.65 179.984 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -38.14 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.521 -0.737 . . . . 0.0 110.637 -179.28 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -157.22 131.99 8.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.965 . . . . 0.0 110.157 179.911 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.21 56.08 27.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.635 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 24.5 m-85 -161.05 148.46 15.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.854 -179.356 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 6.5 tttm -106.25 138.9 41.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.906 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.522 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.3 mt -76.02 93.5 3.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.409 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.466 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -69.84 100.32 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 0.0 109.666 179.6 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.24 -97.17 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.579 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 t -148.41 114.98 5.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -1.204 . . . . 0.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 90.7 p -72.87 0.48 10.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.934 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -145.63 100.13 3.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.91 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 85' ' ' VAL . 19.7 m -115.78 167.63 10.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.623 -179.566 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -136.38 144.15 44.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.557 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 10.2 t -75.95 89.31 2.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 110.253 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' CD ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -65.74 179.89 0.41 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 111.327 -179.622 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.612 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.3 Cg_endo -75.32 125.79 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.271 1.669 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.99 -1.83 13.25 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 7.0 m-80 78.31 96.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.813 -0.816 . . . . 0.0 110.835 179.68 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.432 HG21 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -175.82 -166.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.086 179.556 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.602 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 19.5 m95 -151.64 91.24 1.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.373 0.606 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.53 ' CD ' ' OG ' ' A' ' 104' ' ' SER . 0.0 OUTLIER -115.25 157.78 42.89 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.498 179.739 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.579 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 39.8 Cg_endo -70.8 171.8 56.31 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.01 -2.079 . . . . 0.0 111.85 0.379 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.2 pm0 -23.49 119.02 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.451 0.643 . . . . 0.0 112.624 -178.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.549 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 2.4 tp -45.82 137.28 5.95 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 109.014 178.585 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.591 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 42.8 Cg_endo -70.5 165.78 30.69 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 123.887 1.467 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HG2' ' CG1' ' A' ' 117' ' ' VAL . 0.3 OUTLIER -133.56 108.65 8.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -61.1 89.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' A' ' 94' ' ' LYS . 1.8 m -106.59 -167.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.839 0.828 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 7.7 mtm180 . . . . . 0 C--N 1.291 -1.969 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.293 0.568 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -93.63 174.83 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.363 -179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.54 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -136.48 92.9 2.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.873 . . . . 0.0 110.212 179.844 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -67.47 170.8 6.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.297 179.518 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.45 143.45 1.11 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.847 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 50.9 Cg_endo -70.86 152.45 63.6 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.988 1.52 . . . . 0.0 110.741 -179.207 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.38 170.27 20.61 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.747 1.393 . . . . 0.0 109.865 179.416 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.68 176.3 3.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 109.813 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.55 HG22 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.54 -169.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 122.168 0.985 . . . . 0.0 111.498 179.838 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 7.9 t -40.62 92.66 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.536 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 9' ' ' ILE . 12.1 m120 42.63 45.94 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.49 178.42 19.99 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 180.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.52 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER -126.25 -169.33 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -1.202 . . . . 0.0 110.695 -179.915 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p80 -157.9 125.36 5.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.898 -0.502 . . . . 0.0 110.512 -179.41 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.39 -33.82 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 44.4 -122.43 4.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.59 -0.79 2.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -1.16 . . . . 0.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 7.4 pt-20 -164.12 -167.35 1.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.491 -179.811 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.28 19.31 2.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.88 . . . . 0.0 110.589 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.42 45.43 2.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.007 -1.058 . . . . 0.0 110.441 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.584 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 23.2 m-85 -58.26 179.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.642 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.54 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 2.2 p -147.14 -61.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 111.045 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -163.37 137.37 5.93 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.53 15.04 80.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.552 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.584 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.73 175.3 6.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.948 . . . . 0.0 109.543 179.81 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 39.8 t -149.22 154.11 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.993 -179.756 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.592 HG22 ' CH2' ' A' ' 50' ' ' TRP . 24.3 t -134.24 122.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.252 -179.739 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -74.33 103.31 4.67 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.315 -1.354 . . . . 0.0 108.015 177.805 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.641 ' CE1' ' CG2' ' A' ' 43' ' ' VAL . 2.3 m-30 -68.45 176.57 2.79 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.763 -178.487 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.52 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.5 t -130.79 -177.15 4.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.839 179.616 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.505 ' CB ' ' O ' ' A' ' 35' ' ' TYR . 91.0 m -147.72 135.38 20.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.0 109.616 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 6.5 m120 -99.52 -177.87 3.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 110.744 -179.527 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 6.0 p 44.76 56.77 4.99 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.707 0.765 . . . . 0.0 110.278 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 43.46 49.63 6.94 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 33' ' ' SER . 4.5 m-30 -102.4 131.78 48.83 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.915 -1.344 . . . . 0.0 111.164 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.603 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -74.59 138.52 43.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.742 -0.599 . . . . 0.0 110.679 -179.792 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tt -89.44 109.66 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.128 -0.983 . . . . 0.0 109.453 178.986 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.549 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.6 OUTLIER -103.02 143.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.468 -179.988 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.41 -141.1 11.41 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 41' ' ' SER . 27.6 t30 -111.42 52.39 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.239 . . . . 0.0 109.907 179.462 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.511 ' C ' ' O ' ' A' ' 40' ' ' ASN . 27.7 p 22.67 49.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.749 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 157.11 119.33 0.59 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 29' ' ' TYR . 2.3 t -65.51 -179.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.254 . . . . 0.0 108.176 179.198 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' HA ' HG21 ' A' ' 26' ' ' VAL . 2.6 tp -144.88 97.74 3.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.32 179.048 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 18.4 t -79.79 126.25 30.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.225 178.788 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.6 p -129.68 110.18 11.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.226 -179.865 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.35 22.51 62.56 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.91 8.11 76.64 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.8 114.59 22.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -1.174 . . . . 0.0 110.538 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CH2' HG22 ' A' ' 27' ' ' VAL . 79.8 m95 -69.9 134.81 48.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.787 179.539 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.19 168.36 20.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 111.025 -179.716 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.496 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 15.6 t0 54.07 66.27 4.53 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.734 -0.604 . . . . 0.0 111.047 179.802 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -90.6 138.28 2.56 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.38 1.726 . . . . 0.0 110.154 179.349 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.2 Cg_endo -75.31 175.8 10.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.839 1.442 . . . . 0.0 110.591 179.938 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.549 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.8 p -111.23 -175.24 2.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.832 . . . . 0.0 111.359 -179.019 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 33.6 m -142.51 75.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.859 0.837 . . . . 0.0 108.803 178.839 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -108.6 -148.67 0.43 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.728 -179.146 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.461 HG23 ' HD2' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -125.99 121.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.049 . . . . 0.0 108.632 179.347 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.603 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 20.4 m -114.68 49.46 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.025 -1.047 . . . . 0.0 112.324 -178.197 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -60.55 -172.24 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 C-N-CA 117.779 -1.569 . . . . 0.0 107.519 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -147.95 166.73 15.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 117.84 -1.544 . . . . 0.0 113.979 -178.296 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.0 Cg_endo -87.84 -74.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 125.02 2.063 . . . . 0.0 110.618 179.551 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 166.12 125.4 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.074 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.604 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 48.1 Cg_endo -75.36 65.64 6.37 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.629 1.331 . . . . 0.0 109.455 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.456 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -82.48 175.93 9.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 110.311 -179.536 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.571 ' CG2' ' HA ' ' A' ' 70' ' ' TYR . 0.2 OUTLIER -171.99 167.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 110.404 -179.623 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 46.5 p -72.81 100.39 2.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 110.55 -179.674 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 88.5 m-20 42.85 49.09 5.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.815 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.598 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -161.86 38.52 0.39 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.598 ' O ' ' O ' ' A' ' 69' ' ' GLY . 49.4 p90 -47.0 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.101 1.429 . . . . 0.0 113.141 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.9 OUTLIER -139.06 127.18 22.51 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.682 -176.948 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.6 t -103.89 16.88 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.494 -0.754 . . . . 0.0 110.087 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.65 101.37 6.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.161 -0.962 . . . . 0.0 111.538 -179.008 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 85' ' ' VAL . . . 71.84 103.42 0.06 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.563 ' CE2' ' OH ' ' A' ' 79' ' ' TYR . 7.8 t80 -156.92 154.11 29.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -1.085 . . . . 0.0 110.266 179.431 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 1.1 tttm -161.35 147.96 14.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' LYS . 29.8 mtm180 -42.47 -37.01 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.055 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -131.9 165.03 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 110.118 179.835 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 22.8 m-85 -137.04 -142.87 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 55.6 p -156.48 -117.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.951 -1.093 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.56 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.22 11.65 32.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.752 -1.218 . . . . 0.0 111.845 -178.664 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.549 ' ND2' ' CZ ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -163.64 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.642 -1.286 . . . . 0.0 110.72 178.938 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 82' ' ' ASN . 7.6 m-20 42.41 74.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.723 -1.236 . . . . 0.0 109.272 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 47.4 t30 -68.82 121.91 17.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.614 -178.664 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.609 HG12 ' CH2' ' A' ' 109' ' ' TRP . 29.0 m -106.44 123.14 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.844 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -80.24 139.34 36.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.336 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CZ ' HD11 ' A' ' 113' ' ' LEU . 32.0 m-85 -95.15 143.25 26.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 112.38 -177.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.37 98.18 6.6 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 -179.857 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.454 ' HB2' HD13 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -50.22 134.98 22.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.397 -179.639 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.39 -69.84 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.784 . . . . 0.0 110.402 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 23.5 t80 -172.19 141.71 1.3 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.304 -0.873 . . . . 0.0 110.391 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 47.71 15.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 11.1 m-85 -149.23 150.0 31.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -1.019 . . . . 0.0 109.803 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' A' ' 117' ' ' VAL . 4.8 mtmt -103.3 143.37 32.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.532 HD22 ' CD1' ' A' ' 66' ' ' ILE . 0.7 OUTLIER -85.09 92.38 8.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 110.187 -179.956 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.476 ' HB3' HG23 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -78.96 105.02 10.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.928 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.3 -79.83 0.24 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.227 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.564 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 24.9 p -159.7 99.27 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -1.092 . . . . 0.0 110.922 -179.191 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.41 47.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.073 -1.017 . . . . 0.0 109.591 179.203 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 p -140.63 108.45 5.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.551 179.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 2.8 m -123.67 167.67 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.215 -0.928 . . . . 0.0 111.16 -179.238 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -134.48 145.19 48.58 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.782 0.801 . . . . 0.0 110.339 179.617 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -82.24 80.13 8.53 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.827 -0.546 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.513 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -58.4 -177.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 111.358 -179.212 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 43.9 Cg_endo -77.37 125.42 7.71 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.386 1.73 . . . . 0.0 110.211 -179.707 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.26 -8.37 7.07 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 4.8 m-20 79.47 94.7 0.06 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.749 -0.853 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER 178.49 -166.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.832 . . . . 0.0 111.092 179.445 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.609 ' CH2' HG12 ' A' ' 85' ' ' VAL . 38.0 m95 -144.04 87.69 1.92 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.539 0.685 . . . . 0.0 109.729 -179.845 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.455 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -100.26 140.81 21.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.658 -179.238 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.564 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.0 Cg_endo -74.83 170.93 70.31 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.555 -2.269 . . . . 0.0 110.039 -0.231 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 11.8 pt-20 -36.75 137.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.562 -0.712 . . . . 0.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.574 HD11 ' CZ ' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -46.76 157.86 0.44 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.846 . . . . 0.0 109.799 179.511 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 41.4 Cg_endo -79.95 165.51 21.87 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 124.206 1.635 . . . . 0.0 111.126 -179.715 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 117' ' ' VAL . 9.0 ttmt -124.36 104.53 8.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.3 t -60.34 83.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.356 179.623 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 115' ' ' LYS . 1.8 m -95.77 -175.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.87 0.843 . . . . 0.0 110.808 -179.6 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.538 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.81 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.442 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.231 0.539 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.54 ' HD3' ' CE1' ' A' ' 20' ' ' PHE . 3.9 ttmt -132.88 172.13 13.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.367 -179.734 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.576 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 10.4 t -163.81 136.14 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 110.102 -179.918 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' SER . 6.5 pt20 -117.2 -176.71 3.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -40.3 142.38 0.74 Allowed Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.273 -179.999 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.6 ' O ' ' CE1' ' A' ' 14' ' ' HIS . 55.4 Cg_endo -71.68 167.37 26.69 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 124.143 1.601 . . . . 0.0 110.647 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.03 171.86 15.01 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.797 1.419 . . . . 0.0 108.756 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -78.18 104.96 9.1 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.893 -1.13 . . . . 0.0 110.616 -179.563 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.642 ' HB ' ' CE2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -42.64 173.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.9 0.857 . . . . 0.0 110.012 -179.904 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.574 ' N ' HG13 ' A' ' 9' ' ' ILE . 34.5 m -99.86 140.92 33.38 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.604 -1.238 . . . . 0.0 109.697 178.293 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 6.8 m120 63.37 17.06 10.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.731 -179.02 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -167.05 -164.52 22.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' SER . 7.2 mtp180 -140.39 -171.81 3.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -1.135 . . . . 0.0 110.566 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 7.9 p80 -148.11 133.34 18.41 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.812 -0.555 . . . . 0.0 110.37 -179.937 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 14' ' ' HIS . 3.1 m-20 -167.01 75.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -101.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.917 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -175.84 38.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -1.15 . . . . 0.0 109.793 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.563 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -154.48 -169.38 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.332 -179.665 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 -37.97 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.54 ' CE1' ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -111.72 118.75 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.643 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -104.36 -12.78 16.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 110.429 -179.741 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.54 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 p 45.45 -96.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.921 . . . . 0.0 111.867 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -148.47 154.01 39.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 0.0 110.115 -178.588 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.2 19.64 79.69 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.232 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.643 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 7.1 m -98.34 171.1 8.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.695 -0.885 . . . . 0.0 110.212 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 38.9 t -147.87 155.29 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.176 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.585 HG22 ' CH2' ' A' ' 50' ' ' TRP . 13.1 t -134.12 111.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.639 -179.132 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 103.25 1.52 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.461 -1.296 . . . . 0.0 107.738 178.085 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.642 ' CE2' ' HB ' ' A' ' 9' ' ' ILE . 1.3 m-30 -68.02 -176.55 0.71 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.998 -178.435 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.485 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -133.99 155.3 50.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.291 179.057 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.1 m -126.41 139.72 53.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.561 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' SER . 31.9 m-20 -83.49 174.35 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.0 110.392 179.905 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.487 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 28.8 t 42.31 -165.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.137 179.211 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.84 2.66 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.487 ' CD2' ' HB3' ' A' ' 33' ' ' SER . 12.0 m-85 -89.08 107.76 19.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.95 -1.324 . . . . 0.0 111.185 -179.419 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.596 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.4 OUTLIER -60.39 139.68 57.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 0.0 110.357 179.281 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.498 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.5 OUTLIER -84.38 102.19 12.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.316 179.078 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.543 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.4 OUTLIER -94.3 150.95 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 108.991 179.785 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.31 -143.43 14.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.223 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 3.3 m120 -114.58 49.62 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -1.23 . . . . 0.0 109.837 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.504 ' C ' ' O ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER 25.21 62.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.941 179.505 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 141.88 115.22 1.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.593 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.63 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.9 OUTLIER -58.45 -178.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.522 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.3 tp -142.88 105.8 4.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.005 -1.06 . . . . 0.0 110.097 178.458 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.2 t -88.29 109.4 19.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.9 m -126.77 126.06 42.79 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.13 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.524 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 70.45 28.62 70.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.54 26.44 73.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.03 115.4 12.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 110.174 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.613 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.8 m95 -76.58 136.28 39.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.862 179.812 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.73 171.76 19.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 110.998 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.534 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 53.67 64.73 6.35 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.872 -0.518 . . . . 0.0 111.212 179.77 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -91.99 145.28 2.96 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.958 1.772 . . . . 0.0 109.841 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.545 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.4 Cg_endo -79.44 174.9 11.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.731 1.385 . . . . 0.0 110.11 179.53 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.543 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 14.4 p -114.39 -177.31 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 111.13 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 11' ' ' ASN . 84.7 m -140.57 73.42 1.42 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.019 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -116.52 177.57 4.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.736 -178.975 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.484 HG21 ' CD ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -88.94 145.15 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.1 179.719 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.596 ' CG1' ' CB ' ' A' ' 36' ' ' SER . 29.0 m -129.93 40.96 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.371 -179.128 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.484 ' CD ' HG21 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -78.87 101.21 7.56 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.429 179.843 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 50.2 m -73.04 162.71 73.23 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.454 -0.778 . . . . 0.0 111.253 -178.913 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.3 Cg_endo -70.82 -89.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.359 1.715 . . . . 0.0 110.628 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -172.25 133.42 0.76 Allowed Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.624 ' HG3' ' CZ2' ' A' ' 109' ' ' TRP . 58.0 Cg_endo -86.7 83.8 1.09 Allowed 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 123.69 1.363 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.577 ' C ' ' CG2' ' A' ' 66' ' ' ILE . 4.1 p -100.7 -42.38 6.53 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.39 1.091 . . . . 0.0 110.288 -178.954 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.638 HG23 ' CD1' ' A' ' 87' ' ' PHE . 0.1 OUTLIER 48.86 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.927 -179.216 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.533 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 49.6 m -69.32 107.61 3.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 111.666 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 27.6 m120 38.06 43.78 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.0 111.77 178.438 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -126.6 -44.08 0.25 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.805 -1.664 . . . . 0.0 109.903 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 23.3 p90 41.35 -174.61 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 122.639 1.209 . . . . 0.0 111.827 -179.13 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.627 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.63 153.62 50.89 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.239 -179.243 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -13.88 12.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.888 -1.133 . . . . 0.0 110.287 -178.78 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.9 t -51.41 -54.44 26.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.19 106.6 0.21 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.81 -177.34 3.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.962 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 27.5 tttm -159.68 168.75 25.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.55 -0.719 . . . . 0.0 109.89 -179.585 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.0 mtp85 -65.86 -39.25 90.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 m -139.64 126.21 20.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CD2' ' CH2' ' A' ' 109' ' ' TRP . 60.4 m-85 -95.32 -175.99 3.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.571 ' O ' ' O ' ' A' ' 81' ' ' TYR . 29.0 t -170.47 96.87 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.301 179.941 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.571 ' CB ' HG23 ' A' ' 59' ' ' VAL . 2.2 t80 52.06 125.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.381 -0.825 . . . . 0.0 110.664 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.553 ' HA ' HG23 ' A' ' 102' ' ' THR . 13.7 t-20 73.51 -128.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.941 -1.1 . . . . 0.0 110.381 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' C ' HG21 ' A' ' 102' ' ' THR . 0.4 OUTLIER 54.29 71.08 0.54 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.701 -1.249 . . . . 0.0 109.11 -178.451 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 10.6 t30 -70.39 142.17 52.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.533 -0.73 . . . . 0.0 111.093 -178.998 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.632 ' CG2' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -129.57 120.01 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.328 -0.858 . . . . 0.0 110.072 179.002 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -84.29 124.17 30.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 178.966 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.638 ' CD1' HG23 ' A' ' 66' ' ' ILE . 50.2 m-85 -80.94 136.38 36.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.316 1.055 . . . . 0.0 112.527 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -114.76 86.1 2.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.439 -179.643 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.506 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.68 128.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 0.0 110.795 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 15.1 mmtt -38.95 -84.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.538 -0.726 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 19.0 t80 -160.58 149.6 16.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.12 -0.987 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.49 31.46 14.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.6 m-85 -142.65 146.12 34.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.501 -0.999 . . . . 0.0 110.234 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.73 135.07 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.885 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.584 ' CD2' ' CD1' ' A' ' 66' ' ' ILE . 5.5 mt -67.24 111.06 3.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.524 -179.702 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.429 ' HB2' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.19 106.62 18.31 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.136 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -90.38 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.589 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -149.0 120.39 7.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -1.15 . . . . 0.0 110.538 -179.474 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.5 p -80.15 4.8 16.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 0.0 110.905 -179.635 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -144.9 115.81 7.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 110.093 179.719 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 17.5 m -126.82 -175.53 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.699 -179.714 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 82' ' ' ASN . 13.9 m -157.24 134.4 10.34 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.114 -178.926 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.584 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 6.2 t -59.72 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.877 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.21 172.38 9.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.555 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 41.7 Cg_endo -74.85 123.74 8.19 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.334 1.702 . . . . 0.0 110.925 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.2 -7.61 5.07 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.9 m120 81.12 77.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.971 -0.723 . . . . 0.0 110.384 179.83 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -174.4 -168.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.852 . . . . 0.0 111.612 179.82 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.632 ' CZ3' ' CG2' ' A' ' 85' ' ' VAL . 22.5 m95 -134.37 100.65 4.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 -179.691 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 102' ' ' THR . 2.7 mttm -102.71 149.12 36.46 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.216 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.589 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.9 Cg_endo -75.28 -174.58 14.48 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.906 -2.123 . . . . 0.0 110.551 -0.371 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.1 tp10 -39.13 117.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.341 0.591 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.591 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 1.8 tp -43.74 141.94 2.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.825 . . . . 0.0 110.785 -179.694 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.537 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 41.7 Cg_endo -72.31 167.05 27.95 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.085 1.571 . . . . 0.0 110.502 179.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -132.33 95.33 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.923 . . . . 0.0 110.525 179.879 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.7 t -46.62 102.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.073 -1.017 . . . . 0.0 109.135 179.475 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -113.58 -178.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.729 0.775 . . . . 0.0 111.083 -179.135 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.412 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.162 0.506 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -162.58 171.5 16.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.516 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -130.55 151.96 50.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 41.6 mt-30 -134.03 174.7 10.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.072 -1.018 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.25 130.69 7.62 Favored Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.603 ' HG2' ' CG ' ' A' ' 14' ' ' HIS . 48.8 Cg_endo -70.46 158.83 54.88 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.944 1.497 . . . . 0.0 110.77 -179.752 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.05 175.14 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.014 1.534 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' ILE . 88.7 p -85.75 99.21 11.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.133 179.906 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.0 -170.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.381 1.086 . . . . 0.0 111.917 -179.664 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 9' ' ' ILE . 1.9 p -37.48 95.79 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.012 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 41.03 29.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 110.758 179.682 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -119.32 174.32 15.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 1.6 mtt85 -113.53 -168.49 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 15.3 p80 -158.94 119.45 3.22 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.321 0.581 . . . . 0.0 110.265 -179.899 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -107.11 -162.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.634 -179.621 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 18' ' ' GLU . . . 147.3 -20.67 1.54 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.986 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.12 34.78 16.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -1.132 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.592 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 38.2 mm-40 -121.43 -155.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.004 179.721 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -153.36 -39.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.617 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 7.8 p90 -143.48 80.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.707 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.605 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 25.7 m-85 -49.75 -179.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.052 -1.03 . . . . 0.0 110.112 179.938 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.516 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -142.61 -68.56 0.36 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.616 -1.303 . . . . 0.0 111.183 -179.07 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -156.86 141.42 16.76 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 109.757 -178.954 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 69.27 7.97 58.21 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.843 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.605 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 40.5 m -71.31 174.91 5.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.11 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 36.3 t -156.77 157.63 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 43' ' ' VAL . 34.0 t -144.68 121.26 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.102 -179.655 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.46 101.88 3.06 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.869 178.249 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.619 ' CE2' ' CG2' ' A' ' 9' ' ' ILE . 2.1 m-30 -67.99 154.93 40.59 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.414 -0.804 . . . . 0.0 110.136 -178.31 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.498 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.7 t -114.37 -177.14 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.021 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 57.4 m -146.9 149.89 34.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.25 149.97 5.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -54.34 107.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 179.968 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.1 10.05 9.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.948 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 4.4 m-85 -124.24 120.86 33.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.725 -179.693 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.596 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -73.05 138.2 45.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.428 179.678 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.9 tp -90.42 98.57 11.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.139 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' CG2' ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -92.05 170.39 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.096 179.414 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 83.93 -178.82 52.14 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.684 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.19 121.66 15.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -1.141 . . . . 0.0 109.943 179.917 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.507 ' O ' ' CG2' ' A' ' 28' ' ' THR . 6.2 t -73.11 53.4 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.491 -179.755 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 174.78 88.08 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.336 179.892 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.596 HG22 ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -45.32 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.316 -1.108 . . . . 0.0 108.935 179.45 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 ' CG2' ' A' ' 26' ' ' VAL . 6.3 tp -139.69 106.18 5.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 110.151 178.809 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.61 107.54 14.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.138 -0.976 . . . . 0.0 109.771 179.595 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -129.16 121.33 27.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -7.4 80.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.6 16.37 8.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -144.69 138.17 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -1.14 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.6 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 99.8 m95 -77.92 136.39 38.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.878 179.696 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t -132.12 163.88 27.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.485 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 27.8 m-20 51.09 66.7 5.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.808 -0.558 . . . . 0.0 111.191 179.681 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -90.42 137.88 2.57 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 124.399 1.736 . . . . 0.0 109.733 179.123 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.1 Cg_endo -75.68 178.02 7.93 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.664 1.35 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.52 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.5 p -118.92 147.04 44.45 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 0.0 112.072 -178.635 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 92.4 m -110.37 76.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.317 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.04 178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.457 0.646 . . . . 0.0 110.392 -178.575 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -91.38 134.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.053 179.703 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.603 HG23 ' CB ' ' A' ' 81' ' ' TYR . 28.2 m -119.8 43.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -178.992 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 25.4 mttt -80.06 97.66 6.92 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 119.406 -0.917 . . . . 0.0 108.904 179.5 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 60.2 m -69.06 161.88 69.39 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -178.607 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.1 Cg_endo -72.08 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.503 1.791 . . . . 0.0 110.34 -179.638 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER -157.46 131.55 4.99 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.593 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.613 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.1 Cg_endo -76.91 66.18 7.65 Favored 'Trans proline' 0 C--N 1.297 -2.132 0 O-C-N 123.725 1.382 . . . . 0.0 109.888 -178.906 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.527 ' N ' HD22 ' A' ' 113' ' ' LEU . 0.7 OUTLIER -87.87 -174.65 4.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.547 -0.72 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.562 HD11 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 178.32 166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.355 179.471 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.3 OUTLIER -69.8 96.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.746 -179.594 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.534 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.7 m-20 48.72 40.49 16.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.925 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -146.3 28.58 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.6 p90 -45.15 -175.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.641 1.21 . . . . 0.0 112.346 -179.08 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.538 ' C ' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.5 162.12 15.45 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.347 179.527 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t -144.66 22.74 1.62 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.971 -1.08 . . . . 0.0 110.449 -179.094 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.9 t -100.12 -82.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.698 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.44 75.88 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.711 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -95.88 157.99 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -1.05 . . . . 0.0 109.592 179.554 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.552 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -147.6 168.41 22.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 110.667 -179.636 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -76.3 -35.55 58.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.971 179.798 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 p -124.88 131.82 53.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.716 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.583 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 89.8 m-85 -112.5 170.79 7.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.512 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 81' ' ' TYR . 92.6 p -165.39 91.2 0.51 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 179.9 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.603 ' CB ' HG23 ' A' ' 59' ' ' VAL . 6.0 t80 52.42 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.815 0.817 . . . . 0.0 110.44 -179.47 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' HA ' HG23 ' A' ' 102' ' ' THR . 15.3 t-20 65.33 -127.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.487 -1.383 . . . . 0.0 110.094 -179.215 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 6.2 m-20 51.82 73.92 0.29 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.622 -1.299 . . . . 0.0 109.044 -178.54 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.509 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 6.0 t30 -72.28 146.42 47.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.519 -0.738 . . . . 0.0 111.351 -178.703 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.655 ' CG2' ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -132.16 124.27 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 109.553 179.021 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.8 t0 -83.82 124.23 30.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.995 -1.065 . . . . 0.0 109.48 179.643 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.599 ' CD2' ' CG ' ' A' ' 114' ' ' PRO . 8.4 m-85 -87.11 120.65 28.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.182 -0.949 . . . . 0.0 111.56 -178.651 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -95.75 94.93 7.97 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.169 179.932 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -44.37 125.36 4.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.07 -1.019 . . . . 0.0 109.488 179.78 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 4.9 mmtp -35.85 -67.33 0.16 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.672 -0.643 . . . . 0.0 111.001 -178.938 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 36.3 t80 -173.6 144.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.595 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.37 47.37 11.49 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 10.4 m-85 -149.83 153.87 37.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -1.027 . . . . 0.0 109.899 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' CG ' HG21 ' A' ' 117' ' ' VAL . 4.4 ptpt -113.99 130.11 56.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.534 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -66.66 93.21 0.24 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.603 -179.455 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 117' ' ' VAL . 2.4 t -74.61 103.85 5.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.61 179.508 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.54 -77.76 0.3 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.826 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -172.47 116.1 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.16 . . . . 0.0 110.454 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.576 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -67.78 -77.22 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.87 . . . . 0.0 110.637 -179.944 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 100' ' ' SER . 5.0 p -68.82 104.99 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.792 -179.219 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.4 m -107.41 -170.75 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.906 179.538 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 82' ' ' ASN . 7.8 m -161.49 138.12 8.39 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.289 -178.966 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.653 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.5 t -59.49 105.64 0.38 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 179.78 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.463 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.96 168.16 16.3 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.814 -179.464 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.574 ' CG ' ' CG2' ' A' ' 38' ' ' ILE . 43.1 Cg_endo -76.32 126.91 9.44 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.418 1.747 . . . . 0.0 110.632 -179.519 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 122.41 3.84 9.32 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.287 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.6 OUTLIER 77.3 83.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.756 -0.849 . . . . 0.0 110.635 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.04 -168.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 111.81 179.628 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.655 ' CZ3' ' CG2' ' A' ' 85' ' ' VAL . 33.8 m95 -134.08 95.07 3.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 110.289 -179.601 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -98.95 143.79 27.01 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.614 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.541 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.67 172.63 58.18 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.837 -2.151 . . . . 0.0 110.616 -0.634 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 39.4 tt0 -39.1 128.2 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 0.0 111.263 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.54 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.41 152.16 0.28 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 0.0 109.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CG ' ' CD2' ' A' ' 87' ' ' PHE . 39.7 Cg_endo -82.87 167.5 14.46 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 O-C-N 124.301 1.685 . . . . 0.0 111.119 -179.362 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 117' ' ' VAL . 3.0 ttpt -126.71 108.04 10.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.819 179.66 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.524 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.3 t -64.24 74.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.543 HG21 ' CG ' ' A' ' 94' ' ' LYS . 3.7 m -90.52 -175.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.771 0.796 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.578 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.6 ppt_? . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.481 179.412 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.18 178.57 3.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.871 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -135.39 127.82 30.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.985 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 35.8 mt-30 -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.154 179.254 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -43.37 142.93 1.56 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.042 -1.036 . . . . 0.0 110.461 -179.479 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.627 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.5 Cg_endo -73.5 160.23 44.79 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.191 1.627 . . . . 0.0 110.532 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.5 171.59 17.83 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.522 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.33 98.89 10.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 109.865 179.706 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.611 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -51.4 -170.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.389 1.09 . . . . 0.0 111.944 -179.17 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 5.3 p -58.49 122.79 14.21 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.68 -178.887 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . 2.0 m-20 33.6 34.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.996 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.53 162.58 26.93 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.529 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -111.8 -171.46 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -1.197 . . . . 0.0 110.934 -179.65 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.1 p80 -154.19 123.99 6.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.886 -0.509 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.9 -158.46 0.86 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.654 -179.621 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' OE2' ' A' ' 18' ' ' GLU . . . 138.35 -7.02 3.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 66.93 58.73 0.58 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -1.152 . . . . 0.0 110.186 -179.942 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.587 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -137.22 -69.42 0.46 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.28 -0.887 . . . . 0.0 109.821 -179.84 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 2.7 m-20 68.32 18.01 9.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.614 -0.679 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -170.53 50.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.049 -1.032 . . . . 0.0 110.595 179.761 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.652 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 9.7 m-85 -55.59 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.139 179.389 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 21' ' ' TYR . 1.9 p -161.95 -69.22 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.823 -1.173 . . . . 0.0 111.2 -179.959 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -164.16 138.31 5.55 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.048 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.81 12.21 83.08 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.737 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.602 ' OG ' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -86.19 169.27 13.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.975 . . . . 0.0 109.951 179.947 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 92.6 t -143.59 151.19 16.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.615 178.596 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.652 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 30.0 t -136.59 120.37 23.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.311 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.41 101.41 4.78 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.025 -1.47 . . . . 0.0 107.579 177.989 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.671 ' CZ ' HG23 ' A' ' 43' ' ' VAL . 1.5 m-30 -67.55 127.28 32.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.622 -178.418 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -74.75 169.3 18.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 179.615 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -140.13 134.15 30.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' SER . 1.7 m120 -43.46 116.23 0.91 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.571 179.581 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ASN . 10.6 m -38.65 113.13 0.27 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.639 -179.443 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.34 -26.11 6.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' HG13 ' A' ' 58' ' ' ILE . 2.8 m-85 -91.8 144.86 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -1.142 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.548 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 48.2 t -81.88 119.8 24.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 111.114 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tp -79.48 106.63 11.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.071 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.561 ' HB ' ' OG1' ' A' ' 55' ' ' THR . 0.3 OUTLIER -98.79 152.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.955 . . . . 0.0 109.14 -179.63 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 104.89 -177.91 23.58 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.806 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 42' ' ' GLY . 23.7 p-10 -67.98 131.73 46.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.697 179.571 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.5 p -73.17 56.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.79 179.91 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.497 ' O ' ' ND2' ' A' ' 40' ' ' ASN . . . 165.52 96.13 0.11 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.646 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.671 HG23 ' CZ ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -48.55 177.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.156 . . . . 0.0 108.054 179.38 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.3 tp -143.51 99.16 3.37 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.962 -1.086 . . . . 0.0 110.249 178.777 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.596 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.0 t -80.5 121.18 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.39 178.744 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.23 126.88 41.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.694 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 62.33 25.94 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.905 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.4 31.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.889 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -140.69 119.27 12.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.596 ' CD2' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -77.36 136.29 38.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.629 179.696 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -141.45 160.01 41.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 111.412 -179.33 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.7 t0 53.84 65.84 5.07 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.923 -0.486 . . . . 0.0 111.521 179.332 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.1 Cg_endo -91.26 129.95 1.31 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 124.378 1.725 . . . . 0.0 109.265 178.516 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 44.8 Cg_endo -72.16 166.02 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.574 1.302 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.561 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 24.8 p -104.33 -174.59 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.189 0.995 . . . . 0.0 111.612 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.6 t -146.16 74.6 1.38 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.532 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.22 -170.5 1.67 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.331 -178.459 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.58 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -111.5 86.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 81' ' ' TYR . 20.1 m -76.03 51.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 111.368 -179.115 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -55.22 175.78 0.06 Allowed 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 117.671 -1.612 . . . . 0.0 107.831 179.305 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.543 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 66.9 m -134.24 142.58 43.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.16 -178.305 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 41.8 Cg_endo -74.61 -83.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.491 1.785 . . . . 0.0 110.486 179.439 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.573 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER 177.58 126.19 0.19 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.539 -0.726 . . . . 0.0 109.251 -179.559 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.585 ' N ' ' NE1' ' A' ' 109' ' ' TRP . 50.5 Cg_endo -77.13 57.54 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.788 1.415 . . . . 0.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.539 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.76 166.11 23.51 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.47 0.652 . . . . 0.0 110.593 -179.673 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.579 ' CD1' ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -166.33 167.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.171 179.504 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 116' ' ' CYS . 1.7 t -76.34 113.13 13.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 110.78 -179.403 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.524 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 72.9 m-20 36.21 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.675 -0.641 . . . . 0.0 111.401 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -145.32 38.09 1.26 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.008 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.628 ' O ' ' O ' ' A' ' 69' ' ' GLY . 50.1 p90 -44.85 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 123.438 1.589 . . . . 0.0 113.401 -179.682 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD21 ' CE2' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -139.42 122.83 17.18 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.491 -176.807 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -104.48 15.71 27.58 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.466 -0.771 . . . . 0.0 110.237 -178.951 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.95 95.56 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.44 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 94.02 106.55 1.91 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.711 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 9.2 t80 -173.89 170.49 3.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -1.173 . . . . 0.0 110.255 179.719 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.623 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.0 tttm -179.93 142.72 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.463 -0.773 . . . . 0.0 109.727 -179.684 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 76' ' ' LYS . 12.7 mtp180 -41.42 -27.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -148.08 141.49 25.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 110.175 179.877 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -124.99 -164.75 1.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 109.607 179.762 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.7 p -170.67 107.89 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.613 ' N ' HG22 ' A' ' 59' ' ' VAL . 2.3 t80 53.24 156.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.112 -0.992 . . . . 0.0 110.672 179.167 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.591 ' HA ' HG23 ' A' ' 102' ' ' THR . 27.4 t-20 38.18 -110.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.713 -179.224 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.474 ' OD2' ' N ' ' A' ' 80' ' ' SER . 74.9 m-20 50.79 69.0 0.69 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.765 -1.21 . . . . 0.0 109.143 -179.419 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 84' ' ' ASN . 11.3 p-10 -69.43 129.98 41.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.753 -178.92 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.527 HG23 ' CZ3' ' A' ' 109' ' ' TRP . 15.8 m -121.53 128.85 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.998 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 20.4 t0 -85.37 136.78 33.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 108.575 178.977 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.583 ' CE2' HD21 ' A' ' 71' ' ' LEU . 51.2 m-85 -96.69 143.5 27.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.969 -1.082 . . . . 0.0 111.907 -178.43 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 5.7 tttm -115.38 110.03 18.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.448 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.522 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -66.55 132.79 48.99 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.835 -1.165 . . . . 0.0 109.943 -179.251 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.524 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -38.76 -91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 111.173 -179.132 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.3 t80 -148.44 138.56 22.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 0.0 110.786 -179.293 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 51.08 60.1 7.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.672 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 12.2 m-85 -162.96 136.45 5.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -1.06 . . . . 0.0 109.943 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.536 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 34.5 pttt -101.23 112.23 24.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.423 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.533 ' CD2' ' HB2' ' A' ' 114' ' ' PRO . 1.3 mt -45.58 125.9 6.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.554 ' CB ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -102.24 103.55 14.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 0.0 109.501 179.215 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.59 -57.42 0.58 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.599 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 172.65 119.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -1.148 . . . . 0.0 111.098 -179.417 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -78.11 -3.87 44.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.201 -0.937 . . . . 0.0 110.703 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.7 p -142.09 112.46 7.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 109.806 179.86 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.3 m -121.75 -179.7 4.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.993 -179.272 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -153.29 132.34 12.58 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 103' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 82' ' ' ASN . 36.6 t -78.72 82.91 4.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 110.09 -179.868 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.536 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -55.74 -179.91 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.594 -0.691 . . . . 0.0 111.503 -179.596 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 42.9 Cg_endo -73.43 117.6 5.14 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.559 1.821 . . . . 0.0 110.572 -179.271 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 138.0 -10.25 3.62 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 6.2 m120 83.37 90.42 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.163 -0.61 . . . . 0.0 110.728 179.461 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 103' ' ' CYS . 0.0 OUTLIER -177.35 -161.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 111.527 179.635 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.585 ' NE1' ' N ' ' A' ' 64' ' ' PRO . 17.7 m95 -149.95 80.18 1.37 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.487 0.66 . . . . 0.0 109.729 -179.831 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.496 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.9 mttm -95.18 143.26 25.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.824 -179.739 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -71.04 174.27 45.66 Favored 'Cis proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 -2.0 . . . . 0.0 110.987 -0.144 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.23 128.24 5.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -39.86 144.15 0.54 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 110.272 179.323 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HG2' ' CD1' ' A' ' 66' ' ' ILE . 38.3 Cg_endo -71.74 164.26 36.25 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 111.356 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.493 ' O ' HG21 ' A' ' 117' ' ' VAL . 9.7 tttt -132.59 119.76 20.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 67' ' ' SER . 1.3 m -62.12 113.23 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.047 -1.033 . . . . 0.0 110.194 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.554 HG23 ' CB ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -127.52 173.48 12.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.761 179.113 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.306 0.574 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.59 173.45 11.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.489 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -127.0 108.61 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 0.0 110.458 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.533 ' NE2' ' CE1' ' A' ' 20' ' ' PHE . 9.2 mm100 -87.68 174.81 8.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.2 p -43.01 139.97 2.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.891 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.92 ' HG3' HG11 ' A' ' 27' ' ' VAL . 46.6 Cg_endo -69.59 161.04 47.46 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.083 1.57 . . . . 0.0 111.031 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.86 171.95 16.84 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.089 1.573 . . . . 0.0 109.938 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -73.01 176.47 5.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.051 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.724 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -169.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.175 0.988 . . . . 0.0 111.369 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -52.56 96.41 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.74 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 10' ' ' SER . 8.4 m120 40.63 61.78 1.55 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.453 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.5 161.99 32.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.6 mtt85 -105.88 -176.82 3.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -1.148 . . . . 0.0 109.808 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.62 -176.28 5.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.933 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 1.3 t30 66.52 136.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.065 -1.022 . . . . 0.0 109.905 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.86 -60.43 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 4.0 t80 -151.46 35.85 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -1.089 . . . . 0.0 110.116 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -145.09 -162.74 1.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 1.3 p30 -147.57 -38.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 109.879 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.609 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 3.2 m-85 -93.62 -162.05 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 171.89 -16.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.531 -0.73 . . . . 0.0 110.996 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 7.0 p 47.73 -95.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 112.311 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -152.16 161.75 42.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.788 -1.195 . . . . 0.0 110.428 -178.46 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.85 19.9 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.624 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 6.6 m -105.14 178.04 4.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.54 -0.976 . . . . 0.0 110.566 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.7 t -151.8 156.35 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.103 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.92 HG11 ' HG3' ' A' ' 6' ' ' PRO . 15.0 t -135.09 117.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.572 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.95 103.28 5.1 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.341 -1.343 . . . . 0.0 107.928 178.113 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.87 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.1 m-30 -68.24 128.09 35.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 110.05 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -82.96 157.81 22.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.577 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 35.5 m -123.28 155.17 37.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -47.94 160.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 33' ' ' SER . 12.3 p -59.98 105.16 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.475 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.53 -3.24 29.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.504 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -94.32 131.49 39.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -1.193 . . . . 0.0 110.422 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.592 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -81.39 140.14 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -90.38 99.71 12.68 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.027 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.822 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.5 162.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.185 -0.947 . . . . 0.0 109.078 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.99 171.85 47.9 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -45.96 129.04 9.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -1.159 . . . . 0.0 109.997 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.754 ' O ' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -74.01 53.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.476 -179.666 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.571 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 162.23 119.51 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.737 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.8 t -60.24 -175.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.022 -1.281 . . . . 0.0 108.051 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.584 ' H ' HG12 ' A' ' 43' ' ' VAL . 5.2 tp -146.48 97.49 2.93 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.4 OUTLIER -84.9 108.79 17.72 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.217 178.818 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.8 m -126.84 82.02 2.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.554 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.82 43.57 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.51 11.07 46.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -132.14 120.94 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -1.203 . . . . 0.0 110.28 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.648 ' CH2' HG23 ' A' ' 27' ' ' VAL . 80.8 m95 -76.36 138.75 40.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 0.0 109.742 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -141.41 158.06 44.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.992 . . . . 0.0 111.129 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.517 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 62.62 65.28 1.5 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 111.381 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.8 Cg_endo -91.2 133.61 1.59 Allowed 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 124.275 1.671 . . . . 0.0 110.215 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 51.3 Cg_endo -82.55 177.2 7.17 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.929 1.489 . . . . 0.0 110.34 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 17.8 p -112.04 162.17 15.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 111.528 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 m -129.21 77.1 1.77 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 177.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.55 -170.24 1.69 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.366 0.603 . . . . 0.0 110.32 -178.26 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -100.03 146.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.032 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.736 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 16.4 m -134.23 41.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.916 -1.115 . . . . 0.0 110.999 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 8.2 mtpt -81.02 98.82 8.13 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.931 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 37.4 m -70.22 165.94 38.91 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.589 -0.695 . . . . 0.0 111.387 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 50.6 Cg_endo -75.43 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.315 1.692 . . . . 0.0 110.659 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.482 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -153.78 131.67 6.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.89 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.69 ' HG2' HD22 ' A' ' 71' ' ' LEU . 54.3 Cg_endo -76.12 66.22 6.98 Favored 'Trans proline' 0 C--N 1.295 -2.254 0 O-C-N 123.595 1.313 . . . . 0.0 109.476 -179.689 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.73 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -87.97 175.46 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.531 -0.731 . . . . 0.0 110.686 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -178.26 161.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.0 t -72.11 111.67 7.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.0 110.864 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 61.5 m-20 36.53 49.14 0.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.641 -0.662 . . . . 0.0 111.325 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.534 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -159.42 23.76 0.3 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' HG23 ' A' ' 66' ' ' ILE . 3.8 p90 -36.41 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.953 1.359 . . . . 0.0 112.718 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -49.14 -70.59 0.08 Allowed 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.835 178.038 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER 79.96 10.05 1.34 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.41 -0.806 . . . . 0.0 109.891 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 t -114.34 -44.75 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.541 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -178.67 100.2 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.612 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.03 172.41 6.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -1.07 . . . . 0.0 109.742 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -158.89 161.08 36.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.543 -179.741 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -54.06 -37.47 64.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.772 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 m -144.02 163.31 33.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.538 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.9 m-85 -135.68 -179.2 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 17.3 p -163.06 111.9 1.3 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.042 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.677 ' CB ' HG21 ' A' ' 59' ' ' VAL . 18.2 t80 30.97 38.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.515 -0.741 . . . . 0.0 111.592 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 103' ' ' CYS . 30.6 t30 -176.48 -140.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.444 -1.41 . . . . 0.0 110.995 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 74.3 m-20 55.26 66.53 1.2 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.917 -1.115 . . . . 0.0 108.987 -178.323 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.591 ' N ' HG23 ' A' ' 102' ' ' THR . 8.0 t-20 -70.65 97.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 74' ' ' GLY . 34.9 m -86.15 131.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.172 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -88.56 131.04 35.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.867 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 20.4 m-85 -88.66 125.45 34.84 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.53 1.157 . . . . 0.0 112.758 -177.56 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -104.97 108.63 20.24 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.116 -179.473 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.468 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -60.68 133.99 56.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.766 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -44.61 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 110.241 -179.544 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.594 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.0 p90 -148.93 149.31 31.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 111.007 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 42.9 36.9 2.71 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 17.3 m-85 -139.38 149.43 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -1.087 . . . . 0.0 110.213 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.501 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.44 139.93 46.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.209 179.9 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.747 ' CD2' HD11 ' A' ' 66' ' ' ILE . 23.5 mt -75.6 102.97 5.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.495 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -80.15 95.32 6.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.324 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.24 -85.93 0.16 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.578 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -157.12 125.5 5.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -1.152 . . . . 0.0 110.554 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.3 p -86.19 25.08 1.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.83 . . . . 0.0 110.882 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.4 p -169.89 106.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 1.7 m -127.48 164.84 21.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.046 0.927 . . . . 0.0 110.924 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.591 HG23 ' N ' ' A' ' 84' ' ' ASN . 26.8 m -139.79 139.4 36.41 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.962 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.558 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 11.8 t -49.52 94.4 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.671 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -66.62 174.12 2.02 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.934 -1.104 . . . . 0.0 112.366 -178.095 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.822 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.6 Cg_endo -79.44 14.33 1.83 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.635 1.86 . . . . 0.0 111.809 -178.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -116.31 18.72 13.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.834 ' O ' HG23 ' A' ' 108' ' ' THR . 0.4 OUTLIER 67.32 54.5 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.591 -0.947 . . . . 0.0 110.263 -179.844 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -167.19 -176.88 3.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 110.741 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.602 ' NE1' ' N ' ' A' ' 64' ' ' PRO . 46.6 m95 -105.97 98.84 8.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.415 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -105.73 141.99 23.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.214 -179.575 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.578 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.2 Cg_endo -71.78 174.8 45.13 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.888 -0.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.5 mm-40 -38.38 142.34 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 111.14 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -60.75 141.21 92.82 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.975 179.558 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.734 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.9 Cg_endo -73.13 155.59 52.07 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 124.302 1.685 . . . . 0.0 111.226 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 117' ' ' VAL . 2.6 ttpt -120.17 101.91 8.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.371 -0.83 . . . . 0.0 110.09 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -54.66 103.19 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.094 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -112.71 178.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.633 0.73 . . . . 0.0 110.823 -179.145 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 6.4 ptt85 . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.443 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 178.23 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 110.059 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.582 ' SG ' ' CZ2' ' A' ' 50' ' ' TRP . 2.8 t -160.08 97.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.527 -0.733 . . . . 0.0 110.259 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 pm0 -80.26 -175.26 4.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.1 p -45.26 142.57 2.98 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.473 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.876 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.8 Cg_endo -69.76 157.57 59.93 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.992 1.522 . . . . 0.0 111.261 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.27 173.25 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.971 1.511 . . . . 0.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.68 177.95 4.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.293 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.686 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.85 -170.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.24 1.019 . . . . 0.0 111.722 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 9' ' ' ILE . 25.4 m -38.32 92.48 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.004 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.8 m-20 40.28 34.82 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.338 -0.851 . . . . 0.0 110.78 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.91 12.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -139.7 179.01 6.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.379 -1.071 . . . . 0.0 109.957 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.609 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -137.78 114.23 10.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 110.338 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -135.72 122.81 21.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.42 -111.41 2.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -157.09 29.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 110.113 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 1.6 pm0 -162.99 173.62 13.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -102.26 -51.08 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.936 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -100.41 139.66 35.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.967 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -120.01 -11.96 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.641 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.568 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 21.1 p 51.14 -99.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.556 -0.715 . . . . 0.0 111.694 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -147.95 163.34 37.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.053 -1.029 . . . . 0.0 110.575 -178.579 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.47 25.31 68.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -107.04 -179.62 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.819 . . . . 0.0 110.201 -179.281 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.677 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.3 t -155.04 155.48 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.947 ' O ' HG23 ' A' ' 43' ' ' VAL . 17.2 t -140.51 116.21 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.655 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.49 103.84 2.59 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.374 -1.33 . . . . 0.0 107.851 178.064 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.918 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.8 m-30 -68.28 135.01 51.26 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.327 -178.262 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 4.4 t -90.25 -172.36 3.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.385 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 85.9 m -149.33 159.9 43.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.077 -1.014 . . . . 0.0 110.226 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.558 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 76.0 m-20 -46.04 139.51 4.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.937 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.51 109.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.16 17.62 10.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 32' ' ' ASN . 3.2 m-85 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.017 -1.284 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . 1.069 ' OG ' HG22 ' A' ' 59' ' ' VAL . 66.3 m -92.17 133.16 36.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 111.027 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 29' ' ' TYR . 5.3 tp -88.17 116.17 26.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.37 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.699 HG23 ' CG ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -109.26 157.62 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.086 -1.009 . . . . 0.0 109.815 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.52 -169.37 18.27 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -58.61 119.24 6.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.045 -1.268 . . . . 0.0 109.51 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.706 ' O ' HG23 ' A' ' 28' ' ' THR . 46.1 p -68.45 58.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.588 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.562 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.96 115.22 0.5 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 27' ' ' VAL . 1.9 t -61.52 -175.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.214 . . . . 0.0 108.212 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.559 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.7 tp -144.06 101.38 3.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.189 -0.944 . . . . 0.0 110.115 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.1 t -85.22 108.42 17.73 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.72 179.111 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.506 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -129.31 103.68 7.07 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.211 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 79.43 52.79 4.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.83 50.12 8.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.56 73.42 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -1.051 . . . . 0.0 110.446 -179.854 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 68.8 m95 -46.21 131.72 10.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.562 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 5.9 m -142.65 168.98 18.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 111.099 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.5 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 11.7 m-20 59.95 66.34 2.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.687 -0.633 . . . . 0.0 111.111 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -90.8 130.22 1.47 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 124.366 1.719 . . . . 0.0 110.335 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HG2' HD11 ' A' ' 37' ' ' LEU . 55.6 Cg_endo -79.34 -176.24 3.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.838 1.441 . . . . 0.0 110.534 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.0 p -112.1 -169.42 1.47 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.997 0.903 . . . . 0.0 111.634 -178.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 67.9 m -152.03 86.72 1.31 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.558 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -117.8 -143.39 0.37 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.778 -177.845 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.784 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -134.43 100.5 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.069 HG22 ' OG ' ' A' ' 36' ' ' SER . 30.8 m -101.19 70.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 112.587 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 27.9 mtpt -65.52 -170.86 0.07 Allowed 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 117.239 -1.785 . . . . 0.0 107.989 178.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -143.9 159.8 52.12 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.292 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 46.0 Cg_endo -85.31 -79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 124.783 1.938 . . . . 0.0 110.558 179.377 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 171.63 128.6 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.691 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.819 ' O ' HD21 ' A' ' 71' ' ' LEU . 53.2 Cg_endo -80.27 66.36 8.82 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.8 1.421 . . . . 0.0 109.783 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.743 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -84.25 -171.49 3.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.349 -0.844 . . . . 0.0 109.698 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.743 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 172.44 170.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.298 179.035 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 69.5 m -77.0 107.4 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.155 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 5.7 m-80 38.56 65.92 0.57 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 89' ' ' CYS . . . -155.53 -37.98 0.02 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 43.5 p90 35.14 -155.78 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.591 1.186 . . . . 0.0 112.265 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.819 HD21 ' O ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -155.13 126.89 7.49 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.696 -175.486 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.6 t -100.53 15.92 26.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 86' ' ' ASP . 2.8 m -80.66 -92.3 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 111.258 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.16 88.19 0.18 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -95.76 165.87 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.612 -179.336 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.577 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 5.4 tttt -164.25 156.12 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.459 -0.775 . . . . 0.0 109.756 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -30.47 59.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 0.0 110.45 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.9 p -143.95 138.24 28.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.607 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 25.0 m-85 -114.51 -140.77 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 82.7 p -162.7 -123.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.878 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 1.034 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.27 27.3 8.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.841 -1.162 . . . . 0.0 111.089 -178.276 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.769 ' C ' HG22 ' A' ' 102' ' ' THR . 45.8 t-20 -164.98 -110.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.942 -1.099 . . . . 0.0 110.285 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 0.2 OUTLIER 48.86 71.82 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.661 -1.274 . . . . 0.0 109.101 -179.252 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.811 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.3 t-20 -68.86 109.44 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.716 HG23 ' CE1' ' A' ' 87' ' ' PHE . 27.7 m -99.36 120.63 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 0.0 111.242 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 23.7 t70 -78.88 135.42 37.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.182 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.724 ' CE2' HD23 ' A' ' 71' ' ' LEU . 13.1 m-85 -90.85 133.29 35.34 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.651 -1.281 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.36 81.94 2.12 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.777 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.537 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -40.48 126.74 2.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.55 -0.719 . . . . 0.0 110.745 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 17.2 mtpt -66.56 143.12 57.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 109.506 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.49 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.29 53.47 1.86 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.617 ' CE2' ' HD2' ' A' ' 118' ' ' ARG . 3.2 m-85 -102.29 155.4 18.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -1.035 . . . . 0.0 109.251 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -101.24 146.82 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.637 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 1.4 mt -87.64 90.84 8.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.87 -1.144 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 t -72.48 98.83 2.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.312 -0.868 . . . . 0.0 109.846 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 139.74 -41.38 1.32 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.608 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 98.2 p -178.41 -166.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.166 -1.196 . . . . 0.0 111.386 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -159.23 -39.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.577 0.703 . . . . 0.0 109.174 179.696 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 100' ' ' SER . 37.2 p -123.9 91.96 3.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 24.2 m -103.25 146.3 28.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 111.226 -178.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.811 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -117.78 136.86 53.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.688 0.756 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.561 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -65.73 92.06 0.14 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 110.375 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.474 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -64.82 173.59 1.6 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.484 -0.76 . . . . 0.0 111.012 -179.664 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.845 ' HB3' HG11 ' A' ' 59' ' ' VAL . 42.3 Cg_endo -76.22 125.06 8.26 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.381 1.727 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.71 -3.91 8.06 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 108' ' ' THR . 9.3 m-80 80.75 94.01 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.881 -0.776 . . . . 0.0 110.428 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.6 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.801 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 113' ' ' LEU . 26.1 m95 -153.99 90.21 1.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.435 -0.791 . . . . 0.0 110.403 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.8 mtpp -96.15 141.62 23.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 110.284 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.6 Cg_endo -72.48 170.38 68.29 Favored 'Cis proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.915 -2.119 . . . . 0.0 110.559 -0.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' LEU . 11.9 pt-20 -40.58 131.43 2.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.387 -0.821 . . . . 0.0 110.427 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.583 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -41.27 142.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 0.0 110.03 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.67 ' HG2' HD12 ' A' ' 66' ' ' ILE . 46.4 Cg_endo -77.45 170.26 19.67 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.447 1.761 . . . . 0.0 111.616 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.583 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -126.37 113.2 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.603 -0.685 . . . . 0.0 110.157 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.552 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.7 t -67.72 108.57 2.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.96 . . . . 0.0 109.051 179.353 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.583 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -117.41 -179.61 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.622 0.725 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.617 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.952 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.245 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.122 0.486 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.12 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.659 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 3.9 t -147.9 105.26 3.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.757 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -88.95 -179.11 5.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.342 -179.908 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -44.58 140.14 3.28 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.378 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.801 ' HG2' ' CD2' ' A' ' 14' ' ' HIS . 55.3 Cg_endo -71.31 168.2 24.1 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.031 1.543 . . . . 0.0 110.781 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.43 -178.46 2.61 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.81 1.426 . . . . 0.0 108.457 178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -82.32 45.32 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.843 -1.161 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.804 HD11 ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER 39.08 -170.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 122.204 1.002 . . . . 0.0 110.618 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.691 ' N ' HG13 ' A' ' 9' ' ' ILE . 47.4 m -102.11 112.06 24.58 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.75 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 10' ' ' SER . 3.0 m-20 74.64 38.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.612 -0.68 . . . . 0.0 110.393 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 9' ' ' ILE . . . -179.03 -155.5 14.95 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.481 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -137.36 -171.61 3.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -1.208 . . . . 0.0 110.987 -179.621 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.801 ' CD2' ' HG2' ' A' ' 6' ' ' PRO . 32.7 p-80 -145.0 153.91 41.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.164 0.506 . . . . 0.0 110.097 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -152.68 -87.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.22 -109.07 3.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -178.18 48.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -1.16 . . . . 0.0 110.327 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 176.25 -165.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.463 179.909 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.02 -48.29 1.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.845 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -92.07 139.11 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.659 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.6 OUTLIER -130.63 -13.87 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 111.262 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 17.4 p 44.51 -98.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 111.435 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -147.4 158.29 43.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.072 . . . . 0.0 110.154 -178.764 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.27 21.34 79.35 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.659 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 8.1 m -106.75 176.91 5.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.643 -0.916 . . . . 0.0 110.329 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 43' ' ' VAL . 42.8 t -151.25 152.24 11.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.486 -0.759 . . . . 0.0 109.864 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.79 HG11 ' HG3' ' A' ' 6' ' ' PRO . 12.7 t -130.82 121.95 51.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.997 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.31 102.33 5.04 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.848 177.866 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.657 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.4 m-30 -68.49 151.73 46.38 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 110.665 -178.136 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.412 ' C ' ' SG ' ' A' ' 31' ' ' CYS . 1.2 p -114.53 175.72 5.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.43 -0.794 . . . . 0.0 109.526 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 11.2 m -142.91 154.11 43.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 22.2 m-80 -43.59 157.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.16 115.65 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.266 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.68 10.48 35.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-85 -106.65 138.94 41.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -1.183 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.964 ' OG ' HG22 ' A' ' 59' ' ' VAL . 70.6 m -89.16 117.52 28.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 110.695 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.483 ' C ' HD13 ' A' ' 38' ' ' ILE . 3.2 tp -79.6 119.37 22.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -0.956 . . . . 0.0 109.613 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.606 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -111.88 170.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.145 179.522 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.61 44.08 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 9.7 p30 -57.81 142.22 46.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.092 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 28' ' ' THR . 25.6 p -85.6 56.95 4.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.713 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 159.23 106.57 0.22 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.875 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -53.8 -175.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.011 -1.287 . . . . 0.0 108.547 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.4 tp -144.92 99.17 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 110.197 178.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -83.11 118.6 23.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -0.984 . . . . 0.0 109.744 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -123.87 69.94 1.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 110.481 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.23 50.47 1.23 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 19.64 57.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.86 71.19 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.146 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.618 ' CH2' HG23 ' A' ' 27' ' ' VAL . 83.5 m95 -46.18 133.85 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.136 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 p -143.96 160.99 39.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 61.44 65.17 1.9 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 111.192 179.516 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.37 134.86 1.37 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.361 1.716 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.597 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.9 Cg_endo -76.55 -176.17 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.821 1.432 . . . . 0.0 109.929 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.8 p -115.83 -178.12 3.32 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.276 1.036 . . . . 0.0 112.094 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.804 ' SG ' HD11 ' A' ' 9' ' ' ILE . 55.5 m -148.07 74.76 1.31 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.99 -167.13 1.15 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.485 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.692 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -115.19 105.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -0.852 . . . . 0.0 109.379 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.086 HG21 ' HB3' ' A' ' 81' ' ' TYR . 32.8 m -95.78 67.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 111.674 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mptp? -68.87 174.86 4.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.354 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.76 161.86 60.93 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 118.43 -1.308 . . . . 0.0 113.565 -177.864 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.2 Cg_endo -81.26 -82.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.832 1.964 . . . . 0.0 110.054 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.58 131.93 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.0 110.295 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.669 ' O ' HD11 ' A' ' 71' ' ' LEU . 58.0 Cg_endo -86.79 88.09 0.71 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.739 1.389 . . . . 0.0 108.615 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.3 p -108.77 -42.0 4.62 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.364 1.078 . . . . 0.0 110.554 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.703 HD11 HD23 ' A' ' 95' ' ' LEU . 0.1 OUTLIER 49.91 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.6 -178.867 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -70.45 108.4 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.617 -0.677 . . . . 0.0 111.696 -178.481 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 4.4 m-80 39.05 38.13 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.641 -0.662 . . . . 0.0 111.381 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -118.43 -40.81 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.236 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 1.0 OUTLIER 40.57 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.942 1.353 . . . . 0.0 112.259 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -138.5 159.15 42.79 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.246 -179.002 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 t -134.65 29.09 3.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.301 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -108.14 -72.32 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 0.0 110.805 -179.53 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -143.47 85.69 0.19 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -112.38 167.67 10.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.405 -1.056 . . . . 0.0 110.232 -179.631 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 tttm -165.79 164.46 18.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -62.57 -22.39 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.25 152.38 37.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 110.588 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.596 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 17.0 m-85 -133.23 -146.32 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.301 -0.874 . . . . 0.0 110.069 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 90.5 p -165.32 -120.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 1.086 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -105.11 36.86 2.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.016 -178.912 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.639 ' C ' HG22 ' A' ' 102' ' ' THR . 10.0 p30 -176.2 -114.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.907 -1.121 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 43.95 79.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.816 -1.178 . . . . 0.0 109.567 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.764 ' CA ' HG23 ' A' ' 102' ' ' THR . 20.7 p30 -69.2 137.8 53.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 0.0 110.706 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 85' ' ' VAL . 29.8 m -119.97 118.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.34 -0.85 . . . . 0.0 110.56 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.4 t0 -83.33 123.49 29.69 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.925 ' CE1' HD12 ' A' ' 71' ' ' LEU . 56.9 m-85 -82.27 139.52 34.15 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.278 1.037 . . . . 0.0 113.048 -177.57 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -116.19 86.12 2.43 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.248 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.552 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -38.64 126.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 -179.203 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 1.4 mmtt -38.55 -92.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.552 -0.717 . . . . 0.0 111.038 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -146.92 150.31 34.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.004 -1.06 . . . . 0.0 111.034 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 40.94 33.65 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 19.6 m-85 -134.92 148.25 50.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -1.026 . . . . 0.0 109.975 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 117' ' ' VAL . 3.7 tttt -108.23 151.29 26.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 109.987 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.703 HD23 HD11 ' A' ' 66' ' ' ILE . 10.4 mt -89.22 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.49 103.64 6.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.35 -90.01 0.19 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.607 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.7 m -153.61 121.85 6.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -1.164 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 87' ' ' PHE . 2.7 p -75.5 -6.05 48.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -138.15 120.52 15.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.033 -1.042 . . . . 0.0 109.961 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.451 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 20.3 m -136.84 166.37 23.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.764 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.52 153.35 51.71 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.842 . . . . 0.0 110.427 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -82.81 75.01 9.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.52 -179.519 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.463 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -56.01 174.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 111.072 -179.79 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.745 ' CB ' HG11 ' A' ' 59' ' ' VAL . 42.5 Cg_endo -74.84 123.46 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.427 1.751 . . . . 0.0 110.153 -179.417 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.72 -14.73 4.96 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.594 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 85.06 94.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.646 0.736 . . . . 0.0 111.104 179.43 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.92 -160.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.689 0.756 . . . . 0.0 110.882 179.281 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.769 ' HB3' HD13 ' A' ' 113' ' ' LEU . 19.9 m95 -148.11 77.97 1.42 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.806 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.583 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -88.39 151.73 48.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 110.435 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.65 177.88 31.88 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.908 -0.163 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.58 114.59 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.341 0.591 . . . . 0.0 110.988 -179.229 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.769 HD13 ' HB3' ' A' ' 109' ' ' TRP . 4.3 tp -40.58 142.67 0.75 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.529 -0.732 . . . . 0.0 110.191 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.655 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.3 Cg_endo -70.61 165.32 32.32 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.005 1.529 . . . . 0.0 110.219 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 1.022 ' HG2' HG13 ' A' ' 117' ' ' VAL . 62.3 tttt -128.58 103.28 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.902 179.518 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -58.2 87.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.052 -1.03 . . . . 0.0 109.06 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.022 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -95.42 179.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.837 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 3.1 ptp85 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.271 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.405 ' H3 ' HG13 ' A' ' 1' ' ' VAL . 27.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.278 0.561 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.94 174.34 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -130.45 79.46 1.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 7.9 mp0 -47.49 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 1.3 p -55.04 146.06 40.95 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.058 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.848 ' HG3' HG11 ' A' ' 27' ' ' VAL . 46.5 Cg_endo -69.24 155.08 68.7 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.804 1.423 . . . . 0.0 111.11 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.04 174.64 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.105 1.582 . . . . 0.0 110.305 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.17 179.53 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.64 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -147.78 -169.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 122.208 1.004 . . . . 0.0 111.377 -179.888 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 15.1 m -53.5 97.96 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.543 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' SER . 35.2 m-80 41.0 61.69 1.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -168.61 151.19 17.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.3 mtm180 -104.09 -169.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -1.157 . . . . 0.0 110.675 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.6 p80 -147.75 -153.38 0.49 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.384 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 18' ' ' GLU . 16.2 t-20 58.28 149.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -39.3 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 10.5 t80 -160.64 40.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -1.217 . . . . 0.0 110.581 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -165.03 -166.82 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' SER . 1.6 m-20 -140.24 -41.29 0.42 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 110.657 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.59 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 33.2 p90 -131.04 105.9 8.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.941 -1.1 . . . . 0.0 110.845 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.638 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 12.7 m-85 -72.84 -163.51 0.13 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.612 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.57 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -149.8 -64.83 0.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 111.015 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 5.4 t0 -165.23 146.38 7.41 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 66.27 15.13 62.88 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.638 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 1.5 m -97.21 164.3 12.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 109.962 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 43' ' ' VAL . 43.4 t -138.68 154.35 26.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 110.54 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.848 HG11 ' HG3' ' A' ' 6' ' ' PRO . 11.2 t -131.62 122.3 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.509 -179.08 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -78.95 103.08 8.66 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.371 -1.332 . . . . 0.0 107.71 177.799 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.847 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.3 m-30 -67.66 107.08 2.41 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.421 -178.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -69.21 158.01 35.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 110.312 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 18.8 m -123.44 146.32 48.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 4.1 m120 -43.87 138.56 2.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 109.951 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' ASN . 5.3 t -44.39 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 126.75 -1.22 7.39 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.593 ' CE2' HG13 ' A' ' 58' ' ' ILE . 14.3 m-85 -106.39 143.26 34.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -1.183 . . . . 0.0 110.391 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.671 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -92.24 139.86 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 110.84 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.0 tp -91.34 99.12 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.309 179.105 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -87.98 147.14 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.619 -179.76 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.97 -176.96 27.47 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.7 134.36 51.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -1.15 . . . . 0.0 109.777 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.621 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -73.65 53.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.623 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 159.33 116.46 0.45 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.867 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.5 t -58.44 -178.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.001 -1.294 . . . . 0.0 107.866 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -146.14 94.82 2.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.305 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 0.0 109.078 178.79 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.8 p -132.45 111.31 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.411 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 18.31 39.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.3 31.31 47.17 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -151.95 100.56 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -1.175 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CH2' HG23 ' A' ' 27' ' ' VAL . 81.3 m95 -54.03 136.99 40.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 7.4 m -146.09 155.64 42.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.05 -1.031 . . . . 0.0 111.061 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.539 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.6 t0 68.95 64.86 0.54 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.625 -0.672 . . . . 0.0 111.199 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.2 Cg_endo -92.29 132.71 1.17 Allowed 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.971 1.781 . . . . 0.0 110.597 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 37' ' ' LEU . 54.3 Cg_endo -82.84 173.89 9.93 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.862 1.454 . . . . 0.0 109.481 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.636 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 74.2 p -114.22 134.77 54.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.869 -1.144 . . . . 0.0 111.366 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.2 m -98.09 75.58 2.33 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.8 171.37 7.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.365 0.602 . . . . 0.0 110.533 -178.376 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.593 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -87.94 124.74 41.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.011 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.708 HG23 ' CA ' ' A' ' 80' ' ' SER . 33.9 m -110.38 53.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 111.269 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -78.74 107.68 11.62 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.578 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 71.0 m -74.46 162.86 71.91 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.244 -0.91 . . . . 0.0 111.665 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.8 Cg_endo -71.39 -78.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.622 1.854 . . . . 0.0 110.66 179.319 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.1 OUTLIER 178.41 131.02 0.22 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 54.2 Cg_endo -76.68 65.17 7.53 Favored 'Trans proline' 0 C--N 1.295 -2.275 0 O-C-N 123.714 1.376 . . . . 0.0 110.254 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.837 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -95.93 141.34 29.47 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.036 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.824 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -135.8 154.79 34.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.092 -178.908 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.88 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.77 -179.701 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.7 OUTLIER 68.0 -55.51 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 70' ' ' TYR . . . -52.71 -169.3 0.02 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 88' ' ' LYS . 12.6 p90 175.12 -165.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.14 153.73 42.56 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.233 178.237 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t -139.01 24.83 2.54 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -106.71 -73.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.33 81.1 0.29 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.6 t80 -101.01 164.16 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 109.775 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.625 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -160.5 167.98 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.543 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -71.78 -29.37 64.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.255 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 p -139.12 135.19 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 38.8 m-85 -117.13 -170.28 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.809 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.708 ' CA ' HG23 ' A' ' 59' ' ' VAL . 89.1 p -145.77 -99.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.0 111.201 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.604 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -120.95 22.01 11.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.494 -1.379 . . . . 0.0 110.357 -178.887 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.639 ' C ' HG22 ' A' ' 102' ' ' THR . 16.4 p30 -159.39 -116.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 110.606 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 t70 52.09 73.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.799 -1.188 . . . . 0.0 109.367 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.815 ' CA ' HG23 ' A' ' 102' ' ' THR . 31.4 t30 -69.46 105.02 2.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.799 . . . . 0.0 110.906 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 85' ' ' VAL . 34.6 m -91.54 118.42 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.028 -1.045 . . . . 0.0 110.757 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.85 137.76 38.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.429 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD1' HG21 ' A' ' 66' ' ' ILE . 38.3 m-85 -97.44 155.61 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.943 -178.255 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 70' ' ' TYR . 1.4 mmtt -136.33 123.1 21.18 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.582 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.523 ' N ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.56 132.04 46.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 110.376 -179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -38.62 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.512 -0.742 . . . . 0.0 110.527 179.894 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -172.96 120.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.148 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.565 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 78.59 50.2 6.21 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.567 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 77.4 m-85 -158.83 167.64 28.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.473 -1.016 . . . . 0.0 110.396 -178.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.694 ' O ' HG22 ' A' ' 117' ' ' VAL . 21.1 tttm -121.39 124.87 45.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 0.0 109.607 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 66' ' ' ILE . 2.3 mt -66.69 92.84 0.23 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.913 -1.117 . . . . 0.0 110.076 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.57 112.41 13.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.91 -79.31 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.601 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -169.37 122.47 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -1.053 . . . . 0.0 110.135 -179.635 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -83.86 17.3 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.734 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 85.7 p -157.15 105.86 2.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.974 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.563 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 3.1 m -123.64 175.63 6.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.199 -0.938 . . . . 0.0 110.943 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.815 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.08 132.63 19.79 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.603 0.716 . . . . 0.0 110.176 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.559 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -61.79 89.23 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.507 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.472 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -75.21 178.58 1.74 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 111.186 -179.046 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.879 ' HB3' HD12 ' A' ' 38' ' ' ILE . 44.0 Cg_endo -76.83 130.5 11.51 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.394 1.734 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.83 -10.3 7.52 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 9.3 m-80 81.42 76.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 122.102 -0.646 . . . . 0.0 110.738 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -171.16 -169.28 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 0.0 111.361 179.746 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.702 ' HB3' HD13 ' A' ' 113' ' ' LEU . 32.0 m95 -133.09 95.72 3.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.626 -0.671 . . . . 0.0 110.104 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.9 mmtt -101.61 146.63 32.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.518 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.601 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.32 178.62 33.06 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.782 -2.174 . . . . 0.0 110.528 -0.291 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -37.56 124.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 110.908 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.837 HD23 ' O ' ' A' ' 65' ' ' THR . 1.5 tp -46.48 143.54 3.88 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 110.226 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.824 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.1 Cg_endo -70.67 168.09 23.75 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.056 1.556 . . . . 0.0 110.636 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.3 tttt -132.76 109.42 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -62.8 89.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.13 -0.981 . . . . 0.0 108.85 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.736 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.4 m -104.9 -173.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.925 0.869 . . . . 0.0 111.215 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.567 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtt-85 . . . . . 0 C--N 1.294 -1.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.738 HG13 ' O ' ' A' ' 1' ' ' VAL . 13.3 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.363 0.602 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.38 162.71 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.099 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -130.54 91.71 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.286 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 2.2 mp0 -64.03 164.98 9.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 109.885 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.74 141.52 1.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.799 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.1 Cg_endo -69.27 162.57 41.29 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.954 1.502 . . . . 0.0 110.874 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.32 170.22 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.036 1.546 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -89.36 104.32 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.585 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -51.13 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.103 0.954 . . . . 0.0 111.251 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.64 141.0 30.95 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.085 -179.337 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.4 m120 50.57 19.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -160.68 168.47 36.13 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.054 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.484 ' N ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -132.34 -177.62 4.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -1.106 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.3 p80 -126.67 143.85 51.1 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.563 -0.71 . . . . 0.0 110.553 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.28 -166.98 1.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.127 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.67 -91.28 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -170.64 28.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -1.16 . . . . 0.0 110.211 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -165.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.427 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -164.98 25.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -150.68 49.22 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 110.822 -179.753 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.3 m-85 -50.15 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.541 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p -141.0 -54.53 0.48 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.089 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 6.6 t70 -172.63 148.18 1.9 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.858 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.28 14.72 54.92 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.181 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.622 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.98 174.53 7.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -1.006 . . . . 0.0 109.641 179.854 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 43' ' ' VAL . 49.6 t -148.99 154.71 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.15 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.697 ' O ' HG23 ' A' ' 43' ' ' VAL . 8.7 t -131.85 119.1 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.631 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.92 103.66 5.22 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.141 178.177 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.634 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.33 175.7 3.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.763 -178.699 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -131.55 161.84 31.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.571 179.576 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.927 ' SG ' HD12 ' A' ' 37' ' ' LEU . 55.9 m -140.1 130.94 25.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 110.431 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -44.4 136.74 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.4 p -46.09 111.75 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.93 -9.06 7.59 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CE1' HG12 ' A' ' 58' ' ' ILE . 3.2 m-85 -114.6 115.38 27.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -1.166 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.76 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -63.94 127.91 33.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.602 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.927 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -82.83 99.91 10.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.142 178.983 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.679 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -86.16 145.38 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 109.196 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.91 -143.98 15.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.53 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.6 m120 -126.41 51.24 1.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.201 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 40' ' ' ASN . 10.8 m 22.79 66.38 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.655 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.516 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.85 108.63 0.37 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.9 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -65.27 -177.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.994 -1.298 . . . . 0.0 108.329 178.8 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' H ' HG12 ' A' ' 43' ' ' VAL . 7.6 tp -145.96 97.35 2.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.544 178.606 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.25 115.02 20.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 178.905 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 83.6 p -127.27 109.24 11.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.613 -0.679 . . . . 0.0 110.471 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.42 41.57 13.18 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.703 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 63.41 33.27 86.78 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.64 107.1 4.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -1.182 . . . . 0.0 110.613 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.2 m95 -66.74 138.85 57.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.636 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -149.26 169.75 20.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 111.405 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 49.72 64.85 7.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.784 -0.572 . . . . 0.0 111.421 179.679 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.5 Cg_endo -92.78 147.6 2.64 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 121.919 1.746 . . . . 0.0 110.296 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -81.52 173.89 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.895 1.471 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.617 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.6 p -125.3 141.13 52.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.01 . . . . 0.0 111.231 -179.463 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 75.7 m -100.66 73.91 1.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.7 OUTLIER -118.76 175.84 5.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.043 -179.086 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -88.5 149.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.258 -0.902 . . . . 0.0 108.767 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.818 HG21 ' CB ' ' A' ' 81' ' ' TYR . 33.1 m -124.21 47.46 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 111.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -76.07 155.71 34.56 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.255 178.131 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -120.44 172.24 4.89 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.847 -1.158 . . . . 0.0 111.476 -178.808 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.0 Cg_endo -78.08 -63.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.649 1.868 . . . . 0.0 110.744 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.509 ' CE1' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 163.07 128.56 0.01 OUTLIER Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.203 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.821 ' O ' HD23 ' A' ' 71' ' ' LEU . 48.7 Cg_endo -76.54 69.52 6.65 Favored 'Trans proline' 0 C--N 1.294 -2.302 0 O-C-N 123.696 1.366 . . . . 0.0 110.377 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.733 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -94.22 -173.78 3.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.757 . . . . 0.0 109.403 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.802 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 178.5 169.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 110.272 179.455 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.528 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.32 103.89 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.875 -179.536 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 59.9 m-80 44.68 51.12 8.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -164.64 26.54 0.19 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.619 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -39.27 162.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 123.012 1.386 . . . . 0.0 113.166 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.0 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -45.83 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.603 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER 80.59 25.87 0.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.284 0.564 . . . . 0.0 110.094 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.73 -73.67 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 110.467 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -108.1 -98.31 2.55 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 1.0 ' HB2' HD13 ' A' ' 71' ' ' LEU . 6.8 t80 57.05 164.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.408 -1.054 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.647 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -170.16 167.44 8.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.438 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -52.83 -26.8 15.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.507 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 8.0 t -149.69 146.92 27.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -142.53 175.69 9.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.8 p -170.65 136.61 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.004 -1.06 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.818 ' CB ' HG21 ' A' ' 59' ' ' VAL . 54.6 t80 31.44 104.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.708 -0.62 . . . . 0.0 111.872 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 38.2 t30 90.19 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 122.005 -0.434 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 80' ' ' SER . 4.5 m-20 55.3 76.64 0.25 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.765 -1.209 . . . . 0.0 108.817 -178.314 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t30 -71.29 146.25 49.03 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.63 0.729 . . . . 0.0 111.599 -178.527 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.726 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.3 m -127.53 123.57 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.014 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.04 132.36 34.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.906 -1.121 . . . . 0.0 108.69 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.677 ' CD1' HG21 ' A' ' 66' ' ' ILE . 38.1 m-85 -94.55 136.6 34.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.291 1.043 . . . . 0.0 112.674 -177.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 72' ' ' SER . 2.4 tttp -111.89 102.41 10.66 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.474 -179.109 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.444 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -51.68 131.08 29.74 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 109.705 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.18 -79.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.958 -179.746 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.7 m-85 -165.66 141.31 5.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 0.0 110.298 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.56 61.46 6.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -162.71 175.19 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.45 -1.029 . . . . 0.0 110.208 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.3 tttt -132.14 116.0 16.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.865 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.606 HD23 HD11 ' A' ' 66' ' ' ILE . 5.6 mt -55.3 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.48 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -71.95 99.21 2.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.206 -0.934 . . . . 0.0 109.561 179.341 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.75 -86.24 0.18 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.614 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -162.77 122.07 2.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 110.434 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.9 p -73.52 1.34 10.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.878 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 p -147.55 113.69 5.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.53 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 15.2 m -121.3 -173.39 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.518 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 82' ' ' ASN . 16.1 m -155.83 139.1 15.67 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.942 -178.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.637 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.6 t -69.03 84.03 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 109.371 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.479 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -73.82 177.73 1.94 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.679 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -77.37 130.25 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.569 1.826 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.34 -6.77 12.78 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.877 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 83.15 85.32 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.991 -0.711 . . . . 0.0 111.435 179.364 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.877 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.65 171.83 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.64 0.733 . . . . 0.0 111.14 178.703 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.726 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 51.6 m95 -119.21 93.72 4.18 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.713 -0.617 . . . . 0.0 110.29 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.0 mmtm -98.94 146.05 31.0 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.708 . . . . 0.0 110.566 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.614 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -70.55 169.5 66.38 Favored 'Cis proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.94 -2.108 . . . . 0.0 110.871 -0.786 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 52.2 tt0 -36.03 126.16 0.74 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.568 0.699 . . . . 0.0 111.707 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -42.77 143.51 1.18 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.541 -0.725 . . . . 0.0 109.977 179.105 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.802 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.2 Cg_endo -71.43 164.11 36.83 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 124.158 1.609 . . . . 0.0 111.242 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.523 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -130.57 108.12 9.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 110.411 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.5 t -65.05 93.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 179.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 94' ' ' LYS . 3.2 m -112.35 179.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.708 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.591 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.566 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.489 HG21 ' C ' ' A' ' 47' ' ' GLY . 9.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.233 0.54 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 169.96 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.559 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -135.32 95.73 3.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -71.88 175.73 5.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.483 179.437 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -50.41 138.79 20.87 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.816 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.666 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.8 Cg_endo -68.91 156.26 65.96 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.913 1.481 . . . . 0.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.67 167.69 25.88 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.906 1.477 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' ILE . 84.8 p -81.19 99.67 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.601 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -50.97 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.389 1.09 . . . . 0.0 111.877 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -61.06 116.65 4.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.159 -179.168 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 m120 42.94 43.62 3.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.331 -0.855 . . . . 0.0 111.115 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -158.92 139.06 6.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -95.9 -168.83 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.893 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.651 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 14.9 p80 -148.79 120.74 8.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.801 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -115.63 -71.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.027 . . . . 0.0 110.745 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.58 -97.58 1.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER 179.82 30.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -1.179 . . . . 0.0 110.576 -179.944 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 178.59 -171.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 110.585 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -105.5 -50.53 3.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.018 179.757 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.8 m-85 -88.7 -170.52 2.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 1.7 m-85 -169.52 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.33 -0.856 . . . . 0.0 111.96 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.559 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p 48.72 -97.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.0 -1.062 . . . . 0.0 112.167 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -145.36 157.91 43.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.215 . . . . 0.0 110.342 -178.293 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.4 65.1 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB2' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -92.03 160.78 15.07 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.588 -0.948 . . . . 0.0 110.105 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 43' ' ' VAL . 53.8 t -140.78 152.76 20.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.771 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.973 ' O ' HG23 ' A' ' 43' ' ' VAL . 25.2 t -138.02 116.71 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.123 -1.031 . . . . 0.0 111.391 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.891 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.66 103.61 2.59 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.519 178.098 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.981 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.84 125.95 27.89 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 110.218 -178.138 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -82.05 153.5 26.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.251 -0.906 . . . . 0.0 109.93 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 1.6 t -121.55 138.2 54.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.79 158.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.041 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -62.91 131.51 48.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.33 -33.33 6.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -89.59 136.54 32.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -1.122 . . . . 0.0 109.973 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.724 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.92 144.8 25.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.786 -179.635 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.6 tp -96.39 100.91 12.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.432 -0.792 . . . . 0.0 109.331 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.816 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.1 148.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.06 -168.61 12.64 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.565 -1.303 . . . . 0.0 109.878 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.32 134.16 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.891 ' O ' HG23 ' A' ' 28' ' ' THR . 89.2 p -74.41 56.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.699 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 163.86 114.02 0.3 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.981 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -64.91 -178.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -145.82 99.11 3.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.04 -1.037 . . . . 0.0 110.465 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -86.35 110.11 19.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.356 178.902 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.55 100.37 6.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.381 -0.824 . . . . 0.0 110.629 -179.42 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' C ' HG21 ' A' ' 1' ' ' VAL . . . 84.75 45.14 6.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 62.33 33.6 86.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.34 95.71 2.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -1.156 . . . . 0.0 110.665 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 72.9 m95 -60.07 137.32 58.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.163 -0.961 . . . . 0.0 109.309 179.263 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 t -139.58 179.2 6.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 0.0 111.397 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.3 m-20 38.57 64.75 3.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.78 -0.575 . . . . 0.0 111.535 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.9 Cg_endo -91.97 138.69 2.0 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 121.95 1.767 . . . . 0.0 109.558 178.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 52.3 Cg_endo -78.93 -178.99 5.06 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.734 1.386 . . . . 0.0 110.495 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.537 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 9.0 p -115.06 172.83 6.82 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.801 0.81 . . . . 0.0 111.194 -179.039 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -137.64 77.44 1.63 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.83 -164.26 0.9 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.412 -178.676 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -111.32 131.24 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.985 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.724 HG13 ' HB2' ' A' ' 36' ' ' SER . 11.4 m -125.42 47.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 111.493 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 14.3 mttp -74.08 166.25 23.73 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.846 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.13 171.0 8.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.554 -1.341 . . . . 0.0 112.684 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 51.9 Cg_endo -86.12 -57.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.81 1.953 . . . . 0.0 109.71 178.841 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.523 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 161.76 122.72 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.377 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.887 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.8 Cg_endo -76.1 66.41 6.94 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 O-C-N 123.645 1.34 . . . . 0.0 109.893 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.742 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.4 p -85.34 -173.25 4.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.275 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.823 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 176.52 170.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.34 179.159 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.538 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 1.1 p -79.79 111.16 15.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 111.434 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.506 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 10.3 m-20 36.83 63.0 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -154.48 -44.54 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 33.7 p90 39.99 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.256 1.027 . . . . 0.0 111.302 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.93 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -135.58 154.46 51.34 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.984 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.77 -17.43 13.94 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.895 -1.128 . . . . 0.0 110.2 -178.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.41 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 30.9 t -49.63 -95.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.462 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.06 88.87 0.11 Allowed Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.049 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -78.55 100.34 6.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -1.074 . . . . 0.0 109.479 179.457 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.588 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 1.8 ttmt -88.65 133.72 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.913 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.6 ttt180 -40.27 -32.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.406 -0.809 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -128.23 134.11 48.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.447 -0.783 . . . . 0.0 110.08 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.588 ' CE2' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-85 -117.81 -159.75 0.76 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.703 ' C ' HG23 ' A' ' 59' ' ' VAL . 90.5 p -157.84 -111.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.845 -1.159 . . . . 0.0 111.672 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.613 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -115.24 11.74 16.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.328 -1.482 . . . . 0.0 110.8 -178.396 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.7 OUTLIER -159.03 -3.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.749 -1.219 . . . . 0.0 112.896 -179.243 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -55.04 86.39 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.848 -1.158 . . . . 0.0 108.706 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASN . 48.8 t30 -72.74 129.45 38.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 111.796 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.8 m -116.79 117.14 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -82.99 120.83 26.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 108.955 179.639 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.93 ' CE1' HD12 ' A' ' 71' ' ' LEU . 57.3 m-85 -82.25 138.76 34.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 112.451 -177.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -113.26 84.24 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.067 -179.641 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -38.28 128.95 1.36 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.704 . . . . 0.0 110.712 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.48 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.592 -0.692 . . . . 0.0 110.452 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.1 t80 -166.13 143.3 5.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 0.0 109.889 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.23 46.5 85.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 17.9 m-85 -151.57 157.28 42.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -1.033 . . . . 0.0 109.973 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.36 112.12 19.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.09 179.884 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' A' ' 114' ' ' PRO . 18.6 mt -48.18 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.481 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -74.93 94.06 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.212 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.05 -89.6 0.14 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -154.5 118.17 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -1.172 . . . . 0.0 110.618 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' PHE . 6.2 p -72.82 -7.27 49.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -141.69 101.72 4.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 0.0 109.857 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 10.9 m -111.15 162.49 14.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 110.923 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 82' ' ' ASN . 3.5 m -138.68 134.25 33.37 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.17 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 49.3 t -61.93 95.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.134 -1.027 . . . . 0.0 108.806 179.247 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.4 175.97 0.45 Allowed Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.508 -0.745 . . . . 0.0 111.259 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.816 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.8 Cg_endo -81.24 19.55 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.523 1.802 . . . . 0.0 111.205 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -113.5 8.19 24.35 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.892 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 76.27 61.15 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.785 -0.833 . . . . 0.0 110.508 179.708 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -176.83 173.38 1.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.073 -1.017 . . . . 0.0 111.854 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.734 ' HB3' HD13 ' A' ' 113' ' ' LEU . 27.8 m95 -95.69 92.26 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.575 0.703 . . . . 0.0 110.692 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.533 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 10.5 mmtm -109.61 135.35 20.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.577 -0.702 . . . . 0.0 109.628 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.2 Cg_endo -69.81 166.41 74.25 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.179 -2.009 . . . . 0.0 111.285 -0.036 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -43.67 139.87 2.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.887 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -47.99 146.62 4.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.254 179.441 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.823 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.9 Cg_endo -72.57 160.41 46.65 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 124.363 1.717 . . . . 0.0 110.713 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.552 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.3 ttmt -122.48 106.9 11.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.967 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.108 -0.995 . . . . 0.0 109.18 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 115' ' ' LYS . 2.1 m -113.41 178.59 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.608 0.718 . . . . 0.0 110.812 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.581 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.796 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.269 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 18.9 mttt -159.89 174.23 14.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -122.7 91.58 3.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' SER . 36.8 mt-30 -71.53 175.55 5.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.706 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -41.79 138.04 1.82 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.874 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.715 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.9 Cg_endo -69.08 158.44 57.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.97 1.51 . . . . 0.0 111.091 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.68 169.01 23.34 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.886 1.466 . . . . 0.0 110.264 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.6 p -73.32 176.24 6.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.86 -170.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.166 0.984 . . . . 0.0 111.462 179.726 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 16.7 m -40.08 91.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -178.997 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.0 m120 43.09 40.11 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 110.433 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -132.22 176.48 19.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 3.3 mtp180 -123.29 -174.93 3.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.386 -1.067 . . . . 0.0 109.759 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.25 122.99 6.81 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.1 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 14' ' ' HIS . 72.1 m-80 -156.61 122.12 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' ' OH ' ' A' ' 21' ' ' TYR . . . -118.69 31.16 5.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 2.1 t80 66.53 25.38 10.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.106 . . . . 0.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.497 ' CD ' ' CZ ' ' A' ' 21' ' ' TYR . 9.9 pt-20 -159.34 -174.3 4.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' SER . 12.0 m-20 -123.41 -28.6 3.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 0.0 110.14 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -105.36 -170.81 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.808 -179.465 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 1.4 m-85 -174.3 -31.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.699 -0.626 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.584 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 17.2 m 67.28 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 112.509 178.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.11 155.05 40.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.733 -1.229 . . . . 0.0 109.963 -178.424 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.54 56.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.031 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.66 162.58 18.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.615 -0.932 . . . . 0.0 110.239 -179.897 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 43' ' ' VAL . 78.3 t -139.21 152.29 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.4 t -135.06 124.52 42.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.696 -179.068 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.884 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.26 101.31 4.63 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.073 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.002 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.48 153.24 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.017 -178.547 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.49 ' HB2' ' HG3' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -115.1 160.89 19.11 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.597 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 17.6 m -128.44 149.46 50.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.04 -1.038 . . . . 0.0 110.534 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -56.25 148.92 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 179.825 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 p -49.8 115.48 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.13 31.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 2.0 m-85 -118.1 131.54 56.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -1.203 . . . . 0.0 110.348 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.689 ' CB ' HG13 ' A' ' 59' ' ' VAL . 8.2 m -82.83 138.31 34.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 110.821 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 41' ' ' SER . 6.2 tp -94.59 101.23 13.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.931 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -96.17 159.9 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 89.35 34.77 8.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 6.2 m120 66.18 176.27 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -1.144 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -116.8 70.71 0.78 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.721 179.632 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 169.93 109.69 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.002 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -69.81 -174.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -1.204 . . . . 0.0 108.445 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -144.55 102.19 3.78 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.061 178.699 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -88.52 108.76 19.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 179.083 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -125.84 107.81 10.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.49 41.58 6.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 58.95 30.06 65.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -145.96 105.86 4.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -1.22 . . . . 0.0 110.608 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.638 ' CH2' HG23 ' A' ' 27' ' ' VAL . 85.8 m95 -62.07 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.795 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.6 169.72 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.009 . . . . 0.0 111.075 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 47.45 65.22 7.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.821 -0.55 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.5 Cg_endo -90.81 135.03 1.91 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.381 1.727 . . . . 0.0 109.506 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -74.29 161.36 40.61 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.71 1.374 . . . . 0.0 110.072 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.0 p -104.0 143.83 32.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 111.849 -178.432 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 63.5 m -109.76 74.86 0.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.94 173.81 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.519 0.676 . . . . 0.0 110.755 -178.169 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -86.34 145.37 7.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.689 HG13 ' CB ' ' A' ' 36' ' ' SER . 16.1 m -126.29 48.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.756 -178.164 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 7.0 mtpt -86.05 160.95 19.16 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 118.842 -1.143 . . . . 0.0 107.961 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 16.0 m -122.73 167.86 13.34 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.516 -1.365 . . . . 0.0 112.154 -178.889 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 42.6 Cg_endo -75.42 -59.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.632 1.859 . . . . 0.0 110.47 179.489 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 168.22 124.0 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.184 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.632 ' HG3' HG11 ' A' ' 85' ' ' VAL . 53.4 Cg_endo -75.87 71.96 5.35 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 O-C-N 123.715 1.377 . . . . 0.0 109.707 -179.009 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.476 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -94.78 177.48 5.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.735 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.757 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -171.47 167.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.427 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.48 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.4 OUTLIER -73.39 106.69 5.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.499 -0.751 . . . . 0.0 110.677 -179.498 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.537 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.7 m120 40.7 36.63 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 110.502 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.756 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.0 31.13 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.595 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -44.89 -175.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.577 1.179 . . . . 0.0 112.186 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.803 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -110.45 160.95 16.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.772 179.091 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.6 t -149.6 24.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.739 -1.226 . . . . 0.0 109.951 -179.343 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 86' ' ' ASP . 24.0 t -112.39 -37.26 5.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.734 -179.405 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -165.05 95.62 0.12 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.584 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -125.98 150.24 48.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -1.068 . . . . 0.0 109.734 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 12.7 ttmm -154.15 140.53 18.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.179 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 76' ' ' LYS . 3.3 mtt180 -41.57 -51.88 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.1 m -94.99 168.26 10.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.808 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.595 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 48.8 m-85 -149.16 179.97 7.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.2 m -159.58 -160.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.597 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.71 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 1.8 t80 -73.91 54.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.648 -1.282 . . . . 0.0 109.866 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.732 ' O ' HG22 ' A' ' 102' ' ' THR . 8.4 p-10 173.51 -125.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.91 -1.118 . . . . 0.0 109.939 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.87 67.83 0.84 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.878 -1.139 . . . . 0.0 109.62 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.721 ' N ' HG23 ' A' ' 102' ' ' THR . 7.7 p-10 -69.81 104.05 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.541 -179.045 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 74' ' ' GLY . 17.3 m -83.97 123.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.141 . . . . 0.0 110.546 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.54 ' CB ' ' HB3' ' A' ' 73' ' ' SER . 2.3 t70 -81.11 124.88 29.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.926 -1.109 . . . . 0.0 109.001 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.803 ' CE1' HD12 ' A' ' 71' ' ' LEU . 26.5 m-85 -88.41 123.46 32.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.997 -1.064 . . . . 0.0 111.851 -178.581 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.5 tttm -102.31 109.28 20.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.659 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -58.79 130.51 47.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.071 -1.018 . . . . 0.0 110.192 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 21.7 mmtt -39.41 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 33.9 p90 -144.82 149.62 35.74 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.083 -1.011 . . . . 0.0 110.724 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 39.76 37.3 0.89 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 17.5 m-85 -137.64 146.56 44.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -1.082 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -106.66 162.76 13.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 108.956 179.097 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -96.31 106.29 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.742 -1.224 . . . . 0.0 110.618 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.5 t -86.83 102.06 13.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.505 -0.747 . . . . 0.0 109.578 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 137.47 -43.59 1.2 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 1.0 OUTLIER 175.49 -166.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 111.238 -179.595 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -67.85 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.707 -0.621 . . . . 0.0 109.999 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 56.2 p -92.09 84.01 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.805 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 1.4 m -86.29 166.52 15.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.314 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 82' ' ' ASN . 3.9 m -146.13 139.46 25.98 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.57 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 51.8 t -61.76 104.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.917 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -74.12 176.59 2.72 Favored Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 111.319 -178.495 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.931 ' HB2' HD12 ' A' ' 38' ' ' ILE . 52.4 Cg_endo -80.28 10.03 3.39 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.722 1.906 . . . . 0.0 110.974 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -104.99 7.37 44.44 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.881 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 76.13 61.16 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.708 -0.878 . . . . 0.0 109.953 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -176.97 175.5 1.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.771 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.603 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.7 m95 -98.41 95.36 7.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.573 0.701 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.4 mmmt -107.59 136.36 19.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 44.2 Cg_endo -70.4 166.02 76.88 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.25 -1.979 . . . . 0.0 111.29 0.693 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 14.9 tt0 -42.3 134.93 2.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.51 -0.744 . . . . 0.0 109.88 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD12 ' CZ ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -42.18 139.56 1.76 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.95 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.757 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.1 Cg_endo -71.22 169.54 20.43 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.233 1.649 . . . . 0.0 111.535 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.839 ' HG2' HG13 ' A' ' 117' ' ' VAL . 8.5 tttt -125.04 108.34 11.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.773 . . . . 0.0 110.901 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -61.04 97.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 108.875 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.839 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -103.36 -179.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.828 0.823 . . . . 0.0 111.183 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.35 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 3.9 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.258 0.552 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -160.9 166.37 28.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -126.61 72.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 110.12 -179.892 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -59.28 179.6 0.1 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.302 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.4 p -43.17 142.8 1.48 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.037 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.649 ' HG3' HG21 ' A' ' 27' ' ' VAL . 47.6 Cg_endo -72.49 164.15 36.46 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.057 1.556 . . . . 0.0 110.569 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.48 169.51 21.58 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.98 1.516 . . . . 0.0 110.286 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.243 -0.91 . . . . 0.0 109.804 179.635 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.732 HG21 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.13 -170.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.329 1.061 . . . . 0.0 111.886 179.91 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.1 t -59.85 83.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.285 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.1 m120 54.68 59.28 4.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -159.25 147.24 14.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' SER . 10.2 mtt180 -93.96 -170.43 2.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -1.141 . . . . 0.0 110.919 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.491 ' HB3' ' OE1' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -85.39 -139.23 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.062 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.47 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 52.8 t30 -87.37 -54.99 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.217 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.09 -37.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 11.8 t80 -174.42 79.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.606 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.5 mp0 -108.41 177.41 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 4.9 t0 178.04 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.973 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -141.91 88.89 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.055 -1.028 . . . . 0.0 109.493 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.9 m-85 -98.49 -9.53 24.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.78 . . . . 0.0 111.116 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.578 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.2 p 43.22 -92.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.548 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 21' ' ' TYR . 3.7 t0 -153.57 131.91 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.985 -1.072 . . . . 0.0 110.475 -178.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.46 47.75 2.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 42.2 m -148.41 154.34 39.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -1.171 . . . . 0.0 110.376 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.7 t -129.31 152.61 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 111.567 -178.463 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.649 HG21 ' HG3' ' A' ' 6' ' ' PRO . 33.4 t -122.27 114.39 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.628 -0.67 . . . . 0.0 111.484 -179.568 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -71.99 103.63 3.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.404 -1.318 . . . . 0.0 107.623 177.771 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.732 ' CD2' HG21 ' A' ' 9' ' ' ILE . 2.2 m-30 -67.75 118.56 11.16 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 110.138 -178.198 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.532 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.53 154.66 38.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 179.539 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 36.1 m -128.54 153.46 47.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.63 166.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.844 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.61 98.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 110.399 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 11.08 8.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.0 m-30 -105.76 119.2 38.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.173 . . . . 0.0 110.184 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.828 ' HB2' HG22 ' A' ' 59' ' ' VAL . 19.8 t -68.32 141.87 55.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.581 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.593 ' C ' HD13 ' A' ' 38' ' ' ILE . 1.4 tp -95.89 108.58 20.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.734 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -103.22 140.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.346 -0.846 . . . . 0.0 109.313 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 134.82 -142.03 13.42 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -110.55 52.57 0.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -1.191 . . . . 0.0 110.335 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 40' ' ' ASN . 20.2 p 26.3 59.14 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.881 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.649 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 133.57 122.24 2.28 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.412 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -61.53 176.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.14 -1.212 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.7 tp -142.39 93.97 2.6 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.639 -1.225 . . . . 0.0 110.686 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.92 109.8 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.371 178.213 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 t -131.04 98.26 4.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.549 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.45 9.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.483 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 84.24 10.25 80.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.95 116.6 15.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.072 -1.252 . . . . 0.0 110.765 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.606 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -68.48 140.32 55.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.89 150.61 34.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.062 -1.024 . . . . 0.0 111.188 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 64.35 65.71 1.07 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.685 -0.635 . . . . 0.0 111.637 179.21 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.0 Cg_endo -91.71 136.37 1.78 Allowed 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.369 1.721 . . . . 0.0 109.559 178.588 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.532 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.7 Cg_endo -80.57 179.1 6.35 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.71 1.374 . . . . 0.0 110.745 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' ILE . 5.2 p -123.91 148.9 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.8 . . . . 0.0 111.371 -178.68 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.2 m -110.51 78.59 1.13 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.31 -159.39 0.68 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.415 0.626 . . . . 0.0 110.368 -178.923 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.671 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.15 125.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.936 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.828 HG22 ' HB2' ' A' ' 36' ' ' SER . 22.5 m -118.9 52.99 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.13 -0.981 . . . . 0.0 111.597 -179.102 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 13.2 mtpt -60.82 -179.86 0.14 Allowed 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 117.811 -1.556 . . . . 0.0 107.964 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 93.4 m -136.71 160.51 66.18 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.762 -178.232 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.5 Cg_endo -85.2 -72.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.736 1.913 . . . . 0.0 109.95 178.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.58 124.9 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.743 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.621 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.5 Cg_endo -77.44 65.61 8.0 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.867 1.456 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.458 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -81.86 161.23 23.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.293 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.821 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -157.11 166.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 0.0 110.743 -179.664 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.47 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.39 108.11 10.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.691 -179.385 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.523 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 4.4 m-20 39.93 41.19 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.483 -0.761 . . . . 0.0 110.615 179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.821 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.5 33.11 0.92 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.3 p90 -44.84 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 112.469 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.743 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -112.0 161.67 16.2 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.938 179.353 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.83 30.19 1.48 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.829 -1.169 . . . . 0.0 110.382 -179.131 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -110.81 -86.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.47 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.24 71.8 0.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.1 t80 -99.51 166.25 11.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -1.065 . . . . 0.0 110.018 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.639 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -171.05 161.2 6.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 109.79 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -51.14 -32.57 23.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.098 . . . . 0.0 109.451 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.467 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.2 m -144.82 170.76 15.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.67 -0.644 . . . . 0.0 109.798 179.674 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 3.8 m-85 -143.72 -134.68 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 0.0 109.938 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.4 p -167.34 -133.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.839 -1.163 . . . . 0.0 111.133 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.74 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -87.22 14.88 6.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.771 -1.206 . . . . 0.0 110.873 -178.848 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.599 ' HA ' HG22 ' A' ' 102' ' ' THR . 59.9 t30 -160.53 -116.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.711 -1.243 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 5.8 m-20 54.51 76.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.81 -1.181 . . . . 0.0 108.888 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' HG23 ' A' ' 102' ' ' THR . 22.4 t-20 -71.43 109.83 5.65 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 110.535 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.621 HG11 ' HG3' ' A' ' 64' ' ' PRO . 14.8 m -87.38 119.44 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.4 t0 -80.6 129.52 34.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 108.798 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.743 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.0 m-85 -89.04 142.22 27.82 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.038 -1.039 . . . . 0.0 112.19 -178.237 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -121.26 92.06 3.67 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.51 -179.607 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.41 130.74 3.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.425 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.523 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 5.5 mmtt -42.55 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -153.21 154.58 34.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.421 -179.977 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 43.55 31.53 1.7 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.7 m-85 -143.35 144.88 32.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 110.316 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' VAL . 16.4 pttp -113.59 139.43 49.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.875 . . . . 0.0 109.577 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.601 HD23 HD11 ' A' ' 66' ' ' ILE . 1.2 mt -66.9 114.15 5.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.099 -1.001 . . . . 0.0 111.118 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -92.16 98.02 11.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.613 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 140.14 -45.82 0.97 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.228 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.526 ' CB ' ' CG ' ' A' ' 111' ' ' PRO . 10.7 t -177.3 -172.99 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.249 . . . . 0.0 111.69 -179.458 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 p -144.76 -27.32 0.49 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.792 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -132.48 97.01 3.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.865 -1.147 . . . . 0.0 109.694 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 24.8 m -103.3 162.66 12.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 82' ' ' ASN . 1.1 m -136.56 137.02 39.78 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.784 -0.572 . . . . 0.0 110.148 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.606 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 45.5 t -77.28 96.85 4.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.354 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -66.38 -176.3 0.23 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.602 -0.686 . . . . 0.0 110.741 179.936 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.734 ' HG3' HG23 ' A' ' 38' ' ' ILE . 42.7 Cg_endo -77.81 124.37 6.81 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.978 1.515 . . . . 0.0 110.55 -179.53 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.48 -7.28 6.25 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.711 ' O ' HG23 ' A' ' 108' ' ' THR . 4.8 m-20 79.35 95.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.898 -0.766 . . . . 0.0 110.976 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.0 -160.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -0.767 . . . . 0.0 111.088 179.453 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.686 ' HB3' HD13 ' A' ' 113' ' ' LEU . 26.9 m95 -149.73 111.43 4.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.588 -0.695 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.534 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.7 mttt -112.11 127.1 27.32 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 110.157 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.14 174.08 35.93 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.064 -2.057 . . . . 0.0 110.549 0.161 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 113' ' ' LEU . 3.7 mt-10 -63.96 59.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.602 -0.686 . . . . 0.0 111.27 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.686 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER 55.94 143.95 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 121.442 0.639 . . . . 0.0 111.383 178.951 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.714 ' HG2' HD12 ' A' ' 66' ' ' ILE . 43.0 Cg_endo -84.08 166.87 12.71 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.271 1.669 . . . . 0.0 111.09 -179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.708 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -122.0 109.28 14.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.234 -0.916 . . . . 0.0 110.748 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.1 t -65.28 104.68 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.02 . . . . 0.0 109.258 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.708 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -119.18 -176.02 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.667 0.746 . . . . 0.0 111.023 -179.103 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 . . . . . 0 C--N 1.294 -1.833 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.367 -179.84 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.271 0.558 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.77 174.59 8.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.264 -0.897 . . . . 0.0 110.574 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 52.9 t -130.0 158.58 39.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -133.68 178.06 7.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.415 -0.803 . . . . 0.0 109.978 179.884 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.5 136.88 7.21 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.476 -0.765 . . . . 0.0 110.254 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.613 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.0 Cg_endo -70.24 155.67 63.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.157 1.609 . . . . 0.0 110.998 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.68 174.39 12.74 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.841 1.443 . . . . 0.0 109.785 178.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -69.89 177.15 3.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.099 -1.001 . . . . 0.0 110.2 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.39 -170.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.261 1.029 . . . . 0.0 111.54 179.872 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -47.06 101.32 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.744 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 10' ' ' SER . 24.8 m-20 40.29 47.3 2.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.29 161.81 30.66 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' SER . 5.1 mpt_? -112.01 -169.89 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.489 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.613 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.1 p80 -144.67 119.38 9.82 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.73 81.3 1.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 110.451 -179.538 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -91.28 28.44 8.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 32.9 p90 37.05 50.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.98 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.589 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 14.5 mm-40 -140.11 -169.48 2.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -147.55 -36.91 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 9.0 p90 -142.2 79.09 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.346 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 34.0 m-85 -55.43 -166.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.534 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -152.4 -67.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.91 -1.119 . . . . 0.0 110.743 -179.736 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.96 136.79 9.22 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.546 -0.721 . . . . 0.0 109.357 -179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 73.07 7.9 72.45 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.606 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.8 m -73.54 156.37 38.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -1.031 . . . . 0.0 109.809 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 43' ' ' VAL . 54.1 t -138.66 153.39 25.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.681 ' HB ' HG23 ' A' ' 43' ' ' VAL . 41.4 t -138.67 118.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.37 -179.543 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.16 106.31 3.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.407 -1.317 . . . . 0.0 107.591 178.059 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.926 ' O ' HD13 ' A' ' 37' ' ' LEU . 3.3 m-30 -68.02 139.01 56.3 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 110.356 -178.053 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -93.98 159.07 15.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.0 m -123.23 149.68 44.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -45.54 138.0 4.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -44.42 106.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 179.993 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.52 15.47 6.95 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.04 137.22 50.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -1.123 . . . . 0.0 110.393 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.661 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -85.78 147.01 26.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 110.929 -179.531 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.6 tp -95.9 100.63 12.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.73 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -96.27 173.81 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 108.953 179.55 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 80.62 175.91 49.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.929 179.859 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -42.51 111.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -1.067 . . . . 0.0 110.021 179.822 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 28' ' ' THR . 89.2 p -70.51 55.18 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.611 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.37 95.48 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.91 175.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.357 -1.084 . . . . 0.0 108.768 179.5 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -141.12 101.0 3.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.405 -0.809 . . . . 0.0 109.923 178.707 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 6.2 t -78.09 109.38 12.12 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.64 128.94 55.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.439 -0.788 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.59 30.93 57.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.38 45.56 29.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -151.56 97.78 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.132 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.625 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 97.9 m95 -64.33 125.59 25.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.25 171.34 14.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.639 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 52.59 64.53 7.23 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.721 . . . . 0.0 110.635 -179.833 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.9 130.08 1.43 Allowed 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 121.913 1.742 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.8 Cg_endo -74.27 176.12 10.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.822 1.433 . . . . 0.0 110.536 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.551 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.4 p -105.62 173.67 6.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.842 0.83 . . . . 0.0 111.266 -179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.6 m -139.75 75.43 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.6 mm-40 -114.21 -152.13 0.5 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.735 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.738 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.67 138.42 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.379 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.686 HG23 ' CA ' ' A' ' 80' ' ' SER . 34.5 m -128.25 41.2 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.01 -1.056 . . . . 0.0 110.966 -179.115 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 16.6 mttt -53.93 178.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.358 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.16 162.33 40.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.578 -179.021 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.0 Cg_endo -83.8 -68.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.829 1.963 . . . . 0.0 110.306 179.08 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 161.31 128.73 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.382 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.742 ' HA ' HD21 ' A' ' 113' ' ' LEU . 49.4 Cg_endo -78.01 60.34 7.29 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 O-C-N 123.571 1.301 . . . . 0.0 109.841 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.711 ' C ' HG22 ' A' ' 66' ' ' ILE . 2.3 p -74.76 -177.3 3.18 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.022 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -176.26 167.77 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.967 179.463 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 6.8 m -70.1 89.76 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.589 -0.694 . . . . 0.0 110.688 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.3 m120 50.23 49.62 20.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.87 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.022 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -162.66 40.62 0.36 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.6 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -48.25 -151.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.968 1.366 . . . . 0.0 113.076 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.985 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.46 122.82 13.94 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.619 -176.973 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 t -100.4 14.96 29.37 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.52 -0.737 . . . . 0.0 109.968 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 24.7 t -76.11 -91.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.969 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.43 81.25 0.3 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.609 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.04 125.37 46.1 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.358 -1.083 . . . . 0.0 109.713 179.494 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 77' ' ' ARG . 10.0 ttmm -111.05 149.76 30.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 0.0 109.931 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -41.47 -41.46 2.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.863 . . . . 0.0 110.015 -179.988 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m -137.55 152.94 49.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.439 -0.788 . . . . 0.0 109.981 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -125.62 -162.52 1.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.686 ' CA ' HG23 ' A' ' 59' ' ' VAL . 2.3 m -153.94 -102.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.314 -0.866 . . . . 0.0 109.583 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.614 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.8 137.96 49.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.732 -1.23 . . . . 0.0 108.198 179.234 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.843 ' C ' HG22 ' A' ' 102' ' ' THR . 37.4 t-20 71.49 -104.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.739 -0.6 . . . . 0.0 110.594 -178.372 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 39.5 m-20 44.96 74.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.606 -1.309 . . . . 0.0 109.355 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.831 ' CA ' HG23 ' A' ' 102' ' ' THR . 0.2 OUTLIER -69.82 140.3 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 111.056 -178.956 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.685 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 3.7 m -129.73 126.33 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.0 110.114 179.127 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.83 132.99 33.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.031 . . . . 0.0 109.32 179.399 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.985 ' CE2' HD23 ' A' ' 71' ' ' LEU . 44.4 m-85 -89.31 149.11 23.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.145 -0.972 . . . . 0.0 111.935 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.65 90.2 3.27 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.162 0.506 . . . . 0.0 110.037 -179.514 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.442 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -43.14 124.5 3.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.9 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 110.801 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -97.2 -161.05 0.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 110.372 -179.73 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.75 58.36 0.14 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 3.0 m-30 -112.15 160.79 17.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.721 -0.87 . . . . 0.0 109.404 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.72 ' O ' HG22 ' A' ' 117' ' ' VAL . 10.6 tttt -101.05 136.43 40.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.991 -1.068 . . . . 0.0 110.52 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 66' ' ' ILE . 1.6 mt -79.56 90.65 5.12 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.537 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.8 101.94 1.82 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.829 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.58 -78.02 0.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.133 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -171.48 117.22 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -1.12 . . . . 0.0 110.635 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 -1.51 13.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -0.92 . . . . 0.0 110.966 -179.696 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 p -144.61 112.39 6.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.808 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.531 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.3 m -118.44 177.19 4.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 111.041 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.843 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -146.95 128.68 15.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.969 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.59 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 5.4 t -68.91 88.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.705 . . . . 0.0 109.51 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -69.16 -178.41 0.45 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.793 . . . . 0.0 111.193 -179.248 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.3 Cg_endo -80.7 124.96 5.33 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.564 1.823 . . . . 0.0 110.6 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 128.37 -8.12 6.64 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.762 ' O ' HG23 ' A' ' 108' ' ' THR . 7.2 m-20 83.48 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.5 0.667 . . . . 0.0 111.31 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -170.96 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.723 0.773 . . . . 0.0 111.21 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.685 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 32.1 m95 -137.73 92.37 2.67 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.451 0.643 . . . . 0.0 110.22 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 28.4 mttt -103.56 142.96 25.67 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.8 Cg_endo -70.58 167.57 73.0 Favored 'Cis proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.072 -2.054 . . . . 0.0 111.035 -0.62 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 113' ' ' LEU . 42.5 mt-10 -38.91 129.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.56 -0.712 . . . . 0.0 111.293 -179.239 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -40.06 147.25 0.36 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 110.594 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.806 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.7 Cg_endo -74.04 167.47 27.13 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.441 1.758 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.549 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -130.43 105.08 7.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.919 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.8 t -61.57 101.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.837 . . . . 0.0 109.213 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -115.28 -175.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.698 0.761 . . . . 0.0 110.588 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.0 mtm180 . . . . . 0 C--N 1.295 -1.791 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.32 0.581 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 138.75 44.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.0 110.257 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -108.01 99.21 8.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.847 . . . . 0.0 110.117 -179.921 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 9.9 mt-30 -88.38 177.19 6.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -39.09 136.89 0.97 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.544 -0.723 . . . . 0.0 110.586 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.77 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.2 Cg_endo -71.27 158.31 54.91 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.058 1.557 . . . . 0.0 110.855 -179.453 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.25 170.94 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.754 1.397 . . . . 0.0 109.865 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.59 175.31 4.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.666 179.695 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.652 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -138.37 -170.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.138 0.97 . . . . 0.0 111.463 179.861 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -46.19 90.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER 48.11 48.62 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.786 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -147.65 164.75 28.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.497 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -110.13 -169.95 1.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -1.076 . . . . 0.0 110.524 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -158.89 121.3 3.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.258 0.552 . . . . 0.0 109.981 -179.675 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.79 79.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.137 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.18 -98.0 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 t80 -150.76 34.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.222 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.549 ' CD ' ' CE1' ' A' ' 21' ' ' TYR . 2.5 pt-20 -177.81 -159.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.043 -1.035 . . . . 0.0 110.527 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -162.03 24.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.089 -179.962 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 22' ' ' THR . 0.3 OUTLIER -140.54 29.69 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 36.7 m-85 -37.05 142.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 20' ' ' PHE . 27.8 p -133.8 89.56 2.6 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.228 1.013 . . . . 0.0 110.488 179.248 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER 55.27 152.24 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.83 179.127 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 19.77 8.88 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.705 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.4 m -87.41 177.88 6.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -1.063 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 25' ' ' SER . 26.4 t -158.41 156.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.05 179.495 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.77 HG11 ' HG3' ' A' ' 6' ' ' PRO . 30.3 t -144.99 124.05 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.77 -179.439 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.82 101.34 5.07 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.398 -1.321 . . . . 0.0 107.725 177.881 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.869 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.8 m-30 -67.99 128.12 35.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 110.423 -178.21 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.6 t -77.89 -173.7 3.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.196 -0.94 . . . . 0.0 108.883 178.844 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 89.1 m -147.36 168.25 22.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.104 -0.998 . . . . 0.0 110.239 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.93 148.52 39.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.897 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.5 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.974 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.19 0.29 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -110.88 140.85 45.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -1.138 . . . . 0.0 110.276 -179.811 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -87.68 145.72 26.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.905 . . . . 0.0 110.623 -179.937 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.869 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.05 103.16 15.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.323 -0.86 . . . . 0.0 109.937 179.557 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.678 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -97.18 171.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 108.826 179.124 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 87.0 -168.59 39.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.95 117.82 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -1.125 . . . . 0.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.493 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.69 56.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -0.987 . . . . 0.0 109.644 179.53 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 160.27 94.19 0.1 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG21 ' CZ ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -48.33 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.341 -1.093 . . . . 0.0 108.85 179.849 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 25' ' ' SER . 10.8 tp -142.64 102.04 3.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.985 178.78 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -73.63 118.32 16.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.912 179.612 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -133.92 126.83 31.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.164 -0.96 . . . . 0.0 110.177 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.01 19.46 77.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 83.64 25.67 45.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.4 133.9 26.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.292 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.737 ' CH2' HG23 ' A' ' 27' ' ' VAL . 88.6 m95 -80.07 132.72 36.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.976 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.18 162.16 33.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 110.935 -179.604 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 60.57 66.22 1.9 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.509 -0.745 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.6 Cg_endo -90.75 127.2 1.26 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 121.91 1.74 . . . . 0.0 110.069 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 45.8 Cg_endo -71.15 176.89 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.668 1.352 . . . . 0.0 110.111 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.7 p -113.39 151.45 31.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -0.936 . . . . 0.0 111.916 -178.803 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -116.04 80.74 1.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.878 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -116.8 -162.45 0.85 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 110.425 -178.031 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.664 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -106.4 137.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.173 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.687 HG21 ' CB ' ' A' ' 81' ' ' TYR . 26.0 m -118.77 43.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 111.037 -179.266 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.38 98.79 9.67 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.709 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 56.4 m -68.68 164.31 46.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.803 . . . . 0.0 111.804 -177.78 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -66.61 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.514 1.797 . . . . 0.0 110.303 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.569 ' CE1' ' HE1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -165.27 133.94 2.6 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.778 ' HG2' HD21 ' A' ' 71' ' ' LEU . 51.6 Cg_endo -76.5 69.37 6.68 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 O-C-N 123.703 1.37 . . . . 0.0 110.018 -178.953 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.676 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -92.2 -176.85 4.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 109.07 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.961 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -174.64 162.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.592 179.494 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' OG ' ' A' ' 67' ' ' SER . 3.7 p -69.38 101.31 1.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.547 -0.721 . . . . 0.0 110.395 -179.612 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.509 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 21.6 m-20 41.51 57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.177 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.961 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -170.14 37.31 0.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.762 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.4 p90 -44.06 -170.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 123.419 1.58 . . . . 0.0 112.907 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.946 ' O ' HD12 ' A' ' 71' ' ' LEU . 1.7 pp -107.46 116.16 31.45 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.55 179.498 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -82.28 1.38 37.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.42 -0.8 . . . . 0.0 109.602 -179.725 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 21.0 t -74.72 -86.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.76 . . . . 0.0 110.711 -179.61 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.14 94.5 0.12 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.163 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.944 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.28 104.3 11.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -1.07 . . . . 0.0 109.296 179.303 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.9 tptt -76.75 145.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.304 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -48.37 70.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.042 179.761 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 27.4 p -117.4 135.29 53.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' HB3' ' CB ' ' A' ' 103' ' ' CYS . 95.2 m-85 -113.81 -179.61 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.781 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.9 m -170.54 108.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.976 -1.077 . . . . 0.0 111.308 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CB ' HG21 ' A' ' 59' ' ' VAL . 11.5 t80 34.92 24.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.356 -0.84 . . . . 0.0 113.106 178.771 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.71 ' C ' HG22 ' A' ' 102' ' ' THR . 37.3 t-20 -176.51 -125.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.067 -1.646 . . . . 0.0 111.472 178.388 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 49.29 75.42 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.633 -1.292 . . . . 0.0 108.828 -178.359 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.592 ' CA ' HG23 ' A' ' 102' ' ' THR . 22.4 p-10 -69.57 139.9 53.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.476 -0.765 . . . . 0.0 110.512 -179.054 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.697 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -126.43 120.83 57.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.702 179.07 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 10.7 t0 -75.38 136.02 40.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 108.847 179.368 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 113' ' ' LEU . 16.5 m-85 -99.36 135.15 41.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.952 -1.092 . . . . 0.0 111.895 -178.564 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' TYR . 3.0 ttpt -109.53 154.91 22.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -100.28 128.18 46.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.92 -1.113 . . . . 0.0 110.098 179.891 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -44.68 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.701 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 93' ' ' TYR . 1.2 m-85 -95.71 -163.81 1.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 110.576 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.37 59.45 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.601 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.605 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-85 -109.38 168.94 9.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.788 -0.831 . . . . 0.0 110.009 -179.317 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.544 ' O ' HG22 ' A' ' 117' ' ' VAL . 22.0 mttt -117.3 110.71 18.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.5 mt -49.14 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -74.43 95.74 2.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 110.044 179.817 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.34 -68.78 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.333 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.582 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -175.95 119.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -1.156 . . . . 0.0 111.03 -179.148 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.12 24.13 0.44 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.99 -1.069 . . . . 0.0 111.339 179.676 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 p -167.22 129.17 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.951 -1.093 . . . . 0.0 109.273 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 66.4 m -143.58 160.66 40.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 111.189 -179.145 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.71 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.38 137.83 50.07 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.575 0.703 . . . . 0.0 109.931 179.301 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 1.8 t -56.25 92.75 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.718 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 1.1 p -71.3 179.29 0.97 Allowed Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 110.118 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.678 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.0 Cg_endo -78.51 170.75 17.88 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 O-C-N 124.018 1.536 . . . . 0.0 111.448 -179.026 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 86.13 -57.24 4.79 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -178.906 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.1 m-20 141.66 68.76 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.365 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.26 165.65 24.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.652 -1.28 . . . . 0.0 112.032 -179.473 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.697 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 35.7 m95 -105.99 97.79 7.56 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.307 0.575 . . . . 0.0 109.849 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 5.1 mmmt -99.37 138.85 20.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.56 -179.338 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.582 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.7 Cg_endo -72.06 167.84 75.67 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.793 -0.48 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.4 tt0 -41.4 134.06 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.755 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -42.27 152.07 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.385 -0.822 . . . . 0.0 110.706 -179.736 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.804 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.0 Cg_endo -79.42 159.3 25.85 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.554 1.818 . . . . 0.0 111.487 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.1 tptt -119.03 106.57 12.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.512 -0.742 . . . . 0.0 110.713 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.4 t -62.43 97.86 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 108.774 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.67 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -112.02 178.28 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.55 0.691 . . . . 0.0 110.592 -179.396 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.662 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.713 HG11 ' HA2' ' A' ' 47' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.327 0.584 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -120.11 174.4 6.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -140.11 85.08 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.696 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 25.3 mt-30 -60.47 171.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 p -47.77 149.39 2.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.668 ' HG3' HG21 ' A' ' 27' ' ' VAL . 51.4 Cg_endo -72.31 155.76 55.58 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.95 1.5 . . . . 0.0 110.946 -179.159 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.44 169.08 23.33 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.599 1.315 . . . . 0.0 109.686 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.27 177.22 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.993 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.69 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -170.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.197 0.998 . . . . 0.0 111.475 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -45.62 94.0 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 -179.396 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.0 m120 41.76 53.08 4.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.287 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.85 152.65 24.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.9 mtt180 -94.99 -169.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -1.146 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.2 p80 -160.4 132.72 6.23 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 -179.631 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER 173.77 104.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.056 . . . . 0.0 110.7 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 17' ' ' TYR . . . -81.51 -69.11 1.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.555 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 33.0 p90 178.61 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.334 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.51 -139.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.823 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -149.9 -36.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 110.992 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 14.8 p90 -143.98 90.46 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.859 -1.151 . . . . 0.0 111.227 -179.403 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 44.8 m-85 -57.8 171.2 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.532 178.88 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.474 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -125.96 -49.07 1.6 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.832 -1.168 . . . . 0.0 111.192 -179.359 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -175.44 142.58 0.59 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.304 -0.872 . . . . 0.0 109.565 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.33 69.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -178.741 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.613 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.9 m -87.8 178.38 6.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.615 -0.932 . . . . 0.0 110.15 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.738 HG13 ' O ' ' A' ' 43' ' ' VAL . 31.5 t -154.46 154.04 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.668 HG21 ' HG3' ' A' ' 6' ' ' PRO . 39.6 t -135.8 118.69 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.39 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.856 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -71.0 103.32 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.707 177.915 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.69 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.4 m-30 -68.14 134.46 50.57 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 13' ' ' ARG . 1.1 m -93.15 159.3 15.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.612 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 34.2 m -126.08 154.01 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -44.39 158.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.011 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 t -62.08 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 110.356 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.31 22.36 3.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-30 -113.36 146.18 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -1.216 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.802 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -88.01 134.38 33.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.676 -0.64 . . . . 0.0 110.816 -179.43 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' THR . 1.2 tp -96.24 102.37 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 178.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.48 143.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.233 -0.917 . . . . 0.0 109.08 179.632 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 -175.86 21.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.242 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 5.0 p30 -65.65 142.86 57.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.041 -1.27 . . . . 0.0 109.83 179.763 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.76 51.24 1.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 110.445 -179.713 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.662 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 166.29 102.25 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.394 179.865 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.738 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -49.0 178.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.165 -1.197 . . . . 0.0 108.5 179.157 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -140.05 98.21 3.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 110.081 178.548 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.6 t -79.77 118.58 21.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.433 178.902 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -131.02 114.8 15.64 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.713 ' HA2' HG11 ' A' ' 1' ' ' VAL . . . 70.44 29.02 70.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 76.41 48.29 9.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.616 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -159.06 87.62 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 179.823 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.617 ' CH2' HG23 ' A' ' 27' ' ' VAL . 88.0 m95 -58.42 123.94 17.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.105 -0.997 . . . . 0.0 109.314 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -133.02 165.14 25.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 111.445 -179.22 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 1.6 m-20 58.28 65.57 3.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.86 -0.525 . . . . 0.0 111.242 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.7 Cg_endo -92.87 132.23 0.96 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 121.972 1.782 . . . . 0.0 109.985 178.962 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -75.23 177.32 8.78 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.579 1.305 . . . . 0.0 109.879 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.52 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.4 p -118.84 141.48 48.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 111.721 -178.667 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 89.4 m -106.76 79.87 1.39 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.099 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.23 -151.72 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.808 -0.558 . . . . 0.0 109.928 -178.692 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.52 122.73 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 108.766 179.177 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.802 HG13 ' CB ' ' A' ' 36' ' ' SER . 19.7 m -116.33 52.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 111.653 -178.311 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mtpt -65.2 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.801 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -129.8 151.26 77.86 Favored Pre-proline 0 C--N 1.295 -1.763 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.871 -178.368 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.563 ' HG3' ' HA ' ' A' ' 108' ' ' THR . 47.0 Cg_endo -84.51 9.4 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.649 1.868 . . . . 0.0 109.356 177.439 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.729 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 69.0 120.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.484 -0.76 . . . . 0.0 110.039 -179.172 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.66 ' HA ' HD21 ' A' ' 113' ' ' LEU . 56.2 Cg_endo -83.64 96.87 0.77 Allowed 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 123.957 1.504 . . . . 0.0 109.784 179.773 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 66' ' ' ILE . 2.9 p -110.01 -42.28 4.25 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.191 0.996 . . . . 0.0 110.208 -179.18 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.745 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 48.01 166.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.717 -178.406 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -69.48 104.47 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 111.14 -178.576 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 1.2 m120 40.51 41.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.826 . . . . 0.0 111.252 178.936 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -121.5 -39.14 0.59 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.043 -1.551 . . . . 0.0 109.807 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.5 p90 39.01 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.761 1.267 . . . . 0.0 112.196 -178.862 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.916 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -134.86 155.99 49.71 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.44 -178.916 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.488 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -105.79 -10.24 16.82 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 110.442 -178.891 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 2.8 m -53.74 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.79 79.74 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.729 ' CE2' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -69.19 163.41 24.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -1.075 . . . . 0.0 109.362 179.708 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.2 ttpt -154.56 160.38 41.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 -179.702 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -44.9 -52.35 8.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.202 179.895 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.508 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 74.3 m -131.65 164.67 25.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.1 m-85 -134.22 -140.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.619 ' C ' HG23 ' A' ' 59' ' ' VAL . 59.9 p -170.08 -126.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.915 -1.116 . . . . 0.0 111.155 179.781 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.631 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.09 21.35 8.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.023 -1.048 . . . . 0.0 110.636 -178.663 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.743 ' C ' HG22 ' A' ' 102' ' ' THR . 40.4 t-20 -164.15 -112.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.814 -1.178 . . . . 0.0 110.741 179.212 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 5.6 m-20 46.38 76.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.62 -1.3 . . . . 0.0 108.964 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.671 ' CA ' HG23 ' A' ' 102' ' ' THR . 10.7 p30 -69.23 145.92 52.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.819 . . . . 0.0 110.992 -178.855 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.782 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.1 m -131.08 118.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.22 178.947 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 11.4 t0 -83.04 119.53 24.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.877 . . . . 0.0 108.956 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.916 ' CE1' HD12 ' A' ' 71' ' ' LEU . 47.6 m-85 -78.7 135.56 37.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.136 0.97 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 5.9 tttt -117.1 88.2 2.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 -179.413 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.693 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -36.72 127.69 0.85 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.843 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -36.9 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.744 179.891 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.5 t80 -157.3 142.66 17.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.38 43.2 90.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 18.5 m-85 -147.8 159.06 44.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.528 -0.983 . . . . 0.0 110.182 -179.68 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' O ' HG22 ' A' ' 117' ' ' VAL . 16.8 tttp -122.45 112.24 17.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.693 HD11 ' H ' ' A' ' 89' ' ' CYS . 6.1 mt -48.76 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.37 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.503 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.33 96.38 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.693 179.615 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.27 -115.72 0.9 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 30.0 m -123.35 127.22 48.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -1.144 . . . . 0.0 110.224 -179.877 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -42.87 56.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.7 p -101.54 137.34 40.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 109.862 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 50.5 m -147.64 153.42 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.587 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.743 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.22 145.25 51.37 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.284 179.588 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 3.4 t -67.08 78.09 0.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.65 -0.656 . . . . 0.0 110.45 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.88 172.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 111.064 -179.613 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.783 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -81.82 36.27 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.444 1.76 . . . . 0.0 112.003 -178.309 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -128.07 8.48 6.74 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 178.396 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.675 ' O ' HG23 ' A' ' 108' ' ' THR . 1.2 t30 75.7 59.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.797 -0.825 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -170.25 178.85 3.66 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.445 -179.721 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.782 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 19.9 m95 -108.55 87.93 2.61 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.234 0.54 . . . . 0.0 110.168 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.2 mmtt -99.43 147.45 33.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.577 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.0 Cg_endo -71.13 175.71 39.71 Favored 'Cis proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.998 -2.084 . . . . 0.0 110.883 0.404 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 tt0 -37.15 134.48 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.461 0.648 . . . . 0.0 110.97 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.729 HD13 ' HB3' ' A' ' 109' ' ' TRP . 1.6 tp -59.33 148.26 73.34 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.745 ' HG2' HD12 ' A' ' 66' ' ' ILE . 44.7 Cg_endo -75.45 165.74 30.05 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.049 1.552 . . . . 0.0 110.446 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.572 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -127.05 103.61 7.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -0.967 . . . . 0.0 110.215 179.668 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -55.65 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 109.483 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 115' ' ' LYS . 2.6 m -108.26 -173.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.856 0.836 . . . . 0.0 111.04 -179.491 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.25 179.542 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -126.39 145.8 50.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.059 179.969 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' TYR . 1.7 m -69.25 156.96 37.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.497 -0.752 . . . . 0.0 110.976 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 11.3 mt-30 -127.8 167.86 15.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.98 179.299 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' GLN . 5.1 p -45.81 137.44 5.88 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.888 -1.133 . . . . 0.0 109.402 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.865 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.3 Cg_endo -69.84 160.79 48.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.071 1.564 . . . . 0.0 111.79 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.7 176.94 9.34 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.152 1.606 . . . . 0.0 110.012 178.979 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.09 177.28 7.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.728 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.06 -170.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 179.917 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -43.78 92.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.801 -179.344 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.6 m-80 40.27 52.07 2.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.535 179.701 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -148.97 170.52 29.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 30' ' ' SER . 1.6 mtt180 -115.63 -168.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -1.197 . . . . 0.0 110.783 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 19.3 p80 -156.49 127.08 6.69 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.338 0.59 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -124.11 -41.96 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' VAL . . . 67.53 -102.13 0.78 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.815 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -172.69 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.112 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.489 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 11.0 pt-20 -178.29 -146.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.788 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.22 -43.11 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 28.9 p90 -128.51 118.26 22.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.709 179.335 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.642 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 15.9 m-85 -82.68 -175.05 5.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.516 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' H ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -132.89 -54.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.717 -1.239 . . . . 0.0 111.073 -178.968 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.04 137.28 0.07 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 109.295 -179.423 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.93 16.86 80.29 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -179.254 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.642 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -99.63 177.13 5.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -1.029 . . . . 0.0 110.153 -179.923 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 43' ' ' VAL . 7.9 t -147.18 162.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.865 HG11 ' HG3' ' A' ' 6' ' ' PRO . 14.5 t -137.5 113.94 11.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 105.41 3.84 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.78 178.055 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.9 m-30 -68.09 170.63 8.11 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.86 -178.387 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -123.26 147.68 46.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.764 179.578 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.8 m -124.36 144.46 50.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.148 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.71 149.55 3.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -53.17 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.345 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.17 -2.77 4.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 7.8 m-85 -120.6 126.19 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.175 -1.191 . . . . 0.0 110.219 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.692 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -76.15 149.5 37.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.554 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.4 OUTLIER -92.49 96.15 10.05 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.884 178.836 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.027 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -86.56 148.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 -179.841 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.64 -160.86 22.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.852 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.475 ' O ' ' C ' ' A' ' 41' ' ' SER . 17.1 m-20 -92.17 54.06 2.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -1.203 . . . . 0.0 109.894 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 40' ' ' ASN . 75.5 p 31.1 48.78 0.08 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.41 179.581 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.512 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 143.81 134.98 2.91 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 26' ' ' VAL . 1.8 t -67.1 178.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.254 -1.145 . . . . 0.0 108.34 178.685 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' H ' HG12 ' A' ' 43' ' ' VAL . 5.7 tp -139.65 99.08 3.62 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.202 177.996 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.63 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -83.36 114.62 21.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.393 178.756 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 p -132.65 81.43 1.95 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.13 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' GLY . . . 110.61 60.55 0.49 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.817 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.22 29.67 1.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.863 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -147.35 134.37 20.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -1.131 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.63 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.8 m95 -93.43 139.8 30.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.909 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -139.61 159.81 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.33 70.58 2.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.958 -0.464 . . . . 0.0 111.576 179.405 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -89.99 135.9 2.41 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.182 1.622 . . . . 0.0 109.077 178.612 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.559 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.4 Cg_endo -72.2 146.86 46.84 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 123.691 1.364 . . . . 0.0 110.746 -179.483 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.612 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 55.9 p -90.85 171.96 8.95 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.948 0.88 . . . . 0.0 111.689 -179.047 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 56.6 m -129.7 77.24 1.78 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.653 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.554 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -116.53 -157.29 0.65 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.54 -177.866 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -110.45 139.64 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.501 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 80' ' ' SER . 34.3 m -129.65 43.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.986 . . . . 0.0 111.086 -178.441 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 19.0 mttp -69.61 98.31 1.15 Allowed 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.423 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 56.4 m -69.33 163.52 57.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 110.79 -179.2 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.4 Cg_endo -70.62 -90.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.325 1.698 . . . . 0.0 110.569 -179.877 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -163.74 131.78 2.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -77.35 67.83 7.63 Favored 'Trans proline' 0 C--N 1.298 -2.125 0 O-C-N 123.565 1.298 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.72 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -89.21 -178.28 5.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 179.996 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.72 HG22 ' C ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -176.41 163.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.564 179.398 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.522 ' N ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -70.19 96.24 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.437 -179.737 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.457 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 22.1 m120 47.76 44.19 17.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.625 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.14 32.41 1.05 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.802 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 88' ' ' LYS . 10.5 p90 -45.76 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.523 1.154 . . . . 0.0 112.46 -179.121 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -115.0 164.01 14.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.244 -179.571 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.34 -7.78 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 -179.765 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 t -59.59 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.77 93.82 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.922 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -89.2 177.79 6.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -1.157 . . . . 0.0 109.601 179.527 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -167.33 153.39 7.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 110.189 -179.461 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.1 mtm-85 -46.48 -36.66 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -146.24 154.54 41.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.633 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 45.3 m-85 -123.63 -167.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.0 109.688 179.653 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.719 ' HA ' HG23 ' A' ' 59' ' ' VAL . 5.8 p -170.08 91.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.638 ' CB ' HG21 ' A' ' 59' ' ' VAL . 8.5 t80 56.18 135.38 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.605 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.795 ' O ' HG22 ' A' ' 102' ' ' THR . 63.1 t30 65.09 -127.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.882 -1.137 . . . . 0.0 110.114 -179.258 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 1.7 m-20 52.98 70.75 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.684 -1.26 . . . . 0.0 109.009 -178.556 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.524 ' N ' HG23 ' A' ' 102' ' ' THR . 22.2 p-10 -72.91 140.04 47.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.487 -0.758 . . . . 0.0 111.259 -178.898 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.712 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.1 m -128.29 118.63 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.026 178.623 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.6 t70 -78.35 127.71 32.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.737 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.741 ' CE1' HD12 ' A' ' 71' ' ' LEU . 37.4 m-85 -89.07 122.79 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.249 1.023 . . . . 0.0 112.213 -178.289 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -97.63 94.53 7.03 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.791 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.469 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.24 129.03 6.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.061 -1.024 . . . . 0.0 110.001 -179.836 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' CYS . 2.2 mmtt -40.35 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.53 -179.571 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -158.82 139.58 12.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 0.0 110.25 179.963 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.61 49.48 46.32 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 14.4 m-85 -155.22 147.42 23.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -1.071 . . . . 0.0 109.553 -179.614 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 117' ' ' VAL . 2.3 ttmt -105.06 148.6 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.961 -1.087 . . . . 0.0 110.26 -179.871 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -85.34 87.18 7.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 110.664 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -70.41 106.2 3.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 109.257 179.101 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.68 -86.56 0.21 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -162.91 115.76 1.6 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.164 -1.198 . . . . 0.0 110.676 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' PHE . 19.4 m -64.12 -40.32 95.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.27 -0.894 . . . . 0.0 110.793 179.96 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -107.85 117.61 34.58 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.958 -1.089 . . . . 0.0 110.793 -179.591 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.593 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 13.5 m -119.47 -170.89 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.795 HG22 ' O ' ' A' ' 82' ' ' ASN . 9.3 m -163.08 134.32 4.88 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.408 -178.917 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -62.7 90.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.037 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.538 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 1.3 m -64.63 170.47 3.84 Favored Pre-proline 0 C--N 1.297 -1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 112.057 -178.669 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 1.027 ' HB2' HD12 ' A' ' 38' ' ' ILE . 49.8 Cg_endo -80.32 30.55 0.5 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.811 1.953 . . . . 0.0 111.886 -178.584 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -130.49 12.34 5.72 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 178.661 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.856 ' O ' HG23 ' A' ' 108' ' ' THR . 6.1 m-80 71.75 69.19 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.734 -0.863 . . . . 0.0 110.242 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.856 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -175.19 -163.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 111.206 -179.943 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.712 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 39.2 m95 -133.13 91.77 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -104.25 144.92 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 110.16 -179.705 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.2 Cg_endo -71.18 168.74 71.56 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.943 -2.107 . . . . 0.0 111.23 -0.478 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.46 127.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.472 0.653 . . . . 0.0 111.846 -178.994 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -42.18 142.99 1.1 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.714 . . . . 0.0 109.72 178.976 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.577 ' HB2' HD23 ' A' ' 95' ' ' LEU . 41.3 Cg_endo -71.44 169.91 19.73 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.214 1.639 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' HG22 ' A' ' 117' ' ' VAL . 7.8 tttp -130.61 106.97 8.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.125 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.533 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.0 t -65.4 74.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 109.086 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 115' ' ' LYS . 1.6 m -82.55 -175.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.057 0.932 . . . . 0.0 111.467 -179.154 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.705 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.633 179.883 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 8.1 mttt -138.06 177.33 7.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.546 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -138.92 93.14 2.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.974 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 1.1 mp0 -72.76 -175.89 1.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.21 139.44 45.79 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.024 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.619 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.2 Cg_endo -72.81 153.21 53.36 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.982 1.517 . . . . 0.0 110.275 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.58 169.57 22.01 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.908 1.478 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.7 p -70.86 176.19 4.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.91 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.175 0.988 . . . . 0.0 111.364 179.778 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -40.96 95.84 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.855 -179.215 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 9' ' ' ILE . 15.7 m-80 40.69 38.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.189 -0.944 . . . . 0.0 110.721 179.62 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -141.96 149.21 20.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 1.5 ptt180 -102.84 -173.19 2.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -1.149 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.778 ' HB2' HG11 ' A' ' 27' ' ' VAL . 14.6 p80 -136.64 133.54 36.35 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.259 0.552 . . . . 0.0 110.423 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -56.48 120.39 7.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.268 -179.853 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.09 71.62 0.32 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -88.43 -13.08 41.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -1.1 . . . . 0.0 110.172 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.633 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -120.02 -142.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.97 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -153.03 -39.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.606 179.765 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 5.1 p90 -128.93 79.56 1.92 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.194 -0.941 . . . . 0.0 109.935 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.6 m-85 -52.03 -29.77 22.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 110.779 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.546 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 69.66 -77.08 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.352 -0.843 . . . . 0.0 112.22 178.803 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 1.9 t70 -165.06 160.24 18.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.789 -1.195 . . . . 0.0 110.282 -179.083 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 63.18 16.67 58.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 33.0 m -95.69 173.9 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -1.009 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 43' ' ' VAL . 40.5 t -154.22 153.84 7.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.706 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 14' ' ' HIS . 17.0 t -139.06 111.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.348 -179.437 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -67.3 105.29 1.72 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.295 -1.362 . . . . 0.0 107.783 178.248 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.625 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.19 109.0 3.36 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.442 -0.786 . . . . 0.0 110.147 -178.195 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.491 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -69.24 152.94 44.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.074 -1.016 . . . . 0.0 109.448 179.519 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.6 m -121.01 160.42 23.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.697 -179.37 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -44.69 164.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.366 -0.834 . . . . 0.0 109.972 179.779 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -67.39 86.59 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.59 1.9 5.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 2.6 m-30 -94.04 128.82 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -1.201 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.602 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -76.86 134.49 39.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 110.518 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -89.73 106.16 18.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.428 179.214 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.842 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.83 146.41 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.376 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.75 -172.47 17.46 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.72 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.49 142.81 47.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 109.888 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 28' ' ' THR . 58.5 p -77.92 52.25 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.604 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 149.14 115.29 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -48.78 173.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.56 -1.256 . . . . 0.0 107.732 179.181 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.01 94.94 2.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.777 178.846 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.3 OUTLIER -80.32 105.75 11.82 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.998 178.847 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.2 95.87 3.63 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.271 -179.371 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.96 19.96 5.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.436 ' C ' ' HG3' ' A' ' 49' ' ' GLU . . . 83.35 13.02 77.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 48' ' ' GLY . 47.2 mt-10 -145.96 138.61 25.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.161 . . . . 0.0 110.262 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 94.8 m95 -80.79 143.3 32.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -142.62 160.2 40.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -0.984 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.504 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.5 t0 58.3 65.44 3.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 111.448 179.465 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -91.16 134.19 1.67 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.385 1.729 . . . . 0.0 109.754 178.877 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -81.29 174.05 11.06 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.72 1.379 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.1 p -115.28 140.9 48.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 111.506 -178.635 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 10' ' ' SER . 62.9 m -105.46 76.77 1.23 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.08 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.15 177.65 4.64 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.457 0.646 . . . . 0.0 110.614 -178.292 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -92.0 148.68 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.589 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 13.0 m -129.15 47.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.821 -178.118 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 4.9 mmtt -85.43 160.83 19.64 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.032 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 108' ' ' THR . 65.4 m -135.6 166.3 29.6 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.216 -1.553 . . . . 0.0 113.019 -178.268 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 39.0 Cg_endo -66.94 -87.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.828 1.962 . . . . 0.0 110.386 179.158 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 132.42 1.79 Allowed Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.7 Cg_endo -75.84 65.06 6.81 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 123.825 1.434 . . . . 0.0 108.995 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -83.42 164.32 20.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.664 -0.648 . . . . 0.0 110.877 -179.058 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -164.17 164.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 179.725 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 32.8 t -73.88 106.17 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.514 -0.741 . . . . 0.0 110.848 -179.563 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.548 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 19.0 m-20 42.37 27.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.918 179.315 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.78 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -134.71 33.05 2.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.568 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 7.9 p90 -45.05 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.65 1.214 . . . . 0.0 112.275 -179.439 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.02 160.53 16.75 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.667 179.766 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.509 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 3.0 t -134.43 30.89 3.49 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.942 . . . . 0.0 109.823 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.5 t -103.66 -81.39 0.51 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -179.556 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.8 85.9 0.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.602 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.65 166.02 12.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -1.06 . . . . 0.0 109.684 179.705 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 4.0 tttt -162.41 158.51 24.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 -179.753 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -50.92 -33.41 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 0.0 109.888 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 6.6 p -136.57 173.33 11.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 0.0 109.927 179.682 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.602 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 52.8 m-85 -144.13 -171.69 3.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.2 p -146.2 -157.7 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.248 -0.907 . . . . 0.0 110.624 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.629 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -83.99 61.22 6.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.534 -1.354 . . . . 0.0 110.352 -179.759 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.631 ' HA ' HG21 ' A' ' 102' ' ' THR . 2.1 m-80 162.17 -16.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.986 -1.071 . . . . 0.0 111.518 179.516 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 38.9 m-20 -58.2 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.962 -1.086 . . . . 0.0 108.613 179.232 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p30 -76.78 145.19 38.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.552 -0.717 . . . . 0.0 111.294 -178.134 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.677 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 11.9 m -133.78 116.41 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 178.665 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -80.06 135.37 36.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.777 ' CE1' HD12 ' A' ' 71' ' ' LEU . 49.5 m-85 -92.93 138.72 31.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.893 -1.129 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 0.2 OUTLIER -113.79 92.97 4.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.89 -179.657 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 132.42 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 110.233 -179.731 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.45 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.805 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.7 t80 -157.96 128.89 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 62.24 57.15 18.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 35.6 m-85 -162.12 147.9 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.996 . . . . 0.0 109.982 -179.384 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 117' ' ' VAL . 10.8 mttm -101.85 152.62 20.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.816 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -94.05 87.5 5.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.554 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.649 ' HB2' HG21 ' A' ' 117' ' ' VAL . 11.2 t -71.68 107.72 4.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.057 -1.027 . . . . 0.0 109.609 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.44 -78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.697 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -172.46 116.21 0.33 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.344 -1.092 . . . . 0.0 110.62 -179.693 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.5 p -68.6 -11.91 60.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.5 p -134.3 140.59 46.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.873 -1.142 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.0 m -154.77 162.9 40.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 -179.459 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 82' ' ' ASN . 5.2 m -136.42 138.31 41.39 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.3 0.572 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.565 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 1.9 t -43.58 -28.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.416 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER 64.2 165.99 0.11 Allowed Pre-proline 0 C--N 1.293 -1.88 0 CA-C-O 121.391 0.615 . . . . 0.0 112.031 178.321 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.842 ' CB ' HD12 ' A' ' 38' ' ' ILE . 50.6 Cg_endo -81.96 4.4 7.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.636 1.861 . . . . 0.0 111.1 -179.026 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -103.51 2.64 46.17 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.594 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.816 ' O ' HG23 ' A' ' 108' ' ' THR . 17.0 m-80 73.68 48.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.885 -0.774 . . . . 0.0 110.743 179.825 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -166.44 150.71 7.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 110.864 178.805 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.677 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 58.2 m95 -71.79 88.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.709 0.766 . . . . 0.0 110.959 -179.336 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.4 mmtp -104.02 132.51 20.94 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.729 -0.607 . . . . 0.0 109.559 179.633 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.2 Cg_endo -72.55 167.78 76.8 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.859 -2.142 . . . . 0.0 110.52 0.377 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.6 mp0 -43.1 149.83 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.214 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.744 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -55.13 151.57 17.0 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.264 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.679 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.4 Cg_endo -73.57 169.47 22.25 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 O-C-N 124.299 1.684 . . . . 0.0 110.868 -179.868 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.533 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -126.77 110.14 12.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.24 -0.912 . . . . 0.0 110.475 -179.779 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -66.3 73.81 0.08 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.817 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 96' ' ' SER . 1.2 m -84.09 -175.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.845 0.831 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.582 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 8.2 ptt85 . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.4 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.324 0.583 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -133.17 174.58 10.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 179.685 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.548 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -142.3 85.71 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.936 -179.952 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HG2' ' CE1' ' A' ' 20' ' ' PHE . 76.0 mt-30 -63.05 177.74 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.903 -1.123 . . . . 0.0 109.71 179.803 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 4' ' ' GLN . 3.6 p -43.28 145.87 0.95 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 0.0 109.74 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.829 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.2 Cg_endo -69.84 170.88 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.713 -179.541 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.84 171.75 13.97 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.011 1.532 . . . . 0.0 109.523 178.895 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.02 97.69 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.246 -179.937 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.598 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.31 -175.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 0.0 110.918 -179.779 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -101.85 140.26 36.38 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.546 179.909 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t-20 71.39 8.76 6.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.708 179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -160.13 -179.46 34.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.836 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -132.68 -166.85 1.81 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.364 -1.08 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 17.0 p80 -155.59 -163.38 1.5 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.768 179.968 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 4.6 t-20 65.33 -141.17 0.21 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.02 -67.09 0.41 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -120.09 -4.67 10.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 109.572 179.536 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 26.9 mt-10 -106.68 -174.86 2.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.791 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 169.06 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.07 -1.019 . . . . 0.0 111.153 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.514 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -139.04 67.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 111.396 -179.055 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 3.1 m-85 -75.26 174.58 9.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 108.999 178.56 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.548 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 36.4 p -137.87 -57.34 0.67 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.756 -1.215 . . . . 0.0 111.356 -178.901 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.04 130.15 0.77 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.185 -0.947 . . . . 0.0 110.083 -179.169 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.77 22.39 61.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.471 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.641 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 28.0 m -111.33 168.87 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -1.026 . . . . 0.0 110.049 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 43' ' ' VAL . 21.8 t -140.77 148.22 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 112.205 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.829 HG11 ' HG3' ' A' ' 6' ' ' PRO . 28.8 t -116.3 122.84 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.561 -0.712 . . . . 0.0 111.662 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.83 102.66 7.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.478 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.6 m-30 -68.11 149.87 49.08 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.256 -178.098 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -95.47 152.75 18.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 179.427 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' SG ' HD12 ' A' ' 37' ' ' LEU . 86.0 m -125.63 146.6 49.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 0.0 110.393 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.2 145.66 25.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.231 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.7 p -56.05 110.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.33 -4.62 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.737 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 58' ' ' ILE . 8.9 m-85 -124.42 155.88 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.268 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.657 ' HB3' HG11 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -101.29 149.9 23.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.242 179.659 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.581 ' C ' HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -88.25 108.59 19.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.451 -0.78 . . . . 0.0 109.511 179.242 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.7 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -100.55 143.97 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.175 -179.856 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.68 -156.26 22.37 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 m-20 -93.26 55.49 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.325 . . . . 0.0 109.774 179.497 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 40' ' ' ASN . 53.1 p 30.07 47.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.484 179.636 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.66 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 143.7 136.34 3.1 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.551 179.671 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.858 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.8 t -65.36 179.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.206 -1.173 . . . . 0.0 108.067 178.706 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.6 tp -143.25 95.19 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.669 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -80.57 113.23 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 109.048 178.774 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.11 112.26 18.01 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.265 -179.553 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.23 58.79 8.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.458 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 49.54 53.96 18.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.38 95.23 1.01 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -1.112 . . . . 0.0 110.59 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.734 ' CH2' HG23 ' A' ' 27' ' ' VAL . 74.3 m95 -65.88 133.52 51.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 52' ' ' ASP . 15.9 m -142.7 177.25 8.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.698 -179.37 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 3.2 p30 36.15 71.25 0.93 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.969 -0.457 . . . . 0.0 111.874 179.651 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.23 138.13 3.25 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.05 1.552 . . . . 0.0 109.515 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.52 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 46.4 Cg_endo -73.36 176.95 8.53 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.79 1.416 . . . . 0.0 110.644 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 8.8 p -121.86 157.53 30.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 111.54 -178.679 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 94.1 m -116.68 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.823 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -118.03 -156.96 0.66 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.204 -178.454 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.543 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -108.78 152.86 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.856 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 36' ' ' SER . 26.3 m -137.39 48.29 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 111.115 -178.981 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mttt -90.63 173.45 8.04 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.49 178.7 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 47.8 m -132.65 167.16 24.09 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.479 -1.388 . . . . 0.0 112.333 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.2 Cg_endo -76.19 -53.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.747 1.919 . . . . 0.0 109.909 178.94 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 162.95 125.37 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.946 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 45.6 Cg_endo -75.08 59.78 5.33 Favored 'Trans proline' 0 C--N 1.292 -2.403 0 O-C-N 123.69 1.363 . . . . 0.0 110.554 -178.906 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.747 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -78.62 -171.79 2.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.465 -0.772 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER 178.25 168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.643 179.356 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.509 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -71.79 102.84 2.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.499 -0.75 . . . . 0.0 110.83 -179.638 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 0.8 OUTLIER 40.05 43.99 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.456 -0.778 . . . . 0.0 110.858 179.458 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.902 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -155.02 35.26 0.66 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.621 ' O ' ' O ' ' A' ' 69' ' ' GLY . 15.6 p90 -42.49 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 123.409 1.576 . . . . 0.0 114.188 -179.325 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.859 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -149.34 136.53 19.91 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -175.491 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t -121.8 27.39 8.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 109.775 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -69.83 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 111.39 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -124.03 -73.45 0.25 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.879 -178.823 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' HB2' HD13 ' A' ' 71' ' ' LEU . 22.8 t80 58.44 163.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -1.012 . . . . 0.0 109.973 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.571 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 8.0 tttm -178.94 140.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.455 -0.778 . . . . 0.0 110.059 179.731 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -42.74 -36.01 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 179.67 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 2.6 p -125.88 166.27 17.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.676 . . . . 0.0 109.75 179.369 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 74.0 m-85 -141.07 -168.9 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.9 m -155.54 -158.54 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -69.38 2.94 2.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.349 -1.47 . . . . 0.0 111.19 -179.057 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.797 ' O ' HG22 ' A' ' 102' ' ' THR . 8.8 p30 -139.21 -111.53 0.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.781 -1.199 . . . . 0.0 110.266 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 50.88 65.69 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.849 -1.157 . . . . 0.0 109.623 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.889 ' CA ' HG23 ' A' ' 102' ' ' THR . 18.8 p-10 -69.4 110.86 4.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.797 HG23 ' CE1' ' A' ' 87' ' ' PHE . 26.0 m -97.26 121.85 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.862 -1.149 . . . . 0.0 111.204 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -78.05 138.79 38.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.204 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.797 ' CE1' HG23 ' A' ' 85' ' ' VAL . 24.4 m-85 -98.64 145.54 26.76 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.986 -1.072 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.82 96.81 5.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.648 -0.658 . . . . 0.0 110.093 -179.708 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.605 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -46.46 134.5 9.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -41.14 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.338 -0.851 . . . . 0.0 110.241 -179.855 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -160.74 124.78 3.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 69.27 53.84 16.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.675 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 51.6 m-85 -160.68 152.21 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -1.022 . . . . 0.0 109.892 -179.249 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -107.27 136.78 46.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.012 . . . . 0.0 109.963 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.605 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -75.65 89.82 2.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.075 -179.875 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.4 t -74.74 101.86 4.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -0.905 . . . . 0.0 110.285 -179.999 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.06 -64.79 0.44 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.568 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 177.35 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -1.105 . . . . 0.0 110.377 -179.606 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.8 p -68.94 -3.94 14.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.943 . . . . 0.0 110.743 -179.564 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 64.5 p -140.13 93.76 2.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.555 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 19.5 m -104.04 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 110.991 -179.411 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.889 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.98 137.76 23.78 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.929 -0.709 . . . . 0.0 110.455 -179.614 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.61 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 49.2 t -56.74 107.28 0.38 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -0.778 . . . . 0.0 109.461 179.642 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.5 175.1 4.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.556 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.65 ' CB ' HG12 ' A' ' 59' ' ' VAL . 41.2 Cg_endo -77.45 167.19 24.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.857 1.451 . . . . 0.0 111.584 -179.166 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 89.93 -58.72 3.62 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 -178.545 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.621 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 3.5 m-20 147.13 71.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 122.271 0.228 . . . . 0.0 111.123 178.537 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -169.78 166.95 9.55 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.314 -1.491 . . . . 0.0 112.536 179.236 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 24.2 m95 -101.55 92.09 4.74 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 179.564 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.556 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 16.2 mttt -101.03 142.59 24.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.222 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.568 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.4 Cg_endo -71.0 168.97 70.64 Favored 'Cis proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.706 -0.849 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -39.8 129.96 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.544 -0.723 . . . . 0.0 110.847 -179.6 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -39.7 147.07 0.34 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 0.0 110.422 179.385 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.817 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.5 Cg_endo -70.35 166.7 27.45 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.398 1.736 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HG2' HG13 ' A' ' 117' ' ' VAL . 4.7 ttpt -127.29 107.83 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.463 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.9 t -64.4 90.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.077 -1.015 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.858 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -103.77 -175.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.904 0.859 . . . . 0.0 110.821 -179.414 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.928 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.448 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.228 0.537 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.79 176.79 7.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 4.1 t -159.37 101.25 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.217 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.6 mt-30 -87.46 -177.59 5.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -39.69 141.05 0.77 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 -179.766 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 49.9 Cg_endo -71.32 159.89 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.095 1.576 . . . . 0.0 111.228 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.6 170.91 19.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.102 1.58 . . . . 0.0 109.898 179.371 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -73.26 174.4 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.45 -170.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.219 1.009 . . . . 0.0 111.559 179.631 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -38.62 94.1 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.986 -179.138 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.2 m120 41.39 30.83 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -132.16 150.44 19.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.936 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 30' ' ' SER . 3.8 mtt180 -96.36 -170.87 2.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -1.075 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -147.16 120.09 8.74 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.228 0.537 . . . . 0.0 109.965 -179.738 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -123.46 109.53 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.748 -179.552 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' CA ' ' OH ' ' A' ' 21' ' ' TYR . . . -101.5 -5.47 51.77 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.463 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 68.44 24.2 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.279 -1.13 . . . . 0.0 110.375 179.975 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 3.8 pt-20 -160.57 -160.56 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 19' ' ' ASP . 5.7 t0 -131.83 -27.41 1.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.073 -1.017 . . . . 0.0 110.714 -179.586 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 9.9 m-85 -119.88 134.88 55.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.78 -179.63 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -124.08 -13.93 7.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.459 -0.776 . . . . 0.0 110.204 179.882 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.557 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . 47.6 p 45.95 -98.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.554 -0.716 . . . . 0.0 111.68 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -143.7 156.82 44.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 110.438 -178.443 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 70.13 16.25 72.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.086 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -94.29 174.9 6.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.624 -0.927 . . . . 0.0 110.328 -179.7 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 43' ' ' VAL . 37.9 t -154.21 153.22 8.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.048 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' VAL . 41.5 t -139.65 123.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.66 -179.433 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.56 101.9 3.71 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.247 . . . . 0.0 107.78 177.899 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.045 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.03 134.24 50.34 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.308 -178.208 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.01 163.09 15.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.914 179.606 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.614 ' SG ' HD12 ' A' ' 37' ' ' LEU . 70.9 m -127.36 159.25 35.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 110.175 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.92 154.85 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.894 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 100.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.74 8.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.9 m-30 -110.01 158.66 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -1.177 . . . . 0.0 110.005 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' SER . . . . . 1.042 ' OG ' HG22 ' A' ' 59' ' ' VAL . 24.3 m -103.71 130.39 51.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.389 -0.819 . . . . 0.0 110.677 -179.337 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.2 tp -83.0 117.71 23.0 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.237 179.132 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.59 HG23 ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -115.97 143.77 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.31 -168.02 12.8 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.561 -1.815 . . . . 0.0 108.561 -179.0 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 30.5 p-10 -66.37 130.76 44.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.968 -1.313 . . . . 0.0 109.496 179.476 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 28' ' ' THR . 30.2 p -70.01 57.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.992 . . . . 0.0 109.511 179.767 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.601 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.92 117.34 0.57 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.491 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.045 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -61.19 -176.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.95 -1.323 . . . . 0.0 107.848 179.248 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.606 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.9 tp -144.47 102.29 3.81 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.318 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -86.15 111.91 20.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.363 -0.835 . . . . 0.0 109.656 179.423 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 88.39 2.93 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.43 50.52 3.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 57.27 25.07 53.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' TRP . 2.3 tt0 -125.8 71.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.606 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 72.9 m95 -45.84 129.67 9.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -144.1 173.4 11.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.996 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 53.29 65.1 6.11 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 110.884 -179.949 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.6 Cg_endo -91.53 135.63 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.444 1.76 . . . . 0.0 110.096 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 50.5 Cg_endo -79.91 -173.56 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.739 1.389 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -120.13 -172.01 2.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.963 0.887 . . . . 0.0 111.564 -178.833 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 95.9 m -152.05 80.91 1.26 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.663 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 5.2 mm100 -111.41 -139.8 0.38 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.413 0.625 . . . . 0.0 110.912 -177.747 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.465 HG13 ' C ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -137.57 106.55 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.848 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.042 HG22 ' OG ' ' A' ' 36' ' ' SER . 26.8 m -105.51 64.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.153 -0.967 . . . . 0.0 112.526 -178.224 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 14.8 mttt -67.49 -175.69 0.53 Allowed 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 117.531 -1.668 . . . . 0.0 107.624 178.072 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.64 163.59 35.43 Favored Pre-proline 0 C--N 1.296 -1.741 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.597 -178.085 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -86.91 -83.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.92 2.011 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 175.14 130.75 0.14 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.611 -0.681 . . . . 0.0 109.298 -179.433 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.736 ' HG2' HD21 ' A' ' 71' ' ' LEU . 49.8 Cg_endo -80.02 64.06 8.82 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 O-C-N 123.739 1.389 . . . . 0.0 109.896 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.6 ' C ' HG22 ' A' ' 66' ' ' ILE . 5.4 p -77.05 175.65 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.813 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.0 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.84 168.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 118.522 -1.271 . . . . 0.0 110.7 179.307 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.491 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.69 100.32 3.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.527 -0.733 . . . . 0.0 110.691 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 35.1 m-20 42.41 48.15 4.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.0 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -160.28 37.81 0.45 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 54.3 p90 -50.2 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.952 1.358 . . . . 0.0 112.922 -179.783 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.065 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -142.84 127.03 17.52 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.736 -176.562 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -109.14 19.22 19.72 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 110.192 -179.318 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 31.3 t -84.17 -88.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.906 -179.47 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -101.03 -71.91 0.96 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.279 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 51.1 t80 57.04 170.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -1.07 . . . . 0.0 109.665 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.635 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 174.23 130.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 179.932 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 76' ' ' LYS . 9.4 mtt180 -40.76 -32.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.797 . . . . 0.0 110.027 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.84 126.24 20.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 11.2 m-85 -106.11 -151.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 179.977 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 59.9 p -159.85 -126.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.944 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.985 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -102.07 33.63 3.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.987 -1.071 . . . . 0.0 110.84 -179.243 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.753 ' C ' HG22 ' A' ' 102' ' ' THR . 17.9 t-20 -172.29 -112.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.093 -1.005 . . . . 0.0 110.367 179.007 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 t0 47.39 75.06 0.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.641 -1.287 . . . . 0.0 109.162 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.715 ' CA ' HG23 ' A' ' 102' ' ' THR . 12.7 p-10 -69.62 112.69 6.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.576 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.592 ' CG2' HD22 ' A' ' 71' ' ' LEU . 31.4 m -98.15 121.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.983 -1.073 . . . . 0.0 111.17 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -80.12 139.58 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.395 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 1.065 ' CE2' HD23 ' A' ' 71' ' ' LEU . 65.3 m-85 -95.5 146.52 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.811 -1.181 . . . . 0.0 112.396 -178.205 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.73 91.55 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.367 179.695 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.519 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 135.28 3.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.928 . . . . 0.0 109.957 -179.551 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 6.8 mmmt -39.63 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 110.687 -179.545 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.6 t80 -168.68 130.81 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.297 -0.877 . . . . 0.0 110.358 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.18 53.43 46.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 25.2 m-85 -158.77 150.47 20.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -1.013 . . . . 0.0 109.959 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -102.95 154.59 19.07 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.401 -0.812 . . . . 0.0 109.038 179.362 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.587 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -93.93 96.26 9.6 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 110.499 -179.447 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.13 101.82 4.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 109.646 179.526 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.53 -77.17 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -171.59 114.43 0.37 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 110.896 -179.632 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 m -71.34 -2.45 16.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.231 -0.918 . . . . 0.0 110.481 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -143.33 113.83 7.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.111 179.773 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 27.3 m -126.0 160.16 30.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.753 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.6 139.53 50.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.582 0.706 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.51 84.36 1.52 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.485 -0.76 . . . . 0.0 110.107 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -62.95 173.99 0.95 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.985 -179.55 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.757 ' HB3' HG11 ' A' ' 59' ' ' VAL . 42.8 Cg_endo -73.34 123.46 8.73 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.391 1.732 . . . . 0.0 110.104 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.58 -9.31 4.96 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -178.904 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' HG23 ' A' ' 108' ' ' THR . 4.6 m-20 80.71 89.35 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.909 -0.76 . . . . 0.0 110.295 179.701 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.06 -160.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.281 -0.887 . . . . 0.0 110.933 179.85 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.644 ' HB3' HD11 ' A' ' 113' ' ' LEU . 30.4 m95 -145.84 86.09 1.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.608 0.718 . . . . 0.0 109.712 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 21.0 mttt -99.77 139.05 20.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.705 . . . . 0.0 110.255 -179.349 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.9 Cg_endo -71.34 166.51 77.83 Favored 'Cis proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.009 -2.079 . . . . 0.0 110.781 -0.127 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.2 mp0 -40.37 137.81 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.539 -0.725 . . . . 0.0 110.644 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.788 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -43.52 155.98 0.29 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 179.744 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.695 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.8 Cg_endo -80.06 169.48 17.66 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 124.397 1.735 . . . . 0.0 111.074 -179.609 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.554 ' O ' HG22 ' A' ' 117' ' ' VAL . 6.8 tttt -127.35 111.12 13.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.532 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -67.67 98.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.117 -0.989 . . . . 0.0 109.425 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -112.76 -176.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.736 0.779 . . . . 0.0 110.507 -179.627 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 9.0 ptt85 . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.451 179.63 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.26 0.552 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -122.19 162.6 21.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.581 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -143.33 78.38 1.6 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.22 179.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -51.91 145.44 17.15 Favored Pre-proline 0 C--N 1.3 -1.559 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.76 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.683 ' HG3' HG11 ' A' ' 27' ' ' VAL . 54.7 Cg_endo -73.99 159.86 43.99 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.896 1.472 . . . . 0.0 110.117 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.93 170.0 19.91 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.661 1.348 . . . . 0.0 109.997 179.284 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 p -88.82 105.06 17.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.983 . . . . 0.0 110.365 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.601 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -56.29 -170.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.03 0.919 . . . . 0.0 111.289 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.13 138.15 31.74 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.424 -178.846 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 56' ' ' CYS . 67.9 m-20 49.05 20.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.48 -0.763 . . . . 0.0 110.931 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.2 157.66 27.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.437 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 mpt_? -118.23 -166.33 1.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -1.19 . . . . 0.0 111.059 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.5 p80 -151.22 131.55 13.69 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.614 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -155.34 -145.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 110.751 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . 129.4 4.89 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 7.7 t80 70.96 24.31 4.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.163 -1.198 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' CG ' ' HE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -126.12 168.9 13.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.068 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.24 -31.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 110.515 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.25 139.06 52.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.08 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.661 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.2 m-85 -123.03 -7.08 8.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 110.985 -179.624 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.581 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.8 p 43.3 -96.61 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 111.405 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 17.4 t0 -153.52 138.49 17.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.953 -1.092 . . . . 0.0 110.363 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.49 37.4 8.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.661 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 66.4 m -135.17 161.33 35.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.261 -1.141 . . . . 0.0 109.951 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.3 t -134.19 147.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.0 112.28 -178.141 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 43' ' ' VAL . 32.3 t -117.95 119.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.725 -0.609 . . . . 0.0 111.743 -179.523 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.4 102.95 3.9 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.78 -1.168 . . . . 0.0 107.897 177.641 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.874 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.12 126.72 30.41 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.419 -0.8 . . . . 0.0 109.848 -178.515 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.63 163.62 25.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.0 -1.063 . . . . 0.0 109.36 179.467 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.44 49.44 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.051 -1.03 . . . . 0.0 110.433 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.62 143.34 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -62.55 106.17 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.74 -11.51 6.28 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CE2' HG13 ' A' ' 58' ' ' ILE . 3.9 m-85 -114.06 146.31 40.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.149 -1.206 . . . . 0.0 110.629 -179.617 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.715 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -84.17 142.27 30.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -0.911 . . . . 0.0 110.753 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.5 OUTLIER -98.61 95.01 6.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.535 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.781 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -81.16 152.1 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.785 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 127.92 -146.54 16.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 41' ' ' SER . 36.4 m-80 -120.73 53.26 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 110.128 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 28' ' ' THR . 71.3 p 28.03 48.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.774 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 156.94 125.49 0.87 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.673 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.895 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.0 t -71.48 179.45 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.502 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.86 92.61 2.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.648 -1.282 . . . . 0.0 111.247 179.55 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.598 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -79.47 106.97 11.88 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.407 178.125 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.522 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -135.11 103.51 5.58 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.226 -179.054 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.77 11.25 35.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.5 19.07 60.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' TRP . 9.1 mt-10 -139.16 91.4 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -1.153 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.607 ' CH2' HG23 ' A' ' 27' ' ' VAL . 70.7 m95 -43.3 135.88 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 p -147.64 166.29 27.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 111.048 -179.707 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 57.3 64.35 4.35 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.603 -0.686 . . . . 0.0 111.285 179.837 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.9 Cg_endo -92.72 145.65 2.55 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.992 1.795 . . . . 0.0 110.086 179.084 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 52.9 Cg_endo -84.28 176.79 6.29 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.7 1.369 . . . . 0.0 109.949 179.245 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.63 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 27.3 p -130.21 141.88 50.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 111.54 -179.53 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -100.51 88.52 3.66 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.584 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 51.6 mm-40 -120.36 -165.57 1.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.424 -178.314 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.723 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -115.4 104.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.04 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 81' ' ' TYR . 13.0 m -92.97 47.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 111.801 -178.199 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -88.65 97.7 11.26 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.345 178.586 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 36.0 m -69.55 162.51 66.55 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 112.12 -178.004 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 45.4 Cg_endo -71.61 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.651 1.869 . . . . 0.0 110.762 -179.73 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.42 ' CA ' ' HE1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -161.58 133.65 4.19 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.705 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.673 ' HA ' HD21 ' A' ' 113' ' ' LEU . 50.3 Cg_endo -78.01 65.26 8.34 Favored 'Trans proline' 0 C--N 1.293 -2.35 0 O-C-N 123.674 1.355 . . . . 0.0 109.784 -179.329 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.591 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -83.08 171.95 13.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.608 -0.682 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.67 166.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.522 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.45 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -75.28 109.94 9.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.534 -0.729 . . . . 0.0 111.0 -179.254 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.6 m-80 38.63 34.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.765 . . . . 0.0 110.844 179.299 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.771 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -143.68 30.36 1.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.58 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.3 p90 -45.66 -171.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.718 1.247 . . . . 0.0 112.479 -179.612 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.829 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.4 157.97 24.24 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.794 178.792 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.75 26.52 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.082 -179.181 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -73.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.669 -179.586 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.43 75.97 0.41 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.5 t80 -104.36 165.72 10.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.585 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -163.16 162.88 25.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -56.76 -35.86 69.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.92 179.936 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -139.83 167.35 22.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.988 179.698 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.555 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.0 m-85 -138.51 -173.93 3.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.735 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.8 m -169.39 106.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 111.283 -179.75 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.776 ' CB ' HG21 ' A' ' 59' ' ' VAL . 3.2 t80 46.31 15.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.154 -0.966 . . . . 0.0 112.686 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.721 ' C ' HG22 ' A' ' 102' ' ' THR . 17.1 t-20 -175.84 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 119.926 -1.734 . . . . 0.0 111.987 178.308 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 8.3 m-20 49.63 76.87 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.671 -1.268 . . . . 0.0 108.747 -178.027 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.646 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.5 p-10 -69.2 135.42 50.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 0.0 111.109 -178.689 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 64' ' ' PRO . 10.8 m -115.81 120.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.519 179.11 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t0 -85.15 130.71 34.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 108.651 179.436 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.829 ' CE1' HD12 ' A' ' 71' ' ' LEU . 67.6 m-85 -89.87 129.52 36.23 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.291 1.043 . . . . 0.0 112.567 -177.88 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -104.43 91.64 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.48 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.544 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -45.27 127.38 7.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.957 -1.09 . . . . 0.0 109.59 -179.736 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 15.8 mmtp -37.27 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.687 -0.633 . . . . 0.0 110.787 -179.097 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.586 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 17.6 t80 -158.99 136.12 9.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.544 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.67 44.68 97.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 28.3 m-85 -154.56 150.86 28.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.503 -0.998 . . . . 0.0 109.846 -179.338 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HG3' HG23 ' A' ' 117' ' ' VAL . 18.1 ptpt -116.98 126.46 52.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.674 179.529 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -56.69 112.95 1.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.758 -179.255 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.579 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -89.51 94.79 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.525 179.287 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.85 -39.17 1.42 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.4 OUTLIER 172.55 -178.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.155 -1.203 . . . . 0.0 111.037 -179.65 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 51.7 p -141.76 10.39 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 0.0 109.967 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -169.53 113.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.491 -0.755 . . . . 0.0 109.107 179.831 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.471 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 29.8 m -124.75 162.4 24.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.225 -0.922 . . . . 0.0 111.048 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.721 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.13 142.26 50.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 3.0 t -60.92 83.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.645 -0.66 . . . . 0.0 109.3 179.468 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.94 170.33 8.89 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.0 110.867 -179.245 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.773 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.0 Cg_endo -73.77 127.54 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.176 1.619 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.57 -11.43 5.75 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -179.055 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.7 m120 82.0 76.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.068 -0.666 . . . . 0.0 110.39 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -169.87 -158.81 0.19 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.517 -0.739 . . . . 0.0 110.786 179.789 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.642 ' HB3' HD13 ' A' ' 113' ' ' LEU . 21.0 m95 -142.26 98.96 3.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.343 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 45.8 mttt -100.73 141.9 23.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 110.155 -179.597 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.548 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 49.2 Cg_endo -72.07 170.57 66.39 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.057 -2.059 . . . . 0.0 110.866 0.256 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.5 tt0 -40.28 125.8 2.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 110.114 179.853 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -41.08 141.32 1.02 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.431 -0.793 . . . . 0.0 110.032 -179.84 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.674 ' HG2' HD12 ' A' ' 66' ' ' ILE . 46.6 Cg_endo -80.26 166.87 20.1 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.467 1.772 . . . . 0.0 112.074 -178.38 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.66 ' HG2' HG13 ' A' ' 117' ' ' VAL . 11.0 ttpt -125.63 106.16 9.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.669 . . . . 0.0 109.977 179.53 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -58.7 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.016 . . . . 0.0 109.297 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.66 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.0 m -110.63 -171.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.936 0.874 . . . . 0.0 111.224 -179.438 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.216 0.532 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -115.55 161.97 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.559 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -131.43 81.93 2.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 110.57 -179.862 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.4 mt-30 -60.91 177.06 0.35 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.047 -1.033 . . . . 0.0 109.093 179.225 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.6 p -40.91 144.21 0.65 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 27' ' ' VAL . 44.4 Cg_endo -67.9 162.42 39.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.713 1.375 . . . . 0.0 110.893 -179.097 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.77 166.5 29.78 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.06 1.558 . . . . 0.0 110.118 179.702 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.04 176.07 5.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.179 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.597 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.25 -169.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.164 0.983 . . . . 0.0 111.544 179.934 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 11' ' ' ASN . 29.7 t -63.25 114.04 3.56 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.619 -178.665 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 10' ' ' SER . 3.1 m-80 37.32 41.99 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.664 -0.647 . . . . 0.0 111.266 179.127 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.41 154.86 25.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.575 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -109.56 -179.41 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -1.188 . . . . 0.0 110.777 -179.825 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.617 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.0 p80 -139.29 -154.89 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 12.5 t30 66.53 -170.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.105 -179.898 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.16 -4.76 18.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -32.48 2.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -1.194 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.574 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 179.16 -176.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 0.0 110.291 -179.972 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 5' ' ' SER . 9.9 t70 -103.96 -25.07 13.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.596 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.6 m-85 -105.71 -174.81 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -178.71 -25.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.422 179.655 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 7.6 p 59.55 -94.36 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.588 -0.695 . . . . 0.0 112.661 178.839 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -148.17 159.38 44.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.646 -1.283 . . . . 0.0 110.582 -178.078 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 13.28 57.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.603 -0.94 . . . . 0.0 110.123 -179.867 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.0 t -155.69 155.75 5.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.579 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.696 HG11 ' HG3' ' A' ' 6' ' ' PRO . 21.6 t -139.34 125.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.886 -179.487 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.76 103.9 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.601 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.702 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.2 m-30 -68.09 121.31 15.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -177.937 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -75.67 153.57 37.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.998 . . . . 0.0 109.127 178.904 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 37' ' ' LEU . 79.9 m -121.02 170.54 9.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.692 -179.285 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 34' ' ' GLY . 8.8 m-20 -62.94 137.26 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.887 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -46.96 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 110.324 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 123.32 17.04 3.34 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 13.6 m-85 -125.8 141.1 52.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 110.18 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.662 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -85.24 142.13 29.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.944 . . . . 0.0 110.967 -179.455 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.702 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.0 tp -89.61 98.1 11.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.424 -0.798 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.767 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -86.47 141.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.312 -179.764 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.63 -172.48 14.63 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.654 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -64.5 145.25 56.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.07 179.863 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -76.22 53.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.615 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.5 115.37 0.62 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -54.73 -178.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.004 -1.292 . . . . 0.0 107.853 178.831 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.4 tp -146.19 99.32 3.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 110.217 178.681 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.79 109.18 16.71 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.644 179.103 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.88 107.98 10.07 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.82 8.48 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.895 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . 60.92 38.75 95.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.859 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 25.0 mt-10 -151.04 88.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 110.798 -179.582 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 78.5 m95 -50.68 136.99 20.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.339 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.79 162.22 36.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.958 -1.089 . . . . 0.0 111.507 -179.325 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.9 t0 58.57 66.09 2.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.8 Cg_endo -90.94 126.55 1.14 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 O-C-N 124.394 1.734 . . . . 0.0 109.753 178.774 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -74.24 165.53 31.66 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.864 1.455 . . . . 0.0 110.252 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 66.1 p -105.52 150.91 24.92 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.12 -0.988 . . . . 0.0 111.215 -179.444 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 57' ' ' GLN . 77.0 m -111.72 82.18 1.57 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.77 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 3.1 mm100 -115.4 -150.7 0.47 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.713 0.768 . . . . 0.0 110.738 -177.817 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.803 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.78 125.86 71.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.691 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 36' ' ' SER . 31.0 m -115.68 50.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 0.0 112.08 -178.163 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 30.6 mttt -59.51 -173.31 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 117.739 -1.584 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.529 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -146.0 170.12 8.48 Favored Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.948 -178.724 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.529 ' HD2' ' SG ' ' A' ' 61' ' ' CYS . 45.3 Cg_endo -92.19 -72.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.396 2.064 . . . . 0.0 109.848 179.226 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.18 125.42 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.718 -0.614 . . . . 0.0 109.674 -179.636 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.599 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.6 Cg_endo -78.36 71.07 6.95 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 123.81 1.426 . . . . 0.0 110.172 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.685 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -89.91 171.69 9.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.925 179.915 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.804 HG21 ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -170.84 155.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.057 -1.027 . . . . 0.0 110.266 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 35.5 t -61.45 107.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.751 . . . . 0.0 111.014 -179.357 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 3.3 m-20 39.95 37.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 0.0 110.682 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.587 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -143.48 27.15 2.11 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' HG23 ' A' ' 66' ' ' ILE . 2.0 p90 -44.32 -174.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.737 1.256 . . . . 0.0 112.362 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.739 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.18 164.38 12.93 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.58 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -144.77 20.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 110.039 -179.626 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -103.02 -79.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 110.856 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.27 77.35 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -106.12 168.54 9.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.45 -1.029 . . . . 0.0 110.021 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -171.87 155.58 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 110.262 -179.851 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -52.07 -27.42 13.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.752 179.659 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.52 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 4.4 t -143.59 163.02 34.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.244 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.576 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 21.2 m-85 -137.35 -148.54 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 93.8 p -154.34 -113.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.813 -1.18 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -107.88 12.35 27.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.556 -1.34 . . . . 0.0 110.67 -178.922 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.788 ' C ' HG22 ' A' ' 102' ' ' THR . 30.9 t30 -162.25 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.808 -1.183 . . . . 0.0 110.179 179.471 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ASN . 31.8 t0 43.26 76.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.726 -1.234 . . . . 0.0 108.955 -179.48 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.843 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.3 p30 -68.35 126.96 31.23 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 110.664 -178.385 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG11 ' HG3' ' A' ' 64' ' ' PRO . 15.9 m -109.73 119.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.194 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 6.4 t0 -82.56 134.12 35.19 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.872 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.804 ' CD1' HG21 ' A' ' 66' ' ' ILE . 39.3 m-85 -92.5 131.8 37.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.956 -1.09 . . . . 0.0 112.252 -178.022 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.83 90.43 3.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.905 -179.944 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.548 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.26 129.46 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.65 179.984 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -38.14 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.521 -0.737 . . . . 0.0 110.637 -179.28 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -157.22 131.99 8.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.965 . . . . 0.0 110.157 179.911 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.21 56.08 27.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.635 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 24.5 m-85 -161.05 148.46 15.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.854 -179.356 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 6.5 tttm -106.25 138.9 41.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.906 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 66' ' ' ILE . 1.3 mt -76.02 93.5 3.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.409 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.536 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -69.84 100.32 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 0.0 109.666 179.6 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.24 -97.17 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.591 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 t -148.41 114.98 5.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -1.204 . . . . 0.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 90.7 p -72.87 0.48 10.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.934 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -145.63 100.13 3.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.91 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 85' ' ' VAL . 19.7 m -115.78 167.63 10.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.623 -179.566 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.843 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.38 144.15 44.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.557 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 10.2 t -75.95 89.31 2.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 110.253 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' CD ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -65.74 179.89 0.41 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 111.327 -179.622 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.739 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.3 Cg_endo -75.32 125.79 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.271 1.669 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.99 -1.83 13.25 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 108' ' ' THR . 7.0 m-80 78.31 96.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.813 -0.816 . . . . 0.0 110.835 179.68 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -175.82 -166.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.086 179.556 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.635 ' HB3' HD13 ' A' ' 113' ' ' LEU . 19.5 m95 -151.64 91.24 1.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.373 0.606 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -115.25 157.78 42.89 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.498 179.739 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.591 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 39.8 Cg_endo -70.8 171.8 56.31 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.01 -2.079 . . . . 0.0 111.85 0.379 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.2 pm0 -23.49 119.02 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.451 0.643 . . . . 0.0 112.624 -178.798 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.635 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.4 tp -45.82 137.28 5.95 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 109.014 178.585 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.607 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 42.8 Cg_endo -70.5 165.78 30.69 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 123.887 1.467 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.659 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -133.56 108.65 8.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -61.1 89.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.659 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.8 m -106.59 -167.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.839 0.828 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 7.7 mtm180 . . . . . 0 C--N 1.291 -1.969 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.293 0.568 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' A' ' 22' ' ' THR . 14.3 mttt -93.63 174.83 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.363 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -136.48 92.9 2.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.873 . . . . 0.0 110.212 179.844 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -67.47 170.8 6.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.297 179.518 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.45 143.45 1.11 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.847 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.862 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.9 Cg_endo -70.86 152.45 63.6 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.988 1.52 . . . . 0.0 110.741 -179.207 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.38 170.27 20.61 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.747 1.393 . . . . 0.0 109.865 179.416 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.68 176.3 3.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 109.813 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.684 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.54 -169.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 122.168 0.985 . . . . 0.0 111.498 179.838 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 7.9 t -40.62 92.66 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.536 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 9' ' ' ILE . 12.1 m120 42.63 45.94 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.49 178.42 19.99 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 180.0 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER -126.25 -169.33 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -1.202 . . . . 0.0 110.695 -179.915 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.613 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p80 -157.9 125.36 5.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.898 -0.502 . . . . 0.0 110.512 -179.41 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.39 -33.82 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 44.4 -122.43 4.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.59 -0.79 2.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -1.16 . . . . 0.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 7.4 pt-20 -164.12 -167.35 1.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.491 -179.811 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.28 19.31 2.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.88 . . . . 0.0 110.589 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.42 45.43 2.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.007 -1.058 . . . . 0.0 110.441 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 23.2 m-85 -58.26 179.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.642 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.562 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 2.2 p -147.14 -61.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 111.045 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -163.37 137.37 5.93 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.53 15.04 80.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.552 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.608 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.73 175.3 6.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.948 . . . . 0.0 109.543 179.81 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.8 t -149.22 154.11 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.993 -179.756 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.862 HG11 ' HG3' ' A' ' 6' ' ' PRO . 24.3 t -134.24 122.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.252 -179.739 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.33 103.31 4.67 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.315 -1.354 . . . . 0.0 108.015 177.805 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.991 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.45 176.57 2.79 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.763 -178.487 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.5 t -130.79 -177.15 4.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.839 179.616 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 91.0 m -147.72 135.38 20.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.0 109.616 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.472 ' O ' ' OG ' ' A' ' 33' ' ' SER . 6.5 m120 -99.52 -177.87 3.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 110.744 -179.527 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 6.0 p 44.76 56.77 4.99 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.707 0.765 . . . . 0.0 110.278 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 43.46 49.63 6.94 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 33' ' ' SER . 4.5 m-30 -102.4 131.78 48.83 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.915 -1.344 . . . . 0.0 111.164 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.831 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -74.59 138.52 43.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.742 -0.599 . . . . 0.0 110.679 -179.792 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.587 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.7 tt -89.44 109.66 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.128 -0.983 . . . . 0.0 109.453 178.986 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.815 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -103.02 143.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.468 -179.988 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.41 -141.1 11.41 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 41' ' ' SER . 27.6 t30 -111.42 52.39 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.239 . . . . 0.0 109.907 179.462 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.526 ' O ' HG23 ' A' ' 28' ' ' THR . 27.7 p 22.67 49.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.749 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 157.11 119.33 0.59 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.991 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.3 t -65.51 -179.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.254 . . . . 0.0 108.176 179.198 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.571 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -144.88 97.74 3.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.32 179.048 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.596 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 18.4 t -79.79 126.25 30.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.225 178.788 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.6 p -129.68 110.18 11.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.226 -179.865 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.35 22.51 62.56 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.91 8.11 76.64 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.921 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.8 114.59 22.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -1.174 . . . . 0.0 110.538 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.662 ' CH2' HG23 ' A' ' 27' ' ' VAL . 79.8 m95 -69.9 134.81 48.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.787 179.539 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.19 168.36 20.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 111.025 -179.716 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 15.6 t0 54.07 66.27 4.53 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.734 -0.604 . . . . 0.0 111.047 179.802 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -90.6 138.28 2.56 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.38 1.726 . . . . 0.0 110.154 179.349 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.2 Cg_endo -75.31 175.8 10.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.839 1.442 . . . . 0.0 110.591 179.938 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.8 p -111.23 -175.24 2.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.832 . . . . 0.0 111.359 -179.019 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 33.6 m -142.51 75.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.859 0.837 . . . . 0.0 108.803 178.839 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -108.6 -148.67 0.43 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.728 -179.146 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.808 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -125.99 121.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.049 . . . . 0.0 108.632 179.347 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 36' ' ' SER . 20.4 m -114.68 49.46 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.025 -1.047 . . . . 0.0 112.324 -178.197 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -60.55 -172.24 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 C-N-CA 117.779 -1.569 . . . . 0.0 107.519 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.497 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -147.95 166.73 15.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 117.84 -1.544 . . . . 0.0 113.979 -178.296 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.0 Cg_endo -87.84 -74.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 125.02 2.063 . . . . 0.0 110.618 179.551 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 166.12 125.4 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.074 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.891 ' HG2' HD21 ' A' ' 71' ' ' LEU . 48.1 Cg_endo -75.36 65.64 6.37 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.629 1.331 . . . . 0.0 109.455 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.576 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -82.48 175.93 9.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 110.311 -179.536 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.994 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -171.99 167.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 110.404 -179.623 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 46.5 p -72.81 100.39 2.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 110.55 -179.674 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 88.5 m-20 42.85 49.09 5.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.815 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.994 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -161.86 38.52 0.39 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.613 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 49.4 p90 -47.0 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.101 1.429 . . . . 0.0 113.141 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.919 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -139.06 127.18 22.51 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.682 -176.948 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.6 t -103.89 16.88 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.494 -0.754 . . . . 0.0 110.087 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.65 101.37 6.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.161 -0.962 . . . . 0.0 111.538 -179.008 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.673 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 71.84 103.42 0.06 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.93 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.643 ' CD2' HD11 ' A' ' 71' ' ' LEU . 7.8 t80 -156.92 154.11 29.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -1.085 . . . . 0.0 110.266 179.431 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 1.1 tttm -161.35 147.96 14.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' LYS . 29.8 mtm180 -42.47 -37.01 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.055 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -131.9 165.03 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 110.118 179.835 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 22.8 m-85 -137.04 -142.87 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.556 ' C ' HG23 ' A' ' 59' ' ' VAL . 55.6 p -156.48 -117.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.951 -1.093 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.22 11.65 32.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.752 -1.218 . . . . 0.0 111.845 -178.664 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.787 ' C ' HG22 ' A' ' 102' ' ' THR . 0.5 OUTLIER -163.64 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.642 -1.286 . . . . 0.0 110.72 178.938 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 82' ' ' ASN . 7.6 m-20 42.41 74.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.723 -1.236 . . . . 0.0 109.272 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.701 ' CA ' HG23 ' A' ' 102' ' ' THR . 47.4 t30 -68.82 121.91 17.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.614 -178.664 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 74' ' ' GLY . 29.0 m -106.44 123.14 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.844 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -80.24 139.34 36.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.336 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.675 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 32.0 m-85 -95.15 143.25 26.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 112.38 -177.997 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.37 98.18 6.6 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 -179.857 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.524 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -50.22 134.98 22.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.397 -179.639 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.39 -69.84 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.784 . . . . 0.0 110.402 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 23.5 t80 -172.19 141.71 1.3 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.304 -0.873 . . . . 0.0 110.391 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 47.71 15.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 11.1 m-85 -149.23 150.0 31.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -1.019 . . . . 0.0 109.803 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' VAL . 4.8 mtmt -103.3 143.37 32.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER -85.09 92.38 8.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 110.187 -179.956 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 105.02 10.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.3 -79.83 0.24 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.227 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.574 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 24.9 p -159.7 99.27 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -1.092 . . . . 0.0 110.922 -179.191 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.41 47.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.073 -1.017 . . . . 0.0 109.591 179.203 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 p -140.63 108.45 5.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.551 179.736 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 2.8 m -123.67 167.67 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.215 -0.928 . . . . 0.0 111.16 -179.238 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.787 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -134.48 145.19 48.58 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.782 0.801 . . . . 0.0 110.339 179.617 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -82.24 80.13 8.53 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.827 -0.546 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.528 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -58.4 -177.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 111.358 -179.212 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.815 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -77.37 125.42 7.71 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.386 1.73 . . . . 0.0 110.211 -179.707 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.26 -8.37 7.07 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.715 ' O ' HG23 ' A' ' 108' ' ' THR . 4.8 m-20 79.47 94.7 0.06 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.749 -0.853 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.49 -166.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.832 . . . . 0.0 111.092 179.445 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.669 ' HB3' HD11 ' A' ' 113' ' ' LEU . 38.0 m95 -144.04 87.69 1.92 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.539 0.685 . . . . 0.0 109.729 -179.845 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -100.26 140.81 21.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.658 -179.238 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.574 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.0 Cg_endo -74.83 170.93 70.31 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.555 -2.269 . . . . 0.0 110.039 -0.231 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 11.8 pt-20 -36.75 137.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.562 -0.712 . . . . 0.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.759 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -46.76 157.86 0.44 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.846 . . . . 0.0 109.799 179.511 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.77 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -79.95 165.51 21.87 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 124.206 1.635 . . . . 0.0 111.126 -179.715 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.729 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.0 ttmt -124.36 104.53 8.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.3 t -60.34 83.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.356 179.623 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.729 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.8 m -95.77 -175.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.87 0.843 . . . . 0.0 110.808 -179.6 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.556 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.81 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.442 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 1' ' ' VAL . . . . . 0.675 HG21 ' C ' ' A' ' 47' ' ' GLY . 9.6 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.231 0.539 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 20' ' ' PHE . 3.9 ttmt -132.88 172.13 13.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.367 -179.734 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.576 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 10.4 t -163.81 136.14 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 110.102 -179.918 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' SER . 6.5 pt20 -117.2 -176.71 3.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -40.3 142.38 0.74 Allowed Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.273 -179.999 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.795 ' HG3' HG11 ' A' ' 27' ' ' VAL . 55.4 Cg_endo -71.68 167.37 26.69 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 124.143 1.601 . . . . 0.0 110.647 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.03 171.86 15.01 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.797 1.419 . . . . 0.0 108.756 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -78.18 104.96 9.1 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.893 -1.13 . . . . 0.0 110.616 -179.563 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.824 HG21 ' CG ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -42.64 173.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.9 0.857 . . . . 0.0 110.012 -179.904 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' HG13 ' A' ' 9' ' ' ILE . 34.5 m -99.86 140.92 33.38 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.604 -1.238 . . . . 0.0 109.697 178.293 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 6.8 m120 63.37 17.06 10.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.731 -179.02 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -167.05 -164.52 22.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' SER . 7.2 mtp180 -140.39 -171.81 3.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -1.135 . . . . 0.0 110.566 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 7.9 p80 -148.11 133.34 18.41 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.812 -0.555 . . . . 0.0 110.37 -179.937 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 14' ' ' HIS . 3.1 m-20 -167.01 75.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -101.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.917 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -175.84 38.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -1.15 . . . . 0.0 109.793 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -154.48 -169.38 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.332 -179.665 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 -37.97 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.555 ' CE1' ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -111.72 118.75 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.652 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -104.36 -12.78 16.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 110.429 -179.741 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.548 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 p 45.45 -96.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.921 . . . . 0.0 111.867 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -148.47 154.01 39.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 0.0 110.115 -178.588 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.2 19.64 79.69 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.232 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.652 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 7.1 m -98.34 171.1 8.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.695 -0.885 . . . . 0.0 110.212 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 43' ' ' VAL . 38.9 t -147.87 155.29 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.176 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.795 HG11 ' HG3' ' A' ' 6' ' ' PRO . 13.1 t -134.12 111.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.639 -179.132 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 103.25 1.52 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.461 -1.296 . . . . 0.0 107.738 178.085 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.824 ' CG ' HG21 ' A' ' 9' ' ' ILE . 1.3 m-30 -68.02 -176.55 0.71 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.998 -178.435 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -133.99 155.3 50.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.291 179.057 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.1 m -126.41 139.72 53.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.561 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' SER . 31.9 m-20 -83.49 174.35 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.0 110.392 179.905 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.497 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 28.8 t 42.31 -165.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.137 179.211 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.84 2.66 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 33' ' ' SER . 12.0 m-85 -89.08 107.76 19.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.95 -1.324 . . . . 0.0 111.185 -179.419 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -60.39 139.68 57.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 0.0 110.357 179.281 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.665 HD21 ' HA ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -84.38 102.19 12.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.316 179.078 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -94.3 150.95 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 108.991 179.785 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.31 -143.43 14.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.223 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 3.3 m120 -114.58 49.62 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -1.23 . . . . 0.0 109.837 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.665 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER 25.21 62.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.941 179.505 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 141.88 115.22 1.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.593 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.723 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -58.45 -178.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.522 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.3 tp -142.88 105.8 4.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.005 -1.06 . . . . 0.0 110.097 178.458 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.2 t -88.29 109.4 19.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.9 m -126.77 126.06 42.79 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.13 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.675 ' C ' HG21 ' A' ' 1' ' ' VAL . . . 70.45 28.62 70.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.54 26.44 73.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.03 115.4 12.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 110.174 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.628 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.8 m95 -76.58 136.28 39.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.862 179.812 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.73 171.76 19.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 110.998 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.533 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 53.67 64.73 6.35 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.872 -0.518 . . . . 0.0 111.212 179.77 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -91.99 145.28 2.96 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.958 1.772 . . . . 0.0 109.841 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.4 Cg_endo -79.44 174.9 11.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.731 1.385 . . . . 0.0 110.11 179.53 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.59 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 14.4 p -114.39 -177.31 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 111.13 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.751 ' SG ' HD11 ' A' ' 9' ' ' ILE . 84.7 m -140.57 73.42 1.42 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.019 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -116.52 177.57 4.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.736 -178.975 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' CD ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -88.94 145.15 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.1 179.719 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.655 HG21 ' CB ' ' A' ' 81' ' ' TYR . 29.0 m -129.93 40.96 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.371 -179.128 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.572 ' CD ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -78.87 101.21 7.56 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.429 179.843 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 50.2 m -73.04 162.71 73.23 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.454 -0.778 . . . . 0.0 111.253 -178.913 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.3 Cg_endo -70.82 -89.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.359 1.715 . . . . 0.0 110.628 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -172.25 133.42 0.76 Allowed Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.643 ' HA ' HD21 ' A' ' 113' ' ' LEU . 58.0 Cg_endo -86.7 83.8 1.09 Allowed 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 123.69 1.363 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 66' ' ' ILE . 4.1 p -100.7 -42.38 6.53 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.39 1.091 . . . . 0.0 110.288 -178.954 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.785 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 48.86 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.927 -179.216 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.533 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 49.6 m -69.32 107.61 3.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 111.666 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 27.6 m120 38.06 43.78 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.0 111.77 178.438 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -126.6 -44.08 0.25 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.805 -1.664 . . . . 0.0 109.903 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 23.3 p90 41.35 -174.61 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 122.639 1.209 . . . . 0.0 111.827 -179.13 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.883 HD13 ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.63 153.62 50.89 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.239 -179.243 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -13.88 12.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.888 -1.133 . . . . 0.0 110.287 -178.78 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 40.9 t -51.41 -54.44 26.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.19 106.6 0.21 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.81 -177.34 3.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.962 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 27.5 tttm -159.68 168.75 25.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.55 -0.719 . . . . 0.0 109.89 -179.585 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.0 mtp85 -65.86 -39.25 90.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.981 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 m -139.64 126.21 20.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CD2' ' CH2' ' A' ' 109' ' ' TRP . 60.4 m-85 -95.32 -175.99 3.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 29.0 t -170.47 96.87 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.301 179.941 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CB ' HG21 ' A' ' 59' ' ' VAL . 2.2 t80 52.06 125.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.381 -0.825 . . . . 0.0 110.664 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.712 ' O ' HG22 ' A' ' 102' ' ' THR . 13.7 t-20 73.51 -128.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.941 -1.1 . . . . 0.0 110.381 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 71.08 0.54 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.701 -1.249 . . . . 0.0 109.11 -178.451 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 101' ' ' SER . 6.3 t-20 -70.39 142.17 52.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.533 -0.73 . . . . 0.0 111.093 -178.998 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.78 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -129.57 120.01 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.328 -0.858 . . . . 0.0 110.072 179.002 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -84.29 124.17 30.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 178.966 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.789 ' CE1' HD12 ' A' ' 71' ' ' LEU . 50.2 m-85 -80.94 136.38 36.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.316 1.055 . . . . 0.0 112.527 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -114.76 86.1 2.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.439 -179.643 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.585 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.68 128.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 0.0 110.795 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 15.1 mmtt -38.95 -84.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.538 -0.726 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 19.0 t80 -160.58 149.6 16.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.12 -0.987 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.49 31.46 14.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.6 m-85 -142.65 146.12 34.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.501 -0.999 . . . . 0.0 110.234 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.73 135.07 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.885 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.707 HD23 HD11 ' A' ' 66' ' ' ILE . 5.5 mt -67.24 111.06 3.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.524 -179.702 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.467 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.19 106.62 18.31 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.136 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -90.38 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.801 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -149.0 120.39 7.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -1.15 . . . . 0.0 110.538 -179.474 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 p -80.15 4.8 16.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 0.0 110.905 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -144.9 115.81 7.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 110.093 179.719 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.56 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 17.5 m -126.82 -175.53 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.699 -179.714 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 82' ' ' ASN . 13.9 m -157.24 134.4 10.34 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.114 -178.926 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.584 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 6.2 t -59.72 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.877 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.21 172.38 9.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.767 ' HB3' HD12 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -74.85 123.74 8.19 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.334 1.702 . . . . 0.0 110.925 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.2 -7.61 5.07 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.9 m120 81.12 77.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.971 -0.723 . . . . 0.0 110.384 179.83 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -174.4 -168.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.852 . . . . 0.0 111.612 179.82 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.78 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 22.5 m95 -134.37 100.65 4.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 -179.691 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 102' ' ' THR . 2.7 mttm -102.71 149.12 36.46 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.216 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.9 Cg_endo -75.28 -174.58 14.48 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.906 -2.123 . . . . 0.0 110.551 -0.371 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.1 tp10 -39.13 117.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.341 0.591 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 109' ' ' TRP . 1.8 tp -43.74 141.94 2.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.825 . . . . 0.0 110.785 -179.694 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.785 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.7 Cg_endo -72.31 167.05 27.95 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.085 1.571 . . . . 0.0 110.502 179.507 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -132.33 95.33 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.923 . . . . 0.0 110.525 179.879 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.7 t -46.62 102.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.073 -1.017 . . . . 0.0 109.135 179.475 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -113.58 -178.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.729 0.775 . . . . 0.0 111.083 -179.135 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.162 0.506 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -162.58 171.5 16.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.535 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -130.55 151.96 50.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 41.6 mt-30 -134.03 174.7 10.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.072 -1.018 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.25 130.69 7.62 Favored Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.612 ' HG2' ' CG ' ' A' ' 14' ' ' HIS . 48.8 Cg_endo -70.46 158.83 54.88 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.944 1.497 . . . . 0.0 110.77 -179.752 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.05 175.14 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.014 1.534 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' ILE . 88.7 p -85.75 99.21 11.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.133 179.906 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.0 -170.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.381 1.086 . . . . 0.0 111.917 -179.664 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 9' ' ' ILE . 1.9 p -37.48 95.79 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.012 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 41.03 29.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 110.758 179.682 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -119.32 174.32 15.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.507 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 1.6 mtt85 -113.53 -168.49 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 15.3 p80 -158.94 119.45 3.22 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.321 0.581 . . . . 0.0 110.265 -179.899 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.699 ' O ' HG13 ' A' ' 27' ' ' VAL . 6.1 m120 -107.11 -162.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.634 -179.621 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 18' ' ' GLU . . . 147.3 -20.67 1.54 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.986 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.12 34.78 16.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -1.132 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.611 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 38.2 mm-40 -121.43 -155.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.004 179.721 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -153.36 -39.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.617 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 7.8 p90 -143.48 80.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.707 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 25.7 m-85 -49.75 -179.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.052 -1.03 . . . . 0.0 110.112 179.938 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.535 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -142.61 -68.56 0.36 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.616 -1.303 . . . . 0.0 111.183 -179.07 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -156.86 141.42 16.76 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 109.757 -178.954 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 69.27 7.97 58.21 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.843 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 26' ' ' VAL . 40.5 m -71.31 174.91 5.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.11 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 36.3 t -156.77 157.63 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 15' ' ' ASN . 34.0 t -144.68 121.26 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.102 -179.655 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.46 101.88 3.06 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.869 178.249 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.672 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.99 154.93 40.59 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.414 -0.804 . . . . 0.0 110.136 -178.31 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.507 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.7 t -114.37 -177.14 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.021 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 57.4 m -146.9 149.89 34.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.25 149.97 5.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -54.34 107.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 179.968 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.1 10.05 9.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.948 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 4.4 m-85 -124.24 120.86 33.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.725 -179.693 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.616 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -73.05 138.2 45.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.428 179.678 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.9 tp -90.42 98.57 11.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.139 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -92.05 170.39 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.096 179.414 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 83.93 -178.82 52.14 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.684 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.19 121.66 15.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -1.141 . . . . 0.0 109.943 179.917 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.696 ' O ' HG23 ' A' ' 28' ' ' THR . 6.2 t -73.11 53.4 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.491 -179.755 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 174.78 88.08 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.336 179.892 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -45.32 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.316 -1.108 . . . . 0.0 108.935 179.45 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 25' ' ' SER . 6.3 tp -139.69 106.18 5.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 110.151 178.809 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.61 107.54 14.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.138 -0.976 . . . . 0.0 109.771 179.595 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -129.16 121.33 27.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -7.4 80.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.6 16.37 8.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -144.69 138.17 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -1.14 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 99.8 m95 -77.92 136.39 38.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.878 179.696 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t -132.12 163.88 27.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.476 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 27.8 m-20 51.09 66.7 5.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.808 -0.558 . . . . 0.0 111.191 179.681 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -90.42 137.88 2.57 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 124.399 1.736 . . . . 0.0 109.733 179.123 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.1 Cg_endo -75.68 178.02 7.93 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.664 1.35 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.581 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.5 p -118.92 147.04 44.45 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 0.0 112.072 -178.635 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 92.4 m -110.37 76.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.317 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.04 178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.457 0.646 . . . . 0.0 110.392 -178.575 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -91.38 134.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.053 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 81' ' ' TYR . 28.2 m -119.8 43.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -178.992 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 25.4 mttt -80.06 97.66 6.92 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 119.406 -0.917 . . . . 0.0 108.904 179.5 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 60.2 m -69.06 161.88 69.39 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -178.607 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.1 Cg_endo -72.08 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.503 1.791 . . . . 0.0 110.34 -179.638 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.457 ' O ' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -157.46 131.55 4.99 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.593 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.605 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.1 Cg_endo -76.91 66.18 7.65 Favored 'Trans proline' 0 C--N 1.297 -2.132 0 O-C-N 123.725 1.382 . . . . 0.0 109.888 -178.906 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.737 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -87.87 -174.65 4.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.547 -0.72 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.737 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 178.32 166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.355 179.471 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.3 OUTLIER -69.8 96.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.746 -179.594 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.7 m-20 48.72 40.49 16.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.925 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -146.3 28.58 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.6 p90 -45.15 -175.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.641 1.21 . . . . 0.0 112.346 -179.08 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.5 162.12 15.45 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.347 179.527 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t -144.66 22.74 1.62 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.971 -1.08 . . . . 0.0 110.449 -179.094 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.9 t -100.12 -82.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.698 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.44 75.88 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.711 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -95.88 157.99 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -1.05 . . . . 0.0 109.592 179.554 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.552 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -147.6 168.41 22.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 110.667 -179.636 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -76.3 -35.55 58.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.971 179.798 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 p -124.88 131.82 53.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.716 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.583 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 89.8 m-85 -112.5 170.79 7.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.512 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 81' ' ' TYR . 92.6 p -165.39 91.2 0.51 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 179.9 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.652 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.0 t80 52.42 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.815 0.817 . . . . 0.0 110.44 -179.47 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.774 ' O ' HG22 ' A' ' 102' ' ' THR . 15.3 t-20 65.33 -127.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.487 -1.383 . . . . 0.0 110.094 -179.215 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 6.2 m-20 51.82 73.92 0.29 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.622 -1.299 . . . . 0.0 109.044 -178.54 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 101' ' ' SER . 6.0 t30 -72.28 146.42 47.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.519 -0.738 . . . . 0.0 111.351 -178.703 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.744 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -132.16 124.27 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 109.553 179.021 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.8 t0 -83.82 124.23 30.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.995 -1.065 . . . . 0.0 109.48 179.643 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.679 ' HD2' HG21 ' A' ' 66' ' ' ILE . 8.4 m-85 -87.11 120.65 28.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.182 -0.949 . . . . 0.0 111.56 -178.651 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -95.75 94.93 7.97 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.169 179.932 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -44.37 125.36 4.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.07 -1.019 . . . . 0.0 109.488 179.78 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.554 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 4.9 mmtp -35.85 -67.33 0.16 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.672 -0.643 . . . . 0.0 111.001 -178.938 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 36.3 t80 -173.6 144.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.595 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.37 47.37 11.49 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -149.83 153.87 37.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -1.027 . . . . 0.0 109.899 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' CG ' HG23 ' A' ' 117' ' ' VAL . 4.4 ptpt -113.99 130.11 56.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -66.66 93.21 0.24 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.603 -179.455 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.659 ' HB2' HG21 ' A' ' 117' ' ' VAL . 2.4 t -74.61 103.85 5.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.61 179.508 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.54 -77.76 0.3 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.826 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.562 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -172.47 116.1 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.16 . . . . 0.0 110.454 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.576 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -67.78 -77.22 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.87 . . . . 0.0 110.637 -179.944 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 100' ' ' SER . 5.0 p -68.82 104.99 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.792 -179.219 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.4 m -107.41 -170.75 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.906 179.538 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 82' ' ' ASN . 7.8 m -161.49 138.12 8.39 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.289 -178.966 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.653 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.5 t -59.49 105.64 0.38 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 179.78 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.458 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.96 168.16 16.3 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.814 -179.464 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.783 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.1 Cg_endo -76.32 126.91 9.44 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.418 1.747 . . . . 0.0 110.632 -179.519 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 122.41 3.84 9.32 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.287 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.848 ' O ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER 77.3 83.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.756 -0.849 . . . . 0.0 110.635 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.04 -168.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 111.81 179.628 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.744 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 33.8 m95 -134.08 95.07 3.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 110.289 -179.601 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -98.95 143.79 27.01 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.614 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.67 172.63 58.18 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.837 -2.151 . . . . 0.0 110.616 -0.634 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 39.4 tt0 -39.1 128.2 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 0.0 111.263 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.41 152.16 0.28 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 0.0 109.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CG ' ' CD2' ' A' ' 87' ' ' PHE . 39.7 Cg_endo -82.87 167.5 14.46 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 O-C-N 124.301 1.685 . . . . 0.0 111.119 -179.362 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.557 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.0 ttpt -126.71 108.04 10.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.819 179.66 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.3 t -64.24 74.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.659 HG21 ' HB2' ' A' ' 96' ' ' SER . 3.7 m -90.52 -175.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.771 0.796 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.606 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.6 ppt_? . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.481 179.412 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.18 178.57 3.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.871 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -135.39 127.82 30.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.985 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 35.8 mt-30 -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.154 179.254 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -43.37 142.93 1.56 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.042 -1.036 . . . . 0.0 110.461 -179.479 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.634 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.5 Cg_endo -73.5 160.23 44.79 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.191 1.627 . . . . 0.0 110.532 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.5 171.59 17.83 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.522 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.33 98.89 10.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 109.865 179.706 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.611 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -51.4 -170.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.389 1.09 . . . . 0.0 111.944 -179.17 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 5.3 p -58.49 122.79 14.21 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.68 -178.887 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . 2.0 m-20 33.6 34.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.996 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.53 162.58 26.93 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.529 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -111.8 -171.46 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -1.197 . . . . 0.0 110.934 -179.65 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.634 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.1 p80 -154.19 123.99 6.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.886 -0.509 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.9 -158.46 0.86 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.654 -179.621 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' OE2' ' A' ' 18' ' ' GLU . . . 138.35 -7.02 3.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 66.93 58.73 0.58 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -1.152 . . . . 0.0 110.186 -179.942 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -137.22 -69.42 0.46 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.28 -0.887 . . . . 0.0 109.821 -179.84 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 2.7 m-20 68.32 18.01 9.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.614 -0.679 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -170.53 50.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.049 -1.032 . . . . 0.0 110.595 179.761 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.809 ' O ' HG23 ' A' ' 22' ' ' THR . 9.7 m-85 -55.59 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.139 179.389 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 21' ' ' TYR . 1.9 p -161.95 -69.22 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.823 -1.173 . . . . 0.0 111.2 -179.959 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.5 t70 -164.16 138.31 5.55 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.048 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.81 12.21 83.08 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.737 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -86.19 169.27 13.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.975 . . . . 0.0 109.951 179.947 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 43' ' ' VAL . 92.6 t -143.59 151.19 16.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.615 178.596 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.652 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 30.0 t -136.59 120.37 23.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.311 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.41 101.41 4.78 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.025 -1.47 . . . . 0.0 107.579 177.989 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 1.5 m-30 -67.55 127.28 32.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.622 -178.418 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -74.75 169.3 18.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 179.615 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -140.13 134.15 30.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' SER . 1.7 m120 -43.46 116.23 0.91 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.571 179.581 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ASN . 10.6 m -38.65 113.13 0.27 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.639 -179.443 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.34 -26.11 6.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.601 ' CE2' HG13 ' A' ' 58' ' ' ILE . 2.8 m-85 -91.8 144.86 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -1.142 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.929 ' HB2' HG22 ' A' ' 59' ' ' VAL . 48.2 t -81.88 119.8 24.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 111.114 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tp -79.48 106.63 11.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.071 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -98.79 152.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.955 . . . . 0.0 109.14 -179.63 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 104.89 -177.91 23.58 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.806 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 42' ' ' GLY . 23.7 p-10 -67.98 131.73 46.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.697 179.571 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.768 ' O ' HG23 ' A' ' 28' ' ' THR . 24.5 p -73.17 56.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.79 179.91 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 26' ' ' VAL . . . 165.52 96.13 0.11 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.646 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -48.55 177.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.156 . . . . 0.0 108.054 179.38 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.3 tp -143.51 99.16 3.37 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.962 -1.086 . . . . 0.0 110.249 178.777 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.0 t -80.5 121.18 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.39 178.744 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.23 126.88 41.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.694 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 62.33 25.94 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.905 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.4 31.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.889 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -140.69 119.27 12.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.604 ' CD2' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -77.36 136.29 38.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.629 179.696 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -141.45 160.01 41.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 111.412 -179.33 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.7 t0 53.84 65.84 5.07 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.923 -0.486 . . . . 0.0 111.521 179.332 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.1 Cg_endo -91.26 129.95 1.31 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 124.378 1.725 . . . . 0.0 109.265 178.516 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 44.8 Cg_endo -72.16 166.02 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.574 1.302 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.606 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 24.8 p -104.33 -174.59 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.189 0.995 . . . . 0.0 111.612 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.6 t -146.16 74.6 1.38 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.532 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.22 -170.5 1.67 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.331 -178.459 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.677 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -111.5 86.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.933 HG21 ' CB ' ' A' ' 81' ' ' TYR . 20.1 m -76.03 51.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 111.368 -179.115 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -55.22 175.78 0.06 Allowed 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 117.671 -1.612 . . . . 0.0 107.831 179.305 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 66.9 m -134.24 142.58 43.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.16 -178.305 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 41.8 Cg_endo -74.61 -83.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.491 1.785 . . . . 0.0 110.486 179.439 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.573 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER 177.58 126.19 0.19 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.539 -0.726 . . . . 0.0 109.251 -179.559 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.779 ' HG2' HD21 ' A' ' 71' ' ' LEU . 50.5 Cg_endo -77.13 57.54 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.788 1.415 . . . . 0.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.66 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.76 166.11 23.51 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.47 0.652 . . . . 0.0 110.593 -179.673 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 1.006 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -166.33 167.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.171 179.504 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 116' ' ' CYS . 1.7 t -76.34 113.13 13.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 110.78 -179.403 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.541 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 72.9 m-20 36.21 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.675 -0.641 . . . . 0.0 111.401 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.006 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.32 38.09 1.26 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.008 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.638 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.1 p90 -44.85 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 123.438 1.589 . . . . 0.0 113.401 -179.682 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.819 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -139.42 122.83 17.18 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.491 -176.807 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -104.48 15.71 27.58 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.466 -0.771 . . . . 0.0 110.237 -178.951 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.95 95.56 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.44 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 94.02 106.55 1.91 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.711 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 9.2 t80 -173.89 170.49 3.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -1.173 . . . . 0.0 110.255 179.719 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.623 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.0 tttm -179.93 142.72 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.463 -0.773 . . . . 0.0 109.727 -179.684 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 76' ' ' LYS . 12.7 mtp180 -41.42 -27.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -148.08 141.49 25.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 110.175 179.877 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -124.99 -164.75 1.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 109.607 179.762 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.7 p -170.67 107.89 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.933 ' CB ' HG21 ' A' ' 59' ' ' VAL . 2.3 t80 53.24 156.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.112 -0.992 . . . . 0.0 110.672 179.167 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.821 ' C ' HG22 ' A' ' 102' ' ' THR . 27.4 t-20 38.18 -110.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.713 -179.224 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 81' ' ' TYR . 74.9 m-20 50.79 69.0 0.69 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.765 -1.21 . . . . 0.0 109.143 -179.419 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.84 ' CA ' HG23 ' A' ' 102' ' ' THR . 11.3 p-10 -69.43 129.98 41.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.753 -178.92 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 74' ' ' GLY . 15.8 m -121.53 128.85 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.998 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 20.4 t0 -85.37 136.78 33.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 108.575 178.977 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.696 ' CE2' HD23 ' A' ' 71' ' ' LEU . 51.2 m-85 -96.69 143.5 27.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.969 -1.082 . . . . 0.0 111.907 -178.43 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 5.7 tttm -115.38 110.03 18.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.448 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.522 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -66.55 132.79 48.99 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.835 -1.165 . . . . 0.0 109.943 -179.251 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.541 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -38.76 -91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 111.173 -179.132 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.3 t80 -148.44 138.56 22.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 0.0 110.786 -179.293 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 51.08 60.1 7.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.672 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 12.2 m-85 -162.96 136.45 5.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -1.06 . . . . 0.0 109.943 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 117' ' ' VAL . 34.5 pttt -101.23 112.23 24.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.423 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.673 HD23 HD11 ' A' ' 66' ' ' ILE . 1.3 mt -45.58 125.9 6.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -102.24 103.55 14.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 0.0 109.501 179.215 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.59 -57.42 0.58 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.633 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 172.65 119.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -1.148 . . . . 0.0 111.098 -179.417 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -78.11 -3.87 44.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.201 -0.937 . . . . 0.0 110.703 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.7 p -142.09 112.46 7.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 109.806 179.86 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.3 m -121.75 -179.7 4.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.993 -179.272 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.84 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -153.29 132.34 12.58 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 103' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 82' ' ' ASN . 36.6 t -78.72 82.91 4.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 110.09 -179.868 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.554 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -55.74 -179.91 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.594 -0.691 . . . . 0.0 111.503 -179.596 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.878 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.9 Cg_endo -73.43 117.6 5.14 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.559 1.821 . . . . 0.0 110.572 -179.271 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.65 ' C ' HD21 ' A' ' 107' ' ' ASN . . . 138.0 -10.25 3.62 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.65 HD21 ' C ' ' A' ' 106' ' ' GLY . 6.7 m-80 83.37 90.42 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.163 -0.61 . . . . 0.0 110.728 179.461 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.35 -161.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 111.527 179.635 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.621 ' HB3' HD13 ' A' ' 113' ' ' LEU . 17.7 m95 -149.95 80.18 1.37 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.487 0.66 . . . . 0.0 109.729 -179.831 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.56 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.9 mttm -95.18 143.26 25.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.824 -179.739 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.633 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -71.04 174.27 45.66 Favored 'Cis proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 -2.0 . . . . 0.0 110.987 -0.144 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.23 128.24 5.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -39.86 144.15 0.54 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 110.272 179.323 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.84 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.3 Cg_endo -71.74 164.26 36.25 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 111.356 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.7 tttt -132.59 119.76 20.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 67' ' ' SER . 1.3 m -62.12 113.23 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.047 -1.033 . . . . 0.0 110.194 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.52 173.48 12.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.761 179.113 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.306 0.574 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.59 173.45 11.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.489 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -127.0 108.61 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 0.0 110.458 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.533 ' NE2' ' CE1' ' A' ' 20' ' ' PHE . 9.2 mm100 -87.68 174.81 8.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.2 p -43.01 139.97 2.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.891 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.92 ' HG3' HG11 ' A' ' 27' ' ' VAL . 46.6 Cg_endo -69.59 161.04 47.46 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.083 1.57 . . . . 0.0 111.031 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.86 171.95 16.84 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.089 1.573 . . . . 0.0 109.938 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -73.01 176.47 5.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.051 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.724 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -169.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.175 0.988 . . . . 0.0 111.369 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -52.56 96.41 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.74 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 10' ' ' SER . 8.4 m120 40.63 61.78 1.55 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.453 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.5 161.99 32.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.6 mtt85 -105.88 -176.82 3.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -1.148 . . . . 0.0 109.808 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.62 -176.28 5.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.933 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 1.3 t30 66.52 136.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.065 -1.022 . . . . 0.0 109.905 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.86 -60.43 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 4.0 t80 -151.46 35.85 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -1.089 . . . . 0.0 110.116 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -145.09 -162.74 1.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 1.3 p30 -147.57 -38.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 109.879 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.609 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 3.2 m-85 -93.62 -162.05 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 171.89 -16.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.531 -0.73 . . . . 0.0 110.996 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 7.0 p 47.73 -95.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 112.311 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -152.16 161.75 42.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.788 -1.195 . . . . 0.0 110.428 -178.46 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.85 19.9 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.624 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 6.6 m -105.14 178.04 4.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.54 -0.976 . . . . 0.0 110.566 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.7 t -151.8 156.35 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.103 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.92 HG11 ' HG3' ' A' ' 6' ' ' PRO . 15.0 t -135.09 117.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.572 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.95 103.28 5.1 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.341 -1.343 . . . . 0.0 107.928 178.113 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.87 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.1 m-30 -68.24 128.09 35.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 110.05 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -82.96 157.81 22.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.577 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 35.5 m -123.28 155.17 37.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -47.94 160.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 33' ' ' SER . 12.3 p -59.98 105.16 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.475 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.53 -3.24 29.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.504 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -94.32 131.49 39.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -1.193 . . . . 0.0 110.422 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.592 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -81.39 140.14 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -90.38 99.71 12.68 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.027 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.822 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.5 162.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.185 -0.947 . . . . 0.0 109.078 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.99 171.85 47.9 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -45.96 129.04 9.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -1.159 . . . . 0.0 109.997 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.754 ' O ' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -74.01 53.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.476 -179.666 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.571 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 162.23 119.51 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.737 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.8 t -60.24 -175.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.022 -1.281 . . . . 0.0 108.051 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.584 ' H ' HG12 ' A' ' 43' ' ' VAL . 5.2 tp -146.48 97.49 2.93 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.4 OUTLIER -84.9 108.79 17.72 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.217 178.818 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.8 m -126.84 82.02 2.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.554 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.82 43.57 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.51 11.07 46.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -132.14 120.94 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -1.203 . . . . 0.0 110.28 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.648 ' CH2' HG23 ' A' ' 27' ' ' VAL . 80.8 m95 -76.36 138.75 40.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 0.0 109.742 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -141.41 158.06 44.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.992 . . . . 0.0 111.129 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.517 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 62.62 65.28 1.5 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 111.381 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.8 Cg_endo -91.2 133.61 1.59 Allowed 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 124.275 1.671 . . . . 0.0 110.215 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 51.3 Cg_endo -82.55 177.2 7.17 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.929 1.489 . . . . 0.0 110.34 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 17.8 p -112.04 162.17 15.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 111.528 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 m -129.21 77.1 1.77 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 177.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.55 -170.24 1.69 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.366 0.603 . . . . 0.0 110.32 -178.26 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -100.03 146.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.032 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.736 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 16.4 m -134.23 41.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.916 -1.115 . . . . 0.0 110.999 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 8.2 mtpt -81.02 98.82 8.13 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.931 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 37.4 m -70.22 165.94 38.91 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.589 -0.695 . . . . 0.0 111.387 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 50.6 Cg_endo -75.43 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.315 1.692 . . . . 0.0 110.659 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.482 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -153.78 131.67 6.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.89 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.69 ' HG2' HD22 ' A' ' 71' ' ' LEU . 54.3 Cg_endo -76.12 66.22 6.98 Favored 'Trans proline' 0 C--N 1.295 -2.254 0 O-C-N 123.595 1.313 . . . . 0.0 109.476 -179.689 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.73 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -87.97 175.46 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.531 -0.731 . . . . 0.0 110.686 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -178.26 161.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.0 t -72.11 111.67 7.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.0 110.864 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 61.5 m-20 36.53 49.14 0.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.641 -0.662 . . . . 0.0 111.325 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.534 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -159.42 23.76 0.3 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' HG23 ' A' ' 66' ' ' ILE . 3.8 p90 -36.41 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.953 1.359 . . . . 0.0 112.718 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -49.14 -70.59 0.08 Allowed 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.835 178.038 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER 79.96 10.05 1.34 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.41 -0.806 . . . . 0.0 109.891 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 t -114.34 -44.75 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.541 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -178.67 100.2 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.612 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.03 172.41 6.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -1.07 . . . . 0.0 109.742 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -158.89 161.08 36.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.543 -179.741 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -54.06 -37.47 64.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.772 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 m -144.02 163.31 33.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.538 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.9 m-85 -135.68 -179.2 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 17.3 p -163.06 111.9 1.3 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.042 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.677 ' CB ' HG21 ' A' ' 59' ' ' VAL . 18.2 t80 30.97 38.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.515 -0.741 . . . . 0.0 111.592 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 103' ' ' CYS . 30.6 t30 -176.48 -140.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.444 -1.41 . . . . 0.0 110.995 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 74.3 m-20 55.26 66.53 1.2 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.917 -1.115 . . . . 0.0 108.987 -178.323 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.591 ' N ' HG23 ' A' ' 102' ' ' THR . 8.0 t-20 -70.65 97.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 74' ' ' GLY . 34.9 m -86.15 131.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.172 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -88.56 131.04 35.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.867 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 20.4 m-85 -88.66 125.45 34.84 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.53 1.157 . . . . 0.0 112.758 -177.56 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -104.97 108.63 20.24 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.116 -179.473 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.468 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -60.68 133.99 56.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.766 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -44.61 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 110.241 -179.544 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.594 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.0 p90 -148.93 149.31 31.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 111.007 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 42.9 36.9 2.71 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 17.3 m-85 -139.38 149.43 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -1.087 . . . . 0.0 110.213 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.501 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.44 139.93 46.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.209 179.9 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.747 ' CD2' HD11 ' A' ' 66' ' ' ILE . 23.5 mt -75.6 102.97 5.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.495 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -80.15 95.32 6.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.324 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.24 -85.93 0.16 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.578 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -157.12 125.5 5.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -1.152 . . . . 0.0 110.554 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.3 p -86.19 25.08 1.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.83 . . . . 0.0 110.882 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.4 p -169.89 106.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 1.7 m -127.48 164.84 21.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.046 0.927 . . . . 0.0 110.924 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.591 HG23 ' N ' ' A' ' 84' ' ' ASN . 26.8 m -139.79 139.4 36.41 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.962 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.558 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 11.8 t -49.52 94.4 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.671 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -66.62 174.12 2.02 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.934 -1.104 . . . . 0.0 112.366 -178.095 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.822 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.6 Cg_endo -79.44 14.33 1.83 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.635 1.86 . . . . 0.0 111.809 -178.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -116.31 18.72 13.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.834 ' O ' HG23 ' A' ' 108' ' ' THR . 0.4 OUTLIER 67.32 54.5 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.591 -0.947 . . . . 0.0 110.263 -179.844 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -167.19 -176.88 3.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 110.741 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.602 ' NE1' ' N ' ' A' ' 64' ' ' PRO . 46.6 m95 -105.97 98.84 8.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.415 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -105.73 141.99 23.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.214 -179.575 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.578 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.2 Cg_endo -71.78 174.8 45.13 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.888 -0.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.5 mm-40 -38.38 142.34 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 111.14 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -60.75 141.21 92.82 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.975 179.558 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.734 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.9 Cg_endo -73.13 155.59 52.07 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 124.302 1.685 . . . . 0.0 111.226 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 117' ' ' VAL . 2.6 ttpt -120.17 101.91 8.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.371 -0.83 . . . . 0.0 110.09 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -54.66 103.19 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.094 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -112.71 178.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.633 0.73 . . . . 0.0 110.823 -179.145 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 6.4 ptt85 . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.443 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 178.23 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 110.059 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.582 ' SG ' ' CZ2' ' A' ' 50' ' ' TRP . 2.8 t -160.08 97.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.527 -0.733 . . . . 0.0 110.259 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 pm0 -80.26 -175.26 4.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.1 p -45.26 142.57 2.98 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.473 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.876 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.8 Cg_endo -69.76 157.57 59.93 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.992 1.522 . . . . 0.0 111.261 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.27 173.25 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.971 1.511 . . . . 0.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.68 177.95 4.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.293 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.686 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.85 -170.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.24 1.019 . . . . 0.0 111.722 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 9' ' ' ILE . 25.4 m -38.32 92.48 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.004 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.8 m-20 40.28 34.82 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.338 -0.851 . . . . 0.0 110.78 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.91 12.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -139.7 179.01 6.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.379 -1.071 . . . . 0.0 109.957 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.609 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -137.78 114.23 10.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 110.338 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -135.72 122.81 21.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.42 -111.41 2.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -157.09 29.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 110.113 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 1.6 pm0 -162.99 173.62 13.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -102.26 -51.08 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.936 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -100.41 139.66 35.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.967 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -120.01 -11.96 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.641 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.568 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 21.1 p 51.14 -99.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.556 -0.715 . . . . 0.0 111.694 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -147.95 163.34 37.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.053 -1.029 . . . . 0.0 110.575 -178.579 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.47 25.31 68.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -107.04 -179.62 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.819 . . . . 0.0 110.201 -179.281 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.677 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.3 t -155.04 155.48 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.947 ' O ' HG23 ' A' ' 43' ' ' VAL . 17.2 t -140.51 116.21 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.655 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.49 103.84 2.59 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.374 -1.33 . . . . 0.0 107.851 178.064 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.918 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.8 m-30 -68.28 135.01 51.26 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.327 -178.262 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 4.4 t -90.25 -172.36 3.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.385 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 85.9 m -149.33 159.9 43.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.077 -1.014 . . . . 0.0 110.226 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.558 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 76.0 m-20 -46.04 139.51 4.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.937 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.51 109.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.16 17.62 10.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 32' ' ' ASN . 3.2 m-85 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.017 -1.284 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . 1.069 ' OG ' HG22 ' A' ' 59' ' ' VAL . 66.3 m -92.17 133.16 36.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 111.027 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 29' ' ' TYR . 5.3 tp -88.17 116.17 26.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.37 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.699 HG23 ' CG ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -109.26 157.62 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.086 -1.009 . . . . 0.0 109.815 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.52 -169.37 18.27 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -58.61 119.24 6.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.045 -1.268 . . . . 0.0 109.51 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.706 ' O ' HG23 ' A' ' 28' ' ' THR . 46.1 p -68.45 58.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.588 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.96 115.22 0.5 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 27' ' ' VAL . 1.9 t -61.52 -175.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.214 . . . . 0.0 108.212 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.559 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.7 tp -144.06 101.38 3.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.189 -0.944 . . . . 0.0 110.115 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.1 t -85.22 108.42 17.73 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.72 179.111 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.506 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -129.31 103.68 7.07 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.211 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 79.43 52.79 4.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.83 50.12 8.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.56 73.42 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -1.051 . . . . 0.0 110.446 -179.854 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 68.8 m95 -46.21 131.72 10.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.562 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 5.9 m -142.65 168.98 18.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 111.099 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 11.7 m-20 59.95 66.34 2.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.687 -0.633 . . . . 0.0 111.111 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -90.8 130.22 1.47 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 124.366 1.719 . . . . 0.0 110.335 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HG2' HD11 ' A' ' 37' ' ' LEU . 55.6 Cg_endo -79.34 -176.24 3.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.838 1.441 . . . . 0.0 110.534 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.0 p -112.1 -169.42 1.47 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.997 0.903 . . . . 0.0 111.634 -178.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 67.9 m -152.03 86.72 1.31 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.558 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -117.8 -143.39 0.37 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.778 -177.845 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.784 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -134.43 100.5 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.069 HG22 ' OG ' ' A' ' 36' ' ' SER . 30.8 m -101.19 70.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 112.587 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 27.9 mtpt -65.52 -170.86 0.07 Allowed 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 117.239 -1.785 . . . . 0.0 107.989 178.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -143.9 159.8 52.12 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.292 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 46.0 Cg_endo -85.31 -79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 124.783 1.938 . . . . 0.0 110.558 179.377 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 171.63 128.6 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.691 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.819 ' O ' HD21 ' A' ' 71' ' ' LEU . 53.2 Cg_endo -80.27 66.36 8.82 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.8 1.421 . . . . 0.0 109.783 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.743 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -84.25 -171.49 3.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.349 -0.844 . . . . 0.0 109.698 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.743 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 172.44 170.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.298 179.035 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 69.5 m -77.0 107.4 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.155 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 5.7 m-80 38.56 65.92 0.57 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 89' ' ' CYS . . . -155.53 -37.98 0.02 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 43.5 p90 35.14 -155.78 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.591 1.186 . . . . 0.0 112.265 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.819 HD21 ' O ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -155.13 126.89 7.49 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.696 -175.486 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.6 t -100.53 15.92 26.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 86' ' ' ASP . 2.8 m -80.66 -92.3 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 111.258 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.16 88.19 0.18 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -95.76 165.87 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.612 -179.336 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.577 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 5.4 tttt -164.25 156.12 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.459 -0.775 . . . . 0.0 109.756 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -30.47 59.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 0.0 110.45 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.9 p -143.95 138.24 28.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.607 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 25.0 m-85 -114.51 -140.77 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 82.7 p -162.7 -123.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.878 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 1.034 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.27 27.3 8.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.841 -1.162 . . . . 0.0 111.089 -178.276 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.769 ' C ' HG22 ' A' ' 102' ' ' THR . 45.8 t-20 -164.98 -110.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.942 -1.099 . . . . 0.0 110.285 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 0.2 OUTLIER 48.86 71.82 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.661 -1.274 . . . . 0.0 109.101 -179.252 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.811 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.3 t-20 -68.86 109.44 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.716 HG23 ' CE1' ' A' ' 87' ' ' PHE . 27.7 m -99.36 120.63 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 0.0 111.242 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 23.7 t70 -78.88 135.42 37.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.182 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.724 ' CE2' HD23 ' A' ' 71' ' ' LEU . 13.1 m-85 -90.85 133.29 35.34 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.651 -1.281 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.36 81.94 2.12 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.777 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.537 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -40.48 126.74 2.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.55 -0.719 . . . . 0.0 110.745 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 17.2 mtpt -66.56 143.12 57.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 109.506 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.49 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.29 53.47 1.86 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.617 ' CE2' ' HD2' ' A' ' 118' ' ' ARG . 3.2 m-85 -102.29 155.4 18.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -1.035 . . . . 0.0 109.251 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -101.24 146.82 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.637 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 1.4 mt -87.64 90.84 8.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.87 -1.144 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 t -72.48 98.83 2.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.312 -0.868 . . . . 0.0 109.846 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 139.74 -41.38 1.32 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.608 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 98.2 p -178.41 -166.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.166 -1.196 . . . . 0.0 111.386 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -159.23 -39.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.577 0.703 . . . . 0.0 109.174 179.696 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 100' ' ' SER . 37.2 p -123.9 91.96 3.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 24.2 m -103.25 146.3 28.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 111.226 -178.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.811 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -117.78 136.86 53.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.688 0.756 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.561 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -65.73 92.06 0.14 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 110.375 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.474 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -64.82 173.59 1.6 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.484 -0.76 . . . . 0.0 111.012 -179.664 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.845 ' HB3' HG11 ' A' ' 59' ' ' VAL . 42.3 Cg_endo -76.22 125.06 8.26 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.381 1.727 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.71 -3.91 8.06 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 108' ' ' THR . 9.3 m-80 80.75 94.01 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.881 -0.776 . . . . 0.0 110.428 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.6 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.801 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 113' ' ' LEU . 26.1 m95 -153.99 90.21 1.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.435 -0.791 . . . . 0.0 110.403 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.8 mtpp -96.15 141.62 23.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 110.284 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.6 Cg_endo -72.48 170.38 68.29 Favored 'Cis proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.915 -2.119 . . . . 0.0 110.559 -0.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' LEU . 11.9 pt-20 -40.58 131.43 2.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.387 -0.821 . . . . 0.0 110.427 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.583 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -41.27 142.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 0.0 110.03 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.67 ' HG2' HD12 ' A' ' 66' ' ' ILE . 46.4 Cg_endo -77.45 170.26 19.67 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.447 1.761 . . . . 0.0 111.616 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.583 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -126.37 113.2 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.603 -0.685 . . . . 0.0 110.157 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.552 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.7 t -67.72 108.57 2.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.96 . . . . 0.0 109.051 179.353 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.583 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -117.41 -179.61 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.622 0.725 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.617 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.952 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.245 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.122 0.486 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.12 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.659 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 3.9 t -147.9 105.26 3.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.757 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -88.95 -179.11 5.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.342 -179.908 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -44.58 140.14 3.28 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.378 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.801 ' HG2' ' CD2' ' A' ' 14' ' ' HIS . 55.3 Cg_endo -71.31 168.2 24.1 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.031 1.543 . . . . 0.0 110.781 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.43 -178.46 2.61 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.81 1.426 . . . . 0.0 108.457 178.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -82.32 45.32 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.843 -1.161 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.804 HD11 ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER 39.08 -170.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 122.204 1.002 . . . . 0.0 110.618 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.691 ' N ' HG13 ' A' ' 9' ' ' ILE . 47.4 m -102.11 112.06 24.58 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.75 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 10' ' ' SER . 3.0 m-20 74.64 38.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.612 -0.68 . . . . 0.0 110.393 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 9' ' ' ILE . . . -179.03 -155.5 14.95 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.481 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -137.36 -171.61 3.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -1.208 . . . . 0.0 110.987 -179.621 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.801 ' CD2' ' HG2' ' A' ' 6' ' ' PRO . 32.7 p-80 -145.0 153.91 41.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.164 0.506 . . . . 0.0 110.097 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -152.68 -87.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.22 -109.07 3.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -178.18 48.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -1.16 . . . . 0.0 110.327 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 176.25 -165.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.463 179.909 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.02 -48.29 1.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.845 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -92.07 139.11 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.659 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.6 OUTLIER -130.63 -13.87 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 111.262 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 17.4 p 44.51 -98.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 111.435 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -147.4 158.29 43.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.072 . . . . 0.0 110.154 -178.764 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.27 21.34 79.35 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.659 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 8.1 m -106.75 176.91 5.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.643 -0.916 . . . . 0.0 110.329 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 43' ' ' VAL . 42.8 t -151.25 152.24 11.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.486 -0.759 . . . . 0.0 109.864 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.79 HG11 ' HG3' ' A' ' 6' ' ' PRO . 12.7 t -130.82 121.95 51.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.997 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.31 102.33 5.04 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.848 177.866 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.657 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.4 m-30 -68.49 151.73 46.38 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 110.665 -178.136 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.412 ' C ' ' SG ' ' A' ' 31' ' ' CYS . 1.2 p -114.53 175.72 5.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.43 -0.794 . . . . 0.0 109.526 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 11.2 m -142.91 154.11 43.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 22.2 m-80 -43.59 157.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.16 115.65 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.266 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.68 10.48 35.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-85 -106.65 138.94 41.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -1.183 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.964 ' OG ' HG22 ' A' ' 59' ' ' VAL . 70.6 m -89.16 117.52 28.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 110.695 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' C ' HD13 ' A' ' 38' ' ' ILE . 3.2 tp -79.6 119.37 22.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -0.956 . . . . 0.0 109.613 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.606 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -111.88 170.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.145 179.522 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.61 44.08 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 9.7 p30 -57.81 142.22 46.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.092 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 28' ' ' THR . 25.6 p -85.6 56.95 4.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.713 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 159.23 106.57 0.22 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.875 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -53.8 -175.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.011 -1.287 . . . . 0.0 108.547 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.4 tp -144.92 99.17 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 110.197 178.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -83.11 118.6 23.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -0.984 . . . . 0.0 109.744 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -123.87 69.94 1.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 110.481 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.23 50.47 1.23 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 19.64 57.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.86 71.19 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.146 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.618 ' CH2' HG23 ' A' ' 27' ' ' VAL . 83.5 m95 -46.18 133.85 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.136 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 p -143.96 160.99 39.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 61.44 65.17 1.9 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 111.192 179.516 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.37 134.86 1.37 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.361 1.716 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.597 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.9 Cg_endo -76.55 -176.17 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.821 1.432 . . . . 0.0 109.929 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.8 p -115.83 -178.12 3.32 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.276 1.036 . . . . 0.0 112.094 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.804 ' SG ' HD11 ' A' ' 9' ' ' ILE . 55.5 m -148.07 74.76 1.31 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.99 -167.13 1.15 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.485 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.692 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -115.19 105.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -0.852 . . . . 0.0 109.379 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.086 HG21 ' HB3' ' A' ' 81' ' ' TYR . 32.8 m -95.78 67.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 111.674 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mptp? -68.87 174.86 4.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.354 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.76 161.86 60.93 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 118.43 -1.308 . . . . 0.0 113.565 -177.864 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.2 Cg_endo -81.26 -82.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.832 1.964 . . . . 0.0 110.054 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.58 131.93 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.0 110.295 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.669 ' O ' HD11 ' A' ' 71' ' ' LEU . 58.0 Cg_endo -86.79 88.09 0.71 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.739 1.389 . . . . 0.0 108.615 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.3 p -108.77 -42.0 4.62 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.364 1.078 . . . . 0.0 110.554 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.703 HD11 HD23 ' A' ' 95' ' ' LEU . 0.1 OUTLIER 49.91 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.6 -178.867 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -70.45 108.4 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.617 -0.677 . . . . 0.0 111.696 -178.481 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 4.4 m-80 39.05 38.13 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.641 -0.662 . . . . 0.0 111.381 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -118.43 -40.81 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.236 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 1.0 OUTLIER 40.57 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.942 1.353 . . . . 0.0 112.259 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -138.5 159.15 42.79 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.246 -179.002 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 t -134.65 29.09 3.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.301 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -108.14 -72.32 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 0.0 110.805 -179.53 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -143.47 85.69 0.19 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -112.38 167.67 10.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.405 -1.056 . . . . 0.0 110.232 -179.631 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 tttm -165.79 164.46 18.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -62.57 -22.39 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.25 152.38 37.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 110.588 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.596 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 17.0 m-85 -133.23 -146.32 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.301 -0.874 . . . . 0.0 110.069 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 90.5 p -165.32 -120.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 1.086 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -105.11 36.86 2.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.016 -178.912 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.639 ' C ' HG22 ' A' ' 102' ' ' THR . 10.0 p30 -176.2 -114.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.907 -1.121 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 43.95 79.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.816 -1.178 . . . . 0.0 109.567 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.764 ' CA ' HG23 ' A' ' 102' ' ' THR . 20.7 p30 -69.2 137.8 53.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 0.0 110.706 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 85' ' ' VAL . 29.8 m -119.97 118.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.34 -0.85 . . . . 0.0 110.56 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.4 t0 -83.33 123.49 29.69 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.925 ' CE1' HD12 ' A' ' 71' ' ' LEU . 56.9 m-85 -82.27 139.52 34.15 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.278 1.037 . . . . 0.0 113.048 -177.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -116.19 86.12 2.43 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.248 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.552 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -38.64 126.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 -179.203 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 1.4 mmtt -38.55 -92.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.552 -0.717 . . . . 0.0 111.038 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -146.92 150.31 34.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.004 -1.06 . . . . 0.0 111.034 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 40.94 33.65 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 19.6 m-85 -134.92 148.25 50.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -1.026 . . . . 0.0 109.975 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 117' ' ' VAL . 3.7 tttt -108.23 151.29 26.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 109.987 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.703 HD23 HD11 ' A' ' 66' ' ' ILE . 10.4 mt -89.22 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.49 103.64 6.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.35 -90.01 0.19 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.607 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.7 m -153.61 121.85 6.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -1.164 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 87' ' ' PHE . 2.7 p -75.5 -6.05 48.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -138.15 120.52 15.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.033 -1.042 . . . . 0.0 109.961 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.451 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 20.3 m -136.84 166.37 23.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.764 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.52 153.35 51.71 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.842 . . . . 0.0 110.427 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -82.81 75.01 9.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.52 -179.519 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.463 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -56.01 174.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 111.072 -179.79 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.745 ' CB ' HG11 ' A' ' 59' ' ' VAL . 42.5 Cg_endo -74.84 123.46 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.427 1.751 . . . . 0.0 110.153 -179.417 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.72 -14.73 4.96 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.594 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 85.06 94.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.646 0.736 . . . . 0.0 111.104 179.43 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.92 -160.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.689 0.756 . . . . 0.0 110.882 179.281 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.769 ' HB3' HD13 ' A' ' 113' ' ' LEU . 19.9 m95 -148.11 77.97 1.42 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.806 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.583 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -88.39 151.73 48.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 110.435 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.65 177.88 31.88 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.908 -0.163 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.58 114.59 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.341 0.591 . . . . 0.0 110.988 -179.229 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.769 HD13 ' HB3' ' A' ' 109' ' ' TRP . 4.3 tp -40.58 142.67 0.75 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.529 -0.732 . . . . 0.0 110.191 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.655 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.3 Cg_endo -70.61 165.32 32.32 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.005 1.529 . . . . 0.0 110.219 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 1.022 ' HG2' HG13 ' A' ' 117' ' ' VAL . 62.3 tttt -128.58 103.28 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.902 179.518 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -58.2 87.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.052 -1.03 . . . . 0.0 109.06 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.022 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -95.42 179.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.837 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 3.1 ptp85 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.271 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.405 ' H3 ' HG13 ' A' ' 1' ' ' VAL . 27.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.278 0.561 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.94 174.34 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -130.45 79.46 1.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 7.9 mp0 -47.49 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 1.3 p -55.04 146.06 40.95 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.058 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.848 ' HG3' HG11 ' A' ' 27' ' ' VAL . 46.5 Cg_endo -69.24 155.08 68.7 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.804 1.423 . . . . 0.0 111.11 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.04 174.64 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.105 1.582 . . . . 0.0 110.305 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.17 179.53 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.64 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -147.78 -169.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 122.208 1.004 . . . . 0.0 111.377 -179.888 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 15.1 m -53.5 97.96 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.543 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' SER . 35.2 m-80 41.0 61.69 1.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -168.61 151.19 17.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.3 mtm180 -104.09 -169.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -1.157 . . . . 0.0 110.675 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.6 p80 -147.75 -153.38 0.49 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.384 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 18' ' ' GLU . 16.2 t-20 58.28 149.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -39.3 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' CG ' ' O ' ' A' ' 17' ' ' TYR . 10.5 t80 -160.64 40.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -1.217 . . . . 0.0 110.581 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -165.03 -166.82 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' SER . 1.6 m-20 -140.24 -41.29 0.42 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 110.657 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.59 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 33.2 p90 -131.04 105.9 8.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.941 -1.1 . . . . 0.0 110.845 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.638 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 12.7 m-85 -72.84 -163.51 0.13 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.612 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.57 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -149.8 -64.83 0.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 111.015 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 5.4 t0 -165.23 146.38 7.41 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 66.27 15.13 62.88 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.638 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 1.5 m -97.21 164.3 12.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 109.962 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 43' ' ' VAL . 43.4 t -138.68 154.35 26.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 110.54 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.848 HG11 ' HG3' ' A' ' 6' ' ' PRO . 11.2 t -131.62 122.3 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.509 -179.08 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -78.95 103.08 8.66 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.371 -1.332 . . . . 0.0 107.71 177.799 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.847 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.3 m-30 -67.66 107.08 2.41 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.421 -178.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -69.21 158.01 35.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 110.312 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 18.8 m -123.44 146.32 48.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 4.1 m120 -43.87 138.56 2.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 109.951 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' ASN . 5.3 t -44.39 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 126.75 -1.22 7.39 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.593 ' CE2' HG13 ' A' ' 58' ' ' ILE . 14.3 m-85 -106.39 143.26 34.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -1.183 . . . . 0.0 110.391 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.671 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -92.24 139.86 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 110.84 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.0 tp -91.34 99.12 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.309 179.105 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -87.98 147.14 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.619 -179.76 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.97 -176.96 27.47 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.7 134.36 51.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -1.15 . . . . 0.0 109.777 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.621 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -73.65 53.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.623 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 159.33 116.46 0.45 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.867 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.5 t -58.44 -178.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.001 -1.294 . . . . 0.0 107.866 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -146.14 94.82 2.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.305 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 0.0 109.078 178.79 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.8 p -132.45 111.31 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.411 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 18.31 39.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.3 31.31 47.17 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -151.95 100.56 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -1.175 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CH2' HG23 ' A' ' 27' ' ' VAL . 81.3 m95 -54.03 136.99 40.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 7.4 m -146.09 155.64 42.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.05 -1.031 . . . . 0.0 111.061 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.539 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.6 t0 68.95 64.86 0.54 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.625 -0.672 . . . . 0.0 111.199 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.2 Cg_endo -92.29 132.71 1.17 Allowed 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.971 1.781 . . . . 0.0 110.597 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 37' ' ' LEU . 54.3 Cg_endo -82.84 173.89 9.93 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.862 1.454 . . . . 0.0 109.481 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.636 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 74.2 p -114.22 134.77 54.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.869 -1.144 . . . . 0.0 111.366 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.2 m -98.09 75.58 2.33 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.8 171.37 7.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.365 0.602 . . . . 0.0 110.533 -178.376 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.593 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -87.94 124.74 41.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.011 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.708 HG23 ' CA ' ' A' ' 80' ' ' SER . 33.9 m -110.38 53.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 111.269 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -78.74 107.68 11.62 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.578 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 71.0 m -74.46 162.86 71.91 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.244 -0.91 . . . . 0.0 111.665 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.8 Cg_endo -71.39 -78.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.622 1.854 . . . . 0.0 110.66 179.319 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.1 OUTLIER 178.41 131.02 0.22 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 54.2 Cg_endo -76.68 65.17 7.53 Favored 'Trans proline' 0 C--N 1.295 -2.275 0 O-C-N 123.714 1.376 . . . . 0.0 110.254 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.837 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -95.93 141.34 29.47 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.036 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.824 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -135.8 154.79 34.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.092 -178.908 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.88 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.77 -179.701 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.7 OUTLIER 68.0 -55.51 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 70' ' ' TYR . . . -52.71 -169.3 0.02 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 88' ' ' LYS . 12.6 p90 175.12 -165.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.14 153.73 42.56 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.233 178.237 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t -139.01 24.83 2.54 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -106.71 -73.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.33 81.1 0.29 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.6 t80 -101.01 164.16 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 109.775 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.625 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -160.5 167.98 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.543 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -71.78 -29.37 64.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.255 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 p -139.12 135.19 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 38.8 m-85 -117.13 -170.28 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.809 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.708 ' CA ' HG23 ' A' ' 59' ' ' VAL . 89.1 p -145.77 -99.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.0 111.201 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -120.95 22.01 11.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.494 -1.379 . . . . 0.0 110.357 -178.887 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.639 ' C ' HG22 ' A' ' 102' ' ' THR . 16.4 p30 -159.39 -116.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 110.606 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 t70 52.09 73.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.799 -1.188 . . . . 0.0 109.367 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.815 ' CA ' HG23 ' A' ' 102' ' ' THR . 31.4 t30 -69.46 105.02 2.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.799 . . . . 0.0 110.906 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 85' ' ' VAL . 34.6 m -91.54 118.42 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.028 -1.045 . . . . 0.0 110.757 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.85 137.76 38.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.429 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD1' HG21 ' A' ' 66' ' ' ILE . 38.3 m-85 -97.44 155.61 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.943 -178.255 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 70' ' ' TYR . 1.4 mmtt -136.33 123.1 21.18 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.582 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.523 ' N ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.56 132.04 46.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 110.376 -179.915 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -38.62 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.512 -0.742 . . . . 0.0 110.527 179.894 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -172.96 120.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.148 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.565 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 78.59 50.2 6.21 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.567 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 77.4 m-85 -158.83 167.64 28.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.473 -1.016 . . . . 0.0 110.396 -178.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.694 ' O ' HG22 ' A' ' 117' ' ' VAL . 21.1 tttm -121.39 124.87 45.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 0.0 109.607 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 66' ' ' ILE . 2.3 mt -66.69 92.84 0.23 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.913 -1.117 . . . . 0.0 110.076 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.57 112.41 13.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.91 -79.31 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.601 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -169.37 122.47 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -1.053 . . . . 0.0 110.135 -179.635 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -83.86 17.3 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.734 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 85.7 p -157.15 105.86 2.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.974 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.563 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 3.1 m -123.64 175.63 6.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.199 -0.938 . . . . 0.0 110.943 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.815 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.08 132.63 19.79 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.603 0.716 . . . . 0.0 110.176 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.559 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -61.79 89.23 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.507 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.472 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -75.21 178.58 1.74 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 111.186 -179.046 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.879 ' HB3' HD12 ' A' ' 38' ' ' ILE . 44.0 Cg_endo -76.83 130.5 11.51 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.394 1.734 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.83 -10.3 7.52 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 9.3 m-80 81.42 76.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 122.102 -0.646 . . . . 0.0 110.738 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -171.16 -169.28 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 0.0 111.361 179.746 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.702 ' HB3' HD13 ' A' ' 113' ' ' LEU . 32.0 m95 -133.09 95.72 3.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.626 -0.671 . . . . 0.0 110.104 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.9 mmtt -101.61 146.63 32.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.518 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.601 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.32 178.62 33.06 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.782 -2.174 . . . . 0.0 110.528 -0.291 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -37.56 124.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 110.908 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.837 HD23 ' O ' ' A' ' 65' ' ' THR . 1.5 tp -46.48 143.54 3.88 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 110.226 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.824 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.1 Cg_endo -70.67 168.09 23.75 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.056 1.556 . . . . 0.0 110.636 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.3 tttt -132.76 109.42 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -62.8 89.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.13 -0.981 . . . . 0.0 108.85 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.736 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.4 m -104.9 -173.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.925 0.869 . . . . 0.0 111.215 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.567 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtt-85 . . . . . 0 C--N 1.294 -1.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.738 HG13 ' O ' ' A' ' 1' ' ' VAL . 13.3 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.363 0.602 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.38 162.71 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.099 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -130.54 91.71 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.286 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 2.2 mp0 -64.03 164.98 9.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 109.885 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.74 141.52 1.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.799 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.1 Cg_endo -69.27 162.57 41.29 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.954 1.502 . . . . 0.0 110.874 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.32 170.22 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.036 1.546 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -89.36 104.32 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.585 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -51.13 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.103 0.954 . . . . 0.0 111.251 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.64 141.0 30.95 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.085 -179.337 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.4 m120 50.57 19.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -160.68 168.47 36.13 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.054 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.484 ' N ' ' HD3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -132.34 -177.62 4.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -1.106 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.3 p80 -126.67 143.85 51.1 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.563 -0.71 . . . . 0.0 110.553 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.28 -166.98 1.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.127 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.67 -91.28 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -170.64 28.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -1.16 . . . . 0.0 110.211 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -165.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.427 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -164.98 25.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -150.68 49.22 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 110.822 -179.753 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.3 m-85 -50.15 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.541 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p -141.0 -54.53 0.48 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.089 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 6.6 t70 -172.63 148.18 1.9 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.858 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.28 14.72 54.92 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.181 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.622 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.98 174.53 7.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -1.006 . . . . 0.0 109.641 179.854 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 43' ' ' VAL . 49.6 t -148.99 154.71 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.15 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.697 ' O ' HG23 ' A' ' 43' ' ' VAL . 8.7 t -131.85 119.1 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.631 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.92 103.66 5.22 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.141 178.177 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.634 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.33 175.7 3.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.763 -178.699 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -131.55 161.84 31.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.571 179.576 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.927 ' SG ' HD12 ' A' ' 37' ' ' LEU . 55.9 m -140.1 130.94 25.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 110.431 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -44.4 136.74 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.4 p -46.09 111.75 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.93 -9.06 7.59 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CE1' HG12 ' A' ' 58' ' ' ILE . 3.2 m-85 -114.6 115.38 27.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -1.166 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.76 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -63.94 127.91 33.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.602 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.927 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -82.83 99.91 10.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.142 178.983 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.679 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -86.16 145.38 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 109.196 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.91 -143.98 15.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.53 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.6 m120 -126.41 51.24 1.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.201 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 40' ' ' ASN . 10.8 m 22.79 66.38 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.655 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.516 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.85 108.63 0.37 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.9 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -65.27 -177.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.994 -1.298 . . . . 0.0 108.329 178.8 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' H ' HG12 ' A' ' 43' ' ' VAL . 7.6 tp -145.96 97.35 2.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.544 178.606 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.25 115.02 20.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 178.905 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 83.6 p -127.27 109.24 11.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.613 -0.679 . . . . 0.0 110.471 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.42 41.57 13.18 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.703 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 63.41 33.27 86.78 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.64 107.1 4.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -1.182 . . . . 0.0 110.613 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 76.2 m95 -66.74 138.85 57.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.636 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -149.26 169.75 20.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 111.405 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 49.72 64.85 7.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.784 -0.572 . . . . 0.0 111.421 179.679 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.5 Cg_endo -92.78 147.6 2.64 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 121.919 1.746 . . . . 0.0 110.296 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -81.52 173.89 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.895 1.471 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.617 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.6 p -125.3 141.13 52.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.01 . . . . 0.0 111.231 -179.463 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 75.7 m -100.66 73.91 1.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.7 OUTLIER -118.76 175.84 5.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.043 -179.086 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -88.5 149.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.258 -0.902 . . . . 0.0 108.767 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.818 HG21 ' CB ' ' A' ' 81' ' ' TYR . 33.1 m -124.21 47.46 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 111.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -76.07 155.71 34.56 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.255 178.131 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -120.44 172.24 4.89 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.847 -1.158 . . . . 0.0 111.476 -178.808 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.0 Cg_endo -78.08 -63.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.649 1.868 . . . . 0.0 110.744 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.509 ' CE1' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 163.07 128.56 0.01 OUTLIER Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.203 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.821 ' O ' HD23 ' A' ' 71' ' ' LEU . 48.7 Cg_endo -76.54 69.52 6.65 Favored 'Trans proline' 0 C--N 1.294 -2.302 0 O-C-N 123.696 1.366 . . . . 0.0 110.377 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.733 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -94.22 -173.78 3.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.757 . . . . 0.0 109.403 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.802 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 178.5 169.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 110.272 179.455 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.528 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.32 103.89 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.875 -179.536 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 59.9 m-80 44.68 51.12 8.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -164.64 26.54 0.19 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.619 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -39.27 162.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 123.012 1.386 . . . . 0.0 113.166 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.0 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -45.83 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.603 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER 80.59 25.87 0.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.284 0.564 . . . . 0.0 110.094 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.73 -73.67 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 110.467 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -108.1 -98.31 2.55 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.0 ' HB2' HD13 ' A' ' 71' ' ' LEU . 6.8 t80 57.05 164.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.408 -1.054 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.647 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -170.16 167.44 8.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.438 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -52.83 -26.8 15.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.507 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 8.0 t -149.69 146.92 27.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -142.53 175.69 9.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.8 p -170.65 136.61 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.004 -1.06 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.818 ' CB ' HG21 ' A' ' 59' ' ' VAL . 54.6 t80 31.44 104.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.708 -0.62 . . . . 0.0 111.872 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 38.2 t30 90.19 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 122.005 -0.434 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 80' ' ' SER . 4.5 m-20 55.3 76.64 0.25 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.765 -1.209 . . . . 0.0 108.817 -178.314 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 1.6 t30 -71.29 146.25 49.03 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.63 0.729 . . . . 0.0 111.599 -178.527 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.726 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.3 m -127.53 123.57 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.014 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.04 132.36 34.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.906 -1.121 . . . . 0.0 108.69 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.677 ' CD1' HG21 ' A' ' 66' ' ' ILE . 38.1 m-85 -94.55 136.6 34.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.291 1.043 . . . . 0.0 112.674 -177.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 72' ' ' SER . 2.4 tttp -111.89 102.41 10.66 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.474 -179.109 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.444 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -51.68 131.08 29.74 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 109.705 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.18 -79.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.958 -179.746 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.7 m-85 -165.66 141.31 5.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 0.0 110.298 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.56 61.46 6.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -162.71 175.19 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.45 -1.029 . . . . 0.0 110.208 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.3 tttt -132.14 116.0 16.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.865 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.606 HD23 HD11 ' A' ' 66' ' ' ILE . 5.6 mt -55.3 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.48 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -71.95 99.21 2.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.206 -0.934 . . . . 0.0 109.561 179.341 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.75 -86.24 0.18 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.614 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -162.77 122.07 2.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 110.434 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.9 p -73.52 1.34 10.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.878 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 p -147.55 113.69 5.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.53 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 15.2 m -121.3 -173.39 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.518 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 82' ' ' ASN . 16.1 m -155.83 139.1 15.67 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.942 -178.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.637 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.6 t -69.03 84.03 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 109.371 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.479 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -73.82 177.73 1.94 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.679 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -77.37 130.25 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.569 1.826 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.34 -6.77 12.78 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.877 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 83.15 85.32 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.991 -0.711 . . . . 0.0 111.435 179.364 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.877 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.65 171.83 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.64 0.733 . . . . 0.0 111.14 178.703 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.726 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 51.6 m95 -119.21 93.72 4.18 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.713 -0.617 . . . . 0.0 110.29 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.0 mmtm -98.94 146.05 31.0 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.708 . . . . 0.0 110.566 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.614 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -70.55 169.5 66.38 Favored 'Cis proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.94 -2.108 . . . . 0.0 110.871 -0.786 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 52.2 tt0 -36.03 126.16 0.74 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.568 0.699 . . . . 0.0 111.707 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -42.77 143.51 1.18 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.541 -0.725 . . . . 0.0 109.977 179.105 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.802 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.2 Cg_endo -71.43 164.11 36.83 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 124.158 1.609 . . . . 0.0 111.242 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.523 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -130.57 108.12 9.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 110.411 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.5 t -65.05 93.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 179.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 94' ' ' LYS . 3.2 m -112.35 179.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.708 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.591 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.566 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.489 HG21 ' C ' ' A' ' 47' ' ' GLY . 9.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.233 0.54 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 169.96 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.559 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -135.32 95.73 3.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -71.88 175.73 5.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.483 179.437 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -50.41 138.79 20.87 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.816 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.666 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.8 Cg_endo -68.91 156.26 65.96 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.913 1.481 . . . . 0.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.67 167.69 25.88 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.906 1.477 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' ILE . 84.8 p -81.19 99.67 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.601 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -50.97 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.389 1.09 . . . . 0.0 111.877 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -61.06 116.65 4.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.159 -179.168 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 m120 42.94 43.62 3.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.331 -0.855 . . . . 0.0 111.115 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -158.92 139.06 6.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -95.9 -168.83 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.893 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.651 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 14.9 p80 -148.79 120.74 8.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.801 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -115.63 -71.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.027 . . . . 0.0 110.745 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.58 -97.58 1.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER 179.82 30.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -1.179 . . . . 0.0 110.576 -179.944 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 178.59 -171.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 110.585 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -105.5 -50.53 3.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.018 179.757 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.8 m-85 -88.7 -170.52 2.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 1.7 m-85 -169.52 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.33 -0.856 . . . . 0.0 111.96 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.559 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p 48.72 -97.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.0 -1.062 . . . . 0.0 112.167 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -145.36 157.91 43.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.215 . . . . 0.0 110.342 -178.293 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.4 65.1 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB2' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -92.03 160.78 15.07 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.588 -0.948 . . . . 0.0 110.105 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 43' ' ' VAL . 53.8 t -140.78 152.76 20.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.771 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.973 ' O ' HG23 ' A' ' 43' ' ' VAL . 25.2 t -138.02 116.71 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.123 -1.031 . . . . 0.0 111.391 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.891 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.66 103.61 2.59 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.519 178.098 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.981 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.84 125.95 27.89 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 110.218 -178.138 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -82.05 153.5 26.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.251 -0.906 . . . . 0.0 109.93 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 1.6 t -121.55 138.2 54.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.79 158.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.041 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -62.91 131.51 48.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.33 -33.33 6.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -89.59 136.54 32.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -1.122 . . . . 0.0 109.973 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.724 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.92 144.8 25.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.786 -179.635 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.6 tp -96.39 100.91 12.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.432 -0.792 . . . . 0.0 109.331 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.816 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.1 148.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.06 -168.61 12.64 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.565 -1.303 . . . . 0.0 109.878 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.32 134.16 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.891 ' O ' HG23 ' A' ' 28' ' ' THR . 89.2 p -74.41 56.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.699 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 163.86 114.02 0.3 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.981 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -64.91 -178.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -145.82 99.11 3.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.04 -1.037 . . . . 0.0 110.465 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -86.35 110.11 19.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.356 178.902 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.55 100.37 6.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.381 -0.824 . . . . 0.0 110.629 -179.42 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' C ' HG21 ' A' ' 1' ' ' VAL . . . 84.75 45.14 6.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 62.33 33.6 86.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.34 95.71 2.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -1.156 . . . . 0.0 110.665 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 72.9 m95 -60.07 137.32 58.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.163 -0.961 . . . . 0.0 109.309 179.263 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 t -139.58 179.2 6.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 0.0 111.397 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.3 m-20 38.57 64.75 3.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.78 -0.575 . . . . 0.0 111.535 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.9 Cg_endo -91.97 138.69 2.0 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 121.95 1.767 . . . . 0.0 109.558 178.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 52.3 Cg_endo -78.93 -178.99 5.06 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.734 1.386 . . . . 0.0 110.495 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.537 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 9.0 p -115.06 172.83 6.82 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.801 0.81 . . . . 0.0 111.194 -179.039 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -137.64 77.44 1.63 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.83 -164.26 0.9 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.412 -178.676 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -111.32 131.24 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.985 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.724 HG13 ' HB2' ' A' ' 36' ' ' SER . 11.4 m -125.42 47.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 111.493 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 14.3 mttp -74.08 166.25 23.73 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.846 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.13 171.0 8.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.554 -1.341 . . . . 0.0 112.684 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 51.9 Cg_endo -86.12 -57.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.81 1.953 . . . . 0.0 109.71 178.841 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.523 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 161.76 122.72 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.377 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.887 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.8 Cg_endo -76.1 66.41 6.94 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 O-C-N 123.645 1.34 . . . . 0.0 109.893 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.742 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.4 p -85.34 -173.25 4.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.275 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.823 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 176.52 170.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.34 179.159 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.538 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 1.1 p -79.79 111.16 15.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 111.434 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.506 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 10.3 m-20 36.83 63.0 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -154.48 -44.54 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 33.7 p90 39.99 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.256 1.027 . . . . 0.0 111.302 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.93 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -135.58 154.46 51.34 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.984 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.77 -17.43 13.94 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.895 -1.128 . . . . 0.0 110.2 -178.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.41 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 30.9 t -49.63 -95.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.462 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.06 88.87 0.11 Allowed Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.049 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CD2' ' O ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -78.55 100.34 6.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -1.074 . . . . 0.0 109.479 179.457 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.588 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 1.8 ttmt -88.65 133.72 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.913 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.6 ttt180 -40.27 -32.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.406 -0.809 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -128.23 134.11 48.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.447 -0.783 . . . . 0.0 110.08 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.588 ' CE2' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-85 -117.81 -159.75 0.76 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.703 ' C ' HG23 ' A' ' 59' ' ' VAL . 90.5 p -157.84 -111.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.845 -1.159 . . . . 0.0 111.672 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.613 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -115.24 11.74 16.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.328 -1.482 . . . . 0.0 110.8 -178.396 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.7 OUTLIER -159.03 -3.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.749 -1.219 . . . . 0.0 112.896 -179.243 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -55.04 86.39 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.848 -1.158 . . . . 0.0 108.706 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASN . 48.8 t30 -72.74 129.45 38.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 111.796 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.8 m -116.79 117.14 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -82.99 120.83 26.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 108.955 179.639 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.93 ' CE1' HD12 ' A' ' 71' ' ' LEU . 57.3 m-85 -82.25 138.76 34.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 112.451 -177.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -113.26 84.24 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.067 -179.641 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -38.28 128.95 1.36 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.704 . . . . 0.0 110.712 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.48 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.592 -0.692 . . . . 0.0 110.452 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.1 t80 -166.13 143.3 5.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 0.0 109.889 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.23 46.5 85.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.604 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 17.9 m-85 -151.57 157.28 42.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -1.033 . . . . 0.0 109.973 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.36 112.12 19.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.09 179.884 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' A' ' 114' ' ' PRO . 18.6 mt -48.18 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.481 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -74.93 94.06 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.212 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.05 -89.6 0.14 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -154.5 118.17 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -1.172 . . . . 0.0 110.618 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' PHE . 6.2 p -72.82 -7.27 49.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -141.69 101.72 4.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 0.0 109.857 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 10.9 m -111.15 162.49 14.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 110.923 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 82' ' ' ASN . 3.5 m -138.68 134.25 33.37 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.17 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 49.3 t -61.93 95.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.134 -1.027 . . . . 0.0 108.806 179.247 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.4 175.97 0.45 Allowed Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.508 -0.745 . . . . 0.0 111.259 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.816 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.8 Cg_endo -81.24 19.55 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.523 1.802 . . . . 0.0 111.205 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -113.5 8.19 24.35 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.892 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 76.27 61.15 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.785 -0.833 . . . . 0.0 110.508 179.708 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -176.83 173.38 1.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.073 -1.017 . . . . 0.0 111.854 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.734 ' HB3' HD13 ' A' ' 113' ' ' LEU . 27.8 m95 -95.69 92.26 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.575 0.703 . . . . 0.0 110.692 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.533 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 10.5 mmtm -109.61 135.35 20.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.577 -0.702 . . . . 0.0 109.628 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.2 Cg_endo -69.81 166.41 74.25 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.179 -2.009 . . . . 0.0 111.285 -0.036 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -43.67 139.87 2.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.887 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -47.99 146.62 4.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.254 179.441 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.823 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.9 Cg_endo -72.57 160.41 46.65 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 124.363 1.717 . . . . 0.0 110.713 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.552 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.3 ttmt -122.48 106.9 11.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.967 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.108 -0.995 . . . . 0.0 109.18 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 115' ' ' LYS . 2.1 m -113.41 178.59 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.608 0.718 . . . . 0.0 110.812 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.581 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.796 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.269 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 18.9 mttt -159.89 174.23 14.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -122.7 91.58 3.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' SER . 36.8 mt-30 -71.53 175.55 5.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.706 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -41.79 138.04 1.82 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.874 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.715 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.9 Cg_endo -69.08 158.44 57.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.97 1.51 . . . . 0.0 111.091 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.68 169.01 23.34 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.886 1.466 . . . . 0.0 110.264 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.6 p -73.32 176.24 6.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.86 -170.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.166 0.984 . . . . 0.0 111.462 179.726 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 16.7 m -40.08 91.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -178.997 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.0 m120 43.09 40.11 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 110.433 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -132.22 176.48 19.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 3.3 mtp180 -123.29 -174.93 3.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.386 -1.067 . . . . 0.0 109.759 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.25 122.99 6.81 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.1 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 14' ' ' HIS . 72.1 m-80 -156.61 122.12 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' ' OH ' ' A' ' 21' ' ' TYR . . . -118.69 31.16 5.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 2.1 t80 66.53 25.38 10.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.106 . . . . 0.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.497 ' CD ' ' CZ ' ' A' ' 21' ' ' TYR . 9.9 pt-20 -159.34 -174.3 4.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' SER . 12.0 m-20 -123.41 -28.6 3.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 0.0 110.14 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -105.36 -170.81 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.808 -179.465 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 1.4 m-85 -174.3 -31.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.699 -0.626 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.584 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 17.2 m 67.28 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 112.509 178.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.11 155.05 40.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.733 -1.229 . . . . 0.0 109.963 -178.424 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.54 56.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.031 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.66 162.58 18.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.615 -0.932 . . . . 0.0 110.239 -179.897 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 43' ' ' VAL . 78.3 t -139.21 152.29 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.4 t -135.06 124.52 42.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.696 -179.068 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.884 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.26 101.31 4.63 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.073 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.002 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.48 153.24 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.017 -178.547 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.49 ' HB2' ' HG3' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -115.1 160.89 19.11 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.597 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 17.6 m -128.44 149.46 50.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.04 -1.038 . . . . 0.0 110.534 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -56.25 148.92 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 179.825 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 p -49.8 115.48 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.13 31.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 2.0 m-85 -118.1 131.54 56.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -1.203 . . . . 0.0 110.348 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.689 ' CB ' HG13 ' A' ' 59' ' ' VAL . 8.2 m -82.83 138.31 34.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 110.821 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 41' ' ' SER . 6.2 tp -94.59 101.23 13.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.931 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -96.17 159.9 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 89.35 34.77 8.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 6.2 m120 66.18 176.27 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -1.144 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -116.8 70.71 0.78 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.721 179.632 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 169.93 109.69 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.002 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -69.81 -174.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -1.204 . . . . 0.0 108.445 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.652 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -144.55 102.19 3.78 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.061 178.699 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -88.52 108.76 19.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 179.083 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -125.84 107.81 10.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.49 41.58 6.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 58.95 30.06 65.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -145.96 105.86 4.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -1.22 . . . . 0.0 110.608 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.638 ' CH2' HG23 ' A' ' 27' ' ' VAL . 85.8 m95 -62.07 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.795 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.6 169.72 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.009 . . . . 0.0 111.075 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 47.45 65.22 7.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.821 -0.55 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.5 Cg_endo -90.81 135.03 1.91 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.381 1.727 . . . . 0.0 109.506 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -74.29 161.36 40.61 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.71 1.374 . . . . 0.0 110.072 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.0 p -104.0 143.83 32.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 111.849 -178.432 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 63.5 m -109.76 74.86 0.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.94 173.81 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.519 0.676 . . . . 0.0 110.755 -178.169 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.533 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -86.34 145.37 7.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.689 HG13 ' CB ' ' A' ' 36' ' ' SER . 16.1 m -126.29 48.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.756 -178.164 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 7.0 mtpt -86.05 160.95 19.16 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 118.842 -1.143 . . . . 0.0 107.961 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 16.0 m -122.73 167.86 13.34 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.516 -1.365 . . . . 0.0 112.154 -178.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 42.6 Cg_endo -75.42 -59.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.632 1.859 . . . . 0.0 110.47 179.489 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 168.22 124.0 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.184 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.632 ' HG3' HG11 ' A' ' 85' ' ' VAL . 53.4 Cg_endo -75.87 71.96 5.35 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 O-C-N 123.715 1.377 . . . . 0.0 109.707 -179.009 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.476 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -94.78 177.48 5.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.735 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.757 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -171.47 167.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.427 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.48 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.4 OUTLIER -73.39 106.69 5.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.499 -0.751 . . . . 0.0 110.677 -179.498 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.537 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.7 m120 40.7 36.63 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 110.502 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.756 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.0 31.13 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.595 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -44.89 -175.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.577 1.179 . . . . 0.0 112.186 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.803 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -110.45 160.95 16.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.772 179.091 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.6 t -149.6 24.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.739 -1.226 . . . . 0.0 109.951 -179.343 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 86' ' ' ASP . 24.0 t -112.39 -37.26 5.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.734 -179.405 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -165.05 95.62 0.12 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.584 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -125.98 150.24 48.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -1.068 . . . . 0.0 109.734 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 12.7 ttmm -154.15 140.53 18.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.179 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 76' ' ' LYS . 3.3 mtt180 -41.57 -51.88 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.1 m -94.99 168.26 10.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.808 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.595 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 48.8 m-85 -149.16 179.97 7.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.2 m -159.58 -160.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.597 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.71 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 1.8 t80 -73.91 54.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.648 -1.282 . . . . 0.0 109.866 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.732 ' O ' HG22 ' A' ' 102' ' ' THR . 8.4 p-10 173.51 -125.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.91 -1.118 . . . . 0.0 109.939 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.87 67.83 0.84 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.878 -1.139 . . . . 0.0 109.62 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.721 ' N ' HG23 ' A' ' 102' ' ' THR . 7.7 p-10 -69.81 104.05 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.541 -179.045 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 74' ' ' GLY . 17.3 m -83.97 123.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.141 . . . . 0.0 110.546 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.54 ' CB ' ' HB3' ' A' ' 73' ' ' SER . 2.3 t70 -81.11 124.88 29.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.926 -1.109 . . . . 0.0 109.001 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.803 ' CE1' HD12 ' A' ' 71' ' ' LEU . 26.5 m-85 -88.41 123.46 32.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.997 -1.064 . . . . 0.0 111.851 -178.581 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.5 tttm -102.31 109.28 20.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.659 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -58.79 130.51 47.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.071 -1.018 . . . . 0.0 110.192 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 21.7 mmtt -39.41 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 33.9 p90 -144.82 149.62 35.74 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.083 -1.011 . . . . 0.0 110.724 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 39.76 37.3 0.89 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 17.5 m-85 -137.64 146.56 44.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -1.082 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -106.66 162.76 13.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 108.956 179.097 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -96.31 106.29 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.742 -1.224 . . . . 0.0 110.618 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.5 t -86.83 102.06 13.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.505 -0.747 . . . . 0.0 109.578 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 137.47 -43.59 1.2 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 1.0 OUTLIER 175.49 -166.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 111.238 -179.595 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -67.85 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.707 -0.621 . . . . 0.0 109.999 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 56.2 p -92.09 84.01 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.805 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 1.4 m -86.29 166.52 15.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.314 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 82' ' ' ASN . 3.9 m -146.13 139.46 25.98 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.57 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 51.8 t -61.76 104.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -74.12 176.59 2.72 Favored Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 111.319 -178.495 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.931 ' HB2' HD12 ' A' ' 38' ' ' ILE . 52.4 Cg_endo -80.28 10.03 3.39 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.722 1.906 . . . . 0.0 110.974 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -104.99 7.37 44.44 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.881 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 76.13 61.16 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.708 -0.878 . . . . 0.0 109.953 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -176.97 175.5 1.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.771 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.603 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.7 m95 -98.41 95.36 7.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.573 0.701 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.4 mmmt -107.59 136.36 19.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 44.2 Cg_endo -70.4 166.02 76.88 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.25 -1.979 . . . . 0.0 111.29 0.693 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 14.9 tt0 -42.3 134.93 2.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.51 -0.744 . . . . 0.0 109.88 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD12 ' CZ ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -42.18 139.56 1.76 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.95 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.757 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.1 Cg_endo -71.22 169.54 20.43 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.233 1.649 . . . . 0.0 111.535 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.839 ' HG2' HG13 ' A' ' 117' ' ' VAL . 8.5 tttt -125.04 108.34 11.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.773 . . . . 0.0 110.901 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -61.04 97.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 108.875 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.839 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -103.36 -179.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.828 0.823 . . . . 0.0 111.183 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.35 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 3.9 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.258 0.552 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -160.9 166.37 28.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -126.61 72.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 110.12 -179.892 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -59.28 179.6 0.1 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.302 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.4 p -43.17 142.8 1.48 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.037 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.649 ' HG3' HG21 ' A' ' 27' ' ' VAL . 47.6 Cg_endo -72.49 164.15 36.46 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.057 1.556 . . . . 0.0 110.569 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.48 169.51 21.58 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.98 1.516 . . . . 0.0 110.286 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.243 -0.91 . . . . 0.0 109.804 179.635 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.732 HG21 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.13 -170.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.329 1.061 . . . . 0.0 111.886 179.91 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.1 t -59.85 83.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.285 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.1 m120 54.68 59.28 4.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -159.25 147.24 14.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' SER . 10.2 mtt180 -93.96 -170.43 2.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -1.141 . . . . 0.0 110.919 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.491 ' HB3' ' OE1' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -85.39 -139.23 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.062 179.834 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 52.8 t30 -87.37 -54.99 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.217 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.09 -37.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 11.8 t80 -174.42 79.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.606 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.5 mp0 -108.41 177.41 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 4.9 t0 178.04 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.973 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -141.91 88.89 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.055 -1.028 . . . . 0.0 109.493 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.9 m-85 -98.49 -9.53 24.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.78 . . . . 0.0 111.116 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.578 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.2 p 43.22 -92.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.548 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 21' ' ' TYR . 3.7 t0 -153.57 131.91 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.985 -1.072 . . . . 0.0 110.475 -178.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.46 47.75 2.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 42.2 m -148.41 154.34 39.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -1.171 . . . . 0.0 110.376 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.7 t -129.31 152.61 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 111.567 -178.463 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.649 HG21 ' HG3' ' A' ' 6' ' ' PRO . 33.4 t -122.27 114.39 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.628 -0.67 . . . . 0.0 111.484 -179.568 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -71.99 103.63 3.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.404 -1.318 . . . . 0.0 107.623 177.771 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.732 ' CD2' HG21 ' A' ' 9' ' ' ILE . 2.2 m-30 -67.75 118.56 11.16 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 110.138 -178.198 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.532 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.53 154.66 38.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 179.539 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 36.1 m -128.54 153.46 47.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.63 166.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.844 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.61 98.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 110.399 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 11.08 8.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.0 m-30 -105.76 119.2 38.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.173 . . . . 0.0 110.184 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.828 ' HB2' HG22 ' A' ' 59' ' ' VAL . 19.8 t -68.32 141.87 55.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.581 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.593 ' C ' HD13 ' A' ' 38' ' ' ILE . 1.4 tp -95.89 108.58 20.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.734 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -103.22 140.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.346 -0.846 . . . . 0.0 109.313 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 134.82 -142.03 13.42 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -110.55 52.57 0.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -1.191 . . . . 0.0 110.335 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 40' ' ' ASN . 20.2 p 26.3 59.14 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.881 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.649 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 133.57 122.24 2.28 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.412 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -61.53 176.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.14 -1.212 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.7 tp -142.39 93.97 2.6 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.639 -1.225 . . . . 0.0 110.686 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.92 109.8 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.371 178.213 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 t -131.04 98.26 4.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.549 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.45 9.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.483 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 84.24 10.25 80.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.95 116.6 15.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.072 -1.252 . . . . 0.0 110.765 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.606 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -68.48 140.32 55.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.89 150.61 34.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.062 -1.024 . . . . 0.0 111.188 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 64.35 65.71 1.07 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.685 -0.635 . . . . 0.0 111.637 179.21 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.0 Cg_endo -91.71 136.37 1.78 Allowed 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.369 1.721 . . . . 0.0 109.559 178.588 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.532 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.7 Cg_endo -80.57 179.1 6.35 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.71 1.374 . . . . 0.0 110.745 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' ILE . 5.2 p -123.91 148.9 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.8 . . . . 0.0 111.371 -178.68 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.2 m -110.51 78.59 1.13 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.31 -159.39 0.68 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.415 0.626 . . . . 0.0 110.368 -178.923 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.671 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.15 125.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.936 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.828 HG22 ' HB2' ' A' ' 36' ' ' SER . 22.5 m -118.9 52.99 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.13 -0.981 . . . . 0.0 111.597 -179.102 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 13.2 mtpt -60.82 -179.86 0.14 Allowed 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 117.811 -1.556 . . . . 0.0 107.964 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 93.4 m -136.71 160.51 66.18 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.762 -178.232 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.5 Cg_endo -85.2 -72.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.736 1.913 . . . . 0.0 109.95 178.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.58 124.9 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.743 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.621 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.5 Cg_endo -77.44 65.61 8.0 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.867 1.456 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.458 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -81.86 161.23 23.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.293 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.821 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -157.11 166.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 0.0 110.743 -179.664 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.47 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.39 108.11 10.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.691 -179.385 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.523 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 4.4 m-20 39.93 41.19 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.483 -0.761 . . . . 0.0 110.615 179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.821 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.5 33.11 0.92 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.3 p90 -44.84 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 112.469 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.743 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -112.0 161.67 16.2 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.938 179.353 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.83 30.19 1.48 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.829 -1.169 . . . . 0.0 110.382 -179.131 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -110.81 -86.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.47 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.24 71.8 0.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.1 t80 -99.51 166.25 11.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -1.065 . . . . 0.0 110.018 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.639 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -171.05 161.2 6.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 109.79 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -51.14 -32.57 23.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.098 . . . . 0.0 109.451 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.467 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.2 m -144.82 170.76 15.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.67 -0.644 . . . . 0.0 109.798 179.674 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 3.8 m-85 -143.72 -134.68 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 0.0 109.938 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.4 p -167.34 -133.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.839 -1.163 . . . . 0.0 111.133 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.74 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -87.22 14.88 6.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.771 -1.206 . . . . 0.0 110.873 -178.848 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.599 ' HA ' HG22 ' A' ' 102' ' ' THR . 59.9 t30 -160.53 -116.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.711 -1.243 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 5.8 m-20 54.51 76.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.81 -1.181 . . . . 0.0 108.888 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' HG23 ' A' ' 102' ' ' THR . 22.4 t-20 -71.43 109.83 5.65 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 110.535 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.621 HG11 ' HG3' ' A' ' 64' ' ' PRO . 14.8 m -87.38 119.44 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.4 t0 -80.6 129.52 34.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 108.798 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.743 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.0 m-85 -89.04 142.22 27.82 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.038 -1.039 . . . . 0.0 112.19 -178.237 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -121.26 92.06 3.67 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.51 -179.607 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.41 130.74 3.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.425 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.523 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 5.5 mmtt -42.55 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -153.21 154.58 34.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.421 -179.977 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 43.55 31.53 1.7 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.7 m-85 -143.35 144.88 32.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 110.316 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' VAL . 16.4 pttp -113.59 139.43 49.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.875 . . . . 0.0 109.577 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.601 HD23 HD11 ' A' ' 66' ' ' ILE . 1.2 mt -66.9 114.15 5.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.099 -1.001 . . . . 0.0 111.118 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -92.16 98.02 11.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.613 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 140.14 -45.82 0.97 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.228 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.526 ' CB ' ' CG ' ' A' ' 111' ' ' PRO . 10.7 t -177.3 -172.99 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.249 . . . . 0.0 111.69 -179.458 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 p -144.76 -27.32 0.49 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.792 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -132.48 97.01 3.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.865 -1.147 . . . . 0.0 109.694 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 24.8 m -103.3 162.66 12.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 82' ' ' ASN . 1.1 m -136.56 137.02 39.78 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.784 -0.572 . . . . 0.0 110.148 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.606 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 45.5 t -77.28 96.85 4.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.354 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -66.38 -176.3 0.23 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.602 -0.686 . . . . 0.0 110.741 179.936 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.734 ' HG3' HG23 ' A' ' 38' ' ' ILE . 42.7 Cg_endo -77.81 124.37 6.81 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.978 1.515 . . . . 0.0 110.55 -179.53 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.48 -7.28 6.25 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.711 ' O ' HG23 ' A' ' 108' ' ' THR . 4.8 m-20 79.35 95.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.898 -0.766 . . . . 0.0 110.976 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.0 -160.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -0.767 . . . . 0.0 111.088 179.453 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.686 ' HB3' HD13 ' A' ' 113' ' ' LEU . 26.9 m95 -149.73 111.43 4.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.588 -0.695 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.534 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.7 mttt -112.11 127.1 27.32 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 110.157 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.14 174.08 35.93 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.064 -2.057 . . . . 0.0 110.549 0.161 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 113' ' ' LEU . 3.7 mt-10 -63.96 59.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.602 -0.686 . . . . 0.0 111.27 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.686 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER 55.94 143.95 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 121.442 0.639 . . . . 0.0 111.383 178.951 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.714 ' HG2' HD12 ' A' ' 66' ' ' ILE . 43.0 Cg_endo -84.08 166.87 12.71 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.271 1.669 . . . . 0.0 111.09 -179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.708 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -122.0 109.28 14.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.234 -0.916 . . . . 0.0 110.748 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.1 t -65.28 104.68 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.02 . . . . 0.0 109.258 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.708 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -119.18 -176.02 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.667 0.746 . . . . 0.0 111.023 -179.103 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 . . . . . 0 C--N 1.294 -1.833 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.367 -179.84 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.271 0.558 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.77 174.59 8.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.264 -0.897 . . . . 0.0 110.574 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 52.9 t -130.0 158.58 39.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -133.68 178.06 7.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.415 -0.803 . . . . 0.0 109.978 179.884 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.5 136.88 7.21 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.476 -0.765 . . . . 0.0 110.254 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.613 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.0 Cg_endo -70.24 155.67 63.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.157 1.609 . . . . 0.0 110.998 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.68 174.39 12.74 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.841 1.443 . . . . 0.0 109.785 178.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -69.89 177.15 3.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.099 -1.001 . . . . 0.0 110.2 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.39 -170.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.261 1.029 . . . . 0.0 111.54 179.872 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -47.06 101.32 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.744 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 10' ' ' SER . 24.8 m-20 40.29 47.3 2.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.29 161.81 30.66 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' SER . 5.1 mpt_? -112.01 -169.89 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.489 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.613 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.1 p80 -144.67 119.38 9.82 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.73 81.3 1.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 110.451 -179.538 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -91.28 28.44 8.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 32.9 p90 37.05 50.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.98 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.589 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 14.5 mm-40 -140.11 -169.48 2.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -147.55 -36.91 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 9.0 p90 -142.2 79.09 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.346 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 34.0 m-85 -55.43 -166.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.534 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -152.4 -67.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.91 -1.119 . . . . 0.0 110.743 -179.736 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.96 136.79 9.22 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.546 -0.721 . . . . 0.0 109.357 -179.238 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 73.07 7.9 72.45 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.606 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.8 m -73.54 156.37 38.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -1.031 . . . . 0.0 109.809 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 43' ' ' VAL . 54.1 t -138.66 153.39 25.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.681 ' HB ' HG23 ' A' ' 43' ' ' VAL . 41.4 t -138.67 118.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.37 -179.543 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.16 106.31 3.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.407 -1.317 . . . . 0.0 107.591 178.059 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.926 ' O ' HD13 ' A' ' 37' ' ' LEU . 3.3 m-30 -68.02 139.01 56.3 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 110.356 -178.053 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -93.98 159.07 15.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.0 m -123.23 149.68 44.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -45.54 138.0 4.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -44.42 106.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 179.993 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.52 15.47 6.95 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.04 137.22 50.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -1.123 . . . . 0.0 110.393 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.661 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -85.78 147.01 26.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 110.929 -179.531 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.6 tp -95.9 100.63 12.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.73 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -96.27 173.81 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 108.953 179.55 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 80.62 175.91 49.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.929 179.859 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -42.51 111.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -1.067 . . . . 0.0 110.021 179.822 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 28' ' ' THR . 89.2 p -70.51 55.18 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.611 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.37 95.48 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.91 175.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.357 -1.084 . . . . 0.0 108.768 179.5 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -141.12 101.0 3.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.405 -0.809 . . . . 0.0 109.923 178.707 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 6.2 t -78.09 109.38 12.12 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.64 128.94 55.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.439 -0.788 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.59 30.93 57.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.38 45.56 29.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -151.56 97.78 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.132 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.625 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 97.9 m95 -64.33 125.59 25.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.25 171.34 14.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.639 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 52.59 64.53 7.23 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.721 . . . . 0.0 110.635 -179.833 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.9 130.08 1.43 Allowed 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 121.913 1.742 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.8 Cg_endo -74.27 176.12 10.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.822 1.433 . . . . 0.0 110.536 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.551 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.4 p -105.62 173.67 6.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.842 0.83 . . . . 0.0 111.266 -179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.6 m -139.75 75.43 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.6 mm-40 -114.21 -152.13 0.5 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.735 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.738 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.67 138.42 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.379 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.686 HG23 ' CA ' ' A' ' 80' ' ' SER . 34.5 m -128.25 41.2 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.01 -1.056 . . . . 0.0 110.966 -179.115 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 16.6 mttt -53.93 178.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.358 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.16 162.33 40.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.578 -179.021 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.0 Cg_endo -83.8 -68.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.829 1.963 . . . . 0.0 110.306 179.08 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 161.31 128.73 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.382 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.742 ' HA ' HD21 ' A' ' 113' ' ' LEU . 49.4 Cg_endo -78.01 60.34 7.29 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 O-C-N 123.571 1.301 . . . . 0.0 109.841 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.711 ' C ' HG22 ' A' ' 66' ' ' ILE . 2.3 p -74.76 -177.3 3.18 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.022 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -176.26 167.77 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.967 179.463 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 6.8 m -70.1 89.76 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.589 -0.694 . . . . 0.0 110.688 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.3 m120 50.23 49.62 20.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.87 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.022 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -162.66 40.62 0.36 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.712 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.6 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -48.25 -151.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.968 1.366 . . . . 0.0 113.076 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.985 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.46 122.82 13.94 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.619 -176.973 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 t -100.4 14.96 29.37 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.52 -0.737 . . . . 0.0 109.968 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 24.7 t -76.11 -91.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.969 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.43 81.25 0.3 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.609 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.04 125.37 46.1 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.358 -1.083 . . . . 0.0 109.713 179.494 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 77' ' ' ARG . 10.0 ttmm -111.05 149.76 30.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 0.0 109.931 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -41.47 -41.46 2.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.863 . . . . 0.0 110.015 -179.988 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m -137.55 152.94 49.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.439 -0.788 . . . . 0.0 109.981 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -125.62 -162.52 1.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.686 ' CA ' HG23 ' A' ' 59' ' ' VAL . 2.3 m -153.94 -102.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.314 -0.866 . . . . 0.0 109.583 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.614 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.8 137.96 49.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.732 -1.23 . . . . 0.0 108.198 179.234 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.843 ' C ' HG22 ' A' ' 102' ' ' THR . 37.4 t-20 71.49 -104.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.739 -0.6 . . . . 0.0 110.594 -178.372 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 39.5 m-20 44.96 74.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.606 -1.309 . . . . 0.0 109.355 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.831 ' CA ' HG23 ' A' ' 102' ' ' THR . 0.2 OUTLIER -69.82 140.3 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 111.056 -178.956 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.685 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 3.7 m -129.73 126.33 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.0 110.114 179.127 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.83 132.99 33.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.031 . . . . 0.0 109.32 179.399 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.985 ' CE2' HD23 ' A' ' 71' ' ' LEU . 44.4 m-85 -89.31 149.11 23.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.145 -0.972 . . . . 0.0 111.935 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.65 90.2 3.27 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.162 0.506 . . . . 0.0 110.037 -179.514 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.442 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -43.14 124.5 3.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.9 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 110.801 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -97.2 -161.05 0.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 110.372 -179.73 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.75 58.36 0.14 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 3.0 m-30 -112.15 160.79 17.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.721 -0.87 . . . . 0.0 109.404 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.72 ' O ' HG22 ' A' ' 117' ' ' VAL . 10.6 tttt -101.05 136.43 40.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.991 -1.068 . . . . 0.0 110.52 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 66' ' ' ILE . 1.6 mt -79.56 90.65 5.12 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.537 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.8 101.94 1.82 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.829 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.58 -78.02 0.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.133 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -171.48 117.22 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -1.12 . . . . 0.0 110.635 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 -1.51 13.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -0.92 . . . . 0.0 110.966 -179.696 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 p -144.61 112.39 6.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.808 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.531 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.3 m -118.44 177.19 4.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 111.041 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.843 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -146.95 128.68 15.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.969 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.59 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 5.4 t -68.91 88.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.705 . . . . 0.0 109.51 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -69.16 -178.41 0.45 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.793 . . . . 0.0 111.193 -179.248 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.3 Cg_endo -80.7 124.96 5.33 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.564 1.823 . . . . 0.0 110.6 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 128.37 -8.12 6.64 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.428 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.762 ' O ' HG23 ' A' ' 108' ' ' THR . 7.2 m-20 83.48 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.5 0.667 . . . . 0.0 111.31 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -170.96 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.723 0.773 . . . . 0.0 111.21 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.685 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 32.1 m95 -137.73 92.37 2.67 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.451 0.643 . . . . 0.0 110.22 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 28.4 mttt -103.56 142.96 25.67 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.8 Cg_endo -70.58 167.57 73.0 Favored 'Cis proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.072 -2.054 . . . . 0.0 111.035 -0.62 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 113' ' ' LEU . 42.5 mt-10 -38.91 129.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.56 -0.712 . . . . 0.0 111.293 -179.239 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -40.06 147.25 0.36 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 110.594 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.806 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.7 Cg_endo -74.04 167.47 27.13 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.441 1.758 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.549 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -130.43 105.08 7.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.919 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.8 t -61.57 101.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.837 . . . . 0.0 109.213 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -115.28 -175.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.698 0.761 . . . . 0.0 110.588 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.0 mtm180 . . . . . 0 C--N 1.295 -1.791 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.32 0.581 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 138.75 44.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.0 110.257 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -108.01 99.21 8.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.847 . . . . 0.0 110.117 -179.921 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 9.9 mt-30 -88.38 177.19 6.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -39.09 136.89 0.97 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.544 -0.723 . . . . 0.0 110.586 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.77 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.2 Cg_endo -71.27 158.31 54.91 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.058 1.557 . . . . 0.0 110.855 -179.453 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.25 170.94 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.754 1.397 . . . . 0.0 109.865 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.59 175.31 4.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.666 179.695 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.652 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -138.37 -170.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.138 0.97 . . . . 0.0 111.463 179.861 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -46.19 90.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER 48.11 48.62 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.786 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -147.65 164.75 28.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.497 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -110.13 -169.95 1.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -1.076 . . . . 0.0 110.524 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -158.89 121.3 3.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.258 0.552 . . . . 0.0 109.981 -179.675 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.79 79.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.137 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.18 -98.0 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 t80 -150.76 34.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.222 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' CD ' ' CE1' ' A' ' 21' ' ' TYR . 2.5 pt-20 -177.81 -159.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.043 -1.035 . . . . 0.0 110.527 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -162.03 24.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.089 -179.962 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 22' ' ' THR . 0.3 OUTLIER -140.54 29.69 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 36.7 m-85 -37.05 142.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 20' ' ' PHE . 27.8 p -133.8 89.56 2.6 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.228 1.013 . . . . 0.0 110.488 179.248 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER 55.27 152.24 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.83 179.127 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 19.77 8.88 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.705 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.4 m -87.41 177.88 6.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -1.063 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 25' ' ' SER . 26.4 t -158.41 156.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.05 179.495 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.77 HG11 ' HG3' ' A' ' 6' ' ' PRO . 30.3 t -144.99 124.05 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.77 -179.439 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.82 101.34 5.07 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.398 -1.321 . . . . 0.0 107.725 177.881 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.869 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.8 m-30 -67.99 128.12 35.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 110.423 -178.21 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.6 t -77.89 -173.7 3.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.196 -0.94 . . . . 0.0 108.883 178.844 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 89.1 m -147.36 168.25 22.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.104 -0.998 . . . . 0.0 110.239 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.93 148.52 39.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.897 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.5 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.974 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.19 0.29 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -110.88 140.85 45.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -1.138 . . . . 0.0 110.276 -179.811 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -87.68 145.72 26.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.905 . . . . 0.0 110.623 -179.937 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.869 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.05 103.16 15.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.323 -0.86 . . . . 0.0 109.937 179.557 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.678 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -97.18 171.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 108.826 179.124 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 87.0 -168.59 39.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.95 117.82 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -1.125 . . . . 0.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.493 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.69 56.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -0.987 . . . . 0.0 109.644 179.53 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 160.27 94.19 0.1 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG21 ' CZ ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -48.33 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.341 -1.093 . . . . 0.0 108.85 179.849 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 25' ' ' SER . 10.8 tp -142.64 102.04 3.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.985 178.78 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -73.63 118.32 16.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.912 179.612 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -133.92 126.83 31.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.164 -0.96 . . . . 0.0 110.177 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.01 19.46 77.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 83.64 25.67 45.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.4 133.9 26.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.292 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.737 ' CH2' HG23 ' A' ' 27' ' ' VAL . 88.6 m95 -80.07 132.72 36.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.976 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.18 162.16 33.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 110.935 -179.604 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 60.57 66.22 1.9 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.509 -0.745 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.6 Cg_endo -90.75 127.2 1.26 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 121.91 1.74 . . . . 0.0 110.069 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 45.8 Cg_endo -71.15 176.89 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.668 1.352 . . . . 0.0 110.111 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.7 p -113.39 151.45 31.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -0.936 . . . . 0.0 111.916 -178.803 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -116.04 80.74 1.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.878 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -116.8 -162.45 0.85 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 110.425 -178.031 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.664 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -106.4 137.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.173 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.687 HG21 ' CB ' ' A' ' 81' ' ' TYR . 26.0 m -118.77 43.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 111.037 -179.266 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.38 98.79 9.67 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.709 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 56.4 m -68.68 164.31 46.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.803 . . . . 0.0 111.804 -177.78 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -66.61 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.514 1.797 . . . . 0.0 110.303 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.569 ' CE1' ' HE1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -165.27 133.94 2.6 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.778 ' HG2' HD21 ' A' ' 71' ' ' LEU . 51.6 Cg_endo -76.5 69.37 6.68 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 O-C-N 123.703 1.37 . . . . 0.0 110.018 -178.953 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.676 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -92.2 -176.85 4.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 109.07 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.961 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -174.64 162.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.592 179.494 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' OG ' ' A' ' 67' ' ' SER . 3.7 p -69.38 101.31 1.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.547 -0.721 . . . . 0.0 110.395 -179.612 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.509 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 21.6 m-20 41.51 57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.177 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.961 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -170.14 37.31 0.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.762 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.4 p90 -44.06 -170.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 123.419 1.58 . . . . 0.0 112.907 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.946 ' O ' HD12 ' A' ' 71' ' ' LEU . 1.7 pp -107.46 116.16 31.45 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.55 179.498 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -82.28 1.38 37.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.42 -0.8 . . . . 0.0 109.602 -179.725 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 21.0 t -74.72 -86.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.76 . . . . 0.0 110.711 -179.61 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.14 94.5 0.12 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.163 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.944 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.28 104.3 11.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -1.07 . . . . 0.0 109.296 179.303 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.9 tptt -76.75 145.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.304 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -48.37 70.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.042 179.761 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 27.4 p -117.4 135.29 53.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' HB3' ' CB ' ' A' ' 103' ' ' CYS . 95.2 m-85 -113.81 -179.61 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.781 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.9 m -170.54 108.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.976 -1.077 . . . . 0.0 111.308 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CB ' HG21 ' A' ' 59' ' ' VAL . 11.5 t80 34.92 24.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.356 -0.84 . . . . 0.0 113.106 178.771 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.71 ' C ' HG22 ' A' ' 102' ' ' THR . 37.3 t-20 -176.51 -125.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.067 -1.646 . . . . 0.0 111.472 178.388 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 49.29 75.42 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.633 -1.292 . . . . 0.0 108.828 -178.359 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.592 ' CA ' HG23 ' A' ' 102' ' ' THR . 22.4 p-10 -69.57 139.9 53.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.476 -0.765 . . . . 0.0 110.512 -179.054 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.697 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -126.43 120.83 57.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.702 179.07 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 10.7 t0 -75.38 136.02 40.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 108.847 179.368 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 113' ' ' LEU . 16.5 m-85 -99.36 135.15 41.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.952 -1.092 . . . . 0.0 111.895 -178.564 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' TYR . 3.0 ttpt -109.53 154.91 22.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -100.28 128.18 46.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.92 -1.113 . . . . 0.0 110.098 179.891 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -44.68 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.701 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 93' ' ' TYR . 1.2 m-85 -95.71 -163.81 1.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 110.576 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.37 59.45 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.601 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.605 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-85 -109.38 168.94 9.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.788 -0.831 . . . . 0.0 110.009 -179.317 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.544 ' O ' HG22 ' A' ' 117' ' ' VAL . 22.0 mttt -117.3 110.71 18.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.5 mt -49.14 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -74.43 95.74 2.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 110.044 179.817 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.34 -68.78 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.333 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.582 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -175.95 119.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -1.156 . . . . 0.0 111.03 -179.148 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.12 24.13 0.44 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.99 -1.069 . . . . 0.0 111.339 179.676 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 p -167.22 129.17 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.951 -1.093 . . . . 0.0 109.273 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 66.4 m -143.58 160.66 40.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 111.189 -179.145 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.71 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.38 137.83 50.07 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.575 0.703 . . . . 0.0 109.931 179.301 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 1.8 t -56.25 92.75 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.718 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 1.1 p -71.3 179.29 0.97 Allowed Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 110.118 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.678 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.0 Cg_endo -78.51 170.75 17.88 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 O-C-N 124.018 1.536 . . . . 0.0 111.448 -179.026 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 86.13 -57.24 4.79 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -178.906 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.1 m-20 141.66 68.76 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.365 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.26 165.65 24.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.652 -1.28 . . . . 0.0 112.032 -179.473 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.697 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 35.7 m95 -105.99 97.79 7.56 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.307 0.575 . . . . 0.0 109.849 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 5.1 mmmt -99.37 138.85 20.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.56 -179.338 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.582 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.7 Cg_endo -72.06 167.84 75.67 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.793 -0.48 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.4 tt0 -41.4 134.06 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.755 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -42.27 152.07 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.385 -0.822 . . . . 0.0 110.706 -179.736 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.804 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.0 Cg_endo -79.42 159.3 25.85 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.554 1.818 . . . . 0.0 111.487 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.1 tptt -119.03 106.57 12.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.512 -0.742 . . . . 0.0 110.713 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.4 t -62.43 97.86 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 108.774 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.67 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -112.02 178.28 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.55 0.691 . . . . 0.0 110.592 -179.396 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.662 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.713 HG11 ' HA2' ' A' ' 47' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.327 0.584 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -120.11 174.4 6.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -140.11 85.08 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.696 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 25.3 mt-30 -60.47 171.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 p -47.77 149.39 2.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.668 ' HG3' HG21 ' A' ' 27' ' ' VAL . 51.4 Cg_endo -72.31 155.76 55.58 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.95 1.5 . . . . 0.0 110.946 -179.159 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.44 169.08 23.33 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.599 1.315 . . . . 0.0 109.686 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.27 177.22 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.993 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.69 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -170.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.197 0.998 . . . . 0.0 111.475 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -45.62 94.0 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 -179.396 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.0 m120 41.76 53.08 4.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.287 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.85 152.65 24.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.9 mtt180 -94.99 -169.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -1.146 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.2 p80 -160.4 132.72 6.23 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 -179.631 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER 173.77 104.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.056 . . . . 0.0 110.7 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 17' ' ' TYR . . . -81.51 -69.11 1.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.555 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 33.0 p90 178.61 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.334 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.51 -139.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.823 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -149.9 -36.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 110.992 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 14.8 p90 -143.98 90.46 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.859 -1.151 . . . . 0.0 111.227 -179.403 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 44.8 m-85 -57.8 171.2 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.532 178.88 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.474 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -125.96 -49.07 1.6 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.832 -1.168 . . . . 0.0 111.192 -179.359 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -175.44 142.58 0.59 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.304 -0.872 . . . . 0.0 109.565 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.33 69.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -178.741 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.613 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.9 m -87.8 178.38 6.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.615 -0.932 . . . . 0.0 110.15 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.738 HG13 ' O ' ' A' ' 43' ' ' VAL . 31.5 t -154.46 154.04 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.668 HG21 ' HG3' ' A' ' 6' ' ' PRO . 39.6 t -135.8 118.69 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.39 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.856 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -71.0 103.32 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.707 177.915 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.69 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.4 m-30 -68.14 134.46 50.57 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 13' ' ' ARG . 1.1 m -93.15 159.3 15.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.612 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 34.2 m -126.08 154.01 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -44.39 158.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.011 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 t -62.08 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 110.356 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.31 22.36 3.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-30 -113.36 146.18 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -1.216 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.802 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -88.01 134.38 33.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.676 -0.64 . . . . 0.0 110.816 -179.43 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' THR . 1.2 tp -96.24 102.37 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 178.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.48 143.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.233 -0.917 . . . . 0.0 109.08 179.632 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 -175.86 21.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.242 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 5.0 p30 -65.65 142.86 57.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.041 -1.27 . . . . 0.0 109.83 179.763 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.76 51.24 1.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 110.445 -179.713 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.662 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 166.29 102.25 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.394 179.865 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.738 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -49.0 178.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.165 -1.197 . . . . 0.0 108.5 179.157 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -140.05 98.21 3.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 110.081 178.548 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.6 t -79.77 118.58 21.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.433 178.902 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -131.02 114.8 15.64 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.713 ' HA2' HG11 ' A' ' 1' ' ' VAL . . . 70.44 29.02 70.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 76.41 48.29 9.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.616 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -159.06 87.62 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 179.823 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.617 ' CH2' HG23 ' A' ' 27' ' ' VAL . 88.0 m95 -58.42 123.94 17.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.105 -0.997 . . . . 0.0 109.314 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -133.02 165.14 25.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 111.445 -179.22 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 1.6 m-20 58.28 65.57 3.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.86 -0.525 . . . . 0.0 111.242 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.7 Cg_endo -92.87 132.23 0.96 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 121.972 1.782 . . . . 0.0 109.985 178.962 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -75.23 177.32 8.78 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.579 1.305 . . . . 0.0 109.879 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.52 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.4 p -118.84 141.48 48.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 111.721 -178.667 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 89.4 m -106.76 79.87 1.39 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.099 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.23 -151.72 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.808 -0.558 . . . . 0.0 109.928 -178.692 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.52 122.73 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 108.766 179.177 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.802 HG13 ' CB ' ' A' ' 36' ' ' SER . 19.7 m -116.33 52.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 111.653 -178.311 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mtpt -65.2 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.801 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -129.8 151.26 77.86 Favored Pre-proline 0 C--N 1.295 -1.763 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.871 -178.368 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.563 ' HG3' ' HA ' ' A' ' 108' ' ' THR . 47.0 Cg_endo -84.51 9.4 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.649 1.868 . . . . 0.0 109.356 177.439 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.729 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 69.0 120.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.484 -0.76 . . . . 0.0 110.039 -179.172 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.66 ' HA ' HD21 ' A' ' 113' ' ' LEU . 56.2 Cg_endo -83.64 96.87 0.77 Allowed 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 123.957 1.504 . . . . 0.0 109.784 179.773 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 66' ' ' ILE . 2.9 p -110.01 -42.28 4.25 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.191 0.996 . . . . 0.0 110.208 -179.18 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.745 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 48.01 166.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.717 -178.406 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -69.48 104.47 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 111.14 -178.576 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 1.2 m120 40.51 41.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.826 . . . . 0.0 111.252 178.936 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -121.5 -39.14 0.59 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.043 -1.551 . . . . 0.0 109.807 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.5 p90 39.01 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.761 1.267 . . . . 0.0 112.196 -178.862 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.916 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -134.86 155.99 49.71 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.44 -178.916 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.488 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -105.79 -10.24 16.82 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 110.442 -178.891 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 2.8 m -53.74 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.79 79.74 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.729 ' CE2' ' CE1' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -69.19 163.41 24.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -1.075 . . . . 0.0 109.362 179.708 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.2 ttpt -154.56 160.38 41.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 -179.702 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -44.9 -52.35 8.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.202 179.895 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.508 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 74.3 m -131.65 164.67 25.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.68 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 3.1 m-85 -134.22 -140.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.619 ' C ' HG23 ' A' ' 59' ' ' VAL . 59.9 p -170.08 -126.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.915 -1.116 . . . . 0.0 111.155 179.781 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.631 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.09 21.35 8.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.023 -1.048 . . . . 0.0 110.636 -178.663 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.743 ' C ' HG22 ' A' ' 102' ' ' THR . 40.4 t-20 -164.15 -112.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.814 -1.178 . . . . 0.0 110.741 179.212 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 5.6 m-20 46.38 76.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.62 -1.3 . . . . 0.0 108.964 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.671 ' CA ' HG23 ' A' ' 102' ' ' THR . 10.7 p30 -69.23 145.92 52.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.819 . . . . 0.0 110.992 -178.855 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.782 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.1 m -131.08 118.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.22 178.947 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 11.4 t0 -83.04 119.53 24.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.877 . . . . 0.0 108.956 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.916 ' CE1' HD12 ' A' ' 71' ' ' LEU . 47.6 m-85 -78.7 135.56 37.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.136 0.97 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 5.9 tttt -117.1 88.2 2.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 -179.413 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.693 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -36.72 127.69 0.85 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.843 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -36.9 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.744 179.891 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.5 t80 -157.3 142.66 17.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.38 43.2 90.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 18.5 m-85 -147.8 159.06 44.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.528 -0.983 . . . . 0.0 110.182 -179.68 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' O ' HG22 ' A' ' 117' ' ' VAL . 16.8 tttp -122.45 112.24 17.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.693 HD11 ' H ' ' A' ' 89' ' ' CYS . 6.1 mt -48.76 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.37 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.503 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.33 96.38 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.693 179.615 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.27 -115.72 0.9 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 30.0 m -123.35 127.22 48.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -1.144 . . . . 0.0 110.224 -179.877 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -42.87 56.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.7 p -101.54 137.34 40.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 109.862 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 50.5 m -147.64 153.42 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.587 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.743 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.22 145.25 51.37 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.284 179.588 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 3.4 t -67.08 78.09 0.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.65 -0.656 . . . . 0.0 110.45 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.88 172.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 111.064 -179.613 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.783 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -81.82 36.27 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.444 1.76 . . . . 0.0 112.003 -178.309 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -128.07 8.48 6.74 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 178.396 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.675 ' O ' HG23 ' A' ' 108' ' ' THR . 1.2 t30 75.7 59.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.797 -0.825 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -170.25 178.85 3.66 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.445 -179.721 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.782 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 19.9 m95 -108.55 87.93 2.61 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.234 0.54 . . . . 0.0 110.168 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.2 mmtt -99.43 147.45 33.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.577 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.0 Cg_endo -71.13 175.71 39.71 Favored 'Cis proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.998 -2.084 . . . . 0.0 110.883 0.404 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 tt0 -37.15 134.48 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.461 0.648 . . . . 0.0 110.97 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.729 HD13 ' HB3' ' A' ' 109' ' ' TRP . 1.6 tp -59.33 148.26 73.34 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.745 ' HG2' HD12 ' A' ' 66' ' ' ILE . 44.7 Cg_endo -75.45 165.74 30.05 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.049 1.552 . . . . 0.0 110.446 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.572 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -127.05 103.61 7.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -0.967 . . . . 0.0 110.215 179.668 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -55.65 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 109.483 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 115' ' ' LYS . 2.6 m -108.26 -173.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.856 0.836 . . . . 0.0 111.04 -179.491 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.25 179.542 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -126.39 145.8 50.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.059 179.969 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' TYR . 1.7 m -69.25 156.96 37.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.497 -0.752 . . . . 0.0 110.976 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 11.3 mt-30 -127.8 167.86 15.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.98 179.299 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' GLN . 5.1 p -45.81 137.44 5.88 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.888 -1.133 . . . . 0.0 109.402 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.865 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.3 Cg_endo -69.84 160.79 48.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.071 1.564 . . . . 0.0 111.79 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.7 176.94 9.34 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.152 1.606 . . . . 0.0 110.012 178.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.09 177.28 7.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.728 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.06 -170.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 179.917 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -43.78 92.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.801 -179.344 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.6 m-80 40.27 52.07 2.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.535 179.701 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -148.97 170.52 29.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 30' ' ' SER . 1.6 mtt180 -115.63 -168.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -1.197 . . . . 0.0 110.783 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 19.3 p80 -156.49 127.08 6.69 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.338 0.59 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -124.11 -41.96 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' VAL . . . 67.53 -102.13 0.78 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.815 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -172.69 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.112 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.489 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 11.0 pt-20 -178.29 -146.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.788 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.22 -43.11 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.553 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 28.9 p90 -128.51 118.26 22.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.709 179.335 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.642 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 15.9 m-85 -82.68 -175.05 5.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.516 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' H ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -132.89 -54.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.717 -1.239 . . . . 0.0 111.073 -178.968 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.04 137.28 0.07 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 109.295 -179.423 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.93 16.86 80.29 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -179.254 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.642 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -99.63 177.13 5.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -1.029 . . . . 0.0 110.153 -179.923 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 43' ' ' VAL . 7.9 t -147.18 162.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.865 HG11 ' HG3' ' A' ' 6' ' ' PRO . 14.5 t -137.5 113.94 11.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 105.41 3.84 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.78 178.055 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.9 m-30 -68.09 170.63 8.11 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.86 -178.387 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -123.26 147.68 46.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.764 179.578 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.8 m -124.36 144.46 50.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.148 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.71 149.55 3.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -53.17 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.345 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.17 -2.77 4.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 7.8 m-85 -120.6 126.19 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.175 -1.191 . . . . 0.0 110.219 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.692 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -76.15 149.5 37.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.554 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.4 OUTLIER -92.49 96.15 10.05 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.884 178.836 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.027 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -86.56 148.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 -179.841 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.64 -160.86 22.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.852 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' O ' ' C ' ' A' ' 41' ' ' SER . 17.1 m-20 -92.17 54.06 2.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -1.203 . . . . 0.0 109.894 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 40' ' ' ASN . 75.5 p 31.1 48.78 0.08 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.41 179.581 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.512 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 143.81 134.98 2.91 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 26' ' ' VAL . 1.8 t -67.1 178.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.254 -1.145 . . . . 0.0 108.34 178.685 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' H ' HG12 ' A' ' 43' ' ' VAL . 5.7 tp -139.65 99.08 3.62 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.202 177.996 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.63 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -83.36 114.62 21.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.393 178.756 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 p -132.65 81.43 1.95 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.13 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' GLY . . . 110.61 60.55 0.49 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.817 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.22 29.67 1.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.863 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -147.35 134.37 20.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -1.131 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.63 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.8 m95 -93.43 139.8 30.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.909 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -139.61 159.81 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.33 70.58 2.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.958 -0.464 . . . . 0.0 111.576 179.405 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -89.99 135.9 2.41 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.182 1.622 . . . . 0.0 109.077 178.612 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.559 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.4 Cg_endo -72.2 146.86 46.84 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 123.691 1.364 . . . . 0.0 110.746 -179.483 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.612 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 55.9 p -90.85 171.96 8.95 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.948 0.88 . . . . 0.0 111.689 -179.047 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 56.6 m -129.7 77.24 1.78 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.653 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.554 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -116.53 -157.29 0.65 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.54 -177.866 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.681 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -110.45 139.64 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.501 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 80' ' ' SER . 34.3 m -129.65 43.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.986 . . . . 0.0 111.086 -178.441 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 19.0 mttp -69.61 98.31 1.15 Allowed 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.423 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 56.4 m -69.33 163.52 57.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 110.79 -179.2 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.4 Cg_endo -70.62 -90.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.325 1.698 . . . . 0.0 110.569 -179.877 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -163.74 131.78 2.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -77.35 67.83 7.63 Favored 'Trans proline' 0 C--N 1.298 -2.125 0 O-C-N 123.565 1.298 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.72 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -89.21 -178.28 5.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 179.996 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.72 HG22 ' C ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -176.41 163.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.564 179.398 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.522 ' N ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -70.19 96.24 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.437 -179.737 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.457 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 22.1 m120 47.76 44.19 17.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.14 32.41 1.05 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.802 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 88' ' ' LYS . 10.5 p90 -45.76 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.523 1.154 . . . . 0.0 112.46 -179.121 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -115.0 164.01 14.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.244 -179.571 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.34 -7.78 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 -179.765 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 t -59.59 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.77 93.82 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.922 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -89.2 177.79 6.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -1.157 . . . . 0.0 109.601 179.527 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -167.33 153.39 7.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 110.189 -179.461 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.1 mtm-85 -46.48 -36.66 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -146.24 154.54 41.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.633 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 45.3 m-85 -123.63 -167.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.0 109.688 179.653 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.719 ' HA ' HG23 ' A' ' 59' ' ' VAL . 5.8 p -170.08 91.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.638 ' CB ' HG21 ' A' ' 59' ' ' VAL . 8.5 t80 56.18 135.38 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.605 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.795 ' O ' HG22 ' A' ' 102' ' ' THR . 63.1 t30 65.09 -127.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.882 -1.137 . . . . 0.0 110.114 -179.258 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 1.7 m-20 52.98 70.75 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.684 -1.26 . . . . 0.0 109.009 -178.556 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.524 ' N ' HG23 ' A' ' 102' ' ' THR . 22.2 p-10 -72.91 140.04 47.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.487 -0.758 . . . . 0.0 111.259 -178.898 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.712 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.1 m -128.29 118.63 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.026 178.623 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.6 t70 -78.35 127.71 32.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.737 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.741 ' CE1' HD12 ' A' ' 71' ' ' LEU . 37.4 m-85 -89.07 122.79 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.249 1.023 . . . . 0.0 112.213 -178.289 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -97.63 94.53 7.03 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.791 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.469 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.24 129.03 6.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.061 -1.024 . . . . 0.0 110.001 -179.836 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' CYS . 2.2 mmtt -40.35 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.53 -179.571 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -158.82 139.58 12.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 0.0 110.25 179.963 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.61 49.48 46.32 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 14.4 m-85 -155.22 147.42 23.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -1.071 . . . . 0.0 109.553 -179.614 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 117' ' ' VAL . 2.3 ttmt -105.06 148.6 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.961 -1.087 . . . . 0.0 110.26 -179.871 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -85.34 87.18 7.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 110.664 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -70.41 106.2 3.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 109.257 179.101 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.68 -86.56 0.21 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -162.91 115.76 1.6 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.164 -1.198 . . . . 0.0 110.676 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' PHE . 19.4 m -64.12 -40.32 95.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.27 -0.894 . . . . 0.0 110.793 179.96 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -107.85 117.61 34.58 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.958 -1.089 . . . . 0.0 110.793 -179.591 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.593 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 13.5 m -119.47 -170.89 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.795 HG22 ' O ' ' A' ' 82' ' ' ASN . 9.3 m -163.08 134.32 4.88 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.408 -178.917 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -62.7 90.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.037 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.538 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 1.3 m -64.63 170.47 3.84 Favored Pre-proline 0 C--N 1.297 -1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 112.057 -178.669 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 1.027 ' HB2' HD12 ' A' ' 38' ' ' ILE . 49.8 Cg_endo -80.32 30.55 0.5 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.811 1.953 . . . . 0.0 111.886 -178.584 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -130.49 12.34 5.72 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 178.661 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.856 ' O ' HG23 ' A' ' 108' ' ' THR . 6.1 m-80 71.75 69.19 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.734 -0.863 . . . . 0.0 110.242 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.856 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -175.19 -163.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 111.206 -179.943 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.712 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 39.2 m95 -133.13 91.77 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -104.25 144.92 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 110.16 -179.705 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.2 Cg_endo -71.18 168.74 71.56 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.943 -2.107 . . . . 0.0 111.23 -0.478 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.46 127.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.472 0.653 . . . . 0.0 111.846 -178.994 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -42.18 142.99 1.1 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.714 . . . . 0.0 109.72 178.976 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.577 ' HB2' HD23 ' A' ' 95' ' ' LEU . 41.3 Cg_endo -71.44 169.91 19.73 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.214 1.639 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' HG22 ' A' ' 117' ' ' VAL . 7.8 tttp -130.61 106.97 8.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.125 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.533 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.0 t -65.4 74.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 109.086 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 115' ' ' LYS . 1.6 m -82.55 -175.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.057 0.932 . . . . 0.0 111.467 -179.154 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.705 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.633 179.883 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 8.1 mttt -138.06 177.33 7.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.546 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -138.92 93.14 2.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.974 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 1.1 mp0 -72.76 -175.89 1.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.21 139.44 45.79 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.024 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.619 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.2 Cg_endo -72.81 153.21 53.36 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.982 1.517 . . . . 0.0 110.275 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.58 169.57 22.01 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.908 1.478 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.7 p -70.86 176.19 4.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.91 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.175 0.988 . . . . 0.0 111.364 179.778 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -40.96 95.84 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.855 -179.215 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 9' ' ' ILE . 15.7 m-80 40.69 38.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.189 -0.944 . . . . 0.0 110.721 179.62 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -141.96 149.21 20.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 1.5 ptt180 -102.84 -173.19 2.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -1.149 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.778 ' HB2' HG11 ' A' ' 27' ' ' VAL . 14.6 p80 -136.64 133.54 36.35 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.259 0.552 . . . . 0.0 110.423 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -56.48 120.39 7.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.268 -179.853 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.09 71.62 0.32 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -88.43 -13.08 41.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -1.1 . . . . 0.0 110.172 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.633 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -120.02 -142.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.97 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -153.03 -39.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.606 179.765 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 5.1 p90 -128.93 79.56 1.92 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.194 -0.941 . . . . 0.0 109.935 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.6 m-85 -52.03 -29.77 22.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 110.779 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.546 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 69.66 -77.08 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.352 -0.843 . . . . 0.0 112.22 178.803 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 1.9 t70 -165.06 160.24 18.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.789 -1.195 . . . . 0.0 110.282 -179.083 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 63.18 16.67 58.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 33.0 m -95.69 173.9 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -1.009 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 43' ' ' VAL . 40.5 t -154.22 153.84 7.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.706 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 14' ' ' HIS . 17.0 t -139.06 111.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.348 -179.437 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -67.3 105.29 1.72 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.295 -1.362 . . . . 0.0 107.783 178.248 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.625 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.19 109.0 3.36 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.442 -0.786 . . . . 0.0 110.147 -178.195 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.491 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -69.24 152.94 44.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.074 -1.016 . . . . 0.0 109.448 179.519 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.6 m -121.01 160.42 23.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.697 -179.37 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -44.69 164.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.366 -0.834 . . . . 0.0 109.972 179.779 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -67.39 86.59 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.59 1.9 5.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 2.6 m-30 -94.04 128.82 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -1.201 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.602 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -76.86 134.49 39.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 110.518 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -89.73 106.16 18.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.428 179.214 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.842 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.83 146.41 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.376 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.75 -172.47 17.46 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.72 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.49 142.81 47.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 109.888 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 28' ' ' THR . 58.5 p -77.92 52.25 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.604 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 149.14 115.29 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -48.78 173.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.56 -1.256 . . . . 0.0 107.732 179.181 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.01 94.94 2.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.777 178.846 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.3 OUTLIER -80.32 105.75 11.82 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.998 178.847 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.2 95.87 3.63 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.271 -179.371 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.96 19.96 5.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.436 ' C ' ' HG3' ' A' ' 49' ' ' GLU . . . 83.35 13.02 77.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 48' ' ' GLY . 47.2 mt-10 -145.96 138.61 25.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.161 . . . . 0.0 110.262 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 94.8 m95 -80.79 143.3 32.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -142.62 160.2 40.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -0.984 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.504 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.5 t0 58.3 65.44 3.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 111.448 179.465 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -91.16 134.19 1.67 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.385 1.729 . . . . 0.0 109.754 178.877 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -81.29 174.05 11.06 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.72 1.379 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.1 p -115.28 140.9 48.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 111.506 -178.635 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 10' ' ' SER . 62.9 m -105.46 76.77 1.23 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.08 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.15 177.65 4.64 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.457 0.646 . . . . 0.0 110.614 -178.292 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -92.0 148.68 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.589 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 13.0 m -129.15 47.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.821 -178.118 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 4.9 mmtt -85.43 160.83 19.64 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.032 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 108' ' ' THR . 65.4 m -135.6 166.3 29.6 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.216 -1.553 . . . . 0.0 113.019 -178.268 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 39.0 Cg_endo -66.94 -87.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.828 1.962 . . . . 0.0 110.386 179.158 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 132.42 1.79 Allowed Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.7 Cg_endo -75.84 65.06 6.81 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 123.825 1.434 . . . . 0.0 108.995 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -83.42 164.32 20.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.664 -0.648 . . . . 0.0 110.877 -179.058 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -164.17 164.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 179.725 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 32.8 t -73.88 106.17 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.514 -0.741 . . . . 0.0 110.848 -179.563 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.548 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 19.0 m-20 42.37 27.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.918 179.315 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.78 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -134.71 33.05 2.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.568 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 7.9 p90 -45.05 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.65 1.214 . . . . 0.0 112.275 -179.439 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.777 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.02 160.53 16.75 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.667 179.766 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.509 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 3.0 t -134.43 30.89 3.49 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.942 . . . . 0.0 109.823 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.5 t -103.66 -81.39 0.51 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -179.556 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.8 85.9 0.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.602 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.65 166.02 12.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -1.06 . . . . 0.0 109.684 179.705 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 4.0 tttt -162.41 158.51 24.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 -179.753 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -50.92 -33.41 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 0.0 109.888 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 6.6 p -136.57 173.33 11.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 0.0 109.927 179.682 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.602 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 52.8 m-85 -144.13 -171.69 3.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.2 p -146.2 -157.7 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.248 -0.907 . . . . 0.0 110.624 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.629 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -83.99 61.22 6.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.534 -1.354 . . . . 0.0 110.352 -179.759 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.631 ' HA ' HG21 ' A' ' 102' ' ' THR . 2.1 m-80 162.17 -16.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.986 -1.071 . . . . 0.0 111.518 179.516 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 38.9 m-20 -58.2 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.962 -1.086 . . . . 0.0 108.613 179.232 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p30 -76.78 145.19 38.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.552 -0.717 . . . . 0.0 111.294 -178.134 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.677 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 11.9 m -133.78 116.41 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 178.665 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -80.06 135.37 36.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.777 ' CE1' HD12 ' A' ' 71' ' ' LEU . 49.5 m-85 -92.93 138.72 31.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.893 -1.129 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 0.2 OUTLIER -113.79 92.97 4.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.89 -179.657 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 132.42 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 110.233 -179.731 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.45 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.805 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.7 t80 -157.96 128.89 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 62.24 57.15 18.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 35.6 m-85 -162.12 147.9 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.996 . . . . 0.0 109.982 -179.384 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 117' ' ' VAL . 10.8 mttm -101.85 152.62 20.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.816 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -94.05 87.5 5.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.554 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.649 ' HB2' HG21 ' A' ' 117' ' ' VAL . 11.2 t -71.68 107.72 4.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.057 -1.027 . . . . 0.0 109.609 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.44 -78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.697 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -172.46 116.21 0.33 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.344 -1.092 . . . . 0.0 110.62 -179.693 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.5 p -68.6 -11.91 60.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.5 p -134.3 140.59 46.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.873 -1.142 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.0 m -154.77 162.9 40.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 -179.459 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 82' ' ' ASN . 5.2 m -136.42 138.31 41.39 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.3 0.572 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.565 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 1.9 t -43.58 -28.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.416 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER 64.2 165.99 0.11 Allowed Pre-proline 0 C--N 1.293 -1.88 0 CA-C-O 121.391 0.615 . . . . 0.0 112.031 178.321 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.842 ' CB ' HD12 ' A' ' 38' ' ' ILE . 50.6 Cg_endo -81.96 4.4 7.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.636 1.861 . . . . 0.0 111.1 -179.026 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -103.51 2.64 46.17 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.594 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.816 ' O ' HG23 ' A' ' 108' ' ' THR . 17.0 m-80 73.68 48.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.885 -0.774 . . . . 0.0 110.743 179.825 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -166.44 150.71 7.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 110.864 178.805 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.677 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 58.2 m95 -71.79 88.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.709 0.766 . . . . 0.0 110.959 -179.336 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.4 mmtp -104.02 132.51 20.94 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.729 -0.607 . . . . 0.0 109.559 179.633 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.2 Cg_endo -72.55 167.78 76.8 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.859 -2.142 . . . . 0.0 110.52 0.377 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.6 mp0 -43.1 149.83 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.214 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.744 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -55.13 151.57 17.0 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.264 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.679 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.4 Cg_endo -73.57 169.47 22.25 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 O-C-N 124.299 1.684 . . . . 0.0 110.868 -179.868 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.533 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -126.77 110.14 12.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.24 -0.912 . . . . 0.0 110.475 -179.779 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -66.3 73.81 0.08 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.817 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 96' ' ' SER . 1.2 m -84.09 -175.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.845 0.831 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.582 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 8.2 ptt85 . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.4 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.324 0.583 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -133.17 174.58 10.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 179.685 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.548 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -142.3 85.71 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.936 -179.952 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HG2' ' CE1' ' A' ' 20' ' ' PHE . 76.0 mt-30 -63.05 177.74 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.903 -1.123 . . . . 0.0 109.71 179.803 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 4' ' ' GLN . 3.6 p -43.28 145.87 0.95 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 0.0 109.74 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.829 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.2 Cg_endo -69.84 170.88 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.713 -179.541 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.84 171.75 13.97 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.011 1.532 . . . . 0.0 109.523 178.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.02 97.69 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.246 -179.937 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.598 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.31 -175.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 0.0 110.918 -179.779 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -101.85 140.26 36.38 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.546 179.909 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t-20 71.39 8.76 6.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.708 179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -160.13 -179.46 34.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.836 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -132.68 -166.85 1.81 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.364 -1.08 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 17.0 p80 -155.59 -163.38 1.5 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.768 179.968 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 4.6 t-20 65.33 -141.17 0.21 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.02 -67.09 0.41 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -120.09 -4.67 10.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 109.572 179.536 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 26.9 mt-10 -106.68 -174.86 2.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.791 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 169.06 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.07 -1.019 . . . . 0.0 111.153 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.514 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -139.04 67.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 111.396 -179.055 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 3.1 m-85 -75.26 174.58 9.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 108.999 178.56 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.548 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 36.4 p -137.87 -57.34 0.67 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.756 -1.215 . . . . 0.0 111.356 -178.901 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.04 130.15 0.77 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.185 -0.947 . . . . 0.0 110.083 -179.169 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.77 22.39 61.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.471 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.641 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 28.0 m -111.33 168.87 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -1.026 . . . . 0.0 110.049 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 43' ' ' VAL . 21.8 t -140.77 148.22 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 112.205 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.829 HG11 ' HG3' ' A' ' 6' ' ' PRO . 28.8 t -116.3 122.84 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.561 -0.712 . . . . 0.0 111.662 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.83 102.66 7.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.478 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.6 m-30 -68.11 149.87 49.08 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.256 -178.098 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -95.47 152.75 18.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 179.427 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' SG ' HD12 ' A' ' 37' ' ' LEU . 86.0 m -125.63 146.6 49.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 0.0 110.393 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.2 145.66 25.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.231 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.7 p -56.05 110.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.33 -4.62 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.737 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 58' ' ' ILE . 8.9 m-85 -124.42 155.88 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.268 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.657 ' HB3' HG11 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -101.29 149.9 23.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.242 179.659 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.581 ' C ' HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -88.25 108.59 19.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.451 -0.78 . . . . 0.0 109.511 179.242 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.7 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -100.55 143.97 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.175 -179.856 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.68 -156.26 22.37 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 m-20 -93.26 55.49 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.325 . . . . 0.0 109.774 179.497 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 40' ' ' ASN . 53.1 p 30.07 47.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.484 179.636 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.66 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 143.7 136.34 3.1 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.551 179.671 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.858 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.8 t -65.36 179.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.206 -1.173 . . . . 0.0 108.067 178.706 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.6 tp -143.25 95.19 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.669 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -80.57 113.23 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 109.048 178.774 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.11 112.26 18.01 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.265 -179.553 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.23 58.79 8.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.458 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 49.54 53.96 18.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.38 95.23 1.01 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -1.112 . . . . 0.0 110.59 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.734 ' CH2' HG23 ' A' ' 27' ' ' VAL . 74.3 m95 -65.88 133.52 51.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 52' ' ' ASP . 15.9 m -142.7 177.25 8.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.698 -179.37 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 3.2 p30 36.15 71.25 0.93 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.969 -0.457 . . . . 0.0 111.874 179.651 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.23 138.13 3.25 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.05 1.552 . . . . 0.0 109.515 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 46.4 Cg_endo -73.36 176.95 8.53 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.79 1.416 . . . . 0.0 110.644 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 8.8 p -121.86 157.53 30.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 111.54 -178.679 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 94.1 m -116.68 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.823 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -118.03 -156.96 0.66 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.204 -178.454 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.543 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -108.78 152.86 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.856 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 36' ' ' SER . 26.3 m -137.39 48.29 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 111.115 -178.981 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mttt -90.63 173.45 8.04 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.49 178.7 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 47.8 m -132.65 167.16 24.09 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.479 -1.388 . . . . 0.0 112.333 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.2 Cg_endo -76.19 -53.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.747 1.919 . . . . 0.0 109.909 178.94 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 162.95 125.37 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.946 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 45.6 Cg_endo -75.08 59.78 5.33 Favored 'Trans proline' 0 C--N 1.292 -2.403 0 O-C-N 123.69 1.363 . . . . 0.0 110.554 -178.906 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.747 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -78.62 -171.79 2.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.465 -0.772 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER 178.25 168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.643 179.356 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.509 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -71.79 102.84 2.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.499 -0.75 . . . . 0.0 110.83 -179.638 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 0.8 OUTLIER 40.05 43.99 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.456 -0.778 . . . . 0.0 110.858 179.458 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.902 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -155.02 35.26 0.66 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.621 ' O ' ' O ' ' A' ' 69' ' ' GLY . 15.6 p90 -42.49 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 123.409 1.576 . . . . 0.0 114.188 -179.325 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.859 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -149.34 136.53 19.91 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -175.491 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t -121.8 27.39 8.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 109.775 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -69.83 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 111.39 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -124.03 -73.45 0.25 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.879 -178.823 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.58 ' HB2' HD13 ' A' ' 71' ' ' LEU . 22.8 t80 58.44 163.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -1.012 . . . . 0.0 109.973 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.571 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 8.0 tttm -178.94 140.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.455 -0.778 . . . . 0.0 110.059 179.731 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -42.74 -36.01 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 179.67 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 2.6 p -125.88 166.27 17.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.676 . . . . 0.0 109.75 179.369 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 74.0 m-85 -141.07 -168.9 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.9 m -155.54 -158.54 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -69.38 2.94 2.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.349 -1.47 . . . . 0.0 111.19 -179.057 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.797 ' O ' HG22 ' A' ' 102' ' ' THR . 8.8 p30 -139.21 -111.53 0.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.781 -1.199 . . . . 0.0 110.266 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 50.88 65.69 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.849 -1.157 . . . . 0.0 109.623 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.889 ' CA ' HG23 ' A' ' 102' ' ' THR . 18.8 p-10 -69.4 110.86 4.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.797 HG23 ' CE1' ' A' ' 87' ' ' PHE . 26.0 m -97.26 121.85 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.862 -1.149 . . . . 0.0 111.204 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -78.05 138.79 38.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.204 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.797 ' CE1' HG23 ' A' ' 85' ' ' VAL . 24.4 m-85 -98.64 145.54 26.76 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.986 -1.072 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.82 96.81 5.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.648 -0.658 . . . . 0.0 110.093 -179.708 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.605 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -46.46 134.5 9.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -41.14 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.338 -0.851 . . . . 0.0 110.241 -179.855 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -160.74 124.78 3.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 69.27 53.84 16.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.675 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 51.6 m-85 -160.68 152.21 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -1.022 . . . . 0.0 109.892 -179.249 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -107.27 136.78 46.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.012 . . . . 0.0 109.963 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.605 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -75.65 89.82 2.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.075 -179.875 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.4 t -74.74 101.86 4.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -0.905 . . . . 0.0 110.285 -179.999 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.06 -64.79 0.44 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.568 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 177.35 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -1.105 . . . . 0.0 110.377 -179.606 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.8 p -68.94 -3.94 14.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.943 . . . . 0.0 110.743 -179.564 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 64.5 p -140.13 93.76 2.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.555 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 19.5 m -104.04 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 110.991 -179.411 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.889 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.98 137.76 23.78 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.929 -0.709 . . . . 0.0 110.455 -179.614 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.61 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 49.2 t -56.74 107.28 0.38 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -0.778 . . . . 0.0 109.461 179.642 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.5 175.1 4.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.556 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.65 ' CB ' HG12 ' A' ' 59' ' ' VAL . 41.2 Cg_endo -77.45 167.19 24.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.857 1.451 . . . . 0.0 111.584 -179.166 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 89.93 -58.72 3.62 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 -178.545 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.621 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 3.5 m-20 147.13 71.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 122.271 0.228 . . . . 0.0 111.123 178.537 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -169.78 166.95 9.55 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.314 -1.491 . . . . 0.0 112.536 179.236 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 24.2 m95 -101.55 92.09 4.74 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 179.564 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.556 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 16.2 mttt -101.03 142.59 24.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.222 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.568 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.4 Cg_endo -71.0 168.97 70.64 Favored 'Cis proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.706 -0.849 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -39.8 129.96 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.544 -0.723 . . . . 0.0 110.847 -179.6 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -39.7 147.07 0.34 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 0.0 110.422 179.385 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.817 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.5 Cg_endo -70.35 166.7 27.45 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.398 1.736 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HG2' HG13 ' A' ' 117' ' ' VAL . 4.7 ttpt -127.29 107.83 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.463 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.9 t -64.4 90.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.077 -1.015 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.858 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -103.77 -175.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.904 0.859 . . . . 0.0 110.821 -179.414 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.928 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.448 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.228 0.537 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.79 176.79 7.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 4.1 t -159.37 101.25 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.217 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.6 mt-30 -87.46 -177.59 5.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -39.69 141.05 0.77 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 -179.766 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 49.9 Cg_endo -71.32 159.89 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.095 1.576 . . . . 0.0 111.228 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.6 170.91 19.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.102 1.58 . . . . 0.0 109.898 179.371 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -73.26 174.4 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.45 -170.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.219 1.009 . . . . 0.0 111.559 179.631 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -38.62 94.1 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.986 -179.138 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.2 m120 41.39 30.83 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -132.16 150.44 19.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.936 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 30' ' ' SER . 3.8 mtt180 -96.36 -170.87 2.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -1.075 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -147.16 120.09 8.74 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.228 0.537 . . . . 0.0 109.965 -179.738 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -123.46 109.53 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.748 -179.552 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' CA ' ' OH ' ' A' ' 21' ' ' TYR . . . -101.5 -5.47 51.77 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.463 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 68.44 24.2 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.279 -1.13 . . . . 0.0 110.375 179.975 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 3.8 pt-20 -160.57 -160.56 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 19' ' ' ASP . 5.7 t0 -131.83 -27.41 1.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.073 -1.017 . . . . 0.0 110.714 -179.586 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 9.9 m-85 -119.88 134.88 55.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.78 -179.63 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -124.08 -13.93 7.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.459 -0.776 . . . . 0.0 110.204 179.882 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.557 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . 47.6 p 45.95 -98.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.554 -0.716 . . . . 0.0 111.68 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -143.7 156.82 44.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 110.438 -178.443 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 70.13 16.25 72.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.086 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -94.29 174.9 6.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.624 -0.927 . . . . 0.0 110.328 -179.7 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 43' ' ' VAL . 37.9 t -154.21 153.22 8.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.048 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' VAL . 41.5 t -139.65 123.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.66 -179.433 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.56 101.9 3.71 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.247 . . . . 0.0 107.78 177.899 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.045 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.03 134.24 50.34 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.308 -178.208 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.01 163.09 15.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.914 179.606 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.614 ' SG ' HD12 ' A' ' 37' ' ' LEU . 70.9 m -127.36 159.25 35.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 110.175 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.92 154.85 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.894 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 100.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.74 8.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.9 m-30 -110.01 158.66 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -1.177 . . . . 0.0 110.005 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' SER . . . . . 1.042 ' OG ' HG22 ' A' ' 59' ' ' VAL . 24.3 m -103.71 130.39 51.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.389 -0.819 . . . . 0.0 110.677 -179.337 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.2 tp -83.0 117.71 23.0 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.237 179.132 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.59 HG23 ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -115.97 143.77 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.31 -168.02 12.8 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.561 -1.815 . . . . 0.0 108.561 -179.0 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 30.5 p-10 -66.37 130.76 44.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.968 -1.313 . . . . 0.0 109.496 179.476 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 28' ' ' THR . 30.2 p -70.01 57.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.992 . . . . 0.0 109.511 179.767 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.601 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.92 117.34 0.57 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.491 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.045 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -61.19 -176.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.95 -1.323 . . . . 0.0 107.848 179.248 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.606 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.9 tp -144.47 102.29 3.81 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.318 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -86.15 111.91 20.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.363 -0.835 . . . . 0.0 109.656 179.423 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 88.39 2.93 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.43 50.52 3.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 57.27 25.07 53.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' TRP . 2.3 tt0 -125.8 71.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.606 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 72.9 m95 -45.84 129.67 9.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -144.1 173.4 11.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.996 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 53.29 65.1 6.11 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 110.884 -179.949 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.6 Cg_endo -91.53 135.63 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.444 1.76 . . . . 0.0 110.096 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 50.5 Cg_endo -79.91 -173.56 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.739 1.389 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -120.13 -172.01 2.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.963 0.887 . . . . 0.0 111.564 -178.833 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 95.9 m -152.05 80.91 1.26 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.663 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 5.2 mm100 -111.41 -139.8 0.38 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.413 0.625 . . . . 0.0 110.912 -177.747 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.465 HG13 ' C ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -137.57 106.55 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.848 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.042 HG22 ' OG ' ' A' ' 36' ' ' SER . 26.8 m -105.51 64.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.153 -0.967 . . . . 0.0 112.526 -178.224 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 14.8 mttt -67.49 -175.69 0.53 Allowed 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 117.531 -1.668 . . . . 0.0 107.624 178.072 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.64 163.59 35.43 Favored Pre-proline 0 C--N 1.296 -1.741 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.597 -178.085 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -86.91 -83.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.92 2.011 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 175.14 130.75 0.14 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.611 -0.681 . . . . 0.0 109.298 -179.433 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.736 ' HG2' HD21 ' A' ' 71' ' ' LEU . 49.8 Cg_endo -80.02 64.06 8.82 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 O-C-N 123.739 1.389 . . . . 0.0 109.896 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.6 ' C ' HG22 ' A' ' 66' ' ' ILE . 5.4 p -77.05 175.65 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.813 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.0 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.84 168.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 118.522 -1.271 . . . . 0.0 110.7 179.307 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.491 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.69 100.32 3.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.527 -0.733 . . . . 0.0 110.691 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 35.1 m-20 42.41 48.15 4.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.0 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -160.28 37.81 0.45 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 54.3 p90 -50.2 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.952 1.358 . . . . 0.0 112.922 -179.783 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.065 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -142.84 127.03 17.52 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.736 -176.562 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -109.14 19.22 19.72 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 110.192 -179.318 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 31.3 t -84.17 -88.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.906 -179.47 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -101.03 -71.91 0.96 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.279 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 51.1 t80 57.04 170.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -1.07 . . . . 0.0 109.665 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.635 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 174.23 130.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 179.932 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 76' ' ' LYS . 9.4 mtt180 -40.76 -32.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.797 . . . . 0.0 110.027 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.84 126.24 20.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 11.2 m-85 -106.11 -151.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 179.977 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 59.9 p -159.85 -126.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.944 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.985 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -102.07 33.63 3.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.987 -1.071 . . . . 0.0 110.84 -179.243 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.753 ' C ' HG22 ' A' ' 102' ' ' THR . 17.9 t-20 -172.29 -112.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.093 -1.005 . . . . 0.0 110.367 179.007 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 t0 47.39 75.06 0.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.641 -1.287 . . . . 0.0 109.162 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.715 ' CA ' HG23 ' A' ' 102' ' ' THR . 12.7 p-10 -69.62 112.69 6.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.576 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.592 ' CG2' HD22 ' A' ' 71' ' ' LEU . 31.4 m -98.15 121.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.983 -1.073 . . . . 0.0 111.17 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -80.12 139.58 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.395 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 1.065 ' CE2' HD23 ' A' ' 71' ' ' LEU . 65.3 m-85 -95.5 146.52 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.811 -1.181 . . . . 0.0 112.396 -178.205 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.73 91.55 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.367 179.695 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.519 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 135.28 3.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.928 . . . . 0.0 109.957 -179.551 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 6.8 mmmt -39.63 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 110.687 -179.545 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.6 t80 -168.68 130.81 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.297 -0.877 . . . . 0.0 110.358 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.18 53.43 46.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 25.2 m-85 -158.77 150.47 20.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -1.013 . . . . 0.0 109.959 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -102.95 154.59 19.07 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.401 -0.812 . . . . 0.0 109.038 179.362 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.587 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -93.93 96.26 9.6 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 110.499 -179.447 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.13 101.82 4.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 109.646 179.526 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.53 -77.17 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -171.59 114.43 0.37 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 110.896 -179.632 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 m -71.34 -2.45 16.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.231 -0.918 . . . . 0.0 110.481 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -143.33 113.83 7.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.111 179.773 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 27.3 m -126.0 160.16 30.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.753 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.6 139.53 50.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.582 0.706 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.51 84.36 1.52 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.485 -0.76 . . . . 0.0 110.107 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -62.95 173.99 0.95 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.985 -179.55 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.757 ' HB3' HG11 ' A' ' 59' ' ' VAL . 42.8 Cg_endo -73.34 123.46 8.73 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.391 1.732 . . . . 0.0 110.104 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.58 -9.31 4.96 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -178.904 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' HG23 ' A' ' 108' ' ' THR . 4.6 m-20 80.71 89.35 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.909 -0.76 . . . . 0.0 110.295 179.701 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.06 -160.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.281 -0.887 . . . . 0.0 110.933 179.85 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.644 ' HB3' HD11 ' A' ' 113' ' ' LEU . 30.4 m95 -145.84 86.09 1.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.608 0.718 . . . . 0.0 109.712 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 21.0 mttt -99.77 139.05 20.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.705 . . . . 0.0 110.255 -179.349 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.9 Cg_endo -71.34 166.51 77.83 Favored 'Cis proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.009 -2.079 . . . . 0.0 110.781 -0.127 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.2 mp0 -40.37 137.81 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.539 -0.725 . . . . 0.0 110.644 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.788 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -43.52 155.98 0.29 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 179.744 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.695 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.8 Cg_endo -80.06 169.48 17.66 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 124.397 1.735 . . . . 0.0 111.074 -179.609 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.554 ' O ' HG22 ' A' ' 117' ' ' VAL . 6.8 tttt -127.35 111.12 13.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.532 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -67.67 98.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.117 -0.989 . . . . 0.0 109.425 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -112.76 -176.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.736 0.779 . . . . 0.0 110.507 -179.627 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 9.0 ptt85 . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.451 179.63 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.26 0.552 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -122.19 162.6 21.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.581 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -143.33 78.38 1.6 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.22 179.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -51.91 145.44 17.15 Favored Pre-proline 0 C--N 1.3 -1.559 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.76 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.683 ' HG3' HG11 ' A' ' 27' ' ' VAL . 54.7 Cg_endo -73.99 159.86 43.99 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.896 1.472 . . . . 0.0 110.117 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.93 170.0 19.91 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.661 1.348 . . . . 0.0 109.997 179.284 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 p -88.82 105.06 17.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.983 . . . . 0.0 110.365 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.601 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -56.29 -170.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.03 0.919 . . . . 0.0 111.289 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.13 138.15 31.74 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.424 -178.846 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 56' ' ' CYS . 67.9 m-20 49.05 20.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.48 -0.763 . . . . 0.0 110.931 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.2 157.66 27.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.437 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 mpt_? -118.23 -166.33 1.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -1.19 . . . . 0.0 111.059 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.5 p80 -151.22 131.55 13.69 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.614 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -155.34 -145.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 110.751 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . 129.4 4.89 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 7.7 t80 70.96 24.31 4.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.163 -1.198 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' CG ' ' HE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -126.12 168.9 13.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.068 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.24 -31.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 110.515 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.25 139.06 52.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.08 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.661 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.2 m-85 -123.03 -7.08 8.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 110.985 -179.624 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.581 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.8 p 43.3 -96.61 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 111.405 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 17.4 t0 -153.52 138.49 17.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.953 -1.092 . . . . 0.0 110.363 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.49 37.4 8.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.661 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 66.4 m -135.17 161.33 35.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.261 -1.141 . . . . 0.0 109.951 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.3 t -134.19 147.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.0 112.28 -178.141 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 43' ' ' VAL . 32.3 t -117.95 119.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.725 -0.609 . . . . 0.0 111.743 -179.523 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.4 102.95 3.9 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.78 -1.168 . . . . 0.0 107.897 177.641 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.874 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.12 126.72 30.41 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.419 -0.8 . . . . 0.0 109.848 -178.515 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.63 163.62 25.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.0 -1.063 . . . . 0.0 109.36 179.467 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.44 49.44 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.051 -1.03 . . . . 0.0 110.433 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.62 143.34 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -62.55 106.17 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.74 -11.51 6.28 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CE2' HG13 ' A' ' 58' ' ' ILE . 3.9 m-85 -114.06 146.31 40.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.149 -1.206 . . . . 0.0 110.629 -179.617 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.715 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -84.17 142.27 30.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -0.911 . . . . 0.0 110.753 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.5 OUTLIER -98.61 95.01 6.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.535 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.781 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -81.16 152.1 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.785 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 127.92 -146.54 16.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 41' ' ' SER . 36.4 m-80 -120.73 53.26 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 110.128 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 28' ' ' THR . 71.3 p 28.03 48.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.774 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 156.94 125.49 0.87 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.673 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.895 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.0 t -71.48 179.45 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.502 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.86 92.61 2.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.648 -1.282 . . . . 0.0 111.247 179.55 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.598 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -79.47 106.97 11.88 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.407 178.125 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.522 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -135.11 103.51 5.58 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.226 -179.054 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.77 11.25 35.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.5 19.07 60.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' TRP . 9.1 mt-10 -139.16 91.4 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -1.153 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.607 ' CH2' HG23 ' A' ' 27' ' ' VAL . 70.7 m95 -43.3 135.88 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 p -147.64 166.29 27.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 111.048 -179.707 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 57.3 64.35 4.35 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.603 -0.686 . . . . 0.0 111.285 179.837 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.9 Cg_endo -92.72 145.65 2.55 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.992 1.795 . . . . 0.0 110.086 179.084 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 52.9 Cg_endo -84.28 176.79 6.29 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.7 1.369 . . . . 0.0 109.949 179.245 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.63 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 27.3 p -130.21 141.88 50.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 111.54 -179.53 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -100.51 88.52 3.66 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.584 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 51.6 mm-40 -120.36 -165.57 1.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.424 -178.314 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.723 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -115.4 104.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.04 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 81' ' ' TYR . 13.0 m -92.97 47.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 111.801 -178.199 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -88.65 97.7 11.26 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.345 178.586 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 36.0 m -69.55 162.51 66.55 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 112.12 -178.004 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 45.4 Cg_endo -71.61 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.651 1.869 . . . . 0.0 110.762 -179.73 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.42 ' CA ' ' HE1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -161.58 133.65 4.19 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.705 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.673 ' HA ' HD21 ' A' ' 113' ' ' LEU . 50.3 Cg_endo -78.01 65.26 8.34 Favored 'Trans proline' 0 C--N 1.293 -2.35 0 O-C-N 123.674 1.355 . . . . 0.0 109.784 -179.329 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.591 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -83.08 171.95 13.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.608 -0.682 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.67 166.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.522 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.45 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -75.28 109.94 9.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.534 -0.729 . . . . 0.0 111.0 -179.254 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.6 m-80 38.63 34.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.765 . . . . 0.0 110.844 179.299 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.771 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -143.68 30.36 1.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.58 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.3 p90 -45.66 -171.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.718 1.247 . . . . 0.0 112.479 -179.612 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.829 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.4 157.97 24.24 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.794 178.792 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.75 26.52 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.082 -179.181 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -73.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.669 -179.586 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.43 75.97 0.41 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.5 t80 -104.36 165.72 10.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.585 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -163.16 162.88 25.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -56.76 -35.86 69.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.92 179.936 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -139.83 167.35 22.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.988 179.698 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.555 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.0 m-85 -138.51 -173.93 3.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.735 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.8 m -169.39 106.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 111.283 -179.75 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.776 ' CB ' HG21 ' A' ' 59' ' ' VAL . 3.2 t80 46.31 15.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.154 -0.966 . . . . 0.0 112.686 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.721 ' C ' HG22 ' A' ' 102' ' ' THR . 17.1 t-20 -175.84 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 119.926 -1.734 . . . . 0.0 111.987 178.308 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 8.3 m-20 49.63 76.87 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.671 -1.268 . . . . 0.0 108.747 -178.027 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.646 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.5 p-10 -69.2 135.42 50.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 0.0 111.109 -178.689 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 64' ' ' PRO . 10.8 m -115.81 120.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.519 179.11 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t0 -85.15 130.71 34.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 108.651 179.436 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.829 ' CE1' HD12 ' A' ' 71' ' ' LEU . 67.6 m-85 -89.87 129.52 36.23 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.291 1.043 . . . . 0.0 112.567 -177.88 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -104.43 91.64 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.48 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.544 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -45.27 127.38 7.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.957 -1.09 . . . . 0.0 109.59 -179.736 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 15.8 mmtp -37.27 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.687 -0.633 . . . . 0.0 110.787 -179.097 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.586 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 17.6 t80 -158.99 136.12 9.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.544 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.67 44.68 97.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 28.3 m-85 -154.56 150.86 28.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.503 -0.998 . . . . 0.0 109.846 -179.338 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HG3' HG23 ' A' ' 117' ' ' VAL . 18.1 ptpt -116.98 126.46 52.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.674 179.529 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -56.69 112.95 1.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.758 -179.255 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.579 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -89.51 94.79 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.525 179.287 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.85 -39.17 1.42 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.4 OUTLIER 172.55 -178.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.155 -1.203 . . . . 0.0 111.037 -179.65 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 51.7 p -141.76 10.39 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 0.0 109.967 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -169.53 113.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.491 -0.755 . . . . 0.0 109.107 179.831 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.471 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 29.8 m -124.75 162.4 24.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.225 -0.922 . . . . 0.0 111.048 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.721 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.13 142.26 50.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 3.0 t -60.92 83.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.645 -0.66 . . . . 0.0 109.3 179.468 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.94 170.33 8.89 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.0 110.867 -179.245 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.773 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.0 Cg_endo -73.77 127.54 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.176 1.619 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.57 -11.43 5.75 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -179.055 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.7 m120 82.0 76.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.068 -0.666 . . . . 0.0 110.39 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -169.87 -158.81 0.19 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.517 -0.739 . . . . 0.0 110.786 179.789 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.642 ' HB3' HD13 ' A' ' 113' ' ' LEU . 21.0 m95 -142.26 98.96 3.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.343 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 45.8 mttt -100.73 141.9 23.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 110.155 -179.597 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.548 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 49.2 Cg_endo -72.07 170.57 66.39 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.057 -2.059 . . . . 0.0 110.866 0.256 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.5 tt0 -40.28 125.8 2.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 110.114 179.853 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -41.08 141.32 1.02 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.431 -0.793 . . . . 0.0 110.032 -179.84 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.674 ' HG2' HD12 ' A' ' 66' ' ' ILE . 46.6 Cg_endo -80.26 166.87 20.1 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.467 1.772 . . . . 0.0 112.074 -178.38 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.66 ' HG2' HG13 ' A' ' 117' ' ' VAL . 11.0 ttpt -125.63 106.16 9.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.669 . . . . 0.0 109.977 179.53 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -58.7 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.016 . . . . 0.0 109.297 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.66 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.0 m -110.63 -171.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.936 0.874 . . . . 0.0 111.224 -179.438 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.216 0.532 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -115.55 161.97 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.559 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -131.43 81.93 2.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 110.57 -179.862 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.4 mt-30 -60.91 177.06 0.35 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.047 -1.033 . . . . 0.0 109.093 179.225 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.6 p -40.91 144.21 0.65 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 27' ' ' VAL . 44.4 Cg_endo -67.9 162.42 39.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.713 1.375 . . . . 0.0 110.893 -179.097 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.77 166.5 29.78 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.06 1.558 . . . . 0.0 110.118 179.702 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.04 176.07 5.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.179 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.597 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.25 -169.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.164 0.983 . . . . 0.0 111.544 179.934 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 11' ' ' ASN . 29.7 t -63.25 114.04 3.56 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.619 -178.665 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 10' ' ' SER . 3.1 m-80 37.32 41.99 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.664 -0.647 . . . . 0.0 111.266 179.127 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.41 154.86 25.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.575 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -109.56 -179.41 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -1.188 . . . . 0.0 110.777 -179.825 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.617 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.0 p80 -139.29 -154.89 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 12.5 t30 66.53 -170.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.105 -179.898 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.16 -4.76 18.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -32.48 2.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -1.194 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.574 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 179.16 -176.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 0.0 110.291 -179.972 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 5' ' ' SER . 9.9 t70 -103.96 -25.07 13.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.6 m-85 -105.71 -174.81 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -178.71 -25.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.422 179.655 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 7.6 p 59.55 -94.36 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.588 -0.695 . . . . 0.0 112.661 178.839 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -148.17 159.38 44.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.646 -1.283 . . . . 0.0 110.582 -178.078 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 13.28 57.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.603 -0.94 . . . . 0.0 110.123 -179.867 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.0 t -155.69 155.75 5.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.579 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.696 HG11 ' HG3' ' A' ' 6' ' ' PRO . 21.6 t -139.34 125.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.886 -179.487 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.76 103.9 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.601 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.702 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.2 m-30 -68.09 121.31 15.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -177.937 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -75.67 153.57 37.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.998 . . . . 0.0 109.127 178.904 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 37' ' ' LEU . 79.9 m -121.02 170.54 9.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.692 -179.285 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 34' ' ' GLY . 8.8 m-20 -62.94 137.26 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.887 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -46.96 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 110.324 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 123.32 17.04 3.34 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 13.6 m-85 -125.8 141.1 52.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 110.18 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.662 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -85.24 142.13 29.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.944 . . . . 0.0 110.967 -179.455 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.702 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.0 tp -89.61 98.1 11.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.424 -0.798 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.767 ' N ' HD13 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -86.47 141.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.312 -179.764 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.63 -172.48 14.63 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.654 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -64.5 145.25 56.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.07 179.863 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -76.22 53.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.615 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.5 115.37 0.62 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -54.73 -178.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.004 -1.292 . . . . 0.0 107.853 178.831 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.4 tp -146.19 99.32 3.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 110.217 178.681 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.79 109.18 16.71 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.644 179.103 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.88 107.98 10.07 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.82 8.48 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.895 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . 60.92 38.75 95.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.859 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 25.0 mt-10 -151.04 88.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 110.798 -179.582 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 78.5 m95 -50.68 136.99 20.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.339 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.79 162.22 36.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.958 -1.089 . . . . 0.0 111.507 -179.325 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.9 t0 58.57 66.09 2.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.8 Cg_endo -90.94 126.55 1.14 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 O-C-N 124.394 1.734 . . . . 0.0 109.753 178.774 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -74.24 165.53 31.66 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.864 1.455 . . . . 0.0 110.252 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 66.1 p -105.52 150.91 24.92 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.12 -0.988 . . . . 0.0 111.215 -179.444 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 57' ' ' GLN . 77.0 m -111.72 82.18 1.57 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.77 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 3.1 mm100 -115.4 -150.7 0.47 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.713 0.768 . . . . 0.0 110.738 -177.817 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.803 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.78 125.86 71.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.691 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 36' ' ' SER . 31.0 m -115.68 50.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 0.0 112.08 -178.163 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 30.6 mttt -59.51 -173.31 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 117.739 -1.584 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.529 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -146.0 170.12 8.48 Favored Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.948 -178.724 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.529 ' HD2' ' SG ' ' A' ' 61' ' ' CYS . 45.3 Cg_endo -92.19 -72.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.396 2.064 . . . . 0.0 109.848 179.226 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.18 125.42 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.718 -0.614 . . . . 0.0 109.674 -179.636 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.599 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.6 Cg_endo -78.36 71.07 6.95 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 123.81 1.426 . . . . 0.0 110.172 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.685 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -89.91 171.69 9.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.925 179.915 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.804 HG21 ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -170.84 155.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.057 -1.027 . . . . 0.0 110.266 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 35.5 t -61.45 107.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.751 . . . . 0.0 111.014 -179.357 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 3.3 m-20 39.95 37.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 0.0 110.682 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.587 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -143.48 27.15 2.11 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' HG23 ' A' ' 66' ' ' ILE . 2.0 p90 -44.32 -174.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.737 1.256 . . . . 0.0 112.362 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.739 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.18 164.38 12.93 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.58 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -144.77 20.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 110.039 -179.626 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -103.02 -79.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 110.856 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.27 77.35 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -106.12 168.54 9.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.45 -1.029 . . . . 0.0 110.021 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -171.87 155.58 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 110.262 -179.851 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -52.07 -27.42 13.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.752 179.659 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.52 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 4.4 t -143.59 163.02 34.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.244 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.576 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 21.2 m-85 -137.35 -148.54 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 93.8 p -154.34 -113.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.813 -1.18 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CG ' ' O ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -107.88 12.35 27.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.556 -1.34 . . . . 0.0 110.67 -178.922 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.788 ' C ' HG22 ' A' ' 102' ' ' THR . 30.9 t30 -162.25 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.808 -1.183 . . . . 0.0 110.179 179.471 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ASN . 31.8 t0 43.26 76.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.726 -1.234 . . . . 0.0 108.955 -179.48 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.843 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.3 p30 -68.35 126.96 31.23 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 110.664 -178.385 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG11 ' HG3' ' A' ' 64' ' ' PRO . 15.9 m -109.73 119.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.194 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 6.4 t0 -82.56 134.12 35.19 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.872 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.804 ' CD1' HG21 ' A' ' 66' ' ' ILE . 39.3 m-85 -92.5 131.8 37.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.956 -1.09 . . . . 0.0 112.252 -178.022 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.83 90.43 3.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.905 -179.944 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.548 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.26 129.46 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.65 179.984 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -38.14 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.521 -0.737 . . . . 0.0 110.637 -179.28 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -157.22 131.99 8.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.965 . . . . 0.0 110.157 179.911 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.21 56.08 27.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.635 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 24.5 m-85 -161.05 148.46 15.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.854 -179.356 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 6.5 tttm -106.25 138.9 41.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.906 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 66' ' ' ILE . 1.3 mt -76.02 93.5 3.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.409 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.536 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -69.84 100.32 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 0.0 109.666 179.6 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.24 -97.17 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.591 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 t -148.41 114.98 5.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -1.204 . . . . 0.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 90.7 p -72.87 0.48 10.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.934 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -145.63 100.13 3.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.91 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 85' ' ' VAL . 19.7 m -115.78 167.63 10.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.623 -179.566 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.843 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.38 144.15 44.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.557 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 10.2 t -75.95 89.31 2.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 110.253 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' CD ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -65.74 179.89 0.41 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 111.327 -179.622 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.739 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.3 Cg_endo -75.32 125.79 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.271 1.669 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.99 -1.83 13.25 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 108' ' ' THR . 7.0 m-80 78.31 96.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.813 -0.816 . . . . 0.0 110.835 179.68 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -175.82 -166.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.086 179.556 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.635 ' HB3' HD13 ' A' ' 113' ' ' LEU . 19.5 m95 -151.64 91.24 1.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.373 0.606 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -115.25 157.78 42.89 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.498 179.739 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.591 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 39.8 Cg_endo -70.8 171.8 56.31 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.01 -2.079 . . . . 0.0 111.85 0.379 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.2 pm0 -23.49 119.02 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.451 0.643 . . . . 0.0 112.624 -178.798 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.635 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.4 tp -45.82 137.28 5.95 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 109.014 178.585 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.607 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 42.8 Cg_endo -70.5 165.78 30.69 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 123.887 1.467 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.659 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -133.56 108.65 8.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -61.1 89.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.659 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.8 m -106.59 -167.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.839 0.828 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 7.7 mtm180 . . . . . 0 C--N 1.291 -1.969 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.293 0.568 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' A' ' 22' ' ' THR . 14.3 mttt -93.63 174.83 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.363 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -136.48 92.9 2.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.873 . . . . 0.0 110.212 179.844 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -67.47 170.8 6.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.297 179.518 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.45 143.45 1.11 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.847 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.862 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.9 Cg_endo -70.86 152.45 63.6 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.988 1.52 . . . . 0.0 110.741 -179.207 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.38 170.27 20.61 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.747 1.393 . . . . 0.0 109.865 179.416 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.68 176.3 3.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 109.813 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.684 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.54 -169.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 122.168 0.985 . . . . 0.0 111.498 179.838 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 7.9 t -40.62 92.66 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.536 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 9' ' ' ILE . 12.1 m120 42.63 45.94 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.49 178.42 19.99 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 180.0 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER -126.25 -169.33 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -1.202 . . . . 0.0 110.695 -179.915 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.613 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p80 -157.9 125.36 5.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.898 -0.502 . . . . 0.0 110.512 -179.41 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.39 -33.82 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 44.4 -122.43 4.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.59 -0.79 2.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -1.16 . . . . 0.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 7.4 pt-20 -164.12 -167.35 1.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.491 -179.811 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.28 19.31 2.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.88 . . . . 0.0 110.589 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.42 45.43 2.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.007 -1.058 . . . . 0.0 110.441 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 23.2 m-85 -58.26 179.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.642 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.562 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 2.2 p -147.14 -61.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 111.045 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -163.37 137.37 5.93 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.53 15.04 80.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.552 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.608 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.73 175.3 6.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.948 . . . . 0.0 109.543 179.81 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.8 t -149.22 154.11 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.993 -179.756 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.862 HG11 ' HG3' ' A' ' 6' ' ' PRO . 24.3 t -134.24 122.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.252 -179.739 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.33 103.31 4.67 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.315 -1.354 . . . . 0.0 108.015 177.805 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.991 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.45 176.57 2.79 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.763 -178.487 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.5 t -130.79 -177.15 4.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.839 179.616 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 91.0 m -147.72 135.38 20.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.0 109.616 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.472 ' O ' ' OG ' ' A' ' 33' ' ' SER . 6.5 m120 -99.52 -177.87 3.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 110.744 -179.527 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 6.0 p 44.76 56.77 4.99 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.707 0.765 . . . . 0.0 110.278 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 43.46 49.63 6.94 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 33' ' ' SER . 4.5 m-30 -102.4 131.78 48.83 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.915 -1.344 . . . . 0.0 111.164 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.831 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -74.59 138.52 43.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.742 -0.599 . . . . 0.0 110.679 -179.792 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.587 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.7 tt -89.44 109.66 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.128 -0.983 . . . . 0.0 109.453 178.986 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.815 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -103.02 143.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.468 -179.988 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.41 -141.1 11.41 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 41' ' ' SER . 27.6 t30 -111.42 52.39 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.239 . . . . 0.0 109.907 179.462 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.526 ' O ' HG23 ' A' ' 28' ' ' THR . 27.7 p 22.67 49.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.749 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 157.11 119.33 0.59 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.991 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.3 t -65.51 -179.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.254 . . . . 0.0 108.176 179.198 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.571 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -144.88 97.74 3.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.32 179.048 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.596 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 18.4 t -79.79 126.25 30.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.225 178.788 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.6 p -129.68 110.18 11.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.226 -179.865 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.35 22.51 62.56 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.91 8.11 76.64 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.921 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.8 114.59 22.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -1.174 . . . . 0.0 110.538 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.662 ' CH2' HG23 ' A' ' 27' ' ' VAL . 79.8 m95 -69.9 134.81 48.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.787 179.539 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.19 168.36 20.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 111.025 -179.716 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 15.6 t0 54.07 66.27 4.53 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.734 -0.604 . . . . 0.0 111.047 179.802 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -90.6 138.28 2.56 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.38 1.726 . . . . 0.0 110.154 179.349 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.2 Cg_endo -75.31 175.8 10.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.839 1.442 . . . . 0.0 110.591 179.938 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.8 p -111.23 -175.24 2.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.832 . . . . 0.0 111.359 -179.019 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 33.6 m -142.51 75.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.859 0.837 . . . . 0.0 108.803 178.839 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -108.6 -148.67 0.43 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.728 -179.146 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.808 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -125.99 121.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.049 . . . . 0.0 108.632 179.347 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 36' ' ' SER . 20.4 m -114.68 49.46 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.025 -1.047 . . . . 0.0 112.324 -178.197 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -60.55 -172.24 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 C-N-CA 117.779 -1.569 . . . . 0.0 107.519 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.497 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -147.95 166.73 15.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 117.84 -1.544 . . . . 0.0 113.979 -178.296 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.0 Cg_endo -87.84 -74.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 125.02 2.063 . . . . 0.0 110.618 179.551 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 166.12 125.4 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.074 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.891 ' HG2' HD21 ' A' ' 71' ' ' LEU . 48.1 Cg_endo -75.36 65.64 6.37 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.629 1.331 . . . . 0.0 109.455 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.576 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -82.48 175.93 9.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 110.311 -179.536 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.994 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -171.99 167.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 110.404 -179.623 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 46.5 p -72.81 100.39 2.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 110.55 -179.674 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 88.5 m-20 42.85 49.09 5.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.815 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.994 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -161.86 38.52 0.39 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.613 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 49.4 p90 -47.0 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.101 1.429 . . . . 0.0 113.141 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.919 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -139.06 127.18 22.51 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.682 -176.948 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.6 t -103.89 16.88 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.494 -0.754 . . . . 0.0 110.087 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.65 101.37 6.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.161 -0.962 . . . . 0.0 111.538 -179.008 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.673 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 71.84 103.42 0.06 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.93 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.643 ' CD2' HD11 ' A' ' 71' ' ' LEU . 7.8 t80 -156.92 154.11 29.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -1.085 . . . . 0.0 110.266 179.431 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 1.1 tttm -161.35 147.96 14.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' LYS . 29.8 mtm180 -42.47 -37.01 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.055 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -131.9 165.03 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 110.118 179.835 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 22.8 m-85 -137.04 -142.87 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.556 ' C ' HG23 ' A' ' 59' ' ' VAL . 55.6 p -156.48 -117.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.951 -1.093 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.22 11.65 32.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.752 -1.218 . . . . 0.0 111.845 -178.664 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.787 ' C ' HG22 ' A' ' 102' ' ' THR . 0.5 OUTLIER -163.64 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.642 -1.286 . . . . 0.0 110.72 178.938 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 82' ' ' ASN . 7.6 m-20 42.41 74.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.723 -1.236 . . . . 0.0 109.272 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.701 ' CA ' HG23 ' A' ' 102' ' ' THR . 47.4 t30 -68.82 121.91 17.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.614 -178.664 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 74' ' ' GLY . 29.0 m -106.44 123.14 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.844 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -80.24 139.34 36.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.336 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.675 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 32.0 m-85 -95.15 143.25 26.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 112.38 -177.997 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.37 98.18 6.6 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 -179.857 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.524 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -50.22 134.98 22.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.397 -179.639 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.39 -69.84 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.784 . . . . 0.0 110.402 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 23.5 t80 -172.19 141.71 1.3 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.304 -0.873 . . . . 0.0 110.391 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 47.71 15.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 11.1 m-85 -149.23 150.0 31.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -1.019 . . . . 0.0 109.803 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' VAL . 4.8 mtmt -103.3 143.37 32.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER -85.09 92.38 8.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 110.187 -179.956 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 105.02 10.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.3 -79.83 0.24 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.227 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.574 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 24.9 p -159.7 99.27 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -1.092 . . . . 0.0 110.922 -179.191 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.41 47.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.073 -1.017 . . . . 0.0 109.591 179.203 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 p -140.63 108.45 5.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.551 179.736 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 2.8 m -123.67 167.67 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.215 -0.928 . . . . 0.0 111.16 -179.238 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.787 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -134.48 145.19 48.58 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.782 0.801 . . . . 0.0 110.339 179.617 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -82.24 80.13 8.53 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.827 -0.546 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.528 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -58.4 -177.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 111.358 -179.212 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.815 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -77.37 125.42 7.71 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.386 1.73 . . . . 0.0 110.211 -179.707 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.26 -8.37 7.07 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.715 ' O ' HG23 ' A' ' 108' ' ' THR . 4.8 m-20 79.47 94.7 0.06 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.749 -0.853 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.49 -166.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.832 . . . . 0.0 111.092 179.445 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.669 ' HB3' HD11 ' A' ' 113' ' ' LEU . 38.0 m95 -144.04 87.69 1.92 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.539 0.685 . . . . 0.0 109.729 -179.845 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -100.26 140.81 21.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.658 -179.238 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.574 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.0 Cg_endo -74.83 170.93 70.31 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.555 -2.269 . . . . 0.0 110.039 -0.231 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 11.8 pt-20 -36.75 137.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.562 -0.712 . . . . 0.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.759 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -46.76 157.86 0.44 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.846 . . . . 0.0 109.799 179.511 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.77 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -79.95 165.51 21.87 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 124.206 1.635 . . . . 0.0 111.126 -179.715 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.729 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.0 ttmt -124.36 104.53 8.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.3 t -60.34 83.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.356 179.623 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.729 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.8 m -95.77 -175.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.87 0.843 . . . . 0.0 110.808 -179.6 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.556 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.81 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.442 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.675 HG21 ' C ' ' A' ' 47' ' ' GLY . 9.6 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.231 0.539 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 20' ' ' PHE . 3.9 ttmt -132.88 172.13 13.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.367 -179.734 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.576 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 10.4 t -163.81 136.14 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 110.102 -179.918 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' SER . 6.5 pt20 -117.2 -176.71 3.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -40.3 142.38 0.74 Allowed Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.273 -179.999 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.795 ' HG3' HG11 ' A' ' 27' ' ' VAL . 55.4 Cg_endo -71.68 167.37 26.69 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 124.143 1.601 . . . . 0.0 110.647 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.03 171.86 15.01 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.797 1.419 . . . . 0.0 108.756 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -78.18 104.96 9.1 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.893 -1.13 . . . . 0.0 110.616 -179.563 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.824 HG21 ' CG ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -42.64 173.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.9 0.857 . . . . 0.0 110.012 -179.904 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' HG13 ' A' ' 9' ' ' ILE . 34.5 m -99.86 140.92 33.38 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.604 -1.238 . . . . 0.0 109.697 178.293 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 6.8 m120 63.37 17.06 10.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.731 -179.02 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -167.05 -164.52 22.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' SER . 7.2 mtp180 -140.39 -171.81 3.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -1.135 . . . . 0.0 110.566 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 7.9 p80 -148.11 133.34 18.41 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.812 -0.555 . . . . 0.0 110.37 -179.937 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 14' ' ' HIS . 3.1 m-20 -167.01 75.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -101.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.917 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -175.84 38.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -1.15 . . . . 0.0 109.793 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -154.48 -169.38 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.332 -179.665 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 -37.97 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.555 ' CE1' ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -111.72 118.75 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.652 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -104.36 -12.78 16.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 110.429 -179.741 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.548 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 p 45.45 -96.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.921 . . . . 0.0 111.867 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -148.47 154.01 39.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 0.0 110.115 -178.588 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.2 19.64 79.69 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.232 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.652 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 7.1 m -98.34 171.1 8.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.695 -0.885 . . . . 0.0 110.212 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 43' ' ' VAL . 38.9 t -147.87 155.29 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.176 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.795 HG11 ' HG3' ' A' ' 6' ' ' PRO . 13.1 t -134.12 111.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.639 -179.132 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 103.25 1.52 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.461 -1.296 . . . . 0.0 107.738 178.085 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.824 ' CG ' HG21 ' A' ' 9' ' ' ILE . 1.3 m-30 -68.02 -176.55 0.71 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.998 -178.435 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -133.99 155.3 50.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.291 179.057 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.1 m -126.41 139.72 53.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.561 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' SER . 31.9 m-20 -83.49 174.35 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.0 110.392 179.905 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.497 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 28.8 t 42.31 -165.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.137 179.211 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.84 2.66 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 33' ' ' SER . 12.0 m-85 -89.08 107.76 19.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.95 -1.324 . . . . 0.0 111.185 -179.419 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -60.39 139.68 57.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 0.0 110.357 179.281 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.665 HD21 ' HA ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -84.38 102.19 12.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.316 179.078 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -94.3 150.95 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 108.991 179.785 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.31 -143.43 14.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.223 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 3.3 m120 -114.58 49.62 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -1.23 . . . . 0.0 109.837 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.665 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER 25.21 62.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.941 179.505 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 141.88 115.22 1.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.593 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.723 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -58.45 -178.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.522 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.3 tp -142.88 105.8 4.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.005 -1.06 . . . . 0.0 110.097 178.458 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.2 t -88.29 109.4 19.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.9 m -126.77 126.06 42.79 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.13 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.675 ' C ' HG21 ' A' ' 1' ' ' VAL . . . 70.45 28.62 70.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.54 26.44 73.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.03 115.4 12.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 110.174 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.628 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.8 m95 -76.58 136.28 39.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.862 179.812 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.73 171.76 19.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 110.998 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.533 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 53.67 64.73 6.35 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.872 -0.518 . . . . 0.0 111.212 179.77 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -91.99 145.28 2.96 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.958 1.772 . . . . 0.0 109.841 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.4 Cg_endo -79.44 174.9 11.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.731 1.385 . . . . 0.0 110.11 179.53 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.59 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 14.4 p -114.39 -177.31 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 111.13 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.751 ' SG ' HD11 ' A' ' 9' ' ' ILE . 84.7 m -140.57 73.42 1.42 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.019 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -116.52 177.57 4.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.736 -178.975 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' CD ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -88.94 145.15 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.1 179.719 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.655 HG21 ' CB ' ' A' ' 81' ' ' TYR . 29.0 m -129.93 40.96 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.371 -179.128 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.572 ' CD ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -78.87 101.21 7.56 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.429 179.843 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 50.2 m -73.04 162.71 73.23 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.454 -0.778 . . . . 0.0 111.253 -178.913 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.3 Cg_endo -70.82 -89.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.359 1.715 . . . . 0.0 110.628 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -172.25 133.42 0.76 Allowed Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.643 ' HA ' HD21 ' A' ' 113' ' ' LEU . 58.0 Cg_endo -86.7 83.8 1.09 Allowed 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 123.69 1.363 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 66' ' ' ILE . 4.1 p -100.7 -42.38 6.53 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.39 1.091 . . . . 0.0 110.288 -178.954 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.785 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 48.86 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.927 -179.216 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.533 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 49.6 m -69.32 107.61 3.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 111.666 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 27.6 m120 38.06 43.78 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.0 111.77 178.438 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -126.6 -44.08 0.25 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.805 -1.664 . . . . 0.0 109.903 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 23.3 p90 41.35 -174.61 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 122.639 1.209 . . . . 0.0 111.827 -179.13 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.883 HD13 ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.63 153.62 50.89 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.239 -179.243 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -13.88 12.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.888 -1.133 . . . . 0.0 110.287 -178.78 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 40.9 t -51.41 -54.44 26.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.19 106.6 0.21 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.81 -177.34 3.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.962 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 27.5 tttm -159.68 168.75 25.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.55 -0.719 . . . . 0.0 109.89 -179.585 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.0 mtp85 -65.86 -39.25 90.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.981 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 m -139.64 126.21 20.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CD2' ' CH2' ' A' ' 109' ' ' TRP . 60.4 m-85 -95.32 -175.99 3.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 29.0 t -170.47 96.87 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.301 179.941 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CB ' HG21 ' A' ' 59' ' ' VAL . 2.2 t80 52.06 125.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.381 -0.825 . . . . 0.0 110.664 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.712 ' O ' HG22 ' A' ' 102' ' ' THR . 13.7 t-20 73.51 -128.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.941 -1.1 . . . . 0.0 110.381 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 71.08 0.54 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.701 -1.249 . . . . 0.0 109.11 -178.451 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.56 ' ND2' ' O ' ' A' ' 101' ' ' SER . 6.3 t-20 -70.39 142.17 52.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.533 -0.73 . . . . 0.0 111.093 -178.998 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.78 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -129.57 120.01 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.328 -0.858 . . . . 0.0 110.072 179.002 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -84.29 124.17 30.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 178.966 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.789 ' CE1' HD12 ' A' ' 71' ' ' LEU . 50.2 m-85 -80.94 136.38 36.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.316 1.055 . . . . 0.0 112.527 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -114.76 86.1 2.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.439 -179.643 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.585 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.68 128.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 0.0 110.795 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 15.1 mmtt -38.95 -84.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.538 -0.726 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 19.0 t80 -160.58 149.6 16.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.12 -0.987 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.49 31.46 14.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.6 m-85 -142.65 146.12 34.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.501 -0.999 . . . . 0.0 110.234 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.73 135.07 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.885 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.707 HD23 HD11 ' A' ' 66' ' ' ILE . 5.5 mt -67.24 111.06 3.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.524 -179.702 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.467 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.19 106.62 18.31 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.136 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -90.38 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.801 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -149.0 120.39 7.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -1.15 . . . . 0.0 110.538 -179.474 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 p -80.15 4.8 16.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 0.0 110.905 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -144.9 115.81 7.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 110.093 179.719 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.56 ' O ' ' ND2' ' A' ' 84' ' ' ASN . 17.5 m -126.82 -175.53 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.699 -179.714 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 82' ' ' ASN . 13.9 m -157.24 134.4 10.34 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.114 -178.926 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.584 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 6.2 t -59.72 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.877 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.21 172.38 9.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.767 ' HB3' HD12 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -74.85 123.74 8.19 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.334 1.702 . . . . 0.0 110.925 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.2 -7.61 5.07 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.9 m120 81.12 77.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.971 -0.723 . . . . 0.0 110.384 179.83 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -174.4 -168.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.852 . . . . 0.0 111.612 179.82 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.78 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 22.5 m95 -134.37 100.65 4.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 -179.691 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 102' ' ' THR . 2.7 mttm -102.71 149.12 36.46 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.216 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.9 Cg_endo -75.28 -174.58 14.48 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.906 -2.123 . . . . 0.0 110.551 -0.371 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.1 tp10 -39.13 117.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.341 0.591 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 109' ' ' TRP . 1.8 tp -43.74 141.94 2.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.825 . . . . 0.0 110.785 -179.694 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.785 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.7 Cg_endo -72.31 167.05 27.95 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.085 1.571 . . . . 0.0 110.502 179.507 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -132.33 95.33 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.923 . . . . 0.0 110.525 179.879 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.7 t -46.62 102.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.073 -1.017 . . . . 0.0 109.135 179.475 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -113.58 -178.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.729 0.775 . . . . 0.0 111.083 -179.135 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.162 0.506 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -162.58 171.5 16.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.535 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -130.55 151.96 50.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 41.6 mt-30 -134.03 174.7 10.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.072 -1.018 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.25 130.69 7.62 Favored Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.612 ' HG2' ' CG ' ' A' ' 14' ' ' HIS . 48.8 Cg_endo -70.46 158.83 54.88 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.944 1.497 . . . . 0.0 110.77 -179.752 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.05 175.14 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.014 1.534 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' ILE . 88.7 p -85.75 99.21 11.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.133 179.906 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.0 -170.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.381 1.086 . . . . 0.0 111.917 -179.664 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 9' ' ' ILE . 1.9 p -37.48 95.79 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.012 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 41.03 29.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 110.758 179.682 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -119.32 174.32 15.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 1.6 mtt85 -113.53 -168.49 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 15.3 p80 -158.94 119.45 3.22 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.321 0.581 . . . . 0.0 110.265 -179.899 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.699 ' O ' HG13 ' A' ' 27' ' ' VAL . 6.1 m120 -107.11 -162.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.634 -179.621 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 18' ' ' GLU . . . 147.3 -20.67 1.54 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.986 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.12 34.78 16.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -1.132 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.611 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 38.2 mm-40 -121.43 -155.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.004 179.721 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -153.36 -39.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.617 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 7.8 p90 -143.48 80.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.707 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 25.7 m-85 -49.75 -179.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.052 -1.03 . . . . 0.0 110.112 179.938 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.535 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -142.61 -68.56 0.36 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.616 -1.303 . . . . 0.0 111.183 -179.07 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -156.86 141.42 16.76 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 109.757 -178.954 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 69.27 7.97 58.21 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.843 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 26' ' ' VAL . 40.5 m -71.31 174.91 5.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.11 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 36.3 t -156.77 157.63 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 15' ' ' ASN . 34.0 t -144.68 121.26 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.102 -179.655 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.46 101.88 3.06 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.869 178.249 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.672 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.99 154.93 40.59 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.414 -0.804 . . . . 0.0 110.136 -178.31 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.507 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.7 t -114.37 -177.14 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.021 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 57.4 m -146.9 149.89 34.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.25 149.97 5.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -54.34 107.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 179.968 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.1 10.05 9.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.948 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 4.4 m-85 -124.24 120.86 33.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.725 -179.693 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.616 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -73.05 138.2 45.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.428 179.678 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.9 tp -90.42 98.57 11.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.139 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -92.05 170.39 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.096 179.414 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 83.93 -178.82 52.14 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.684 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.19 121.66 15.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -1.141 . . . . 0.0 109.943 179.917 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.696 ' O ' HG23 ' A' ' 28' ' ' THR . 6.2 t -73.11 53.4 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.491 -179.755 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 174.78 88.08 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.336 179.892 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -45.32 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.316 -1.108 . . . . 0.0 108.935 179.45 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 25' ' ' SER . 6.3 tp -139.69 106.18 5.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 110.151 178.809 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.61 107.54 14.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.138 -0.976 . . . . 0.0 109.771 179.595 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -129.16 121.33 27.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -7.4 80.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.6 16.37 8.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -144.69 138.17 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -1.14 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 99.8 m95 -77.92 136.39 38.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.878 179.696 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t -132.12 163.88 27.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.476 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 27.8 m-20 51.09 66.7 5.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.808 -0.558 . . . . 0.0 111.191 179.681 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -90.42 137.88 2.57 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 124.399 1.736 . . . . 0.0 109.733 179.123 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.1 Cg_endo -75.68 178.02 7.93 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.664 1.35 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.581 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.5 p -118.92 147.04 44.45 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 0.0 112.072 -178.635 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 92.4 m -110.37 76.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.317 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.04 178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.457 0.646 . . . . 0.0 110.392 -178.575 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -91.38 134.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.053 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 81' ' ' TYR . 28.2 m -119.8 43.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -178.992 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 25.4 mttt -80.06 97.66 6.92 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 119.406 -0.917 . . . . 0.0 108.904 179.5 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 60.2 m -69.06 161.88 69.39 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -178.607 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.1 Cg_endo -72.08 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.503 1.791 . . . . 0.0 110.34 -179.638 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.457 ' O ' HG23 ' A' ' 65' ' ' THR . 0.1 OUTLIER -157.46 131.55 4.99 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.593 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.605 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.1 Cg_endo -76.91 66.18 7.65 Favored 'Trans proline' 0 C--N 1.297 -2.132 0 O-C-N 123.725 1.382 . . . . 0.0 109.888 -178.906 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.737 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -87.87 -174.65 4.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.547 -0.72 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.737 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 178.32 166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.355 179.471 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.3 OUTLIER -69.8 96.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.746 -179.594 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.7 m-20 48.72 40.49 16.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.925 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -146.3 28.58 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.6 p90 -45.15 -175.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.641 1.21 . . . . 0.0 112.346 -179.08 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD13 ' H ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.5 162.12 15.45 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.347 179.527 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t -144.66 22.74 1.62 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.971 -1.08 . . . . 0.0 110.449 -179.094 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.9 t -100.12 -82.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.698 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.44 75.88 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.711 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -95.88 157.99 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -1.05 . . . . 0.0 109.592 179.554 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.552 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -147.6 168.41 22.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 110.667 -179.636 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -76.3 -35.55 58.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.971 179.798 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 p -124.88 131.82 53.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.716 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.583 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 89.8 m-85 -112.5 170.79 7.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.512 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 81' ' ' TYR . 92.6 p -165.39 91.2 0.51 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 179.9 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.652 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.0 t80 52.42 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.815 0.817 . . . . 0.0 110.44 -179.47 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.774 ' O ' HG22 ' A' ' 102' ' ' THR . 15.3 t-20 65.33 -127.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.487 -1.383 . . . . 0.0 110.094 -179.215 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 6.2 m-20 51.82 73.92 0.29 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.622 -1.299 . . . . 0.0 109.044 -178.54 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 101' ' ' SER . 6.0 t30 -72.28 146.42 47.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.519 -0.738 . . . . 0.0 111.351 -178.703 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.744 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -132.16 124.27 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 109.553 179.021 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.8 t0 -83.82 124.23 30.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.995 -1.065 . . . . 0.0 109.48 179.643 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.679 ' HD2' HG21 ' A' ' 66' ' ' ILE . 8.4 m-85 -87.11 120.65 28.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.182 -0.949 . . . . 0.0 111.56 -178.651 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -95.75 94.93 7.97 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.169 179.932 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -44.37 125.36 4.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.07 -1.019 . . . . 0.0 109.488 179.78 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.554 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 4.9 mmtp -35.85 -67.33 0.16 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.672 -0.643 . . . . 0.0 111.001 -178.938 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 36.3 t80 -173.6 144.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.595 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.37 47.37 11.49 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -149.83 153.87 37.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -1.027 . . . . 0.0 109.899 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' CG ' HG23 ' A' ' 117' ' ' VAL . 4.4 ptpt -113.99 130.11 56.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -66.66 93.21 0.24 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.603 -179.455 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.659 ' HB2' HG21 ' A' ' 117' ' ' VAL . 2.4 t -74.61 103.85 5.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.61 179.508 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.54 -77.76 0.3 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.826 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.562 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -172.47 116.1 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.16 . . . . 0.0 110.454 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.576 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -67.78 -77.22 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.87 . . . . 0.0 110.637 -179.944 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 100' ' ' SER . 5.0 p -68.82 104.99 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.792 -179.219 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.4 m -107.41 -170.75 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.906 179.538 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 82' ' ' ASN . 7.8 m -161.49 138.12 8.39 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.289 -178.966 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.653 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.5 t -59.49 105.64 0.38 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 179.78 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.458 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.96 168.16 16.3 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.814 -179.464 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.783 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.1 Cg_endo -76.32 126.91 9.44 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.418 1.747 . . . . 0.0 110.632 -179.519 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 122.41 3.84 9.32 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.287 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.848 ' O ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER 77.3 83.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.756 -0.849 . . . . 0.0 110.635 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.04 -168.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 111.81 179.628 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.744 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 33.8 m95 -134.08 95.07 3.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 110.289 -179.601 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -98.95 143.79 27.01 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.614 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.67 172.63 58.18 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.837 -2.151 . . . . 0.0 110.616 -0.634 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 39.4 tt0 -39.1 128.2 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 0.0 111.263 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.41 152.16 0.28 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 0.0 109.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CG ' ' CD2' ' A' ' 87' ' ' PHE . 39.7 Cg_endo -82.87 167.5 14.46 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 O-C-N 124.301 1.685 . . . . 0.0 111.119 -179.362 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.557 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.0 ttpt -126.71 108.04 10.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.819 179.66 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.3 t -64.24 74.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.659 HG21 ' HB2' ' A' ' 96' ' ' SER . 3.7 m -90.52 -175.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.771 0.796 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.606 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.6 ppt_? . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.481 179.412 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.18 178.57 3.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.871 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -135.39 127.82 30.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.985 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 35.8 mt-30 -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.154 179.254 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -43.37 142.93 1.56 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.042 -1.036 . . . . 0.0 110.461 -179.479 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.634 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.5 Cg_endo -73.5 160.23 44.79 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.191 1.627 . . . . 0.0 110.532 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.5 171.59 17.83 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.522 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.33 98.89 10.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 109.865 179.706 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.611 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -51.4 -170.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.389 1.09 . . . . 0.0 111.944 -179.17 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 5.3 p -58.49 122.79 14.21 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.68 -178.887 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . 2.0 m-20 33.6 34.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.996 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.53 162.58 26.93 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.529 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -111.8 -171.46 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -1.197 . . . . 0.0 110.934 -179.65 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.634 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.1 p80 -154.19 123.99 6.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.886 -0.509 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.9 -158.46 0.86 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.654 -179.621 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' OE2' ' A' ' 18' ' ' GLU . . . 138.35 -7.02 3.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 66.93 58.73 0.58 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -1.152 . . . . 0.0 110.186 -179.942 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -137.22 -69.42 0.46 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.28 -0.887 . . . . 0.0 109.821 -179.84 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 2.7 m-20 68.32 18.01 9.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.614 -0.679 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -170.53 50.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.049 -1.032 . . . . 0.0 110.595 179.761 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.809 ' O ' HG23 ' A' ' 22' ' ' THR . 9.7 m-85 -55.59 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.139 179.389 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 21' ' ' TYR . 1.9 p -161.95 -69.22 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.823 -1.173 . . . . 0.0 111.2 -179.959 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.5 t70 -164.16 138.31 5.55 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.048 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.81 12.21 83.08 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.737 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -86.19 169.27 13.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.975 . . . . 0.0 109.951 179.947 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 43' ' ' VAL . 92.6 t -143.59 151.19 16.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.615 178.596 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.652 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 30.0 t -136.59 120.37 23.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.311 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.41 101.41 4.78 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.025 -1.47 . . . . 0.0 107.579 177.989 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 1.5 m-30 -67.55 127.28 32.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.622 -178.418 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -74.75 169.3 18.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 179.615 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -140.13 134.15 30.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' SER . 1.7 m120 -43.46 116.23 0.91 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.571 179.581 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ASN . 10.6 m -38.65 113.13 0.27 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.639 -179.443 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.34 -26.11 6.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.601 ' CE2' HG13 ' A' ' 58' ' ' ILE . 2.8 m-85 -91.8 144.86 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -1.142 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.929 ' HB2' HG22 ' A' ' 59' ' ' VAL . 48.2 t -81.88 119.8 24.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 111.114 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tp -79.48 106.63 11.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.071 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -98.79 152.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.955 . . . . 0.0 109.14 -179.63 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 104.89 -177.91 23.58 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.806 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 42' ' ' GLY . 23.7 p-10 -67.98 131.73 46.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.697 179.571 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.768 ' O ' HG23 ' A' ' 28' ' ' THR . 24.5 p -73.17 56.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.79 179.91 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 26' ' ' VAL . . . 165.52 96.13 0.11 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.646 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -48.55 177.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.156 . . . . 0.0 108.054 179.38 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.3 tp -143.51 99.16 3.37 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.962 -1.086 . . . . 0.0 110.249 178.777 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.0 t -80.5 121.18 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.39 178.744 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.23 126.88 41.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.694 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 62.33 25.94 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.905 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.4 31.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.889 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -140.69 119.27 12.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.604 ' CD2' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -77.36 136.29 38.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.629 179.696 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -141.45 160.01 41.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 111.412 -179.33 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.7 t0 53.84 65.84 5.07 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.923 -0.486 . . . . 0.0 111.521 179.332 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.1 Cg_endo -91.26 129.95 1.31 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 124.378 1.725 . . . . 0.0 109.265 178.516 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 44.8 Cg_endo -72.16 166.02 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.574 1.302 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.606 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 24.8 p -104.33 -174.59 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.189 0.995 . . . . 0.0 111.612 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.6 t -146.16 74.6 1.38 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.532 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.22 -170.5 1.67 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.331 -178.459 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.677 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -111.5 86.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.933 HG21 ' CB ' ' A' ' 81' ' ' TYR . 20.1 m -76.03 51.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 111.368 -179.115 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -55.22 175.78 0.06 Allowed 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 117.671 -1.612 . . . . 0.0 107.831 179.305 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 66.9 m -134.24 142.58 43.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.16 -178.305 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 41.8 Cg_endo -74.61 -83.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.491 1.785 . . . . 0.0 110.486 179.439 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.573 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER 177.58 126.19 0.19 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.539 -0.726 . . . . 0.0 109.251 -179.559 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.779 ' HG2' HD21 ' A' ' 71' ' ' LEU . 50.5 Cg_endo -77.13 57.54 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.788 1.415 . . . . 0.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.66 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.76 166.11 23.51 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.47 0.652 . . . . 0.0 110.593 -179.673 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 1.006 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -166.33 167.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.171 179.504 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 116' ' ' CYS . 1.7 t -76.34 113.13 13.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 110.78 -179.403 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.541 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 72.9 m-20 36.21 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.675 -0.641 . . . . 0.0 111.401 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.006 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.32 38.09 1.26 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.008 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.638 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.1 p90 -44.85 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 123.438 1.589 . . . . 0.0 113.401 -179.682 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.819 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -139.42 122.83 17.18 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.491 -176.807 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -104.48 15.71 27.58 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.466 -0.771 . . . . 0.0 110.237 -178.951 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.95 95.56 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.44 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 94.02 106.55 1.91 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.711 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 9.2 t80 -173.89 170.49 3.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -1.173 . . . . 0.0 110.255 179.719 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.623 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.0 tttm -179.93 142.72 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.463 -0.773 . . . . 0.0 109.727 -179.684 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 76' ' ' LYS . 12.7 mtp180 -41.42 -27.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -148.08 141.49 25.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 110.175 179.877 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' N ' ' CD1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -124.99 -164.75 1.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 109.607 179.762 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.7 p -170.67 107.89 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.933 ' CB ' HG21 ' A' ' 59' ' ' VAL . 2.3 t80 53.24 156.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.112 -0.992 . . . . 0.0 110.672 179.167 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.821 ' C ' HG22 ' A' ' 102' ' ' THR . 27.4 t-20 38.18 -110.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.713 -179.224 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 81' ' ' TYR . 74.9 m-20 50.79 69.0 0.69 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.765 -1.21 . . . . 0.0 109.143 -179.419 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.84 ' CA ' HG23 ' A' ' 102' ' ' THR . 11.3 p-10 -69.43 129.98 41.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.753 -178.92 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 74' ' ' GLY . 15.8 m -121.53 128.85 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.998 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 20.4 t0 -85.37 136.78 33.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 108.575 178.977 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.696 ' CE2' HD23 ' A' ' 71' ' ' LEU . 51.2 m-85 -96.69 143.5 27.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.969 -1.082 . . . . 0.0 111.907 -178.43 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 5.7 tttm -115.38 110.03 18.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.448 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.522 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -66.55 132.79 48.99 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.835 -1.165 . . . . 0.0 109.943 -179.251 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.541 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -38.76 -91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 111.173 -179.132 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.3 t80 -148.44 138.56 22.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 0.0 110.786 -179.293 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 51.08 60.1 7.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.672 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 12.2 m-85 -162.96 136.45 5.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -1.06 . . . . 0.0 109.943 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 117' ' ' VAL . 34.5 pttt -101.23 112.23 24.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.423 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.673 HD23 HD11 ' A' ' 66' ' ' ILE . 1.3 mt -45.58 125.9 6.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -102.24 103.55 14.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 0.0 109.501 179.215 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.59 -57.42 0.58 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.633 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 172.65 119.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -1.148 . . . . 0.0 111.098 -179.417 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -78.11 -3.87 44.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.201 -0.937 . . . . 0.0 110.703 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.7 p -142.09 112.46 7.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 109.806 179.86 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.3 m -121.75 -179.7 4.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.993 -179.272 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.84 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -153.29 132.34 12.58 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 103' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 82' ' ' ASN . 36.6 t -78.72 82.91 4.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 110.09 -179.868 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.554 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -55.74 -179.91 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.594 -0.691 . . . . 0.0 111.503 -179.596 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.878 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.9 Cg_endo -73.43 117.6 5.14 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.559 1.821 . . . . 0.0 110.572 -179.271 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.65 ' C ' HD21 ' A' ' 107' ' ' ASN . . . 138.0 -10.25 3.62 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.65 HD21 ' C ' ' A' ' 106' ' ' GLY . 6.7 m-80 83.37 90.42 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.163 -0.61 . . . . 0.0 110.728 179.461 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.35 -161.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 111.527 179.635 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.621 ' HB3' HD13 ' A' ' 113' ' ' LEU . 17.7 m95 -149.95 80.18 1.37 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.487 0.66 . . . . 0.0 109.729 -179.831 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.56 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.9 mttm -95.18 143.26 25.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.824 -179.739 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.633 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -71.04 174.27 45.66 Favored 'Cis proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 -2.0 . . . . 0.0 110.987 -0.144 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.23 128.24 5.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -39.86 144.15 0.54 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 110.272 179.323 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.84 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.3 Cg_endo -71.74 164.26 36.25 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 111.356 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.7 tttt -132.59 119.76 20.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 67' ' ' SER . 1.3 m -62.12 113.23 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.047 -1.033 . . . . 0.0 110.194 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.52 173.48 12.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.761 179.113 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.306 0.574 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.59 173.45 11.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.489 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -127.0 108.61 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 0.0 110.458 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.533 ' NE2' ' CE1' ' A' ' 20' ' ' PHE . 9.2 mm100 -87.68 174.81 8.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.2 p -43.01 139.97 2.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.891 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.92 ' HG3' HG11 ' A' ' 27' ' ' VAL . 46.6 Cg_endo -69.59 161.04 47.46 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.083 1.57 . . . . 0.0 111.031 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.86 171.95 16.84 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.089 1.573 . . . . 0.0 109.938 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -73.01 176.47 5.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.051 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.724 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -169.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.175 0.988 . . . . 0.0 111.369 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -52.56 96.41 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.74 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 10' ' ' SER . 8.4 m120 40.63 61.78 1.55 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.453 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.5 161.99 32.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.6 mtt85 -105.88 -176.82 3.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -1.148 . . . . 0.0 109.808 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.62 -176.28 5.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.933 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 1.3 t30 66.52 136.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.065 -1.022 . . . . 0.0 109.905 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.86 -60.43 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 4.0 t80 -151.46 35.85 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -1.089 . . . . 0.0 110.116 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -145.09 -162.74 1.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 1.3 p30 -147.57 -38.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 109.879 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.609 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 3.2 m-85 -93.62 -162.05 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 171.89 -16.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.531 -0.73 . . . . 0.0 110.996 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 7.0 p 47.73 -95.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 112.311 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -152.16 161.75 42.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.788 -1.195 . . . . 0.0 110.428 -178.46 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.85 19.9 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.624 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 6.6 m -105.14 178.04 4.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.54 -0.976 . . . . 0.0 110.566 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.7 t -151.8 156.35 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.103 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.92 HG11 ' HG3' ' A' ' 6' ' ' PRO . 15.0 t -135.09 117.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.572 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.95 103.28 5.1 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.341 -1.343 . . . . 0.0 107.928 178.113 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.87 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.1 m-30 -68.24 128.09 35.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 110.05 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -82.96 157.81 22.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.577 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 35.5 m -123.28 155.17 37.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -47.94 160.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 33' ' ' SER . 12.3 p -59.98 105.16 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.475 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.53 -3.24 29.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.504 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -94.32 131.49 39.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -1.193 . . . . 0.0 110.422 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.592 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -81.39 140.14 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -90.38 99.71 12.68 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.822 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.5 162.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.185 -0.947 . . . . 0.0 109.078 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.99 171.85 47.9 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -45.96 129.04 9.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -1.159 . . . . 0.0 109.997 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.754 ' O ' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -74.01 53.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.476 -179.666 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.571 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 162.23 119.51 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.737 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.8 t -60.24 -175.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.022 -1.281 . . . . 0.0 108.051 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.584 ' H ' HG12 ' A' ' 43' ' ' VAL . 5.2 tp -146.48 97.49 2.93 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.6 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.4 OUTLIER -84.9 108.79 17.72 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.217 178.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.8 m -126.84 82.02 2.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.554 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.82 43.57 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.51 11.07 46.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -132.14 120.94 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -1.203 . . . . 0.0 110.28 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.648 ' CH2' HG23 ' A' ' 27' ' ' VAL . 80.8 m95 -76.36 138.75 40.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 0.0 109.742 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -141.41 158.06 44.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.992 . . . . 0.0 111.129 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.517 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 62.62 65.28 1.5 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 111.381 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.8 Cg_endo -91.2 133.61 1.59 Allowed 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 124.275 1.671 . . . . 0.0 110.215 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 51.3 Cg_endo -82.55 177.2 7.17 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.929 1.489 . . . . 0.0 110.34 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 17.8 p -112.04 162.17 15.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 111.528 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 m -129.21 77.1 1.77 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 177.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.55 -170.24 1.69 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.366 0.603 . . . . 0.0 110.32 -178.26 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.636 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -100.03 146.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.032 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.736 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 16.4 m -134.23 41.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.916 -1.115 . . . . 0.0 110.999 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 8.2 mtpt -81.02 98.82 8.13 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.931 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 37.4 m -70.22 165.94 38.91 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.589 -0.695 . . . . 0.0 111.387 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 50.6 Cg_endo -75.43 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.315 1.692 . . . . 0.0 110.659 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.482 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -153.78 131.67 6.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.89 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.69 ' HG2' HD22 ' A' ' 71' ' ' LEU . 54.3 Cg_endo -76.12 66.22 6.98 Favored 'Trans proline' 0 C--N 1.295 -2.254 0 O-C-N 123.595 1.313 . . . . 0.0 109.476 -179.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.73 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -87.97 175.46 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.531 -0.731 . . . . 0.0 110.686 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -178.26 161.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.0 t -72.11 111.67 7.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.0 110.864 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 61.5 m-20 36.53 49.14 0.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.641 -0.662 . . . . 0.0 111.325 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.534 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -159.42 23.76 0.3 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' HG23 ' A' ' 66' ' ' ILE . 3.8 p90 -36.41 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.953 1.359 . . . . 0.0 112.718 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -49.14 -70.59 0.08 Allowed 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.835 178.038 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER 79.96 10.05 1.34 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.41 -0.806 . . . . 0.0 109.891 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 t -114.34 -44.75 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.541 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -178.67 100.2 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.612 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.03 172.41 6.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -1.07 . . . . 0.0 109.742 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -158.89 161.08 36.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.543 -179.741 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -54.06 -37.47 64.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.772 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 m -144.02 163.31 33.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.538 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.9 m-85 -135.68 -179.2 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 17.3 p -163.06 111.9 1.3 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.042 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.677 ' CB ' HG21 ' A' ' 59' ' ' VAL . 18.2 t80 30.97 38.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.515 -0.741 . . . . 0.0 111.592 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 103' ' ' CYS . 30.6 t30 -176.48 -140.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.444 -1.41 . . . . 0.0 110.995 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 74.3 m-20 55.26 66.53 1.2 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.917 -1.115 . . . . 0.0 108.987 -178.323 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.591 ' N ' HG23 ' A' ' 102' ' ' THR . 25.0 t30 -70.65 97.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 74' ' ' GLY . 34.9 m -86.15 131.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.172 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -88.56 131.04 35.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 20.4 m-85 -88.66 125.45 34.84 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.53 1.157 . . . . 0.0 112.758 -177.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -104.97 108.63 20.24 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.116 -179.473 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.468 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -60.68 133.99 56.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.766 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -44.61 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 110.241 -179.544 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.594 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.0 p90 -148.93 149.31 31.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 111.007 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 42.9 36.9 2.71 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 17.3 m-85 -139.38 149.43 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -1.087 . . . . 0.0 110.213 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.501 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.44 139.93 46.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.209 179.9 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.747 ' CD2' HD11 ' A' ' 66' ' ' ILE . 23.5 mt -75.6 102.97 5.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.495 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -80.15 95.32 6.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.324 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.24 -85.93 0.16 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.578 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -157.12 125.5 5.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -1.152 . . . . 0.0 110.554 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.3 p -86.19 25.08 1.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.83 . . . . 0.0 110.882 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.4 p -169.89 106.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 1.7 m -127.48 164.84 21.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.046 0.927 . . . . 0.0 110.924 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.591 HG23 ' N ' ' A' ' 84' ' ' ASN . 26.8 m -139.79 139.4 36.41 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.962 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.558 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 11.8 t -49.52 94.4 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.671 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -66.62 174.12 2.02 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.934 -1.104 . . . . 0.0 112.366 -178.095 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.822 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.6 Cg_endo -79.44 14.33 1.83 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.635 1.86 . . . . 0.0 111.809 -178.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -116.31 18.72 13.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.834 ' O ' HG23 ' A' ' 108' ' ' THR . 10.2 t-20 67.32 54.5 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.591 -0.947 . . . . 0.0 110.263 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -167.19 -176.88 3.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 110.741 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.602 ' NE1' ' N ' ' A' ' 64' ' ' PRO . 46.6 m95 -105.97 98.84 8.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.415 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -105.73 141.99 23.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.214 -179.575 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.578 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.2 Cg_endo -71.78 174.8 45.13 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.888 -0.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.5 mm-40 -38.38 142.34 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 111.14 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -60.75 141.21 92.82 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.975 179.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.734 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.9 Cg_endo -73.13 155.59 52.07 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 124.302 1.685 . . . . 0.0 111.226 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 117' ' ' VAL . 2.6 ttpt -120.17 101.91 8.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.371 -0.83 . . . . 0.0 110.09 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -54.66 103.19 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.094 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -112.71 178.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.633 0.73 . . . . 0.0 110.823 -179.145 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 6.4 ptt85 . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.443 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 178.23 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 110.059 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.582 ' SG ' ' CZ2' ' A' ' 50' ' ' TRP . 2.8 t -160.08 97.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.527 -0.733 . . . . 0.0 110.259 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 pm0 -80.26 -175.26 4.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.1 p -45.26 142.57 2.98 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.473 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.876 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.8 Cg_endo -69.76 157.57 59.93 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.992 1.522 . . . . 0.0 111.261 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.27 173.25 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.971 1.511 . . . . 0.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.68 177.95 4.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.293 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.686 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.85 -170.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.24 1.019 . . . . 0.0 111.722 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 9' ' ' ILE . 25.4 m -38.32 92.48 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.004 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.8 m-20 40.28 34.82 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.338 -0.851 . . . . 0.0 110.78 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.91 12.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -139.7 179.01 6.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.379 -1.071 . . . . 0.0 109.957 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.609 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -137.78 114.23 10.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 110.338 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.72 122.81 21.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.42 -111.41 2.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.494 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -157.09 29.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 110.113 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 1.6 pm0 -162.99 173.62 13.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -102.26 -51.08 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.936 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -100.41 139.66 35.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.967 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -120.01 -11.96 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.641 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.568 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 21.1 p 51.14 -99.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.556 -0.715 . . . . 0.0 111.694 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -147.95 163.34 37.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.053 -1.029 . . . . 0.0 110.575 -178.579 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.47 25.31 68.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -107.04 -179.62 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.819 . . . . 0.0 110.201 -179.281 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.677 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.3 t -155.04 155.48 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.947 ' O ' HG23 ' A' ' 43' ' ' VAL . 17.2 t -140.51 116.21 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.655 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.49 103.84 2.59 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.374 -1.33 . . . . 0.0 107.851 178.064 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.918 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.8 m-30 -68.28 135.01 51.26 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.327 -178.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 4.4 t -90.25 -172.36 3.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.385 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 85.9 m -149.33 159.9 43.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.077 -1.014 . . . . 0.0 110.226 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.558 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 76.0 m-20 -46.04 139.51 4.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.937 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.51 109.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.16 17.62 10.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 32' ' ' ASN . 3.2 m-85 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.017 -1.284 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 1.069 ' OG ' HG22 ' A' ' 59' ' ' VAL . 66.3 m -92.17 133.16 36.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 111.027 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 29' ' ' TYR . 5.3 tp -88.17 116.17 26.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.37 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.699 HG23 ' CG ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -109.26 157.62 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.086 -1.009 . . . . 0.0 109.815 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.52 -169.37 18.27 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -58.61 119.24 6.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.045 -1.268 . . . . 0.0 109.51 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.706 ' O ' HG23 ' A' ' 28' ' ' THR . 46.1 p -68.45 58.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.588 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.562 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.96 115.22 0.5 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 27' ' ' VAL . 1.9 t -61.52 -175.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.214 . . . . 0.0 108.212 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.559 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.7 tp -144.06 101.38 3.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.189 -0.944 . . . . 0.0 110.115 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.1 t -85.22 108.42 17.73 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.72 179.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.506 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -129.31 103.68 7.07 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.211 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 79.43 52.79 4.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.83 50.12 8.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.56 73.42 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -1.051 . . . . 0.0 110.446 -179.854 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 68.8 m95 -46.21 131.72 10.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.562 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 5.9 m -142.65 168.98 18.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 111.099 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.5 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 11.7 m-20 59.95 66.34 2.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.687 -0.633 . . . . 0.0 111.111 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -90.8 130.22 1.47 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 124.366 1.719 . . . . 0.0 110.335 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HG2' HD11 ' A' ' 37' ' ' LEU . 55.6 Cg_endo -79.34 -176.24 3.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.838 1.441 . . . . 0.0 110.534 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.0 p -112.1 -169.42 1.47 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.997 0.903 . . . . 0.0 111.634 -178.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 67.9 m -152.03 86.72 1.31 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.558 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -117.8 -143.39 0.37 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.778 -177.845 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.784 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -134.43 100.5 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.069 HG22 ' OG ' ' A' ' 36' ' ' SER . 30.8 m -101.19 70.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 112.587 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 27.9 mtpt -65.52 -170.86 0.07 Allowed 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 117.239 -1.785 . . . . 0.0 107.989 178.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -143.9 159.8 52.12 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.292 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 46.0 Cg_endo -85.31 -79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 124.783 1.938 . . . . 0.0 110.558 179.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 171.63 128.6 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.691 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.819 ' O ' HD21 ' A' ' 71' ' ' LEU . 53.2 Cg_endo -80.27 66.36 8.82 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.8 1.421 . . . . 0.0 109.783 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.743 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -84.25 -171.49 3.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.349 -0.844 . . . . 0.0 109.698 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.743 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 172.44 170.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.298 179.035 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 69.5 m -77.0 107.4 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.155 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 5.7 m-80 38.56 65.92 0.57 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 89' ' ' CYS . . . -155.53 -37.98 0.02 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 43.5 p90 35.14 -155.78 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.591 1.186 . . . . 0.0 112.265 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.819 HD21 ' O ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -155.13 126.89 7.49 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.696 -175.486 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.6 t -100.53 15.92 26.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 86' ' ' ASP . 2.8 m -80.66 -92.3 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 111.258 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.16 88.19 0.18 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -95.76 165.87 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.612 -179.336 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.577 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 5.4 tttt -164.25 156.12 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.459 -0.775 . . . . 0.0 109.756 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -30.47 59.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 0.0 110.45 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.9 p -143.95 138.24 28.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.607 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 25.0 m-85 -114.51 -140.77 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 82.7 p -162.7 -123.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.878 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 1.034 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.27 27.3 8.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.841 -1.162 . . . . 0.0 111.089 -178.276 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.769 ' C ' HG22 ' A' ' 102' ' ' THR . 45.8 t-20 -164.98 -110.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.942 -1.099 . . . . 0.0 110.285 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 0.2 OUTLIER 48.86 71.82 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.661 -1.274 . . . . 0.0 109.101 -179.252 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.811 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.3 t-20 -68.86 109.44 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.716 HG23 ' CE1' ' A' ' 87' ' ' PHE . 27.7 m -99.36 120.63 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 0.0 111.242 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 23.7 t70 -78.88 135.42 37.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.724 ' CE2' HD23 ' A' ' 71' ' ' LEU . 13.1 m-85 -90.85 133.29 35.34 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.651 -1.281 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.36 81.94 2.12 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.777 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.537 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -40.48 126.74 2.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.55 -0.719 . . . . 0.0 110.745 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 17.2 mtpt -66.56 143.12 57.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 109.506 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.49 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.29 53.47 1.86 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.617 ' CE2' ' HD2' ' A' ' 118' ' ' ARG . 3.2 m-85 -102.29 155.4 18.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -1.035 . . . . 0.0 109.251 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -101.24 146.82 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.637 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 1.4 mt -87.64 90.84 8.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.87 -1.144 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 t -72.48 98.83 2.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.312 -0.868 . . . . 0.0 109.846 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 139.74 -41.38 1.32 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.608 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 98.2 p -178.41 -166.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.166 -1.196 . . . . 0.0 111.386 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -159.23 -39.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.577 0.703 . . . . 0.0 109.174 179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 100' ' ' SER . 37.2 p -123.9 91.96 3.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 24.2 m -103.25 146.3 28.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 111.226 -178.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.811 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -117.78 136.86 53.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.688 0.756 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.561 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -65.73 92.06 0.14 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 110.375 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.474 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -64.82 173.59 1.6 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.484 -0.76 . . . . 0.0 111.012 -179.664 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.845 ' HB3' HG11 ' A' ' 59' ' ' VAL . 42.3 Cg_endo -76.22 125.06 8.26 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.381 1.727 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.71 -3.91 8.06 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 108' ' ' THR . 9.3 m-80 80.75 94.01 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.881 -0.776 . . . . 0.0 110.428 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.6 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.801 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 113' ' ' LEU . 26.1 m95 -153.99 90.21 1.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.435 -0.791 . . . . 0.0 110.403 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.8 mtpp -96.15 141.62 23.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 110.284 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.6 Cg_endo -72.48 170.38 68.29 Favored 'Cis proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.915 -2.119 . . . . 0.0 110.559 -0.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' LEU . 11.9 pt-20 -40.58 131.43 2.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.387 -0.821 . . . . 0.0 110.427 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.583 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -41.27 142.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 0.0 110.03 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.67 ' HG2' HD12 ' A' ' 66' ' ' ILE . 46.4 Cg_endo -77.45 170.26 19.67 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.447 1.761 . . . . 0.0 111.616 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.583 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -126.37 113.2 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.603 -0.685 . . . . 0.0 110.157 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.552 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.7 t -67.72 108.57 2.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.96 . . . . 0.0 109.051 179.353 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.583 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -117.41 -179.61 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.622 0.725 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.617 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.952 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.245 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.122 0.486 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.12 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.659 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 3.9 t -147.9 105.26 3.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.757 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -88.95 -179.11 5.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.342 -179.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -44.58 140.14 3.28 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.378 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.79 ' HG3' HG11 ' A' ' 27' ' ' VAL . 55.3 Cg_endo -71.31 168.2 24.1 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.031 1.543 . . . . 0.0 110.781 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.43 -178.46 2.61 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.81 1.426 . . . . 0.0 108.457 178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -82.32 45.32 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.843 -1.161 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.804 HD11 ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER 39.08 -170.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 122.204 1.002 . . . . 0.0 110.618 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.691 ' N ' HG13 ' A' ' 9' ' ' ILE . 47.4 m -102.11 112.06 24.58 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.75 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 74.64 38.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.612 -0.68 . . . . 0.0 110.393 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 9' ' ' ILE . . . -179.03 -155.5 14.95 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.481 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -137.36 -171.61 3.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -1.208 . . . . 0.0 110.987 -179.621 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.601 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 9.6 p80 -145.0 153.91 41.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.164 0.506 . . . . 0.0 110.097 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -152.68 -87.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.22 -109.07 3.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -178.18 48.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -1.16 . . . . 0.0 110.327 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 176.25 -165.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.463 179.909 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.02 -48.29 1.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.845 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -92.07 139.11 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.659 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.6 OUTLIER -130.63 -13.87 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 111.262 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 17.4 p 44.51 -98.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 111.435 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -147.4 158.29 43.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.072 . . . . 0.0 110.154 -178.764 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.27 21.34 79.35 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.659 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 8.1 m -106.75 176.91 5.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.643 -0.916 . . . . 0.0 110.329 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 43' ' ' VAL . 42.8 t -151.25 152.24 11.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.486 -0.759 . . . . 0.0 109.864 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.79 HG11 ' HG3' ' A' ' 6' ' ' PRO . 12.7 t -130.82 121.95 51.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.997 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.31 102.33 5.04 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.848 177.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.657 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.4 m-30 -68.49 151.73 46.38 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 110.665 -178.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.412 ' C ' ' SG ' ' A' ' 31' ' ' CYS . 1.2 p -114.53 175.72 5.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.43 -0.794 . . . . 0.0 109.526 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 11.2 m -142.91 154.11 43.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 22.2 m-80 -43.59 157.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.16 115.65 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.266 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.68 10.48 35.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-85 -106.65 138.94 41.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -1.183 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.964 ' OG ' HG22 ' A' ' 59' ' ' VAL . 70.6 m -89.16 117.52 28.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 110.695 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.483 ' C ' HD13 ' A' ' 38' ' ' ILE . 3.2 tp -79.6 119.37 22.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -0.956 . . . . 0.0 109.613 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.606 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -111.88 170.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.145 179.522 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.61 44.08 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 9.7 p30 -57.81 142.22 46.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.092 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 28' ' ' THR . 25.6 p -85.6 56.95 4.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.713 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 159.23 106.57 0.22 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.875 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -53.8 -175.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.011 -1.287 . . . . 0.0 108.547 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.601 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.4 tp -144.92 99.17 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 110.197 178.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -83.11 118.6 23.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -0.984 . . . . 0.0 109.744 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -123.87 69.94 1.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 110.481 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.23 50.47 1.23 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 19.64 57.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.86 71.19 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.146 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.618 ' CH2' HG23 ' A' ' 27' ' ' VAL . 83.5 m95 -46.18 133.85 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.136 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 p -143.96 160.99 39.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 61.44 65.17 1.9 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 111.192 179.516 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.37 134.86 1.37 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.361 1.716 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.597 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.9 Cg_endo -76.55 -176.17 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.821 1.432 . . . . 0.0 109.929 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.8 p -115.83 -178.12 3.32 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.276 1.036 . . . . 0.0 112.094 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.804 ' SG ' HD11 ' A' ' 9' ' ' ILE . 55.5 m -148.07 74.76 1.31 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.99 -167.13 1.15 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.485 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.692 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -115.19 105.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -0.852 . . . . 0.0 109.379 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.086 HG21 ' HB3' ' A' ' 81' ' ' TYR . 32.8 m -95.78 67.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 111.674 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mptp? -68.87 174.86 4.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.354 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.76 161.86 60.93 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 118.43 -1.308 . . . . 0.0 113.565 -177.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.2 Cg_endo -81.26 -82.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.832 1.964 . . . . 0.0 110.054 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.58 131.93 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.0 110.295 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.669 ' O ' HD11 ' A' ' 71' ' ' LEU . 58.0 Cg_endo -86.79 88.09 0.71 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.739 1.389 . . . . 0.0 108.615 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.3 p -108.77 -42.0 4.62 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.364 1.078 . . . . 0.0 110.554 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.703 HD11 HD23 ' A' ' 95' ' ' LEU . 0.1 OUTLIER 49.91 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.6 -178.867 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -70.45 108.4 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.617 -0.677 . . . . 0.0 111.696 -178.481 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 4.4 m-80 39.05 38.13 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.641 -0.662 . . . . 0.0 111.381 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -118.43 -40.81 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.236 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 1.0 OUTLIER 40.57 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.942 1.353 . . . . 0.0 112.259 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.925 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -138.5 159.15 42.79 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.246 -179.002 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 t -134.65 29.09 3.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.301 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -108.14 -72.32 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 0.0 110.805 -179.53 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -143.47 85.69 0.19 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -112.38 167.67 10.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.405 -1.056 . . . . 0.0 110.232 -179.631 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 tttm -165.79 164.46 18.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -62.57 -22.39 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.25 152.38 37.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 110.588 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.596 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 17.0 m-85 -133.23 -146.32 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.301 -0.874 . . . . 0.0 110.069 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 90.5 p -165.32 -120.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 1.086 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -105.11 36.86 2.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.016 -178.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.639 ' C ' HG22 ' A' ' 102' ' ' THR . 10.0 p30 -176.2 -114.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.907 -1.121 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 43.95 79.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.816 -1.178 . . . . 0.0 109.567 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.764 ' CA ' HG23 ' A' ' 102' ' ' THR . 20.7 p30 -69.2 137.8 53.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 0.0 110.706 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 85' ' ' VAL . 29.8 m -119.97 118.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.34 -0.85 . . . . 0.0 110.56 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.4 t0 -83.33 123.49 29.69 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.925 ' CE1' HD12 ' A' ' 71' ' ' LEU . 56.9 m-85 -82.27 139.52 34.15 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.278 1.037 . . . . 0.0 113.048 -177.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -116.19 86.12 2.43 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.248 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.552 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -38.64 126.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 -179.203 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 1.4 mmtt -38.55 -92.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.552 -0.717 . . . . 0.0 111.038 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -146.92 150.31 34.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.004 -1.06 . . . . 0.0 111.034 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 40.94 33.65 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 19.6 m-85 -134.92 148.25 50.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -1.026 . . . . 0.0 109.975 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 117' ' ' VAL . 3.7 tttt -108.23 151.29 26.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 109.987 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.703 HD23 HD11 ' A' ' 66' ' ' ILE . 10.4 mt -89.22 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.49 103.64 6.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.35 -90.01 0.19 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.607 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.7 m -153.61 121.85 6.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -1.164 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 87' ' ' PHE . 2.7 p -75.5 -6.05 48.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -138.15 120.52 15.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.033 -1.042 . . . . 0.0 109.961 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.451 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 20.3 m -136.84 166.37 23.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.764 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.52 153.35 51.71 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.842 . . . . 0.0 110.427 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -82.81 75.01 9.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.52 -179.519 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.463 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -56.01 174.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 111.072 -179.79 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.745 ' CB ' HG11 ' A' ' 59' ' ' VAL . 42.5 Cg_endo -74.84 123.46 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.427 1.751 . . . . 0.0 110.153 -179.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.72 -14.73 4.96 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.594 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 85.06 94.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.646 0.736 . . . . 0.0 111.104 179.43 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.92 -160.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.689 0.756 . . . . 0.0 110.882 179.281 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.769 ' HB3' HD13 ' A' ' 113' ' ' LEU . 19.9 m95 -148.11 77.97 1.42 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.806 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.583 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -88.39 151.73 48.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 110.435 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.65 177.88 31.88 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.908 -0.163 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.58 114.59 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.341 0.591 . . . . 0.0 110.988 -179.229 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.769 HD13 ' HB3' ' A' ' 109' ' ' TRP . 4.3 tp -40.58 142.67 0.75 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.529 -0.732 . . . . 0.0 110.191 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.655 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.3 Cg_endo -70.61 165.32 32.32 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.005 1.529 . . . . 0.0 110.219 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 1.022 ' HG2' HG13 ' A' ' 117' ' ' VAL . 62.3 tttt -128.58 103.28 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.902 179.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -58.2 87.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.052 -1.03 . . . . 0.0 109.06 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.022 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -95.42 179.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.837 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 3.1 ptp85 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.271 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.405 ' H3 ' HG13 ' A' ' 1' ' ' VAL . 27.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.278 0.561 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.94 174.34 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -130.45 79.46 1.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 7.9 mp0 -47.49 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 1.3 p -55.04 146.06 40.95 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.058 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.848 ' HG3' HG11 ' A' ' 27' ' ' VAL . 46.5 Cg_endo -69.24 155.08 68.7 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.804 1.423 . . . . 0.0 111.11 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.04 174.64 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.105 1.582 . . . . 0.0 110.305 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.17 179.53 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.64 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -147.78 -169.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 122.208 1.004 . . . . 0.0 111.377 -179.888 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 15.1 m -53.5 97.96 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.543 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' SER . 35.2 m-80 41.0 61.69 1.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -168.61 151.19 17.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.3 mtm180 -104.09 -169.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -1.157 . . . . 0.0 110.675 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.6 p80 -147.75 -153.38 0.49 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.384 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 18' ' ' GLU . 16.2 t-20 58.28 149.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -39.3 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.488 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 t80 -160.64 40.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -1.217 . . . . 0.0 110.581 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -165.03 -166.82 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' SER . 1.6 m-20 -140.24 -41.29 0.42 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 110.657 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 20' ' ' PHE . 33.2 p90 -131.04 105.9 8.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.941 -1.1 . . . . 0.0 110.845 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.638 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 12.7 m-85 -72.84 -163.51 0.13 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.612 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.57 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -149.8 -64.83 0.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 111.015 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 5.4 t0 -165.23 146.38 7.41 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 66.27 15.13 62.88 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.638 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 1.5 m -97.21 164.3 12.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 109.962 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 43' ' ' VAL . 43.4 t -138.68 154.35 26.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 110.54 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.848 HG11 ' HG3' ' A' ' 6' ' ' PRO . 11.2 t -131.62 122.3 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.509 -179.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -78.95 103.08 8.66 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.371 -1.332 . . . . 0.0 107.71 177.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.847 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.3 m-30 -67.66 107.08 2.41 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.421 -178.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -69.21 158.01 35.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 110.312 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 18.8 m -123.44 146.32 48.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 4.1 m120 -43.87 138.56 2.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 109.951 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' ASN . 5.3 t -44.39 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 126.75 -1.22 7.39 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.593 ' CE2' HG13 ' A' ' 58' ' ' ILE . 14.3 m-85 -106.39 143.26 34.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -1.183 . . . . 0.0 110.391 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.671 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -92.24 139.86 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 110.84 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.0 tp -91.34 99.12 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.309 179.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -87.98 147.14 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.619 -179.76 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.97 -176.96 27.47 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.7 134.36 51.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -1.15 . . . . 0.0 109.777 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.621 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -73.65 53.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.623 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 159.33 116.46 0.45 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.867 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.5 t -58.44 -178.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.001 -1.294 . . . . 0.0 107.866 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -146.14 94.82 2.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.305 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 0.0 109.078 178.79 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.8 p -132.45 111.31 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.411 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 18.31 39.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.3 31.31 47.17 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -151.95 100.56 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -1.175 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CH2' HG23 ' A' ' 27' ' ' VAL . 81.3 m95 -54.03 136.99 40.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 7.4 m -146.09 155.64 42.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.05 -1.031 . . . . 0.0 111.061 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.539 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.6 t0 68.95 64.86 0.54 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.625 -0.672 . . . . 0.0 111.199 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.2 Cg_endo -92.29 132.71 1.17 Allowed 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.971 1.781 . . . . 0.0 110.597 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 37' ' ' LEU . 54.3 Cg_endo -82.84 173.89 9.93 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.862 1.454 . . . . 0.0 109.481 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.636 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 74.2 p -114.22 134.77 54.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.869 -1.144 . . . . 0.0 111.366 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.2 m -98.09 75.58 2.33 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.8 171.37 7.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.365 0.602 . . . . 0.0 110.533 -178.376 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.593 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -87.94 124.74 41.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.011 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.708 HG23 ' CA ' ' A' ' 80' ' ' SER . 33.9 m -110.38 53.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 111.269 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -78.74 107.68 11.62 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.578 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 71.0 m -74.46 162.86 71.91 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.244 -0.91 . . . . 0.0 111.665 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.8 Cg_endo -71.39 -78.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.622 1.854 . . . . 0.0 110.66 179.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER 178.41 131.02 0.22 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 54.2 Cg_endo -76.68 65.17 7.53 Favored 'Trans proline' 0 C--N 1.295 -2.275 0 O-C-N 123.714 1.376 . . . . 0.0 110.254 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.837 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -95.93 141.34 29.47 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.036 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.824 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -135.8 154.79 34.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.092 -178.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.88 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.77 -179.701 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.7 OUTLIER 68.0 -55.51 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 70' ' ' TYR . . . -52.71 -169.3 0.02 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 88' ' ' LYS . 12.6 p90 175.12 -165.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.14 153.73 42.56 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.233 178.237 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t -139.01 24.83 2.54 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -106.71 -73.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.33 81.1 0.29 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.6 t80 -101.01 164.16 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 109.775 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.625 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -160.5 167.98 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.543 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -71.78 -29.37 64.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.255 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 p -139.12 135.19 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 38.8 m-85 -117.13 -170.28 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.809 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.708 ' CA ' HG23 ' A' ' 59' ' ' VAL . 89.1 p -145.77 -99.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.0 111.201 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.604 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -120.95 22.01 11.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.494 -1.379 . . . . 0.0 110.357 -178.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.639 ' C ' HG22 ' A' ' 102' ' ' THR . 16.4 p30 -159.39 -116.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 110.606 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 t70 52.09 73.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.799 -1.188 . . . . 0.0 109.367 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.815 ' CA ' HG23 ' A' ' 102' ' ' THR . 31.4 t30 -69.46 105.02 2.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.799 . . . . 0.0 110.906 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 85' ' ' VAL . 34.6 m -91.54 118.42 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.028 -1.045 . . . . 0.0 110.757 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.85 137.76 38.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.429 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD1' HG21 ' A' ' 66' ' ' ILE . 38.3 m-85 -97.44 155.61 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.943 -178.255 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 70' ' ' TYR . 1.4 mmtt -136.33 123.1 21.18 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.582 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.523 ' N ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.56 132.04 46.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 110.376 -179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -38.62 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.512 -0.742 . . . . 0.0 110.527 179.894 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -172.96 120.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.148 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.565 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 78.59 50.2 6.21 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.567 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 77.4 m-85 -158.83 167.64 28.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.473 -1.016 . . . . 0.0 110.396 -178.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.694 ' O ' HG22 ' A' ' 117' ' ' VAL . 21.1 tttm -121.39 124.87 45.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 0.0 109.607 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 66' ' ' ILE . 2.3 mt -66.69 92.84 0.23 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.913 -1.117 . . . . 0.0 110.076 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.57 112.41 13.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.91 -79.31 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.601 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -169.37 122.47 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -1.053 . . . . 0.0 110.135 -179.635 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -83.86 17.3 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.734 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 85.7 p -157.15 105.86 2.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.974 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.563 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 3.1 m -123.64 175.63 6.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.199 -0.938 . . . . 0.0 110.943 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.815 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.08 132.63 19.79 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.603 0.716 . . . . 0.0 110.176 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.559 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -61.79 89.23 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.507 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.472 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -75.21 178.58 1.74 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 111.186 -179.046 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.879 ' HB3' HD12 ' A' ' 38' ' ' ILE . 44.0 Cg_endo -76.83 130.5 11.51 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.394 1.734 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.83 -10.3 7.52 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 9.3 m-80 81.42 76.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 122.102 -0.646 . . . . 0.0 110.738 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -171.16 -169.28 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 0.0 111.361 179.746 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.702 ' HB3' HD13 ' A' ' 113' ' ' LEU . 32.0 m95 -133.09 95.72 3.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.626 -0.671 . . . . 0.0 110.104 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.9 mmtt -101.61 146.63 32.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.518 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.601 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.32 178.62 33.06 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.782 -2.174 . . . . 0.0 110.528 -0.291 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -37.56 124.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 110.908 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.837 HD23 ' O ' ' A' ' 65' ' ' THR . 1.5 tp -46.48 143.54 3.88 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 110.226 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.824 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.1 Cg_endo -70.67 168.09 23.75 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.056 1.556 . . . . 0.0 110.636 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.3 tttt -132.76 109.42 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -62.8 89.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.13 -0.981 . . . . 0.0 108.85 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.736 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.4 m -104.9 -173.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.925 0.869 . . . . 0.0 111.215 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.567 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtt-85 . . . . . 0 C--N 1.294 -1.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.738 HG13 ' O ' ' A' ' 1' ' ' VAL . 13.3 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.363 0.602 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.38 162.71 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.099 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -130.54 91.71 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.286 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 2.2 mp0 -64.03 164.98 9.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 109.885 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.74 141.52 1.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.799 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.1 Cg_endo -69.27 162.57 41.29 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.954 1.502 . . . . 0.0 110.874 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.32 170.22 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.036 1.546 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -89.36 104.32 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.585 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -51.13 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.103 0.954 . . . . 0.0 111.251 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.64 141.0 30.95 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.085 -179.337 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.4 m120 50.57 19.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -160.68 168.47 36.13 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.054 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.484 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -132.34 -177.62 4.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -1.106 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.3 p80 -126.67 143.85 51.1 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.563 -0.71 . . . . 0.0 110.553 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.28 -166.98 1.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.127 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.67 -91.28 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -170.64 28.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -1.16 . . . . 0.0 110.211 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -165.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.427 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -164.98 25.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -150.68 49.22 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 110.822 -179.753 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.3 m-85 -50.15 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.541 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p -141.0 -54.53 0.48 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.089 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 6.6 t70 -172.63 148.18 1.9 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.858 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.28 14.72 54.92 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.181 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.622 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.98 174.53 7.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -1.006 . . . . 0.0 109.641 179.854 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 43' ' ' VAL . 49.6 t -148.99 154.71 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.15 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.697 ' O ' HG23 ' A' ' 43' ' ' VAL . 8.7 t -131.85 119.1 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.631 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.92 103.66 5.22 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.141 178.177 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.634 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.33 175.7 3.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.763 -178.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -131.55 161.84 31.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.571 179.576 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.927 ' SG ' HD12 ' A' ' 37' ' ' LEU . 55.9 m -140.1 130.94 25.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 110.431 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -44.4 136.74 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.4 p -46.09 111.75 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.93 -9.06 7.59 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CE1' HG12 ' A' ' 58' ' ' ILE . 3.2 m-85 -114.6 115.38 27.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -1.166 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.76 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -63.94 127.91 33.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.602 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.927 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -82.83 99.91 10.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.142 178.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.679 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -86.16 145.38 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 109.196 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.91 -143.98 15.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.53 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.6 m120 -126.41 51.24 1.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.201 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 40' ' ' ASN . 10.8 m 22.79 66.38 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.655 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.516 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.85 108.63 0.37 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.9 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -65.27 -177.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.994 -1.298 . . . . 0.0 108.329 178.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.544 ' H ' HG12 ' A' ' 43' ' ' VAL . 7.6 tp -145.96 97.35 2.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.544 178.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.25 115.02 20.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 178.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 83.6 p -127.27 109.24 11.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.613 -0.679 . . . . 0.0 110.471 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.42 41.57 13.18 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 63.41 33.27 86.78 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.64 107.1 4.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -1.182 . . . . 0.0 110.613 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 76.2 m95 -66.74 138.85 57.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.636 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -149.26 169.75 20.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 111.405 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 49.72 64.85 7.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.784 -0.572 . . . . 0.0 111.421 179.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.5 Cg_endo -92.78 147.6 2.64 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 121.919 1.746 . . . . 0.0 110.296 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -81.52 173.89 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.895 1.471 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.617 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.6 p -125.3 141.13 52.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.01 . . . . 0.0 111.231 -179.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 75.7 m -100.66 73.91 1.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.7 OUTLIER -118.76 175.84 5.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.043 -179.086 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -88.5 149.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.258 -0.902 . . . . 0.0 108.767 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.818 HG21 ' CB ' ' A' ' 81' ' ' TYR . 33.1 m -124.21 47.46 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 111.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -76.07 155.71 34.56 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.255 178.131 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -120.44 172.24 4.89 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.847 -1.158 . . . . 0.0 111.476 -178.808 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.0 Cg_endo -78.08 -63.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.649 1.868 . . . . 0.0 110.744 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.581 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 163.07 128.56 0.01 OUTLIER Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.203 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.821 ' O ' HD23 ' A' ' 71' ' ' LEU . 48.7 Cg_endo -76.54 69.52 6.65 Favored 'Trans proline' 0 C--N 1.294 -2.302 0 O-C-N 123.696 1.366 . . . . 0.0 110.377 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.733 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -94.22 -173.78 3.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.757 . . . . 0.0 109.403 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.802 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 178.5 169.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 110.272 179.455 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.528 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.32 103.89 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.875 -179.536 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 59.9 m-80 44.68 51.12 8.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -164.64 26.54 0.19 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.619 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -39.27 162.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 123.012 1.386 . . . . 0.0 113.166 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.0 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -45.83 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.603 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER 80.59 25.87 0.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.284 0.564 . . . . 0.0 110.094 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.73 -73.67 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 110.467 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -108.1 -98.31 2.55 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 1.0 ' HB2' HD13 ' A' ' 71' ' ' LEU . 6.8 t80 57.05 164.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.408 -1.054 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.647 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -170.16 167.44 8.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.438 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -52.83 -26.8 15.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.507 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 8.0 t -149.69 146.92 27.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -142.53 175.69 9.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.8 p -170.65 136.61 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.004 -1.06 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.818 ' CB ' HG21 ' A' ' 59' ' ' VAL . 54.6 t80 31.44 104.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.708 -0.62 . . . . 0.0 111.872 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 38.2 t30 90.19 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 122.005 -0.434 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 80' ' ' SER . 4.5 m-20 55.3 76.64 0.25 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.765 -1.209 . . . . 0.0 108.817 -178.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 t-20 -71.29 146.25 49.03 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.63 0.729 . . . . 0.0 111.599 -178.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.726 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.3 m -127.53 123.57 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.014 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.04 132.36 34.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.906 -1.121 . . . . 0.0 108.69 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.677 ' CD1' HG21 ' A' ' 66' ' ' ILE . 38.1 m-85 -94.55 136.6 34.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.291 1.043 . . . . 0.0 112.674 -177.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 72' ' ' SER . 2.4 tttp -111.89 102.41 10.66 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.474 -179.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.444 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -51.68 131.08 29.74 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 109.705 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.18 -79.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.958 -179.746 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.7 m-85 -165.66 141.31 5.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 0.0 110.298 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.56 61.46 6.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -162.71 175.19 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.45 -1.029 . . . . 0.0 110.208 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.3 tttt -132.14 116.0 16.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.865 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.606 HD23 HD11 ' A' ' 66' ' ' ILE . 5.6 mt -55.3 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.48 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -71.95 99.21 2.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.206 -0.934 . . . . 0.0 109.561 179.341 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.75 -86.24 0.18 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.614 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -162.77 122.07 2.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 110.434 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.9 p -73.52 1.34 10.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.878 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 p -147.55 113.69 5.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.53 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 15.2 m -121.3 -173.39 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.518 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 82' ' ' ASN . 16.1 m -155.83 139.1 15.67 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.942 -178.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.637 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.6 t -69.03 84.03 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 109.371 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.479 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -73.82 177.73 1.94 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.679 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -77.37 130.25 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.569 1.826 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.34 -6.77 12.78 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.877 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 83.15 85.32 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.991 -0.711 . . . . 0.0 111.435 179.364 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.877 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.65 171.83 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.64 0.733 . . . . 0.0 111.14 178.703 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.726 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 51.6 m95 -119.21 93.72 4.18 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.713 -0.617 . . . . 0.0 110.29 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.0 mmtm -98.94 146.05 31.0 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.708 . . . . 0.0 110.566 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.614 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -70.55 169.5 66.38 Favored 'Cis proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.94 -2.108 . . . . 0.0 110.871 -0.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 52.2 tt0 -36.03 126.16 0.74 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.568 0.699 . . . . 0.0 111.707 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -42.77 143.51 1.18 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.541 -0.725 . . . . 0.0 109.977 179.105 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.802 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.2 Cg_endo -71.43 164.11 36.83 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 124.158 1.609 . . . . 0.0 111.242 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.523 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -130.57 108.12 9.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 110.411 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.5 t -65.05 93.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 179.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 94' ' ' LYS . 3.2 m -112.35 179.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.708 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.591 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.566 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.489 HG21 ' C ' ' A' ' 47' ' ' GLY . 9.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.233 0.54 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 169.96 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.559 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -135.32 95.73 3.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -71.88 175.73 5.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.483 179.437 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -50.41 138.79 20.87 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.816 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.666 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.8 Cg_endo -68.91 156.26 65.96 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.913 1.481 . . . . 0.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.67 167.69 25.88 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.906 1.477 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' ILE . 84.8 p -81.19 99.67 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.601 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -50.97 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.389 1.09 . . . . 0.0 111.877 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -61.06 116.65 4.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.159 -179.168 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 m120 42.94 43.62 3.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.331 -0.855 . . . . 0.0 111.115 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -158.92 139.06 6.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -95.9 -168.83 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.893 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.651 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 14.9 p80 -148.79 120.74 8.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.801 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -71.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.027 . . . . 0.0 110.745 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.58 -97.58 1.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER 179.82 30.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -1.179 . . . . 0.0 110.576 -179.944 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 178.59 -171.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 110.585 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -105.5 -50.53 3.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.018 179.757 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.8 m-85 -88.7 -170.52 2.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 1.7 m-85 -169.52 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.33 -0.856 . . . . 0.0 111.96 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.559 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p 48.72 -97.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.0 -1.062 . . . . 0.0 112.167 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -145.36 157.91 43.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.215 . . . . 0.0 110.342 -178.293 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.4 65.1 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB2' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -92.03 160.78 15.07 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.588 -0.948 . . . . 0.0 110.105 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 43' ' ' VAL . 53.8 t -140.78 152.76 20.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.771 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.973 ' O ' HG23 ' A' ' 43' ' ' VAL . 25.2 t -138.02 116.71 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.123 -1.031 . . . . 0.0 111.391 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.891 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.66 103.61 2.59 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.519 178.098 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.981 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.84 125.95 27.89 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 110.218 -178.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -82.05 153.5 26.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.251 -0.906 . . . . 0.0 109.93 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 1.6 t -121.55 138.2 54.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.79 158.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.041 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -62.91 131.51 48.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.33 -33.33 6.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -89.59 136.54 32.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -1.122 . . . . 0.0 109.973 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.724 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.92 144.8 25.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.786 -179.635 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.6 tp -96.39 100.91 12.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.432 -0.792 . . . . 0.0 109.331 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.816 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.1 148.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.06 -168.61 12.64 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.565 -1.303 . . . . 0.0 109.878 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.32 134.16 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.891 ' O ' HG23 ' A' ' 28' ' ' THR . 89.2 p -74.41 56.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.699 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 163.86 114.02 0.3 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.981 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -64.91 -178.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -145.82 99.11 3.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.04 -1.037 . . . . 0.0 110.465 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -86.35 110.11 19.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.356 178.902 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.55 100.37 6.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.381 -0.824 . . . . 0.0 110.629 -179.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.489 ' C ' HG21 ' A' ' 1' ' ' VAL . . . 84.75 45.14 6.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 62.33 33.6 86.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.34 95.71 2.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -1.156 . . . . 0.0 110.665 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 72.9 m95 -60.07 137.32 58.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.163 -0.961 . . . . 0.0 109.309 179.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 t -139.58 179.2 6.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 0.0 111.397 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.3 m-20 38.57 64.75 3.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.78 -0.575 . . . . 0.0 111.535 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.9 Cg_endo -91.97 138.69 2.0 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 121.95 1.767 . . . . 0.0 109.558 178.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 52.3 Cg_endo -78.93 -178.99 5.06 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.734 1.386 . . . . 0.0 110.495 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.537 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 9.0 p -115.06 172.83 6.82 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.801 0.81 . . . . 0.0 111.194 -179.039 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -137.64 77.44 1.63 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.83 -164.26 0.9 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.412 -178.676 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.666 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -111.32 131.24 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.985 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.724 HG13 ' HB2' ' A' ' 36' ' ' SER . 11.4 m -125.42 47.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 111.493 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 14.3 mttp -74.08 166.25 23.73 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.846 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.13 171.0 8.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.554 -1.341 . . . . 0.0 112.684 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.57 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 51.9 Cg_endo -86.12 -57.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.81 1.953 . . . . 0.0 109.71 178.841 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 161.76 122.72 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.377 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.887 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.8 Cg_endo -76.1 66.41 6.94 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 O-C-N 123.645 1.34 . . . . 0.0 109.893 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.742 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.4 p -85.34 -173.25 4.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.275 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.823 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 176.52 170.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.34 179.159 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.538 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 1.1 p -79.79 111.16 15.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 111.434 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.506 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 10.3 m-20 36.83 63.0 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -154.48 -44.54 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 33.7 p90 39.99 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.256 1.027 . . . . 0.0 111.302 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.93 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -135.58 154.46 51.34 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.984 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.77 -17.43 13.94 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.895 -1.128 . . . . 0.0 110.2 -178.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.41 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 30.9 t -49.63 -95.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.462 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.06 88.87 0.11 Allowed Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.049 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.6 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -78.55 100.34 6.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -1.074 . . . . 0.0 109.479 179.457 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.588 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 1.8 ttmt -88.65 133.72 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.913 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.6 ttt180 -40.27 -32.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.406 -0.809 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -128.23 134.11 48.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.447 -0.783 . . . . 0.0 110.08 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.588 ' CE2' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-85 -117.81 -159.75 0.76 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.703 ' C ' HG23 ' A' ' 59' ' ' VAL . 90.5 p -157.84 -111.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.845 -1.159 . . . . 0.0 111.672 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.613 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -115.24 11.74 16.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.328 -1.482 . . . . 0.0 110.8 -178.396 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.7 OUTLIER -159.03 -3.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.749 -1.219 . . . . 0.0 112.896 -179.243 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -55.04 86.39 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.848 -1.158 . . . . 0.0 108.706 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASN . 48.8 t30 -72.74 129.45 38.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 111.796 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.592 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.8 m -116.79 117.14 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -82.99 120.83 26.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 108.955 179.639 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.93 ' CE1' HD12 ' A' ' 71' ' ' LEU . 57.3 m-85 -82.25 138.76 34.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 112.451 -177.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -113.26 84.24 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.067 -179.641 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -38.28 128.95 1.36 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.704 . . . . 0.0 110.712 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.48 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.592 -0.692 . . . . 0.0 110.452 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.567 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.1 t80 -166.13 143.3 5.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 0.0 109.889 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.23 46.5 85.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 17.9 m-85 -151.57 157.28 42.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -1.033 . . . . 0.0 109.973 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.463 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.36 112.12 19.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.09 179.884 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' A' ' 114' ' ' PRO . 18.6 mt -48.18 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.481 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -74.93 94.06 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.212 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.05 -89.6 0.14 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -154.5 118.17 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -1.172 . . . . 0.0 110.618 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' PHE . 6.2 p -72.82 -7.27 49.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -141.69 101.72 4.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 0.0 109.857 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 10.9 m -111.15 162.49 14.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 110.923 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 82' ' ' ASN . 3.5 m -138.68 134.25 33.37 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.17 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 49.3 t -61.93 95.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.134 -1.027 . . . . 0.0 108.806 179.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.4 175.97 0.45 Allowed Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.508 -0.745 . . . . 0.0 111.259 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.816 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.8 Cg_endo -81.24 19.55 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.523 1.802 . . . . 0.0 111.205 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -113.5 8.19 24.35 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.892 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 76.27 61.15 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.785 -0.833 . . . . 0.0 110.508 179.708 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -176.83 173.38 1.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.073 -1.017 . . . . 0.0 111.854 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.734 ' HB3' HD13 ' A' ' 113' ' ' LEU . 27.8 m95 -95.69 92.26 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.575 0.703 . . . . 0.0 110.692 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.533 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 10.5 mmtm -109.61 135.35 20.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.577 -0.702 . . . . 0.0 109.628 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.2 Cg_endo -69.81 166.41 74.25 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.179 -2.009 . . . . 0.0 111.285 -0.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -43.67 139.87 2.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.887 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -47.99 146.62 4.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.254 179.441 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.823 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.9 Cg_endo -72.57 160.41 46.65 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 124.363 1.717 . . . . 0.0 110.713 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.552 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.3 ttmt -122.48 106.9 11.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.967 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.108 -0.995 . . . . 0.0 109.18 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 115' ' ' LYS . 2.1 m -113.41 178.59 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.608 0.718 . . . . 0.0 110.812 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.581 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.796 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.269 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 18.9 mttt -159.89 174.23 14.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -122.7 91.58 3.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' SER . 36.8 mt-30 -71.53 175.55 5.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.706 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -41.79 138.04 1.82 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.874 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.715 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.9 Cg_endo -69.08 158.44 57.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.97 1.51 . . . . 0.0 111.091 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.68 169.01 23.34 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.886 1.466 . . . . 0.0 110.264 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.6 p -73.32 176.24 6.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.86 -170.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.166 0.984 . . . . 0.0 111.462 179.726 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 16.7 m -40.08 91.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -178.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.0 m120 43.09 40.11 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 110.433 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -132.22 176.48 19.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 3.3 mtp180 -123.29 -174.93 3.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.386 -1.067 . . . . 0.0 109.759 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.25 122.99 6.81 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.1 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 14' ' ' HIS . 72.1 m-80 -156.61 122.12 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' ' OH ' ' A' ' 21' ' ' TYR . . . -118.69 31.16 5.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 2.1 t80 66.53 25.38 10.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.106 . . . . 0.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.497 ' CD ' ' CZ ' ' A' ' 21' ' ' TYR . 9.9 pt-20 -159.34 -174.3 4.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' SER . 12.0 m-20 -123.41 -28.6 3.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 0.0 110.14 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -105.36 -170.81 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.808 -179.465 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 1.4 m-85 -174.3 -31.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.699 -0.626 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.584 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 17.2 m 67.28 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 112.509 178.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.11 155.05 40.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.733 -1.229 . . . . 0.0 109.963 -178.424 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.54 56.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.66 162.58 18.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.615 -0.932 . . . . 0.0 110.239 -179.897 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 43' ' ' VAL . 78.3 t -139.21 152.29 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.4 t -135.06 124.52 42.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.696 -179.068 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.884 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.26 101.31 4.63 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.073 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.002 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.48 153.24 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.017 -178.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.49 ' HB2' ' HG3' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -115.1 160.89 19.11 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.597 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 17.6 m -128.44 149.46 50.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.04 -1.038 . . . . 0.0 110.534 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -56.25 148.92 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 179.825 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 p -49.8 115.48 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.13 31.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 2.0 m-85 -118.1 131.54 56.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -1.203 . . . . 0.0 110.348 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.689 ' CB ' HG13 ' A' ' 59' ' ' VAL . 8.2 m -82.83 138.31 34.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 110.821 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 41' ' ' SER . 6.2 tp -94.59 101.23 13.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.931 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -96.17 159.9 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 89.35 34.77 8.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 6.2 m120 66.18 176.27 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -1.144 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -116.8 70.71 0.78 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.721 179.632 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 169.93 109.69 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.002 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -69.81 -174.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -1.204 . . . . 0.0 108.445 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.652 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -144.55 102.19 3.78 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.061 178.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -88.52 108.76 19.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 179.083 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -125.84 107.81 10.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.49 41.58 6.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.455 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 58.95 30.06 65.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -145.96 105.86 4.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -1.22 . . . . 0.0 110.608 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.638 ' CH2' HG23 ' A' ' 27' ' ' VAL . 85.8 m95 -62.07 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.795 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.6 169.72 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.009 . . . . 0.0 111.075 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 47.45 65.22 7.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.821 -0.55 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.5 Cg_endo -90.81 135.03 1.91 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.381 1.727 . . . . 0.0 109.506 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -74.29 161.36 40.61 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.71 1.374 . . . . 0.0 110.072 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.0 p -104.0 143.83 32.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 111.849 -178.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 63.5 m -109.76 74.86 0.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.94 173.81 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.519 0.676 . . . . 0.0 110.755 -178.169 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -86.34 145.37 7.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.689 HG13 ' CB ' ' A' ' 36' ' ' SER . 16.1 m -126.29 48.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.756 -178.164 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 7.0 mtpt -86.05 160.95 19.16 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 118.842 -1.143 . . . . 0.0 107.961 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 16.0 m -122.73 167.86 13.34 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.516 -1.365 . . . . 0.0 112.154 -178.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 42.6 Cg_endo -75.42 -59.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.632 1.859 . . . . 0.0 110.47 179.489 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.22 124.0 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.184 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.632 ' HG3' HG11 ' A' ' 85' ' ' VAL . 53.4 Cg_endo -75.87 71.96 5.35 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 O-C-N 123.715 1.377 . . . . 0.0 109.707 -179.009 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.476 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -94.78 177.48 5.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.735 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.757 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -171.47 167.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.427 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.48 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.4 OUTLIER -73.39 106.69 5.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.499 -0.751 . . . . 0.0 110.677 -179.498 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.537 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.7 m120 40.7 36.63 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 110.502 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.756 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.0 31.13 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.595 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -44.89 -175.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.577 1.179 . . . . 0.0 112.186 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.803 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -110.45 160.95 16.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.772 179.091 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.6 t -149.6 24.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.739 -1.226 . . . . 0.0 109.951 -179.343 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 86' ' ' ASP . 24.0 t -112.39 -37.26 5.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.734 -179.405 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -165.05 95.62 0.12 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.584 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -125.98 150.24 48.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -1.068 . . . . 0.0 109.734 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 12.7 ttmm -154.15 140.53 18.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.179 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 76' ' ' LYS . 3.3 mtt180 -41.57 -51.88 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.1 m -94.99 168.26 10.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.808 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.595 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 48.8 m-85 -149.16 179.97 7.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.2 m -159.58 -160.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.597 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.71 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 1.8 t80 -73.91 54.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.648 -1.282 . . . . 0.0 109.866 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.732 ' O ' HG22 ' A' ' 102' ' ' THR . 8.4 p-10 173.51 -125.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.91 -1.118 . . . . 0.0 109.939 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.87 67.83 0.84 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.878 -1.139 . . . . 0.0 109.62 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.721 ' N ' HG23 ' A' ' 102' ' ' THR . 7.7 p-10 -69.81 104.05 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.541 -179.045 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 74' ' ' GLY . 17.3 m -83.97 123.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.141 . . . . 0.0 110.546 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.54 ' CB ' ' HB3' ' A' ' 73' ' ' SER . 2.3 t70 -81.11 124.88 29.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.926 -1.109 . . . . 0.0 109.001 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.803 ' CE1' HD12 ' A' ' 71' ' ' LEU . 26.5 m-85 -88.41 123.46 32.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.997 -1.064 . . . . 0.0 111.851 -178.581 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.5 tttm -102.31 109.28 20.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.659 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -58.79 130.51 47.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.071 -1.018 . . . . 0.0 110.192 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 21.7 mmtt -39.41 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 33.9 p90 -144.82 149.62 35.74 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.083 -1.011 . . . . 0.0 110.724 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 39.76 37.3 0.89 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 17.5 m-85 -137.64 146.56 44.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -1.082 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -106.66 162.76 13.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 108.956 179.097 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -96.31 106.29 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.742 -1.224 . . . . 0.0 110.618 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.5 t -86.83 102.06 13.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.505 -0.747 . . . . 0.0 109.578 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 137.47 -43.59 1.2 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 1.0 OUTLIER 175.49 -166.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 111.238 -179.595 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -67.85 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.707 -0.621 . . . . 0.0 109.999 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 56.2 p -92.09 84.01 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.805 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 1.4 m -86.29 166.52 15.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.314 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 82' ' ' ASN . 3.9 m -146.13 139.46 25.98 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.57 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 51.8 t -61.76 104.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -74.12 176.59 2.72 Favored Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 111.319 -178.495 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.931 ' HB2' HD12 ' A' ' 38' ' ' ILE . 52.4 Cg_endo -80.28 10.03 3.39 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.722 1.906 . . . . 0.0 110.974 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -104.99 7.37 44.44 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.881 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 76.13 61.16 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.708 -0.878 . . . . 0.0 109.953 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -176.97 175.5 1.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.771 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.603 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.7 m95 -98.41 95.36 7.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.573 0.701 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.4 mmmt -107.59 136.36 19.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 44.2 Cg_endo -70.4 166.02 76.88 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.25 -1.979 . . . . 0.0 111.29 0.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 14.9 tt0 -42.3 134.93 2.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.51 -0.744 . . . . 0.0 109.88 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD12 ' CZ ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -42.18 139.56 1.76 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.95 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.757 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.1 Cg_endo -71.22 169.54 20.43 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.233 1.649 . . . . 0.0 111.535 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.839 ' HG2' HG13 ' A' ' 117' ' ' VAL . 8.5 tttt -125.04 108.34 11.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.773 . . . . 0.0 110.901 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -61.04 97.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 108.875 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.839 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -103.36 -179.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.828 0.823 . . . . 0.0 111.183 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.35 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 3.9 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.258 0.552 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -160.9 166.37 28.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -126.61 72.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 110.12 -179.892 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.28 179.6 0.1 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.302 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.4 p -43.17 142.8 1.48 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.037 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.649 ' HG3' HG21 ' A' ' 27' ' ' VAL . 47.6 Cg_endo -72.49 164.15 36.46 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.057 1.556 . . . . 0.0 110.569 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.48 169.51 21.58 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.98 1.516 . . . . 0.0 110.286 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.243 -0.91 . . . . 0.0 109.804 179.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.732 HG21 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.13 -170.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.329 1.061 . . . . 0.0 111.886 179.91 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.1 t -59.85 83.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.285 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.1 m120 54.68 59.28 4.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -159.25 147.24 14.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' SER . 10.2 mtt180 -93.96 -170.43 2.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -1.141 . . . . 0.0 110.919 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.525 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 11.8 m170 -85.39 -139.23 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.47 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 52.8 t30 -87.37 -54.99 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.217 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.09 -37.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 11.8 t80 -174.42 79.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.606 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.5 mp0 -108.41 177.41 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 4.9 t0 178.04 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.973 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -141.91 88.89 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.055 -1.028 . . . . 0.0 109.493 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.9 m-85 -98.49 -9.53 24.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.78 . . . . 0.0 111.116 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.578 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.2 p 43.22 -92.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.548 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 21' ' ' TYR . 3.7 t0 -153.57 131.91 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.985 -1.072 . . . . 0.0 110.475 -178.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.46 47.75 2.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 42.2 m -148.41 154.34 39.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -1.171 . . . . 0.0 110.376 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.7 t -129.31 152.61 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 111.567 -178.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.649 HG21 ' HG3' ' A' ' 6' ' ' PRO . 33.4 t -122.27 114.39 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.628 -0.67 . . . . 0.0 111.484 -179.568 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -71.99 103.63 3.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.404 -1.318 . . . . 0.0 107.623 177.771 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.732 ' CD2' HG21 ' A' ' 9' ' ' ILE . 2.2 m-30 -67.75 118.56 11.16 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 110.138 -178.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.532 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.53 154.66 38.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 179.539 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 36.1 m -128.54 153.46 47.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.63 166.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.844 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.61 98.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 110.399 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 11.08 8.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.0 m-30 -105.76 119.2 38.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.173 . . . . 0.0 110.184 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.828 ' HB2' HG22 ' A' ' 59' ' ' VAL . 19.8 t -68.32 141.87 55.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.581 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.593 ' C ' HD13 ' A' ' 38' ' ' ILE . 1.4 tp -95.89 108.58 20.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.734 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -103.22 140.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.346 -0.846 . . . . 0.0 109.313 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 134.82 -142.03 13.42 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.501 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -110.55 52.57 0.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -1.191 . . . . 0.0 110.335 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 40' ' ' ASN . 20.2 p 26.3 59.14 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.881 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.649 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 133.57 122.24 2.28 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.412 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -61.53 176.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.14 -1.212 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.7 tp -142.39 93.97 2.6 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.639 -1.225 . . . . 0.0 110.686 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.92 109.8 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.371 178.213 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 t -131.04 98.26 4.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.549 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.45 9.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.483 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 84.24 10.25 80.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.95 116.6 15.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.072 -1.252 . . . . 0.0 110.765 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.606 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -68.48 140.32 55.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.89 150.61 34.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.062 -1.024 . . . . 0.0 111.188 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 64.35 65.71 1.07 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.685 -0.635 . . . . 0.0 111.637 179.21 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.0 Cg_endo -91.71 136.37 1.78 Allowed 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.369 1.721 . . . . 0.0 109.559 178.588 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.532 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.7 Cg_endo -80.57 179.1 6.35 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.71 1.374 . . . . 0.0 110.745 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' ILE . 5.2 p -123.91 148.9 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.8 . . . . 0.0 111.371 -178.68 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.2 m -110.51 78.59 1.13 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.31 -159.39 0.68 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.415 0.626 . . . . 0.0 110.368 -178.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.671 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.15 125.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.936 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.828 HG22 ' HB2' ' A' ' 36' ' ' SER . 22.5 m -118.9 52.99 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.13 -0.981 . . . . 0.0 111.597 -179.102 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 13.2 mtpt -60.82 -179.86 0.14 Allowed 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 117.811 -1.556 . . . . 0.0 107.964 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 93.4 m -136.71 160.51 66.18 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.762 -178.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.5 Cg_endo -85.2 -72.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.736 1.913 . . . . 0.0 109.95 178.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.58 124.9 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.743 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.621 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.5 Cg_endo -77.44 65.61 8.0 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.867 1.456 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.458 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -81.86 161.23 23.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.293 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.821 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -157.11 166.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 0.0 110.743 -179.664 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.47 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.39 108.11 10.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.691 -179.385 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.523 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 0.9 OUTLIER 39.93 41.19 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.483 -0.761 . . . . 0.0 110.615 179.573 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.821 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.5 33.11 0.92 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.3 p90 -44.84 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 112.469 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.743 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -112.0 161.67 16.2 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.938 179.353 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.83 30.19 1.48 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.829 -1.169 . . . . 0.0 110.382 -179.131 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -110.81 -86.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.47 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.24 71.8 0.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.1 t80 -99.51 166.25 11.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -1.065 . . . . 0.0 110.018 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.639 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -171.05 161.2 6.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 109.79 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -51.14 -32.57 23.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.098 . . . . 0.0 109.451 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.467 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.2 m -144.82 170.76 15.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.67 -0.644 . . . . 0.0 109.798 179.674 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 3.8 m-85 -143.72 -134.68 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 0.0 109.938 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.4 p -167.34 -133.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.839 -1.163 . . . . 0.0 111.133 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.74 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -87.22 14.88 6.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.771 -1.206 . . . . 0.0 110.873 -178.848 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.599 ' HA ' HG22 ' A' ' 102' ' ' THR . 59.9 t30 -160.53 -116.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.711 -1.243 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 5.8 m-20 54.51 76.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.81 -1.181 . . . . 0.0 108.888 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' HG23 ' A' ' 102' ' ' THR . 22.4 t-20 -71.43 109.83 5.65 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 110.535 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.621 HG11 ' HG3' ' A' ' 64' ' ' PRO . 14.8 m -87.38 119.44 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.4 t0 -80.6 129.52 34.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 108.798 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.743 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.0 m-85 -89.04 142.22 27.82 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.038 -1.039 . . . . 0.0 112.19 -178.237 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -121.26 92.06 3.67 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.51 -179.607 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.41 130.74 3.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.425 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.523 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 5.5 mmtt -42.55 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -153.21 154.58 34.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.421 -179.977 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 43.55 31.53 1.7 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.7 m-85 -143.35 144.88 32.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 110.316 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' VAL . 16.4 pttp -113.59 139.43 49.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.875 . . . . 0.0 109.577 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.601 HD23 HD11 ' A' ' 66' ' ' ILE . 1.2 mt -66.9 114.15 5.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.099 -1.001 . . . . 0.0 111.118 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -92.16 98.02 11.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.613 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 140.14 -45.82 0.97 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.228 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.526 ' CB ' ' CG ' ' A' ' 111' ' ' PRO . 10.7 t -177.3 -172.99 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.249 . . . . 0.0 111.69 -179.458 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 p -144.76 -27.32 0.49 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -132.48 97.01 3.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.865 -1.147 . . . . 0.0 109.694 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 24.8 m -103.3 162.66 12.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 82' ' ' ASN . 1.1 m -136.56 137.02 39.78 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.784 -0.572 . . . . 0.0 110.148 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.606 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 45.5 t -77.28 96.85 4.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.354 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -66.38 -176.3 0.23 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.602 -0.686 . . . . 0.0 110.741 179.936 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.734 ' HG3' HG23 ' A' ' 38' ' ' ILE . 42.7 Cg_endo -77.81 124.37 6.81 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.978 1.515 . . . . 0.0 110.55 -179.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.48 -7.28 6.25 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.711 ' O ' HG23 ' A' ' 108' ' ' THR . 4.8 m-20 79.35 95.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.898 -0.766 . . . . 0.0 110.976 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.0 -160.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -0.767 . . . . 0.0 111.088 179.453 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.686 ' HB3' HD13 ' A' ' 113' ' ' LEU . 26.9 m95 -149.73 111.43 4.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.588 -0.695 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.534 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.7 mttt -112.11 127.1 27.32 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 110.157 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.14 174.08 35.93 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.064 -2.057 . . . . 0.0 110.549 0.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 113' ' ' LEU . 3.7 mt-10 -63.96 59.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.602 -0.686 . . . . 0.0 111.27 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.686 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER 55.94 143.95 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 121.442 0.639 . . . . 0.0 111.383 178.951 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.714 ' HG2' HD12 ' A' ' 66' ' ' ILE . 43.0 Cg_endo -84.08 166.87 12.71 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.271 1.669 . . . . 0.0 111.09 -179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.708 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -122.0 109.28 14.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.234 -0.916 . . . . 0.0 110.748 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.1 t -65.28 104.68 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.02 . . . . 0.0 109.258 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.708 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -119.18 -176.02 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.667 0.746 . . . . 0.0 111.023 -179.103 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 . . . . . 0 C--N 1.294 -1.833 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.367 -179.84 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.271 0.558 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.77 174.59 8.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.264 -0.897 . . . . 0.0 110.574 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 52.9 t -130.0 158.58 39.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -133.68 178.06 7.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.415 -0.803 . . . . 0.0 109.978 179.884 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.5 136.88 7.21 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.476 -0.765 . . . . 0.0 110.254 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.613 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.0 Cg_endo -70.24 155.67 63.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.157 1.609 . . . . 0.0 110.998 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.68 174.39 12.74 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.841 1.443 . . . . 0.0 109.785 178.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -69.89 177.15 3.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.099 -1.001 . . . . 0.0 110.2 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.39 -170.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.261 1.029 . . . . 0.0 111.54 179.872 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -47.06 101.32 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.744 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 10' ' ' SER . 24.8 m-20 40.29 47.3 2.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.29 161.81 30.66 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' SER . 5.1 mpt_? -112.01 -169.89 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.489 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.613 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.1 p80 -144.67 119.38 9.82 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.73 81.3 1.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 110.451 -179.538 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -91.28 28.44 8.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 32.9 p90 37.05 50.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.98 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.589 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 14.5 mm-40 -140.11 -169.48 2.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -147.55 -36.91 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.589 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 9.0 p90 -142.2 79.09 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.346 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 34.0 m-85 -55.43 -166.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.534 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -152.4 -67.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.91 -1.119 . . . . 0.0 110.743 -179.736 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.96 136.79 9.22 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.546 -0.721 . . . . 0.0 109.357 -179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 73.07 7.9 72.45 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.606 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.8 m -73.54 156.37 38.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -1.031 . . . . 0.0 109.809 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 43' ' ' VAL . 54.1 t -138.66 153.39 25.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.681 ' HB ' HG23 ' A' ' 43' ' ' VAL . 41.4 t -138.67 118.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.37 -179.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.16 106.31 3.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.407 -1.317 . . . . 0.0 107.591 178.059 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.926 ' O ' HD13 ' A' ' 37' ' ' LEU . 3.3 m-30 -68.02 139.01 56.3 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 110.356 -178.053 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -93.98 159.07 15.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.0 m -123.23 149.68 44.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -45.54 138.0 4.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -44.42 106.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 179.993 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.52 15.47 6.95 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.04 137.22 50.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -1.123 . . . . 0.0 110.393 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.661 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -85.78 147.01 26.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 110.929 -179.531 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.6 tp -95.9 100.63 12.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.73 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -96.27 173.81 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 108.953 179.55 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 80.62 175.91 49.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.929 179.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -42.51 111.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -1.067 . . . . 0.0 110.021 179.822 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 28' ' ' THR . 89.2 p -70.51 55.18 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.611 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.37 95.48 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.91 175.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.357 -1.084 . . . . 0.0 108.768 179.5 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -141.12 101.0 3.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.405 -0.809 . . . . 0.0 109.923 178.707 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 6.2 t -78.09 109.38 12.12 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.64 128.94 55.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.439 -0.788 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.59 30.93 57.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.38 45.56 29.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -151.56 97.78 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.132 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.625 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 97.9 m95 -64.33 125.59 25.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.25 171.34 14.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.639 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 52.59 64.53 7.23 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.721 . . . . 0.0 110.635 -179.833 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.9 130.08 1.43 Allowed 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 121.913 1.742 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.8 Cg_endo -74.27 176.12 10.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.822 1.433 . . . . 0.0 110.536 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.551 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.4 p -105.62 173.67 6.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.842 0.83 . . . . 0.0 111.266 -179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.6 m -139.75 75.43 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.6 mm-40 -114.21 -152.13 0.5 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.735 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.738 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.67 138.42 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.379 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.686 HG23 ' CA ' ' A' ' 80' ' ' SER . 34.5 m -128.25 41.2 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.01 -1.056 . . . . 0.0 110.966 -179.115 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 16.6 mttt -53.93 178.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.358 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.16 162.33 40.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.578 -179.021 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.0 Cg_endo -83.8 -68.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.829 1.963 . . . . 0.0 110.306 179.08 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.31 128.73 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.382 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.742 ' HA ' HD21 ' A' ' 113' ' ' LEU . 49.4 Cg_endo -78.01 60.34 7.29 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 O-C-N 123.571 1.301 . . . . 0.0 109.841 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.711 ' C ' HG22 ' A' ' 66' ' ' ILE . 2.3 p -74.76 -177.3 3.18 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.022 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -176.26 167.77 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.967 179.463 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 6.8 m -70.1 89.76 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.589 -0.694 . . . . 0.0 110.688 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.3 m120 50.23 49.62 20.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.87 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.022 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -162.66 40.62 0.36 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.6 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -48.25 -151.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.968 1.366 . . . . 0.0 113.076 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.985 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.46 122.82 13.94 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.619 -176.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 t -100.4 14.96 29.37 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.52 -0.737 . . . . 0.0 109.968 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 24.7 t -76.11 -91.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.969 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.43 81.25 0.3 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.609 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.04 125.37 46.1 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.358 -1.083 . . . . 0.0 109.713 179.494 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 77' ' ' ARG . 10.0 ttmm -111.05 149.76 30.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 0.0 109.931 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -41.47 -41.46 2.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.863 . . . . 0.0 110.015 -179.988 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m -137.55 152.94 49.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.439 -0.788 . . . . 0.0 109.981 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -125.62 -162.52 1.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.686 ' CA ' HG23 ' A' ' 59' ' ' VAL . 2.3 m -153.94 -102.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.314 -0.866 . . . . 0.0 109.583 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.614 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.8 137.96 49.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.732 -1.23 . . . . 0.0 108.198 179.234 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.843 ' C ' HG22 ' A' ' 102' ' ' THR . 37.4 t-20 71.49 -104.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.739 -0.6 . . . . 0.0 110.594 -178.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 39.5 m-20 44.96 74.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.606 -1.309 . . . . 0.0 109.355 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.831 ' CA ' HG23 ' A' ' 102' ' ' THR . 1.1 t-20 -69.82 140.3 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 111.056 -178.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.685 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 3.7 m -129.73 126.33 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.0 110.114 179.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.83 132.99 33.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.031 . . . . 0.0 109.32 179.399 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.985 ' CE2' HD23 ' A' ' 71' ' ' LEU . 44.4 m-85 -89.31 149.11 23.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.145 -0.972 . . . . 0.0 111.935 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.65 90.2 3.27 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.162 0.506 . . . . 0.0 110.037 -179.514 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.442 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -43.14 124.5 3.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.9 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 110.801 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -97.2 -161.05 0.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 110.372 -179.73 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.75 58.36 0.14 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.558 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 3.0 m-30 -112.15 160.79 17.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.721 -0.87 . . . . 0.0 109.404 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.72 ' O ' HG22 ' A' ' 117' ' ' VAL . 10.6 tttt -101.05 136.43 40.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.991 -1.068 . . . . 0.0 110.52 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 66' ' ' ILE . 1.6 mt -79.56 90.65 5.12 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.537 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.8 101.94 1.82 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.829 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.58 -78.02 0.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.133 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -171.48 117.22 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -1.12 . . . . 0.0 110.635 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 -1.51 13.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -0.92 . . . . 0.0 110.966 -179.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 p -144.61 112.39 6.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.808 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.531 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.3 m -118.44 177.19 4.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 111.041 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.843 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -146.95 128.68 15.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.969 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.59 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 5.4 t -68.91 88.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.705 . . . . 0.0 109.51 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -69.16 -178.41 0.45 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.793 . . . . 0.0 111.193 -179.248 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.3 Cg_endo -80.7 124.96 5.33 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.564 1.823 . . . . 0.0 110.6 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 128.37 -8.12 6.64 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.762 ' O ' HG23 ' A' ' 108' ' ' THR . 7.2 m-20 83.48 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.5 0.667 . . . . 0.0 111.31 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -170.96 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.723 0.773 . . . . 0.0 111.21 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.685 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 32.1 m95 -137.73 92.37 2.67 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.451 0.643 . . . . 0.0 110.22 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 28.4 mttt -103.56 142.96 25.67 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.8 Cg_endo -70.58 167.57 73.0 Favored 'Cis proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.072 -2.054 . . . . 0.0 111.035 -0.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 113' ' ' LEU . 42.5 mt-10 -38.91 129.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.56 -0.712 . . . . 0.0 111.293 -179.239 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -40.06 147.25 0.36 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 110.594 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.806 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.7 Cg_endo -74.04 167.47 27.13 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.441 1.758 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.549 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -130.43 105.08 7.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.919 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.8 t -61.57 101.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.837 . . . . 0.0 109.213 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -115.28 -175.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.698 0.761 . . . . 0.0 110.588 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.0 mtm180 . . . . . 0 C--N 1.295 -1.791 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.32 0.581 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 138.75 44.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.0 110.257 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -108.01 99.21 8.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.847 . . . . 0.0 110.117 -179.921 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 9.9 mt-30 -88.38 177.19 6.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -39.09 136.89 0.97 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.544 -0.723 . . . . 0.0 110.586 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.77 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.2 Cg_endo -71.27 158.31 54.91 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.058 1.557 . . . . 0.0 110.855 -179.453 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.25 170.94 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.754 1.397 . . . . 0.0 109.865 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.59 175.31 4.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.666 179.695 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.652 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -138.37 -170.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.138 0.97 . . . . 0.0 111.463 179.861 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -46.19 90.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER 48.11 48.62 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.786 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -147.65 164.75 28.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.497 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -110.13 -169.95 1.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -1.076 . . . . 0.0 110.524 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -158.89 121.3 3.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.258 0.552 . . . . 0.0 109.981 -179.675 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.79 79.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.137 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.18 -98.0 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 t80 -150.76 34.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.222 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.549 ' CD ' ' CE1' ' A' ' 21' ' ' TYR . 2.5 pt-20 -177.81 -159.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.043 -1.035 . . . . 0.0 110.527 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -162.03 24.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.089 -179.962 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 22' ' ' THR . 0.3 OUTLIER -140.54 29.69 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 36.7 m-85 -37.05 142.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 20' ' ' PHE . 27.8 p -133.8 89.56 2.6 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.228 1.013 . . . . 0.0 110.488 179.248 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER 55.27 152.24 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.83 179.127 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 19.77 8.88 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.705 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.4 m -87.41 177.88 6.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -1.063 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 25' ' ' SER . 26.4 t -158.41 156.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.05 179.495 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.77 HG11 ' HG3' ' A' ' 6' ' ' PRO . 30.3 t -144.99 124.05 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.77 -179.439 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.82 101.34 5.07 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.398 -1.321 . . . . 0.0 107.725 177.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.869 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.8 m-30 -67.99 128.12 35.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 110.423 -178.21 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.6 t -77.89 -173.7 3.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.196 -0.94 . . . . 0.0 108.883 178.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 89.1 m -147.36 168.25 22.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.104 -0.998 . . . . 0.0 110.239 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.93 148.52 39.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.897 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.5 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.974 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.19 0.29 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -110.88 140.85 45.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -1.138 . . . . 0.0 110.276 -179.811 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -87.68 145.72 26.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.905 . . . . 0.0 110.623 -179.937 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.869 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.05 103.16 15.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.323 -0.86 . . . . 0.0 109.937 179.557 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.678 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -97.18 171.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 108.826 179.124 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 87.0 -168.59 39.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.95 117.82 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -1.125 . . . . 0.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.493 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.69 56.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -0.987 . . . . 0.0 109.644 179.53 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 160.27 94.19 0.1 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG21 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -48.33 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.341 -1.093 . . . . 0.0 108.85 179.849 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 25' ' ' SER . 10.8 tp -142.64 102.04 3.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.985 178.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -73.63 118.32 16.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.912 179.612 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -133.92 126.83 31.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.164 -0.96 . . . . 0.0 110.177 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.01 19.46 77.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 83.64 25.67 45.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.4 133.9 26.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.292 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.737 ' CH2' HG23 ' A' ' 27' ' ' VAL . 88.6 m95 -80.07 132.72 36.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.976 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.18 162.16 33.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 110.935 -179.604 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 60.57 66.22 1.9 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.509 -0.745 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.6 Cg_endo -90.75 127.2 1.26 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 121.91 1.74 . . . . 0.0 110.069 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 45.8 Cg_endo -71.15 176.89 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.668 1.352 . . . . 0.0 110.111 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.7 p -113.39 151.45 31.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -0.936 . . . . 0.0 111.916 -178.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -116.04 80.74 1.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.878 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -116.8 -162.45 0.85 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 110.425 -178.031 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.664 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -106.4 137.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.173 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.687 HG21 ' CB ' ' A' ' 81' ' ' TYR . 26.0 m -118.77 43.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 111.037 -179.266 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.438 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -83.38 98.79 9.67 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.709 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 56.4 m -68.68 164.31 46.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.803 . . . . 0.0 111.804 -177.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -66.61 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.514 1.797 . . . . 0.0 110.303 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -165.27 133.94 2.6 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.778 ' HG2' HD21 ' A' ' 71' ' ' LEU . 51.6 Cg_endo -76.5 69.37 6.68 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 O-C-N 123.703 1.37 . . . . 0.0 110.018 -178.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.676 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -92.2 -176.85 4.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 109.07 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.961 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -174.64 162.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.592 179.494 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' OG ' ' A' ' 67' ' ' SER . 3.7 p -69.38 101.31 1.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.547 -0.721 . . . . 0.0 110.395 -179.612 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.509 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 21.6 m-20 41.51 57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.177 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.961 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -170.14 37.31 0.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.762 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.4 p90 -44.06 -170.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 123.419 1.58 . . . . 0.0 112.907 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.946 ' O ' HD12 ' A' ' 71' ' ' LEU . 1.7 pp -107.46 116.16 31.45 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.55 179.498 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -82.28 1.38 37.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.42 -0.8 . . . . 0.0 109.602 -179.725 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 21.0 t -74.72 -86.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.76 . . . . 0.0 110.711 -179.61 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.14 94.5 0.12 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.163 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.944 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.28 104.3 11.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -1.07 . . . . 0.0 109.296 179.303 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.9 tptt -76.75 145.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.304 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -48.37 70.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.042 179.761 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 27.4 p -117.4 135.29 53.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.598 ' HB3' ' CB ' ' A' ' 103' ' ' CYS . 95.2 m-85 -113.81 -179.61 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.781 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.9 m -170.54 108.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.976 -1.077 . . . . 0.0 111.308 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CB ' HG21 ' A' ' 59' ' ' VAL . 11.5 t80 34.92 24.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.356 -0.84 . . . . 0.0 113.106 178.771 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.71 ' C ' HG22 ' A' ' 102' ' ' THR . 37.3 t-20 -176.51 -125.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.067 -1.646 . . . . 0.0 111.472 178.388 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 49.29 75.42 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.633 -1.292 . . . . 0.0 108.828 -178.359 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.592 ' CA ' HG23 ' A' ' 102' ' ' THR . 22.4 p-10 -69.57 139.9 53.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.476 -0.765 . . . . 0.0 110.512 -179.054 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.697 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -126.43 120.83 57.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.702 179.07 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 10.7 t0 -75.38 136.02 40.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 108.847 179.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 113' ' ' LEU . 16.5 m-85 -99.36 135.15 41.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.952 -1.092 . . . . 0.0 111.895 -178.564 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' TYR . 3.0 ttpt -109.53 154.91 22.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -100.28 128.18 46.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.92 -1.113 . . . . 0.0 110.098 179.891 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -44.68 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.701 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 93' ' ' TYR . 1.2 m-85 -95.71 -163.81 1.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 110.576 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.37 59.45 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.601 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.605 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-85 -109.38 168.94 9.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.788 -0.831 . . . . 0.0 110.009 -179.317 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.544 ' O ' HG22 ' A' ' 117' ' ' VAL . 22.0 mttt -117.3 110.71 18.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.5 mt -49.14 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -74.43 95.74 2.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 110.044 179.817 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.34 -68.78 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.333 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.582 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -175.95 119.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -1.156 . . . . 0.0 111.03 -179.148 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.12 24.13 0.44 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.99 -1.069 . . . . 0.0 111.339 179.676 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 p -167.22 129.17 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.951 -1.093 . . . . 0.0 109.273 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 66.4 m -143.58 160.66 40.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 111.189 -179.145 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.71 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.38 137.83 50.07 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.575 0.703 . . . . 0.0 109.931 179.301 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 1.8 t -56.25 92.75 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.718 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 1.1 p -71.3 179.29 0.97 Allowed Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 110.118 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.678 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.0 Cg_endo -78.51 170.75 17.88 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 O-C-N 124.018 1.536 . . . . 0.0 111.448 -179.026 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 86.13 -57.24 4.79 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -178.906 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.6 OUTLIER 141.66 68.76 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.365 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.26 165.65 24.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.652 -1.28 . . . . 0.0 112.032 -179.473 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.697 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 35.7 m95 -105.99 97.79 7.56 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.307 0.575 . . . . 0.0 109.849 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 5.1 mmmt -99.37 138.85 20.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.56 -179.338 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.582 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.7 Cg_endo -72.06 167.84 75.67 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.793 -0.48 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.4 tt0 -41.4 134.06 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.755 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -42.27 152.07 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.385 -0.822 . . . . 0.0 110.706 -179.736 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.804 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.0 Cg_endo -79.42 159.3 25.85 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.554 1.818 . . . . 0.0 111.487 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.1 tptt -119.03 106.57 12.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.512 -0.742 . . . . 0.0 110.713 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.4 t -62.43 97.86 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 108.774 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.67 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -112.02 178.28 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.55 0.691 . . . . 0.0 110.592 -179.396 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.662 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.713 HG11 ' HA2' ' A' ' 47' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.327 0.584 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -120.11 174.4 6.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -140.11 85.08 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.696 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 25.3 mt-30 -60.47 171.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 p -47.77 149.39 2.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.668 ' HG3' HG21 ' A' ' 27' ' ' VAL . 51.4 Cg_endo -72.31 155.76 55.58 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.95 1.5 . . . . 0.0 110.946 -179.159 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.44 169.08 23.33 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.599 1.315 . . . . 0.0 109.686 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.27 177.22 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.993 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.69 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -170.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.197 0.998 . . . . 0.0 111.475 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -45.62 94.0 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 -179.396 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.0 m120 41.76 53.08 4.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.287 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.85 152.65 24.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.9 mtt180 -94.99 -169.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -1.146 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.2 p80 -160.4 132.72 6.23 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 -179.631 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER 173.77 104.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.056 . . . . 0.0 110.7 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 17' ' ' TYR . . . -81.51 -69.11 1.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.555 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 33.0 p90 178.61 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.334 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.51 -139.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.823 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -149.9 -36.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 110.992 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 14.8 p90 -143.98 90.46 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.859 -1.151 . . . . 0.0 111.227 -179.403 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 44.8 m-85 -57.8 171.2 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.532 178.88 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.474 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -125.96 -49.07 1.6 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.832 -1.168 . . . . 0.0 111.192 -179.359 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -175.44 142.58 0.59 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.304 -0.872 . . . . 0.0 109.565 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.33 69.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -178.741 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.613 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.9 m -87.8 178.38 6.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.615 -0.932 . . . . 0.0 110.15 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.738 HG13 ' O ' ' A' ' 43' ' ' VAL . 31.5 t -154.46 154.04 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.668 HG21 ' HG3' ' A' ' 6' ' ' PRO . 39.6 t -135.8 118.69 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.39 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.856 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -71.0 103.32 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.707 177.915 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.69 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.4 m-30 -68.14 134.46 50.57 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 13' ' ' ARG . 1.1 m -93.15 159.3 15.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.612 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 34.2 m -126.08 154.01 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -44.39 158.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.011 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 t -62.08 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 110.356 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.31 22.36 3.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-30 -113.36 146.18 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -1.216 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.802 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -88.01 134.38 33.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.676 -0.64 . . . . 0.0 110.816 -179.43 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' THR . 1.2 tp -96.24 102.37 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 178.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.48 143.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.233 -0.917 . . . . 0.0 109.08 179.632 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 -175.86 21.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.242 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 5.0 p30 -65.65 142.86 57.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.041 -1.27 . . . . 0.0 109.83 179.763 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.76 51.24 1.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 110.445 -179.713 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.662 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 166.29 102.25 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.394 179.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.738 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -49.0 178.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.165 -1.197 . . . . 0.0 108.5 179.157 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -140.05 98.21 3.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 110.081 178.548 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.6 t -79.77 118.58 21.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.433 178.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -131.02 114.8 15.64 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.713 ' HA2' HG11 ' A' ' 1' ' ' VAL . . . 70.44 29.02 70.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 76.41 48.29 9.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.616 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -159.06 87.62 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 179.823 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.617 ' CH2' HG23 ' A' ' 27' ' ' VAL . 88.0 m95 -58.42 123.94 17.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.105 -0.997 . . . . 0.0 109.314 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -133.02 165.14 25.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 111.445 -179.22 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 1.6 m-20 58.28 65.57 3.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.86 -0.525 . . . . 0.0 111.242 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.7 Cg_endo -92.87 132.23 0.96 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 121.972 1.782 . . . . 0.0 109.985 178.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -75.23 177.32 8.78 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.579 1.305 . . . . 0.0 109.879 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.52 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.4 p -118.84 141.48 48.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 111.721 -178.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 89.4 m -106.76 79.87 1.39 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.23 -151.72 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.808 -0.558 . . . . 0.0 109.928 -178.692 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.707 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.52 122.73 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 108.766 179.177 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.802 HG13 ' CB ' ' A' ' 36' ' ' SER . 19.7 m -116.33 52.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 111.653 -178.311 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mtpt -65.2 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.801 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -129.8 151.26 77.86 Favored Pre-proline 0 C--N 1.295 -1.763 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.871 -178.368 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.563 ' HG3' ' HA ' ' A' ' 108' ' ' THR . 47.0 Cg_endo -84.51 9.4 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.649 1.868 . . . . 0.0 109.356 177.439 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.535 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 69.0 120.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.484 -0.76 . . . . 0.0 110.039 -179.172 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.66 ' HA ' HD21 ' A' ' 113' ' ' LEU . 56.2 Cg_endo -83.64 96.87 0.77 Allowed 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 123.957 1.504 . . . . 0.0 109.784 179.773 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 66' ' ' ILE . 2.9 p -110.01 -42.28 4.25 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.191 0.996 . . . . 0.0 110.208 -179.18 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.745 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 48.01 166.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.717 -178.406 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -69.48 104.47 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 111.14 -178.576 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 1.2 m120 40.51 41.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.826 . . . . 0.0 111.252 178.936 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -121.5 -39.14 0.59 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.043 -1.551 . . . . 0.0 109.807 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.5 p90 39.01 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.761 1.267 . . . . 0.0 112.196 -178.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.916 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -134.86 155.99 49.71 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.44 -178.916 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.488 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -105.79 -10.24 16.82 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 110.442 -178.891 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 2.8 m -53.74 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.79 79.74 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -69.19 163.41 24.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -1.075 . . . . 0.0 109.362 179.708 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.2 ttpt -154.56 160.38 41.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 -179.702 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -44.9 -52.35 8.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.202 179.895 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.508 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 74.3 m -131.65 164.67 25.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 3.1 m-85 -134.22 -140.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.619 ' C ' HG23 ' A' ' 59' ' ' VAL . 59.9 p -170.08 -126.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.915 -1.116 . . . . 0.0 111.155 179.781 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.631 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.09 21.35 8.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.023 -1.048 . . . . 0.0 110.636 -178.663 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.743 ' C ' HG22 ' A' ' 102' ' ' THR . 40.4 t-20 -164.15 -112.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.814 -1.178 . . . . 0.0 110.741 179.212 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 5.6 m-20 46.38 76.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.62 -1.3 . . . . 0.0 108.964 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.671 ' CA ' HG23 ' A' ' 102' ' ' THR . 2.2 p-10 -69.23 145.92 52.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.819 . . . . 0.0 110.992 -178.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.782 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.1 m -131.08 118.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.22 178.947 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 11.4 t0 -83.04 119.53 24.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.877 . . . . 0.0 108.956 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.916 ' CE1' HD12 ' A' ' 71' ' ' LEU . 47.6 m-85 -78.7 135.56 37.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.136 0.97 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 5.9 tttt -117.1 88.2 2.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 -179.413 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.693 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -36.72 127.69 0.85 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.843 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -36.9 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.744 179.891 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.5 t80 -157.3 142.66 17.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.38 43.2 90.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 18.5 m-85 -147.8 159.06 44.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.528 -0.983 . . . . 0.0 110.182 -179.68 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' O ' HG22 ' A' ' 117' ' ' VAL . 16.8 tttp -122.45 112.24 17.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.693 HD11 ' H ' ' A' ' 89' ' ' CYS . 6.1 mt -48.76 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.37 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.503 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.33 96.38 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.693 179.615 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.27 -115.72 0.9 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 30.0 m -123.35 127.22 48.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -1.144 . . . . 0.0 110.224 -179.877 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -42.87 56.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.7 p -101.54 137.34 40.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 109.862 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 50.5 m -147.64 153.42 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.587 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.743 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.22 145.25 51.37 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.284 179.588 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 3.4 t -67.08 78.09 0.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.65 -0.656 . . . . 0.0 110.45 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.88 172.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 111.064 -179.613 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.783 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -81.82 36.27 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.444 1.76 . . . . 0.0 112.003 -178.309 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -128.07 8.48 6.74 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 178.396 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.675 ' O ' HG23 ' A' ' 108' ' ' THR . 1.2 t30 75.7 59.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.797 -0.825 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -170.25 178.85 3.66 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.445 -179.721 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.782 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 19.9 m95 -108.55 87.93 2.61 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.234 0.54 . . . . 0.0 110.168 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.2 mmtt -99.43 147.45 33.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.577 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.0 Cg_endo -71.13 175.71 39.71 Favored 'Cis proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.998 -2.084 . . . . 0.0 110.883 0.404 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 tt0 -37.15 134.48 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.461 0.648 . . . . 0.0 110.97 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.729 HD13 ' HB3' ' A' ' 109' ' ' TRP . 1.6 tp -59.33 148.26 73.34 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.745 ' HG2' HD12 ' A' ' 66' ' ' ILE . 44.7 Cg_endo -75.45 165.74 30.05 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.049 1.552 . . . . 0.0 110.446 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.572 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -127.05 103.61 7.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -0.967 . . . . 0.0 110.215 179.668 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -55.65 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 109.483 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 115' ' ' LYS . 2.6 m -108.26 -173.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.856 0.836 . . . . 0.0 111.04 -179.491 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.25 179.542 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -126.39 145.8 50.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.059 179.969 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' TYR . 1.7 m -69.25 156.96 37.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.497 -0.752 . . . . 0.0 110.976 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 11.3 mt-30 -127.8 167.86 15.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.98 179.299 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' GLN . 5.1 p -45.81 137.44 5.88 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.888 -1.133 . . . . 0.0 109.402 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.865 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.3 Cg_endo -69.84 160.79 48.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.071 1.564 . . . . 0.0 111.79 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.7 176.94 9.34 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.152 1.606 . . . . 0.0 110.012 178.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.09 177.28 7.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.728 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.06 -170.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 179.917 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -43.78 92.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.801 -179.344 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.6 m-80 40.27 52.07 2.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.535 179.701 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -148.97 170.52 29.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 30' ' ' SER . 1.6 mtt180 -115.63 -168.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -1.197 . . . . 0.0 110.783 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 19.3 p80 -156.49 127.08 6.69 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.338 0.59 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -124.11 -41.96 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' VAL . . . 67.53 -102.13 0.78 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.815 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -172.69 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.112 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.489 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 11.0 pt-20 -178.29 -146.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.788 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.22 -43.11 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.553 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 28.9 p90 -128.51 118.26 22.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.709 179.335 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.642 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 15.9 m-85 -82.68 -175.05 5.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.516 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' H ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -132.89 -54.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.717 -1.239 . . . . 0.0 111.073 -178.968 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.04 137.28 0.07 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 109.295 -179.423 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.93 16.86 80.29 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -179.254 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.642 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -99.63 177.13 5.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -1.029 . . . . 0.0 110.153 -179.923 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 43' ' ' VAL . 7.9 t -147.18 162.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.865 HG11 ' HG3' ' A' ' 6' ' ' PRO . 14.5 t -137.5 113.94 11.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 105.41 3.84 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.78 178.055 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.9 m-30 -68.09 170.63 8.11 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.86 -178.387 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -123.26 147.68 46.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.764 179.578 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.8 m -124.36 144.46 50.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.148 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.71 149.55 3.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -53.17 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.345 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.17 -2.77 4.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 7.8 m-85 -120.6 126.19 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.175 -1.191 . . . . 0.0 110.219 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.692 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -76.15 149.5 37.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.554 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.4 OUTLIER -92.49 96.15 10.05 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.884 178.836 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.027 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -86.56 148.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 -179.841 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.64 -160.86 22.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.475 ' O ' ' C ' ' A' ' 41' ' ' SER . 17.1 m-20 -92.17 54.06 2.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -1.203 . . . . 0.0 109.894 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 40' ' ' ASN . 75.5 p 31.1 48.78 0.08 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.41 179.581 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.512 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 143.81 134.98 2.91 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 26' ' ' VAL . 1.8 t -67.1 178.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.254 -1.145 . . . . 0.0 108.34 178.685 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.475 ' H ' HG12 ' A' ' 43' ' ' VAL . 5.7 tp -139.65 99.08 3.62 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.202 177.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.63 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -83.36 114.62 21.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.393 178.756 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 p -132.65 81.43 1.95 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.13 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' GLY . . . 110.61 60.55 0.49 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.817 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.22 29.67 1.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.863 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -147.35 134.37 20.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -1.131 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.63 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.8 m95 -93.43 139.8 30.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.909 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -139.61 159.81 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.33 70.58 2.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.958 -0.464 . . . . 0.0 111.576 179.405 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -89.99 135.9 2.41 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.182 1.622 . . . . 0.0 109.077 178.612 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.559 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.4 Cg_endo -72.2 146.86 46.84 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 123.691 1.364 . . . . 0.0 110.746 -179.483 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.612 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 55.9 p -90.85 171.96 8.95 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.948 0.88 . . . . 0.0 111.689 -179.047 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 56.6 m -129.7 77.24 1.78 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.653 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.554 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -116.53 -157.29 0.65 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.54 -177.866 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.681 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -110.45 139.64 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.501 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 80' ' ' SER . 34.3 m -129.65 43.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.986 . . . . 0.0 111.086 -178.441 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 19.0 mttp -69.61 98.31 1.15 Allowed 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.423 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 56.4 m -69.33 163.52 57.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 110.79 -179.2 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.4 Cg_endo -70.62 -90.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.325 1.698 . . . . 0.0 110.569 -179.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -163.74 131.78 2.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -77.35 67.83 7.63 Favored 'Trans proline' 0 C--N 1.298 -2.125 0 O-C-N 123.565 1.298 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.72 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -89.21 -178.28 5.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 179.996 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.72 HG22 ' C ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -176.41 163.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.564 179.398 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' N ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -70.19 96.24 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.437 -179.737 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.457 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 22.1 m120 47.76 44.19 17.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.625 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.14 32.41 1.05 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.802 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 88' ' ' LYS . 10.5 p90 -45.76 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.523 1.154 . . . . 0.0 112.46 -179.121 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.741 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -115.0 164.01 14.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.244 -179.571 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.34 -7.78 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 -179.765 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 t -59.59 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.77 93.82 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.922 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -89.2 177.79 6.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -1.157 . . . . 0.0 109.601 179.527 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -167.33 153.39 7.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 110.189 -179.461 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.1 mtm-85 -46.48 -36.66 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -146.24 154.54 41.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.633 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 45.3 m-85 -123.63 -167.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.0 109.688 179.653 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.719 ' HA ' HG23 ' A' ' 59' ' ' VAL . 5.8 p -170.08 91.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.638 ' CB ' HG21 ' A' ' 59' ' ' VAL . 8.5 t80 56.18 135.38 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.605 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.795 ' O ' HG22 ' A' ' 102' ' ' THR . 63.1 t30 65.09 -127.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.882 -1.137 . . . . 0.0 110.114 -179.258 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 1.7 m-20 52.98 70.75 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.684 -1.26 . . . . 0.0 109.009 -178.556 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.524 ' N ' HG23 ' A' ' 102' ' ' THR . 22.2 p-10 -72.91 140.04 47.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.487 -0.758 . . . . 0.0 111.259 -178.898 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.712 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.1 m -128.29 118.63 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.026 178.623 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.6 t70 -78.35 127.71 32.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.737 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.741 ' CE1' HD12 ' A' ' 71' ' ' LEU . 37.4 m-85 -89.07 122.79 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.249 1.023 . . . . 0.0 112.213 -178.289 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -97.63 94.53 7.03 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.791 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.469 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.24 129.03 6.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.061 -1.024 . . . . 0.0 110.001 -179.836 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' CYS . 2.2 mmtt -40.35 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.53 -179.571 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -158.82 139.58 12.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 0.0 110.25 179.963 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.61 49.48 46.32 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 14.4 m-85 -155.22 147.42 23.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -1.071 . . . . 0.0 109.553 -179.614 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 117' ' ' VAL . 2.3 ttmt -105.06 148.6 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.961 -1.087 . . . . 0.0 110.26 -179.871 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -85.34 87.18 7.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 110.664 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -70.41 106.2 3.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 109.257 179.101 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.68 -86.56 0.21 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -162.91 115.76 1.6 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.164 -1.198 . . . . 0.0 110.676 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' PHE . 19.4 m -64.12 -40.32 95.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.27 -0.894 . . . . 0.0 110.793 179.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -107.85 117.61 34.58 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.958 -1.089 . . . . 0.0 110.793 -179.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.593 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 13.5 m -119.47 -170.89 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.795 HG22 ' O ' ' A' ' 82' ' ' ASN . 9.3 m -163.08 134.32 4.88 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.408 -178.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -62.7 90.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.037 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.538 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 1.3 m -64.63 170.47 3.84 Favored Pre-proline 0 C--N 1.297 -1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 112.057 -178.669 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 1.027 ' HB2' HD12 ' A' ' 38' ' ' ILE . 49.8 Cg_endo -80.32 30.55 0.5 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.811 1.953 . . . . 0.0 111.886 -178.584 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -130.49 12.34 5.72 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 178.661 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.856 ' O ' HG23 ' A' ' 108' ' ' THR . 6.1 m-80 71.75 69.19 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.734 -0.863 . . . . 0.0 110.242 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.856 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -175.19 -163.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 111.206 -179.943 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.712 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 39.2 m95 -133.13 91.77 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -104.25 144.92 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 110.16 -179.705 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.2 Cg_endo -71.18 168.74 71.56 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.943 -2.107 . . . . 0.0 111.23 -0.478 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.46 127.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.472 0.653 . . . . 0.0 111.846 -178.994 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -42.18 142.99 1.1 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.714 . . . . 0.0 109.72 178.976 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.577 ' HB2' HD23 ' A' ' 95' ' ' LEU . 41.3 Cg_endo -71.44 169.91 19.73 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.214 1.639 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' HG22 ' A' ' 117' ' ' VAL . 7.8 tttp -130.61 106.97 8.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.125 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.533 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.0 t -65.4 74.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 109.086 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 115' ' ' LYS . 1.6 m -82.55 -175.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.057 0.932 . . . . 0.0 111.467 -179.154 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.705 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.633 179.883 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 8.1 mttt -138.06 177.33 7.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.546 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -138.92 93.14 2.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.974 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 1.1 mp0 -72.76 -175.89 1.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.21 139.44 45.79 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.024 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.619 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.2 Cg_endo -72.81 153.21 53.36 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.982 1.517 . . . . 0.0 110.275 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.58 169.57 22.01 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.908 1.478 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.7 p -70.86 176.19 4.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.91 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.175 0.988 . . . . 0.0 111.364 179.778 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -40.96 95.84 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.855 -179.215 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 9' ' ' ILE . 15.7 m-80 40.69 38.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.189 -0.944 . . . . 0.0 110.721 179.62 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -141.96 149.21 20.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 1.5 ptt180 -102.84 -173.19 2.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -1.149 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.778 ' HB2' HG11 ' A' ' 27' ' ' VAL . 14.6 p80 -136.64 133.54 36.35 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.259 0.552 . . . . 0.0 110.423 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -56.48 120.39 7.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.268 -179.853 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.09 71.62 0.32 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -88.43 -13.08 41.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -1.1 . . . . 0.0 110.172 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.633 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -120.02 -142.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.97 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -153.03 -39.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.606 179.765 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 5.1 p90 -128.93 79.56 1.92 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.194 -0.941 . . . . 0.0 109.935 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.6 m-85 -52.03 -29.77 22.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 110.779 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.546 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 69.66 -77.08 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.352 -0.843 . . . . 0.0 112.22 178.803 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 1.9 t70 -165.06 160.24 18.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.789 -1.195 . . . . 0.0 110.282 -179.083 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 63.18 16.67 58.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 33.0 m -95.69 173.9 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -1.009 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 43' ' ' VAL . 40.5 t -154.22 153.84 7.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.706 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 14' ' ' HIS . 17.0 t -139.06 111.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.348 -179.437 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -67.3 105.29 1.72 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.295 -1.362 . . . . 0.0 107.783 178.248 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.625 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.19 109.0 3.36 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.442 -0.786 . . . . 0.0 110.147 -178.195 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.491 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -69.24 152.94 44.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.074 -1.016 . . . . 0.0 109.448 179.519 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.6 m -121.01 160.42 23.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.697 -179.37 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -44.69 164.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.366 -0.834 . . . . 0.0 109.972 179.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -67.39 86.59 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.59 1.9 5.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 2.6 m-30 -94.04 128.82 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -1.201 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.602 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -76.86 134.49 39.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 110.518 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -89.73 106.16 18.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.428 179.214 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.842 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.83 146.41 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.376 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.75 -172.47 17.46 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.72 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.49 142.81 47.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 109.888 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 28' ' ' THR . 58.5 p -77.92 52.25 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.604 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 149.14 115.29 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -48.78 173.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.56 -1.256 . . . . 0.0 107.732 179.181 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.01 94.94 2.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.777 178.846 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.3 OUTLIER -80.32 105.75 11.82 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.998 178.847 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.2 95.87 3.63 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.271 -179.371 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.96 19.96 5.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.436 ' C ' ' HG3' ' A' ' 49' ' ' GLU . . . 83.35 13.02 77.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 48' ' ' GLY . 47.2 mt-10 -145.96 138.61 25.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.161 . . . . 0.0 110.262 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 94.8 m95 -80.79 143.3 32.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -142.62 160.2 40.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -0.984 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.504 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.5 t0 58.3 65.44 3.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 111.448 179.465 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -91.16 134.19 1.67 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.385 1.729 . . . . 0.0 109.754 178.877 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -81.29 174.05 11.06 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.72 1.379 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.1 p -115.28 140.9 48.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 111.506 -178.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 10' ' ' SER . 62.9 m -105.46 76.77 1.23 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.08 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.15 177.65 4.64 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.457 0.646 . . . . 0.0 110.614 -178.292 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -92.0 148.68 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.589 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 13.0 m -129.15 47.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.821 -178.118 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 4.9 mmtt -85.43 160.83 19.64 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.032 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 108' ' ' THR . 65.4 m -135.6 166.3 29.6 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.216 -1.553 . . . . 0.0 113.019 -178.268 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 39.0 Cg_endo -66.94 -87.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.828 1.962 . . . . 0.0 110.386 179.158 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 132.42 1.79 Allowed Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.7 Cg_endo -75.84 65.06 6.81 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 123.825 1.434 . . . . 0.0 108.995 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -83.42 164.32 20.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.664 -0.648 . . . . 0.0 110.877 -179.058 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -164.17 164.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 179.725 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 32.8 t -73.88 106.17 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.514 -0.741 . . . . 0.0 110.848 -179.563 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.548 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 19.0 m-20 42.37 27.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.918 179.315 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.78 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -134.71 33.05 2.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.568 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 7.9 p90 -45.05 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.65 1.214 . . . . 0.0 112.275 -179.439 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.02 160.53 16.75 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.667 179.766 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.509 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 3.0 t -134.43 30.89 3.49 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.942 . . . . 0.0 109.823 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.5 t -103.66 -81.39 0.51 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -179.556 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.8 85.9 0.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.602 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.65 166.02 12.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -1.06 . . . . 0.0 109.684 179.705 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 4.0 tttt -162.41 158.51 24.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 -179.753 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -50.92 -33.41 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 0.0 109.888 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 6.6 p -136.57 173.33 11.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 0.0 109.927 179.682 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.602 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 52.8 m-85 -144.13 -171.69 3.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.2 p -146.2 -157.7 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.248 -0.907 . . . . 0.0 110.624 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.629 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -83.99 61.22 6.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.534 -1.354 . . . . 0.0 110.352 -179.759 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.631 ' HA ' HG21 ' A' ' 102' ' ' THR . 0.4 OUTLIER 162.17 -16.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.986 -1.071 . . . . 0.0 111.518 179.516 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 38.9 m-20 -58.2 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.962 -1.086 . . . . 0.0 108.613 179.232 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p30 -76.78 145.19 38.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.552 -0.717 . . . . 0.0 111.294 -178.134 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.677 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 11.9 m -133.78 116.41 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 178.665 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -80.06 135.37 36.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.777 ' CE1' HD12 ' A' ' 71' ' ' LEU . 49.5 m-85 -92.93 138.72 31.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.893 -1.129 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 0.2 OUTLIER -113.79 92.97 4.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.89 -179.657 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 132.42 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 110.233 -179.731 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.45 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.805 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.7 t80 -157.96 128.89 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 62.24 57.15 18.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 35.6 m-85 -162.12 147.9 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.996 . . . . 0.0 109.982 -179.384 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 117' ' ' VAL . 10.8 mttm -101.85 152.62 20.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.816 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -94.05 87.5 5.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.554 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.649 ' HB2' HG21 ' A' ' 117' ' ' VAL . 11.2 t -71.68 107.72 4.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.057 -1.027 . . . . 0.0 109.609 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.44 -78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -172.46 116.21 0.33 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.344 -1.092 . . . . 0.0 110.62 -179.693 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.5 p -68.6 -11.91 60.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.5 p -134.3 140.59 46.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.873 -1.142 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.0 m -154.77 162.9 40.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 -179.459 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 82' ' ' ASN . 5.2 m -136.42 138.31 41.39 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.3 0.572 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.565 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 1.9 t -43.58 -28.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.416 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER 64.2 165.99 0.11 Allowed Pre-proline 0 C--N 1.293 -1.88 0 CA-C-O 121.391 0.615 . . . . 0.0 112.031 178.321 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.842 ' CB ' HD12 ' A' ' 38' ' ' ILE . 50.6 Cg_endo -81.96 4.4 7.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.636 1.861 . . . . 0.0 111.1 -179.026 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -103.51 2.64 46.17 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.594 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.816 ' O ' HG23 ' A' ' 108' ' ' THR . 17.0 m-80 73.68 48.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.885 -0.774 . . . . 0.0 110.743 179.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -166.44 150.71 7.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 110.864 178.805 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.677 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 58.2 m95 -71.79 88.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.709 0.766 . . . . 0.0 110.959 -179.336 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.4 mmtp -104.02 132.51 20.94 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.729 -0.607 . . . . 0.0 109.559 179.633 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.2 Cg_endo -72.55 167.78 76.8 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.859 -2.142 . . . . 0.0 110.52 0.377 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.6 mp0 -43.1 149.83 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.214 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.744 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -55.13 151.57 17.0 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.264 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.679 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.4 Cg_endo -73.57 169.47 22.25 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 O-C-N 124.299 1.684 . . . . 0.0 110.868 -179.868 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.533 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -126.77 110.14 12.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.24 -0.912 . . . . 0.0 110.475 -179.779 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -66.3 73.81 0.08 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.817 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 96' ' ' SER . 1.2 m -84.09 -175.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.845 0.831 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.582 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 8.2 ptt85 . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.4 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.324 0.583 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -133.17 174.58 10.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 179.685 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.548 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -142.3 85.71 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.936 -179.952 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HG2' ' CE1' ' A' ' 20' ' ' PHE . 30.0 mt-30 -63.05 177.74 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.903 -1.123 . . . . 0.0 109.71 179.803 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 4' ' ' GLN . 3.6 p -43.28 145.87 0.95 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 0.0 109.74 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.829 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.2 Cg_endo -69.84 170.88 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.713 -179.541 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.84 171.75 13.97 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.011 1.532 . . . . 0.0 109.523 178.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.02 97.69 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.246 -179.937 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.598 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.31 -175.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 0.0 110.918 -179.779 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -101.85 140.26 36.38 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.546 179.909 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t-20 71.39 8.76 6.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.708 179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -160.13 -179.46 34.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.836 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -132.68 -166.85 1.81 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.364 -1.08 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 17.0 p80 -155.59 -163.38 1.5 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.768 179.968 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 4.6 t-20 65.33 -141.17 0.21 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.02 -67.09 0.41 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -120.09 -4.67 10.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 109.572 179.536 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 26.9 mt-10 -106.68 -174.86 2.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.791 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 169.06 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.07 -1.019 . . . . 0.0 111.153 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.514 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -139.04 67.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 111.396 -179.055 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 3.1 m-85 -75.26 174.58 9.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 108.999 178.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.548 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 36.4 p -137.87 -57.34 0.67 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.756 -1.215 . . . . 0.0 111.356 -178.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.04 130.15 0.77 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.185 -0.947 . . . . 0.0 110.083 -179.169 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.77 22.39 61.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.471 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.641 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 28.0 m -111.33 168.87 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -1.026 . . . . 0.0 110.049 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 43' ' ' VAL . 21.8 t -140.77 148.22 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 112.205 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.829 HG11 ' HG3' ' A' ' 6' ' ' PRO . 28.8 t -116.3 122.84 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.561 -0.712 . . . . 0.0 111.662 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.83 102.66 7.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.478 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.6 m-30 -68.11 149.87 49.08 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.256 -178.098 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -95.47 152.75 18.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 179.427 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.467 ' SG ' HD12 ' A' ' 37' ' ' LEU . 86.0 m -125.63 146.6 49.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 0.0 110.393 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.2 145.66 25.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.231 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.7 p -56.05 110.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.33 -4.62 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 58' ' ' ILE . 8.9 m-85 -124.42 155.88 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.268 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.657 ' HB3' HG11 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -101.29 149.9 23.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.242 179.659 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.581 ' C ' HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -88.25 108.59 19.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.451 -0.78 . . . . 0.0 109.511 179.242 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.7 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -100.55 143.97 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.175 -179.856 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.68 -156.26 22.37 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 m-20 -93.26 55.49 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.325 . . . . 0.0 109.774 179.497 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 40' ' ' ASN . 53.1 p 30.07 47.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.484 179.636 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.66 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 143.7 136.34 3.1 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.551 179.671 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.858 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.8 t -65.36 179.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.206 -1.173 . . . . 0.0 108.067 178.706 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.6 tp -143.25 95.19 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.669 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -80.57 113.23 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 109.048 178.774 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.11 112.26 18.01 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.265 -179.553 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.23 58.79 8.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.458 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 49.54 53.96 18.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.38 95.23 1.01 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -1.112 . . . . 0.0 110.59 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.734 ' CH2' HG23 ' A' ' 27' ' ' VAL . 74.3 m95 -65.88 133.52 51.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 52' ' ' ASP . 15.9 m -142.7 177.25 8.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.698 -179.37 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 3.2 p30 36.15 71.25 0.93 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.969 -0.457 . . . . 0.0 111.874 179.651 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.23 138.13 3.25 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.05 1.552 . . . . 0.0 109.515 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.52 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 46.4 Cg_endo -73.36 176.95 8.53 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.79 1.416 . . . . 0.0 110.644 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 8.8 p -121.86 157.53 30.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 111.54 -178.679 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 94.1 m -116.68 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -118.03 -156.96 0.66 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.204 -178.454 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.543 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -108.78 152.86 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.856 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 36' ' ' SER . 26.3 m -137.39 48.29 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 111.115 -178.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mttt -90.63 173.45 8.04 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.49 178.7 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 47.8 m -132.65 167.16 24.09 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.479 -1.388 . . . . 0.0 112.333 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.2 Cg_endo -76.19 -53.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.747 1.919 . . . . 0.0 109.909 178.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.95 125.37 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.946 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 45.6 Cg_endo -75.08 59.78 5.33 Favored 'Trans proline' 0 C--N 1.292 -2.403 0 O-C-N 123.69 1.363 . . . . 0.0 110.554 -178.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.747 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -78.62 -171.79 2.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.465 -0.772 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER 178.25 168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.643 179.356 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.509 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -71.79 102.84 2.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.499 -0.75 . . . . 0.0 110.83 -179.638 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 2.5 m-20 40.05 43.99 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.456 -0.778 . . . . 0.0 110.858 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.902 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -155.02 35.26 0.66 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.621 ' O ' ' O ' ' A' ' 69' ' ' GLY . 15.6 p90 -42.49 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 123.409 1.576 . . . . 0.0 114.188 -179.325 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.859 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -149.34 136.53 19.91 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -175.491 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t -121.8 27.39 8.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 109.775 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -69.83 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 111.39 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -124.03 -73.45 0.25 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.879 -178.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' HB2' HD13 ' A' ' 71' ' ' LEU . 22.8 t80 58.44 163.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -1.012 . . . . 0.0 109.973 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.571 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 8.0 tttm -178.94 140.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.455 -0.778 . . . . 0.0 110.059 179.731 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -42.74 -36.01 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 179.67 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 2.6 p -125.88 166.27 17.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.676 . . . . 0.0 109.75 179.369 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 74.0 m-85 -141.07 -168.9 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.9 m -155.54 -158.54 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -69.38 2.94 2.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.349 -1.47 . . . . 0.0 111.19 -179.057 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.797 ' O ' HG22 ' A' ' 102' ' ' THR . 8.8 p30 -139.21 -111.53 0.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.781 -1.199 . . . . 0.0 110.266 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 50.88 65.69 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.849 -1.157 . . . . 0.0 109.623 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.889 ' CA ' HG23 ' A' ' 102' ' ' THR . 18.8 p-10 -69.4 110.86 4.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.797 HG23 ' CE1' ' A' ' 87' ' ' PHE . 26.0 m -97.26 121.85 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.862 -1.149 . . . . 0.0 111.204 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -78.05 138.79 38.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.204 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.797 ' CE1' HG23 ' A' ' 85' ' ' VAL . 24.4 m-85 -98.64 145.54 26.76 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.986 -1.072 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.82 96.81 5.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.648 -0.658 . . . . 0.0 110.093 -179.708 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.605 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -46.46 134.5 9.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -41.14 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.338 -0.851 . . . . 0.0 110.241 -179.855 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -160.74 124.78 3.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 69.27 53.84 16.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.675 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 51.6 m-85 -160.68 152.21 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -1.022 . . . . 0.0 109.892 -179.249 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -107.27 136.78 46.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.012 . . . . 0.0 109.963 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.605 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -75.65 89.82 2.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.075 -179.875 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.4 t -74.74 101.86 4.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -0.905 . . . . 0.0 110.285 -179.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.06 -64.79 0.44 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.568 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 177.35 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -1.105 . . . . 0.0 110.377 -179.606 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.8 p -68.94 -3.94 14.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.943 . . . . 0.0 110.743 -179.564 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 64.5 p -140.13 93.76 2.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.555 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 19.5 m -104.04 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 110.991 -179.411 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.889 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.98 137.76 23.78 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.929 -0.709 . . . . 0.0 110.455 -179.614 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.61 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 49.2 t -56.74 107.28 0.38 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -0.778 . . . . 0.0 109.461 179.642 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.5 175.1 4.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.556 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.65 ' CB ' HG12 ' A' ' 59' ' ' VAL . 41.2 Cg_endo -77.45 167.19 24.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.857 1.451 . . . . 0.0 111.584 -179.166 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 89.93 -58.72 3.62 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 -178.545 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.621 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 147.13 71.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 122.271 0.228 . . . . 0.0 111.123 178.537 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -169.78 166.95 9.55 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.314 -1.491 . . . . 0.0 112.536 179.236 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 24.2 m95 -101.55 92.09 4.74 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 179.564 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.556 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 16.2 mttt -101.03 142.59 24.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.222 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.568 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.4 Cg_endo -71.0 168.97 70.64 Favored 'Cis proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.706 -0.849 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -39.8 129.96 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.544 -0.723 . . . . 0.0 110.847 -179.6 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -39.7 147.07 0.34 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 0.0 110.422 179.385 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.817 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.5 Cg_endo -70.35 166.7 27.45 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.398 1.736 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HG2' HG13 ' A' ' 117' ' ' VAL . 4.7 ttpt -127.29 107.83 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.463 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.9 t -64.4 90.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.077 -1.015 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.858 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -103.77 -175.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.904 0.859 . . . . 0.0 110.821 -179.414 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.928 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.448 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.228 0.537 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.79 176.79 7.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 4.1 t -159.37 101.25 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.217 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.6 mt-30 -87.46 -177.59 5.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -39.69 141.05 0.77 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 -179.766 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 49.9 Cg_endo -71.32 159.89 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.095 1.576 . . . . 0.0 111.228 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.6 170.91 19.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.102 1.58 . . . . 0.0 109.898 179.371 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -73.26 174.4 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.45 -170.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.219 1.009 . . . . 0.0 111.559 179.631 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -38.62 94.1 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.986 -179.138 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.2 m120 41.39 30.83 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -132.16 150.44 19.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.936 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 30' ' ' SER . 3.8 mtt180 -96.36 -170.87 2.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -1.075 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -147.16 120.09 8.74 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.228 0.537 . . . . 0.0 109.965 -179.738 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -123.46 109.53 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.748 -179.552 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' CA ' ' OH ' ' A' ' 21' ' ' TYR . . . -101.5 -5.47 51.77 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.463 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 68.44 24.2 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.279 -1.13 . . . . 0.0 110.375 179.975 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 3.8 pt-20 -160.57 -160.56 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 19' ' ' ASP . 5.7 t0 -131.83 -27.41 1.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.073 -1.017 . . . . 0.0 110.714 -179.586 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 9.9 m-85 -119.88 134.88 55.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.78 -179.63 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -124.08 -13.93 7.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.459 -0.776 . . . . 0.0 110.204 179.882 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.557 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . 47.6 p 45.95 -98.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.554 -0.716 . . . . 0.0 111.68 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -143.7 156.82 44.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 110.438 -178.443 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 70.13 16.25 72.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.086 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -94.29 174.9 6.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.624 -0.927 . . . . 0.0 110.328 -179.7 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 43' ' ' VAL . 37.9 t -154.21 153.22 8.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.048 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' VAL . 41.5 t -139.65 123.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.66 -179.433 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.56 101.9 3.71 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.247 . . . . 0.0 107.78 177.899 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.045 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.03 134.24 50.34 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.308 -178.208 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.01 163.09 15.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.914 179.606 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.614 ' SG ' HD12 ' A' ' 37' ' ' LEU . 70.9 m -127.36 159.25 35.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 110.175 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.92 154.85 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.894 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 100.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.74 8.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.9 m-30 -110.01 158.66 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -1.177 . . . . 0.0 110.005 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 1.042 ' OG ' HG22 ' A' ' 59' ' ' VAL . 24.3 m -103.71 130.39 51.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.389 -0.819 . . . . 0.0 110.677 -179.337 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.2 tp -83.0 117.71 23.0 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.237 179.132 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.59 HG23 ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -115.97 143.77 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.31 -168.02 12.8 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.561 -1.815 . . . . 0.0 108.561 -179.0 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 30.5 p-10 -66.37 130.76 44.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.968 -1.313 . . . . 0.0 109.496 179.476 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 28' ' ' THR . 30.2 p -70.01 57.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.992 . . . . 0.0 109.511 179.767 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.601 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.92 117.34 0.57 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.491 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.045 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -61.19 -176.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.95 -1.323 . . . . 0.0 107.848 179.248 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.606 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.9 tp -144.47 102.29 3.81 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.318 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -86.15 111.91 20.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.363 -0.835 . . . . 0.0 109.656 179.423 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 88.39 2.93 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.43 50.52 3.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 57.27 25.07 53.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' TRP . 2.3 tt0 -125.8 71.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.606 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 72.9 m95 -45.84 129.67 9.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -144.1 173.4 11.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.996 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 53.29 65.1 6.11 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 110.884 -179.949 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.6 Cg_endo -91.53 135.63 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.444 1.76 . . . . 0.0 110.096 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 50.5 Cg_endo -79.91 -173.56 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.739 1.389 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -120.13 -172.01 2.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.963 0.887 . . . . 0.0 111.564 -178.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 95.9 m -152.05 80.91 1.26 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 5.2 mm100 -111.41 -139.8 0.38 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.413 0.625 . . . . 0.0 110.912 -177.747 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.465 HG13 ' C ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -137.57 106.55 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.848 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.042 HG22 ' OG ' ' A' ' 36' ' ' SER . 26.8 m -105.51 64.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.153 -0.967 . . . . 0.0 112.526 -178.224 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 14.8 mttt -67.49 -175.69 0.53 Allowed 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 117.531 -1.668 . . . . 0.0 107.624 178.072 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.64 163.59 35.43 Favored Pre-proline 0 C--N 1.296 -1.741 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.597 -178.085 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -86.91 -83.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.92 2.011 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.484 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 175.14 130.75 0.14 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.611 -0.681 . . . . 0.0 109.298 -179.433 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.736 ' HG2' HD21 ' A' ' 71' ' ' LEU . 49.8 Cg_endo -80.02 64.06 8.82 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 O-C-N 123.739 1.389 . . . . 0.0 109.896 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.6 ' C ' HG22 ' A' ' 66' ' ' ILE . 5.4 p -77.05 175.65 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.813 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.0 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.84 168.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 118.522 -1.271 . . . . 0.0 110.7 179.307 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.491 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.69 100.32 3.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.527 -0.733 . . . . 0.0 110.691 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 35.1 m-20 42.41 48.15 4.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.0 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -160.28 37.81 0.45 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 54.3 p90 -50.2 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.952 1.358 . . . . 0.0 112.922 -179.783 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.065 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -142.84 127.03 17.52 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.736 -176.562 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -109.14 19.22 19.72 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 110.192 -179.318 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 31.3 t -84.17 -88.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.906 -179.47 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -101.03 -71.91 0.96 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.279 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 51.1 t80 57.04 170.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -1.07 . . . . 0.0 109.665 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.635 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 174.23 130.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 179.932 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 76' ' ' LYS . 9.4 mtt180 -40.76 -32.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.797 . . . . 0.0 110.027 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.84 126.24 20.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 11.2 m-85 -106.11 -151.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 179.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 59.9 p -159.85 -126.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.944 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.985 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -102.07 33.63 3.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.987 -1.071 . . . . 0.0 110.84 -179.243 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.753 ' C ' HG22 ' A' ' 102' ' ' THR . 17.9 t-20 -172.29 -112.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.093 -1.005 . . . . 0.0 110.367 179.007 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 t0 47.39 75.06 0.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.641 -1.287 . . . . 0.0 109.162 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.715 ' CA ' HG23 ' A' ' 102' ' ' THR . 12.7 p-10 -69.62 112.69 6.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.576 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.592 ' CG2' HD22 ' A' ' 71' ' ' LEU . 31.4 m -98.15 121.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.983 -1.073 . . . . 0.0 111.17 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -80.12 139.58 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.395 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 1.065 ' CE2' HD23 ' A' ' 71' ' ' LEU . 65.3 m-85 -95.5 146.52 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.811 -1.181 . . . . 0.0 112.396 -178.205 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.73 91.55 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.367 179.695 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.519 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 135.28 3.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.928 . . . . 0.0 109.957 -179.551 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 6.8 mmmt -39.63 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 110.687 -179.545 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.6 t80 -168.68 130.81 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.297 -0.877 . . . . 0.0 110.358 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.18 53.43 46.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 25.2 m-85 -158.77 150.47 20.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -1.013 . . . . 0.0 109.959 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -102.95 154.59 19.07 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.401 -0.812 . . . . 0.0 109.038 179.362 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.587 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -93.93 96.26 9.6 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 110.499 -179.447 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.13 101.82 4.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 109.646 179.526 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.53 -77.17 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -171.59 114.43 0.37 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 110.896 -179.632 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 m -71.34 -2.45 16.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.231 -0.918 . . . . 0.0 110.481 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -143.33 113.83 7.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.111 179.773 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 27.3 m -126.0 160.16 30.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.753 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.6 139.53 50.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.582 0.706 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.51 84.36 1.52 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.485 -0.76 . . . . 0.0 110.107 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -62.95 173.99 0.95 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.985 -179.55 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.757 ' HB3' HG11 ' A' ' 59' ' ' VAL . 42.8 Cg_endo -73.34 123.46 8.73 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.391 1.732 . . . . 0.0 110.104 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.58 -9.31 4.96 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -178.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' HG23 ' A' ' 108' ' ' THR . 1.8 m120 80.71 89.35 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.909 -0.76 . . . . 0.0 110.295 179.701 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.06 -160.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.281 -0.887 . . . . 0.0 110.933 179.85 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.644 ' HB3' HD11 ' A' ' 113' ' ' LEU . 30.4 m95 -145.84 86.09 1.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.608 0.718 . . . . 0.0 109.712 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 21.0 mttt -99.77 139.05 20.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.705 . . . . 0.0 110.255 -179.349 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.9 Cg_endo -71.34 166.51 77.83 Favored 'Cis proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.009 -2.079 . . . . 0.0 110.781 -0.127 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.2 mp0 -40.37 137.81 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.539 -0.725 . . . . 0.0 110.644 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.788 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -43.52 155.98 0.29 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 179.744 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.695 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.8 Cg_endo -80.06 169.48 17.66 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 124.397 1.735 . . . . 0.0 111.074 -179.609 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.554 ' O ' HG22 ' A' ' 117' ' ' VAL . 6.8 tttt -127.35 111.12 13.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.532 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -67.67 98.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.117 -0.989 . . . . 0.0 109.425 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -112.76 -176.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.736 0.779 . . . . 0.0 110.507 -179.627 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 9.0 ptt85 . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.451 179.63 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.26 0.552 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -122.19 162.6 21.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.581 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -143.33 78.38 1.6 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.22 179.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -51.91 145.44 17.15 Favored Pre-proline 0 C--N 1.3 -1.559 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.76 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.683 ' HG3' HG11 ' A' ' 27' ' ' VAL . 54.7 Cg_endo -73.99 159.86 43.99 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.896 1.472 . . . . 0.0 110.117 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.93 170.0 19.91 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.661 1.348 . . . . 0.0 109.997 179.284 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 p -88.82 105.06 17.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.983 . . . . 0.0 110.365 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.601 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -56.29 -170.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.03 0.919 . . . . 0.0 111.289 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.13 138.15 31.74 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.424 -178.846 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 56' ' ' CYS . 10.5 m120 49.05 20.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.48 -0.763 . . . . 0.0 110.931 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.2 157.66 27.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.437 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 mpt_? -118.23 -166.33 1.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -1.19 . . . . 0.0 111.059 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.5 p80 -151.22 131.55 13.69 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.614 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -155.34 -145.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 110.751 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . 129.4 4.89 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 7.7 t80 70.96 24.31 4.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.163 -1.198 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.43 ' CG ' ' HE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -126.12 168.9 13.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.068 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.24 -31.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 110.515 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.25 139.06 52.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.08 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.661 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.2 m-85 -123.03 -7.08 8.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 110.985 -179.624 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.581 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.8 p 43.3 -96.61 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 111.405 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 17.4 t0 -153.52 138.49 17.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.953 -1.092 . . . . 0.0 110.363 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.49 37.4 8.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.661 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 66.4 m -135.17 161.33 35.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.261 -1.141 . . . . 0.0 109.951 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.3 t -134.19 147.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.0 112.28 -178.141 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 43' ' ' VAL . 32.3 t -117.95 119.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.725 -0.609 . . . . 0.0 111.743 -179.523 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.4 102.95 3.9 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.78 -1.168 . . . . 0.0 107.897 177.641 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.874 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.12 126.72 30.41 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.419 -0.8 . . . . 0.0 109.848 -178.515 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.63 163.62 25.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.0 -1.063 . . . . 0.0 109.36 179.467 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.44 49.44 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.051 -1.03 . . . . 0.0 110.433 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.62 143.34 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -62.55 106.17 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.74 -11.51 6.28 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CE2' HG13 ' A' ' 58' ' ' ILE . 3.9 m-85 -114.06 146.31 40.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.149 -1.206 . . . . 0.0 110.629 -179.617 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.715 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -84.17 142.27 30.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -0.911 . . . . 0.0 110.753 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.5 OUTLIER -98.61 95.01 6.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.535 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.781 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -81.16 152.1 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.785 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 127.92 -146.54 16.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 41' ' ' SER . 36.4 m-80 -120.73 53.26 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 110.128 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 28' ' ' THR . 71.3 p 28.03 48.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.774 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.603 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 156.94 125.49 0.87 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.673 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.895 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.0 t -71.48 179.45 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.502 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.86 92.61 2.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.648 -1.282 . . . . 0.0 111.247 179.55 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.598 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -79.47 106.97 11.88 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.407 178.125 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.522 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -135.11 103.51 5.58 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.226 -179.054 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.77 11.25 35.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.5 19.07 60.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' TRP . 9.1 mt-10 -139.16 91.4 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -1.153 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.607 ' CH2' HG23 ' A' ' 27' ' ' VAL . 70.7 m95 -43.3 135.88 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 p -147.64 166.29 27.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 111.048 -179.707 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 57.3 64.35 4.35 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.603 -0.686 . . . . 0.0 111.285 179.837 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.9 Cg_endo -92.72 145.65 2.55 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.992 1.795 . . . . 0.0 110.086 179.084 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.554 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 52.9 Cg_endo -84.28 176.79 6.29 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.7 1.369 . . . . 0.0 109.949 179.245 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.63 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 27.3 p -130.21 141.88 50.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 111.54 -179.53 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -100.51 88.52 3.66 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.584 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 51.6 mm-40 -120.36 -165.57 1.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.424 -178.314 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.723 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -115.4 104.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.04 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 81' ' ' TYR . 13.0 m -92.97 47.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 111.801 -178.199 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -88.65 97.7 11.26 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.345 178.586 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 36.0 m -69.55 162.51 66.55 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 112.12 -178.004 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 45.4 Cg_endo -71.61 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.651 1.869 . . . . 0.0 110.762 -179.73 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.42 ' CA ' ' HE1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -161.58 133.65 4.19 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.705 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.673 ' HA ' HD21 ' A' ' 113' ' ' LEU . 50.3 Cg_endo -78.01 65.26 8.34 Favored 'Trans proline' 0 C--N 1.293 -2.35 0 O-C-N 123.674 1.355 . . . . 0.0 109.784 -179.329 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.591 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -83.08 171.95 13.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.608 -0.682 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.67 166.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.522 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.45 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -75.28 109.94 9.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.534 -0.729 . . . . 0.0 111.0 -179.254 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.6 m-80 38.63 34.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.765 . . . . 0.0 110.844 179.299 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.771 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -143.68 30.36 1.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.58 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.3 p90 -45.66 -171.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.718 1.247 . . . . 0.0 112.479 -179.612 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.829 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.4 157.97 24.24 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.794 178.792 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.75 26.52 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.082 -179.181 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -73.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.669 -179.586 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.43 75.97 0.41 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.5 t80 -104.36 165.72 10.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.585 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -163.16 162.88 25.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -56.76 -35.86 69.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.92 179.936 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -139.83 167.35 22.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.988 179.698 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.555 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.0 m-85 -138.51 -173.93 3.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.735 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.8 m -169.39 106.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 111.283 -179.75 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.776 ' CB ' HG21 ' A' ' 59' ' ' VAL . 3.2 t80 46.31 15.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.154 -0.966 . . . . 0.0 112.686 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.721 ' C ' HG22 ' A' ' 102' ' ' THR . 17.1 t-20 -175.84 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 119.926 -1.734 . . . . 0.0 111.987 178.308 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 8.3 m-20 49.63 76.87 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.671 -1.268 . . . . 0.0 108.747 -178.027 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.646 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.5 p-10 -69.2 135.42 50.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 0.0 111.109 -178.689 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 64' ' ' PRO . 10.8 m -115.81 120.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.519 179.11 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t0 -85.15 130.71 34.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 108.651 179.436 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.829 ' CE1' HD12 ' A' ' 71' ' ' LEU . 67.6 m-85 -89.87 129.52 36.23 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.291 1.043 . . . . 0.0 112.567 -177.88 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -104.43 91.64 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.48 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.544 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -45.27 127.38 7.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.957 -1.09 . . . . 0.0 109.59 -179.736 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 15.8 mmtp -37.27 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.687 -0.633 . . . . 0.0 110.787 -179.097 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.586 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 17.6 t80 -158.99 136.12 9.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.544 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.67 44.68 97.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 28.3 m-85 -154.56 150.86 28.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.503 -0.998 . . . . 0.0 109.846 -179.338 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HG3' HG23 ' A' ' 117' ' ' VAL . 18.1 ptpt -116.98 126.46 52.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.674 179.529 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -56.69 112.95 1.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.758 -179.255 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.579 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -89.51 94.79 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.525 179.287 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.85 -39.17 1.42 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.4 OUTLIER 172.55 -178.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.155 -1.203 . . . . 0.0 111.037 -179.65 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 51.7 p -141.76 10.39 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 0.0 109.967 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -169.53 113.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.491 -0.755 . . . . 0.0 109.107 179.831 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.471 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 29.8 m -124.75 162.4 24.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.225 -0.922 . . . . 0.0 111.048 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.721 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.13 142.26 50.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 3.0 t -60.92 83.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.645 -0.66 . . . . 0.0 109.3 179.468 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.94 170.33 8.89 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.0 110.867 -179.245 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.773 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.0 Cg_endo -73.77 127.54 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.176 1.619 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.57 -11.43 5.75 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -179.055 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 14.0 m-20 82.0 76.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.068 -0.666 . . . . 0.0 110.39 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -169.87 -158.81 0.19 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.517 -0.739 . . . . 0.0 110.786 179.789 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.642 ' HB3' HD13 ' A' ' 113' ' ' LEU . 21.0 m95 -142.26 98.96 3.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.343 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 45.8 mttt -100.73 141.9 23.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 110.155 -179.597 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.548 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 49.2 Cg_endo -72.07 170.57 66.39 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.057 -2.059 . . . . 0.0 110.866 0.256 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.5 tt0 -40.28 125.8 2.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 110.114 179.853 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -41.08 141.32 1.02 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.431 -0.793 . . . . 0.0 110.032 -179.84 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.674 ' HG2' HD12 ' A' ' 66' ' ' ILE . 46.6 Cg_endo -80.26 166.87 20.1 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.467 1.772 . . . . 0.0 112.074 -178.38 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.66 ' HG2' HG13 ' A' ' 117' ' ' VAL . 11.0 ttpt -125.63 106.16 9.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.669 . . . . 0.0 109.977 179.53 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -58.7 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.016 . . . . 0.0 109.297 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.66 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.0 m -110.63 -171.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.936 0.874 . . . . 0.0 111.224 -179.438 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.216 0.532 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -115.55 161.97 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.559 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -131.43 81.93 2.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 110.57 -179.862 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.4 mt-30 -60.91 177.06 0.35 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.047 -1.033 . . . . 0.0 109.093 179.225 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.6 p -40.91 144.21 0.65 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 27' ' ' VAL . 44.4 Cg_endo -67.9 162.42 39.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.713 1.375 . . . . 0.0 110.893 -179.097 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.77 166.5 29.78 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.06 1.558 . . . . 0.0 110.118 179.702 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.04 176.07 5.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.179 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.597 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.25 -169.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.164 0.983 . . . . 0.0 111.544 179.934 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 11' ' ' ASN . 29.7 t -63.25 114.04 3.56 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.619 -178.665 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER 37.32 41.99 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.664 -0.647 . . . . 0.0 111.266 179.127 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.41 154.86 25.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.575 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -109.56 -179.41 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -1.188 . . . . 0.0 110.777 -179.825 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.617 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.0 p80 -139.29 -154.89 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 12.5 t30 66.53 -170.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.105 -179.898 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.16 -4.76 18.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -32.48 2.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -1.194 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.574 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 179.16 -176.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 0.0 110.291 -179.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 5' ' ' SER . 9.9 t70 -103.96 -25.07 13.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.596 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.6 m-85 -105.71 -174.81 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -178.71 -25.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.422 179.655 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 7.6 p 59.55 -94.36 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.588 -0.695 . . . . 0.0 112.661 178.839 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -148.17 159.38 44.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.646 -1.283 . . . . 0.0 110.582 -178.078 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 13.28 57.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.603 -0.94 . . . . 0.0 110.123 -179.867 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.0 t -155.69 155.75 5.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.579 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.696 HG11 ' HG3' ' A' ' 6' ' ' PRO . 21.6 t -139.34 125.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.886 -179.487 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.76 103.9 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.702 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.2 m-30 -68.09 121.31 15.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -177.937 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -75.67 153.57 37.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.998 . . . . 0.0 109.127 178.904 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 37' ' ' LEU . 79.9 m -121.02 170.54 9.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.692 -179.285 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -62.94 137.26 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -46.96 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 110.324 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 123.32 17.04 3.34 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 13.6 m-85 -125.8 141.1 52.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 110.18 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.662 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -85.24 142.13 29.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.944 . . . . 0.0 110.967 -179.455 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.702 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.0 tp -89.61 98.1 11.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.424 -0.798 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.767 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -86.47 141.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.312 -179.764 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.63 -172.48 14.63 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.654 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -64.5 145.25 56.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.07 179.863 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -76.22 53.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.615 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.5 115.37 0.62 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -54.73 -178.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.004 -1.292 . . . . 0.0 107.853 178.831 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.4 tp -146.19 99.32 3.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 110.217 178.681 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.79 109.18 16.71 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.644 179.103 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.88 107.98 10.07 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.82 8.48 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.895 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . 60.92 38.75 95.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 25.0 mt-10 -151.04 88.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 110.798 -179.582 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 78.5 m95 -50.68 136.99 20.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.339 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.79 162.22 36.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.958 -1.089 . . . . 0.0 111.507 -179.325 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.9 t0 58.57 66.09 2.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.8 Cg_endo -90.94 126.55 1.14 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 O-C-N 124.394 1.734 . . . . 0.0 109.753 178.774 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -74.24 165.53 31.66 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.864 1.455 . . . . 0.0 110.252 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 66.1 p -105.52 150.91 24.92 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.12 -0.988 . . . . 0.0 111.215 -179.444 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 57' ' ' GLN . 77.0 m -111.72 82.18 1.57 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 3.1 mm100 -115.4 -150.7 0.47 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.713 0.768 . . . . 0.0 110.738 -177.817 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.803 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.78 125.86 71.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.691 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 36' ' ' SER . 31.0 m -115.68 50.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 0.0 112.08 -178.163 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 30.6 mttt -59.51 -173.31 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 117.739 -1.584 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.529 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -146.0 170.12 8.48 Favored Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.948 -178.724 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.529 ' HD2' ' SG ' ' A' ' 61' ' ' CYS . 45.3 Cg_endo -92.19 -72.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.396 2.064 . . . . 0.0 109.848 179.226 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.18 125.42 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.718 -0.614 . . . . 0.0 109.674 -179.636 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.599 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.6 Cg_endo -78.36 71.07 6.95 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 123.81 1.426 . . . . 0.0 110.172 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.685 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -89.91 171.69 9.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.925 179.915 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.804 HG21 ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -170.84 155.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.057 -1.027 . . . . 0.0 110.266 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 35.5 t -61.45 107.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.751 . . . . 0.0 111.014 -179.357 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 3.3 m-20 39.95 37.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 0.0 110.682 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.587 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -143.48 27.15 2.11 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' HG23 ' A' ' 66' ' ' ILE . 2.0 p90 -44.32 -174.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.737 1.256 . . . . 0.0 112.362 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.739 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.18 164.38 12.93 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.58 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -144.77 20.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 110.039 -179.626 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -103.02 -79.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 110.856 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.27 77.35 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -106.12 168.54 9.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.45 -1.029 . . . . 0.0 110.021 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -171.87 155.58 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 110.262 -179.851 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -52.07 -27.42 13.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.752 179.659 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.52 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 4.4 t -143.59 163.02 34.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.244 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.576 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 21.2 m-85 -137.35 -148.54 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 93.8 p -154.34 -113.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.813 -1.18 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -107.88 12.35 27.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.556 -1.34 . . . . 0.0 110.67 -178.922 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.788 ' C ' HG22 ' A' ' 102' ' ' THR . 12.5 t-20 -162.25 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.808 -1.183 . . . . 0.0 110.179 179.471 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ASN . 31.8 t0 43.26 76.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.726 -1.234 . . . . 0.0 108.955 -179.48 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.843 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.3 p30 -68.35 126.96 31.23 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 110.664 -178.385 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.579 HG11 ' HG3' ' A' ' 64' ' ' PRO . 15.9 m -109.73 119.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.194 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 6.4 t0 -82.56 134.12 35.19 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.804 ' CD1' HG21 ' A' ' 66' ' ' ILE . 39.3 m-85 -92.5 131.8 37.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.956 -1.09 . . . . 0.0 112.252 -178.022 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.83 90.43 3.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.905 -179.944 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.548 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.26 129.46 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.65 179.984 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -38.14 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.521 -0.737 . . . . 0.0 110.637 -179.28 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -157.22 131.99 8.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.965 . . . . 0.0 110.157 179.911 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.21 56.08 27.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.635 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 24.5 m-85 -161.05 148.46 15.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.854 -179.356 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 6.5 tttm -106.25 138.9 41.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.906 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 66' ' ' ILE . 1.3 mt -76.02 93.5 3.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.409 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.536 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -69.84 100.32 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 0.0 109.666 179.6 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.24 -97.17 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.591 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 t -148.41 114.98 5.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -1.204 . . . . 0.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 90.7 p -72.87 0.48 10.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.934 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -145.63 100.13 3.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.91 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 85' ' ' VAL . 19.7 m -115.78 167.63 10.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.623 -179.566 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.843 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.38 144.15 44.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.557 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 10.2 t -75.95 89.31 2.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 110.253 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' CD ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -65.74 179.89 0.41 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 111.327 -179.622 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.739 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.3 Cg_endo -75.32 125.79 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.271 1.669 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.99 -1.83 13.25 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 108' ' ' THR . 7.0 m-80 78.31 96.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.813 -0.816 . . . . 0.0 110.835 179.68 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -175.82 -166.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.086 179.556 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.635 ' HB3' HD13 ' A' ' 113' ' ' LEU . 19.5 m95 -151.64 91.24 1.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.373 0.606 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -115.25 157.78 42.89 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.498 179.739 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.591 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 39.8 Cg_endo -70.8 171.8 56.31 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.01 -2.079 . . . . 0.0 111.85 0.379 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.2 pm0 -23.49 119.02 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.451 0.643 . . . . 0.0 112.624 -178.798 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.635 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.4 tp -45.82 137.28 5.95 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 109.014 178.585 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.607 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 42.8 Cg_endo -70.5 165.78 30.69 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 123.887 1.467 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.659 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -133.56 108.65 8.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -61.1 89.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.659 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.8 m -106.59 -167.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.839 0.828 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 7.7 mtm180 . . . . . 0 C--N 1.291 -1.969 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.293 0.568 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' A' ' 22' ' ' THR . 14.3 mttt -93.63 174.83 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.363 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -136.48 92.9 2.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.873 . . . . 0.0 110.212 179.844 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -67.47 170.8 6.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.297 179.518 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.45 143.45 1.11 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.847 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.862 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.9 Cg_endo -70.86 152.45 63.6 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.988 1.52 . . . . 0.0 110.741 -179.207 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.38 170.27 20.61 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.747 1.393 . . . . 0.0 109.865 179.416 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.68 176.3 3.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 109.813 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.684 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.54 -169.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 122.168 0.985 . . . . 0.0 111.498 179.838 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 7.9 t -40.62 92.66 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.536 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 9' ' ' ILE . 12.1 m120 42.63 45.94 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.49 178.42 19.99 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 180.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.531 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER -126.25 -169.33 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -1.202 . . . . 0.0 110.695 -179.915 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.613 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p80 -157.9 125.36 5.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.898 -0.502 . . . . 0.0 110.512 -179.41 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.39 -33.82 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 44.4 -122.43 4.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.59 -0.79 2.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -1.16 . . . . 0.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 7.4 pt-20 -164.12 -167.35 1.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.491 -179.811 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.28 19.31 2.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.88 . . . . 0.0 110.589 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.42 45.43 2.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.007 -1.058 . . . . 0.0 110.441 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 23.2 m-85 -58.26 179.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.642 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.562 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 2.2 p -147.14 -61.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 111.045 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -163.37 137.37 5.93 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.53 15.04 80.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.552 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.608 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.73 175.3 6.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.948 . . . . 0.0 109.543 179.81 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.8 t -149.22 154.11 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.993 -179.756 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.862 HG11 ' HG3' ' A' ' 6' ' ' PRO . 24.3 t -134.24 122.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.252 -179.739 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.33 103.31 4.67 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.315 -1.354 . . . . 0.0 108.015 177.805 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.991 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.45 176.57 2.79 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.763 -178.487 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.5 t -130.79 -177.15 4.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.839 179.616 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 91.0 m -147.72 135.38 20.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.0 109.616 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.472 ' O ' ' OG ' ' A' ' 33' ' ' SER . 6.5 m120 -99.52 -177.87 3.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 110.744 -179.527 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 6.0 p 44.76 56.77 4.99 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.707 0.765 . . . . 0.0 110.278 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 43.46 49.63 6.94 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 33' ' ' SER . 4.5 m-30 -102.4 131.78 48.83 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.915 -1.344 . . . . 0.0 111.164 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.831 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -74.59 138.52 43.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.742 -0.599 . . . . 0.0 110.679 -179.792 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.587 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.7 tt -89.44 109.66 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.128 -0.983 . . . . 0.0 109.453 178.986 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.815 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -103.02 143.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.468 -179.988 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.41 -141.1 11.41 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 41' ' ' SER . 27.6 t30 -111.42 52.39 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.239 . . . . 0.0 109.907 179.462 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.526 ' O ' HG23 ' A' ' 28' ' ' THR . 27.7 p 22.67 49.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.749 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 157.11 119.33 0.59 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.991 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.3 t -65.51 -179.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.254 . . . . 0.0 108.176 179.198 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.571 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -144.88 97.74 3.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.32 179.048 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.596 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 18.4 t -79.79 126.25 30.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.225 178.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.6 p -129.68 110.18 11.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.226 -179.865 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.35 22.51 62.56 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.91 8.11 76.64 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.8 114.59 22.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -1.174 . . . . 0.0 110.538 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.662 ' CH2' HG23 ' A' ' 27' ' ' VAL . 79.8 m95 -69.9 134.81 48.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.787 179.539 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.19 168.36 20.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 111.025 -179.716 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 15.6 t0 54.07 66.27 4.53 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.734 -0.604 . . . . 0.0 111.047 179.802 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -90.6 138.28 2.56 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.38 1.726 . . . . 0.0 110.154 179.349 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.2 Cg_endo -75.31 175.8 10.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.839 1.442 . . . . 0.0 110.591 179.938 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.8 p -111.23 -175.24 2.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.832 . . . . 0.0 111.359 -179.019 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 33.6 m -142.51 75.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.859 0.837 . . . . 0.0 108.803 178.839 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -108.6 -148.67 0.43 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.728 -179.146 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.808 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -125.99 121.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.049 . . . . 0.0 108.632 179.347 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 36' ' ' SER . 20.4 m -114.68 49.46 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.025 -1.047 . . . . 0.0 112.324 -178.197 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -60.55 -172.24 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 C-N-CA 117.779 -1.569 . . . . 0.0 107.519 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.497 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -147.95 166.73 15.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 117.84 -1.544 . . . . 0.0 113.979 -178.296 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.0 Cg_endo -87.84 -74.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 125.02 2.063 . . . . 0.0 110.618 179.551 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 166.12 125.4 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.074 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.891 ' HG2' HD21 ' A' ' 71' ' ' LEU . 48.1 Cg_endo -75.36 65.64 6.37 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.629 1.331 . . . . 0.0 109.455 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.576 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -82.48 175.93 9.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 110.311 -179.536 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.994 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -171.99 167.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 110.404 -179.623 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 46.5 p -72.81 100.39 2.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 110.55 -179.674 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 88.5 m-20 42.85 49.09 5.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.815 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.994 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -161.86 38.52 0.39 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.613 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 49.4 p90 -47.0 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.101 1.429 . . . . 0.0 113.141 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.919 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -139.06 127.18 22.51 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.682 -176.948 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.6 t -103.89 16.88 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.494 -0.754 . . . . 0.0 110.087 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.65 101.37 6.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.161 -0.962 . . . . 0.0 111.538 -179.008 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.673 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 71.84 103.42 0.06 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.643 ' CD2' HD11 ' A' ' 71' ' ' LEU . 7.8 t80 -156.92 154.11 29.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -1.085 . . . . 0.0 110.266 179.431 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 1.1 tttm -161.35 147.96 14.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' LYS . 29.8 mtm180 -42.47 -37.01 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.055 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -131.9 165.03 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 110.118 179.835 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 22.8 m-85 -137.04 -142.87 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.556 ' C ' HG23 ' A' ' 59' ' ' VAL . 55.6 p -156.48 -117.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.951 -1.093 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.585 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.22 11.65 32.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.752 -1.218 . . . . 0.0 111.845 -178.664 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.787 ' C ' HG22 ' A' ' 102' ' ' THR . 0.5 OUTLIER -163.64 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.642 -1.286 . . . . 0.0 110.72 178.938 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 82' ' ' ASN . 7.6 m-20 42.41 74.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.723 -1.236 . . . . 0.0 109.272 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.701 ' CA ' HG23 ' A' ' 102' ' ' THR . 47.4 t30 -68.82 121.91 17.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.614 -178.664 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 74' ' ' GLY . 29.0 m -106.44 123.14 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.844 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -80.24 139.34 36.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.336 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.675 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 32.0 m-85 -95.15 143.25 26.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 112.38 -177.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.37 98.18 6.6 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 -179.857 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.524 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -50.22 134.98 22.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.397 -179.639 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.39 -69.84 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.784 . . . . 0.0 110.402 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 23.5 t80 -172.19 141.71 1.3 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.304 -0.873 . . . . 0.0 110.391 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 47.71 15.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 11.1 m-85 -149.23 150.0 31.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -1.019 . . . . 0.0 109.803 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' VAL . 4.8 mtmt -103.3 143.37 32.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER -85.09 92.38 8.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 110.187 -179.956 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 105.02 10.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.3 -79.83 0.24 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.227 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.574 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 24.9 p -159.7 99.27 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -1.092 . . . . 0.0 110.922 -179.191 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.41 47.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.073 -1.017 . . . . 0.0 109.591 179.203 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 p -140.63 108.45 5.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.551 179.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 2.8 m -123.67 167.67 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.215 -0.928 . . . . 0.0 111.16 -179.238 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.787 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -134.48 145.19 48.58 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.782 0.801 . . . . 0.0 110.339 179.617 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -82.24 80.13 8.53 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.827 -0.546 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.528 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -58.4 -177.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 111.358 -179.212 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.815 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -77.37 125.42 7.71 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.386 1.73 . . . . 0.0 110.211 -179.707 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.26 -8.37 7.07 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.715 ' O ' HG23 ' A' ' 108' ' ' THR . 4.8 m-20 79.47 94.7 0.06 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.749 -0.853 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.49 -166.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.832 . . . . 0.0 111.092 179.445 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.669 ' HB3' HD11 ' A' ' 113' ' ' LEU . 38.0 m95 -144.04 87.69 1.92 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.539 0.685 . . . . 0.0 109.729 -179.845 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -100.26 140.81 21.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.658 -179.238 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.574 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.0 Cg_endo -74.83 170.93 70.31 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.555 -2.269 . . . . 0.0 110.039 -0.231 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 11.8 pt-20 -36.75 137.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.562 -0.712 . . . . 0.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.759 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -46.76 157.86 0.44 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.846 . . . . 0.0 109.799 179.511 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.77 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -79.95 165.51 21.87 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 124.206 1.635 . . . . 0.0 111.126 -179.715 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.729 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.0 ttmt -124.36 104.53 8.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.3 t -60.34 83.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.356 179.623 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.729 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.8 m -95.77 -175.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.87 0.843 . . . . 0.0 110.808 -179.6 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.556 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.81 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.442 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . 0.675 HG21 ' C ' ' A' ' 47' ' ' GLY . 9.6 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.231 0.539 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 20' ' ' PHE . 3.9 ttmt -132.88 172.13 13.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.367 -179.734 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.576 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 10.4 t -163.81 136.14 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 110.102 -179.918 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' SER . 6.5 pt20 -117.2 -176.71 3.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -40.3 142.38 0.74 Allowed Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.273 -179.999 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.795 ' HG3' HG11 ' A' ' 27' ' ' VAL . 55.4 Cg_endo -71.68 167.37 26.69 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 124.143 1.601 . . . . 0.0 110.647 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.03 171.86 15.01 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.797 1.419 . . . . 0.0 108.756 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -78.18 104.96 9.1 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.893 -1.13 . . . . 0.0 110.616 -179.563 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.824 HG21 ' CG ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -42.64 173.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.9 0.857 . . . . 0.0 110.012 -179.904 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' HG13 ' A' ' 9' ' ' ILE . 34.5 m -99.86 140.92 33.38 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.604 -1.238 . . . . 0.0 109.697 178.293 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 6.8 m120 63.37 17.06 10.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.731 -179.02 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -167.05 -164.52 22.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' SER . 7.2 mtp180 -140.39 -171.81 3.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -1.135 . . . . 0.0 110.566 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 7.9 p80 -148.11 133.34 18.41 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.812 -0.555 . . . . 0.0 110.37 -179.937 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 14' ' ' HIS . 3.1 m-20 -167.01 75.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -101.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.917 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -175.84 38.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -1.15 . . . . 0.0 109.793 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -154.48 -169.38 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.332 -179.665 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 -37.97 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.555 ' CE1' ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -111.72 118.75 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.652 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -104.36 -12.78 16.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 110.429 -179.741 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.548 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 p 45.45 -96.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.921 . . . . 0.0 111.867 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -148.47 154.01 39.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 0.0 110.115 -178.588 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.2 19.64 79.69 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.232 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.652 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 7.1 m -98.34 171.1 8.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.695 -0.885 . . . . 0.0 110.212 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 43' ' ' VAL . 38.9 t -147.87 155.29 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.176 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.795 HG11 ' HG3' ' A' ' 6' ' ' PRO . 13.1 t -134.12 111.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.639 -179.132 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 103.25 1.52 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.461 -1.296 . . . . 0.0 107.738 178.085 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.824 ' CG ' HG21 ' A' ' 9' ' ' ILE . 1.3 m-30 -68.02 -176.55 0.71 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.998 -178.435 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -133.99 155.3 50.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.291 179.057 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.1 m -126.41 139.72 53.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.561 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' SER . 31.9 m-20 -83.49 174.35 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.0 110.392 179.905 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.497 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 28.8 t 42.31 -165.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.137 179.211 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.84 2.66 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 33' ' ' SER . 12.0 m-85 -89.08 107.76 19.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.95 -1.324 . . . . 0.0 111.185 -179.419 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -60.39 139.68 57.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 0.0 110.357 179.281 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.665 HD21 ' HA ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -84.38 102.19 12.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.316 179.078 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -94.3 150.95 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 108.991 179.785 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.31 -143.43 14.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.223 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 3.3 m120 -114.58 49.62 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -1.23 . . . . 0.0 109.837 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.665 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER 25.21 62.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.941 179.505 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 141.88 115.22 1.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.593 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.723 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -58.45 -178.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.522 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.3 tp -142.88 105.8 4.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.005 -1.06 . . . . 0.0 110.097 178.458 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.2 t -88.29 109.4 19.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.9 m -126.77 126.06 42.79 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.13 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.675 ' C ' HG21 ' A' ' 1' ' ' VAL . . . 70.45 28.62 70.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.54 26.44 73.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.03 115.4 12.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 110.174 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.628 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.8 m95 -76.58 136.28 39.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.862 179.812 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.73 171.76 19.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 110.998 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.533 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 53.67 64.73 6.35 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.872 -0.518 . . . . 0.0 111.212 179.77 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -91.99 145.28 2.96 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.958 1.772 . . . . 0.0 109.841 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.4 Cg_endo -79.44 174.9 11.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.731 1.385 . . . . 0.0 110.11 179.53 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.59 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 14.4 p -114.39 -177.31 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 111.13 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.751 ' SG ' HD11 ' A' ' 9' ' ' ILE . 84.7 m -140.57 73.42 1.42 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.019 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -116.52 177.57 4.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.736 -178.975 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' CD ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -88.94 145.15 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.1 179.719 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.655 HG21 ' CB ' ' A' ' 81' ' ' TYR . 29.0 m -129.93 40.96 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.371 -179.128 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.572 ' CD ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -78.87 101.21 7.56 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.429 179.843 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 50.2 m -73.04 162.71 73.23 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.454 -0.778 . . . . 0.0 111.253 -178.913 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.3 Cg_endo -70.82 -89.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.359 1.715 . . . . 0.0 110.628 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -172.25 133.42 0.76 Allowed Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.643 ' HA ' HD21 ' A' ' 113' ' ' LEU . 58.0 Cg_endo -86.7 83.8 1.09 Allowed 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 123.69 1.363 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 66' ' ' ILE . 4.1 p -100.7 -42.38 6.53 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.39 1.091 . . . . 0.0 110.288 -178.954 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.785 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 48.86 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.927 -179.216 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.533 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 49.6 m -69.32 107.61 3.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 111.666 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 27.6 m120 38.06 43.78 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.0 111.77 178.438 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -126.6 -44.08 0.25 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.805 -1.664 . . . . 0.0 109.903 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 23.3 p90 41.35 -174.61 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 122.639 1.209 . . . . 0.0 111.827 -179.13 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.883 HD13 ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.63 153.62 50.89 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.239 -179.243 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -13.88 12.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.888 -1.133 . . . . 0.0 110.287 -178.78 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 40.9 t -51.41 -54.44 26.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.19 106.6 0.21 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.81 -177.34 3.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.962 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 27.5 tttm -159.68 168.75 25.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.55 -0.719 . . . . 0.0 109.89 -179.585 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.0 mtp85 -65.86 -39.25 90.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.981 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 m -139.64 126.21 20.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CD2' ' CH2' ' A' ' 109' ' ' TRP . 60.4 m-85 -95.32 -175.99 3.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 29.0 t -170.47 96.87 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.301 179.941 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CB ' HG21 ' A' ' 59' ' ' VAL . 2.2 t80 52.06 125.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.381 -0.825 . . . . 0.0 110.664 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.712 ' O ' HG22 ' A' ' 102' ' ' THR . 13.7 t-20 73.51 -128.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.941 -1.1 . . . . 0.0 110.381 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 71.08 0.54 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.701 -1.249 . . . . 0.0 109.11 -178.451 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.542 ' N ' HG23 ' A' ' 102' ' ' THR . 10.6 t30 -70.39 142.17 52.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.533 -0.73 . . . . 0.0 111.093 -178.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.78 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -129.57 120.01 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.328 -0.858 . . . . 0.0 110.072 179.002 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -84.29 124.17 30.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 178.966 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.789 ' CE1' HD12 ' A' ' 71' ' ' LEU . 50.2 m-85 -80.94 136.38 36.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.316 1.055 . . . . 0.0 112.527 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -114.76 86.1 2.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.439 -179.643 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.585 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.68 128.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 0.0 110.795 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 15.1 mmtt -38.95 -84.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.538 -0.726 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 19.0 t80 -160.58 149.6 16.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.12 -0.987 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.49 31.46 14.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.6 m-85 -142.65 146.12 34.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.501 -0.999 . . . . 0.0 110.234 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.73 135.07 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.885 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.707 HD23 HD11 ' A' ' 66' ' ' ILE . 5.5 mt -67.24 111.06 3.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.524 -179.702 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.467 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.19 106.62 18.31 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.136 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -90.38 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -149.0 120.39 7.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -1.15 . . . . 0.0 110.538 -179.474 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 p -80.15 4.8 16.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 0.0 110.905 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -144.9 115.81 7.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 110.093 179.719 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 17.5 m -126.82 -175.53 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.699 -179.714 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 82' ' ' ASN . 13.9 m -157.24 134.4 10.34 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.114 -178.926 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.584 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 6.2 t -59.72 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.877 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.21 172.38 9.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.767 ' HB3' HD12 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -74.85 123.74 8.19 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.334 1.702 . . . . 0.0 110.925 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.2 -7.61 5.07 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.9 m120 81.12 77.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.971 -0.723 . . . . 0.0 110.384 179.83 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -174.4 -168.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.852 . . . . 0.0 111.612 179.82 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.78 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 22.5 m95 -134.37 100.65 4.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 -179.691 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 102' ' ' THR . 2.7 mttm -102.71 149.12 36.46 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.216 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.9 Cg_endo -75.28 -174.58 14.48 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.906 -2.123 . . . . 0.0 110.551 -0.371 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.1 tp10 -39.13 117.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.341 0.591 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 109' ' ' TRP . 1.8 tp -43.74 141.94 2.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.825 . . . . 0.0 110.785 -179.694 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.785 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.7 Cg_endo -72.31 167.05 27.95 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.085 1.571 . . . . 0.0 110.502 179.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -132.33 95.33 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.923 . . . . 0.0 110.525 179.879 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.7 t -46.62 102.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.073 -1.017 . . . . 0.0 109.135 179.475 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -113.58 -178.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.729 0.775 . . . . 0.0 111.083 -179.135 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.162 0.506 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -162.58 171.5 16.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.535 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -130.55 151.96 50.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 41.6 mt-30 -134.03 174.7 10.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.072 -1.018 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.25 130.69 7.62 Favored Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.612 ' HG2' ' CG ' ' A' ' 14' ' ' HIS . 48.8 Cg_endo -70.46 158.83 54.88 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.944 1.497 . . . . 0.0 110.77 -179.752 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.05 175.14 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.014 1.534 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' ILE . 88.7 p -85.75 99.21 11.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.133 179.906 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.0 -170.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.381 1.086 . . . . 0.0 111.917 -179.664 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 9' ' ' ILE . 1.9 p -37.48 95.79 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.012 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 41.03 29.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 110.758 179.682 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -119.32 174.32 15.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.507 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 1.6 mtt85 -113.53 -168.49 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 15.3 p80 -158.94 119.45 3.22 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.321 0.581 . . . . 0.0 110.265 -179.899 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.699 ' O ' HG13 ' A' ' 27' ' ' VAL . 3.6 m-80 -107.11 -162.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.634 -179.621 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 18' ' ' GLU . . . 147.3 -20.67 1.54 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.986 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.12 34.78 16.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -1.132 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.611 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 38.2 mm-40 -121.43 -155.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.004 179.721 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -153.36 -39.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.617 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 7.8 p90 -143.48 80.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.707 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 25.7 m-85 -49.75 -179.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.052 -1.03 . . . . 0.0 110.112 179.938 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.535 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -142.61 -68.56 0.36 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.616 -1.303 . . . . 0.0 111.183 -179.07 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -156.86 141.42 16.76 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 109.757 -178.954 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 69.27 7.97 58.21 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.843 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 26' ' ' VAL . 40.5 m -71.31 174.91 5.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.11 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 36.3 t -156.77 157.63 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 15' ' ' ASN . 34.0 t -144.68 121.26 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.102 -179.655 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.46 101.88 3.06 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.869 178.249 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.672 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.99 154.93 40.59 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.414 -0.804 . . . . 0.0 110.136 -178.31 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.507 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.7 t -114.37 -177.14 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.021 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 57.4 m -146.9 149.89 34.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.25 149.97 5.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -54.34 107.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 179.968 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.1 10.05 9.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.948 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 4.4 m-85 -124.24 120.86 33.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.725 -179.693 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.616 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -73.05 138.2 45.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.428 179.678 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.9 tp -90.42 98.57 11.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.139 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -92.05 170.39 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.096 179.414 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 83.93 -178.82 52.14 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.684 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.19 121.66 15.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -1.141 . . . . 0.0 109.943 179.917 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.696 ' O ' HG23 ' A' ' 28' ' ' THR . 6.2 t -73.11 53.4 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.491 -179.755 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 174.78 88.08 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.336 179.892 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -45.32 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.316 -1.108 . . . . 0.0 108.935 179.45 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 25' ' ' SER . 6.3 tp -139.69 106.18 5.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 110.151 178.809 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.61 107.54 14.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.138 -0.976 . . . . 0.0 109.771 179.595 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -129.16 121.33 27.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -7.4 80.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.6 16.37 8.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -144.69 138.17 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -1.14 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 99.8 m95 -77.92 136.39 38.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.878 179.696 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t -132.12 163.88 27.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.476 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 27.8 m-20 51.09 66.7 5.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.808 -0.558 . . . . 0.0 111.191 179.681 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -90.42 137.88 2.57 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 124.399 1.736 . . . . 0.0 109.733 179.123 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.1 Cg_endo -75.68 178.02 7.93 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.664 1.35 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.581 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.5 p -118.92 147.04 44.45 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 0.0 112.072 -178.635 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 92.4 m -110.37 76.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.317 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.04 178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.457 0.646 . . . . 0.0 110.392 -178.575 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.548 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -91.38 134.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.053 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 81' ' ' TYR . 28.2 m -119.8 43.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -178.992 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 25.4 mttt -80.06 97.66 6.92 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 119.406 -0.917 . . . . 0.0 108.904 179.5 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 60.2 m -69.06 161.88 69.39 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -178.607 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.1 Cg_endo -72.08 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.503 1.791 . . . . 0.0 110.34 -179.638 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.457 ' O ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -157.46 131.55 4.99 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.593 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.605 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.1 Cg_endo -76.91 66.18 7.65 Favored 'Trans proline' 0 C--N 1.297 -2.132 0 O-C-N 123.725 1.382 . . . . 0.0 109.888 -178.906 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.737 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -87.87 -174.65 4.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.547 -0.72 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.737 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 178.32 166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.355 179.471 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.3 OUTLIER -69.8 96.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.746 -179.594 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.7 m-20 48.72 40.49 16.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.925 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -146.3 28.58 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.6 p90 -45.15 -175.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.641 1.21 . . . . 0.0 112.346 -179.08 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.712 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.5 162.12 15.45 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.347 179.527 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t -144.66 22.74 1.62 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.971 -1.08 . . . . 0.0 110.449 -179.094 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.9 t -100.12 -82.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.698 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.44 75.88 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.711 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -95.88 157.99 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -1.05 . . . . 0.0 109.592 179.554 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.552 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -147.6 168.41 22.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 110.667 -179.636 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -76.3 -35.55 58.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.971 179.798 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 p -124.88 131.82 53.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.716 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.583 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 89.8 m-85 -112.5 170.79 7.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.512 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 81' ' ' TYR . 92.6 p -165.39 91.2 0.51 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 179.9 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.652 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.0 t80 52.42 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.815 0.817 . . . . 0.0 110.44 -179.47 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.774 ' O ' HG22 ' A' ' 102' ' ' THR . 15.3 t-20 65.33 -127.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.487 -1.383 . . . . 0.0 110.094 -179.215 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 6.2 m-20 51.82 73.92 0.29 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.622 -1.299 . . . . 0.0 109.044 -178.54 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 101' ' ' SER . 6.0 t30 -72.28 146.42 47.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.519 -0.738 . . . . 0.0 111.351 -178.703 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.744 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -132.16 124.27 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 109.553 179.021 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.8 t0 -83.82 124.23 30.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.995 -1.065 . . . . 0.0 109.48 179.643 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.679 ' HD2' HG21 ' A' ' 66' ' ' ILE . 8.4 m-85 -87.11 120.65 28.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.182 -0.949 . . . . 0.0 111.56 -178.651 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -95.75 94.93 7.97 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.169 179.932 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -44.37 125.36 4.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.07 -1.019 . . . . 0.0 109.488 179.78 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.554 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 4.9 mmtp -35.85 -67.33 0.16 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.672 -0.643 . . . . 0.0 111.001 -178.938 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 36.3 t80 -173.6 144.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.595 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.37 47.37 11.49 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -149.83 153.87 37.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -1.027 . . . . 0.0 109.899 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' CG ' HG23 ' A' ' 117' ' ' VAL . 4.4 ptpt -113.99 130.11 56.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -66.66 93.21 0.24 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.603 -179.455 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.659 ' HB2' HG21 ' A' ' 117' ' ' VAL . 2.4 t -74.61 103.85 5.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.61 179.508 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.54 -77.76 0.3 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.826 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.562 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -172.47 116.1 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.16 . . . . 0.0 110.454 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.576 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -67.78 -77.22 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.87 . . . . 0.0 110.637 -179.944 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 100' ' ' SER . 5.0 p -68.82 104.99 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.792 -179.219 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.4 m -107.41 -170.75 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.906 179.538 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 82' ' ' ASN . 7.8 m -161.49 138.12 8.39 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.289 -178.966 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.653 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.5 t -59.49 105.64 0.38 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 179.78 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.458 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.96 168.16 16.3 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.814 -179.464 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.783 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.1 Cg_endo -76.32 126.91 9.44 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.418 1.747 . . . . 0.0 110.632 -179.519 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 122.41 3.84 9.32 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.287 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.848 ' O ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER 77.3 83.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.756 -0.849 . . . . 0.0 110.635 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.04 -168.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 111.81 179.628 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.744 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 33.8 m95 -134.08 95.07 3.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 110.289 -179.601 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -98.95 143.79 27.01 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.614 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.67 172.63 58.18 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.837 -2.151 . . . . 0.0 110.616 -0.634 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 39.4 tt0 -39.1 128.2 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 0.0 111.263 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.41 152.16 0.28 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 0.0 109.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CG ' ' CD2' ' A' ' 87' ' ' PHE . 39.7 Cg_endo -82.87 167.5 14.46 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 O-C-N 124.301 1.685 . . . . 0.0 111.119 -179.362 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.557 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.0 ttpt -126.71 108.04 10.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.819 179.66 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.3 t -64.24 74.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.659 HG21 ' HB2' ' A' ' 96' ' ' SER . 3.7 m -90.52 -175.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.771 0.796 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.606 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.6 ppt_? . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.481 179.412 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.18 178.57 3.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.871 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -135.39 127.82 30.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.985 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 35.8 mt-30 -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.154 179.254 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -43.37 142.93 1.56 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.042 -1.036 . . . . 0.0 110.461 -179.479 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.634 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.5 Cg_endo -73.5 160.23 44.79 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.191 1.627 . . . . 0.0 110.532 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.5 171.59 17.83 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.522 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.33 98.89 10.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 109.865 179.706 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.611 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -51.4 -170.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.389 1.09 . . . . 0.0 111.944 -179.17 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 5.3 p -58.49 122.79 14.21 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.68 -178.887 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . 2.0 m-20 33.6 34.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.996 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.53 162.58 26.93 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.529 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -111.8 -171.46 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -1.197 . . . . 0.0 110.934 -179.65 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.634 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.1 p80 -154.19 123.99 6.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.886 -0.509 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.9 -158.46 0.86 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.654 -179.621 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' OE2' ' A' ' 18' ' ' GLU . . . 138.35 -7.02 3.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 66.93 58.73 0.58 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -1.152 . . . . 0.0 110.186 -179.942 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -137.22 -69.42 0.46 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.28 -0.887 . . . . 0.0 109.821 -179.84 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 2.7 m-20 68.32 18.01 9.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.614 -0.679 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -170.53 50.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.049 -1.032 . . . . 0.0 110.595 179.761 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.809 ' O ' HG23 ' A' ' 22' ' ' THR . 9.7 m-85 -55.59 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.139 179.389 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 21' ' ' TYR . 1.9 p -161.95 -69.22 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.823 -1.173 . . . . 0.0 111.2 -179.959 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.5 t70 -164.16 138.31 5.55 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.048 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.81 12.21 83.08 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.737 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -86.19 169.27 13.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.975 . . . . 0.0 109.951 179.947 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 43' ' ' VAL . 92.6 t -143.59 151.19 16.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.615 178.596 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.652 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 30.0 t -136.59 120.37 23.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.311 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.41 101.41 4.78 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.025 -1.47 . . . . 0.0 107.579 177.989 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 1.5 m-30 -67.55 127.28 32.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.622 -178.418 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -74.75 169.3 18.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 179.615 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -140.13 134.15 30.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' SER . 1.7 m120 -43.46 116.23 0.91 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.571 179.581 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ASN . 10.6 m -38.65 113.13 0.27 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.639 -179.443 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.34 -26.11 6.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.601 ' CE2' HG13 ' A' ' 58' ' ' ILE . 2.8 m-85 -91.8 144.86 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -1.142 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.929 ' HB2' HG22 ' A' ' 59' ' ' VAL . 48.2 t -81.88 119.8 24.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 111.114 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tp -79.48 106.63 11.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.071 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -98.79 152.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.955 . . . . 0.0 109.14 -179.63 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 104.89 -177.91 23.58 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.806 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 42' ' ' GLY . 23.7 p-10 -67.98 131.73 46.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.697 179.571 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.768 ' O ' HG23 ' A' ' 28' ' ' THR . 24.5 p -73.17 56.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.79 179.91 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 26' ' ' VAL . . . 165.52 96.13 0.11 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.646 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -48.55 177.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.156 . . . . 0.0 108.054 179.38 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.3 tp -143.51 99.16 3.37 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.962 -1.086 . . . . 0.0 110.249 178.777 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.0 t -80.5 121.18 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.39 178.744 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.23 126.88 41.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.694 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 62.33 25.94 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.905 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.4 31.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.889 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -140.69 119.27 12.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.604 ' CD2' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -77.36 136.29 38.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.629 179.696 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -141.45 160.01 41.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 111.412 -179.33 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.7 t0 53.84 65.84 5.07 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.923 -0.486 . . . . 0.0 111.521 179.332 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.1 Cg_endo -91.26 129.95 1.31 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 124.378 1.725 . . . . 0.0 109.265 178.516 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 44.8 Cg_endo -72.16 166.02 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.574 1.302 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.606 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 24.8 p -104.33 -174.59 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.189 0.995 . . . . 0.0 111.612 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.6 t -146.16 74.6 1.38 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.532 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.22 -170.5 1.67 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.331 -178.459 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.677 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -111.5 86.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.933 HG21 ' CB ' ' A' ' 81' ' ' TYR . 20.1 m -76.03 51.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 111.368 -179.115 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -55.22 175.78 0.06 Allowed 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 117.671 -1.612 . . . . 0.0 107.831 179.305 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 66.9 m -134.24 142.58 43.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.16 -178.305 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 41.8 Cg_endo -74.61 -83.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.491 1.785 . . . . 0.0 110.486 179.439 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.573 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER 177.58 126.19 0.19 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.539 -0.726 . . . . 0.0 109.251 -179.559 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.779 ' HG2' HD21 ' A' ' 71' ' ' LEU . 50.5 Cg_endo -77.13 57.54 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.788 1.415 . . . . 0.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.66 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.76 166.11 23.51 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.47 0.652 . . . . 0.0 110.593 -179.673 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 1.006 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -166.33 167.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.171 179.504 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 116' ' ' CYS . 1.7 t -76.34 113.13 13.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 110.78 -179.403 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.541 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 72.9 m-20 36.21 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.675 -0.641 . . . . 0.0 111.401 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.006 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.32 38.09 1.26 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.008 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.638 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.1 p90 -44.85 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 123.438 1.589 . . . . 0.0 113.401 -179.682 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.819 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -139.42 122.83 17.18 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.491 -176.807 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -104.48 15.71 27.58 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.466 -0.771 . . . . 0.0 110.237 -178.951 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.95 95.56 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.44 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 94.02 106.55 1.91 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.711 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 9.2 t80 -173.89 170.49 3.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -1.173 . . . . 0.0 110.255 179.719 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.623 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.0 tttm -179.93 142.72 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.463 -0.773 . . . . 0.0 109.727 -179.684 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 76' ' ' LYS . 12.7 mtp180 -41.42 -27.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -148.08 141.49 25.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 110.175 179.877 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -124.99 -164.75 1.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 109.607 179.762 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.7 p -170.67 107.89 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.933 ' CB ' HG21 ' A' ' 59' ' ' VAL . 2.3 t80 53.24 156.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.112 -0.992 . . . . 0.0 110.672 179.167 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.821 ' C ' HG22 ' A' ' 102' ' ' THR . 27.4 t-20 38.18 -110.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.713 -179.224 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 81' ' ' TYR . 74.9 m-20 50.79 69.0 0.69 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.765 -1.21 . . . . 0.0 109.143 -179.419 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.84 ' CA ' HG23 ' A' ' 102' ' ' THR . 11.3 p-10 -69.43 129.98 41.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.753 -178.92 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 74' ' ' GLY . 15.8 m -121.53 128.85 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.998 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 20.4 t0 -85.37 136.78 33.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 108.575 178.977 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.696 ' CE2' HD23 ' A' ' 71' ' ' LEU . 51.2 m-85 -96.69 143.5 27.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.969 -1.082 . . . . 0.0 111.907 -178.43 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 5.7 tttm -115.38 110.03 18.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.448 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.522 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -66.55 132.79 48.99 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.835 -1.165 . . . . 0.0 109.943 -179.251 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.541 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -38.76 -91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 111.173 -179.132 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.3 t80 -148.44 138.56 22.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 0.0 110.786 -179.293 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 51.08 60.1 7.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.672 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 12.2 m-85 -162.96 136.45 5.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -1.06 . . . . 0.0 109.943 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 117' ' ' VAL . 34.5 pttt -101.23 112.23 24.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.423 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.673 HD23 HD11 ' A' ' 66' ' ' ILE . 1.3 mt -45.58 125.9 6.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -102.24 103.55 14.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 0.0 109.501 179.215 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.59 -57.42 0.58 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.633 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 172.65 119.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -1.148 . . . . 0.0 111.098 -179.417 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -78.11 -3.87 44.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.201 -0.937 . . . . 0.0 110.703 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.7 p -142.09 112.46 7.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 109.806 179.86 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.3 m -121.75 -179.7 4.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.993 -179.272 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.84 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -153.29 132.34 12.58 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 103' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 82' ' ' ASN . 36.6 t -78.72 82.91 4.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 110.09 -179.868 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.554 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -55.74 -179.91 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.594 -0.691 . . . . 0.0 111.503 -179.596 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.878 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.9 Cg_endo -73.43 117.6 5.14 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.559 1.821 . . . . 0.0 110.572 -179.271 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 138.0 -10.25 3.62 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 6.2 m120 83.37 90.42 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.163 -0.61 . . . . 0.0 110.728 179.461 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.35 -161.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 111.527 179.635 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.621 ' HB3' HD13 ' A' ' 113' ' ' LEU . 17.7 m95 -149.95 80.18 1.37 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.487 0.66 . . . . 0.0 109.729 -179.831 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.56 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.9 mttm -95.18 143.26 25.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.824 -179.739 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.633 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -71.04 174.27 45.66 Favored 'Cis proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 -2.0 . . . . 0.0 110.987 -0.144 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.23 128.24 5.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -39.86 144.15 0.54 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 110.272 179.323 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.84 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.3 Cg_endo -71.74 164.26 36.25 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 111.356 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.7 tttt -132.59 119.76 20.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 67' ' ' SER . 1.3 m -62.12 113.23 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.047 -1.033 . . . . 0.0 110.194 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.52 173.48 12.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.761 179.113 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.306 0.574 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.59 173.45 11.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.0 110.489 -179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.542 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.1 m -127.0 108.61 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.313 -0.867 . . . . 0.0 110.458 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.533 ' NE2' ' CE1' ' A' ' 20' ' ' PHE . 9.2 mm100 -87.68 174.81 8.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.2 p -43.01 139.97 2.05 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 0.0 109.891 179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.92 ' HG3' HG11 ' A' ' 27' ' ' VAL . 46.6 Cg_endo -69.59 161.04 47.46 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.083 1.57 . . . . 0.0 111.031 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.86 171.95 16.84 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.089 1.573 . . . . 0.0 109.938 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.4 p -73.01 176.47 5.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.232 -0.918 . . . . 0.0 110.051 179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.724 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -169.54 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.175 0.988 . . . . 0.0 111.369 179.735 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 11' ' ' ASN . 0.2 OUTLIER -52.56 96.41 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.74 -179.182 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 10' ' ' SER . 8.4 m120 40.63 61.78 1.55 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.433 -0.792 . . . . 0.0 110.453 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -158.5 161.99 32.11 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.6 mtt85 -105.88 -176.82 3.19 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.248 -1.148 . . . . 0.0 109.808 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.62 -176.28 5.75 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.933 179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.488 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 1.3 t30 66.52 136.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.065 -1.022 . . . . 0.0 109.905 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.86 -60.43 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 4.0 t80 -151.46 35.85 0.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.348 -1.089 . . . . 0.0 110.116 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -145.09 -162.74 1.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 110.418 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 20' ' ' PHE . 1.3 p30 -147.57 -38.69 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -0.779 . . . . 0.0 109.879 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.609 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 3.2 m-85 -93.62 -162.05 0.9 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.407 -0.808 . . . . 0.0 109.866 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.2 OUTLIER 171.89 -16.67 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.531 -0.73 . . . . 0.0 110.996 179.331 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.542 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 7.0 p 47.73 -95.44 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.322 -0.861 . . . . 0.0 112.311 179.199 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.2 OUTLIER -152.16 161.75 42.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.788 -1.195 . . . . 0.0 110.428 -178.46 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 68.85 19.9 73.88 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.624 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 6.6 m -105.14 178.04 4.68 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.54 -0.976 . . . . 0.0 110.566 -179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.7 t -151.8 156.35 6.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.103 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.92 HG11 ' HG3' ' A' ' 6' ' ' PRO . 15.0 t -135.09 117.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.572 -179.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.754 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.95 103.28 5.1 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 118.341 -1.343 . . . . 0.0 107.928 178.113 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.87 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.1 m-30 -68.24 128.09 35.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.43 -0.794 . . . . 0.0 110.05 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -82.96 157.81 22.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -0.925 . . . . 0.0 110.018 179.577 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 35.5 m -123.28 155.17 37.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.357 -179.82 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -47.94 160.6 0.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.029 179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 33' ' ' SER . 12.3 p -59.98 105.16 0.36 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 110.475 -179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.53 -3.24 29.32 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.504 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 3.0 m-30 -94.32 131.49 39.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -1.193 . . . . 0.0 110.422 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.592 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -81.39 140.14 34.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.423 -0.798 . . . . 0.0 110.676 -179.842 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.87 HD13 ' O ' ' A' ' 29' ' ' TYR . 4.5 tp -90.38 99.71 12.68 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.396 -0.815 . . . . 0.0 109.322 179.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.822 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.5 162.24 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.185 -0.947 . . . . 0.0 109.078 179.914 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.99 171.85 47.9 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -45.96 129.04 9.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -1.159 . . . . 0.0 109.997 -179.998 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.754 ' O ' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -74.01 53.82 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.204 -0.935 . . . . 0.0 110.476 -179.666 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.571 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 162.23 119.51 0.5 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.737 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.8 t -60.24 -175.91 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.022 -1.281 . . . . 0.0 108.051 178.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.584 ' H ' HG12 ' A' ' 43' ' ' VAL . 5.2 tp -146.48 97.49 2.93 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.33 -0.856 . . . . 0.0 110.253 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.6 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.4 OUTLIER -84.9 108.79 17.72 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.217 178.818 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.8 m -126.84 82.02 2.05 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.554 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.82 43.57 0.94 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 64.51 11.07 46.57 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -132.14 120.94 22.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -1.203 . . . . 0.0 110.28 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.648 ' CH2' HG23 ' A' ' 27' ' ' VAL . 80.8 m95 -76.36 138.75 40.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.367 -0.833 . . . . 0.0 109.742 179.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -141.41 158.06 44.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.114 -0.992 . . . . 0.0 111.129 -179.665 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.517 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 1.9 m-20 62.62 65.28 1.5 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.625 -0.672 . . . . 0.0 111.381 179.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.8 Cg_endo -91.2 133.61 1.59 Allowed 'Trans proline' 0 C--N 1.301 -1.955 0 O-C-N 124.275 1.671 . . . . 0.0 110.215 179.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' HB3' ' O ' ' A' ' 40' ' ' ASN . 51.3 Cg_endo -82.55 177.2 7.17 Favored 'Trans proline' 0 C--N 1.302 -1.912 0 O-C-N 123.929 1.489 . . . . 0.0 110.34 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 17.8 p -112.04 162.17 15.68 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.313 -0.867 . . . . 0.0 111.528 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 13.7 m -129.21 77.1 1.77 Allowed 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.643 -1.244 . . . . 0.0 107.643 177.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.55 -170.24 1.69 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.366 0.603 . . . . 0.0 110.32 -178.26 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.636 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -100.03 146.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.032 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.736 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 16.4 m -134.23 41.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 120.916 -1.115 . . . . 0.0 110.999 -179.085 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 8.2 mtpt -81.02 98.82 8.13 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.931 179.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 37.4 m -70.22 165.94 38.91 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.589 -0.695 . . . . 0.0 111.387 -178.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 50.6 Cg_endo -75.43 -91.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.315 1.692 . . . . 0.0 110.659 -179.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.482 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -153.78 131.67 6.35 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.89 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.69 ' HG2' HD22 ' A' ' 71' ' ' LEU . 54.3 Cg_endo -76.12 66.22 6.98 Favored 'Trans proline' 0 C--N 1.295 -2.254 0 O-C-N 123.595 1.313 . . . . 0.0 109.476 -179.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.73 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.3 OUTLIER -87.97 175.46 7.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.531 -0.731 . . . . 0.0 110.686 -179.404 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.747 HD11 ' CD2' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -178.26 161.35 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.257 -0.902 . . . . 0.0 110.259 179.615 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.552 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.0 t -72.11 111.67 7.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.53 -0.731 . . . . 0.0 110.864 -179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 61.5 m-20 36.53 49.14 0.68 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.641 -0.662 . . . . 0.0 111.325 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.534 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -159.42 23.76 0.3 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' HG23 ' A' ' 66' ' ' ILE . 3.8 p90 -36.41 163.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 122.953 1.359 . . . . 0.0 112.718 -179.119 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -49.14 -70.59 0.08 Allowed 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.835 178.038 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.574 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER 79.96 10.05 1.34 Allowed 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.41 -0.806 . . . . 0.0 109.891 179.888 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 t -114.34 -44.75 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.541 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -178.67 100.2 0.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.612 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -109.03 172.41 6.86 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -1.07 . . . . 0.0 109.742 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -158.89 161.08 36.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 110.543 -179.741 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -54.06 -37.47 64.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.855 . . . . 0.0 109.772 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.2 m -144.02 163.31 33.87 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.481 -0.762 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.538 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 14.9 m-85 -135.68 -179.2 5.5 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.882 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 17.3 p -163.06 111.9 1.3 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.032 -1.042 . . . . 0.0 110.996 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.677 ' CB ' HG21 ' A' ' 59' ' ' VAL . 18.2 t80 30.97 38.33 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.515 -0.741 . . . . 0.0 111.592 179.301 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' A' ' 103' ' ' CYS . 30.6 t30 -176.48 -140.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.444 -1.41 . . . . 0.0 110.995 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 74.3 m-20 55.26 66.53 1.2 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.917 -1.115 . . . . 0.0 108.987 -178.323 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.591 ' N ' HG23 ' A' ' 102' ' ' THR . 25.0 t30 -70.65 97.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.495 -0.753 . . . . 0.0 110.653 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 74' ' ' GLY . 34.9 m -86.15 131.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.172 179.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -88.56 131.04 35.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.716 ' HA ' ' HA ' ' A' ' 71' ' ' LEU . 20.4 m-85 -88.66 125.45 34.84 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.53 1.157 . . . . 0.0 112.758 -177.56 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.479 ' HB2' ' OG ' ' A' ' 72' ' ' SER . 0.1 OUTLIER -104.97 108.63 20.24 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.116 -179.473 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.468 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -60.68 133.99 56.64 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.766 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -44.61 -88.93 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.097 -1.002 . . . . 0.0 110.241 -179.544 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.594 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 52.0 p90 -148.93 149.31 31.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.22 -0.925 . . . . 0.0 111.007 -179.781 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 42.9 36.9 2.71 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.594 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 17.3 m-85 -139.38 149.43 44.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -1.087 . . . . 0.0 110.213 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.501 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.44 139.93 46.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.209 179.9 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.747 ' CD2' HD11 ' A' ' 66' ' ' ILE . 23.5 mt -75.6 102.97 5.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 0.0 110.495 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -80.15 95.32 6.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.268 -0.895 . . . . 0.0 109.441 179.324 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.24 -85.93 0.16 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.578 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -157.12 125.5 5.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -1.152 . . . . 0.0 110.554 -179.604 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.3 p -86.19 25.08 1.22 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.373 -0.83 . . . . 0.0 110.882 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 77.4 p -169.89 106.37 0.35 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.487 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 1.7 m -127.48 164.84 21.02 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.046 0.927 . . . . 0.0 110.924 -179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.591 HG23 ' N ' ' A' ' 84' ' ' ASN . 26.8 m -139.79 139.4 36.41 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.962 -179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.558 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 11.8 t -49.52 94.4 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.541 -0.864 . . . . 0.0 108.671 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.1 OUTLIER -66.62 174.12 2.02 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.934 -1.104 . . . . 0.0 112.366 -178.095 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.822 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.6 Cg_endo -79.44 14.33 1.83 Allowed 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 124.635 1.86 . . . . 0.0 111.809 -178.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 107' ' ' ASN . . . -116.31 18.72 13.61 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.981 -1.647 . . . . 0.0 108.981 179.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.834 ' O ' HG23 ' A' ' 108' ' ' THR . 10.2 t-20 67.32 54.5 0.71 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.591 -0.947 . . . . 0.0 110.263 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.4 OUTLIER -167.19 -176.88 3.47 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.187 -0.945 . . . . 0.0 110.741 -179.887 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.602 ' NE1' ' N ' ' A' ' 64' ' ' PRO . 46.6 m95 -105.97 98.84 8.47 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.55 -0.719 . . . . 0.0 110.415 -179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -105.73 141.99 23.85 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.508 -0.745 . . . . 0.0 110.214 -179.575 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.578 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.2 Cg_endo -71.78 174.8 45.13 Favored 'Cis proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.933 -2.111 . . . . 0.0 110.888 -0.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 3.5 mm-40 -38.38 142.34 0.19 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 111.14 -179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.4 OUTLIER -60.75 141.21 92.82 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.441 -0.787 . . . . 0.0 109.975 179.558 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.734 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.9 Cg_endo -73.13 155.59 52.07 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 O-C-N 124.302 1.685 . . . . 0.0 111.226 -179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 117' ' ' VAL . 2.6 ttpt -120.17 101.91 8.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.371 -0.83 . . . . 0.0 110.09 179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.553 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -54.66 103.19 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.055 -1.028 . . . . 0.0 109.094 179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -112.71 178.14 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-O 121.633 0.73 . . . . 0.0 110.823 -179.145 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 6.4 ptt85 . . . . . 0 C--N 1.297 -1.687 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.443 179.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.224 0.535 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.09 178.23 6.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 110.059 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.582 ' SG ' ' CZ2' ' A' ' 50' ' ' TRP . 2.8 t -160.08 97.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.527 -0.733 . . . . 0.0 110.259 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.0 pm0 -80.26 -175.26 4.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.387 -0.821 . . . . 0.0 109.857 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.1 p -45.26 142.57 2.98 Favored Pre-proline 0 C--N 1.295 -1.776 0 C-N-CA 119.757 -0.777 . . . . 0.0 109.473 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.876 ' HG3' HG11 ' A' ' 27' ' ' VAL . 45.8 Cg_endo -69.76 157.57 59.93 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.992 1.522 . . . . 0.0 111.261 -178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -75.27 173.25 14.84 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.971 1.511 . . . . 0.0 110.285 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.68 177.95 4.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 110.293 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.686 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.85 -170.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 122.24 1.019 . . . . 0.0 111.722 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 9' ' ' ILE . 25.4 m -38.32 92.48 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.004 -179.203 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.8 m-20 40.28 34.82 0.23 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.338 -0.851 . . . . 0.0 110.78 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -128.59 -167.91 12.29 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.521 ' HG3' ' CB ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -139.7 179.01 6.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.379 -1.071 . . . . 0.0 109.957 -179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.609 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -137.78 114.23 10.31 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 110.338 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.72 122.81 21.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -121.42 -111.41 2.19 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.494 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -157.09 29.43 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -1.17 . . . . 0.0 110.113 179.924 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.575 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 1.6 pm0 -162.99 173.62 13.38 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.225 -0.922 . . . . 0.0 110.468 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -102.26 -51.08 3.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.382 -0.824 . . . . 0.0 109.936 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -100.41 139.66 35.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.864 . . . . 0.0 109.967 179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.3 OUTLIER -120.01 -11.96 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.641 -179.429 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.568 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 21.1 p 51.14 -99.01 0.07 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.556 -0.715 . . . . 0.0 111.694 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -147.95 163.34 37.12 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.053 -1.029 . . . . 0.0 110.575 -178.579 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.47 25.31 68.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -107.04 -179.62 3.99 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.808 -0.819 . . . . 0.0 110.201 -179.281 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.677 HG13 ' O ' ' A' ' 43' ' ' VAL . 24.3 t -155.04 155.48 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.658 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.947 ' O ' HG23 ' A' ' 43' ' ' VAL . 17.2 t -140.51 116.21 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.449 -0.901 . . . . 0.0 111.655 -179.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.49 103.84 2.59 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.374 -1.33 . . . . 0.0 107.851 178.064 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.918 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.8 m-30 -68.28 135.01 51.26 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.327 -178.262 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.521 ' CB ' ' HG3' ' A' ' 13' ' ' ARG . 4.4 t -90.25 -172.36 3.44 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.308 -0.87 . . . . 0.0 109.385 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 85.9 m -149.33 159.9 43.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.077 -1.014 . . . . 0.0 110.226 -179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.558 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 76.0 m-20 -46.04 139.51 4.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 109.937 179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -45.51 109.06 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.211 -0.931 . . . . 0.0 110.412 -179.703 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.16 17.62 10.66 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.721 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 32' ' ' ASN . 3.2 m-85 -122.03 144.37 48.94 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.017 -1.284 . . . . 0.0 110.572 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 1.069 ' OG ' HG22 ' A' ' 59' ' ' VAL . 66.3 m -92.17 133.16 36.04 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.459 -0.776 . . . . 0.0 111.027 -179.536 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.91 HD13 ' O ' ' A' ' 29' ' ' TYR . 5.3 tp -88.17 116.17 26.17 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.37 178.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.699 HG23 ' CG ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -109.26 157.62 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.086 -1.009 . . . . 0.0 109.815 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.52 -169.37 18.27 Favored Glycine 0 N--CA 1.485 1.942 0 N-CA-C 108.666 -1.773 . . . . 0.0 108.666 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' O ' ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -58.61 119.24 6.71 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.045 -1.268 . . . . 0.0 109.51 179.455 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.706 ' O ' HG23 ' A' ' 28' ' ' THR . 46.1 p -68.45 58.17 0.08 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.069 -1.019 . . . . 0.0 109.588 179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.96 115.22 0.5 Allowed Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.947 HG23 ' O ' ' A' ' 27' ' ' VAL . 1.9 t -61.52 -175.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.214 . . . . 0.0 108.212 179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.559 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.7 tp -144.06 101.38 3.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.189 -0.944 . . . . 0.0 110.115 179.412 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.588 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.1 t -85.22 108.42 17.73 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.72 179.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.506 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -129.31 103.68 7.07 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.211 -179.839 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 23' ' ' ASP . . . 79.43 52.79 4.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.83 50.12 8.77 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -153.56 73.42 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.413 -1.051 . . . . 0.0 110.446 -179.854 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.588 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 68.8 m95 -46.21 131.72 10.19 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 109.562 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 5.9 m -142.65 168.98 18.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.964 -1.085 . . . . 0.0 111.099 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 11.7 m-20 59.95 66.34 2.08 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.687 -0.633 . . . . 0.0 111.111 179.669 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 47.0 Cg_endo -90.8 130.22 1.47 Allowed 'Trans proline' 0 C--N 1.3 -1.985 0 O-C-N 124.366 1.719 . . . . 0.0 110.335 179.249 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.757 ' HG2' HD11 ' A' ' 37' ' ' LEU . 55.6 Cg_endo -79.34 -176.24 3.16 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.838 1.441 . . . . 0.0 110.534 179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.556 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 11.0 p -112.1 -169.42 1.47 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.997 0.903 . . . . 0.0 111.634 -178.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 36' ' ' SER . 67.9 m -152.03 86.72 1.31 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.558 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -117.8 -143.39 0.37 Allowed 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.778 -177.845 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.784 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -134.43 100.5 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.219 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.069 HG22 ' OG ' ' A' ' 36' ' ' SER . 30.8 m -101.19 70.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.191 -0.943 . . . . 0.0 112.587 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' OD1' ' A' ' 107' ' ' ASN . 27.9 mtpt -65.52 -170.86 0.07 Allowed 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 117.239 -1.785 . . . . 0.0 107.989 178.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.485 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -143.9 159.8 52.12 Favored Pre-proline 0 C--N 1.295 -1.767 0 C-N-CA 118.39 -1.324 . . . . 0.0 113.292 -178.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.572 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 46.0 Cg_endo -85.31 -79.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 124.783 1.938 . . . . 0.0 110.558 179.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 171.63 128.6 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -179.691 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.819 ' O ' HD21 ' A' ' 71' ' ' LEU . 53.2 Cg_endo -80.27 66.36 8.82 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.8 1.421 . . . . 0.0 109.783 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.743 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -84.25 -171.49 3.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.349 -0.844 . . . . 0.0 109.698 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.743 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 172.44 170.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.298 179.035 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 69.5 m -77.0 107.4 9.32 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.397 -0.814 . . . . 0.0 111.155 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 5.7 m-80 38.56 65.92 0.57 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.438 -0.789 . . . . 0.0 110.866 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 89' ' ' CYS . . . -155.53 -37.98 0.02 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 43.5 p90 35.14 -155.78 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.591 1.186 . . . . 0.0 112.265 -179.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.819 HD21 ' O ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -155.13 126.89 7.49 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.696 -175.486 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.6 t -100.53 15.92 26.4 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -178.278 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.484 ' OG ' ' HB3' ' A' ' 86' ' ' ASP . 2.8 m -80.66 -92.3 0.05 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.268 -0.895 . . . . 0.0 111.258 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.16 88.19 0.18 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -95.76 165.87 12.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.539 -0.977 . . . . 0.0 110.612 -179.336 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.577 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 5.4 tttt -164.25 156.12 16.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.459 -0.775 . . . . 0.0 109.756 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.18 -30.47 59.95 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 0.0 110.45 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 93.9 p -143.95 138.24 28.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.231 -0.918 . . . . 0.0 110.555 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.607 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 25.0 m-85 -114.51 -140.77 0.38 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.335 -0.853 . . . . 0.0 110.187 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 82.7 p -162.7 -123.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -0.878 . . . . 0.0 110.341 179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 1.034 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.27 27.3 8.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.841 -1.162 . . . . 0.0 111.089 -178.276 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.769 ' C ' HG22 ' A' ' 102' ' ' THR . 45.8 t-20 -164.98 -110.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.942 -1.099 . . . . 0.0 110.285 178.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 0.2 OUTLIER 48.86 71.82 0.34 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.661 -1.274 . . . . 0.0 109.101 -179.252 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.811 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.3 t-20 -68.86 109.44 3.9 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.716 HG23 ' CE1' ' A' ' 87' ' ' PHE . 27.7 m -99.36 120.63 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.123 -0.986 . . . . 0.0 111.242 -179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB3' ' OG ' ' A' ' 73' ' ' SER . 23.7 t70 -78.88 135.42 37.0 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.724 ' CE2' HD23 ' A' ' 71' ' ' LEU . 13.1 m-85 -90.85 133.29 35.34 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.651 -1.281 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -102.36 81.94 2.12 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.345 0.593 . . . . 0.0 109.777 -179.728 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.537 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -40.48 126.74 2.34 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.55 -0.719 . . . . 0.0 110.745 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 17.2 mtpt -66.56 143.12 57.24 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.172 -0.955 . . . . 0.0 109.506 179.532 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 52.49 -176.63 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.865 -1.147 . . . . 0.0 110.663 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.29 53.47 1.86 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.617 ' CE2' ' HD2' ' A' ' 118' ' ' ARG . 3.2 m-85 -102.29 155.4 18.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -1.035 . . . . 0.0 109.251 179.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -101.24 146.82 27.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.099 -1.0 . . . . 0.0 110.132 -179.637 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 114' ' ' PRO . 1.4 mt -87.64 90.84 8.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.87 -1.144 . . . . 0.0 110.188 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 t -72.48 98.83 2.35 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.312 -0.868 . . . . 0.0 109.846 179.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 98' ' ' SER . . . 139.74 -41.38 1.32 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.608 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 98.2 p -178.41 -166.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.166 -1.196 . . . . 0.0 111.386 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 87' ' ' PHE . 0.7 OUTLIER -159.23 -39.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.577 0.703 . . . . 0.0 109.174 179.696 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 100' ' ' SER . 37.2 p -123.9 91.96 3.57 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.308 -0.87 . . . . 0.0 108.804 178.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 24.2 m -103.25 146.3 28.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 111.226 -178.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.811 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -117.78 136.86 53.12 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.688 0.756 . . . . 0.0 109.932 179.35 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.561 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -65.73 92.06 0.14 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.697 -0.627 . . . . 0.0 110.375 -179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.474 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -64.82 173.59 1.6 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.484 -0.76 . . . . 0.0 111.012 -179.664 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.845 ' HB3' HG11 ' A' ' 59' ' ' VAL . 42.3 Cg_endo -76.22 125.06 8.26 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 124.381 1.727 . . . . 0.0 110.577 -179.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.71 -3.91 8.06 Favored Glycine 0 N--CA 1.484 1.865 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.614 ' O ' HG23 ' A' ' 108' ' ' THR . 9.3 m-80 80.75 94.01 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.881 -0.776 . . . . 0.0 110.428 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.614 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.6 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.801 179.811 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 113' ' ' LEU . 26.1 m95 -153.99 90.21 1.35 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.435 -0.791 . . . . 0.0 110.403 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.8 mtpp -96.15 141.62 23.41 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.339 -0.851 . . . . 0.0 110.284 -179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.6 Cg_endo -72.48 170.38 68.29 Favored 'Cis proline' 0 C--N 1.314 -1.268 0 C-N-CA 121.915 -2.119 . . . . 0.0 110.559 -0.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 113' ' ' LEU . 11.9 pt-20 -40.58 131.43 2.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.387 -0.821 . . . . 0.0 110.427 -179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.583 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -41.27 142.26 0.95 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 0.0 110.03 179.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.67 ' HG2' HD12 ' A' ' 66' ' ' ILE . 46.4 Cg_endo -77.45 170.26 19.67 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 O-C-N 124.447 1.761 . . . . 0.0 111.616 -178.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.583 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -126.37 113.2 16.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.603 -0.685 . . . . 0.0 110.157 179.764 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.552 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.7 t -67.72 108.57 2.99 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.96 . . . . 0.0 109.051 179.353 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.583 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -117.41 -179.61 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 121.622 0.725 . . . . 0.0 110.098 -178.99 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.617 ' HD2' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.952 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.245 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.122 0.486 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -146.12 169.07 19.45 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 110.659 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.595 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 3.9 t -147.9 105.26 3.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.569 -0.707 . . . . 0.0 109.757 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -88.95 -179.11 5.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.342 -179.908 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -44.58 140.14 3.28 Favored Pre-proline 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.378 179.734 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.79 ' HG3' HG11 ' A' ' 27' ' ' VAL . 55.3 Cg_endo -71.31 168.2 24.1 Favored 'Trans proline' 0 C--N 1.301 -1.93 0 O-C-N 124.031 1.543 . . . . 0.0 110.781 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -70.43 -178.46 2.61 Favored 'Trans proline' 0 C--N 1.301 -1.933 0 O-C-N 123.81 1.426 . . . . 0.0 108.457 178.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.564 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.8 OUTLIER -82.32 45.32 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.843 -1.161 . . . . 0.0 110.437 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.804 HD11 ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER 39.08 -170.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-O 122.204 1.002 . . . . 0.0 110.618 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.691 ' N ' HG13 ' A' ' 9' ' ' ILE . 47.4 m -102.11 112.06 24.58 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.75 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.3 m120 74.64 38.43 0.49 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.612 -0.68 . . . . 0.0 110.393 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 9' ' ' ILE . . . -179.03 -155.5 14.95 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.54 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.481 ' O ' HG21 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -137.36 -171.61 3.01 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.147 -1.208 . . . . 0.0 110.987 -179.621 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.601 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 9.6 p80 -145.0 153.91 41.98 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.164 0.506 . . . . 0.0 110.097 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -152.68 -87.52 0.06 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.127 -0.983 . . . . 0.0 110.431 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.22 -109.07 3.54 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -178.18 48.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.227 -1.16 . . . . 0.0 110.327 179.836 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' CG ' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER 176.25 -165.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.138 -0.977 . . . . 0.0 110.463 179.909 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -128.02 -48.29 1.35 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.477 -0.764 . . . . 0.0 109.845 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -92.07 139.11 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.298 -0.876 . . . . 0.0 109.924 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.659 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.6 OUTLIER -130.63 -13.87 3.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.15 -0.969 . . . . 0.0 111.262 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.565 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 17.4 p 44.51 -98.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 111.435 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 46' ' ' SER . 0.5 OUTLIER -147.4 158.29 43.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.985 -1.072 . . . . 0.0 110.154 -178.764 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.27 21.34 79.35 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -179.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.659 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 8.1 m -106.75 176.91 5.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.643 -0.916 . . . . 0.0 110.329 -179.702 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 43' ' ' VAL . 42.8 t -151.25 152.24 11.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.486 -0.759 . . . . 0.0 109.864 179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.79 HG11 ' HG3' ' A' ' 6' ' ' PRO . 12.7 t -130.82 121.95 51.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.997 -178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.31 102.33 5.04 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.848 177.866 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.657 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.4 m-30 -68.49 151.73 46.38 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.548 -0.72 . . . . 0.0 110.665 -178.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.412 ' C ' ' SG ' ' A' ' 31' ' ' CYS . 1.2 p -114.53 175.72 5.36 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.43 -0.794 . . . . 0.0 109.526 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 11.2 m -142.91 154.11 43.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.185 -0.947 . . . . 0.0 109.933 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 22.2 m-80 -43.59 157.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 110.096 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.16 115.65 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.131 -0.981 . . . . 0.0 110.266 -179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.68 10.48 35.28 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.531 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-85 -106.65 138.94 41.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -1.183 . . . . 0.0 110.442 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.964 ' OG ' HG22 ' A' ' 59' ' ' VAL . 70.6 m -89.16 117.52 28.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.411 -0.806 . . . . 0.0 110.695 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' C ' HD13 ' A' ' 38' ' ' ILE . 3.2 tp -79.6 119.37 22.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.171 -0.956 . . . . 0.0 109.613 179.238 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.606 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -111.88 170.48 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.13 -0.981 . . . . 0.0 109.145 179.522 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.39 -177.61 44.08 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.437 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 9.7 p30 -57.81 142.22 46.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -1.176 . . . . 0.0 110.092 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 28' ' ' THR . 25.6 p -85.6 56.95 4.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 110.089 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.713 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 159.23 106.57 0.22 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.875 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -53.8 -175.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.011 -1.287 . . . . 0.0 108.547 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.601 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.4 tp -144.92 99.17 3.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 110.197 178.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.61 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -83.11 118.6 23.68 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.125 -0.984 . . . . 0.0 109.744 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -123.87 69.94 1.06 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.159 -0.963 . . . . 0.0 110.481 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.23 50.47 1.23 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.09 19.64 57.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -125.86 71.19 1.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.218 -1.166 . . . . 0.0 110.146 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.618 ' CH2' HG23 ' A' ' 27' ' ' VAL . 83.5 m95 -46.18 133.85 8.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.323 -0.86 . . . . 0.0 110.136 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.6 p -143.96 160.99 39.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.171 -0.956 . . . . 0.0 110.828 -179.702 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.4 OUTLIER 61.44 65.17 1.9 Allowed Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.65 -0.656 . . . . 0.0 111.192 179.516 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 53.3 Cg_endo -92.37 134.86 1.37 Allowed 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.361 1.716 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.597 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.9 Cg_endo -76.55 -176.17 2.97 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.821 1.432 . . . . 0.0 109.929 179.28 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.557 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 15.8 p -115.83 -178.12 3.32 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.276 1.036 . . . . 0.0 112.094 -178.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.804 ' SG ' HD11 ' A' ' 9' ' ' ILE . 55.5 m -148.07 74.76 1.31 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.438 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.99 -167.13 1.15 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.485 -178.443 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.692 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -115.19 105.11 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.338 -0.852 . . . . 0.0 109.379 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.086 HG21 ' HB3' ' A' ' 81' ' ' TYR . 32.8 m -95.78 67.24 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.355 -0.841 . . . . 0.0 111.674 -179.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 1.1 mptp? -68.87 174.86 4.03 Favored 'General case' 0 C--N 1.289 -2.06 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.354 178.412 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -132.76 161.86 60.93 Favored Pre-proline 0 C--N 1.298 -1.649 0 C-N-CA 118.43 -1.308 . . . . 0.0 113.565 -177.864 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.48 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.2 Cg_endo -81.26 -82.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 124.832 1.964 . . . . 0.0 110.054 178.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.48 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.58 131.93 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.0 110.295 -179.727 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.669 ' O ' HD11 ' A' ' 71' ' ' LEU . 58.0 Cg_endo -86.79 88.09 0.71 Allowed 'Trans proline' 0 C--N 1.3 -2.006 0 O-C-N 123.739 1.389 . . . . 0.0 108.615 178.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.683 ' O ' HG23 ' A' ' 66' ' ' ILE . 3.3 p -108.77 -42.0 4.62 Favored 'General case' 0 N--CA 1.501 2.081 0 CA-C-O 122.364 1.078 . . . . 0.0 110.554 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.703 HD11 HD23 ' A' ' 95' ' ' LEU . 0.1 OUTLIER 49.91 168.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.6 -178.867 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.1 OUTLIER -70.45 108.4 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.617 -0.677 . . . . 0.0 111.696 -178.481 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.487 ' O ' ' HG3' ' A' ' 90' ' ' LYS . 4.4 m-80 39.05 38.13 0.28 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.641 -0.662 . . . . 0.0 111.381 178.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -118.43 -40.81 0.65 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.033 -1.556 . . . . 0.0 109.236 179.511 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 1.0 OUTLIER 40.57 -173.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 122.942 1.353 . . . . 0.0 112.259 -179.713 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.925 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -138.5 159.15 42.79 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.246 -179.002 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 t -134.65 29.09 3.56 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.044 -1.035 . . . . 0.0 110.301 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.505 ' HB2' ' CB ' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -108.14 -72.32 0.73 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.178 -0.951 . . . . 0.0 110.805 -179.53 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -143.47 85.69 0.19 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.603 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -112.38 167.67 10.25 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.405 -1.056 . . . . 0.0 110.232 -179.631 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 tttm -165.79 164.46 18.78 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 110.495 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 -62.57 -22.39 66.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.152 -0.967 . . . . 0.0 110.113 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -148.25 152.38 37.05 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.384 -0.823 . . . . 0.0 110.588 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.596 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 17.0 m-85 -133.23 -146.32 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.301 -0.874 . . . . 0.0 110.069 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 90.5 p -165.32 -120.35 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.285 -0.884 . . . . 0.0 110.009 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 1.086 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -105.11 36.86 2.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.877 -1.139 . . . . 0.0 111.016 -178.912 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.639 ' C ' HG22 ' A' ' 102' ' ' THR . 10.0 p30 -176.2 -114.68 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.907 -1.121 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 82' ' ' ASN . 0.7 OUTLIER 43.95 79.58 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.816 -1.178 . . . . 0.0 109.567 -179.189 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.764 ' CA ' HG23 ' A' ' 102' ' ' THR . 20.7 p30 -69.2 137.8 53.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.349 -0.845 . . . . 0.0 110.706 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.516 ' O ' HG23 ' A' ' 85' ' ' VAL . 29.8 m -119.97 118.27 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.34 -0.85 . . . . 0.0 110.56 179.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.4 t0 -83.33 123.49 29.69 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.925 ' CE1' HD12 ' A' ' 71' ' ' LEU . 56.9 m-85 -82.27 139.52 34.15 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.278 1.037 . . . . 0.0 113.048 -177.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -116.19 86.12 2.43 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.248 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.552 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -38.64 126.93 1.5 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.503 -0.748 . . . . 0.0 110.936 -179.203 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 68' ' ' ASN . 1.4 mmtt -38.55 -92.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.552 -0.717 . . . . 0.0 111.038 -179.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.589 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -146.92 150.31 34.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.004 -1.06 . . . . 0.0 111.034 -179.562 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 40.94 33.65 0.69 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 19.6 m-85 -134.92 148.25 50.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -1.026 . . . . 0.0 109.975 -179.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 117' ' ' VAL . 3.7 tttt -108.23 151.29 26.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -0.926 . . . . 0.0 109.987 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.703 HD23 HD11 ' A' ' 66' ' ' ILE . 10.4 mt -89.22 97.77 11.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.062 -1.024 . . . . 0.0 110.116 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.49 103.64 6.59 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.35 -90.01 0.19 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.607 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 3.7 m -153.61 121.85 6.17 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.221 -1.164 . . . . 0.0 110.421 -179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 87' ' ' PHE . 2.7 p -75.5 -6.05 48.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.314 -0.866 . . . . 0.0 110.499 -179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.8 p -138.15 120.52 15.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.033 -1.042 . . . . 0.0 109.961 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.451 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 20.3 m -136.84 166.37 23.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -0.906 . . . . 0.0 110.621 -179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.764 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -133.52 153.35 51.71 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.352 -0.842 . . . . 0.0 110.427 179.897 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -82.81 75.01 9.73 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.69 -0.631 . . . . 0.0 110.52 -179.519 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.463 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -56.01 174.97 0.23 Allowed Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.33 -0.856 . . . . 0.0 111.072 -179.79 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.745 ' CB ' HG11 ' A' ' 59' ' ' VAL . 42.5 Cg_endo -74.84 123.46 7.98 Favored 'Trans proline' 0 C--N 1.303 -1.858 0 O-C-N 124.427 1.751 . . . . 0.0 110.153 -179.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.575 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 132.72 -14.73 4.96 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -178.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.594 ' O ' HG23 ' A' ' 108' ' ' THR . 1.0 OUTLIER 85.06 94.7 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.646 0.736 . . . . 0.0 111.104 179.43 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.594 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.92 -160.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.689 0.756 . . . . 0.0 110.882 179.281 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.769 ' HB3' HD13 ' A' ' 113' ' ' LEU . 19.9 m95 -148.11 77.97 1.42 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.62 -0.675 . . . . 0.0 109.806 -179.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.583 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -88.39 151.73 48.91 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.388 -0.82 . . . . 0.0 110.435 -179.58 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.607 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.65 177.88 31.88 Favored 'Cis proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.982 -2.091 . . . . 0.0 110.908 -0.163 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.58 114.59 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.341 0.591 . . . . 0.0 110.988 -179.229 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.769 HD13 ' HB3' ' A' ' 109' ' ' TRP . 4.3 tp -40.58 142.67 0.75 Allowed Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.529 -0.732 . . . . 0.0 110.191 179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.655 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.3 Cg_endo -70.61 165.32 32.32 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 124.005 1.529 . . . . 0.0 110.219 179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 1.022 ' HG2' HG13 ' A' ' 117' ' ' VAL . 62.3 tttt -128.58 103.28 7.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.912 . . . . 0.0 109.902 179.518 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -58.2 87.08 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.052 -1.03 . . . . 0.0 109.06 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.022 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -95.42 179.57 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-O 121.694 0.759 . . . . 0.0 110.837 -179.369 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.587 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 3.1 ptp85 . . . . . 0 C--N 1.296 -1.751 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.271 179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.405 ' H3 ' HG13 ' A' ' 1' ' ' VAL . 27.3 m . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.278 0.561 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.94 174.34 9.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.57 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -130.45 79.46 1.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.431 -0.793 . . . . 0.0 109.979 -179.935 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.567 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 7.9 mp0 -47.49 173.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 1.3 p -55.04 146.06 40.95 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.212 -0.93 . . . . 0.0 109.058 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.848 ' HG3' HG11 ' A' ' 27' ' ' VAL . 46.5 Cg_endo -69.24 155.08 68.7 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.804 1.423 . . . . 0.0 111.11 -178.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.04 174.64 12.07 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.105 1.582 . . . . 0.0 110.305 179.726 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.17 179.53 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.284 -0.885 . . . . 0.0 110.64 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -147.78 -169.14 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 122.208 1.004 . . . . 0.0 111.377 -179.888 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 15.1 m -53.5 97.96 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.543 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' SER . 35.2 m-80 41.0 61.69 1.65 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -168.61 151.19 17.55 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.524 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.3 mtm180 -104.09 -169.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.232 -1.157 . . . . 0.0 110.675 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.6 p80 -147.75 -153.38 0.49 Allowed 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.384 -179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 18' ' ' GLU . 16.2 t-20 58.28 149.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.307 -0.871 . . . . 0.0 110.029 -179.62 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -146.98 -39.3 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.488 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 10.5 t80 -160.64 40.96 0.17 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.131 -1.217 . . . . 0.0 110.581 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.548 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 0.2 OUTLIER -165.03 -166.82 1.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.571 179.73 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 5' ' ' SER . 1.6 m-20 -140.24 -41.29 0.42 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.108 -0.995 . . . . 0.0 110.657 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 20' ' ' PHE . 33.2 p90 -131.04 105.9 8.03 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.941 -1.1 . . . . 0.0 110.845 -179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.638 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 12.7 m-85 -72.84 -163.51 0.13 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.612 179.275 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.57 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -149.8 -64.83 0.21 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.882 -1.136 . . . . 0.0 111.015 -179.844 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 24' ' ' GLY . 5.4 t0 -165.23 146.38 7.41 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.349 -0.844 . . . . 0.0 109.823 -179.111 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 66.27 15.13 62.88 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.536 -1.826 . . . . 0.0 108.536 -179.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.638 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 1.5 m -97.21 164.3 12.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.486 -1.008 . . . . 0.0 109.962 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 43' ' ' VAL . 43.4 t -138.68 154.35 26.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 110.54 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.848 HG11 ' HG3' ' A' ' 6' ' ' PRO . 11.2 t -131.62 122.3 49.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.509 -179.08 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -78.95 103.08 8.66 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 118.371 -1.332 . . . . 0.0 107.71 177.799 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.847 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.3 m-30 -67.66 107.08 2.41 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.421 -178.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.9 OUTLIER -69.21 158.01 35.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.0 110.312 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 18.8 m -123.44 146.32 48.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 110.304 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 4.1 m120 -43.87 138.56 2.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.243 -0.91 . . . . 0.0 109.951 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 32' ' ' ASN . 5.3 t -44.39 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 110.282 -179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 126.75 -1.22 7.39 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.593 ' CE2' HG13 ' A' ' 58' ' ' ILE . 14.3 m-85 -106.39 143.26 34.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -1.183 . . . . 0.0 110.391 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.671 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -92.24 139.86 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -0.826 . . . . 0.0 110.84 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.847 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.0 tp -91.34 99.12 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.309 179.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.7 OUTLIER -87.98 147.14 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 109.619 -179.76 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.97 -176.96 27.47 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -55.7 134.36 51.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -1.15 . . . . 0.0 109.777 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.621 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.1 OUTLIER -73.65 53.89 0.45 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 110.189 -179.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.623 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 159.33 116.46 0.45 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.743 -1.217 . . . . 0.0 110.115 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.867 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.5 t -58.44 -178.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.001 -1.294 . . . . 0.0 107.866 178.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -146.14 94.82 2.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.076 -1.015 . . . . 0.0 110.305 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.585 ' SG ' ' CD2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -80.49 108.96 14.55 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.076 -1.015 . . . . 0.0 109.078 178.79 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 92.8 p -132.45 111.31 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.411 -179.254 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.33 18.31 39.52 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 78.3 31.31 47.17 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -151.95 100.56 2.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.202 -1.175 . . . . 0.0 110.37 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.612 ' CH2' HG23 ' A' ' 27' ' ' VAL . 81.3 m95 -54.03 136.99 40.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' CB ' ' A' ' 52' ' ' ASP . 7.4 m -146.09 155.64 42.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.05 -1.031 . . . . 0.0 111.061 179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.539 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.6 t0 68.95 64.86 0.54 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.625 -0.672 . . . . 0.0 111.199 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.2 Cg_endo -92.29 132.71 1.17 Allowed 'Trans proline' 0 C--N 1.3 -1.975 0 C-N-CA 121.971 1.781 . . . . 0.0 110.597 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' HG2' HD11 ' A' ' 37' ' ' LEU . 54.3 Cg_endo -82.84 173.89 9.93 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.862 1.454 . . . . 0.0 109.481 179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.636 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 74.2 p -114.22 134.77 54.69 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.869 -1.144 . . . . 0.0 111.366 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 10' ' ' SER . 9.2 m -98.09 75.58 2.33 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -113.8 171.37 7.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.365 0.602 . . . . 0.0 110.533 -178.376 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.593 HG13 ' CE2' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -87.94 124.74 41.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.011 179.581 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.708 HG23 ' CA ' ' A' ' 80' ' ' SER . 33.9 m -110.38 53.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 111.269 -178.527 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 20.7 mmmt -78.74 107.68 11.62 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 118.261 -1.376 . . . . 0.0 109.578 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 71.0 m -74.46 162.86 71.91 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.244 -0.91 . . . . 0.0 111.665 -179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.8 Cg_endo -71.39 -78.37 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.622 1.854 . . . . 0.0 110.66 179.319 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.54 ' HB3' ' CG2' ' A' ' 65' ' ' THR . 0.0 OUTLIER 178.41 131.02 0.22 Allowed Pre-proline 0 C--N 1.297 -1.687 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.714 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD3' ' CZ2' ' A' ' 109' ' ' TRP . 54.2 Cg_endo -76.68 65.17 7.53 Favored 'Trans proline' 0 C--N 1.295 -2.275 0 O-C-N 123.714 1.376 . . . . 0.0 110.254 -178.502 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.837 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -95.93 141.34 29.47 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.036 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.824 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -135.8 154.79 34.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 118.029 -1.468 . . . . 0.0 111.092 -178.908 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -43.88 99.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.676 -0.64 . . . . 0.0 110.77 -179.701 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' CB ' ' O ' ' A' ' 67' ' ' SER . 0.7 OUTLIER 68.0 -55.51 0.5 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.193 -0.942 . . . . 0.0 109.969 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 70' ' ' TYR . . . -52.71 -169.3 0.02 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.59 ' O ' ' N ' ' A' ' 88' ' ' LYS . 12.6 p90 175.12 -165.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -125.14 153.73 42.56 Favored 'General case' 0 C--N 1.282 -2.365 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.233 178.237 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.6 t -139.01 24.83 2.54 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.07 -1.019 . . . . 0.0 110.174 -178.595 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.7 t -106.71 -73.46 0.69 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.278 -0.889 . . . . 0.0 110.587 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.33 81.1 0.29 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.6 t80 -101.01 164.16 11.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.391 -1.064 . . . . 0.0 109.775 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.625 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -160.5 167.98 26.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.99 . . . . 0.0 110.543 -179.858 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -71.78 -29.37 64.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.255 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 p -139.12 135.19 33.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.313 -0.867 . . . . 0.0 110.396 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 38.8 m-85 -117.13 -170.28 1.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.809 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.708 ' CA ' HG23 ' A' ' 59' ' ' VAL . 89.1 p -145.77 -99.4 0.1 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.996 -1.065 . . . . 0.0 111.201 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -120.95 22.01 11.19 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.494 -1.379 . . . . 0.0 110.357 -178.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.639 ' C ' HG22 ' A' ' 102' ' ' THR . 16.4 p30 -159.39 -116.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.946 -1.096 . . . . 0.0 110.606 179.485 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 t70 52.09 73.44 0.33 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.799 -1.188 . . . . 0.0 109.367 -179.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.815 ' CA ' HG23 ' A' ' 102' ' ' THR . 31.4 t30 -69.46 105.02 2.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.421 -0.799 . . . . 0.0 110.906 -178.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.577 ' O ' HG23 ' A' ' 85' ' ' VAL . 34.6 m -91.54 118.42 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.028 -1.045 . . . . 0.0 110.757 179.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -77.85 137.76 38.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 178.429 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.706 ' CD1' HG21 ' A' ' 66' ' ' ILE . 38.3 m-85 -97.44 155.61 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 118.249 -1.38 . . . . 0.0 111.943 -178.255 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.59 ' N ' ' O ' ' A' ' 70' ' ' TYR . 1.4 mmtt -136.33 123.1 21.18 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.582 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.523 ' N ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -68.56 132.04 46.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.052 -1.03 . . . . 0.0 110.376 -179.915 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -38.62 -76.25 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.512 -0.742 . . . . 0.0 110.527 179.894 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.507 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -172.96 120.6 0.37 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.26 -0.9 . . . . 0.0 110.148 179.892 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.565 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 78.59 50.2 6.21 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -179.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.567 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 77.4 m-85 -158.83 167.64 28.92 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.473 -1.016 . . . . 0.0 110.396 -178.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.694 ' O ' HG22 ' A' ' 117' ' ' VAL . 21.1 tttm -121.39 124.87 45.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 0.0 109.607 179.453 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 66' ' ' ILE . 2.3 mt -66.69 92.84 0.23 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.913 -1.117 . . . . 0.0 110.076 -179.796 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -76.57 112.41 13.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.29 -0.881 . . . . 0.0 110.13 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 134.91 -79.31 0.33 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.601 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -169.37 122.47 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.41 -1.053 . . . . 0.0 110.135 -179.635 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -83.86 17.3 2.4 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.215 -0.928 . . . . 0.0 110.643 -179.734 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 85.7 p -157.15 105.86 2.15 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.197 -0.939 . . . . 0.0 109.974 179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.563 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 3.1 m -123.64 175.63 6.71 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.199 -0.938 . . . . 0.0 110.943 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.815 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.08 132.63 19.79 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.603 0.716 . . . . 0.0 110.176 -179.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.559 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.6 OUTLIER -61.79 89.23 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.507 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.472 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -75.21 178.58 1.74 Allowed Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.288 -0.883 . . . . 0.0 111.186 -179.046 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.879 ' HB3' HD12 ' A' ' 38' ' ' ILE . 44.0 Cg_endo -76.83 130.5 11.51 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.394 1.734 . . . . 0.0 110.01 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 125.83 -10.3 7.52 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 -178.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 61' ' ' CYS . 9.3 m-80 81.42 76.98 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 122.102 -0.646 . . . . 0.0 110.738 179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -171.16 -169.28 0.72 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.264 -0.898 . . . . 0.0 111.361 179.746 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.702 ' HB3' HD13 ' A' ' 113' ' ' LEU . 32.0 m95 -133.09 95.72 3.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.626 -0.671 . . . . 0.0 110.104 179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.529 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.9 mmtt -101.61 146.63 32.57 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.292 -0.88 . . . . 0.0 110.518 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.601 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.1 Cg_endo -74.32 178.62 33.06 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 121.782 -2.174 . . . . 0.0 110.528 -0.291 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.0 OUTLIER -37.56 124.55 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.692 -0.63 . . . . 0.0 110.908 -179.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.837 HD23 ' O ' ' A' ' 65' ' ' THR . 1.5 tp -46.48 143.54 3.88 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 110.226 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.824 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.1 Cg_endo -70.67 168.09 23.75 Favored 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 124.056 1.556 . . . . 0.0 110.636 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.736 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.3 tttt -132.76 109.42 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.856 . . . . 0.0 110.257 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 2.0 t -62.8 89.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.13 -0.981 . . . . 0.0 108.85 179.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.736 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.4 m -104.9 -173.8 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-O 121.925 0.869 . . . . 0.0 111.215 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.567 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 6.7 mtt-85 . . . . . 0 C--N 1.294 -1.812 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.407 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.738 HG13 ' O ' ' A' ' 1' ' ' VAL . 13.3 p . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.363 0.602 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.8 mttm -119.38 162.71 18.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 110.099 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -130.54 91.71 3.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.915 . . . . 0.0 110.286 -179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.428 ' O ' ' C ' ' A' ' 5' ' ' SER . 2.2 mp0 -64.03 164.98 9.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.109 -0.995 . . . . 0.0 109.885 179.833 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.74 141.52 1.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.233 -0.917 . . . . 0.0 109.799 179.908 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.1 Cg_endo -69.27 162.57 41.29 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.954 1.502 . . . . 0.0 110.874 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.32 170.22 19.73 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.036 1.546 . . . . 0.0 109.899 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.47 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -89.36 104.32 16.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.094 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.585 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -51.13 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 122.103 0.954 . . . . 0.0 111.251 -179.5 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.64 141.0 30.95 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.085 -179.337 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 13.4 m120 50.57 19.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 110.678 179.682 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -160.68 168.47 36.13 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.634 -1.27 . . . . 0.0 110.054 -179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.484 ' HD3' ' N ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -132.34 -177.62 4.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -1.106 . . . . 0.0 110.326 179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 10.3 p80 -126.67 143.85 51.1 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.563 -0.71 . . . . 0.0 110.553 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.28 -166.98 1.8 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.127 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.67 -91.28 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -170.64 28.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -1.16 . . . . 0.0 110.211 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.26 -165.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 0.0 110.427 -179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -164.98 25.29 0.06 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.283 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -150.68 49.22 0.87 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.128 -0.982 . . . . 0.0 110.822 -179.753 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.622 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 14.3 m-85 -50.15 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.69 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.541 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p -141.0 -54.53 0.48 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.883 -1.136 . . . . 0.0 111.089 -179.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 6.6 t70 -172.63 148.18 1.9 Allowed 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.319 -0.863 . . . . 0.0 109.858 -179.206 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 63.28 14.72 54.92 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.181 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.622 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -94.98 174.53 7.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.49 -1.006 . . . . 0.0 109.641 179.854 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 43' ' ' VAL . 49.6 t -148.99 154.71 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.15 -179.516 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.697 ' O ' HG23 ' A' ' 43' ' ' VAL . 8.7 t -131.85 119.1 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.631 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.92 103.66 5.22 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 118.632 -1.227 . . . . 0.0 108.141 178.177 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.634 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.33 175.7 3.19 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.763 -178.699 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.508 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -131.55 161.84 31.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.895 . . . . 0.0 109.571 179.576 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.927 ' SG ' HD12 ' A' ' 37' ' ' LEU . 55.9 m -140.1 130.94 25.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.086 -1.009 . . . . 0.0 110.431 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -44.4 136.74 3.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 110.278 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.4 p -46.09 111.75 0.4 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 0.0 110.145 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.93 -9.06 7.59 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CE1' HG12 ' A' ' 58' ' ' ILE . 3.2 m-85 -114.6 115.38 27.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.218 -1.166 . . . . 0.0 110.258 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.76 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -63.94 127.91 33.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.326 -0.859 . . . . 0.0 110.602 179.68 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.927 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -82.83 99.91 10.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.142 178.983 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.679 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -86.16 145.38 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 109.196 -179.888 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.91 -143.98 15.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.53 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.6 m120 -126.41 51.24 1.83 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -1.201 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.53 ' C ' ' O ' ' A' ' 40' ' ' ASN . 10.8 m 22.79 66.38 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.655 179.691 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.516 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.85 108.63 0.37 Allowed Glycine 0 N--CA 1.489 2.199 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.264 179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.9 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -65.27 -177.23 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 120.994 -1.298 . . . . 0.0 108.329 178.8 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.544 ' H ' HG12 ' A' ' 43' ' ' VAL . 7.6 tp -145.96 97.35 2.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.929 -1.107 . . . . 0.0 110.544 178.606 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.25 115.02 20.44 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.137 -0.977 . . . . 0.0 109.363 178.905 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.518 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 83.6 p -127.27 109.24 11.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.613 -0.679 . . . . 0.0 110.471 -179.51 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.42 41.57 13.18 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 63.41 33.27 86.78 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.764 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.64 107.1 4.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.19 -1.182 . . . . 0.0 110.613 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 76.2 m95 -66.74 138.85 57.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.341 -0.849 . . . . 0.0 109.636 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 t -149.26 169.75 20.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.028 -1.045 . . . . 0.0 111.405 -179.513 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER 49.72 64.85 7.8 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.784 -0.572 . . . . 0.0 111.421 179.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.5 Cg_endo -92.78 147.6 2.64 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 121.919 1.746 . . . . 0.0 110.296 179.085 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.589 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 50.8 Cg_endo -81.52 173.89 11.04 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.895 1.471 . . . . 0.0 109.833 179.108 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.617 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.6 p -125.3 141.13 52.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.085 -1.01 . . . . 0.0 111.231 -179.463 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 75.7 m -100.66 73.91 1.64 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.7 OUTLIER -118.76 175.84 5.55 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.043 -179.086 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.411 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.1 OUTLIER -88.5 149.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.258 -0.902 . . . . 0.0 108.767 179.057 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.818 HG21 ' CB ' ' A' ' 81' ' ' TYR . 33.1 m -124.21 47.46 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 111.891 -178.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -76.07 155.71 34.56 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 118.139 -1.425 . . . . 0.0 107.255 178.131 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.49 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -120.44 172.24 4.89 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 120.847 -1.158 . . . . 0.0 111.476 -178.808 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.0 Cg_endo -78.08 -63.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.649 1.868 . . . . 0.0 110.744 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.581 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER 163.07 128.56 0.01 OUTLIER Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -179.203 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.821 ' O ' HD23 ' A' ' 71' ' ' LEU . 48.7 Cg_endo -76.54 69.52 6.65 Favored 'Trans proline' 0 C--N 1.294 -2.302 0 O-C-N 123.696 1.366 . . . . 0.0 110.377 -179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.733 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.6 OUTLIER -94.22 -173.78 3.18 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.488 -0.757 . . . . 0.0 109.403 179.678 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.802 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 178.5 169.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.11 -0.994 . . . . 0.0 110.272 179.455 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.528 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.32 103.89 7.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.41 -0.806 . . . . 0.0 110.875 -179.536 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 59.9 m-80 44.68 51.12 8.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.368 -0.832 . . . . 0.0 111.038 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -164.64 26.54 0.19 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.545 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.619 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -39.27 162.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 123.012 1.386 . . . . 0.0 113.166 -178.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.0 HD13 ' HB2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -45.83 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.603 178.171 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.578 ' CB ' ' O ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER 80.59 25.87 0.29 Allowed 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.284 0.564 . . . . 0.0 110.094 -179.934 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -134.73 -73.67 0.47 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 110.467 -179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -108.1 -98.31 2.55 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.0 ' HB2' HD13 ' A' ' 71' ' ' LEU . 6.8 t80 57.05 164.06 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.408 -1.054 . . . . 0.0 110.798 -179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.647 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -170.16 167.44 8.7 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.438 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -52.83 -26.8 15.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.049 -1.032 . . . . 0.0 110.507 -179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 76' ' ' LYS . 8.0 t -149.69 146.92 27.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.276 -0.89 . . . . 0.0 110.659 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.672 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -142.53 175.69 9.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.407 -0.808 . . . . 0.0 109.464 179.609 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.8 p -170.65 136.61 1.25 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.004 -1.06 . . . . 0.0 110.393 179.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.818 ' CB ' HG21 ' A' ' 59' ' ' VAL . 54.6 t80 31.44 104.52 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.708 -0.62 . . . . 0.0 111.872 179.41 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.636 ' CB ' ' O ' ' A' ' 81' ' ' TYR . 38.2 t30 90.19 -133.67 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.355 0 O-C-N 122.005 -0.434 . . . . 0.0 110.227 -179.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 80' ' ' SER . 4.5 m-20 55.3 76.64 0.25 Allowed 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.765 -1.209 . . . . 0.0 108.817 -178.314 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 t-20 -71.29 146.25 49.03 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.63 0.729 . . . . 0.0 111.599 -178.527 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.726 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.3 m -127.53 123.57 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.014 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -85.04 132.36 34.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.906 -1.121 . . . . 0.0 108.69 -179.97 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.677 ' CD1' HG21 ' A' ' 66' ' ' ILE . 38.1 m-85 -94.55 136.6 34.67 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.291 1.043 . . . . 0.0 112.674 -177.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 72' ' ' SER . 2.4 tttp -111.89 102.41 10.66 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.474 -179.109 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.444 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -51.68 131.08 29.74 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.041 -1.037 . . . . 0.0 109.705 179.532 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.18 -79.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.318 -0.864 . . . . 0.0 109.958 -179.746 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.516 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 1.7 m-85 -165.66 141.31 5.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.47 -0.768 . . . . 0.0 110.298 179.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.578 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 52.56 61.46 6.71 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -162.71 175.19 11.58 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.45 -1.029 . . . . 0.0 110.208 -179.34 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.3 tttt -132.14 116.0 16.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 109.865 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.606 HD23 HD11 ' A' ' 66' ' ' ILE . 5.6 mt -55.3 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.94 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.48 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -71.95 99.21 2.19 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.206 -0.934 . . . . 0.0 109.561 179.341 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.75 -86.24 0.18 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.824 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.614 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -162.77 122.07 2.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 110.434 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.9 p -73.52 1.34 10.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.296 -0.878 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 36.3 p -147.55 113.69 5.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.108 -0.995 . . . . 0.0 110.3 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.53 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 15.2 m -121.3 -173.39 2.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.203 -0.936 . . . . 0.0 110.518 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.555 HG22 ' C ' ' A' ' 82' ' ' ASN . 16.1 m -155.83 139.1 15.67 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.942 -178.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.637 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.6 t -69.03 84.03 0.33 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.648 -0.657 . . . . 0.0 109.371 179.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.479 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -73.82 177.73 1.94 Allowed Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.374 -0.829 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.679 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -77.37 130.25 10.83 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.569 1.826 . . . . 0.0 110.908 -179.376 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.595 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.34 -6.77 12.78 Favored Glycine 0 N--CA 1.483 1.792 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.877 ' O ' HG23 ' A' ' 108' ' ' THR . 0.9 OUTLIER 83.15 85.32 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.991 -0.711 . . . . 0.0 111.435 179.364 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.877 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 175.65 171.83 0.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.64 0.733 . . . . 0.0 111.14 178.703 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.726 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 51.6 m95 -119.21 93.72 4.18 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.713 -0.617 . . . . 0.0 110.29 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 7.0 mmtm -98.94 146.05 31.0 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.708 . . . . 0.0 110.566 -179.566 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.614 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 45.7 Cg_endo -70.55 169.5 66.38 Favored 'Cis proline' 0 C--N 1.315 -1.191 0 C-N-CA 121.94 -2.108 . . . . 0.0 110.871 -0.786 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 52.2 tt0 -36.03 126.16 0.74 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.568 0.699 . . . . 0.0 111.707 -178.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.572 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.3 OUTLIER -42.77 143.51 1.18 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.541 -0.725 . . . . 0.0 109.977 179.105 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.802 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.2 Cg_endo -71.43 164.11 36.83 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 124.158 1.609 . . . . 0.0 111.242 -179.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.523 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -130.57 108.12 9.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 110.411 179.808 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.5 t -65.05 93.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 179.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 94' ' ' LYS . 3.2 m -112.35 179.62 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.571 0.7 . . . . 0.0 110.708 -179.418 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.591 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 118.921 -1.112 . . . . 0.0 110.566 179.341 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.489 HG21 ' C ' ' A' ' 47' ' ' GLY . 9.3 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.233 0.54 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.5 169.96 13.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.094 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.559 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -135.32 95.73 3.34 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 0.0 110.271 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.3 OUTLIER -71.88 175.73 5.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.078 -1.014 . . . . 0.0 109.483 179.437 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.516 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.7 OUTLIER -50.41 138.79 20.87 Favored Pre-proline 0 C--N 1.299 -1.592 0 O-C-N 121.313 -0.867 . . . . 0.0 109.816 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.666 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.8 Cg_endo -68.91 156.26 65.96 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.913 1.481 . . . . 0.0 110.485 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.67 167.69 25.88 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 O-C-N 123.906 1.477 . . . . 0.0 110.231 179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 9' ' ' ILE . 84.8 p -81.19 99.67 8.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 0.0 109.712 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.601 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -50.97 -169.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-O 122.389 1.09 . . . . 0.0 111.877 -179.233 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -61.06 116.65 4.69 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.159 -179.168 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 34.7 m120 42.94 43.62 3.63 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.331 -0.855 . . . . 0.0 111.115 179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -158.92 139.06 6.0 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -95.9 -168.83 1.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 110.893 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.651 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 14.9 p80 -148.79 120.74 8.2 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.801 -179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.63 -71.05 0.76 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.027 . . . . 0.0 110.745 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 75.58 -97.58 1.1 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER 179.82 30.73 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -1.179 . . . . 0.0 110.576 -179.944 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 0.8 OUTLIER 178.59 -171.18 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.053 -1.029 . . . . 0.0 110.585 -179.979 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.516 ' O ' ' N ' ' A' ' 5' ' ' SER . 0.9 OUTLIER -105.5 -50.53 3.19 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.375 -0.828 . . . . 0.0 110.018 179.757 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.8 m-85 -88.7 -170.52 2.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.21 -0.931 . . . . 0.0 110.256 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.645 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 1.7 m-85 -169.52 -15.99 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.33 -0.856 . . . . 0.0 111.96 -179.613 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.559 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.3 p 48.72 -97.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.0 -1.062 . . . . 0.0 112.167 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.7 OUTLIER -145.36 157.91 43.94 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.757 -1.215 . . . . 0.0 110.342 -178.293 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.37 13.4 65.1 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 -179.019 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.498 ' HB2' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -92.03 160.78 15.07 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.588 -0.948 . . . . 0.0 110.105 -179.908 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.881 HG13 ' O ' ' A' ' 43' ' ' VAL . 53.8 t -140.78 152.76 20.72 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.771 179.129 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.973 ' O ' HG23 ' A' ' 43' ' ' VAL . 25.2 t -138.02 116.71 13.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.123 -1.031 . . . . 0.0 111.391 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.891 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -70.66 103.61 2.59 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.383 -1.327 . . . . 0.0 107.519 178.098 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.981 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.84 125.95 27.89 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.495 -0.753 . . . . 0.0 110.218 -178.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -82.05 153.5 26.1 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.251 -0.906 . . . . 0.0 109.93 179.735 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . 1.6 t -121.55 138.2 54.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.296 -0.877 . . . . 0.0 110.057 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.79 158.67 0.95 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.104 -0.998 . . . . 0.0 110.041 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 p -62.91 131.51 48.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.174 -0.954 . . . . 0.0 110.302 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.33 -33.33 6.56 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -89.59 136.54 32.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -1.122 . . . . 0.0 109.973 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.724 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -89.92 144.8 25.62 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.284 -0.885 . . . . 0.0 110.786 -179.635 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.6 tp -96.39 100.91 12.48 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.432 -0.792 . . . . 0.0 109.331 179.139 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.816 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.1 148.65 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.06 -168.61 12.64 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.565 -1.303 . . . . 0.0 109.878 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.32 134.16 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.306 -1.114 . . . . 0.0 110.145 179.886 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.891 ' O ' HG23 ' A' ' 28' ' ' THR . 89.2 p -74.41 56.14 0.65 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -0.927 . . . . 0.0 109.699 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 163.86 114.02 0.3 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.981 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.0 t -64.91 -178.9 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.2 tp -145.82 99.11 3.22 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.04 -1.037 . . . . 0.0 110.465 179.505 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -86.35 110.11 19.45 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.147 -0.971 . . . . 0.0 109.356 178.902 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.55 100.37 6.77 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.381 -0.824 . . . . 0.0 110.629 -179.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.489 ' C ' HG21 ' A' ' 1' ' ' VAL . . . 84.75 45.14 6.15 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 62.33 33.6 86.68 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.34 95.71 2.66 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.235 -1.156 . . . . 0.0 110.665 -179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 72.9 m95 -60.07 137.32 58.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.163 -0.961 . . . . 0.0 109.309 179.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.7 t -139.58 179.2 6.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 0.0 111.397 -179.187 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 4.3 m-20 38.57 64.75 3.39 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.78 -0.575 . . . . 0.0 111.535 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.9 Cg_endo -91.97 138.69 2.0 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 121.95 1.767 . . . . 0.0 109.558 178.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 52.3 Cg_endo -78.93 -178.99 5.06 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.734 1.386 . . . . 0.0 110.495 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.537 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 9.0 p -115.06 172.83 6.82 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.801 0.81 . . . . 0.0 111.194 -179.039 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -137.64 77.44 1.63 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.598 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.512 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.83 -164.26 0.9 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.412 -178.676 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.666 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -111.32 131.24 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.985 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.724 HG13 ' HB2' ' A' ' 36' ' ' SER . 11.4 m -125.42 47.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 120.906 -1.121 . . . . 0.0 111.493 -178.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 14.3 mttp -74.08 166.25 23.73 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.846 179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -125.13 171.0 8.11 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.554 -1.341 . . . . 0.0 112.684 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.57 ' O ' ' CD2' ' A' ' 63' ' ' HIS . 51.9 Cg_endo -86.12 -57.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.81 1.953 . . . . 0.0 109.71 178.841 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.1 OUTLIER 161.76 122.72 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -179.377 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.887 ' HA ' HD21 ' A' ' 113' ' ' LEU . 55.8 Cg_endo -76.1 66.41 6.94 Favored 'Trans proline' 0 C--N 1.296 -2.224 0 O-C-N 123.645 1.34 . . . . 0.0 109.893 -179.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.742 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.4 p -85.34 -173.25 4.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.525 -0.734 . . . . 0.0 109.275 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.823 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 176.52 170.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.34 179.159 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.538 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 1.1 p -79.79 111.16 15.83 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.407 -0.808 . . . . 0.0 111.434 -178.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.506 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 10.3 m-20 36.83 63.0 0.72 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.646 -0.659 . . . . 0.0 111.211 178.996 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.579 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -154.48 -44.54 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 33.7 p90 39.99 -169.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.256 1.027 . . . . 0.0 111.302 -179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.93 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -135.58 154.46 51.34 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.984 179.858 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.77 -17.43 13.94 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.895 -1.128 . . . . 0.0 110.2 -178.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.41 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 30.9 t -49.63 -95.58 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.35 -0.844 . . . . 0.0 110.462 -179.699 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -158.06 88.87 0.11 Allowed Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.049 -179.813 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.6 ' O ' ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -78.55 100.34 6.89 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -1.074 . . . . 0.0 109.479 179.457 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.588 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 1.8 ttmt -88.65 133.72 34.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.913 -179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.446 ' C ' ' O ' ' A' ' 76' ' ' LYS . 2.6 ttt180 -40.27 -32.41 0.18 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.406 -0.809 . . . . 0.0 110.359 -179.818 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 m -128.23 134.11 48.94 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.447 -0.783 . . . . 0.0 110.08 179.762 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.588 ' CE2' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-85 -117.81 -159.75 0.76 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.223 -0.923 . . . . 0.0 109.766 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.703 ' C ' HG23 ' A' ' 59' ' ' VAL . 90.5 p -157.84 -111.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.845 -1.159 . . . . 0.0 111.672 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.613 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -115.24 11.74 16.31 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.328 -1.482 . . . . 0.0 110.8 -178.396 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.602 ' HA ' HG22 ' A' ' 102' ' ' THR . 0.7 OUTLIER -159.03 -3.49 0.08 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.749 -1.219 . . . . 0.0 112.896 -179.243 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -55.04 86.39 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 O-C-N 120.848 -1.158 . . . . 0.0 108.706 179.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASN . 48.8 t30 -72.74 129.45 38.23 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.429 -0.794 . . . . 0.0 111.796 -178.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.592 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.8 m -116.79 117.14 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.316 -0.865 . . . . 0.0 109.624 178.278 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -82.99 120.83 26.22 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.354 -0.841 . . . . 0.0 108.955 179.639 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.93 ' CE1' HD12 ' A' ' 71' ' ' LEU . 57.3 m-85 -82.25 138.76 34.53 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 112.451 -177.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.617 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -113.26 84.24 1.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.067 -179.641 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.503 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -38.28 128.95 1.36 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.574 -0.704 . . . . 0.0 110.712 -179.798 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -37.48 -83.64 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.592 -0.692 . . . . 0.0 110.452 179.886 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.567 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.1 t80 -166.13 143.3 5.28 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 0.0 109.889 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.23 46.5 85.95 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.604 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' ' 118' ' ' ARG . 17.9 m-85 -151.57 157.28 42.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.443 -1.033 . . . . 0.0 109.973 -179.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.463 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -119.36 112.12 19.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 0.0 110.09 179.884 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' A' ' 114' ' ' PRO . 18.6 mt -48.18 95.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.218 -0.926 . . . . 0.0 110.436 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.481 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -74.93 94.06 2.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.467 179.212 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.05 -89.6 0.14 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -154.5 118.17 4.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -1.172 . . . . 0.0 110.618 -179.833 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' N ' ' A' ' 87' ' ' PHE . 6.2 p -72.82 -7.27 49.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.327 -0.858 . . . . 0.0 110.468 -179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -141.69 101.72 4.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.141 -0.974 . . . . 0.0 109.857 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.496 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 10.9 m -111.15 162.49 14.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.357 -0.839 . . . . 0.0 110.923 -179.561 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.602 HG22 ' HA ' ' A' ' 82' ' ' ASN . 3.5 m -138.68 134.25 33.37 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.17 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 49.3 t -61.93 95.41 0.06 Allowed 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.134 -1.027 . . . . 0.0 108.806 179.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.4 175.97 0.45 Allowed Pre-proline 0 C--N 1.298 -1.638 0 O-C-N 121.508 -0.745 . . . . 0.0 111.259 -178.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.816 ' CB ' HD12 ' A' ' 38' ' ' ILE . 47.8 Cg_endo -81.24 19.55 1.15 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.523 1.802 . . . . 0.0 111.205 -179.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.552 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -113.5 8.19 24.35 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.162 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.892 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 76.27 61.15 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.785 -0.833 . . . . 0.0 110.508 179.708 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.892 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -176.83 173.38 1.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.073 -1.017 . . . . 0.0 111.854 179.89 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.734 ' HB3' HD13 ' A' ' 113' ' ' LEU . 27.8 m95 -95.69 92.26 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.575 0.703 . . . . 0.0 110.692 -179.618 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.533 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 10.5 mmtm -109.61 135.35 20.37 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.577 -0.702 . . . . 0.0 109.628 179.694 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.2 Cg_endo -69.81 166.41 74.25 Favored 'Cis proline' 0 C--N 1.313 -1.333 0 C-N-CA 122.179 -2.009 . . . . 0.0 111.285 -0.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -43.67 139.87 2.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.59 -0.694 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.887 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -47.99 146.62 4.05 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.778 . . . . 0.0 110.254 179.441 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.823 ' HG2' HD12 ' A' ' 66' ' ' ILE . 42.9 Cg_endo -72.57 160.41 46.65 Favored 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 124.363 1.717 . . . . 0.0 110.713 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.552 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.3 ttmt -122.48 106.9 11.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.967 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.0 t -62.59 96.33 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.108 -0.995 . . . . 0.0 109.18 179.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 115' ' ' LYS . 2.1 m -113.41 178.59 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-O 121.608 0.718 . . . . 0.0 110.812 -179.309 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.581 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.796 0 C-N-CA 119.176 -1.009 . . . . 0.0 110.269 179.507 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 77.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.298 0.571 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 1' ' ' VAL . 18.9 mttt -159.89 174.23 14.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.874 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.584 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -122.7 91.58 3.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.239 -0.913 . . . . 0.0 110.213 179.954 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' SER . 36.8 mt-30 -71.53 175.55 5.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.706 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 19' ' ' ASP . 0.9 OUTLIER -41.79 138.04 1.82 Allowed Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.375 -0.828 . . . . 0.0 109.874 179.892 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.715 ' HG3' HG11 ' A' ' 27' ' ' VAL . 47.9 Cg_endo -69.08 158.44 57.84 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.97 1.51 . . . . 0.0 111.091 -178.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.68 169.01 23.34 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.886 1.466 . . . . 0.0 110.264 179.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.6 p -73.32 176.24 6.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.202 -0.936 . . . . 0.0 110.15 179.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.86 -170.44 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 122.166 0.984 . . . . 0.0 111.462 179.726 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 16.7 m -40.08 91.91 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.035 -178.997 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 9' ' ' ILE . 6.0 m120 43.09 40.11 2.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.061 -1.024 . . . . 0.0 110.433 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -132.22 176.48 19.32 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.49 ' HG3' ' HB2' ' A' ' 30' ' ' SER . 3.3 mtp180 -123.29 -174.93 3.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.386 -1.067 . . . . 0.0 109.759 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 20.6 p80 -153.25 122.99 6.81 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.1 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.409 ' CG ' ' O ' ' A' ' 14' ' ' HIS . 72.1 m-80 -156.61 122.12 4.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.163 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA3' ' OH ' ' A' ' 21' ' ' TYR . . . -118.69 31.16 5.65 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 2.1 t80 66.53 25.38 10.1 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.321 -1.106 . . . . 0.0 110.358 179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.497 ' CD ' ' CZ ' ' A' ' 21' ' ' TYR . 9.9 pt-20 -159.34 -174.3 4.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.196 -0.94 . . . . 0.0 110.424 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 5' ' ' SER . 12.0 m-20 -123.41 -28.6 3.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.809 . . . . 0.0 110.14 179.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -105.36 -170.81 1.8 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.307 -0.871 . . . . 0.0 110.808 -179.465 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 20' ' ' PHE . 1.4 m-85 -174.3 -31.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.699 -0.626 . . . . 0.0 109.985 179.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.584 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 17.2 m 67.28 -93.96 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.501 -0.749 . . . . 0.0 112.509 178.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -149.11 155.05 40.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.733 -1.229 . . . . 0.0 109.963 -178.424 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.58 12.54 56.63 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 -179.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -85.66 162.58 18.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.615 -0.932 . . . . 0.0 110.239 -179.897 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 43' ' ' VAL . 78.3 t -139.21 152.29 23.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.774 ' O ' HG23 ' A' ' 43' ' ' VAL . 24.4 t -135.06 124.52 42.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.101 -1.04 . . . . 0.0 111.696 -179.068 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.884 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.26 101.31 4.63 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 118.858 -1.137 . . . . 0.0 108.073 178.422 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.002 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.48 153.24 44.13 Favored 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.017 -178.547 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.49 ' HB2' ' HG3' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -115.1 160.89 19.11 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.597 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 17.6 m -128.44 149.46 50.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.04 -1.038 . . . . 0.0 110.534 -179.814 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -56.25 148.92 17.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 110.242 179.825 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.2 p -49.8 115.48 1.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 110.45 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.52 8.13 31.1 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.556 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 2.0 m-85 -118.1 131.54 56.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -1.203 . . . . 0.0 110.348 -179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.689 ' CB ' HG13 ' A' ' 59' ' ' VAL . 8.2 m -82.83 138.31 34.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 110.821 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 41' ' ' SER . 6.2 tp -94.59 101.23 13.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 110.099 179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.931 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -96.17 159.9 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.098 179.236 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 40' ' ' ASN . . . 89.35 34.77 8.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.454 ' CB ' ' O ' ' A' ' 39' ' ' GLY . 6.2 m120 66.18 176.27 0.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -1.144 . . . . 0.0 109.978 -179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.884 ' O ' HG23 ' A' ' 28' ' ' THR . 0.7 OUTLIER -116.8 70.71 0.78 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.721 179.632 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA2' ' O ' ' A' ' 27' ' ' VAL . . . 169.93 109.69 0.22 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.002 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -69.81 -174.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.152 -1.204 . . . . 0.0 108.445 179.177 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.652 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -144.55 102.19 3.78 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.061 178.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -88.52 108.76 19.58 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.196 -0.94 . . . . 0.0 109.61 179.083 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 53.0 p -125.84 107.81 10.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.49 41.58 6.06 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.455 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 58.95 30.06 65.96 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.815 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -145.96 105.86 4.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.126 -1.22 . . . . 0.0 110.608 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.638 ' CH2' HG23 ' A' ' 27' ' ' VAL . 85.8 m95 -62.07 137.01 58.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.795 179.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.6 169.72 17.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.085 -1.009 . . . . 0.0 111.075 -179.463 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 47.45 65.22 7.28 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.821 -0.55 . . . . 0.0 110.974 179.835 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.5 Cg_endo -90.81 135.03 1.91 Allowed 'Trans proline' 0 C--N 1.299 -2.06 0 O-C-N 124.381 1.727 . . . . 0.0 109.506 179.055 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.545 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.2 Cg_endo -74.29 161.36 40.61 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 123.71 1.374 . . . . 0.0 110.072 -179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.0 p -104.0 143.83 32.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 111.849 -178.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.556 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 63.5 m -109.76 74.86 0.91 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -114.94 173.81 6.29 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.519 0.676 . . . . 0.0 110.755 -178.169 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -86.34 145.37 7.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.987 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.689 HG13 ' CB ' ' A' ' 36' ' ' SER . 16.1 m -126.29 48.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 118.856 -1.138 . . . . 0.0 111.756 -178.164 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 7.0 mtpt -86.05 160.95 19.16 Favored 'General case' 0 C--N 1.284 -2.26 0 C-N-CA 118.842 -1.143 . . . . 0.0 107.961 178.412 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 16.0 m -122.73 167.86 13.34 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.516 -1.365 . . . . 0.0 112.154 -178.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 42.6 Cg_endo -75.42 -59.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 124.632 1.859 . . . . 0.0 110.47 179.489 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 168.22 124.0 0.04 OUTLIER Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.184 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.632 ' HG3' HG11 ' A' ' 85' ' ' VAL . 53.4 Cg_endo -75.87 71.96 5.35 Favored 'Trans proline' 0 C--N 1.296 -2.219 0 O-C-N 123.715 1.377 . . . . 0.0 109.707 -179.009 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.476 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -94.78 177.48 5.89 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.303 -0.873 . . . . 0.0 109.566 -179.735 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.757 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -171.47 167.37 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.427 179.809 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.48 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.4 OUTLIER -73.39 106.69 5.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.499 -0.751 . . . . 0.0 110.677 -179.498 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.537 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.7 m120 40.7 36.63 0.41 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 110.502 179.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.756 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.0 31.13 1.76 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.595 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.4 p90 -44.89 -175.27 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 122.577 1.179 . . . . 0.0 112.186 -179.492 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.803 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -110.45 160.95 16.14 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.772 179.091 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.485 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 1.6 t -149.6 24.09 0.88 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.739 -1.226 . . . . 0.0 109.951 -179.343 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.54 ' HB3' ' CB ' ' A' ' 86' ' ' ASP . 24.0 t -112.39 -37.26 5.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.279 -0.888 . . . . 0.0 110.734 -179.405 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.78 ' O ' HG12 ' A' ' 85' ' ' VAL . . . -165.05 95.62 0.12 Allowed Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.584 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 1.8 t80 -125.98 150.24 48.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.385 -1.068 . . . . 0.0 109.734 179.514 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 12.7 ttmm -154.15 140.53 18.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.166 -0.959 . . . . 0.0 110.179 -179.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 76' ' ' LYS . 3.3 mtt180 -41.57 -51.88 3.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.211 -0.931 . . . . 0.0 110.399 -179.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.1 m -94.99 168.26 10.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.808 . . . . 0.0 110.24 179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.595 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 48.8 m-85 -149.16 179.97 7.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.319 -0.863 . . . . 0.0 110.104 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.2 m -159.58 -160.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.043 -1.036 . . . . 0.0 110.597 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.71 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 1.8 t80 -73.91 54.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.648 -1.282 . . . . 0.0 109.866 -179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.732 ' O ' HG22 ' A' ' 102' ' ' THR . 8.4 p-10 173.51 -125.08 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.91 -1.118 . . . . 0.0 109.939 179.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 49.87 67.83 0.84 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.878 -1.139 . . . . 0.0 109.62 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.721 ' N ' HG23 ' A' ' 102' ' ' THR . 7.7 p-10 -69.81 104.05 2.35 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.553 -0.717 . . . . 0.0 110.541 -179.045 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 74' ' ' GLY . 17.3 m -83.97 123.22 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.874 -1.141 . . . . 0.0 110.546 179.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.54 ' CB ' ' HB3' ' A' ' 73' ' ' SER . 2.3 t70 -81.11 124.88 29.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.926 -1.109 . . . . 0.0 109.001 179.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.803 ' CE1' HD12 ' A' ' 71' ' ' LEU . 26.5 m-85 -88.41 123.46 32.99 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.997 -1.064 . . . . 0.0 111.851 -178.581 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 70' ' ' TYR . 9.5 tttm -102.31 109.28 20.9 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.659 179.802 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -58.79 130.51 47.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.071 -1.018 . . . . 0.0 110.192 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.537 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 21.7 mmtt -39.41 -91.2 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.457 -0.777 . . . . 0.0 110.671 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 33.9 p90 -144.82 149.62 35.74 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.083 -1.011 . . . . 0.0 110.724 -179.831 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.582 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 39.76 37.3 0.89 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 179.714 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 17.5 m-85 -137.64 146.56 44.04 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.361 -1.082 . . . . 0.0 110.584 -179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 116' ' ' CYS . 0.0 OUTLIER -106.66 162.76 13.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 0.0 108.956 179.097 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.664 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -96.31 106.29 18.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.742 -1.224 . . . . 0.0 110.618 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.5 t -86.83 102.06 13.94 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.505 -0.747 . . . . 0.0 109.578 179.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 137.47 -43.59 1.2 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.564 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 1.0 OUTLIER 175.49 -166.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 111.238 -179.595 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -148.9 -67.85 0.22 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.707 -0.621 . . . . 0.0 109.999 -179.774 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 56.2 p -92.09 84.01 5.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.89 . . . . 0.0 109.805 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 1.4 m -86.29 166.52 15.59 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 110.314 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 82' ' ' ASN . 3.9 m -146.13 139.46 25.98 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.618 -179.132 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.57 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 51.8 t -61.76 104.51 0.45 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -74.12 176.59 2.72 Favored Pre-proline 0 C--N 1.298 -1.674 0 O-C-N 121.083 -1.011 . . . . 0.0 111.319 -178.495 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.931 ' HB2' HD12 ' A' ' 38' ' ' ILE . 52.4 Cg_endo -80.28 10.03 3.39 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.722 1.906 . . . . 0.0 110.974 -178.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.553 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -104.99 7.37 44.44 Favored Glycine 0 N--CA 1.483 1.802 0 N-CA-C 108.96 -1.656 . . . . 0.0 108.96 179.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.881 ' O ' HG23 ' A' ' 108' ' ' THR . 0.5 OUTLIER 76.13 61.16 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.708 -0.878 . . . . 0.0 109.953 179.94 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.881 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -176.97 175.5 1.57 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.771 179.944 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.603 ' CD2' ' HB3' ' A' ' 64' ' ' PRO . 31.7 m95 -98.41 95.36 7.29 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.573 0.701 . . . . 0.0 110.518 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.532 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 1.4 mmmt -107.59 136.36 19.64 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.585 -0.697 . . . . 0.0 109.422 179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 44.2 Cg_endo -70.4 166.02 76.88 Favored 'Cis proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.25 -1.979 . . . . 0.0 111.29 0.693 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 111' ' ' PRO . 14.9 tt0 -42.3 134.93 2.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.51 -0.744 . . . . 0.0 109.88 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD12 ' CZ ' ' A' ' 87' ' ' PHE . 0.6 OUTLIER -42.18 139.56 1.76 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.95 -179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.757 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.1 Cg_endo -71.22 169.54 20.43 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.233 1.649 . . . . 0.0 111.535 -179.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.839 ' HG2' HG13 ' A' ' 117' ' ' VAL . 8.5 tttt -125.04 108.34 11.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.464 -0.773 . . . . 0.0 110.901 -179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.547 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -61.04 97.52 0.06 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 108.875 178.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.839 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -103.36 -179.16 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.828 0.823 . . . . 0.0 111.183 -178.974 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.35 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.483 ' CG2' ' HA3' ' A' ' 48' ' ' GLY . 3.9 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.258 0.552 . . . . 0.0 110.104 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -160.9 166.37 28.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.191 -0.943 . . . . 0.0 110.162 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.578 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -126.61 72.58 1.34 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 110.12 -179.892 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 0.1 OUTLIER -59.28 179.6 0.1 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.261 -0.9 . . . . 0.0 110.302 -179.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.4 p -43.17 142.8 1.48 Allowed Pre-proline 0 C--N 1.3 -1.576 0 O-C-N 121.529 -0.732 . . . . 0.0 110.037 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.649 ' HG3' HG21 ' A' ' 27' ' ' VAL . 47.6 Cg_endo -72.49 164.15 36.46 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 124.057 1.556 . . . . 0.0 110.569 -179.801 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.48 169.51 21.58 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.98 1.516 . . . . 0.0 110.286 179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.16 178.24 7.21 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.243 -0.91 . . . . 0.0 109.804 179.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.732 HG21 ' CD2' ' A' ' 29' ' ' TYR . 0.2 OUTLIER -142.13 -170.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 CA-C-O 122.329 1.061 . . . . 0.0 111.886 179.91 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 3.1 t -59.85 83.52 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.285 -179.03 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 9' ' ' ILE . 21.1 m120 54.68 59.28 4.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.617 179.394 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -159.25 147.24 14.36 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 30' ' ' SER . 10.2 mtt180 -93.96 -170.43 2.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -1.141 . . . . 0.0 110.919 -179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.525 ' N ' ' CD2' ' A' ' 14' ' ' HIS . 11.8 m170 -85.39 -139.23 0.08 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.062 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 52.8 t30 -87.37 -54.99 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.217 179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -175.09 -37.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 11.8 t80 -174.42 79.3 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.227 -1.161 . . . . 0.0 110.48 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.606 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 8.5 mp0 -108.41 177.41 4.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 110.118 179.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.519 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 4.9 t0 178.04 -24.27 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.973 179.26 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -141.91 88.89 2.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.055 -1.028 . . . . 0.0 109.493 179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.9 m-85 -98.49 -9.53 24.9 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.451 -0.78 . . . . 0.0 111.116 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.578 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.2 p 43.22 -92.15 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.548 179.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 21' ' ' TYR . 3.7 t0 -153.57 131.91 12.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.985 -1.072 . . . . 0.0 110.475 -178.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.46 47.75 2.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 42.2 m -148.41 154.34 39.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.209 -1.171 . . . . 0.0 110.376 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.876 HG13 ' O ' ' A' ' 43' ' ' VAL . 26.7 t -129.31 152.61 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.3 -0.875 . . . . 0.0 111.567 -178.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.649 HG21 ' HG3' ' A' ' 6' ' ' PRO . 33.4 t -122.27 114.39 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.628 -0.67 . . . . 0.0 111.484 -179.568 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -71.99 103.63 3.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 118.404 -1.318 . . . . 0.0 107.623 177.771 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.732 ' CD2' HG21 ' A' ' 9' ' ' ILE . 2.2 m-30 -67.75 118.56 11.16 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.496 -0.753 . . . . 0.0 110.138 -178.198 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.532 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -74.53 154.66 38.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.643 179.539 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.496 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 36.1 m -128.54 153.46 47.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -0.984 . . . . 0.0 110.39 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.63 166.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.844 179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -68.61 98.93 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.936 . . . . 0.0 110.399 -179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.13 11.08 8.47 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 3.0 m-30 -105.76 119.2 38.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.173 . . . . 0.0 110.184 179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.828 ' HB2' HG22 ' A' ' 59' ' ' VAL . 19.8 t -68.32 141.87 55.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 110.581 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.593 ' C ' HD13 ' A' ' 38' ' ' ILE . 1.4 tp -95.89 108.58 20.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.252 -0.905 . . . . 0.0 109.291 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.734 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -103.22 140.22 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.346 -0.846 . . . . 0.0 109.313 -179.839 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 134.82 -142.03 13.42 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.501 ' O ' ' C ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -110.55 52.57 0.73 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.175 -1.191 . . . . 0.0 110.335 179.968 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.501 ' C ' ' O ' ' A' ' 40' ' ' ASN . 20.2 p 26.3 59.14 0.07 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.881 179.269 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.649 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 133.57 122.24 2.28 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.412 179.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.876 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.7 t -61.53 176.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.14 -1.212 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.7 tp -142.39 93.97 2.6 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.639 -1.225 . . . . 0.0 110.686 178.786 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.92 109.8 17.35 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.371 178.213 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.9 t -131.04 98.26 4.53 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.549 -178.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.84 20.45 9.94 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.829 -1.308 . . . . 0.0 109.829 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.483 ' HA3' ' CG2' ' A' ' 1' ' ' VAL . . . 84.24 10.25 80.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -133.95 116.6 15.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.072 -1.252 . . . . 0.0 110.765 -179.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.606 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -68.48 140.32 55.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.837 179.439 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.89 150.61 34.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.062 -1.024 . . . . 0.0 111.188 -179.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.515 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 64.35 65.71 1.07 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.685 -0.635 . . . . 0.0 111.637 179.21 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.0 Cg_endo -91.71 136.37 1.78 Allowed 'Trans proline' 0 C--N 1.299 -2.052 0 O-C-N 124.369 1.721 . . . . 0.0 109.559 178.588 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.532 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.7 Cg_endo -80.57 179.1 6.35 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.71 1.374 . . . . 0.0 110.745 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 38' ' ' ILE . 5.2 p -123.91 148.9 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.8 . . . . 0.0 111.371 -178.68 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' SER . 94.2 m -110.51 78.59 1.13 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.16 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.31 -159.39 0.68 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.415 0.626 . . . . 0.0 110.368 -178.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.671 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.15 125.64 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.36 -0.837 . . . . 0.0 108.936 179.88 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.828 HG22 ' HB2' ' A' ' 36' ' ' SER . 22.5 m -118.9 52.99 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.13 -0.981 . . . . 0.0 111.597 -179.102 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 13.2 mtpt -60.82 -179.86 0.14 Allowed 'General case' 0 C--N 1.282 -2.351 0 C-N-CA 117.811 -1.556 . . . . 0.0 107.964 178.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.525 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 93.4 m -136.71 160.51 66.18 Favored Pre-proline 0 C--N 1.297 -1.71 0 C-N-CA 118.529 -1.268 . . . . 0.0 112.762 -178.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.505 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 43.5 Cg_endo -85.2 -72.56 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.736 1.913 . . . . 0.0 109.95 178.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.58 124.9 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.472 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.743 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.621 ' HG3' HG11 ' A' ' 85' ' ' VAL . 50.5 Cg_endo -77.44 65.61 8.0 Favored 'Trans proline' 0 C--N 1.297 -2.14 0 O-C-N 123.867 1.456 . . . . 0.0 109.768 179.841 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.458 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -81.86 161.23 23.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.596 -0.69 . . . . 0.0 110.293 -179.68 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.821 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -157.11 166.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.133 -0.98 . . . . 0.0 110.743 -179.664 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.47 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -77.39 108.11 10.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.602 -0.686 . . . . 0.0 110.691 -179.385 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.523 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 0.9 OUTLIER 39.93 41.19 0.83 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.483 -0.761 . . . . 0.0 110.615 179.573 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.821 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -151.5 33.11 0.92 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.3 p90 -44.84 -176.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 112.469 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.743 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -112.0 161.67 16.2 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.938 179.353 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.83 30.19 1.48 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.829 -1.169 . . . . 0.0 110.382 -179.131 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 28.9 t -110.81 -86.29 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 110.47 -179.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.24 71.8 0.3 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.639 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 2.1 t80 -99.51 166.25 11.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.39 -1.065 . . . . 0.0 110.018 179.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.639 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -171.05 161.2 6.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.855 . . . . 0.0 109.79 179.917 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 46.0 mtp180 -51.14 -32.57 23.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.944 -1.098 . . . . 0.0 109.451 179.738 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.467 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 1.2 m -144.82 170.76 15.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.67 -0.644 . . . . 0.0 109.798 179.674 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 3.8 m-85 -143.72 -134.68 0.09 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.218 -0.926 . . . . 0.0 109.938 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.569 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 60.4 p -167.34 -133.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.839 -1.163 . . . . 0.0 111.133 -179.9 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.74 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -87.22 14.88 6.97 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.771 -1.206 . . . . 0.0 110.873 -178.848 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.599 ' HA ' HG22 ' A' ' 102' ' ' THR . 59.9 t30 -160.53 -116.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.711 -1.243 . . . . 0.0 110.775 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' ASN . 5.8 m-20 54.51 76.89 0.22 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.81 -1.181 . . . . 0.0 108.888 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' HG23 ' A' ' 102' ' ' THR . 22.4 t-20 -71.43 109.83 5.65 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.442 -0.786 . . . . 0.0 110.535 -178.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.621 HG11 ' HG3' ' A' ' 64' ' ' PRO . 14.8 m -87.38 119.44 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.98 -1.075 . . . . 0.0 110.49 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.526 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 3.4 t0 -80.6 129.52 34.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.316 -0.865 . . . . 0.0 108.798 179.228 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.743 ' CE1' HD12 ' A' ' 71' ' ' LEU . 35.0 m-85 -89.04 142.22 27.82 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.038 -1.039 . . . . 0.0 112.19 -178.237 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -121.26 92.06 3.67 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.51 -179.607 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -42.41 130.74 3.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 110.417 -179.425 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.523 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 5.5 mmtt -42.55 -89.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.445 -0.785 . . . . 0.0 110.121 -179.787 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.583 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -153.21 154.58 34.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.913 . . . . 0.0 110.421 -179.977 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.584 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 43.55 31.53 1.7 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.7 m-85 -143.35 144.88 32.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.456 -1.026 . . . . 0.0 110.316 -179.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 117' ' ' VAL . 16.4 pttp -113.59 139.43 49.01 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.301 -0.875 . . . . 0.0 109.577 179.54 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.601 HD23 HD11 ' A' ' 66' ' ' ILE . 1.2 mt -66.9 114.15 5.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.099 -1.001 . . . . 0.0 111.118 -179.226 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -92.16 98.02 11.27 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.613 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 140.14 -45.82 0.97 Allowed Glycine 0 N--CA 1.489 2.18 0 C-N-CA 119.666 -1.254 . . . . 0.0 110.228 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.526 ' CB ' ' CG ' ' A' ' 111' ' ' PRO . 10.7 t -177.3 -172.99 0.41 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.077 -1.249 . . . . 0.0 111.69 -179.458 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 p -144.76 -27.32 0.49 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.461 179.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.4 p -132.48 97.01 3.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.865 -1.147 . . . . 0.0 109.694 179.601 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 24.8 m -103.3 162.66 12.81 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 111.065 -179.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.599 HG22 ' HA ' ' A' ' 82' ' ' ASN . 1.1 m -136.56 137.02 39.78 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.784 -0.572 . . . . 0.0 110.148 -179.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.606 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 45.5 t -77.28 96.85 4.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.056 -1.027 . . . . 0.0 110.354 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.499 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -66.38 -176.3 0.23 Allowed Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.602 -0.686 . . . . 0.0 110.741 179.936 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.734 ' HG3' HG23 ' A' ' 38' ' ' ILE . 42.7 Cg_endo -77.81 124.37 6.81 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.978 1.515 . . . . 0.0 110.55 -179.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 129.48 -7.28 6.25 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.971 -1.652 . . . . 0.0 108.971 -179.207 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.711 ' O ' HG23 ' A' ' 108' ' ' THR . 4.8 m-20 79.35 95.62 0.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.898 -0.766 . . . . 0.0 110.976 179.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.0 -160.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.473 -0.767 . . . . 0.0 111.088 179.453 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.686 ' HB3' HD13 ' A' ' 113' ' ' LEU . 26.9 m95 -149.73 111.43 4.52 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.588 -0.695 . . . . 0.0 110.004 -179.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.534 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.7 mttt -112.11 127.1 27.32 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 110.157 -179.376 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.544 ' O ' ' N ' ' A' ' 113' ' ' LEU . 41.5 Cg_endo -68.14 174.08 35.93 Favored 'Cis proline' 0 C--N 1.315 -1.188 0 C-N-CA 122.064 -2.057 . . . . 0.0 110.549 0.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' A' ' 113' ' ' LEU . 3.7 mt-10 -63.96 59.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.602 -0.686 . . . . 0.0 111.27 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.686 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER 55.94 143.95 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.648 0 CA-C-O 121.442 0.639 . . . . 0.0 111.383 178.951 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.714 ' HG2' HD12 ' A' ' 66' ' ' ILE . 43.0 Cg_endo -84.08 166.87 12.71 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 O-C-N 124.271 1.669 . . . . 0.0 111.09 -179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.708 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.8 OUTLIER -122.0 109.28 14.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.234 -0.916 . . . . 0.0 110.748 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.537 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.1 t -65.28 104.68 0.98 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.067 -1.02 . . . . 0.0 109.258 179.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.708 HG13 ' HG2' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -119.18 -176.02 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 CA-C-O 121.667 0.746 . . . . 0.0 111.023 -179.103 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 . . . . . 0 C--N 1.294 -1.833 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.367 -179.84 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 96.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.271 0.558 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.77 174.59 8.95 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.264 -0.897 . . . . 0.0 110.574 -179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 52.9 t -130.0 158.58 39.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.389 -0.82 . . . . 0.0 110.014 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -133.68 178.06 7.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.415 -0.803 . . . . 0.0 109.978 179.884 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.5 136.88 7.21 Favored Pre-proline 0 C--N 1.298 -1.648 0 O-C-N 121.476 -0.765 . . . . 0.0 110.254 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.613 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.0 Cg_endo -70.24 155.67 63.85 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.157 1.609 . . . . 0.0 110.998 -179.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.68 174.39 12.74 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.841 1.443 . . . . 0.0 109.785 178.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.0 m -69.89 177.15 3.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.099 -1.001 . . . . 0.0 110.2 -179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.756 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.39 -170.27 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 122.261 1.029 . . . . 0.0 111.54 179.872 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -47.06 101.32 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.744 -179.323 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 10' ' ' SER . 24.8 m-20 40.29 47.3 2.12 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.382 -0.824 . . . . 0.0 110.685 179.723 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.29 161.81 30.66 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' SER . 5.1 mpt_? -112.01 -169.89 1.55 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -1.13 . . . . 0.0 110.489 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.613 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.1 p80 -144.67 119.38 9.82 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.735 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.73 81.3 1.97 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.082 -1.011 . . . . 0.0 110.451 -179.538 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.579 ' O ' ' CG ' ' A' ' 17' ' ' TYR . . . -91.28 28.44 8.14 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 16' ' ' GLY . 32.9 p90 37.05 50.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.535 -0.98 . . . . 0.0 110.643 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.589 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 14.5 mm-40 -140.11 -169.48 2.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 110.272 -179.929 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -147.55 -36.91 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.292 -179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.589 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 9.0 p90 -142.2 79.09 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.116 -0.99 . . . . 0.0 110.346 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.648 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 34.0 m-85 -55.43 -166.79 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.631 179.726 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.534 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -152.4 -67.83 0.16 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.91 -1.119 . . . . 0.0 110.743 -179.736 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -159.96 136.79 9.22 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.546 -0.721 . . . . 0.0 109.357 -179.238 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 73.07 7.9 72.45 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.479 -1.848 . . . . 0.0 108.479 -178.606 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.648 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.8 m -73.54 156.37 38.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.448 -1.031 . . . . 0.0 109.809 179.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.759 HG13 ' O ' ' A' ' 43' ' ' VAL . 54.1 t -138.66 153.39 25.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.889 179.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.681 ' HB ' HG23 ' A' ' 43' ' ' VAL . 41.4 t -138.67 118.53 14.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.37 -179.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -71.16 106.31 3.72 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.407 -1.317 . . . . 0.0 107.591 178.059 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.926 ' O ' HD13 ' A' ' 37' ' ' LEU . 3.3 m-30 -68.02 139.01 56.3 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 110.356 -178.053 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -93.98 159.07 15.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 179.549 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.0 m -123.23 149.68 44.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.408 ' O ' ' C ' ' A' ' 33' ' ' SER . 0.6 OUTLIER -45.54 138.0 4.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.201 -0.937 . . . . 0.0 110.27 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 32' ' ' ASN . 0.1 OUTLIER -44.42 106.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.197 -0.939 . . . . 0.0 110.182 179.993 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.52 15.47 6.95 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.04 137.22 50.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -1.123 . . . . 0.0 110.393 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.661 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -85.78 147.01 26.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.307 -0.871 . . . . 0.0 110.929 -179.531 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.926 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.6 tp -95.9 100.63 12.29 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.372 -0.83 . . . . 0.0 109.55 179.073 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.73 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -96.27 173.81 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 108.953 179.55 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 80.62 175.91 49.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.495 -1.336 . . . . 0.0 109.929 179.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' A' ' 54' ' ' PRO . 0.5 OUTLIER -42.51 111.33 0.24 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.386 -1.067 . . . . 0.0 110.021 179.822 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 28' ' ' THR . 89.2 p -70.51 55.18 0.16 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 110.102 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.611 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.37 95.48 0.11 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.759 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -45.91 175.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.357 -1.084 . . . . 0.0 108.768 179.5 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.582 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.2 OUTLIER -141.12 101.0 3.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.405 -0.809 . . . . 0.0 109.923 178.707 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.625 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 6.2 t -78.09 109.38 12.12 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.82 179.521 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -117.64 128.94 55.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.439 -0.788 . . . . 0.0 109.838 179.787 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.59 30.93 57.01 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.38 45.56 29.65 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -151.56 97.78 2.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.275 -1.132 . . . . 0.0 110.51 -179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.625 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 97.9 m95 -64.33 125.59 25.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 110.034 179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.25 171.34 14.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.254 -0.904 . . . . 0.0 110.639 -179.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 52.59 64.53 7.23 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.546 -0.721 . . . . 0.0 110.635 -179.833 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 49.7 Cg_endo -90.9 130.08 1.43 Allowed 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 121.913 1.742 . . . . 0.0 110.233 179.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 49.8 Cg_endo -74.27 176.12 10.03 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.822 1.433 . . . . 0.0 110.536 179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.551 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.4 p -105.62 173.67 6.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.842 0.83 . . . . 0.0 111.266 -179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 10' ' ' SER . 4.6 m -139.75 75.43 1.51 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' SER . 1.6 mm-40 -114.21 -152.13 0.5 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.735 -177.733 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.738 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -118.67 138.42 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.379 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.686 HG23 ' CA ' ' A' ' 80' ' ' SER . 34.5 m -128.25 41.2 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.01 -1.056 . . . . 0.0 110.966 -179.115 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 16.6 mttt -53.93 178.87 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.354 0 C-N-CA 118.641 -1.224 . . . . 0.0 108.358 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -144.16 162.33 40.78 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 118.506 -1.278 . . . . 0.0 112.578 -179.021 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.529 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 44.0 Cg_endo -83.8 -68.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.829 1.963 . . . . 0.0 110.306 179.08 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.529 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 161.31 128.73 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.382 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.742 ' HA ' HD21 ' A' ' 113' ' ' LEU . 49.4 Cg_endo -78.01 60.34 7.29 Favored 'Trans proline' 0 C--N 1.294 -2.3 0 O-C-N 123.571 1.301 . . . . 0.0 109.841 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.711 ' C ' HG22 ' A' ' 66' ' ' ILE . 2.3 p -74.76 -177.3 3.18 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.022 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -176.26 167.77 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 C-N-CA 118.411 -1.316 . . . . 0.0 110.967 179.463 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 6.8 m -70.1 89.76 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.589 -0.694 . . . . 0.0 110.688 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 2.3 m120 50.23 49.62 20.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.0 110.87 179.45 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.022 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -162.66 40.62 0.36 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.6 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.2 p90 -48.25 -151.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 122.968 1.366 . . . . 0.0 113.076 -179.749 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.985 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -142.46 122.82 13.94 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.619 -176.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.5 t -100.4 14.96 29.37 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.52 -0.737 . . . . 0.0 109.968 -179.269 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 24.7 t -76.11 -91.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.38 -0.825 . . . . 0.0 110.969 -179.4 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -135.43 81.25 0.3 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.319 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.609 ' HB2' ' CD1' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -100.04 125.37 46.1 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.358 -1.083 . . . . 0.0 109.713 179.494 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 77' ' ' ARG . 10.0 ttmm -111.05 149.76 30.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.469 -0.769 . . . . 0.0 109.931 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -41.47 -41.46 2.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.863 . . . . 0.0 110.015 -179.988 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m -137.55 152.94 49.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.439 -0.788 . . . . 0.0 109.981 179.713 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.2 OUTLIER -125.62 -162.52 1.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.951 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.686 ' CA ' HG23 ' A' ' 59' ' ' VAL . 2.3 m -153.94 -102.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.314 -0.866 . . . . 0.0 109.583 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.614 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -111.8 137.96 49.03 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.732 -1.23 . . . . 0.0 108.198 179.234 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.843 ' C ' HG22 ' A' ' 102' ' ' THR . 37.4 t-20 71.49 -104.49 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.739 -0.6 . . . . 0.0 110.594 -178.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.458 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 39.5 m-20 44.96 74.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.606 -1.309 . . . . 0.0 109.355 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.831 ' CA ' HG23 ' A' ' 102' ' ' THR . 1.1 t-20 -69.82 140.3 53.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.0 111.056 -178.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.685 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 3.7 m -129.73 126.33 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.299 -0.876 . . . . 0.0 110.114 179.127 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.1 OUTLIER -86.83 132.99 33.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.051 -1.031 . . . . 0.0 109.32 179.399 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.985 ' CE2' HD23 ' A' ' 71' ' ' LEU . 44.4 m-85 -89.31 149.11 23.19 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.145 -0.972 . . . . 0.0 111.935 -178.59 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.554 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -121.65 90.2 3.27 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.162 0.506 . . . . 0.0 110.037 -179.514 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.442 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -43.14 124.5 3.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.176 -0.952 . . . . 0.0 110.489 -179.706 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.8 OUTLIER -41.9 -84.94 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 110.801 -179.757 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.55 ' O ' ' N ' ' A' ' 93' ' ' TYR . 0.7 OUTLIER -97.2 -161.05 0.84 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 110.372 -179.73 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.75 58.36 0.14 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.558 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 3.0 m-30 -112.15 160.79 17.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.721 -0.87 . . . . 0.0 109.404 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.72 ' O ' HG22 ' A' ' 117' ' ' VAL . 10.6 tttt -101.05 136.43 40.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.991 -1.068 . . . . 0.0 110.52 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.556 HD23 HD11 ' A' ' 66' ' ' ILE . 1.6 mt -79.56 90.65 5.12 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.783 -1.198 . . . . 0.0 109.797 179.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.537 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -69.8 101.94 1.82 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.829 179.957 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 142.58 -78.02 0.28 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.133 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.587 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -171.48 117.22 0.42 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -1.12 . . . . 0.0 110.635 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.53 -1.51 13.65 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -0.92 . . . . 0.0 110.966 -179.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.1 p -144.61 112.39 6.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.089 -1.007 . . . . 0.0 109.808 179.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.531 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 3.3 m -118.44 177.19 4.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.23 -0.919 . . . . 0.0 111.041 -179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.843 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -146.95 128.68 15.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.464 -0.773 . . . . 0.0 110.051 179.969 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.59 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 5.4 t -68.91 88.92 0.4 Allowed 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.573 -0.705 . . . . 0.0 109.51 179.516 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.507 ' CB ' ' CD ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -69.16 -178.41 0.45 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.432 -0.793 . . . . 0.0 111.193 -179.248 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.701 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.3 Cg_endo -80.7 124.96 5.33 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 O-C-N 124.564 1.823 . . . . 0.0 110.6 -179.501 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.566 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 128.37 -8.12 6.64 Favored Glycine 0 N--CA 1.481 1.664 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.428 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.762 ' O ' HG23 ' A' ' 108' ' ' THR . 7.2 m-20 83.48 90.91 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.5 0.667 . . . . 0.0 111.31 179.441 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.762 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 176.25 -170.96 0.07 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.723 0.773 . . . . 0.0 111.21 179.023 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.685 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 32.1 m95 -137.73 92.37 2.67 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.451 0.643 . . . . 0.0 110.22 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.563 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 28.4 mttt -103.56 142.96 25.67 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 110.295 -179.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.587 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.8 Cg_endo -70.58 167.57 73.0 Favored 'Cis proline' 0 C--N 1.314 -1.269 0 C-N-CA 122.072 -2.054 . . . . 0.0 111.035 -0.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 113' ' ' LEU . 42.5 mt-10 -38.91 129.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.56 -0.712 . . . . 0.0 111.293 -179.239 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.742 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -40.06 147.25 0.36 Allowed Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.652 -0.655 . . . . 0.0 110.594 179.211 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.806 ' HG2' HD12 ' A' ' 66' ' ' ILE . 39.7 Cg_endo -74.04 167.47 27.13 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 124.441 1.758 . . . . 0.0 110.831 179.601 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.549 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.7 OUTLIER -130.43 105.08 7.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.162 -0.961 . . . . 0.0 110.822 -179.919 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.8 t -61.57 101.44 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.36 -0.837 . . . . 0.0 109.213 179.139 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.72 HG22 ' O ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -115.28 -175.93 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.698 0.761 . . . . 0.0 110.588 -179.404 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HG2' ' CZ ' ' A' ' 93' ' ' TYR . 7.0 mtm180 . . . . . 0 C--N 1.295 -1.791 0 C-N-CA 118.844 -1.143 . . . . 0.0 110.186 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.32 0.581 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.63 138.75 44.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.256 -0.902 . . . . 0.0 110.257 179.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 21' ' ' TYR . 0.5 OUTLIER -108.01 99.21 8.67 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.847 . . . . 0.0 110.117 -179.921 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' SER . 9.9 mt-30 -88.38 177.19 6.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.0 109.985 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.9 OUTLIER -39.09 136.89 0.97 Allowed Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.544 -0.723 . . . . 0.0 110.586 -179.734 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.77 ' HG3' HG11 ' A' ' 27' ' ' VAL . 53.2 Cg_endo -71.27 158.31 54.91 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 124.058 1.557 . . . . 0.0 110.855 -179.453 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.25 170.94 19.26 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.754 1.397 . . . . 0.0 109.865 179.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.59 175.31 4.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 109.666 179.695 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.652 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -138.37 -170.2 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.138 0.97 . . . . 0.0 111.463 179.861 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.3 OUTLIER -46.19 90.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.095 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER 48.11 48.62 18.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 179.786 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -147.65 164.75 28.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.497 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.0 OUTLIER -110.13 -169.95 1.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.371 -1.076 . . . . 0.0 110.524 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.603 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 14.6 p80 -158.89 121.3 3.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.258 0.552 . . . . 0.0 109.981 -179.675 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -161.79 79.09 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.137 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -68.18 -98.0 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 t80 -150.76 34.55 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.213 -1.169 . . . . 0.0 110.222 -179.737 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' CD ' ' CE1' ' A' ' 21' ' ' TYR . 2.5 pt-20 -177.81 -159.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.043 -1.035 . . . . 0.0 110.527 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -162.03 24.71 0.11 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.415 -0.803 . . . . 0.0 110.089 -179.962 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 22' ' ' THR . 0.3 OUTLIER -140.54 29.69 1.94 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.191 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 36.7 m-85 -37.05 142.04 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 0.0 111.135 179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 20' ' ' PHE . 27.8 p -133.8 89.56 2.6 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.228 1.013 . . . . 0.0 110.488 179.248 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER 55.27 152.24 0.01 OUTLIER 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.83 179.127 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 53.29 19.77 8.88 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.705 ' O ' HG23 ' A' ' 26' ' ' VAL . 6.4 m -87.41 177.88 6.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -1.063 . . . . 0.0 109.972 179.784 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 25' ' ' SER . 26.4 t -158.41 156.54 3.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.05 179.495 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.77 HG11 ' HG3' ' A' ' 6' ' ' PRO . 30.3 t -144.99 124.05 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.77 -179.439 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.82 101.34 5.07 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.398 -1.321 . . . . 0.0 107.725 177.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.869 ' O ' HD13 ' A' ' 37' ' ' LEU . 1.8 m-30 -67.99 128.12 35.34 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.512 -0.743 . . . . 0.0 110.423 -178.21 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.497 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 2.6 t -77.89 -173.7 3.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.196 -0.94 . . . . 0.0 108.883 178.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.513 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 89.1 m -147.36 168.25 22.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.104 -0.998 . . . . 0.0 110.239 179.823 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.93 148.52 39.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.266 -0.897 . . . . 0.0 110.433 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.5 93.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.974 179.749 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.19 0.29 7.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -110.88 140.85 45.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -1.138 . . . . 0.0 110.276 -179.811 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.604 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -87.68 145.72 26.03 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.253 -0.905 . . . . 0.0 110.623 -179.937 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.869 HD13 ' O ' ' A' ' 29' ' ' TYR . 1.9 tp -92.05 103.16 15.7 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.323 -0.86 . . . . 0.0 109.937 179.557 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.678 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -97.18 171.0 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.244 -0.91 . . . . 0.0 108.826 179.124 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 87.0 -168.59 39.26 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -65.95 117.82 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -1.125 . . . . 0.0 110.022 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.493 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER -72.69 56.14 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -0.987 . . . . 0.0 109.644 179.53 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 160.27 94.19 0.1 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.585 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG21 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -48.33 179.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 O-C-N 121.341 -1.093 . . . . 0.0 108.85 179.849 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 25' ' ' SER . 10.8 tp -142.64 102.04 3.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.515 -0.741 . . . . 0.0 109.985 178.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.583 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.1 OUTLIER -73.63 118.32 16.44 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 0.0 109.912 179.612 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -133.92 126.83 31.21 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.164 -0.96 . . . . 0.0 110.177 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.01 19.46 77.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.999 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 83.64 25.67 45.52 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -142.4 133.9 26.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.218 -1.166 . . . . 0.0 110.292 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.737 ' CH2' HG23 ' A' ' 27' ' ' VAL . 88.6 m95 -80.07 132.72 36.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.976 179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.18 162.16 33.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.166 -0.959 . . . . 0.0 110.935 -179.604 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER 60.57 66.22 1.9 Allowed Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.509 -0.745 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.6 Cg_endo -90.75 127.2 1.26 Allowed 'Trans proline' 0 C--N 1.3 -2.023 0 C-N-CA 121.91 1.74 . . . . 0.0 110.069 179.281 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 45.8 Cg_endo -71.15 176.89 7.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.668 1.352 . . . . 0.0 110.111 179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 21.7 p -113.39 151.45 31.3 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.203 -0.936 . . . . 0.0 111.916 -178.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 10' ' ' SER . 69.4 m -116.04 80.74 1.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 176.878 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.2 OUTLIER -116.8 -162.45 0.85 Allowed 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.495 0.664 . . . . 0.0 110.425 -178.031 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.664 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -106.4 137.0 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.173 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.687 HG21 ' CB ' ' A' ' 81' ' ' TYR . 26.0 m -118.77 43.01 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.076 -1.015 . . . . 0.0 111.037 -179.266 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.438 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -83.38 98.79 9.67 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.709 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 62' ' ' PRO . 56.4 m -68.68 164.31 46.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.803 . . . . 0.0 111.804 -177.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 38.0 Cg_endo -66.61 -86.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 124.514 1.797 . . . . 0.0 110.303 179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.462 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -165.27 133.94 2.6 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.778 ' HG2' HD21 ' A' ' 71' ' ' LEU . 51.6 Cg_endo -76.5 69.37 6.68 Favored 'Trans proline' 0 C--N 1.295 -2.281 0 O-C-N 123.703 1.37 . . . . 0.0 110.018 -178.953 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.676 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -92.2 -176.85 4.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.444 -0.785 . . . . 0.0 109.07 179.65 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.961 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -174.64 162.87 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 C-N-CA 118.75 -1.18 . . . . 0.0 110.592 179.494 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.476 ' O ' ' OG ' ' A' ' 67' ' ' SER . 3.7 p -69.38 101.31 1.52 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.547 -0.721 . . . . 0.0 110.395 -179.612 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.509 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 21.6 m-20 41.51 57.32 3.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 110.177 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.961 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -170.14 37.31 0.19 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.762 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 1.4 p90 -44.06 -170.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 123.419 1.58 . . . . 0.0 112.907 -179.416 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.946 ' O ' HD12 ' A' ' 71' ' ' LEU . 1.7 pp -107.46 116.16 31.45 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 113.83 -1.532 . . . . 0.0 109.55 179.498 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 88' ' ' LYS . 0.3 OUTLIER -82.28 1.38 37.09 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.42 -0.8 . . . . 0.0 109.602 -179.725 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 21.0 t -74.72 -86.82 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.485 -0.76 . . . . 0.0 110.711 -179.61 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -163.14 94.5 0.12 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.163 -179.683 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.944 ' CB ' HD11 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -81.28 104.3 11.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.38 -1.07 . . . . 0.0 109.296 179.303 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.9 tptt -76.75 145.02 38.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.203 -0.936 . . . . 0.0 110.304 -179.608 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -48.37 70.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.139 -0.976 . . . . 0.0 110.042 179.761 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 27.4 p -117.4 135.29 53.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.489 -0.757 . . . . 0.0 110.012 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.598 ' HB3' ' CB ' ' A' ' 103' ' ' CYS . 95.2 m-85 -113.81 -179.61 3.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 110.129 -179.781 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 2.9 m -170.54 108.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.976 -1.077 . . . . 0.0 111.308 179.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.687 ' CB ' HG21 ' A' ' 59' ' ' VAL . 11.5 t80 34.92 24.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.356 -0.84 . . . . 0.0 113.106 178.771 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.71 ' C ' HG22 ' A' ' 102' ' ' THR . 37.3 t-20 -176.51 -125.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.067 -1.646 . . . . 0.0 111.472 178.388 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.2 t0 49.29 75.42 0.15 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 120.633 -1.292 . . . . 0.0 108.828 -178.359 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.592 ' CA ' HG23 ' A' ' 102' ' ' THR . 22.4 p-10 -69.57 139.9 53.75 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.476 -0.765 . . . . 0.0 110.512 -179.054 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.697 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.5 m -126.43 120.83 57.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.346 -0.846 . . . . 0.0 109.702 179.07 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 10.7 t0 -75.38 136.02 40.78 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.073 -1.017 . . . . 0.0 108.847 179.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.615 ' CE2' HD12 ' A' ' 113' ' ' LEU . 16.5 m-85 -99.36 135.15 41.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.952 -1.092 . . . . 0.0 111.895 -178.564 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 70' ' ' TYR . 3.0 ttpt -109.53 154.91 22.04 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.278 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -100.28 128.18 46.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.92 -1.113 . . . . 0.0 110.098 179.891 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -44.68 -79.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.3 -179.701 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.505 ' O ' ' N ' ' A' ' 93' ' ' TYR . 1.2 m-85 -95.71 -163.81 1.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.452 -0.78 . . . . 0.0 110.576 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.37 59.45 0.17 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.601 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.605 ' HB2' ' SG ' ' A' ' 116' ' ' CYS . 8.6 m-85 -109.38 168.94 9.02 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.788 -0.831 . . . . 0.0 110.009 -179.317 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.544 ' O ' HG22 ' A' ' 117' ' ' VAL . 22.0 mttt -117.3 110.71 18.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.951 -179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.5 mt -49.14 93.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.133 -0.979 . . . . 0.0 110.09 -179.879 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -74.43 95.74 2.77 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 110.044 179.817 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.34 -68.78 0.34 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.712 -1.232 . . . . 0.0 110.333 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.582 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -175.95 119.82 0.16 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.234 -1.156 . . . . 0.0 111.03 -179.148 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.12 24.13 0.44 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.99 -1.069 . . . . 0.0 111.339 179.676 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.2 p -167.22 129.17 1.64 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.951 -1.093 . . . . 0.0 109.273 179.527 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 66.4 m -143.58 160.66 40.25 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.001 . . . . 0.0 111.189 -179.145 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.71 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.38 137.83 50.07 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.575 0.703 . . . . 0.0 109.931 179.301 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 79' ' ' TYR . 1.8 t -56.25 92.75 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.642 -0.661 . . . . 0.0 109.718 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.471 ' O ' ' SG ' ' A' ' 61' ' ' CYS . 1.1 p -71.3 179.29 0.97 Allowed Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.057 -1.027 . . . . 0.0 110.118 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.678 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.0 Cg_endo -78.51 170.75 17.88 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 O-C-N 124.018 1.536 . . . . 0.0 111.448 -179.026 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.629 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 86.13 -57.24 4.79 Favored Glycine 0 N--CA 1.481 1.682 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 -178.906 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.6 OUTLIER 141.66 68.76 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.715 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.365 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.26 165.65 24.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.652 -1.28 . . . . 0.0 112.032 -179.473 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.697 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 35.7 m95 -105.99 97.79 7.56 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.307 0.575 . . . . 0.0 109.849 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 5.1 mmmt -99.37 138.85 20.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.56 -179.338 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.582 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.7 Cg_endo -72.06 167.84 75.67 Favored 'Cis proline' 0 N--CA 1.49 1.277 0 C-N-CA 121.961 -2.1 . . . . 0.0 110.793 -0.48 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.4 tt0 -41.4 134.06 2.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.0 110.328 -179.68 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.755 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -42.27 152.07 0.34 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.385 -0.822 . . . . 0.0 110.706 -179.736 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.804 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.0 Cg_endo -79.42 159.3 25.85 Favored 'Trans proline' 0 C--N 1.301 -1.957 0 O-C-N 124.554 1.818 . . . . 0.0 111.487 -179.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.67 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.1 tptt -119.03 106.57 12.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.512 -0.742 . . . . 0.0 110.713 -179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.4 t -62.43 97.86 0.1 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.146 -0.971 . . . . 0.0 108.774 178.964 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.67 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -112.02 178.28 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 121.55 0.691 . . . . 0.0 110.592 -179.396 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HB3' ' CE2' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.662 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.713 HG11 ' HA2' ' A' ' 47' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.327 0.584 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -120.11 174.4 6.51 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 110.178 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.541 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -140.11 85.08 2.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 110.643 -179.696 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 25.3 mt-30 -60.47 171.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.984 . . . . 0.0 110.015 179.677 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.5 p -47.77 149.39 2.26 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 179.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.668 ' HG3' HG21 ' A' ' 27' ' ' VAL . 51.4 Cg_endo -72.31 155.76 55.58 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.95 1.5 . . . . 0.0 110.946 -179.159 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -74.44 169.08 23.33 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.599 1.315 . . . . 0.0 109.686 179.253 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.27 177.22 2.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.139 -0.976 . . . . 0.0 109.993 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.69 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -141.34 -170.38 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.197 0.998 . . . . 0.0 111.475 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -45.62 94.0 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.538 -179.396 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.481 ' N ' ' O ' ' A' ' 9' ' ' ILE . 11.0 m120 41.76 53.08 4.05 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 0.0 110.287 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -151.85 152.65 24.36 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' HB2' ' HB2' ' A' ' 30' ' ' SER . 9.9 mtt180 -94.99 -169.12 1.93 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -1.146 . . . . 0.0 110.786 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.614 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 17.2 p80 -160.4 132.72 6.23 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.99 -179.631 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER 173.77 104.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.011 -1.056 . . . . 0.0 110.7 179.94 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' O ' ' HB3' ' A' ' 17' ' ' TYR . . . -81.51 -69.11 1.41 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.555 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 33.0 p90 178.61 41.35 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -1.117 . . . . 0.0 110.334 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -152.51 -139.92 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.823 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.7 OUTLIER -149.9 -36.36 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.042 -1.036 . . . . 0.0 110.992 -179.881 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 14.8 p90 -143.98 90.46 2.13 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.859 -1.151 . . . . 0.0 111.227 -179.403 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.613 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 44.8 m-85 -57.8 171.2 0.51 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.532 178.88 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.474 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 0.6 OUTLIER -125.96 -49.07 1.6 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.832 -1.168 . . . . 0.0 111.192 -179.359 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -175.44 142.58 0.59 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.304 -0.872 . . . . 0.0 109.565 -179.352 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.42 14.33 69.1 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 -178.741 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.613 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 5.9 m -87.8 178.38 6.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.615 -0.932 . . . . 0.0 110.15 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.738 HG13 ' O ' ' A' ' 43' ' ' VAL . 31.5 t -154.46 154.04 7.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.266 179.901 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.668 HG21 ' HG3' ' A' ' 6' ' ' PRO . 39.6 t -135.8 118.69 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.237 -0.985 . . . . 0.0 111.39 -179.701 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.856 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -71.0 103.32 2.65 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.248 . . . . 0.0 107.707 177.915 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.69 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.4 m-30 -68.14 134.46 50.57 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -178.082 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 13' ' ' ARG . 1.1 m -93.15 159.3 15.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.383 -0.823 . . . . 0.0 109.612 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 34.2 m -126.08 154.01 43.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 110.255 -179.794 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -44.39 158.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.011 179.859 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 t -62.08 92.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 0.0 110.356 -179.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.31 22.36 3.17 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.759 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.533 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 1.5 m-30 -113.36 146.18 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.133 -1.216 . . . . 0.0 110.574 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.802 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -88.01 134.38 33.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.676 -0.64 . . . . 0.0 110.816 -179.43 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' THR . 1.2 tp -96.24 102.37 14.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.492 178.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -94.48 143.0 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.233 -0.917 . . . . 0.0 109.08 179.632 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 -175.86 21.21 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.242 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 5.0 p30 -65.65 142.86 57.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.041 -1.27 . . . . 0.0 109.83 179.763 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 28' ' ' THR . 0.3 OUTLIER -79.76 51.24 1.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 110.445 -179.713 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.662 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 166.29 102.25 0.16 Allowed Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.394 179.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.738 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -49.0 178.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.165 -1.197 . . . . 0.0 108.5 179.157 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -140.05 98.21 3.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.454 -0.779 . . . . 0.0 110.081 178.548 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.6 t -79.77 118.58 21.69 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 109.433 178.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.4 t -131.02 114.8 15.64 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.394 -0.923 . . . . 0.0 110.568 -179.954 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.713 ' HA2' HG11 ' A' ' 1' ' ' VAL . . . 70.44 29.02 70.36 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.446 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 76.41 48.29 9.48 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 179.616 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -159.06 87.62 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.286 -1.126 . . . . 0.0 110.485 179.823 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.617 ' CH2' HG23 ' A' ' 27' ' ' VAL . 88.0 m95 -58.42 123.94 17.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.105 -0.997 . . . . 0.0 109.314 179.47 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.5 m -133.02 165.14 25.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.018 -1.052 . . . . 0.0 111.445 -179.22 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' O ' ' ND2' ' A' ' 40' ' ' ASN . 1.6 m-20 58.28 65.57 3.08 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.86 -0.525 . . . . 0.0 111.242 179.716 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.528 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.7 Cg_endo -92.87 132.23 0.96 Allowed 'Trans proline' 0 C--N 1.299 -2.029 0 C-N-CA 121.972 1.782 . . . . 0.0 109.985 178.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -75.23 177.32 8.78 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.579 1.305 . . . . 0.0 109.879 179.488 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.52 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 8.4 p -118.84 141.48 48.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.228 -0.92 . . . . 0.0 111.721 -178.667 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 89.4 m -106.76 79.87 1.39 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.099 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -111.23 -151.72 0.49 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.808 -0.558 . . . . 0.0 109.928 -178.692 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.707 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.52 122.73 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 108.766 179.177 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.802 HG13 ' CB ' ' A' ' 36' ' ' SER . 19.7 m -116.33 52.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 111.653 -178.311 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mtpt -65.2 -169.44 0.05 OUTLIER 'General case' 0 C--N 1.284 -2.279 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.801 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.564 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -129.8 151.26 77.86 Favored Pre-proline 0 C--N 1.295 -1.763 0 C-N-CA 119.139 -1.024 . . . . 0.0 112.871 -178.368 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.563 ' HG3' ' HA ' ' A' ' 108' ' ' THR . 47.0 Cg_endo -84.51 9.4 4.15 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.649 1.868 . . . . 0.0 109.356 177.439 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.535 ' NE2' ' CE2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER 69.0 120.22 0.03 OUTLIER Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.484 -0.76 . . . . 0.0 110.039 -179.172 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.66 ' HA ' HD21 ' A' ' 113' ' ' LEU . 56.2 Cg_endo -83.64 96.87 0.77 Allowed 'Trans proline' 0 C--N 1.299 -2.058 0 O-C-N 123.957 1.504 . . . . 0.0 109.784 179.773 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 66' ' ' ILE . 2.9 p -110.01 -42.28 4.25 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.191 0.996 . . . . 0.0 110.208 -179.18 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.745 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER 48.01 166.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.717 -178.406 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' A' ' 116' ' ' CYS . 0.7 OUTLIER -69.48 104.47 2.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 111.14 -178.576 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.499 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 1.2 m120 40.51 41.43 1.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.378 -0.826 . . . . 0.0 111.252 178.936 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.596 ' O ' ' CD1' ' A' ' 70' ' ' TYR . . . -121.5 -39.14 0.59 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.043 -1.551 . . . . 0.0 109.807 179.882 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 18.5 p90 39.01 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.761 1.267 . . . . 0.0 112.196 -178.862 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.916 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -134.86 155.99 49.71 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.44 -178.916 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.488 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -105.79 -10.24 16.82 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.999 -1.063 . . . . 0.0 110.442 -178.891 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.406 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 2.8 m -53.74 -91.16 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.251 -0.906 . . . . 0.0 110.146 -179.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.79 79.74 0.12 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -69.19 163.41 24.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.372 -1.075 . . . . 0.0 109.362 179.708 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 3.2 ttpt -154.56 160.38 41.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 110.124 -179.702 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.5 OUTLIER -44.9 -52.35 8.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.133 -0.979 . . . . 0.0 110.202 179.895 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.508 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 74.3 m -131.65 164.67 25.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.339 -0.85 . . . . 0.0 110.403 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.68 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 3.1 m-85 -134.22 -140.12 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 0.0 109.564 179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.619 ' C ' HG23 ' A' ' 59' ' ' VAL . 59.9 p -170.08 -126.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.915 -1.116 . . . . 0.0 111.155 179.781 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.631 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -96.09 21.35 8.91 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.023 -1.048 . . . . 0.0 110.636 -178.663 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.743 ' C ' HG22 ' A' ' 102' ' ' THR . 40.4 t-20 -164.15 -112.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.814 -1.178 . . . . 0.0 110.741 179.212 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 5.6 m-20 46.38 76.55 0.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.62 -1.3 . . . . 0.0 108.964 -179.02 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.671 ' CA ' HG23 ' A' ' 102' ' ' THR . 2.2 p-10 -69.23 145.92 52.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.819 . . . . 0.0 110.992 -178.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.782 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 2.1 m -131.08 118.96 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 110.22 178.947 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 11.4 t0 -83.04 119.53 24.59 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.296 -0.877 . . . . 0.0 108.956 179.339 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.916 ' CE1' HD12 ' A' ' 71' ' ' LEU . 47.6 m-85 -78.7 135.56 37.2 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.136 0.97 . . . . 0.0 112.317 -178.035 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.627 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 5.9 tttt -117.1 88.2 2.86 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 -179.413 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.693 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.5 OUTLIER -36.72 127.69 0.85 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.567 -0.708 . . . . 0.0 110.843 -179.722 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -36.9 -88.41 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.744 179.891 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.5 t80 -157.3 142.66 17.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.219 -0.925 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.56 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 56.38 43.2 90.01 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.767 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 18.5 m-85 -147.8 159.06 44.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.528 -0.983 . . . . 0.0 110.182 -179.68 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' O ' HG22 ' A' ' 117' ' ' VAL . 16.8 tttp -122.45 112.24 17.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 179.814 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.693 HD11 ' H ' ' A' ' 89' ' ' CYS . 6.1 mt -48.76 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 110.37 -179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.503 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -81.33 96.38 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.286 -0.884 . . . . 0.0 109.693 179.615 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.27 -115.72 0.9 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.79 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 30.0 m -123.35 127.22 48.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.255 -1.144 . . . . 0.0 110.224 -179.877 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.96 -42.87 56.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 26.7 p -101.54 137.34 40.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.123 -0.986 . . . . 0.0 109.862 179.731 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 50.5 m -147.64 153.42 39.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.266 -0.896 . . . . 0.0 110.587 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.743 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.22 145.25 51.37 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.634 -0.826 . . . . 0.0 110.284 179.588 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 3.4 t -67.08 78.09 0.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.65 -0.656 . . . . 0.0 110.45 -179.732 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -50.88 172.2 0.14 Allowed Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.937 -1.102 . . . . 0.0 111.064 -179.613 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.783 ' CB ' HD12 ' A' ' 38' ' ' ILE . 49.2 Cg_endo -81.82 36.27 0.62 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.444 1.76 . . . . 0.0 112.003 -178.309 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . -128.07 8.48 6.74 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 108.361 -1.896 . . . . 0.0 108.361 178.396 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.675 ' O ' HG23 ' A' ' 108' ' ' THR . 1.2 t30 75.7 59.74 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.797 -0.825 . . . . 0.0 109.724 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -170.25 178.85 3.66 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.773 -1.171 . . . . 0.0 112.445 -179.721 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.782 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 19.9 m95 -108.55 87.93 2.61 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.234 0.54 . . . . 0.0 110.168 -179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 4.2 mmtt -99.43 147.45 33.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.326 -0.859 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.577 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 45.0 Cg_endo -71.13 175.71 39.71 Favored 'Cis proline' 0 N--CA 1.489 1.244 0 C-N-CA 121.998 -2.084 . . . . 0.0 110.883 0.404 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.5 tt0 -37.15 134.48 0.56 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.461 0.648 . . . . 0.0 110.97 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.729 HD13 ' HB3' ' A' ' 109' ' ' TRP . 1.6 tp -59.33 148.26 73.34 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.356 -0.84 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.745 ' HG2' HD12 ' A' ' 66' ' ' ILE . 44.7 Cg_endo -75.45 165.74 30.05 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.049 1.552 . . . . 0.0 110.446 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.572 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -127.05 103.61 7.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.153 -0.967 . . . . 0.0 110.215 179.668 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.527 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -55.65 90.27 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.029 -1.044 . . . . 0.0 109.483 179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 115' ' ' LYS . 2.6 m -108.26 -173.06 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.856 0.836 . . . . 0.0 111.04 -179.491 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.25 179.542 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.367 0.603 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -126.39 145.8 50.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.882 . . . . 0.0 110.059 179.969 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 21' ' ' TYR . 1.7 m -69.25 156.96 37.89 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.497 -0.752 . . . . 0.0 110.976 -179.651 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 11.3 mt-30 -127.8 167.86 15.94 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.399 -0.813 . . . . 0.0 108.98 179.299 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' GLN . 5.1 p -45.81 137.44 5.88 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 120.888 -1.133 . . . . 0.0 109.402 -179.943 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.865 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.3 Cg_endo -69.84 160.79 48.37 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.071 1.564 . . . . 0.0 111.79 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.7 176.94 9.34 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.152 1.606 . . . . 0.0 110.012 178.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.09 177.28 7.25 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.212 -0.93 . . . . 0.0 110.323 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.728 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -144.06 -170.07 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 CA-C-O 122.191 0.996 . . . . 0.0 111.609 179.917 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -43.78 92.79 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.801 -179.344 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 9' ' ' ILE . 2.6 m-80 40.27 52.07 2.81 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.415 -0.803 . . . . 0.0 110.535 179.701 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 30' ' ' SER . . . -148.97 170.52 29.34 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.809 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' A' ' 30' ' ' SER . 1.6 mtt180 -115.63 -168.54 1.43 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.165 -1.197 . . . . 0.0 110.783 -179.883 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.601 ' CE1' ' O ' ' A' ' 6' ' ' PRO . 19.3 p80 -156.49 127.08 6.69 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.338 0.59 . . . . 0.0 110.521 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -124.11 -41.96 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.248 -0.907 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.451 ' HA2' ' HA ' ' A' ' 27' ' ' VAL . . . 67.53 -102.13 0.78 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.815 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 18' ' ' GLU . 0.1 OUTLIER -172.69 29.31 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 110.112 -179.952 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.489 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 11.0 pt-20 -178.29 -146.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.89 . . . . 0.0 109.788 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -127.22 -43.11 1.65 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 179.76 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.553 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 28.9 p90 -128.51 118.26 22.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.264 -0.898 . . . . 0.0 109.709 179.335 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.642 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 15.9 m-85 -82.68 -175.05 5.57 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.892 . . . . 0.0 110.516 -179.433 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' H ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -132.89 -54.17 0.93 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.717 -1.239 . . . . 0.0 111.073 -178.968 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.04 137.28 0.07 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.535 -0.728 . . . . 0.0 109.295 -179.423 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.93 16.86 80.29 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 -179.254 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.642 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -99.63 177.13 5.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.451 -1.029 . . . . 0.0 110.153 -179.923 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 43' ' ' VAL . 7.9 t -147.18 162.58 7.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.956 -179.152 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.865 HG11 ' HG3' ' A' ' 6' ' ' PRO . 14.5 t -137.5 113.94 11.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.271 -179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.94 105.41 3.84 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.672 -1.211 . . . . 0.0 107.78 178.055 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 9' ' ' ILE . 2.9 m-30 -68.09 170.63 8.11 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.86 -178.387 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.537 ' O ' ' CA ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -123.26 147.68 46.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.307 -0.871 . . . . 0.0 109.764 179.578 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 18.8 m -124.36 144.46 50.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.125 -0.985 . . . . 0.0 110.148 -179.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.71 149.55 3.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.959 . . . . 0.0 110.059 179.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.8 m -53.17 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.309 -0.869 . . . . 0.0 110.345 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.17 -2.77 4.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 7.8 m-85 -120.6 126.19 49.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.175 -1.191 . . . . 0.0 110.219 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.692 ' OG ' HG21 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -76.15 149.5 37.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 110.554 179.979 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.4 OUTLIER -92.49 96.15 10.05 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.884 178.836 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.027 HD12 ' HB2' ' A' ' 105' ' ' PRO . 0.5 OUTLIER -86.56 148.9 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.433 -0.792 . . . . 0.0 109.184 -179.841 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.64 -160.86 22.83 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.852 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.475 ' O ' ' C ' ' A' ' 41' ' ' SER . 17.1 m-20 -92.17 54.06 2.28 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -1.203 . . . . 0.0 109.894 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.475 ' C ' ' O ' ' A' ' 40' ' ' ASN . 75.5 p 31.1 48.78 0.08 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.41 179.581 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.512 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 143.81 134.98 2.91 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.604 -1.284 . . . . 0.0 110.371 179.794 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 26' ' ' VAL . 1.8 t -67.1 178.43 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.254 -1.145 . . . . 0.0 108.34 178.685 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.475 ' H ' HG12 ' A' ' 43' ' ' VAL . 5.7 tp -139.65 99.08 3.62 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.202 177.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.63 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -83.36 114.62 21.56 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.393 178.756 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 p -132.65 81.43 1.95 Allowed 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.13 -179.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 48' ' ' GLY . . . 110.61 60.55 0.49 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.817 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.421 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . 44.22 29.67 1.7 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.863 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -147.35 134.37 20.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -1.131 . . . . 0.0 110.243 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.63 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 89.8 m95 -93.43 139.8 30.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.909 179.733 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -139.61 159.81 41.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.14 -0.975 . . . . 0.0 111.007 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.33 70.58 2.0 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.958 -0.464 . . . . 0.0 111.576 179.405 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -89.99 135.9 2.41 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.182 1.622 . . . . 0.0 109.077 178.612 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.559 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 45.4 Cg_endo -72.2 146.86 46.84 Favored 'Trans proline' 0 C--N 1.301 -1.954 0 O-C-N 123.691 1.364 . . . . 0.0 110.746 -179.483 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.612 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 55.9 p -90.85 171.96 8.95 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.948 0.88 . . . . 0.0 111.689 -179.047 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 10' ' ' SER . 56.6 m -129.7 77.24 1.78 Allowed 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.653 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.554 ' HG3' ' CG1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -116.53 -157.29 0.65 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.54 -177.866 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.681 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -110.45 139.64 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.501 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 80' ' ' SER . 34.3 m -129.65 43.58 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.122 -0.986 . . . . 0.0 111.086 -178.441 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 19.0 mttp -69.61 98.31 1.15 Allowed 'General case' 0 C--N 1.28 -2.44 0 C-N-CA 118.662 -1.215 . . . . 0.0 109.423 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 56.4 m -69.33 163.52 57.41 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.414 -0.804 . . . . 0.0 110.79 -179.2 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.4 Cg_endo -70.62 -90.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.325 1.698 . . . . 0.0 110.569 -179.877 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.409 ' O ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -163.74 131.78 2.69 Favored Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.931 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 55.7 Cg_endo -77.35 67.83 7.63 Favored 'Trans proline' 0 C--N 1.298 -2.125 0 O-C-N 123.565 1.298 . . . . 0.0 109.974 -179.29 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.72 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -89.21 -178.28 5.61 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 179.996 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.72 HG22 ' C ' ' A' ' 65' ' ' THR . 0.1 OUTLIER -176.41 163.36 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.564 179.398 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' N ' HG13 ' A' ' 66' ' ' ILE . 0.5 OUTLIER -70.19 96.24 1.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 110.437 -179.737 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.457 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 22.1 m120 47.76 44.19 17.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 179.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.625 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -150.14 32.41 1.05 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.802 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.569 ' O ' ' N ' ' A' ' 88' ' ' LYS . 10.5 p90 -45.76 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.523 1.154 . . . . 0.0 112.46 -179.121 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.741 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -115.0 164.01 14.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.244 -179.571 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.34 -7.78 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -0.846 . . . . 0.0 109.94 -179.765 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 t -59.59 -77.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 110.128 179.925 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -167.77 93.82 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.922 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -89.2 177.79 6.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -1.157 . . . . 0.0 109.601 179.527 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -167.33 153.39 7.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 110.189 -179.461 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 40.1 mtm-85 -46.48 -36.66 6.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.271 -0.893 . . . . 0.0 110.324 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 94.0 p -146.24 154.54 41.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.29 -0.881 . . . . 0.0 110.633 -179.837 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 45.3 m-85 -123.63 -167.52 1.63 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.335 -0.853 . . . . 0.0 109.688 179.653 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.719 ' HA ' HG23 ' A' ' 59' ' ' VAL . 5.8 p -170.08 91.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.046 -1.034 . . . . 0.0 110.489 179.38 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.638 ' CB ' HG21 ' A' ' 59' ' ' VAL . 8.5 t80 56.18 135.38 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.605 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.795 ' O ' HG22 ' A' ' 102' ' ' THR . 63.1 t30 65.09 -127.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.882 -1.137 . . . . 0.0 110.114 -179.258 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.481 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 1.7 m-20 52.98 70.75 0.55 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.684 -1.26 . . . . 0.0 109.009 -178.556 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.524 ' N ' HG23 ' A' ' 102' ' ' THR . 22.2 p-10 -72.91 140.04 47.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.487 -0.758 . . . . 0.0 111.259 -178.898 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.712 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 4.1 m -128.29 118.63 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.222 -0.924 . . . . 0.0 110.026 178.623 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.6 t70 -78.35 127.71 32.61 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.399 -0.813 . . . . 0.0 109.385 179.737 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.741 ' CE1' HD12 ' A' ' 71' ' ' LEU . 37.4 m-85 -89.07 122.79 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.249 1.023 . . . . 0.0 112.213 -178.289 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -97.63 94.53 7.03 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.791 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.469 ' SG ' ' HG ' ' A' ' 95' ' ' LEU . 0.1 OUTLIER -44.24 129.03 6.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.061 -1.024 . . . . 0.0 110.001 -179.836 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 89' ' ' CYS . 2.2 mmtt -40.35 -85.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.423 -0.798 . . . . 0.0 110.53 -179.571 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.574 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -158.82 139.58 12.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.19 -0.944 . . . . 0.0 110.25 179.963 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.597 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 51.61 49.48 46.32 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.884 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.597 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 14.4 m-85 -155.22 147.42 23.74 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.379 -1.071 . . . . 0.0 109.553 -179.614 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 117' ' ' VAL . 2.3 ttmt -105.06 148.6 26.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.961 -1.087 . . . . 0.0 110.26 -179.871 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -85.34 87.18 7.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.239 -0.913 . . . . 0.0 110.664 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.49 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 1.0 OUTLIER -70.41 106.2 3.32 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.124 -0.985 . . . . 0.0 109.257 179.101 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 139.68 -86.56 0.21 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.574 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.581 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -162.91 115.76 1.6 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.164 -1.198 . . . . 0.0 110.676 -179.578 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 87' ' ' PHE . 19.4 m -64.12 -40.32 95.95 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.27 -0.894 . . . . 0.0 110.793 179.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -107.85 117.61 34.58 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.958 -1.089 . . . . 0.0 110.793 -179.591 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.593 ' HG ' ' HE2' ' A' ' 87' ' ' PHE . 13.5 m -119.47 -170.89 2.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 179.51 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.795 HG22 ' O ' ' A' ' 82' ' ' ASN . 9.3 m -163.08 134.32 4.88 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.408 -178.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.617 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -62.7 90.75 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.037 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.538 ' HB3' ' HD2' ' A' ' 105' ' ' PRO . 1.3 m -64.63 170.47 3.84 Favored Pre-proline 0 C--N 1.297 -1.692 0 O-C-N 121.379 -0.826 . . . . 0.0 112.057 -178.669 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 1.027 ' HB2' HD12 ' A' ' 38' ' ' ILE . 49.8 Cg_endo -80.32 30.55 0.5 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.811 1.953 . . . . 0.0 111.886 -178.584 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -130.49 12.34 5.72 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 108.095 -2.002 . . . . 0.0 108.095 178.661 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.856 ' O ' HG23 ' A' ' 108' ' ' THR . 6.1 m-80 71.75 69.19 0.16 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.734 -0.863 . . . . 0.0 110.242 -179.77 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.856 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -175.19 -163.17 0.12 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 111.206 -179.943 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.712 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 39.2 m95 -133.13 91.77 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 110.187 -179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.569 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -104.25 144.92 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.427 -0.795 . . . . 0.0 110.16 -179.705 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 46.2 Cg_endo -71.18 168.74 71.56 Favored 'Cis proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.943 -2.107 . . . . 0.0 111.23 -0.478 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -35.46 127.68 0.6 Allowed 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.472 0.653 . . . . 0.0 111.846 -178.994 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -42.18 142.99 1.1 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.558 -0.714 . . . . 0.0 109.72 178.976 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.577 ' HB2' HD23 ' A' ' 95' ' ' LEU . 41.3 Cg_endo -71.44 169.91 19.73 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 O-C-N 124.214 1.639 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' HG22 ' A' ' 117' ' ' VAL . 7.8 tttp -130.61 106.97 8.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 110.125 179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.533 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 3.0 t -65.4 74.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.96 . . . . 0.0 109.086 179.651 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 115' ' ' LYS . 1.6 m -82.55 -175.31 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.057 0.932 . . . . 0.0 111.467 -179.154 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.297 -1.705 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.633 179.883 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.58 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 8.1 mttt -138.06 177.33 7.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.546 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -138.92 93.14 2.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.517 -0.739 . . . . 0.0 110.086 -179.974 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 19' ' ' ASP . 1.1 mp0 -72.76 -175.89 1.84 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.21 139.44 45.79 Favored Pre-proline 0 C--N 1.297 -1.705 0 O-C-N 121.675 -0.641 . . . . 0.0 110.024 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.619 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.2 Cg_endo -72.81 153.21 53.36 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.982 1.517 . . . . 0.0 110.275 -179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -73.58 169.57 22.01 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.908 1.478 . . . . 0.0 110.102 179.566 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.7 p -70.86 176.19 4.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.306 -0.871 . . . . 0.0 110.206 -179.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -142.91 -170.3 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.175 0.988 . . . . 0.0 111.364 179.778 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -40.96 95.84 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.855 -179.215 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' N ' ' O ' ' A' ' 9' ' ' ILE . 15.7 m-80 40.69 38.22 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.189 -0.944 . . . . 0.0 110.721 179.62 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.467 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -141.96 149.21 20.97 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.845 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.491 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 1.5 ptt180 -102.84 -173.19 2.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -1.149 . . . . 0.0 110.39 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.778 ' HB2' HG11 ' A' ' 27' ' ' VAL . 14.6 p80 -136.64 133.54 36.35 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 121.259 0.552 . . . . 0.0 110.423 -179.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -56.48 120.39 7.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.864 . . . . 0.0 110.268 -179.853 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -119.09 71.62 0.32 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.97 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -88.43 -13.08 41.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -1.1 . . . . 0.0 110.172 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.633 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -120.02 -142.58 0.35 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.0 109.97 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 4' ' ' GLN . 0.8 OUTLIER -153.03 -39.18 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.138 -0.976 . . . . 0.0 110.606 179.765 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.497 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 5.1 p90 -128.93 79.56 1.92 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.194 -0.941 . . . . 0.0 109.935 179.679 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.637 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 2.6 m-85 -52.03 -29.77 22.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.473 -0.767 . . . . 0.0 110.779 -179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.546 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER 69.66 -77.08 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.352 -0.843 . . . . 0.0 112.22 178.803 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.52 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 1.9 t70 -165.06 160.24 18.68 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.789 -1.195 . . . . 0.0 110.282 -179.083 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 63.18 16.67 58.15 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.72 -1.752 . . . . 0.0 108.72 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.637 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 33.0 m -95.69 173.9 7.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.484 -1.009 . . . . 0.0 110.231 -179.924 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 43' ' ' VAL . 40.5 t -154.22 153.84 7.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.706 179.487 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 14' ' ' HIS . 17.0 t -139.06 111.27 5.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.348 -179.437 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -67.3 105.29 1.72 Allowed 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.295 -1.362 . . . . 0.0 107.783 178.248 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.625 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.4 m-30 -68.19 109.0 3.36 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.442 -0.786 . . . . 0.0 110.147 -178.195 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.491 ' HB2' ' CG ' ' A' ' 13' ' ' ARG . 0.6 OUTLIER -69.24 152.94 44.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.074 -1.016 . . . . 0.0 109.448 179.519 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 35' ' ' TYR . 33.6 m -121.01 160.42 23.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 110.697 -179.37 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -44.69 164.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.366 -0.834 . . . . 0.0 109.972 179.779 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -67.39 86.59 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 110.223 -179.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.59 1.9 5.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 2.6 m-30 -94.04 128.82 40.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -1.201 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.602 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . 0.3 OUTLIER -76.86 134.49 39.01 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.295 -0.878 . . . . 0.0 110.518 -179.908 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER -89.73 106.16 18.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.206 -0.934 . . . . 0.0 109.428 179.214 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.842 HD12 ' CB ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -98.83 146.41 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.21 -0.931 . . . . 0.0 109.376 179.828 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.75 -172.47 17.46 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.362 -1.399 . . . . 0.0 109.72 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.49 142.81 47.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.337 -1.096 . . . . 0.0 109.888 179.726 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 28' ' ' THR . 58.5 p -77.92 52.25 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.604 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 149.14 115.29 0.77 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.665 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -48.78 173.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 C-N-CA 118.56 -1.256 . . . . 0.0 107.732 179.181 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -140.01 94.94 2.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.457 -0.777 . . . . 0.0 109.777 178.846 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.3 OUTLIER -80.32 105.75 11.82 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.904 -1.118 . . . . 0.0 108.998 178.847 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.2 95.87 3.63 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.271 -179.371 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.96 19.96 5.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.436 ' C ' ' HG3' ' A' ' 49' ' ' GLU . . . 83.35 13.02 77.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HG3' ' C ' ' A' ' 48' ' ' GLY . 47.2 mt-10 -145.96 138.61 25.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -1.161 . . . . 0.0 110.262 -179.934 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 94.8 m95 -80.79 143.3 32.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 0.0 109.998 179.793 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -142.62 160.2 40.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.126 -0.984 . . . . 0.0 111.16 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.504 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.5 t0 58.3 65.44 3.13 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.661 -0.65 . . . . 0.0 111.448 179.465 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.3 Cg_endo -91.16 134.19 1.67 Allowed 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 124.385 1.729 . . . . 0.0 109.754 178.877 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.1 Cg_endo -81.29 174.05 11.06 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.72 1.379 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 38' ' ' ILE . 8.1 p -115.28 140.9 48.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.233 -0.917 . . . . 0.0 111.506 -178.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 10' ' ' SER . 62.9 m -105.46 76.77 1.23 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.08 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -117.15 177.65 4.64 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.457 0.646 . . . . 0.0 110.614 -178.292 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.545 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -92.0 148.68 4.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.589 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.716 ' CG1' ' HA ' ' A' ' 105' ' ' PRO . 13.0 m -129.15 47.88 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.821 -178.118 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 4.9 mmtt -85.43 160.83 19.64 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.032 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.553 ' SG ' ' N ' ' A' ' 108' ' ' THR . 65.4 m -135.6 166.3 29.6 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 120.216 -1.553 . . . . 0.0 113.019 -178.268 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 39.0 Cg_endo -66.94 -87.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 O-C-N 124.828 1.962 . . . . 0.0 110.386 179.158 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.77 132.42 1.79 Allowed Pre-proline 0 C--N 1.299 -1.597 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.601 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.7 Cg_endo -75.84 65.06 6.81 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 123.825 1.434 . . . . 0.0 108.995 -179.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.414 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -83.42 164.32 20.0 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.664 -0.648 . . . . 0.0 110.877 -179.058 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.78 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.3 OUTLIER -164.17 164.52 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.422 -0.799 . . . . 0.0 110.287 179.725 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.455 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 32.8 t -73.88 106.17 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.514 -0.741 . . . . 0.0 110.848 -179.563 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.548 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 19.0 m-20 42.37 27.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.372 -0.83 . . . . 0.0 110.918 179.315 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.78 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -134.71 33.05 2.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.568 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 7.9 p90 -45.05 -175.42 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 122.65 1.214 . . . . 0.0 112.275 -179.439 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.777 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.02 160.53 16.75 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.667 179.766 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.509 ' HB3' ' HD2' ' A' ' 88' ' ' LYS . 3.0 t -134.43 30.89 3.49 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.942 . . . . 0.0 109.823 -179.425 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.5 t -103.66 -81.39 0.51 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.363 -0.836 . . . . 0.0 110.664 -179.556 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -146.8 85.9 0.17 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.602 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -94.65 166.02 12.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -1.06 . . . . 0.0 109.684 179.705 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.585 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 4.0 tttt -162.41 158.51 24.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.926 . . . . 0.0 110.196 -179.753 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -50.92 -33.41 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 0.0 109.888 179.782 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 6.6 p -136.57 173.33 11.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.383 -0.823 . . . . 0.0 109.927 179.682 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.602 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 52.8 m-85 -144.13 -171.69 3.62 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.164 -0.96 . . . . 0.0 110.731 -179.669 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 1.2 p -146.2 -157.7 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.248 -0.907 . . . . 0.0 110.624 -179.844 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.629 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.9 OUTLIER -83.99 61.22 6.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.534 -1.354 . . . . 0.0 110.352 -179.759 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.631 ' HA ' HG21 ' A' ' 102' ' ' THR . 0.4 OUTLIER 162.17 -16.82 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.986 -1.071 . . . . 0.0 111.518 179.516 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.521 ' OD2' ' HA ' ' A' ' 79' ' ' TYR . 38.9 m-20 -58.2 83.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.962 -1.086 . . . . 0.0 108.613 179.232 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 82' ' ' ASN . 6.1 p30 -76.78 145.19 38.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.552 -0.717 . . . . 0.0 111.294 -178.134 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.677 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 11.9 m -133.78 116.41 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 178.665 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 5.2 t0 -80.06 135.37 36.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.182 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.777 ' CE1' HD12 ' A' ' 71' ' ' LEU . 49.5 m-85 -92.93 138.72 31.24 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.893 -1.129 . . . . 0.0 112.506 -178.031 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 72' ' ' SER . 0.2 OUTLIER -113.79 92.97 4.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.89 -179.657 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 132.42 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 110.233 -179.731 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.45 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.375 -0.828 . . . . 0.0 110.416 -179.805 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 3.7 t80 -157.96 128.89 6.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.367 -0.833 . . . . 0.0 110.127 -179.799 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 62.24 57.15 18.16 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 35.6 m-85 -162.12 147.9 13.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.507 -0.996 . . . . 0.0 109.982 -179.384 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 117' ' ' VAL . 10.8 mttm -101.85 152.62 20.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.816 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 114' ' ' PRO . 1.2 mt -94.05 87.5 5.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.0 110.554 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.649 ' HB2' HG21 ' A' ' 117' ' ' VAL . 11.2 t -71.68 107.72 4.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.057 -1.027 . . . . 0.0 109.609 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.44 -78.87 0.28 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -172.46 116.21 0.33 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.344 -1.092 . . . . 0.0 110.62 -179.693 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 85.5 p -68.6 -11.91 60.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.0 110.85 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.5 p -134.3 140.59 46.5 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.873 -1.142 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.536 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.0 m -154.77 162.9 40.94 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.267 -0.896 . . . . 0.0 110.877 -179.459 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 82' ' ' ASN . 5.2 m -136.42 138.31 41.39 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.3 0.572 . . . . 0.0 110.029 -179.617 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.565 ' HB2' ' CB ' ' A' ' 79' ' ' TYR . 1.9 t -43.58 -28.17 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.432 -0.792 . . . . 0.0 109.538 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.416 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.1 OUTLIER 64.2 165.99 0.11 Allowed Pre-proline 0 C--N 1.293 -1.88 0 CA-C-O 121.391 0.615 . . . . 0.0 112.031 178.321 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.842 ' CB ' HD12 ' A' ' 38' ' ' ILE . 50.6 Cg_endo -81.96 4.4 7.07 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.636 1.861 . . . . 0.0 111.1 -179.026 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 107' ' ' ASN . . . -103.51 2.64 46.17 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.594 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.816 ' O ' HG23 ' A' ' 108' ' ' THR . 17.0 m-80 73.68 48.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.885 -0.774 . . . . 0.0 110.743 179.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -166.44 150.71 7.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 110.864 178.805 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.677 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 58.2 m95 -71.79 88.18 1.0 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.709 0.766 . . . . 0.0 110.959 -179.336 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.483 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 3.4 mmtp -104.02 132.51 20.94 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.729 -0.607 . . . . 0.0 109.559 179.633 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.2 Cg_endo -72.55 167.78 76.8 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 C-N-CA 121.859 -2.142 . . . . 0.0 110.52 0.377 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.6 mp0 -43.1 149.83 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.325 -0.859 . . . . 0.0 110.214 -179.809 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.744 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.8 OUTLIER -55.13 151.57 17.0 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 0.0 110.264 179.909 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.679 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.4 Cg_endo -73.57 169.47 22.25 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 O-C-N 124.299 1.684 . . . . 0.0 110.868 -179.868 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.533 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -126.77 110.14 12.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.24 -0.912 . . . . 0.0 110.475 -179.779 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.545 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.6 t -66.3 73.81 0.08 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.307 -0.871 . . . . 0.0 109.683 179.817 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.649 HG21 ' HB2' ' A' ' 96' ' ' SER . 1.2 m -84.09 -175.96 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.845 0.831 . . . . 0.0 110.901 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.582 ' HB3' ' CD1' ' A' ' 93' ' ' TYR . 8.2 ptt85 . . . . . 0 C--N 1.299 -1.621 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.4 179.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.7 t . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.324 0.583 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -133.17 174.58 10.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 179.685 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.548 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -142.3 85.71 1.93 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.409 -0.807 . . . . 0.0 109.936 -179.952 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.514 ' HG2' ' CE1' ' A' ' 20' ' ' PHE . 30.0 mt-30 -63.05 177.74 0.56 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.903 -1.123 . . . . 0.0 109.71 179.803 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 4' ' ' GLN . 3.6 p -43.28 145.87 0.95 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 0.0 109.74 -180.0 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.829 ' HG3' HG11 ' A' ' 27' ' ' VAL . 49.2 Cg_endo -69.84 170.88 15.62 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.713 -179.541 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.84 171.75 13.97 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 O-C-N 124.011 1.532 . . . . 0.0 109.523 178.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -98.02 97.69 9.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.188 -0.945 . . . . 0.0 110.246 -179.937 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.598 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.31 -175.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 0.0 110.918 -179.779 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -101.85 140.26 36.38 Favored 'General case' 0 C--N 1.297 -1.705 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.546 179.909 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 10' ' ' SER . 2.3 t-20 71.39 8.76 6.38 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.356 -0.84 . . . . 0.0 110.708 179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' A' ' 56' ' ' CYS . . . -160.13 -179.46 34.93 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.836 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -132.68 -166.85 1.81 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.364 -1.08 . . . . 0.0 110.602 -179.902 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 17.0 p80 -155.59 -163.38 1.5 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.768 179.968 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 4.6 t-20 65.33 -141.17 0.21 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 0.0 110.103 179.93 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.02 -67.09 0.41 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -120.09 -4.67 10.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -1.044 . . . . 0.0 109.572 179.536 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.628 ' HB3' ' CE1' ' A' ' 21' ' ' TYR . 26.9 mt-10 -106.68 -174.86 2.64 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.435 -0.791 . . . . 0.0 109.854 179.958 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER 169.06 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.07 -1.019 . . . . 0.0 111.153 179.381 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.514 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -139.04 67.8 1.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 111.396 -179.055 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 3.1 m-85 -75.26 174.58 9.31 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.139 -0.976 . . . . 0.0 108.999 178.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.548 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 36.4 p -137.87 -57.34 0.67 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.756 -1.215 . . . . 0.0 111.356 -178.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.04 130.15 0.77 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.185 -0.947 . . . . 0.0 110.083 -179.169 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.77 22.39 61.82 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.829 -1.709 . . . . 0.0 108.829 -179.471 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.641 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 28.0 m -111.33 168.87 9.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -1.026 . . . . 0.0 110.049 -179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.858 HG13 ' O ' ' A' ' 43' ' ' VAL . 21.8 t -140.77 148.22 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.926 -1.109 . . . . 0.0 112.205 -178.603 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.829 HG11 ' HG3' ' A' ' 6' ' ' PRO . 28.8 t -116.3 122.84 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.561 -0.712 . . . . 0.0 111.662 -179.914 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -77.83 102.66 7.34 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 177.478 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.631 ' CE1' HG21 ' A' ' 43' ' ' VAL . 1.6 m-30 -68.11 149.87 49.08 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.256 -178.098 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -95.47 152.75 18.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.544 179.427 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.467 ' SG ' HD12 ' A' ' 37' ' ' LEU . 86.0 m -125.63 146.6 49.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.957 . . . . 0.0 110.393 -179.869 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -56.2 145.66 25.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.302 -0.874 . . . . 0.0 110.231 179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.7 p -56.05 110.16 0.7 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.269 -0.894 . . . . 0.0 110.313 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.33 -4.62 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 179.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 58' ' ' ILE . 8.9 m-85 -124.42 155.88 38.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.268 . . . . 0.0 110.62 -179.82 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.657 ' HB3' HG11 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -101.29 149.9 23.54 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 110.242 179.659 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.581 ' C ' HD13 ' A' ' 38' ' ' ILE . 1.0 OUTLIER -88.25 108.59 19.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.451 -0.78 . . . . 0.0 109.511 179.242 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.7 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -100.55 143.97 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.175 -179.856 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.68 -156.26 22.37 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 41' ' ' SER . 1.2 m-20 -93.26 55.49 2.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.325 . . . . 0.0 109.774 179.497 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.479 ' C ' ' O ' ' A' ' 40' ' ' ASN . 53.1 p 30.07 47.63 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.484 179.636 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.66 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 143.7 136.34 3.1 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.286 -1.435 . . . . 0.0 110.551 179.671 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.858 ' O ' HG13 ' A' ' 26' ' ' VAL . 1.8 t -65.36 179.08 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.206 -1.173 . . . . 0.0 108.067 178.706 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.468 ' H ' HG12 ' A' ' 43' ' ' VAL . 1.6 tp -143.25 95.19 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.072 . . . . 0.0 110.669 179.177 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.6 OUTLIER -80.57 113.23 18.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.229 -0.919 . . . . 0.0 109.048 178.774 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.11 112.26 18.01 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.265 -179.553 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 65.23 58.79 8.83 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.458 ' HA2' ' SG ' ' A' ' 3' ' ' CYS . . . 49.54 53.96 18.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.38 95.23 1.01 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.31 -1.112 . . . . 0.0 110.59 -179.905 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.734 ' CH2' HG23 ' A' ' 27' ' ' VAL . 74.3 m95 -65.88 133.52 51.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.442 179.347 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 52' ' ' ASP . 15.9 m -142.7 177.25 8.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.929 -1.107 . . . . 0.0 111.698 -179.37 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 44' ' ' LEU . 3.2 p30 36.15 71.25 0.93 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.969 -0.457 . . . . 0.0 111.874 179.651 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -89.23 138.13 3.25 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 124.05 1.552 . . . . 0.0 109.515 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.52 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 46.4 Cg_endo -73.36 176.95 8.53 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.79 1.416 . . . . 0.0 110.644 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 8.8 p -121.86 157.53 30.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.465 -0.772 . . . . 0.0 111.54 -178.679 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.413 ' SG ' ' HA3' ' A' ' 12' ' ' GLY . 94.1 m -116.68 79.35 1.31 Allowed 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -118.03 -156.96 0.66 Allowed 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.204 -178.454 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.543 HG12 ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -108.78 152.86 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.856 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.657 HG11 ' HB3' ' A' ' 36' ' ' SER . 26.3 m -137.39 48.29 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.783 -1.198 . . . . 0.0 111.115 -178.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 24.0 mttt -90.63 173.45 8.04 Favored 'General case' 0 C--N 1.284 -2.24 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.49 178.7 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 79' ' ' TYR . 47.8 m -132.65 167.16 24.09 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 120.479 -1.388 . . . . 0.0 112.333 -179.335 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 44.2 Cg_endo -76.19 -53.82 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.747 1.919 . . . . 0.0 109.909 178.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.511 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 162.95 125.37 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -178.946 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 45.6 Cg_endo -75.08 59.78 5.33 Favored 'Trans proline' 0 C--N 1.292 -2.403 0 O-C-N 123.69 1.363 . . . . 0.0 110.554 -178.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.747 ' C ' HG22 ' A' ' 66' ' ' ILE . 1.2 p -78.62 -171.79 2.66 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.465 -0.772 . . . . 0.0 109.382 179.481 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.902 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER 178.25 168.92 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.643 179.356 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.509 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -71.79 102.84 2.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.499 -0.75 . . . . 0.0 110.83 -179.638 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.532 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 2.5 m-20 40.05 43.99 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.456 -0.778 . . . . 0.0 110.858 179.458 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.902 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -155.02 35.26 0.66 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.885 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.621 ' O ' ' O ' ' A' ' 69' ' ' GLY . 15.6 p90 -42.49 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 123.409 1.576 . . . . 0.0 114.188 -179.325 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.859 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -149.34 136.53 19.91 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.027 -175.491 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.4 t -121.8 27.39 8.17 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 109.775 -179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.16 -69.83 0.73 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.89 . . . . 0.0 111.39 -179.073 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -124.03 -73.45 0.25 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.775 -1.203 . . . . 0.0 110.879 -178.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.58 ' HB2' HD13 ' A' ' 71' ' ' LEU . 22.8 t80 58.44 163.18 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -1.012 . . . . 0.0 109.973 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.571 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 8.0 tttm -178.94 140.86 0.17 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.455 -0.778 . . . . 0.0 110.059 179.731 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -42.74 -36.01 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.222 -0.924 . . . . 0.0 109.472 179.67 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 76' ' ' LYS . 2.6 p -125.88 166.27 17.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.618 -0.676 . . . . 0.0 109.75 179.369 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 74.0 m-85 -141.07 -168.9 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.9 m -155.54 -158.54 0.83 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.107 -0.996 . . . . 0.0 110.538 -179.872 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.584 ' N ' ' CG2' ' A' ' 59' ' ' VAL . 0.6 OUTLIER -69.38 2.94 2.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.349 -1.47 . . . . 0.0 111.19 -179.057 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.797 ' O ' HG22 ' A' ' 102' ' ' THR . 8.8 p30 -139.21 -111.53 0.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.781 -1.199 . . . . 0.0 110.266 179.537 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 50.88 65.69 1.4 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.849 -1.157 . . . . 0.0 109.623 -179.406 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.889 ' CA ' HG23 ' A' ' 102' ' ' THR . 18.8 p-10 -69.4 110.86 4.91 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.508 -0.745 . . . . 0.0 110.018 -179.306 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.797 HG23 ' CE1' ' A' ' 87' ' ' PHE . 26.0 m -97.26 121.85 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.862 -1.149 . . . . 0.0 111.204 -179.727 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -78.05 138.79 38.96 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 178.204 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.797 ' CE1' HG23 ' A' ' 85' ' ' VAL . 24.4 m-85 -98.64 145.54 26.76 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.986 -1.072 . . . . 0.0 111.254 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.82 96.81 5.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.648 -0.658 . . . . 0.0 110.093 -179.708 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.605 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -46.46 134.5 9.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 110.065 179.949 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -41.14 -86.44 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.338 -0.851 . . . . 0.0 110.241 -179.855 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.54 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -160.74 124.78 3.53 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.271 -0.893 . . . . 0.0 110.19 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.58 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 69.27 53.84 16.04 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.675 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 51.6 m-85 -160.68 152.21 19.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -1.022 . . . . 0.0 109.892 -179.249 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -107.27 136.78 46.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.012 . . . . 0.0 109.963 179.772 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.605 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.9 OUTLIER -75.65 89.82 2.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.075 -179.875 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.489 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.4 t -74.74 101.86 4.45 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.251 -0.905 . . . . 0.0 110.285 -179.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.06 -64.79 0.44 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.568 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 177.35 105.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.322 -1.105 . . . . 0.0 110.377 -179.606 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 96.8 p -68.94 -3.94 14.74 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.192 -0.943 . . . . 0.0 110.743 -179.564 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 64.5 p -140.13 93.76 2.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.125 -0.985 . . . . 0.0 109.722 179.823 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.555 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 19.5 m -104.04 174.28 5.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.228 -0.92 . . . . 0.0 110.991 -179.411 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.889 HG23 ' CA ' ' A' ' 84' ' ' ASN . 1.0 OUTLIER -146.98 137.76 23.78 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.929 -0.709 . . . . 0.0 110.455 -179.614 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.61 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 49.2 t -56.74 107.28 0.38 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.455 -0.778 . . . . 0.0 109.461 179.642 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.5 175.1 4.96 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.137 -0.977 . . . . 0.0 109.556 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.65 ' CB ' HG12 ' A' ' 59' ' ' VAL . 41.2 Cg_endo -77.45 167.19 24.82 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 123.857 1.451 . . . . 0.0 111.584 -179.166 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.621 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 89.93 -58.72 3.62 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 -178.545 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.621 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 147.13 71.33 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.686 0 C-N-CA 122.271 0.228 . . . . 0.0 111.123 178.537 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.447 ' OG1' ' C ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -169.78 166.95 9.55 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.314 -1.491 . . . . 0.0 112.536 179.236 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.61 ' CZ3' ' N ' ' A' ' 103' ' ' CYS . 24.2 m95 -101.55 92.09 4.74 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.294 0.569 . . . . 0.0 109.684 179.564 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.556 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 16.2 mttt -101.03 142.59 24.93 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.384 -0.823 . . . . 0.0 110.625 -179.222 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.568 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.4 Cg_endo -71.0 168.97 70.64 Favored 'Cis proline' 0 N--CA 1.489 1.221 0 C-N-CA 122.081 -2.049 . . . . 0.0 110.706 -0.849 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -39.8 129.96 2.0 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.544 -0.723 . . . . 0.0 110.847 -179.6 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -39.7 147.07 0.34 Allowed Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 0.0 110.422 179.385 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.817 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.5 Cg_endo -70.35 166.7 27.45 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 124.398 1.736 . . . . 0.0 110.739 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.858 ' HG2' HG13 ' A' ' 117' ' ' VAL . 4.7 ttpt -127.29 107.83 10.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.341 -0.85 . . . . 0.0 110.463 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 1.9 t -64.4 90.04 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.077 -1.015 . . . . 0.0 109.089 179.524 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.858 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.3 m -103.77 -175.26 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.904 0.859 . . . . 0.0 110.821 -179.414 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.587 ' N ' ' CD ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.928 0 CA-C-O 118.072 -0.966 . . . . 0.0 110.448 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.228 0.537 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.79 176.79 7.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 110.511 -179.743 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 4.1 t -159.37 101.25 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.535 -0.728 . . . . 0.0 110.217 -179.6 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' O ' ' C ' ' A' ' 5' ' ' SER . 18.6 mt-30 -87.46 -177.59 5.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.714 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER -39.69 141.05 0.77 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.689 . . . . 0.0 110.223 -179.766 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 49.9 Cg_endo -71.32 159.89 50.41 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.095 1.576 . . . . 0.0 111.228 -179.204 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.6 170.91 19.23 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 O-C-N 124.102 1.58 . . . . 0.0 109.898 179.371 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 p -73.26 174.4 8.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 109.755 179.618 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.45 -170.93 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 122.219 1.009 . . . . 0.0 111.559 179.631 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -38.62 94.1 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.986 -179.138 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.2 m120 41.39 30.83 0.14 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.379 -0.826 . . . . 0.0 110.298 179.721 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 9' ' ' ILE . . . -132.16 150.44 19.62 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.936 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 30' ' ' SER . 3.8 mtt180 -96.36 -170.87 2.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.372 -1.075 . . . . 0.0 110.568 179.944 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.608 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 18.9 p80 -147.16 120.09 8.74 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.228 0.537 . . . . 0.0 109.965 -179.738 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -123.46 109.53 13.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.174 -0.954 . . . . 0.0 110.748 -179.552 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' CA ' ' OH ' ' A' ' 21' ' ' TYR . . . -101.5 -5.47 51.77 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.463 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.2 OUTLIER 68.44 24.2 7.23 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.279 -1.13 . . . . 0.0 110.375 179.975 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' OE1' ' CE1' ' A' ' 21' ' ' TYR . 3.8 pt-20 -160.57 -160.56 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 0.0 110.01 179.693 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' ' 19' ' ' ASP . 5.7 t0 -131.83 -27.41 1.88 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.073 -1.017 . . . . 0.0 110.714 -179.586 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.426 ' CE1' ' HG2' ' A' ' 4' ' ' GLN . 9.9 m-85 -119.88 134.88 55.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.11 -0.994 . . . . 0.0 110.78 -179.63 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.616 ' CE2' ' CG2' ' A' ' 27' ' ' VAL . 0.8 OUTLIER -124.08 -13.93 7.18 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.459 -0.776 . . . . 0.0 110.204 179.882 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.557 ' CA ' ' HB3' ' A' ' 3' ' ' CYS . 47.6 p 45.95 -98.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.554 -0.716 . . . . 0.0 111.68 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 45' ' ' CYS . 0.5 OUTLIER -143.7 156.82 44.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 110.438 -178.443 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 70.13 16.25 72.84 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.446 -1.862 . . . . 0.0 108.446 -179.086 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -94.29 174.9 6.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.624 -0.927 . . . . 0.0 110.328 -179.7 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 43' ' ' VAL . 37.9 t -154.21 153.22 8.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.048 179.498 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' VAL . 41.5 t -139.65 123.84 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.209 -0.997 . . . . 0.0 111.66 -179.433 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.56 101.9 3.71 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.581 -1.247 . . . . 0.0 107.78 177.899 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.045 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.2 m-30 -68.03 134.24 50.34 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.308 -178.208 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.01 163.09 15.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.152 -0.967 . . . . 0.0 109.914 179.606 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.614 ' SG ' HD12 ' A' ' 37' ' ' LEU . 70.9 m -127.36 159.25 35.0 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 110.175 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.92 154.85 1.0 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.269 -0.894 . . . . 0.0 110.279 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 100.17 0.37 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 110.194 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 123.24 4.74 8.26 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.887 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 56' ' ' CYS . 1.9 m-30 -110.01 158.66 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.199 -1.177 . . . . 0.0 110.005 179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 1.042 ' OG ' HG22 ' A' ' 59' ' ' VAL . 24.3 m -103.71 130.39 51.2 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.389 -0.819 . . . . 0.0 110.677 -179.337 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.739 HD13 ' O ' ' A' ' 29' ' ' TYR . 3.2 tp -83.0 117.71 23.0 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.237 179.132 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.59 HG23 ' CG ' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -115.97 143.77 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 0.0 109.561 179.966 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.31 -168.02 12.8 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.561 -1.815 . . . . 0.0 108.561 -179.0 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.489 ' ND2' ' O ' ' A' ' 52' ' ' ASP . 30.5 p-10 -66.37 130.76 44.31 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.968 -1.313 . . . . 0.0 109.496 179.476 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 28' ' ' THR . 30.2 p -70.01 57.78 0.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.992 . . . . 0.0 109.511 179.767 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.601 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 155.92 117.34 0.57 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -179.491 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.045 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.2 t -61.19 -176.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.95 -1.323 . . . . 0.0 107.848 179.248 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.606 ' H ' HG12 ' A' ' 43' ' ' VAL . 4.9 tp -144.47 102.29 3.81 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.318 179.195 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 1.8 t -86.15 111.91 20.82 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.363 -0.835 . . . . 0.0 109.656 179.423 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -120.54 88.39 2.93 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.316 -179.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.43 50.52 3.79 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 3' ' ' CYS . . . 57.27 25.07 53.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' TRP . 2.3 tt0 -125.8 71.32 1.23 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -1.173 . . . . 0.0 110.606 179.966 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 3' ' ' CYS . 72.9 m95 -45.84 129.67 9.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.911 . . . . 0.0 109.586 179.488 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 p -144.1 173.4 11.76 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.162 -0.961 . . . . 0.0 110.996 -179.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.525 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.7 OUTLIER 53.29 65.1 6.11 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.727 -0.608 . . . . 0.0 110.884 -179.949 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.525 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.6 Cg_endo -91.53 135.63 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.992 0 O-C-N 124.444 1.76 . . . . 0.0 110.096 179.374 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.426 ' HG2' ' HB2' ' A' ' 29' ' ' TYR . 50.5 Cg_endo -79.91 -173.56 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.739 1.389 . . . . 0.0 110.37 179.593 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 37' ' ' LEU . 5.3 p -120.13 -172.01 2.27 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.963 0.887 . . . . 0.0 111.564 -178.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 95.9 m -152.05 80.91 1.26 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.663 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 5.2 mm100 -111.41 -139.8 0.38 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.413 0.625 . . . . 0.0 110.912 -177.747 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.465 HG13 ' C ' ' A' ' 57' ' ' GLN . 0.2 OUTLIER -137.57 106.55 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.848 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.042 HG22 ' OG ' ' A' ' 36' ' ' SER . 26.8 m -105.51 64.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.153 -0.967 . . . . 0.0 112.526 -178.224 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.502 ' O ' ' ND2' ' A' ' 107' ' ' ASN . 14.8 mttt -67.49 -175.69 0.53 Allowed 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 117.531 -1.668 . . . . 0.0 107.624 178.072 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.64 163.59 35.43 Favored Pre-proline 0 C--N 1.296 -1.741 0 C-N-CA 118.152 -1.419 . . . . 0.0 113.597 -178.085 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 61' ' ' CYS . 47.9 Cg_endo -86.91 -83.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.92 2.011 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.484 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 175.14 130.75 0.14 Allowed Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.611 -0.681 . . . . 0.0 109.298 -179.433 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.736 ' HG2' HD21 ' A' ' 71' ' ' LEU . 49.8 Cg_endo -80.02 64.06 8.82 Favored 'Trans proline' 0 C--N 1.299 -2.059 0 O-C-N 123.739 1.389 . . . . 0.0 109.896 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.6 ' C ' HG22 ' A' ' 66' ' ' ILE . 5.4 p -77.05 175.65 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.402 -0.811 . . . . 0.0 109.471 179.813 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.0 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.84 168.3 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 C-N-CA 118.522 -1.271 . . . . 0.0 110.7 179.307 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.491 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.3 OUTLIER -73.69 100.32 3.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.527 -0.733 . . . . 0.0 110.691 -179.594 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 35.1 m-20 42.41 48.15 4.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 110.667 179.401 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.0 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -160.28 37.81 0.45 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.925 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 54.3 p90 -50.2 -151.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 122.952 1.358 . . . . 0.0 112.922 -179.783 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.065 HD23 ' CE2' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -142.84 127.03 17.52 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.736 -176.562 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -109.14 19.22 19.72 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.369 -0.832 . . . . 0.0 110.192 -179.318 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . 31.3 t -84.17 -88.01 0.11 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.3 -0.875 . . . . 0.0 110.906 -179.47 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 75' ' ' PHE . . . -101.03 -71.91 0.96 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 -179.279 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 51.1 t80 57.04 170.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -1.07 . . . . 0.0 109.665 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.635 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER 174.23 130.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.151 -0.968 . . . . 0.0 110.24 179.932 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 76' ' ' LYS . 9.4 mtt180 -40.76 -32.66 0.23 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.424 -0.797 . . . . 0.0 110.027 179.833 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.84 126.24 20.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.468 -0.77 . . . . 0.0 109.948 179.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 11.2 m-85 -106.11 -151.85 0.46 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 179.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 59.9 p -159.85 -126.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.382 -0.824 . . . . 0.0 109.944 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.985 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -102.07 33.63 3.0 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.987 -1.071 . . . . 0.0 110.84 -179.243 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.753 ' C ' HG22 ' A' ' 102' ' ' THR . 17.9 t-20 -172.29 -112.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.093 -1.005 . . . . 0.0 110.367 179.007 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 82' ' ' ASN . 5.0 t0 47.39 75.06 0.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 120.641 -1.287 . . . . 0.0 109.162 -179.148 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.715 ' CA ' HG23 ' A' ' 102' ' ' THR . 12.7 p-10 -69.62 112.69 6.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.34 -0.85 . . . . 0.0 109.979 -179.576 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.592 ' CG2' HD22 ' A' ' 71' ' ' LEU . 31.4 m -98.15 121.56 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.983 -1.073 . . . . 0.0 111.17 -179.883 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -80.12 139.58 36.78 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.395 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 1.065 ' CE2' HD23 ' A' ' 71' ' ' LEU . 65.3 m-85 -95.5 146.52 24.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.811 -1.181 . . . . 0.0 112.396 -178.205 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -116.73 91.55 3.62 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.367 179.695 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.519 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -42.94 135.28 3.11 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.214 -0.928 . . . . 0.0 109.957 -179.551 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.448 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 6.8 mmmt -39.63 -76.39 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 110.687 -179.545 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.576 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 31.6 t80 -168.68 130.81 1.32 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.297 -0.877 . . . . 0.0 110.358 -179.852 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.515 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.18 53.43 46.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.777 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 25.2 m-85 -158.77 150.47 20.94 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.478 -1.013 . . . . 0.0 109.959 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 117' ' ' VAL . 0.7 OUTLIER -102.95 154.59 19.07 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.401 -0.812 . . . . 0.0 109.038 179.362 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.587 HD23 ' HB2' ' A' ' 114' ' ' PRO . 0.8 OUTLIER -93.93 96.26 9.6 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.626 -1.296 . . . . 0.0 110.499 -179.447 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -74.13 101.82 4.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.311 -0.868 . . . . 0.0 109.646 179.526 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.53 -77.17 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.585 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -171.59 114.43 0.37 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 110.896 -179.632 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 m -71.34 -2.45 16.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.231 -0.918 . . . . 0.0 110.481 179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.9 p -143.33 113.83 7.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.119 -0.988 . . . . 0.0 110.111 179.773 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.517 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 27.3 m -126.0 160.16 30.77 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 110.638 -179.866 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.753 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -130.6 139.53 50.41 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.582 0.706 . . . . 0.0 110.045 179.941 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.596 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -73.51 84.36 1.52 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.485 -0.76 . . . . 0.0 110.107 179.989 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' HA ' ' A' ' 81' ' ' TYR . 0.5 OUTLIER -62.95 173.99 0.95 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.24 -0.913 . . . . 0.0 110.985 -179.55 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.757 ' HB3' HG11 ' A' ' 59' ' ' VAL . 42.8 Cg_endo -73.34 123.46 8.73 Favored 'Trans proline' 0 C--N 1.304 -1.813 0 O-C-N 124.391 1.732 . . . . 0.0 110.104 -179.701 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.58 -9.31 4.96 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.494 -1.842 . . . . 0.0 108.494 -178.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.641 ' O ' HG23 ' A' ' 108' ' ' THR . 1.8 m120 80.71 89.35 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.909 -0.76 . . . . 0.0 110.295 179.701 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -179.06 -160.63 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.281 -0.887 . . . . 0.0 110.933 179.85 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.644 ' HB3' HD11 ' A' ' 113' ' ' LEU . 30.4 m95 -145.84 86.09 1.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.608 0.718 . . . . 0.0 109.712 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 21.0 mttt -99.77 139.05 20.53 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.571 -0.705 . . . . 0.0 110.255 -179.349 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.585 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.9 Cg_endo -71.34 166.51 77.83 Favored 'Cis proline' 0 N--CA 1.49 1.273 0 C-N-CA 122.009 -2.079 . . . . 0.0 110.781 -0.127 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.2 mp0 -40.37 137.81 1.01 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.539 -0.725 . . . . 0.0 110.644 -179.463 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.788 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -43.52 155.98 0.29 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.949 179.744 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.695 ' HG2' HD12 ' A' ' 66' ' ' ILE . 40.8 Cg_endo -80.06 169.48 17.66 Favored 'Trans proline' 0 C--N 1.299 -2.045 0 O-C-N 124.397 1.735 . . . . 0.0 111.074 -179.609 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.554 ' O ' HG22 ' A' ' 117' ' ' VAL . 6.8 tttt -127.35 111.12 13.52 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.263 -0.898 . . . . 0.0 110.473 -179.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.532 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 1.8 t -67.67 98.24 0.68 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.117 -0.989 . . . . 0.0 109.425 179.567 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.554 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -112.76 -176.06 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.736 0.779 . . . . 0.0 110.507 -179.627 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 9.0 ptt85 . . . . . 0 C--N 1.296 -1.747 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.451 179.63 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 121.26 0.552 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -122.19 162.6 21.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.275 -0.891 . . . . 0.0 110.28 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.581 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.8 OUTLIER -143.33 78.38 1.6 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 0.0 110.132 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.22 179.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.243 -0.911 . . . . 0.0 110.388 -179.977 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 p -51.91 145.44 17.15 Favored Pre-proline 0 C--N 1.3 -1.559 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.76 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.683 ' HG3' HG11 ' A' ' 27' ' ' VAL . 54.7 Cg_endo -73.99 159.86 43.99 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.896 1.472 . . . . 0.0 110.117 -179.764 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.93 170.0 19.91 Favored 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.661 1.348 . . . . 0.0 109.997 179.284 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.7 p -88.82 105.06 17.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.126 -0.983 . . . . 0.0 110.365 -179.834 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.601 HG23 ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -56.29 -170.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.03 0.919 . . . . 0.0 111.289 -179.717 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.13 138.15 31.74 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.424 -178.846 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 56' ' ' CYS . 10.5 m120 49.05 20.58 0.39 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.48 -0.763 . . . . 0.0 110.931 179.382 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.2 157.66 27.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.437 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.5 mpt_? -118.23 -166.33 1.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.177 -1.19 . . . . 0.0 111.059 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.5 p80 -151.22 131.55 13.69 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.614 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -155.34 -145.24 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.946 -1.096 . . . . 0.0 110.751 -179.725 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . 129.4 4.89 4.79 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 7.7 t80 70.96 24.31 4.05 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.163 -1.198 . . . . 0.0 110.284 179.942 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.43 ' CG ' ' HE1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -126.12 168.9 13.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.305 -0.872 . . . . 0.0 110.068 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -133.24 -31.28 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.36 -0.837 . . . . 0.0 110.515 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.25 139.06 52.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.079 -1.013 . . . . 0.0 110.08 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.661 ' CD2' ' HB3' ' A' ' 25' ' ' SER . 2.2 m-85 -123.03 -7.08 8.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 110.985 -179.624 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.581 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 1.8 p 43.3 -96.61 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.401 -0.812 . . . . 0.0 111.405 -179.793 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 46' ' ' SER . 17.4 t0 -153.52 138.49 17.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.953 -1.092 . . . . 0.0 110.363 -178.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 87.49 37.4 8.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.661 ' HB3' ' CD2' ' A' ' 21' ' ' TYR . 66.4 m -135.17 161.33 35.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.261 -1.141 . . . . 0.0 109.951 -179.91 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.3 t -134.19 147.63 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.0 112.28 -178.141 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.714 ' O ' HG23 ' A' ' 43' ' ' VAL . 32.3 t -117.95 119.28 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.725 -0.609 . . . . 0.0 111.743 -179.523 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -73.4 102.95 3.9 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.78 -1.168 . . . . 0.0 107.897 177.641 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.874 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -68.12 126.72 30.41 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.419 -0.8 . . . . 0.0 109.848 -178.515 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.53 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.7 OUTLIER -69.63 163.62 25.15 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.0 -1.063 . . . . 0.0 109.36 179.467 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.55 149.44 49.44 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.051 -1.03 . . . . 0.0 110.433 -179.522 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.62 143.34 57.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -0.849 . . . . 0.0 110.026 179.707 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -62.55 106.17 0.74 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.216 -0.928 . . . . 0.0 110.379 -179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 128.74 -11.51 6.28 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CE2' HG13 ' A' ' 58' ' ' ILE . 3.9 m-85 -114.06 146.31 40.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.149 -1.206 . . . . 0.0 110.629 -179.617 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.715 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -84.17 142.27 30.45 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -0.911 . . . . 0.0 110.753 179.9 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' THR . 0.5 OUTLIER -98.61 95.01 6.97 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.535 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.781 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -81.16 152.1 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -179.785 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 127.92 -146.54 16.74 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.503 ' O ' ' C ' ' A' ' 41' ' ' SER . 36.4 m-80 -120.73 53.26 1.13 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -1.123 . . . . 0.0 110.128 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.613 ' O ' HG23 ' A' ' 28' ' ' THR . 71.3 p 28.03 48.72 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.774 179.535 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.603 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 156.94 125.49 0.87 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.673 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.895 ' O ' HG13 ' A' ' 26' ' ' VAL . 2.0 t -71.48 179.45 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.502 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -141.86 92.61 2.46 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.648 -1.282 . . . . 0.0 111.247 179.55 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.598 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -79.47 106.97 11.88 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 118.985 -1.086 . . . . 0.0 108.407 178.125 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.522 ' HA ' ' OD1' ' A' ' 23' ' ' ASP . 0.3 OUTLIER -135.11 103.51 5.58 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.226 -179.054 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.77 11.25 35.5 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.5 19.07 60.87 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 50' ' ' TRP . 9.1 mt-10 -139.16 91.4 2.51 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.239 -1.153 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.607 ' CH2' HG23 ' A' ' 27' ' ' VAL . 70.7 m95 -43.3 135.88 3.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.266 -0.896 . . . . 0.0 109.88 179.562 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 p -147.64 166.29 27.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.128 -0.983 . . . . 0.0 111.048 -179.707 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 57.3 64.35 4.35 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.603 -0.686 . . . . 0.0 111.285 179.837 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 52.9 Cg_endo -92.72 145.65 2.55 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 C-N-CA 121.992 1.795 . . . . 0.0 110.086 179.084 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.554 ' CA ' ' O ' ' A' ' 38' ' ' ILE . 52.9 Cg_endo -84.28 176.79 6.29 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.7 1.369 . . . . 0.0 109.949 179.245 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.63 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 27.3 p -130.21 141.88 50.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.081 -1.012 . . . . 0.0 111.54 -179.53 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -100.51 88.52 3.66 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.584 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 51.6 mm-40 -120.36 -165.57 1.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.424 -178.314 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.723 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -115.4 104.9 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.04 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 81' ' ' TYR . 13.0 m -92.97 47.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.304 -0.872 . . . . 0.0 111.801 -178.199 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.8 mttt -88.65 97.7 11.26 Favored 'General case' 0 C--N 1.285 -2.238 0 C-N-CA 118.917 -1.113 . . . . 0.0 108.345 178.586 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 36.0 m -69.55 162.51 66.55 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 0.0 112.12 -178.004 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 45.4 Cg_endo -71.61 -90.26 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.651 1.869 . . . . 0.0 110.762 -179.73 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.42 ' CA ' ' HE1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -161.58 133.65 4.19 Favored Pre-proline 0 C--N 1.301 -1.531 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.705 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.673 ' HA ' HD21 ' A' ' 113' ' ' LEU . 50.3 Cg_endo -78.01 65.26 8.34 Favored 'Trans proline' 0 C--N 1.293 -2.35 0 O-C-N 123.674 1.355 . . . . 0.0 109.784 -179.329 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.591 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.2 OUTLIER -83.08 171.95 13.22 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.608 -0.682 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.771 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -172.67 166.11 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 119.284 -0.967 . . . . 0.0 110.522 179.719 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.45 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 0.6 OUTLIER -75.28 109.94 9.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.534 -0.729 . . . . 0.0 111.0 -179.254 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' CB ' ' HG3' ' A' ' 90' ' ' LYS . 4.6 m-80 38.63 34.63 0.09 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.765 . . . . 0.0 110.844 179.299 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.771 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -143.68 30.36 1.95 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.837 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.58 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 2.3 p90 -45.66 -171.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.718 1.247 . . . . 0.0 112.479 -179.612 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.829 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -116.4 157.97 24.24 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.794 178.792 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.75 26.52 1.39 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.983 -1.073 . . . . 0.0 110.082 -179.181 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -73.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.669 -179.586 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.43 75.97 0.41 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.627 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 1.5 t80 -104.36 165.72 10.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.585 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.1 OUTLIER -163.16 162.88 25.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.162 -0.961 . . . . 0.0 110.299 -179.913 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -56.76 -35.86 69.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.92 179.936 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.9 t -139.83 167.35 22.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.503 -0.748 . . . . 0.0 109.988 179.698 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.555 ' OH ' ' CE2' ' A' ' 75' ' ' PHE . 16.0 m-85 -138.51 -173.93 3.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 109.735 -179.986 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 3.8 m -169.39 106.41 0.39 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 111.283 -179.75 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.776 ' CB ' HG21 ' A' ' 59' ' ' VAL . 3.2 t80 46.31 15.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.154 -0.966 . . . . 0.0 112.686 178.27 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.721 ' C ' HG22 ' A' ' 102' ' ' THR . 17.1 t-20 -175.84 -122.75 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 119.926 -1.734 . . . . 0.0 111.987 178.308 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' A' ' 82' ' ' ASN . 8.3 m-20 49.63 76.87 0.12 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.671 -1.268 . . . . 0.0 108.747 -178.027 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.646 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.5 p-10 -69.2 135.42 50.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.373 -0.83 . . . . 0.0 111.109 -178.689 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.667 HG11 ' HG3' ' A' ' 64' ' ' PRO . 10.8 m -115.81 120.54 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.522 -0.736 . . . . 0.0 109.519 179.11 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.1 t0 -85.15 130.71 34.56 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.166 -0.959 . . . . 0.0 108.651 179.436 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.829 ' CE1' HD12 ' A' ' 71' ' ' LEU . 67.6 m-85 -89.87 129.52 36.23 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 122.291 1.043 . . . . 0.0 112.567 -177.88 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.522 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -104.43 91.64 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.48 179.802 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.544 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -45.27 127.38 7.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.957 -1.09 . . . . 0.0 109.59 -179.736 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 68' ' ' ASN . 15.8 mmtp -37.27 -87.99 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.687 -0.633 . . . . 0.0 110.787 -179.097 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.586 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 17.6 t80 -158.99 136.12 9.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.119 -0.988 . . . . 0.0 110.444 179.962 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.544 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 60.67 44.68 97.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.861 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.586 ' CD2' ' O ' ' A' ' 91' ' ' TYR . 28.3 m-85 -154.56 150.86 28.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.503 -0.998 . . . . 0.0 109.846 -179.338 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HG3' HG23 ' A' ' 117' ' ' VAL . 18.1 ptpt -116.98 126.46 52.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.674 179.529 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.578 HD21 ' HB3' ' A' ' 87' ' ' PHE . 1.1 mt -56.69 112.95 1.44 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.758 -179.255 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.579 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -89.51 94.79 10.0 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.428 -0.795 . . . . 0.0 109.525 179.287 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.472 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.85 -39.17 1.42 Allowed Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.845 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.557 ' O ' ' HB3' ' A' ' 114' ' ' PRO . 0.4 OUTLIER 172.55 -178.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.155 -1.203 . . . . 0.0 111.037 -179.65 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' OD1' ' A' ' 86' ' ' ASP . 51.7 p -141.76 10.39 2.01 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 0.0 109.967 -179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -169.53 113.92 0.53 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.491 -0.755 . . . . 0.0 109.107 179.831 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.471 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 29.8 m -124.75 162.4 24.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.225 -0.922 . . . . 0.0 111.048 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.721 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -129.13 142.26 50.94 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.345 -0.847 . . . . 0.0 110.397 -179.748 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.541 ' O ' ' CA ' ' A' ' 81' ' ' TYR . 3.0 t -60.92 83.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.645 -0.66 . . . . 0.0 109.3 179.468 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 102' ' ' THR . 0.4 OUTLIER -68.94 170.33 8.89 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.0 110.867 -179.245 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.773 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.0 Cg_endo -73.77 127.54 11.67 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.176 1.619 . . . . 0.0 110.414 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.563 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 130.57 -11.43 5.75 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.626 -1.789 . . . . 0.0 108.626 -179.055 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 14.0 m-20 82.0 76.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 122.068 -0.666 . . . . 0.0 110.39 179.705 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -169.87 -158.81 0.19 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.517 -0.739 . . . . 0.0 110.786 179.789 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.642 ' HB3' HD13 ' A' ' 113' ' ' LEU . 21.0 m95 -142.26 98.96 3.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.41 -0.806 . . . . 0.0 110.14 -179.343 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.548 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 45.8 mttt -100.73 141.9 23.57 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.387 -0.821 . . . . 0.0 110.155 -179.597 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.548 ' C ' ' HA ' ' A' ' 110' ' ' LYS . 49.2 Cg_endo -72.07 170.57 66.39 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 C-N-CA 122.057 -2.059 . . . . 0.0 110.866 0.256 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 111' ' ' PRO . 2.5 tt0 -40.28 125.8 2.12 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.571 -0.706 . . . . 0.0 110.114 179.853 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.673 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -41.08 141.32 1.02 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.431 -0.793 . . . . 0.0 110.032 -179.84 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.674 ' HG2' HD12 ' A' ' 66' ' ' ILE . 46.6 Cg_endo -80.26 166.87 20.1 Favored 'Trans proline' 0 C--N 1.299 -2.074 0 O-C-N 124.467 1.772 . . . . 0.0 112.074 -178.38 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.66 ' HG2' HG13 ' A' ' 117' ' ' VAL . 11.0 ttpt -125.63 106.16 9.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.629 -0.669 . . . . 0.0 109.977 179.53 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.531 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.9 t -58.7 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.074 -1.016 . . . . 0.0 109.297 179.568 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.66 HG13 ' HG2' ' A' ' 115' ' ' LYS . 2.0 m -110.63 -171.3 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.936 0.874 . . . . 0.0 111.224 -179.438 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.467 -179.862 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.216 0.532 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -115.55 161.97 17.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 109.879 179.824 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.559 ' HB2' ' N ' ' A' ' 22' ' ' THR . 0.9 OUTLIER -131.43 81.93 2.01 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.102 -0.999 . . . . 0.0 110.57 -179.862 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.468 ' O ' ' C ' ' A' ' 5' ' ' SER . 3.4 mt-30 -60.91 177.06 0.35 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.047 -1.033 . . . . 0.0 109.093 179.225 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.513 ' N ' ' O ' ' A' ' 19' ' ' ASP . 1.6 p -40.91 144.21 0.65 Allowed Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.696 ' HG3' HG11 ' A' ' 27' ' ' VAL . 44.4 Cg_endo -67.9 162.42 39.79 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.713 1.375 . . . . 0.0 110.893 -179.097 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -72.77 166.5 29.78 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 124.06 1.558 . . . . 0.0 110.118 179.702 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.04 176.07 5.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.862 . . . . 0.0 110.179 179.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.597 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.25 -169.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 CA-C-O 122.164 0.983 . . . . 0.0 111.544 179.934 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.443 ' O ' ' C ' ' A' ' 11' ' ' ASN . 29.7 t -63.25 114.04 3.56 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.619 -178.665 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 10' ' ' SER . 0.8 OUTLIER 37.32 41.99 0.28 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.664 -0.647 . . . . 0.0 111.266 179.127 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.41 154.86 25.79 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.575 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HG2' ' CB ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -109.56 -179.41 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -1.188 . . . . 0.0 110.777 -179.825 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.617 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 23.0 p80 -139.29 -154.89 0.55 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.607 -0.683 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 12.5 t30 66.53 -170.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.105 -179.898 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 117.16 -4.76 18.19 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.1 -32.48 2.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.17 -1.194 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.574 ' OE2' ' CE1' ' A' ' 21' ' ' TYR . 5.9 pt-20 179.16 -176.22 0.25 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.317 -0.864 . . . . 0.0 110.291 -179.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 5' ' ' SER . 9.9 t70 -103.96 -25.07 13.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 110.175 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' O ' ' CG ' ' A' ' 21' ' ' TYR . 2.6 m-85 -105.71 -174.81 2.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.199 -0.938 . . . . 0.0 110.258 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.4 OUTLIER -178.71 -25.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.422 179.655 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 7.6 p 59.55 -94.36 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.588 -0.695 . . . . 0.0 112.661 178.839 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.563 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.4 OUTLIER -148.17 159.38 44.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.646 -1.283 . . . . 0.0 110.582 -178.078 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.08 13.28 57.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 -179.303 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.607 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.603 -0.94 . . . . 0.0 110.123 -179.867 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 43' ' ' VAL . 25.0 t -155.69 155.75 5.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.579 -179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.696 HG11 ' HG3' ' A' ' 6' ' ' PRO . 21.6 t -139.34 125.51 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.886 -179.487 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.76 103.9 9.02 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.601 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.702 ' O ' HD13 ' A' ' 37' ' ' LEU . 2.2 m-30 -68.09 121.31 15.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.346 -0.846 . . . . 0.0 110.562 -177.937 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -75.67 153.57 37.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.102 -0.998 . . . . 0.0 109.127 178.904 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.425 ' SG ' HD12 ' A' ' 37' ' ' LEU . 79.9 m -121.02 170.54 9.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.975 -1.078 . . . . 0.0 110.692 -179.285 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.458 ' O ' ' N ' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -62.94 137.26 58.22 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 110.125 179.887 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -46.96 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 110.324 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 32' ' ' ASN . . . 123.32 17.04 3.34 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.736 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 57' ' ' GLN . 13.6 m-85 -125.8 141.1 52.16 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.241 . . . . 0.0 110.18 179.976 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.662 ' HB2' HG13 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -85.24 142.13 29.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.944 . . . . 0.0 110.967 -179.455 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.702 HD13 ' O ' ' A' ' 29' ' ' TYR . 2.0 tp -89.61 98.1 11.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.424 -0.798 . . . . 0.0 109.147 178.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.767 HD13 ' N ' ' A' ' 38' ' ' ILE . 0.7 OUTLIER -86.47 141.81 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.331 -0.855 . . . . 0.0 109.312 -179.764 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.63 -172.48 14.63 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.654 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -64.5 145.25 56.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -1.133 . . . . 0.0 110.07 179.863 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.1 p -76.22 53.39 0.81 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.136 -179.941 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.615 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 152.5 115.37 0.62 Allowed Glycine 0 N--CA 1.49 2.245 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.103 -179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.769 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.5 OUTLIER -54.73 -178.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.004 -1.292 . . . . 0.0 107.853 178.831 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' SER . 5.4 tp -146.19 99.32 3.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.363 -0.836 . . . . 0.0 110.217 178.681 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.592 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -82.79 109.18 16.71 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.644 179.103 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.88 107.98 10.07 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.38 35.82 8.48 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.895 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 49' ' ' GLU . . . 60.92 38.75 95.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 48' ' ' GLY . 25.0 mt-10 -151.04 88.5 1.46 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.284 -1.127 . . . . 0.0 110.798 -179.582 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.592 ' CE2' ' SG ' ' A' ' 45' ' ' CYS . 78.5 m95 -50.68 136.99 20.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.056 -1.027 . . . . 0.0 109.247 179.339 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.79 162.22 36.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.958 -1.089 . . . . 0.0 111.507 -179.325 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.9 t0 58.57 66.09 2.69 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.774 -0.579 . . . . 0.0 111.513 179.277 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.502 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 48.8 Cg_endo -90.94 126.55 1.14 Allowed 'Trans proline' 0 C--N 1.298 -2.104 0 O-C-N 124.394 1.734 . . . . 0.0 109.753 178.774 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 48.0 Cg_endo -74.24 165.53 31.66 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.864 1.455 . . . . 0.0 110.252 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.611 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 66.1 p -105.52 150.91 24.92 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.12 -0.988 . . . . 0.0 111.215 -179.444 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.406 ' C ' ' OE1' ' A' ' 57' ' ' GLN . 77.0 m -111.72 82.18 1.57 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 3.1 mm100 -115.4 -150.7 0.47 Allowed 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.713 0.768 . . . . 0.0 110.738 -177.817 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.803 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -123.78 125.86 71.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.691 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.662 HG13 ' HB2' ' A' ' 36' ' ' SER . 31.0 m -115.68 50.12 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.002 -1.061 . . . . 0.0 112.08 -178.163 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 30.6 mttt -59.51 -173.31 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 117.739 -1.584 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.529 ' SG ' ' HD2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -146.0 170.12 8.48 Favored Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 118.478 -1.289 . . . . 0.0 112.948 -178.724 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.529 ' HD2' ' SG ' ' A' ' 61' ' ' CYS . 45.3 Cg_endo -92.19 -72.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.396 2.064 . . . . 0.0 109.848 179.226 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 165.18 125.42 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.718 -0.614 . . . . 0.0 109.674 -179.636 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.599 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 52.6 Cg_endo -78.36 71.07 6.95 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 O-C-N 123.81 1.426 . . . . 0.0 110.172 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.685 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.1 OUTLIER -89.91 171.69 9.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.0 109.925 179.915 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.804 HG21 ' CD1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -170.84 155.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.057 -1.027 . . . . 0.0 110.266 179.983 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 35.5 t -61.45 107.05 0.72 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.499 -0.751 . . . . 0.0 111.014 -179.357 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 3.3 m-20 39.95 37.27 0.35 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.506 -0.746 . . . . 0.0 110.682 179.469 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.587 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -143.48 27.15 2.11 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.632 ' HA ' HG23 ' A' ' 66' ' ' ILE . 2.0 p90 -44.32 -174.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 122.737 1.256 . . . . 0.0 112.362 -179.44 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.739 HD12 ' CE1' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -111.18 164.38 12.93 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.58 179.403 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 t -144.77 20.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.054 -1.029 . . . . 0.0 110.039 -179.626 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.6 t -103.02 -79.67 0.53 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.322 -0.861 . . . . 0.0 110.856 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.27 77.35 0.39 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 0.7 OUTLIER -106.12 168.54 9.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.45 -1.029 . . . . 0.0 110.021 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.627 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 0.3 OUTLIER -171.87 155.58 3.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.319 -0.863 . . . . 0.0 110.262 -179.851 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -52.07 -27.42 13.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.752 179.659 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.52 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 4.4 t -143.59 163.02 34.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 110.244 179.824 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.576 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 21.2 m-85 -137.35 -148.54 0.28 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -0.906 . . . . 0.0 110.03 179.983 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 93.8 p -154.34 -113.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.813 -1.18 . . . . 0.0 111.284 -179.733 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -107.88 12.35 27.25 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.556 -1.34 . . . . 0.0 110.67 -178.922 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.788 ' C ' HG22 ' A' ' 102' ' ' THR . 12.5 t-20 -162.25 -95.47 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.808 -1.183 . . . . 0.0 110.179 179.471 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.473 ' C ' ' O ' ' A' ' 82' ' ' ASN . 31.8 t0 43.26 76.47 0.08 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.726 -1.234 . . . . 0.0 108.955 -179.48 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.843 ' CA ' HG23 ' A' ' 102' ' ' THR . 6.3 p30 -68.35 126.96 31.23 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.351 -0.843 . . . . 0.0 110.664 -178.385 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.579 HG11 ' HG3' ' A' ' 64' ' ' PRO . 15.9 m -109.73 119.26 58.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 110.194 179.633 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 6.4 t0 -82.56 134.12 35.19 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.872 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.804 ' CD1' HG21 ' A' ' 66' ' ' ILE . 39.3 m-85 -92.5 131.8 37.34 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.956 -1.09 . . . . 0.0 112.252 -178.022 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -104.83 90.43 3.47 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.905 -179.944 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.548 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -44.26 129.46 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.65 179.984 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.3 OUTLIER -38.14 -87.74 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.521 -0.737 . . . . 0.0 110.637 -179.28 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -157.22 131.99 8.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.155 -0.965 . . . . 0.0 110.157 179.911 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 59.21 56.08 27.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.635 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 24.5 m-85 -161.05 148.46 15.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.515 -0.991 . . . . 0.0 109.854 -179.356 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 117' ' ' VAL . 6.5 tttm -106.25 138.9 41.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.259 -0.901 . . . . 0.0 109.88 179.906 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.588 HD23 HD11 ' A' ' 66' ' ' ILE . 1.3 mt -76.02 93.5 3.29 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.09 -1.007 . . . . 0.0 110.409 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.536 ' HB2' HG21 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -69.84 100.32 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 0.0 109.666 179.6 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 141.24 -97.17 0.21 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.715 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.591 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 5.8 t -148.41 114.98 5.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -1.204 . . . . 0.0 110.517 -179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.515 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 90.7 p -72.87 0.48 10.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.356 -0.84 . . . . 0.0 110.934 -179.89 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.0 p -145.63 100.13 3.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.91 179.812 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 85' ' ' VAL . 19.7 m -115.78 167.63 10.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.623 -179.566 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.843 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -136.38 144.15 44.41 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.494 -0.754 . . . . 0.0 110.441 -179.952 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.557 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 10.2 t -75.95 89.31 2.95 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.614 -0.679 . . . . 0.0 110.253 179.84 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.53 ' OG ' ' CD ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -65.74 179.89 0.41 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.245 -0.909 . . . . 0.0 111.327 -179.622 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.739 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.3 Cg_endo -75.32 125.79 9.34 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 124.271 1.669 . . . . 0.0 110.446 -179.678 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 119.99 -1.83 13.25 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.29 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.545 ' O ' HG23 ' A' ' 108' ' ' THR . 7.0 m-80 78.31 96.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.813 -0.816 . . . . 0.0 110.835 179.68 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -175.82 -166.47 0.19 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.086 179.556 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.635 ' HB3' HD13 ' A' ' 113' ' ' LEU . 19.5 m95 -151.64 91.24 1.63 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.373 0.606 . . . . 0.0 110.396 -179.491 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.561 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.0 OUTLIER -115.25 157.78 42.89 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.344 -0.847 . . . . 0.0 109.498 179.739 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.591 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 39.8 Cg_endo -70.8 171.8 56.31 Favored 'Cis proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.01 -2.079 . . . . 0.0 111.85 0.379 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.5 ' C ' ' O ' ' A' ' 111' ' ' PRO . 1.2 pm0 -23.49 119.02 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 CA-C-O 121.451 0.643 . . . . 0.0 112.624 -178.798 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.635 HD13 ' HB3' ' A' ' 109' ' ' TRP . 2.4 tp -45.82 137.28 5.95 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.394 -0.816 . . . . 0.0 109.014 178.585 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.607 ' HG3' ' CD2' ' A' ' 87' ' ' PHE . 42.8 Cg_endo -70.5 165.78 30.69 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 O-C-N 123.887 1.467 . . . . 0.0 111.204 -179.425 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.659 ' HG2' HG13 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -133.56 108.65 8.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.482 -0.761 . . . . 0.0 109.323 178.925 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.536 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.2 t -61.1 89.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.599 -179.612 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.659 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.8 m -106.59 -167.28 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-O 121.839 0.828 . . . . 0.0 110.569 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.476 ' HG2' ' CE1' ' A' ' 93' ' ' TYR . 7.7 mtm180 . . . . . 0 C--N 1.291 -1.969 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.293 0.568 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' A' ' 22' ' ' THR . 14.3 mttt -93.63 174.83 6.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.924 . . . . 0.0 110.363 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -136.48 92.9 2.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.302 -0.873 . . . . 0.0 110.212 179.844 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -67.47 170.8 6.9 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.297 179.518 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 4' ' ' GLN . 1.0 OUTLIER -42.45 143.45 1.11 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.883 -179.847 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.862 ' HG3' HG11 ' A' ' 27' ' ' VAL . 50.9 Cg_endo -70.86 152.45 63.6 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.988 1.52 . . . . 0.0 110.741 -179.207 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -74.38 170.27 20.61 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.747 1.393 . . . . 0.0 109.865 179.416 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.68 176.3 3.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.078 -1.014 . . . . 0.0 109.813 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.684 HG21 ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -140.54 -169.83 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 CA-C-O 122.168 0.985 . . . . 0.0 111.498 179.838 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 7.9 t -40.62 92.66 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.536 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 9' ' ' ILE . 12.1 m120 42.63 45.94 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -140.49 178.42 19.99 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 180.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.531 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 0.1 OUTLIER -126.25 -169.33 2.0 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.156 -1.202 . . . . 0.0 110.695 -179.915 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.613 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 13.8 p80 -157.9 125.36 5.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.898 -0.502 . . . . 0.0 110.512 -179.41 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.39 -33.82 1.25 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 44.4 -122.43 4.58 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.59 -0.79 2.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -1.16 . . . . 0.0 110.597 -179.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 7.4 pt-20 -164.12 -167.35 1.31 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.491 -179.811 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -138.28 19.31 2.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.291 -0.88 . . . . 0.0 110.589 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.42 45.43 2.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.007 -1.058 . . . . 0.0 110.441 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.608 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 23.2 m-85 -58.26 179.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 110.205 179.642 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.562 ' CA ' ' HB2' ' A' ' 3' ' ' CYS . 2.2 p -147.14 -61.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.961 -1.087 . . . . 0.0 111.045 -179.585 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -163.37 137.37 5.93 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.331 -0.856 . . . . 0.0 109.563 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.53 15.04 80.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.168 -1.973 . . . . 0.0 108.168 -178.552 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.608 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 0.6 OUTLIER -96.73 175.3 6.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.589 -0.948 . . . . 0.0 109.543 179.81 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 43' ' ' VAL . 39.8 t -149.22 154.11 9.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.993 -179.756 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.862 HG11 ' HG3' ' A' ' 6' ' ' PRO . 24.3 t -134.24 122.62 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.252 -179.739 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 41' ' ' SER . 0.0 OUTLIER -74.33 103.31 4.67 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 118.315 -1.354 . . . . 0.0 108.015 177.805 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.991 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.3 m-30 -68.45 176.57 2.79 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.763 -178.487 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.5 t -130.79 -177.15 4.24 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.231 -0.918 . . . . 0.0 109.839 179.616 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 35' ' ' TYR . 91.0 m -147.72 135.38 20.93 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.347 -0.846 . . . . 0.0 109.616 179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.472 ' O ' ' OG ' ' A' ' 33' ' ' SER . 6.5 m120 -99.52 -177.87 3.72 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -0.889 . . . . 0.0 110.744 -179.527 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.595 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 6.0 p 44.76 56.77 4.99 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.707 0.765 . . . . 0.0 110.278 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 43.46 49.63 6.94 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 179.281 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 33' ' ' SER . 4.5 m-30 -102.4 131.78 48.83 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.915 -1.344 . . . . 0.0 111.164 -179.874 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.831 ' CB ' HG13 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -74.59 138.52 43.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.742 -0.599 . . . . 0.0 110.679 -179.792 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.587 ' C ' HD13 ' A' ' 38' ' ' ILE . 2.7 tt -89.44 109.66 20.56 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.128 -0.983 . . . . 0.0 109.453 178.986 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.815 HG23 ' HG3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -103.02 143.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.135 -0.978 . . . . 0.0 109.468 -179.988 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.41 -141.1 11.41 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.881 -1.687 . . . . 0.0 108.881 -179.393 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.511 ' O ' ' C ' ' A' ' 41' ' ' SER . 27.6 t30 -111.42 52.39 0.75 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.093 -1.239 . . . . 0.0 109.907 179.462 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.526 ' O ' HG23 ' A' ' 28' ' ' THR . 27.7 p 22.67 49.69 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.749 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.555 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 157.11 119.33 0.59 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.991 HG21 ' CE1' ' A' ' 29' ' ' TYR . 2.3 t -65.51 -179.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.067 -1.254 . . . . 0.0 108.176 179.198 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.571 ' H ' HG12 ' A' ' 43' ' ' VAL . 2.6 tp -144.88 97.74 3.07 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.32 179.048 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.596 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 18.4 t -79.79 126.25 30.72 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.225 178.788 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.6 p -129.68 110.18 11.57 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.226 -179.865 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.35 22.51 62.56 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.91 8.11 76.64 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -118.8 114.59 22.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.204 -1.174 . . . . 0.0 110.538 -179.871 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.662 ' CH2' HG23 ' A' ' 27' ' ' VAL . 79.8 m95 -69.9 134.81 48.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.393 -0.817 . . . . 0.0 109.787 179.539 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.19 168.36 20.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.084 -1.01 . . . . 0.0 111.025 -179.716 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.488 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 15.6 t0 54.07 66.27 4.53 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.734 -0.604 . . . . 0.0 111.047 179.802 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 50.1 Cg_endo -90.6 138.28 2.56 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 O-C-N 124.38 1.726 . . . . 0.0 110.154 179.349 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 47.2 Cg_endo -75.31 175.8 10.78 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.839 1.442 . . . . 0.0 110.591 179.938 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 12.8 p -111.23 -175.24 2.66 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.368 -0.832 . . . . 0.0 111.359 -179.019 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' O ' ' CD2' ' A' ' 35' ' ' TYR . 33.6 m -142.51 75.37 1.49 Allowed 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.859 0.837 . . . . 0.0 108.803 178.839 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.546 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -108.6 -148.67 0.43 Allowed 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.728 -179.146 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.808 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -125.99 121.31 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.021 -1.049 . . . . 0.0 108.632 179.347 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.831 HG13 ' CB ' ' A' ' 36' ' ' SER . 20.4 m -114.68 49.46 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.025 -1.047 . . . . 0.0 112.324 -178.197 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.2 OUTLIER -60.55 -172.24 0.02 OUTLIER 'General case' 0 C--N 1.28 -2.425 0 C-N-CA 117.779 -1.569 . . . . 0.0 107.519 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.497 ' CB ' ' HB2' ' A' ' 79' ' ' TYR . 1.1 m -147.95 166.73 15.02 Favored Pre-proline 0 C--N 1.294 -1.832 0 C-N-CA 117.84 -1.544 . . . . 0.0 113.979 -178.296 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 63' ' ' HIS . 45.0 Cg_endo -87.84 -74.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 125.02 2.063 . . . . 0.0 110.618 179.551 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.5 ' CB ' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER 166.12 125.4 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.074 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.891 ' HG2' HD21 ' A' ' 71' ' ' LEU . 48.1 Cg_endo -75.36 65.64 6.37 Favored 'Trans proline' 0 C--N 1.299 -2.065 0 O-C-N 123.629 1.331 . . . . 0.0 109.455 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.576 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -82.48 175.93 9.81 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.502 -0.749 . . . . 0.0 110.311 -179.536 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.994 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -171.99 167.57 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 110.404 -179.623 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.469 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 46.5 p -72.81 100.39 2.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 110.55 -179.674 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 88.5 m-20 42.85 49.09 5.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.815 179.342 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.994 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -161.86 38.52 0.39 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.82 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.613 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 49.4 p90 -47.0 -151.25 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 123.101 1.429 . . . . 0.0 113.141 -179.738 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.919 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -139.06 127.18 22.51 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.682 -176.948 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' A' ' 72' ' ' SER . 1.6 t -103.89 16.88 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.494 -0.754 . . . . 0.0 110.087 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.65 101.37 6.12 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.161 -0.962 . . . . 0.0 111.538 -179.008 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.673 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 71.84 103.42 0.06 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 178.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.643 ' CD2' HD11 ' A' ' 71' ' ' LEU . 7.8 t80 -156.92 154.11 29.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -1.085 . . . . 0.0 110.266 179.431 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.592 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 1.1 tttm -161.35 147.96 14.54 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 179.939 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' A' ' 76' ' ' LYS . 29.8 mtm180 -42.47 -37.01 1.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.227 -0.921 . . . . 0.0 110.055 179.789 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.434 ' C ' ' CD1' ' A' ' 79' ' ' TYR . 0.4 OUTLIER -131.9 165.03 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.463 -0.773 . . . . 0.0 110.118 179.835 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.592 ' CZ ' ' O ' ' A' ' 76' ' ' LYS . 22.8 m-85 -137.04 -142.87 0.17 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -0.888 . . . . 0.0 110.106 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.556 ' C ' HG23 ' A' ' 59' ' ' VAL . 55.6 p -156.48 -117.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.951 -1.093 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.585 ' HB3' HG21 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -105.22 11.65 32.78 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.752 -1.218 . . . . 0.0 111.845 -178.664 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.787 ' C ' HG22 ' A' ' 102' ' ' THR . 0.5 OUTLIER -163.64 -94.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.642 -1.286 . . . . 0.0 110.72 178.938 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 82' ' ' ASN . 7.6 m-20 42.41 74.26 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.723 -1.236 . . . . 0.0 109.272 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.701 ' CA ' HG23 ' A' ' 102' ' ' THR . 47.4 t30 -68.82 121.91 17.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.888 . . . . 0.0 110.614 -178.664 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.673 HG12 ' O ' ' A' ' 74' ' ' GLY . 29.0 m -106.44 123.14 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 110.844 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -80.24 139.34 36.74 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.336 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.675 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 32.0 m-85 -95.15 143.25 26.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.82 -1.175 . . . . 0.0 112.38 -177.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.0 OUTLIER -115.37 98.18 6.6 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.769 -179.857 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.524 ' H ' HD11 ' A' ' 95' ' ' LEU . 0.1 OUTLIER -50.22 134.98 22.04 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.042 -1.036 . . . . 0.0 110.397 -179.639 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -41.39 -69.84 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.446 -0.784 . . . . 0.0 110.402 -179.974 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 23.5 t80 -172.19 141.71 1.3 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.304 -0.873 . . . . 0.0 110.391 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.588 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 46.18 47.71 15.5 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.588 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 11.1 m-85 -149.23 150.0 31.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.467 -1.019 . . . . 0.0 109.803 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 117' ' ' VAL . 4.8 mtmt -103.3 143.37 32.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.162 -0.961 . . . . 0.0 110.092 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 89' ' ' CYS . 0.7 OUTLIER -85.09 92.38 8.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.159 -0.963 . . . . 0.0 110.187 -179.956 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.96 105.02 10.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.3 -79.83 0.24 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.718 -1.229 . . . . 0.0 110.227 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.574 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 24.9 p -159.7 99.27 1.41 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -1.092 . . . . 0.0 110.922 -179.191 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -12.41 47.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.073 -1.017 . . . . 0.0 109.591 179.203 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 p -140.63 108.45 5.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.452 -0.78 . . . . 0.0 109.551 179.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 2.8 m -123.67 167.67 13.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.215 -0.928 . . . . 0.0 111.16 -179.238 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.787 HG22 ' C ' ' A' ' 82' ' ' ASN . 0.2 OUTLIER -134.48 145.19 48.58 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.782 0.801 . . . . 0.0 110.339 179.617 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.574 ' SG ' ' CE2' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -82.24 80.13 8.53 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.827 -0.546 . . . . 0.0 110.098 179.943 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.528 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -58.4 -177.1 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.567 -0.708 . . . . 0.0 111.358 -179.212 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.815 ' HG3' HG23 ' A' ' 38' ' ' ILE . 43.9 Cg_endo -77.37 125.42 7.71 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.386 1.73 . . . . 0.0 110.211 -179.707 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 127.26 -8.37 7.07 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 108.876 -1.689 . . . . 0.0 108.876 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.715 ' O ' HG23 ' A' ' 108' ' ' THR . 4.8 m-20 79.47 94.7 0.06 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.749 -0.853 . . . . 0.0 110.683 179.593 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.715 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.49 -166.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.832 . . . . 0.0 111.092 179.445 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.669 ' HB3' HD11 ' A' ' 113' ' ' LEU . 38.0 m95 -144.04 87.69 1.92 Allowed 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.539 0.685 . . . . 0.0 109.729 -179.845 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -100.26 140.81 21.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.658 -179.238 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.574 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 43.0 Cg_endo -74.83 170.93 70.31 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 C-N-CA 121.555 -2.269 . . . . 0.0 110.039 -0.231 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 11.8 pt-20 -36.75 137.16 0.33 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.562 -0.712 . . . . 0.0 111.248 -179.078 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.759 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.0 OUTLIER -46.76 157.86 0.44 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.846 . . . . 0.0 109.799 179.511 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.77 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.4 Cg_endo -79.95 165.51 21.87 Favored 'Trans proline' 0 C--N 1.301 -1.971 0 O-C-N 124.206 1.635 . . . . 0.0 111.126 -179.715 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.729 ' HG2' HG13 ' A' ' 117' ' ' VAL . 9.0 ttmt -124.36 104.53 8.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.488 -0.758 . . . . 0.0 110.389 -179.883 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.54 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 2.3 t -60.34 83.65 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.156 -0.965 . . . . 0.0 109.356 179.623 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.729 HG13 ' HG2' ' A' ' 115' ' ' LYS . 1.8 m -95.77 -175.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.87 0.843 . . . . 0.0 110.808 -179.6 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.556 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.0 OUTLIER . . . . . 0 C--N 1.294 -1.81 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.442 179.444 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.675 HG21 ' C ' ' A' ' 47' ' ' GLY . 9.6 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.231 0.539 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 20' ' ' PHE . 3.9 ttmt -132.88 172.13 13.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.0 110.367 -179.734 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.576 ' SG ' ' CE2' ' A' ' 50' ' ' TRP . 10.4 t -163.81 136.14 5.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.0 110.102 -179.918 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.454 ' O ' ' C ' ' A' ' 5' ' ' SER . 6.5 pt20 -117.2 -176.71 3.05 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.376 -0.828 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -40.3 142.38 0.74 Allowed Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.273 -179.999 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.795 ' HG3' HG11 ' A' ' 27' ' ' VAL . 55.4 Cg_endo -71.68 167.37 26.69 Favored 'Trans proline' 0 C--N 1.302 -1.873 0 O-C-N 124.143 1.601 . . . . 0.0 110.647 -179.313 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.03 171.86 15.01 Favored 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.797 1.419 . . . . 0.0 108.756 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -78.18 104.96 9.1 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.893 -1.13 . . . . 0.0 110.616 -179.563 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.824 HG21 ' CG ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -42.64 173.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.173 0 CA-C-O 121.9 0.857 . . . . 0.0 110.012 -179.904 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.594 ' N ' HG13 ' A' ' 9' ' ' ILE . 34.5 m -99.86 140.92 33.38 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 118.604 -1.238 . . . . 0.0 109.697 178.293 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 6.8 m120 63.37 17.06 10.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.731 -179.02 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 30' ' ' SER . . . -167.05 -164.52 22.84 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.828 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' SER . 7.2 mtp180 -140.39 -171.81 3.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.271 -1.135 . . . . 0.0 110.566 -179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.609 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 7.9 p80 -148.11 133.34 18.41 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.812 -0.555 . . . . 0.0 110.37 -179.937 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.42 ' OD1' ' O ' ' A' ' 14' ' ' HIS . 3.1 m-20 -167.01 75.97 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.92 . . . . 0.0 110.237 -179.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.5 -101.55 0.01 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.917 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -175.84 38.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -1.15 . . . . 0.0 109.793 179.996 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.574 ' HG3' ' CE1' ' A' ' 21' ' ' TYR . 0.7 OUTLIER -154.48 -169.38 3.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.332 -179.665 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.8 -37.97 1.9 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.34 -0.85 . . . . 0.0 110.081 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.555 ' CE1' ' HD3' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -111.72 118.75 36.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 110.079 179.888 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.652 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 0.5 OUTLIER -104.36 -12.78 16.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.299 -0.876 . . . . 0.0 110.429 -179.741 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.548 ' N ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 p 45.45 -96.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.921 . . . . 0.0 111.867 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.524 ' OD2' ' N ' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -148.47 154.01 39.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.886 -1.134 . . . . 0.0 110.115 -178.588 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.2 19.64 79.69 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.232 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.652 ' HB3' ' CD1' ' A' ' 21' ' ' TYR . 7.1 m -98.34 171.1 8.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.695 -0.885 . . . . 0.0 110.212 -179.855 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.723 HG13 ' O ' ' A' ' 43' ' ' VAL . 38.9 t -147.87 155.29 10.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.176 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.795 HG11 ' HG3' ' A' ' 6' ' ' PRO . 13.1 t -134.12 111.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.639 -179.132 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 103.25 1.52 Allowed 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.461 -1.296 . . . . 0.0 107.738 178.085 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.824 ' CG ' HG21 ' A' ' 9' ' ' ILE . 1.3 m-30 -68.02 -176.55 0.71 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.666 -0.813 . . . . 0.0 109.998 -178.435 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.494 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -133.99 155.3 50.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.291 179.057 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 74.1 m -126.41 139.72 53.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 0.0 110.561 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.46 ' O ' ' O ' ' A' ' 33' ' ' SER . 31.9 m-20 -83.49 174.35 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.574 -0.704 . . . . 0.0 110.392 179.905 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.497 ' HB3' ' CD2' ' A' ' 35' ' ' TYR . 28.8 t 42.31 -165.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.137 179.211 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.0 44.84 2.66 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.675 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 33' ' ' SER . 12.0 m-85 -89.08 107.76 19.22 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.95 -1.324 . . . . 0.0 111.185 -179.419 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.655 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -60.39 139.68 57.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 0.0 110.357 179.281 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.665 HD21 ' HA ' ' A' ' 41' ' ' SER . 0.5 OUTLIER -84.38 102.19 12.56 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.316 179.078 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.767 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -94.3 150.95 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.099 -1.001 . . . . 0.0 108.991 179.785 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.31 -143.43 14.41 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.223 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' O ' ' C ' ' A' ' 41' ' ' SER . 3.3 m120 -114.58 49.62 1.01 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.109 -1.23 . . . . 0.0 109.837 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.665 ' HA ' HD21 ' A' ' 37' ' ' LEU . 0.5 OUTLIER 25.21 62.92 0.06 Allowed 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.941 179.505 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' C ' HG13 ' A' ' 26' ' ' VAL . . . 141.88 115.22 1.12 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.397 -1.382 . . . . 0.0 110.533 179.593 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.723 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -58.45 -178.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.522 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 25' ' ' SER . 4.3 tp -142.88 105.8 4.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.005 -1.06 . . . . 0.0 110.097 178.458 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 4.2 t -88.29 109.4 19.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.185 -0.947 . . . . 0.0 109.832 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 52.9 m -126.77 126.06 42.79 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.13 179.759 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.675 ' C ' HG21 ' A' ' 1' ' ' VAL . . . 70.45 28.62 70.92 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.981 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.54 26.44 73.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.03 115.4 12.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -1.163 . . . . 0.0 110.174 179.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.628 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 87.8 m95 -76.58 136.28 39.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.222 -0.924 . . . . 0.0 109.862 179.812 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.73 171.76 19.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 110.998 -179.765 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.533 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 0.2 OUTLIER 53.67 64.73 6.35 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.872 -0.518 . . . . 0.0 111.212 179.77 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -91.99 145.28 2.96 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 C-N-CA 121.958 1.772 . . . . 0.0 109.841 179.138 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 29' ' ' TYR . 46.4 Cg_endo -79.44 174.9 11.31 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.731 1.385 . . . . 0.0 110.11 179.53 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.59 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 14.4 p -114.39 -177.31 3.1 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.315 -0.865 . . . . 0.0 111.13 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.751 ' SG ' HD11 ' A' ' 9' ' ' ILE . 84.7 m -140.57 73.42 1.42 Allowed 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.019 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.578 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -116.52 177.57 4.65 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.736 -178.975 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' CD ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -88.94 145.15 7.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.1 179.719 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.655 HG21 ' CB ' ' A' ' 81' ' ' TYR . 29.0 m -129.93 40.96 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 110.371 -179.128 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.572 ' CD ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -78.87 101.21 7.56 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.274 -0.97 . . . . 0.0 109.429 179.843 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 50.2 m -73.04 162.71 73.23 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.454 -0.778 . . . . 0.0 111.253 -178.913 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 43.3 Cg_endo -70.82 -89.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 124.359 1.715 . . . . 0.0 110.628 -179.505 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -172.25 133.42 0.76 Allowed Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.449 -0.782 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.643 ' HA ' HD21 ' A' ' 113' ' ' LEU . 58.0 Cg_endo -86.7 83.8 1.09 Allowed 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 123.69 1.363 . . . . 0.0 109.616 -179.943 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.68 ' O ' HG23 ' A' ' 66' ' ' ILE . 4.1 p -100.7 -42.38 6.53 Favored 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 122.39 1.091 . . . . 0.0 110.288 -178.954 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.785 HD12 ' HG2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER 48.86 170.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.927 -179.216 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.533 ' N ' ' CG1' ' A' ' 66' ' ' ILE . 49.6 m -69.32 107.61 3.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 111.666 -178.847 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.512 ' O ' ' CG ' ' A' ' 90' ' ' LYS . 27.6 m120 38.06 43.78 0.58 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.537 -0.727 . . . . 0.0 111.77 178.438 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 70' ' ' TYR . . . -126.6 -44.08 0.25 Allowed Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.805 -1.664 . . . . 0.0 109.903 179.82 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.62 ' CZ ' ' HB3' ' A' ' 88' ' ' LYS . 23.3 p90 41.35 -174.61 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 122.639 1.209 . . . . 0.0 111.827 -179.13 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.883 HD13 ' N ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -132.63 153.62 50.89 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.239 -179.243 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.15 -13.88 12.96 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.888 -1.133 . . . . 0.0 110.287 -178.78 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.411 ' CB ' ' H ' ' A' ' 86' ' ' ASP . 40.9 t -51.41 -54.44 26.66 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.316 -0.865 . . . . 0.0 110.214 -179.887 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 161.19 106.6 0.21 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -102.81 -177.34 3.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -1.081 . . . . 0.0 109.962 179.905 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 75' ' ' PHE . 27.5 tttm -159.68 168.75 25.25 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.55 -0.719 . . . . 0.0 109.89 -179.585 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.402 ' N ' ' HG2' ' A' ' 76' ' ' LYS . 26.0 mtp85 -65.86 -39.25 90.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 110.252 179.981 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 m -139.64 126.21 20.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.283 -0.886 . . . . 0.0 110.518 -179.854 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.582 ' CD2' ' CH2' ' A' ' 109' ' ' TRP . 60.4 m-85 -95.32 -175.99 3.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -0.898 . . . . 0.0 110.11 179.749 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 29.0 t -170.47 96.87 0.25 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.101 -0.999 . . . . 0.0 110.301 179.941 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.655 ' CB ' HG21 ' A' ' 59' ' ' VAL . 2.2 t80 52.06 125.03 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.381 -0.825 . . . . 0.0 110.664 -179.907 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.712 ' O ' HG22 ' A' ' 102' ' ' THR . 13.7 t-20 73.51 -128.86 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.941 -1.1 . . . . 0.0 110.381 -179.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.29 71.08 0.54 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.701 -1.249 . . . . 0.0 109.11 -178.451 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.542 ' N ' HG23 ' A' ' 102' ' ' THR . 10.6 t30 -70.39 142.17 52.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.533 -0.73 . . . . 0.0 111.093 -178.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.78 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER -129.57 120.01 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.328 -0.858 . . . . 0.0 110.072 179.002 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -84.29 124.17 30.96 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.187 -0.946 . . . . 0.0 108.641 178.966 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.789 ' CE1' HD12 ' A' ' 71' ' ' LEU . 50.2 m-85 -80.94 136.38 36.03 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.316 1.055 . . . . 0.0 112.527 -177.859 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.4 OUTLIER -114.76 86.1 2.38 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.439 -179.643 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.585 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -37.68 128.07 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.543 -0.723 . . . . 0.0 110.795 -179.361 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.512 ' CG ' ' O ' ' A' ' 68' ' ' ASN . 15.1 mmtt -38.95 -84.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.538 -0.726 . . . . 0.0 110.613 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 19.0 t80 -160.58 149.6 16.98 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.12 -0.987 . . . . 0.0 110.508 -179.952 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.59 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 49.49 31.46 14.21 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.59 ' CD1' ' O ' ' A' ' 92' ' ' GLY . 16.6 m-85 -142.65 146.12 34.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.501 -0.999 . . . . 0.0 110.234 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -111.73 135.07 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 179.885 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.707 HD23 HD11 ' A' ' 66' ' ' ILE . 5.5 mt -67.24 111.06 3.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 0.0 110.524 -179.702 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.467 ' HB2' HG21 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.19 106.62 18.31 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.136 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 135.03 -90.38 0.23 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.615 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.5 OUTLIER -149.0 120.39 7.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -1.15 . . . . 0.0 110.538 -179.474 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HA ' ' HB2' ' A' ' 87' ' ' PHE . 8.5 p -80.15 4.8 16.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.32 -0.863 . . . . 0.0 110.905 -179.635 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.8 p -144.9 115.81 7.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.102 -0.999 . . . . 0.0 110.093 179.719 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 17.5 m -126.82 -175.53 3.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.294 -0.878 . . . . 0.0 110.699 -179.714 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 82' ' ' ASN . 13.9 m -157.24 134.4 10.34 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.114 -178.926 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.584 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 6.2 t -59.72 87.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.573 -0.704 . . . . 0.0 109.877 179.301 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.21 172.38 9.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.137 -0.977 . . . . 0.0 110.707 -179.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.767 ' HB3' HD12 ' A' ' 38' ' ' ILE . 41.7 Cg_endo -74.85 123.74 8.19 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.334 1.702 . . . . 0.0 110.925 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.562 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 133.2 -7.61 5.07 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 108.826 -1.709 . . . . 0.0 108.826 -179.442 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 5.9 m120 81.12 77.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.971 -0.723 . . . . 0.0 110.384 179.83 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.499 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -174.4 -168.09 0.36 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.336 -0.852 . . . . 0.0 111.612 179.82 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.78 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 22.5 m95 -134.37 100.65 4.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.722 -0.611 . . . . 0.0 110.29 -179.691 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' O ' ' N ' ' A' ' 102' ' ' THR . 2.7 mttm -102.71 149.12 36.46 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 110.216 -179.891 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.615 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 51.9 Cg_endo -75.28 -174.58 14.48 Favored 'Cis proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.906 -2.123 . . . . 0.0 110.551 -0.371 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 111' ' ' PRO . 10.1 tp10 -39.13 117.35 0.68 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.341 0.591 . . . . 0.0 110.362 179.925 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.701 HD13 ' HB3' ' A' ' 109' ' ' TRP . 1.8 tp -43.74 141.94 2.07 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.381 -0.825 . . . . 0.0 110.785 -179.694 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.785 ' HG2' HD12 ' A' ' 66' ' ' ILE . 41.7 Cg_endo -72.31 167.05 27.95 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.085 1.571 . . . . 0.0 110.502 179.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.573 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -132.33 95.33 3.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.224 -0.923 . . . . 0.0 110.525 179.879 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.528 ' CB ' ' O ' ' A' ' 67' ' ' SER . 1.7 t -46.62 102.68 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.073 -1.017 . . . . 0.0 109.135 179.475 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -113.58 -178.76 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.729 0.775 . . . . 0.0 111.083 -179.135 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.717 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.232 179.874 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.162 0.506 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.8 pttm -162.58 171.5 16.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -0.945 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.535 ' HB2' ' N ' ' A' ' 22' ' ' THR . 1.2 m -130.55 151.96 50.45 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 0.0 110.367 -179.878 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 20' ' ' PHE . 41.6 mt-30 -134.03 174.7 10.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.072 -1.018 . . . . 0.0 109.835 179.647 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.25 130.69 7.62 Favored Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.328 -0.858 . . . . 0.0 110.012 -179.641 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.612 ' HG2' ' CG ' ' A' ' 14' ' ' HIS . 48.8 Cg_endo -70.46 158.83 54.88 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.944 1.497 . . . . 0.0 110.77 -179.752 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -74.05 175.14 11.28 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.014 1.534 . . . . 0.0 110.202 179.761 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 9' ' ' ILE . 88.7 p -85.75 99.21 11.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.907 . . . . 0.0 110.133 179.906 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.619 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -50.0 -170.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 122.381 1.086 . . . . 0.0 111.917 -179.664 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 9' ' ' ILE . 1.9 p -37.48 95.79 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.012 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ILE . 0.9 OUTLIER 41.03 29.61 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.321 -0.862 . . . . 0.0 110.758 179.682 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 31' ' ' CYS . . . -119.32 174.32 15.37 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.943 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' CB ' ' HB3' ' A' ' 30' ' ' SER . 1.6 mtt85 -113.53 -168.49 1.35 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 110.437 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.612 ' CG ' ' HG2' ' A' ' 6' ' ' PRO . 15.3 p80 -158.94 119.45 3.22 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.321 0.581 . . . . 0.0 110.265 -179.899 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.699 ' O ' HG13 ' A' ' 27' ' ' VAL . 3.6 m-80 -107.11 -162.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.634 -179.621 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 18' ' ' GLU . . . 147.3 -20.67 1.54 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.986 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 62.12 34.78 16.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.276 -1.132 . . . . 0.0 110.391 -179.958 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.611 ' HG3' ' CZ ' ' A' ' 21' ' ' TYR . 38.2 mm-40 -121.43 -155.38 0.63 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.281 -0.887 . . . . 0.0 110.004 179.721 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -153.36 -39.87 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 110.268 179.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.617 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 7.8 p90 -143.48 80.19 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.23 179.707 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 25' ' ' SER . 25.7 m-85 -49.75 -179.12 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.052 -1.03 . . . . 0.0 110.112 179.938 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.535 ' N ' ' HB2' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -142.61 -68.56 0.36 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.616 -1.303 . . . . 0.0 111.183 -179.07 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -156.86 141.42 16.76 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.358 -0.839 . . . . 0.0 109.757 -178.954 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 69.27 7.97 58.21 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.616 -1.793 . . . . 0.0 108.616 -178.843 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 26' ' ' VAL . 40.5 m -71.31 174.91 5.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -1.11 . . . . 0.0 110.027 179.817 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 36.3 t -156.77 157.63 3.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.31 179.642 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 15' ' ' ASN . 34.0 t -144.68 121.26 4.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.102 -179.655 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.696 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -72.46 101.88 3.06 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.403 -1.319 . . . . 0.0 107.869 178.249 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.672 ' CE1' HG21 ' A' ' 43' ' ' VAL . 2.1 m-30 -67.99 154.93 40.59 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.414 -0.804 . . . . 0.0 110.136 -178.31 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.507 ' HB3' ' CB ' ' A' ' 13' ' ' ARG . 5.7 t -114.37 -177.14 3.06 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.333 -0.854 . . . . 0.0 109.216 179.021 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 57.4 m -146.9 149.89 34.13 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.163 -0.961 . . . . 0.0 110.274 179.995 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.25 149.97 5.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 0.0 110.201 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.7 m -54.34 107.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.215 179.968 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.1 10.05 9.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.948 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 56' ' ' CYS . 4.4 m-85 -124.24 120.86 33.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.155 -1.203 . . . . 0.0 110.725 -179.693 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.616 ' HB3' HD11 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -73.05 138.2 45.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 110.428 179.678 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.532 ' HA ' ' O ' ' A' ' 55' ' ' THR . 3.9 tp -90.42 98.57 11.85 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.207 -0.933 . . . . 0.0 109.533 179.139 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.783 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -92.05 170.39 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.248 -0.907 . . . . 0.0 109.096 179.414 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.482 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 83.93 -178.82 52.14 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.684 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.19 121.66 15.28 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.261 -1.141 . . . . 0.0 109.943 179.917 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.696 ' O ' HG23 ' A' ' 28' ' ' THR . 6.2 t -73.11 53.4 0.37 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.391 -0.818 . . . . 0.0 110.491 -179.755 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.499 ' O ' ' O ' ' A' ' 43' ' ' VAL . . . 174.78 88.08 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.336 179.892 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.682 HG23 ' HB ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -45.32 173.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.316 -1.108 . . . . 0.0 108.935 179.45 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 25' ' ' SER . 6.3 tp -139.69 106.18 5.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.155 -0.966 . . . . 0.0 110.151 178.809 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.602 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 0.5 OUTLIER -81.61 107.54 14.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.138 -0.976 . . . . 0.0 109.771 179.595 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -129.16 121.33 27.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.367 -0.833 . . . . 0.0 110.328 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -7.4 80.82 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.879 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 112.6 16.37 8.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.972 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -144.69 138.17 27.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.262 -1.14 . . . . 0.0 110.381 -179.938 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.602 ' CZ3' ' HB2' ' A' ' 45' ' ' CYS . 99.8 m95 -77.92 136.39 38.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.368 -0.833 . . . . 0.0 109.878 179.696 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 t -132.12 163.88 27.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 110.889 -179.435 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.476 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 27.8 m-20 51.09 66.7 5.07 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.808 -0.558 . . . . 0.0 111.191 179.681 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.3 Cg_endo -90.42 137.88 2.57 Favored 'Trans proline' 0 C--N 1.3 -1.993 0 O-C-N 124.399 1.736 . . . . 0.0 109.733 179.123 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 51.1 Cg_endo -75.68 178.02 7.93 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.664 1.35 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.581 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 18.5 p -118.92 147.04 44.45 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.171 -0.956 . . . . 0.0 112.072 -178.635 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.51 ' O ' ' CD1' ' A' ' 35' ' ' TYR . 92.4 m -110.37 76.03 0.96 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.317 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -115.04 178.73 4.18 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 121.457 0.646 . . . . 0.0 110.392 -178.575 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.548 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -91.38 134.53 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.654 -0.819 . . . . 0.0 109.053 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.652 HG21 ' CB ' ' A' ' 81' ' ' TYR . 28.2 m -119.8 43.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 110.645 -178.992 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 25.4 mttt -80.06 97.66 6.92 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 119.406 -0.917 . . . . 0.0 108.904 179.5 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 107' ' ' ASN . 60.2 m -69.06 161.88 69.39 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -178.607 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 61' ' ' CYS . 47.1 Cg_endo -72.08 -91.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.503 1.791 . . . . 0.0 110.34 -179.638 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.457 ' O ' HG23 ' A' ' 65' ' ' THR . 0.0 OUTLIER -157.46 131.55 4.99 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.593 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.605 ' HB3' ' CD2' ' A' ' 109' ' ' TRP . 50.1 Cg_endo -76.91 66.18 7.65 Favored 'Trans proline' 0 C--N 1.297 -2.132 0 O-C-N 123.725 1.382 . . . . 0.0 109.888 -178.906 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.737 ' C ' HG22 ' A' ' 66' ' ' ILE . 0.7 OUTLIER -87.87 -174.65 4.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.547 -0.72 . . . . 0.0 109.519 179.955 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.737 HG22 ' C ' ' A' ' 65' ' ' THR . 0.2 OUTLIER 178.32 166.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.355 179.471 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' A' ' 116' ' ' CYS . 0.3 OUTLIER -69.8 96.02 0.95 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.367 -0.833 . . . . 0.0 110.746 -179.594 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.554 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 6.7 m-20 48.72 40.49 16.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.925 179.435 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 70' ' ' TYR . . . -146.3 28.58 1.66 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.702 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 88' ' ' LYS . 1.6 p90 -45.15 -175.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.641 1.21 . . . . 0.0 112.346 -179.08 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.712 ' H ' HD13 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.5 162.12 15.45 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.347 179.527 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.9 t -144.66 22.74 1.62 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.971 -1.08 . . . . 0.0 110.449 -179.094 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 39.9 t -100.12 -82.45 0.45 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 110.42 -179.698 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.44 75.88 0.41 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.711 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -95.88 157.99 15.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.415 -1.05 . . . . 0.0 109.592 179.554 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.552 ' O ' ' CZ ' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -147.6 168.41 22.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 0.0 110.667 -179.636 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -76.3 -35.55 58.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.35 -0.844 . . . . 0.0 109.971 179.798 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 p -124.88 131.82 53.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 0.0 109.871 179.716 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.583 ' OH ' ' CD2' ' A' ' 75' ' ' PHE . 89.8 m-85 -112.5 170.79 7.93 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.156 -0.965 . . . . 0.0 110.646 -179.512 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.594 ' O ' ' O ' ' A' ' 81' ' ' TYR . 92.6 p -165.39 91.2 0.51 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.191 -0.943 . . . . 0.0 109.964 179.9 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.652 ' CB ' HG21 ' A' ' 59' ' ' VAL . 6.0 t80 52.42 138.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.815 0.817 . . . . 0.0 110.44 -179.47 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.774 ' O ' HG22 ' A' ' 102' ' ' THR . 15.3 t-20 65.33 -127.92 0.32 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.487 -1.383 . . . . 0.0 110.094 -179.215 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 103' ' ' CYS . 6.2 m-20 51.82 73.92 0.29 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.622 -1.299 . . . . 0.0 109.044 -178.54 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 101' ' ' SER . 6.0 t30 -72.28 146.42 47.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.519 -0.738 . . . . 0.0 111.351 -178.703 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.744 HG22 ' CZ3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -132.16 124.27 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 109.553 179.021 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 7.8 t0 -83.82 124.23 30.72 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.995 -1.065 . . . . 0.0 109.48 179.643 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.679 ' HD2' HG21 ' A' ' 66' ' ' ILE . 8.4 m-85 -87.11 120.65 28.61 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.182 -0.949 . . . . 0.0 111.56 -178.651 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.566 ' N ' ' O ' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -95.75 94.93 7.97 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.169 179.932 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' O ' ' C ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -44.37 125.36 4.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.07 -1.019 . . . . 0.0 109.488 179.78 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.554 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 4.9 mmtp -35.85 -67.33 0.16 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.672 -0.643 . . . . 0.0 111.001 -178.938 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.585 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 36.3 t80 -173.6 144.25 1.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.152 -0.967 . . . . 0.0 110.812 -179.88 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.595 ' O ' ' CD1' ' A' ' 93' ' ' TYR . . . 45.37 47.37 11.49 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 10.4 m-85 -149.83 153.87 37.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.455 -1.027 . . . . 0.0 109.899 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' CG ' HG23 ' A' ' 117' ' ' VAL . 4.4 ptpt -113.99 130.11 56.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.648 179.623 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.568 ' CD2' ' HB3' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -66.66 93.21 0.24 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.603 -179.455 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.659 ' HB2' HG21 ' A' ' 117' ' ' VAL . 2.4 t -74.61 103.85 5.07 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.406 -0.809 . . . . 0.0 109.61 179.508 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 140.54 -77.76 0.3 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.826 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.562 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.3 OUTLIER -172.47 116.1 0.32 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.227 -1.16 . . . . 0.0 110.454 -179.543 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.576 ' O ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -67.78 -77.22 0.08 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.87 . . . . 0.0 110.637 -179.944 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.443 ' O ' ' OG ' ' A' ' 100' ' ' SER . 5.0 p -68.82 104.99 2.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 110.792 -179.219 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.52 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 68.4 m -107.41 -170.75 1.75 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.444 -0.785 . . . . 0.0 109.906 179.538 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.774 HG22 ' O ' ' A' ' 82' ' ' ASN . 7.8 m -161.49 138.12 8.39 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.289 -178.966 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.653 ' N ' ' CZ3' ' A' ' 109' ' ' TRP . 4.5 t -59.49 105.64 0.38 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.599 -0.688 . . . . 0.0 109.551 179.78 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.458 ' OG ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.96 168.16 16.3 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.122 -0.986 . . . . 0.0 110.814 -179.464 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.783 ' HB3' HD12 ' A' ' 38' ' ' ILE . 43.1 Cg_endo -76.32 126.91 9.44 Favored 'Trans proline' 0 C--N 1.301 -1.935 0 O-C-N 124.418 1.747 . . . . 0.0 110.632 -179.519 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 122.41 3.84 9.32 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.287 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.848 ' O ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER 77.3 83.59 0.08 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.756 -0.849 . . . . 0.0 110.635 179.703 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER 178.04 -168.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.147 -0.971 . . . . 0.0 111.81 179.628 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.744 ' CZ3' HG22 ' A' ' 85' ' ' VAL . 33.8 m95 -134.08 95.07 3.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.545 -0.722 . . . . 0.0 110.289 -179.601 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.543 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 0.9 OUTLIER -98.95 143.79 27.01 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.386 -0.821 . . . . 0.0 110.486 -179.614 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.562 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 44.6 Cg_endo -72.67 172.63 58.18 Favored 'Cis proline' 0 C--N 1.315 -1.232 0 C-N-CA 121.837 -2.151 . . . . 0.0 110.616 -0.634 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 113' ' ' LEU . 39.4 tt0 -39.1 128.2 1.68 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 0.0 111.263 -179.306 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.567 ' CD1' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -41.41 152.16 0.28 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 0.0 109.976 179.211 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CG ' ' CD2' ' A' ' 87' ' ' PHE . 39.7 Cg_endo -82.87 167.5 14.46 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 O-C-N 124.301 1.685 . . . . 0.0 111.119 -179.362 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.557 ' HG2' HG13 ' A' ' 117' ' ' VAL . 3.0 ttpt -126.71 108.04 10.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.871 . . . . 0.0 109.819 179.66 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 93' ' ' TYR . 4.3 t -64.24 74.91 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.659 HG21 ' HB2' ' A' ' 96' ' ' SER . 3.7 m -90.52 -175.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 121.771 0.796 . . . . 0.0 110.528 -179.903 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.606 ' HB3' ' CE1' ' A' ' 93' ' ' TYR . 1.6 ppt_? . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 118.981 -1.088 . . . . 0.0 110.481 179.412 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 53.6 t . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.18 178.57 3.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.356 -0.84 . . . . 0.0 110.54 -179.871 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.561 ' O ' ' N ' ' A' ' 21' ' ' TYR . 0.8 OUTLIER -135.39 127.82 30.45 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.508 -0.745 . . . . 0.0 110.058 179.985 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 5' ' ' SER . 35.8 mt-30 -101.12 166.89 10.56 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.154 179.254 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -43.37 142.93 1.56 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.042 -1.036 . . . . 0.0 110.461 -179.479 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.634 ' HG2' ' ND1' ' A' ' 14' ' ' HIS . 54.5 Cg_endo -73.5 160.23 44.79 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 124.191 1.627 . . . . 0.0 110.532 -179.668 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.5 171.59 17.83 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.991 1.522 . . . . 0.0 110.045 179.386 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.3 OUTLIER -84.33 98.89 10.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.0 109.865 179.706 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.611 ' CG2' ' CE2' ' A' ' 29' ' ' TYR . 0.3 OUTLIER -51.4 -170.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 122.389 1.09 . . . . 0.0 111.944 -179.17 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 56' ' ' CYS . 5.3 p -58.49 122.79 14.21 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.68 -178.887 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.451 ' C ' ' O ' ' A' ' 10' ' ' SER . 2.0 m-20 33.6 34.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.771 -0.581 . . . . 0.0 111.729 178.996 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -141.53 162.58 26.93 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.529 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -111.8 -171.46 1.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -1.197 . . . . 0.0 110.934 -179.65 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.634 ' ND1' ' HG2' ' A' ' 6' ' ' PRO . 16.1 p80 -154.19 123.99 6.72 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.886 -0.509 . . . . 0.0 109.78 -179.759 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.9 -158.46 0.86 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 0.0 110.654 -179.621 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' CA ' ' OE2' ' A' ' 18' ' ' GLU . . . 138.35 -7.02 3.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.796 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CB ' ' O ' ' A' ' 16' ' ' GLY . 0.1 OUTLIER 66.93 58.73 0.58 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.241 -1.152 . . . . 0.0 110.186 -179.942 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.58 ' HG2' ' CZ ' ' A' ' 21' ' ' TYR . 0.0 OUTLIER -137.22 -69.42 0.46 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.28 -0.887 . . . . 0.0 109.821 -179.84 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 2.7 m-20 68.32 18.01 9.18 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.614 -0.679 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.476 ' O ' ' O ' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -170.53 50.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.049 -1.032 . . . . 0.0 110.595 179.761 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.809 ' O ' HG23 ' A' ' 22' ' ' THR . 9.7 m-85 -55.59 -160.55 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.139 179.389 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 21' ' ' TYR . 1.9 p -161.95 -69.22 0.06 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.823 -1.173 . . . . 0.0 111.2 -179.959 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 47' ' ' GLY . 2.5 t70 -164.16 138.31 5.55 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.048 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 74.81 12.21 83.08 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -178.737 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.521 ' OG ' ' CD1' ' A' ' 21' ' ' TYR . 0.1 OUTLIER -86.19 169.27 13.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.542 -0.975 . . . . 0.0 109.951 179.947 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 43' ' ' VAL . 92.6 t -143.59 151.19 16.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.615 178.596 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.652 ' CG2' ' CE2' ' A' ' 21' ' ' TYR . 30.0 t -136.59 120.37 23.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 119.167 -1.013 . . . . 0.0 111.311 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 41' ' ' SER . 0.1 OUTLIER -75.41 101.41 4.78 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 118.025 -1.47 . . . . 0.0 107.579 177.989 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 1.5 m-30 -67.55 127.28 32.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.622 -178.418 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -74.75 169.3 18.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.0 -1.063 . . . . 0.0 109.683 179.615 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 32' ' ' ASN . 0.0 OUTLIER -140.13 134.15 30.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 110.301 -179.585 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 33' ' ' SER . 1.7 m120 -43.46 116.23 0.91 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -0.935 . . . . 0.0 109.571 179.581 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.457 ' C ' ' O ' ' A' ' 32' ' ' ASN . 10.6 m -38.65 113.13 0.27 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.476 -0.765 . . . . 0.0 110.639 -179.443 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.34 -26.11 6.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.939 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.601 ' CE2' HG13 ' A' ' 58' ' ' ILE . 2.8 m-85 -91.8 144.86 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.258 -1.142 . . . . 0.0 110.263 -179.943 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.929 ' HB2' HG22 ' A' ' 59' ' ' VAL . 48.2 t -81.88 119.8 24.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 111.114 -179.645 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' THR . 2.7 tp -79.48 106.63 11.65 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 178.071 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.878 HD12 ' HB3' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -98.79 152.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.171 -0.955 . . . . 0.0 109.14 -179.63 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 54' ' ' PRO . . . 104.89 -177.91 23.58 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 119.352 -1.404 . . . . 0.0 109.806 -179.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 42' ' ' GLY . 23.7 p-10 -67.98 131.73 46.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.408 -1.054 . . . . 0.0 109.697 179.571 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.768 ' O ' HG23 ' A' ' 28' ' ' THR . 24.5 p -73.17 56.09 0.45 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.154 -0.966 . . . . 0.0 109.79 179.91 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 26' ' ' VAL . . . 165.52 96.13 0.11 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.646 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.725 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -48.55 177.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.234 -1.156 . . . . 0.0 108.054 179.38 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.464 ' HA ' ' O ' ' A' ' 25' ' ' SER . 1.3 tp -143.51 99.16 3.37 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.962 -1.086 . . . . 0.0 110.249 178.777 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 50' ' ' TRP . 13.0 t -80.5 121.18 25.45 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.39 178.744 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.23 126.88 41.81 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 110.292 179.694 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.478 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . 62.33 25.94 67.33 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.905 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 81.28 32.4 31.58 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.889 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -140.69 119.27 12.35 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 110.225 179.959 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.604 ' CD2' ' HB2' ' A' ' 45' ' ' CYS . 84.6 m95 -77.36 136.29 38.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.184 -0.948 . . . . 0.0 109.629 179.696 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.7 p -141.45 160.01 41.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.05 -1.031 . . . . 0.0 111.412 -179.33 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 3.7 t0 53.84 65.84 5.07 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.923 -0.486 . . . . 0.0 111.521 179.332 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 52' ' ' ASP . 51.1 Cg_endo -91.26 129.95 1.31 Allowed 'Trans proline' 0 C--N 1.298 -2.083 0 O-C-N 124.378 1.725 . . . . 0.0 109.265 178.516 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 38' ' ' ILE . 44.8 Cg_endo -72.16 166.02 30.92 Favored 'Trans proline' 0 C--N 1.302 -1.909 0 O-C-N 123.574 1.302 . . . . 0.0 110.412 -179.64 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.606 ' OG1' ' HB ' ' A' ' 38' ' ' ILE . 24.8 p -104.33 -174.59 2.58 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.189 0.995 . . . . 0.0 111.612 -178.625 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.488 ' CB ' ' O ' ' A' ' 10' ' ' SER . 1.6 t -146.16 74.6 1.38 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.532 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.488 ' O ' ' N ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -112.22 -170.5 1.67 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.331 -178.459 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.677 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.1 OUTLIER -111.5 86.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.326 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.933 HG21 ' CB ' ' A' ' 81' ' ' TYR . 20.1 m -76.03 51.11 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.197 -0.939 . . . . 0.0 111.368 -179.115 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 107' ' ' ASN . 0.3 OUTLIER -55.22 175.78 0.06 Allowed 'General case' 0 C--N 1.279 -2.486 0 C-N-CA 117.671 -1.612 . . . . 0.0 107.831 179.305 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 79' ' ' TYR . 66.9 m -134.24 142.58 43.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 C-N-CA 118.497 -1.281 . . . . 0.0 112.16 -178.305 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 41.8 Cg_endo -74.61 -83.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 124.491 1.785 . . . . 0.0 110.486 179.439 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.573 ' CD2' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER 177.58 126.19 0.19 Allowed Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.539 -0.726 . . . . 0.0 109.251 -179.559 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.779 ' HG2' HD21 ' A' ' 71' ' ' LEU . 50.5 Cg_endo -77.13 57.54 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.163 0 O-C-N 123.788 1.415 . . . . 0.0 109.237 179.835 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.66 ' O ' HD23 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -72.76 166.11 23.51 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.47 0.652 . . . . 0.0 110.593 -179.673 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 1.006 HD13 ' O ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -166.33 167.21 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.155 -0.966 . . . . 0.0 110.171 179.504 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' HB2' ' A' ' 116' ' ' CYS . 1.7 t -76.34 113.13 13.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.521 -0.737 . . . . 0.0 110.78 -179.403 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.541 ' CA ' ' HG3' ' A' ' 90' ' ' LYS . 72.9 m-20 36.21 32.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.675 -0.641 . . . . 0.0 111.401 179.212 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.006 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -145.32 38.09 1.26 Allowed Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.008 -179.856 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.638 ' HA ' ' CG2' ' A' ' 66' ' ' ILE . 50.1 p90 -44.85 -152.92 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 123.438 1.589 . . . . 0.0 113.401 -179.682 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.819 ' O ' HD12 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -139.42 122.83 17.18 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.491 -176.807 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.1 t -104.48 15.71 27.58 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.466 -0.771 . . . . 0.0 110.237 -178.951 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.95 95.56 2.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.331 -0.855 . . . . 0.0 110.44 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.56 ' O ' HG12 ' A' ' 85' ' ' VAL . . . 94.02 106.55 1.91 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.711 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 76' ' ' LYS . 9.2 t80 -173.89 170.49 3.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -1.173 . . . . 0.0 110.255 179.719 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.623 ' N ' ' CD1' ' A' ' 75' ' ' PHE . 4.0 tttm -179.93 142.72 0.16 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.463 -0.773 . . . . 0.0 109.727 -179.684 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 76' ' ' LYS . 12.7 mtp180 -41.42 -27.88 0.1 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 179.973 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.469 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER -148.08 141.49 25.3 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 110.175 179.877 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.636 ' CD1' ' N ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -124.99 -164.75 1.31 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.339 -0.851 . . . . 0.0 109.607 179.762 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.571 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 80.7 p -170.67 107.89 0.31 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.13 -0.981 . . . . 0.0 110.399 -179.914 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.933 ' CB ' HG21 ' A' ' 59' ' ' VAL . 2.3 t80 53.24 156.38 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.112 -0.992 . . . . 0.0 110.672 179.167 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.821 ' C ' HG22 ' A' ' 102' ' ' THR . 27.4 t-20 38.18 -110.63 0.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.377 -0.827 . . . . 0.0 110.713 -179.224 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 81' ' ' TYR . 74.9 m-20 50.79 69.0 0.69 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.765 -1.21 . . . . 0.0 109.143 -179.419 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.84 ' CA ' HG23 ' A' ' 102' ' ' THR . 11.3 p-10 -69.43 129.98 41.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.676 -0.64 . . . . 0.0 110.753 -178.92 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 74' ' ' GLY . 15.8 m -121.53 128.85 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.998 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 20.4 t0 -85.37 136.78 33.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.161 -0.962 . . . . 0.0 108.575 178.977 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.696 ' CE2' HD23 ' A' ' 71' ' ' LEU . 51.2 m-85 -96.69 143.5 27.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.969 -1.082 . . . . 0.0 111.907 -178.43 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' ' 70' ' ' TYR . 5.7 tttm -115.38 110.03 18.75 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.448 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.522 ' SG ' ' CB ' ' A' ' 93' ' ' TYR . 4.6 t -66.55 132.79 48.99 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.835 -1.165 . . . . 0.0 109.943 -179.251 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.541 ' HG3' ' CA ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -38.76 -91.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.552 -0.718 . . . . 0.0 111.173 -179.132 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 93' ' ' TYR . 2.3 t80 -148.44 138.56 22.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.16 -0.963 . . . . 0.0 110.786 -179.293 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.587 ' O ' ' CG ' ' A' ' 93' ' ' TYR . . . 51.08 60.1 7.48 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.672 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 92' ' ' GLY . 12.2 m-85 -162.96 136.45 5.89 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.398 -1.06 . . . . 0.0 109.943 -179.691 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.675 ' O ' HG23 ' A' ' 117' ' ' VAL . 34.5 pttt -101.23 112.23 24.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 0.0 109.658 179.423 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.673 HD23 HD11 ' A' ' 66' ' ' ILE . 1.3 mt -45.58 125.9 6.28 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.949 -1.094 . . . . 0.0 110.736 -179.413 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -102.24 103.55 14.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.446 -0.784 . . . . 0.0 109.501 179.215 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 141.59 -57.42 0.58 Allowed Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.653 -1.261 . . . . 0.0 110.029 -179.923 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.633 ' CB ' ' HG2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER 172.65 119.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.249 -1.148 . . . . 0.0 111.098 -179.417 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.8 m -78.11 -3.87 44.55 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.201 -0.937 . . . . 0.0 110.703 179.795 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 58.7 p -142.09 112.46 7.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.958 . . . . 0.0 109.806 179.86 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 3.3 m -121.75 -179.7 4.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 110.993 -179.272 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.84 HG23 ' CA ' ' A' ' 84' ' ' ASN . 0.2 OUTLIER -153.29 132.34 12.58 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.857 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 103' ' ' CYS . . . . . 0.53 ' N ' ' O ' ' A' ' 82' ' ' ASN . 36.6 t -78.72 82.91 4.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.996 -1.065 . . . . 0.0 110.09 -179.868 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.554 ' CB ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -55.74 -179.91 0.08 OUTLIER Pre-proline 0 C--N 1.295 -1.775 0 O-C-N 121.594 -0.691 . . . . 0.0 111.503 -179.596 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.878 ' HB3' HD12 ' A' ' 38' ' ' ILE . 42.9 Cg_endo -73.43 117.6 5.14 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.559 1.821 . . . . 0.0 110.572 -179.271 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 107' ' ' ASN . . . 138.0 -10.25 3.62 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.398 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 106' ' ' GLY . 6.2 m120 83.37 90.42 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 O-C-N 122.163 -0.61 . . . . 0.0 110.728 179.461 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -177.35 -161.09 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.297 -0.877 . . . . 0.0 111.527 179.635 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.621 ' HB3' HD13 ' A' ' 113' ' ' LEU . 17.7 m95 -149.95 80.18 1.37 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.487 0.66 . . . . 0.0 109.729 -179.831 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.56 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 8.9 mttm -95.18 143.26 25.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.474 -0.766 . . . . 0.0 109.824 -179.739 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.633 ' HG2' ' CB ' ' A' ' 98' ' ' SER . 48.8 Cg_endo -71.04 174.27 45.66 Favored 'Cis proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.199 -2.0 . . . . 0.0 110.987 -0.144 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -44.23 128.24 5.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.43 -0.794 . . . . 0.0 110.837 -179.657 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -39.86 144.15 0.54 Allowed Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.588 -0.695 . . . . 0.0 110.272 179.323 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.84 ' HG2' HD12 ' A' ' 66' ' ' ILE . 38.3 Cg_endo -71.74 164.26 36.25 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 111.356 179.969 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.556 ' O ' HG22 ' A' ' 117' ' ' VAL . 9.7 tttt -132.59 119.76 20.91 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.502 -0.749 . . . . 0.0 109.973 179.425 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.498 ' HB2' ' O ' ' A' ' 67' ' ' SER . 1.3 m -62.12 113.23 2.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.047 -1.033 . . . . 0.0 110.194 -179.863 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.52 173.48 12.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.197 -0.939 . . . . 0.0 109.761 179.113 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 C-N-CA 118.753 -1.179 . . . . 0.0 110.477 -179.578 . . . . . . . . 1 1 . 1 stop_ save_